,0,1,2
0,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
1,imatinib,systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
2,imatinib,systemic mastocytosis,platelet derived growth factor receptor alpha
3,paracetamol,pain,prostaglandin-endoperoxide synthase 1
4,paracetamol,pain,prostaglandin-endoperoxide synthase 2
5,paracetamol,pain,prostaglandin e synthase 3
6,aspirin,pain,prostaglandin-endoperoxide synthase 1
7,aspirin,pain,prostaglandin-endoperoxide synthase 2
8,aspirin,thrombotic disease,prostaglandin-endoperoxide synthase 1
9,naproxen,pain,prostaglandin-endoperoxide synthase 2
10,cortisone,keratitis,nuclear receptor subfamily 3 group c member 1
11,dexamethasone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
12,pinacidil,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
13,antazoline,vasomotor rhinitis,histamine receptor h1
14,levofloxacin,pyelonephritis,dna topoisomerase ii alpha
15,meloxicam,pain,prostaglandin-endoperoxide synthase 2
16,fluticasone,bronchitis,nuclear receptor subfamily 3 group c member 1
17,fluphenazine,schizophrenia,dopamine receptor d2
18,fluphenazine,schizophrenia,dopamine receptor d1
19,terfenadine,allergic contact dermatitis,histamine receptor h1
20,norethisterone,menorrhagia,progesterone receptor
21,ziprasidone,schizophrenia,dopamine receptor d2
22,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 2a
23,carbinoxamine,atopic conjunctivitis,histamine receptor h1
24,fsh,primary ovarian failure,follicle stimulating hormone receptor
25,warfarin,pulmonary embolism,vitamin k epoxide reductase complex subunit 1
26,loratadine,allergic rhinitis,histamine receptor h1
27,oxymetazoline,nasal congestion,adrenoceptor alpha 1a
28,duloxetine,major depressive disorder,solute carrier family 6 member 4
29,doxylamine,allergic rhinitis,histamine receptor h1
30,minoxidil,alopecia,potassium inwardly rectifying channel subfamily j member 1
31,minoxidil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 1
32,sildenafil,erectile dysfunction,phosphodiesterase 5a
33,betamethasone,crohn disease,nuclear receptor subfamily 3 group c member 1
34,triamcinolone,crohn disease,nuclear receptor subfamily 3 group c member 1
35,gabapentin,restless legs syndrome,calcium voltage-gated channel auxiliary subunit alpha2delta 1
36,prednisolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
37,pimozide,tourette syndrome,dopamine receptor d2
38,levonorgestrel,menorrhagia,progesterone receptor
39,dimethyl fumarate,multiple sclerosis,kelch like ech associated protein 1
40,protriptyline,major depressive disorder,solute carrier family 6 member 2
41,terguride,pulmonary hypertension,5-hydroxytryptamine receptor 2b
42,lafutidine,gastroesophageal reflux disease,histamine receptor h2
43,ospemifene,psychologic dyspareunia,estrogen receptor 1
44,glipizide,hyperglycemia,atp binding cassette subfamily c member 8
45,landiolol,tachycardia,adrenoceptor beta 1
46,levocabastine,atopic conjunctivitis,histamine receptor h1
47,acenocoumarol,pulmonary embolism,vitamin k epoxide reductase complex subunit 1
48,dexamethasone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
49,mosapramine,schizophrenia,dopamine receptor d2
50,thyrotropin alfa,thyroid tumor,thyroid stimulating hormone receptor
51,metolazone,hypertensive disorder,solute carrier family 12 member 3
52,gepirone,major depressive disorder,5-hydroxytryptamine receptor 1a
53,tramadol,pain,opioid receptor mu 1
54,trimethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
55,apalutamide,prostate cancer,androgen receptor
56,aminoglutethimide,breast neoplasm,cytochrome p450 family 19 subfamily a member 1
57,anastrozole,breast neoplasm,cytochrome p450 family 19 subfamily a member 1
58,etizolam,anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha1
59,sulfasalazine,ulcerative colitis,arachidonate 5-lipoxygenase
60,vinpocetine,dementia,phosphodiesterase 1a
61,glutethimide,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
62,afamelanotide,erythropoietic protoporphyria,melanocortin 1 receptor
63,voclosporin,uveitis,"protein phosphatase 3 regulatory subunit b, alpha"
64,cobicistat,hiv infectious disease,cytochrome p450 family 3 subfamily a member 43
65,medrysone,uveitis,nuclear receptor subfamily 3 group c member 1
66,medrysone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
67,medrysone,iritis,nuclear receptor subfamily 3 group c member 1
68,medrysone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
69,diflunisal,osteoarthritis,prostaglandin-endoperoxide synthase 1
70,diflunisal,osteoarthritis,prostaglandin-endoperoxide synthase 2
71,diflunisal,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
72,diflunisal,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
73,diflunisal,pain,prostaglandin-endoperoxide synthase 1
74,diflunisal,pain,prostaglandin-endoperoxide synthase 2
75,diflunisal,chronic pain,prostaglandin-endoperoxide synthase 1
76,diflunisal,chronic pain,prostaglandin-endoperoxide synthase 2
77,polythiazide,hypertensive disorder,solute carrier family 12 member 3
78,mepyramine,atopic conjunctivitis,histamine receptor h1
79,mepyramine,seasonal allergic rhinitis,histamine receptor h1
80,mepyramine,sneeze,histamine receptor h1
81,mepyramine,allergic rhinitis,histamine receptor h1
82,mepyramine,dysmenorrhea,histamine receptor h1
83,mepyramine,vasomotor rhinitis,histamine receptor h1
84,mepyramine,urticaria,histamine receptor h1
85,mepyramine,pruritus,histamine receptor h1
86,azilsartan medoxomil,hypertensive disorder,angiotensin ii receptor type 1
87,hydroxocobalamin,vitamin b12 deficiency,5-methyltetrahydrofolate-homocysteine methyltransferase
88,hydroxocobalamin,vitamin b12 deficiency,methylmalonyl-coa mutase
89,hydroxocobalamin,vitamin deficiency disorder,5-methyltetrahydrofolate-homocysteine methyltransferase
90,hydroxocobalamin,vitamin deficiency disorder,methylmalonyl-coa mutase
91,hydroxocobalamin,pernicious anemia,5-methyltetrahydrofolate-homocysteine methyltransferase
92,formoterol,pulmonary emphysema,adrenoceptor beta 2
93,bromocriptine,acromegaly,dopamine receptor d2
94,bromocriptine,acromegaly,dopamine receptor d3
95,bromocriptine,postencephalitic parkinson disease,dopamine receptor d2
96,bromocriptine,postencephalitic parkinson disease,dopamine receptor d3
97,bromocriptine,parkinson disease,dopamine receptor d2
98,bromocriptine,parkinson disease,dopamine receptor d3
99,bromocriptine,hyperprolactinemia,dopamine receptor d2
100,bromocriptine,hyperprolactinemia,dopamine receptor d3
101,pramipexole,parkinson disease,dopamine receptor d2
102,pramipexole,parkinson disease,dopamine receptor d3
103,pramipexole,parkinson disease,dopamine receptor d4
104,pramipexole,restless legs syndrome,dopamine receptor d2
105,pramipexole,restless legs syndrome,dopamine receptor d3
106,pramipexole,restless legs syndrome,dopamine receptor d4
107,spironolactone,hyperaldosteronism,nuclear receptor subfamily 3 group c member 2
108,spironolactone,edema,nuclear receptor subfamily 3 group c member 2
109,spironolactone,ascites,nuclear receptor subfamily 3 group c member 2
110,spironolactone,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
111,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
112,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
113,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
114,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
115,amobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
116,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
117,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
118,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
119,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
120,amobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
121,saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
122,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1d
123,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1b
124,eletriptan,migraine disorder,5-hydroxytryptamine receptor 2a
125,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1a
126,terbutaline,pulmonary emphysema,adrenoceptor beta 2
127,terbutaline,pulmonary emphysema,adrenoceptor beta 3
128,terbutaline,pruritus,adrenoceptor beta 2
129,terbutaline,pruritus,adrenoceptor beta 3
130,terbutaline,asthma,adrenoceptor beta 2
131,terbutaline,asthma,adrenoceptor beta 3
132,terbutaline,bronchitis,adrenoceptor beta 2
133,terbutaline,bronchitis,adrenoceptor beta 3
134,belotecan,non-small cell lung carcinoma,dna topoisomerase i
135,belotecan,ovarian cancer,dna topoisomerase i
136,amphetamine,obesity disorder,solute carrier family 18 member a2
137,amphetamine,obesity disorder,trace amine associated receptor 1
138,amphetamine,obesity disorder,cart prepropeptide
139,amphetamine,narcolepsy,solute carrier family 18 member a2
140,amphetamine,narcolepsy,trace amine associated receptor 1
141,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
142,amphetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
143,cinnarizine,nausea,histamine receptor h1
144,cinnarizine,central nervous system origin vertigo,histamine receptor h1
145,cinnarizine,motion sickness,histamine receptor h1
146,carmofur,colonic neoplasm,n-acylsphingosine amidohydrolase 1
147,topiroxostat,hyperuricemia,xanthine dehydrogenase
148,topiroxostat,gout,xanthine dehydrogenase
149,leuprolide,endometriosis,gonadotropin releasing hormone receptor
150,leuprolide,precocious puberty,gonadotropin releasing hormone receptor
151,glimepiride,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
152,glimepiride,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
153,loxapine,schizophrenia,dopamine receptor d2
154,loxapine,schizophrenia,5-hydroxytryptamine receptor 2a
155,loxapine,bipolar disorder,dopamine receptor d2
156,loxapine,bipolar disorder,5-hydroxytryptamine receptor 2a
157,oxaprozin,osteoarthritis,prostaglandin-endoperoxide synthase 1
158,oxaprozin,osteoarthritis,prostaglandin-endoperoxide synthase 2
159,oxaprozin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
160,oxaprozin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
161,oxaprozin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
162,oxaprozin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
163,pimozide,tourette syndrome,dopamine receptor d3
164,dehydroepiandrosterone,psychologic dyspareunia,estrogen receptor 1
165,dehydroepiandrosterone,psychologic dyspareunia,estrogen receptor 2
166,dehydroepiandrosterone,psychologic dyspareunia,androgen receptor
167,dehydroepiandrosterone,systemic lupus erythematosus,androgen receptor
168,omacetaxine mepesuccinate,"chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein l3
169,anagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
170,clemastine,urticaria,histamine receptor h1
171,clemastine,pruritus,histamine receptor h1
172,clemastine,sneeze,histamine receptor h1
173,clemastine,vasomotor rhinitis,histamine receptor h1
174,clemastine,allergic rhinitis,histamine receptor h1
175,clemastine,atopic conjunctivitis,histamine receptor h1
176,sapropterin,phenylketonuria,phenylalanine hydroxylase
177,insulin detemir,diabetes mellitus,insulin receptor
178,benzbromarone,hyperuricemia,solute carrier family 22 member 12
179,benzbromarone,gout,solute carrier family 22 member 12
180,phendimetrazine,obesity disorder,adrenoceptor alpha 1a
181,phendimetrazine,obesity disorder,adrenoceptor alpha 1b
182,phendimetrazine,obesity disorder,solute carrier family 6 member 2
183,valproic acid,absence epilepsy,aldehyde dehydrogenase 5 family member a1
184,valproic acid,absence epilepsy,histone deacetylase 9
185,valproic acid,bipolar disorder,myristoylated alanine rich protein kinase c substrate
186,valproic acid,epilepsy,histone deacetylase 9
187,valproic acid,migraine disorder,solute carrier family 27 member 2
188,levomethadyl acetate,opiate dependence,opioid receptor mu 1
189,bunolol,open-angle glaucoma,adrenoceptor beta 1
190,bunolol,open-angle glaucoma,adrenoceptor beta 2
191,bunolol,ocular hypertension,adrenoceptor beta 1
192,bunolol,ocular hypertension,adrenoceptor beta 2
193,clopidogrel,acute coronary syndrome,purinergic receptor p2y12
194,clopidogrel,intracranial embolism,purinergic receptor p2y12
195,carbetocin,post-partum hemorrhage,oxytocin receptor
196,brompheniramine,seasonal allergic rhinitis,histamine receptor h1
197,brompheniramine,urticaria,histamine receptor h1
198,brompheniramine,pruritus,histamine receptor h1
199,brompheniramine,atopic conjunctivitis,histamine receptor h1
200,brompheniramine,vasomotor rhinitis,histamine receptor h1
201,brompheniramine,allergic rhinitis,histamine receptor h1
202,belotecan,ovarian cancer,thymidylate synthetase
203,belotecan,ovarian cancer,cytidine/uridine monophosphate kinase 1
204,belotecan,ovarian cancer,ribonucleotide reductase catalytic subunit m1
205,belotecan,non-small cell lung carcinoma,thymidylate synthetase
206,belotecan,non-small cell lung carcinoma,cytidine/uridine monophosphate kinase 1
207,belotecan,non-small cell lung carcinoma,ribonucleotide reductase catalytic subunit m1
208,fentanyl,pain,opioid receptor mu 1
209,fentanyl,pain,opioid receptor delta 1
210,bitolterol,bronchitis,adrenoceptor beta 2
211,bitolterol,bronchiectasis,adrenoceptor beta 2
212,bitolterol,asthma,adrenoceptor beta 2
213,bitolterol,pulmonary emphysema,adrenoceptor beta 2
214,diazoxide,pancreatic insulinoma,potassium inwardly rectifying channel subfamily j member 11
215,diazoxide,hyperinsulinism,potassium inwardly rectifying channel subfamily j member 11
216,diazoxide,islet cell adenomatosis,potassium inwardly rectifying channel subfamily j member 11
217,floctafenine,acute pain,prostaglandin-endoperoxide synthase 1
218,floctafenine,acute pain,prostaglandin-endoperoxide synthase 2
219,umeclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 2
220,umeclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
221,acrivastine,vasomotor rhinitis,histamine receptor h1
222,acrivastine,atopic conjunctivitis,histamine receptor h1
223,acrivastine,seasonal allergic rhinitis,histamine receptor h1
224,acrivastine,sneeze,histamine receptor h1
225,acrivastine,common cold,histamine receptor h1
226,acrivastine,allergic rhinitis,histamine receptor h1
227,oxytocin,post-partum hemorrhage,oxytocin receptor
228,ribavirin,chronic hepatitis c virus infection,inosine monophosphate dehydrogenase 1
229,ribavirin,respiratory syncytial virus infectious disease,inosine monophosphate dehydrogenase 1
230,butenafine,tinea pedis,squalene epoxidase
231,butenafine,pityriasis versicolor,squalene epoxidase
232,regorafenib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
233,regorafenib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
234,regorafenib,hepatocellular carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
235,regorafenib,hepatocellular carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
236,regorafenib,hepatocellular carcinoma,platelet derived growth factor receptor alpha
237,regorafenib,hepatocellular carcinoma,fibroblast growth factor receptor 1
238,regorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 1
239,regorafenib,hepatocellular carcinoma,kinase insert domain receptor
240,selexipag,pulmonary arterial hypertension,prostaglandin i2 receptor
241,mizolastine,allergic rhinitis,histamine receptor h1
242,carbenoxolone,peptic ulcer disease,hydroxysteroid 11-beta dehydrogenase 1
243,carbenoxolone,peptic ulcer disease,15-hydroxyprostaglandin dehydrogenase
244,mizolastine,perennial allergic rhinitis,histamine receptor h1
245,abiraterone acetate,prostate cancer,cytochrome p450 family 17 subfamily a member 1
246,abiraterone acetate,prostate cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
247,abiraterone acetate,prostate cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
248,abiraterone acetate,prostate cancer,cytochrome p450 family 11 subfamily b member 1
249,abiraterone acetate,prostate cancer,cytochrome p450 family 21 subfamily a member 2
250,abiraterone acetate,prostate cancer,cytochrome p450 family 1 subfamily a member 2
251,abiraterone acetate,prostate cancer,cytochrome p450 family 2 subfamily c member 9
252,abiraterone acetate,prostate cancer,cytochrome p450 family 3 subfamily a member 4
253,abiraterone acetate,prostate cancer,androgen receptor
254,venlafaxine,panic disorder,solute carrier family 6 member 4
255,venlafaxine,panic disorder,solute carrier family 6 member 2
256,venlafaxine,social phobia,solute carrier family 6 member 4
257,venlafaxine,social phobia,solute carrier family 6 member 2
258,venlafaxine,social phobia,solute carrier family 6 member 3
259,venlafaxine,major depressive disorder,solute carrier family 6 member 4
260,venlafaxine,major depressive disorder,solute carrier family 6 member 2
261,venlafaxine,major depressive disorder,solute carrier family 6 member 3
262,amoxapine,depressive disorder,solute carrier family 6 member 4
263,venlafaxine,depressive disorder,solute carrier family 6 member 2
264,amoxapine,depressive disorder,dopamine receptor d1
265,tulobuterol,asthma,adrenoceptor beta 2
266,tulobuterol,pulmonary emphysema,adrenoceptor beta 2
267,rupatadine,allergic rhinitis,histamine receptor h1
268,rupatadine,allergic rhinitis,platelet activating factor receptor
269,rupatadine,urticaria,histamine receptor h1
270,rupatadine,urticaria,platelet activating factor receptor
271,clobetasone,atopic eczema,nuclear receptor subfamily 3 group c member 1
272,clobetasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
273,defibrotide,hepatic veno-occlusive disease,"plasminogen activator, tissue type"
274,defibrotide,hepatic veno-occlusive disease,serpin family e member 1
275,celiprolol,hypertensive disorder,adrenoceptor beta 1
276,celiprolol,hypertensive disorder,adrenoceptor beta 2
277,celiprolol,angina pectoris,adrenoceptor beta 1
278,celiprolol,angina pectoris,adrenoceptor beta 2
279,vigabatrin,west syndrome,4-aminobutyrate aminotransferase
280,linagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
281,oxyphencyclimine,peptic ulcer disease,cholinergic receptor muscarinic 3
282,propylthiouracil,hyperthyroidism,thyroid peroxidase
283,propylthiouracil,thyroid crisis,thyroid peroxidase
284,butorphanol,pain,opioid receptor kappa 1
285,butorphanol,pain,opioid receptor delta 1
286,butorphanol,pain,opioid receptor mu 1
287,butorphanol,labor pain,opioid receptor kappa 1
288,butorphanol,labor pain,opioid receptor delta 1
289,butorphanol,labor pain,opioid receptor mu 1
290,dextropropoxyphene,pain,opioid receptor mu 1
291,dextropropoxyphene,pain,opioid receptor delta 1
292,cilazapril,hypertensive disorder,angiotensin i converting enzyme
293,icatibant,hereditary angioedema,bradykinin receptor b2
294,limaprost,thromboangiitis obliterans,prostaglandin e receptor 2
295,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha1
296,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha2
297,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha3
298,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha4
299,butalbital,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha5
300,riluzole,amyotrophic lateral sclerosis,sodium voltage-gated channel alpha subunit 5
301,hydrochlorothiazide,edema,solute carrier family 12 member 3
302,hydrochlorothiazide,hypertensive disorder,solute carrier family 12 member 3
303,irbesartan,hypertensive disorder,angiotensin ii receptor type 1
304,irbesartan,diabetic kidney disease,angiotensin ii receptor type 1
305,estrone sulphate,postmenopausal atrophic vaginitis,estrogen receptor 1
306,entacapone,parkinson disease,catechol-o-methyltransferase
307,"1,25-dihydroxyvitamin d3",hypophosphatemia,vitamin d receptor
308,"1,25-dihydroxyvitamin d3",hypocalcemia,vitamin d receptor
309,"1,25-dihydroxyvitamin d3",hypoparathyroidism,vitamin d receptor
310,"1,25-dihydroxyvitamin d3",renal osteodystrophy,vitamin d receptor
311,carbachol,open-angle glaucoma,cholinergic receptor nicotinic alpha 2 subunit
312,tazarotene,acne,retinoic acid receptor alpha
313,tazarotene,acne,retinoid x receptor beta
314,tazarotene,acne,retinoic acid receptor gamma
315,tazarotene,acne,retinoic acid receptor beta
316,tazarotene,psoriasis,retinoic acid receptor alpha
317,tazarotene,psoriasis,retinoid x receptor beta
318,tazarotene,psoriasis,retinoic acid receptor gamma
319,tazarotene,psoriasis,retinoic acid receptor beta
320,avanafil,erectile dysfunction,phosphodiesterase 5a
321,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4a
322,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4b
323,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4c
324,dyphylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4d
325,dyphylline,chronic bronchitis,phosphodiesterase 4a
326,dyphylline,chronic bronchitis,phosphodiesterase 4b
327,dyphylline,chronic bronchitis,phosphodiesterase 4c
328,dyphylline,chronic bronchitis,phosphodiesterase 4d
329,dyphylline,bronchial disorder,phosphodiesterase 4a
330,dyphylline,bronchial disorder,phosphodiesterase 4b
331,dyphylline,bronchial disorder,phosphodiesterase 4c
332,dyphylline,bronchial disorder,phosphodiesterase 4d
333,dyphylline,pulmonary emphysema,phosphodiesterase 4a
334,dyphylline,pulmonary emphysema,phosphodiesterase 4b
335,dyphylline,pulmonary emphysema,phosphodiesterase 4c
336,dyphylline,pulmonary emphysema,phosphodiesterase 4d
337,dyphylline,asthma,phosphodiesterase 4a
338,dyphylline,asthma,phosphodiesterase 4b
339,dyphylline,asthma,phosphodiesterase 4c
340,dyphylline,asthma,phosphodiesterase 4d
341,lenvatinib,thyroid gland papillary carcinoma,platelet derived growth factor receptor alpha
342,lenvatinib,thyroid gland papillary carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
343,lenvatinib,thyroid gland papillary carcinoma,ret proto-oncogene
344,lenvatinib,thyroid gland follicular carcinoma,platelet derived growth factor receptor alpha
345,lenvatinib,thyroid gland follicular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
346,lenvatinib,thyroid gland follicular carcinoma,ret proto-oncogene
347,lenvatinib,renal cell carcinoma,platelet derived growth factor receptor alpha
348,lenvatinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
349,lenvatinib,renal cell carcinoma,ret proto-oncogene
350,liraglutide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
351,crizotinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
352,crizotinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
353,triflupromazine,psychotic disorder,dopamine receptor d1
354,triflupromazine,psychotic disorder,dopamine receptor d2
355,triflupromazine,psychotic disorder,cholinergic receptor muscarinic 1
356,triflupromazine,psychotic disorder,cholinergic receptor muscarinic 2
357,triflupromazine,psychotic disorder,5-hydroxytryptamine receptor 2b
358,triflupromazine,vomiting,dopamine receptor d2
359,triflupromazine,nausea,dopamine receptor d2
360,buprenorphine,chronic pain,opioid receptor mu 1
361,buprenorphine,chronic pain,opioid receptor kappa 1
362,buprenorphine,opiate dependence,opioid receptor mu 1
363,buprenorphine,opiate dependence,opioid receptor kappa 1
364,nebivolol,hypertensive disorder,adrenoceptor beta 1
365,papaverine,peripheral vascular disease,phosphodiesterase 4b
366,pioglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
367,sotalol,atrial fibrillation,adrenoceptor beta 1
368,sotalol,atrial fibrillation,adrenoceptor beta 2
369,sotalol,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
370,sufentanil,post-operative pain,opioid receptor mu 1
371,tirofiban,acute coronary syndrome,integrin subunit alpha 2b
372,tirofiban,acute coronary syndrome,integrin subunit beta 3
373,valrubicin,urinary bladder neoplasm,dna topoisomerase ii alpha
374,cabergoline,hyperprolactinemia,dopamine receptor d2
375,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
376,estradiol valerate,premenstrual dysphoric disorder,estrogen receptor 1
377,estradiol valerate,premenstrual dysphoric disorder,estrogen receptor 2
378,estradiol valerate,hot flashes,estrogen receptor 1
379,estradiol valerate,hot flashes,estrogen receptor 2
380,estradiol valerate,postmenopausal osteoporosis,estrogen receptor 1
381,estradiol valerate,postmenopausal osteoporosis,estrogen receptor 2
382,estradiol valerate,postmenopausal atrophic vaginitis,estrogen receptor 1
383,estradiol valerate,postmenopausal atrophic vaginitis,estrogen receptor 2
384,estradiol valerate,acne,estrogen receptor 1
385,estradiol valerate,acne,estrogen receptor 2
386,metformin,type 2 diabetes mellitus,electron transfer flavoprotein dehydrogenase
387,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
388,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
389,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase b
390,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase a
391,mebendazole,trichuriasis,tubulin alpha 1a
392,mebendazole,trichuriasis,tubulin beta 4b class ivb
393,mebendazole,ascariasis,tubulin alpha 1a
394,mebendazole,ascariasis,tubulin beta 4b class ivb
395,mebendazole,enterobiasis,tubulin alpha 1a
396,mebendazole,enterobiasis,tubulin beta 4b class ivb
397,prednicarbate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
398,prednicarbate,pruritus ani,nuclear receptor subfamily 3 group c member 1
399,prednicarbate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
400,prednicarbate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
401,prednicarbate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
402,prednicarbate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
403,prednicarbate,exanthem,nuclear receptor subfamily 3 group c member 1
404,prednicarbate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
405,prednicarbate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
406,metoclopramide,gastroesophageal reflux disease,dopamine receptor d2
407,metoclopramide,gastroesophageal reflux disease,cholinergic receptor muscarinic 1
408,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 4
409,fesoterodine,urge incontinence,cholinergic receptor muscarinic 3
410,chlorthalidone,hypertensive disorder,solute carrier family 12 member 1
411,chlorthalidone,edema,solute carrier family 12 member 1
412,nicardipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
413,nicardipine,angina pectoris,calcium voltage-gated channel auxiliary subunit beta 2
414,nicardipine,angina pectoris,calcium voltage-gated channel auxiliary subunit alpha2delta 1
415,nicardipine,angina pectoris,calcium voltage-gated channel subunit alpha1 d
416,nicardipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
417,nicardipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
418,nicardipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
419,nicardipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
420,benzphetamine,obesity disorder,adrenoceptor alpha 1a
421,anakinra,rheumatoid arthritis,interleukin 1 receptor type 1
422,anakinra,cryopyrin-associated periodic syndrome,interleukin 1 receptor type 1
423,darifenacin,urge incontinence,cholinergic receptor muscarinic 3
424,desoximetasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
425,desoximetasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
426,desoximetasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
427,desoximetasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
428,desoximetasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
429,desoximetasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
430,desoximetasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
431,desoximetasone,exanthem,nuclear receptor subfamily 3 group c member 1
432,desoximetasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
433,almotriptan,migraine disorder,5-hydroxytryptamine receptor 1b
434,almotriptan,migraine disorder,5-hydroxytryptamine receptor 1d
435,acebutolol,premature ventricular contraction,adrenoceptor beta 1
436,apraclonidine,open-angle glaucoma,adrenoceptor alpha 2a
437,eplerenone,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
438,febuxostat,hyperuricemia,xanthine dehydrogenase
439,cilastatin,bacterial endocarditis,dipeptidase 1
440,cilastatin,abdominal abscess,dipeptidase 1
441,cilastatin,abdominal infection,dipeptidase 1
442,cilastatin,streptococcal pneumonia,dipeptidase 1
443,cilastatin,bacterial pneumonia,dipeptidase 1
444,cilastatin,endometritis,dipeptidase 1
445,clonidine,hypertensive disorder,adrenoceptor alpha 2a
446,clonidine,hypertensive disorder,adrenoceptor alpha 2b
447,clonidine,hypertensive disorder,adrenoceptor alpha 2c
448,clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
449,clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
450,clonidine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
451,clonidine,open-angle glaucoma,adrenoceptor alpha 2a
452,clonidine,open-angle glaucoma,adrenoceptor alpha 2b
453,clonidine,open-angle glaucoma,adrenoceptor alpha 2c
454,tranexamic acid,endometriosis,plasminogen
455,tranexamic acid,menorrhagia,plasminogen
456,trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 g
457,trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 h
458,trimethadione,epilepsy,calcium voltage-gated channel subunit alpha1 i
459,crisaborole,"dermatitis, atopic",phosphodiesterase 4a
460,crisaborole,"dermatitis, atopic",phosphodiesterase 4b
461,crisaborole,"dermatitis, atopic",phosphodiesterase 4c
462,crisaborole,"dermatitis, atopic",phosphodiesterase 4d
463,ibrutinib,waldenstrom macroglobulinemia,bruton tyrosine kinase
464,ibrutinib,mantle cell lymphoma,bruton tyrosine kinase
465,selegiline,parkinson disease,monoamine oxidase b
466,selegiline,parkinson disease,monoamine oxidase a
467,selegiline,major depressive disorder,monoamine oxidase b
468,selegiline,major depressive disorder,monoamine oxidase a
469,sitagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
470,beraprost,pulmonary arterial hypertension,prostaglandin i2 receptor
471,valbenazine,tardive dyskinesia,solute carrier family 18 member a2
472,radotinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
473,bepridil,angina pectoris,"troponin c1, slow skeletal and cardiac type"
474,ethinylestradiol,premenstrual dysphoric disorder,estrogen receptor 1
475,ethinylestradiol,hot flashes,estrogen receptor 1
476,ethinylestradiol,acne,estrogen receptor 1
477,ethinylestradiol,postmenopausal atrophic vaginitis,estrogen receptor 1
478,ethinylestradiol,postmenopausal osteoporosis,estrogen receptor 1
479,sildenafil,pulmonary arterial hypertension,phosphodiesterase 5a
480,miglitol,type 2 diabetes mellitus,maltase-glucoamylase
481,miglitol,type 2 diabetes mellitus,alpha glucosidase
482,miglitol,type 2 diabetes mellitus,glucosidase ii alpha subunit
483,miglitol,type 2 diabetes mellitus,"glucosidase alpha, neutral c"
484,isoprenaline,cardiac arrest,adrenoceptor beta 1
485,isoprenaline,cardiac arrest,adrenoceptor beta 2
486,isoprenaline,cardiac arrest,adrenoceptor beta 3
487,isoprenaline,atrioventricular block,adrenoceptor beta 1
488,isoprenaline,atrioventricular block,adrenoceptor beta 2
489,isoprenaline,atrioventricular block,adrenoceptor beta 3
490,isoprenaline,decreased cardiac output,adrenoceptor beta 1
491,isoprenaline,decreased cardiac output,adrenoceptor beta 2
492,isoprenaline,decreased cardiac output,adrenoceptor beta 3
493,isoprenaline,common cold,adrenoceptor beta 1
494,isoprenaline,common cold,adrenoceptor beta 2
495,isoprenaline,common cold,adrenoceptor beta 3
496,isoprenaline,shock,adrenoceptor beta 1
497,isoprenaline,shock,adrenoceptor beta 2
498,isoprenaline,shock,adrenoceptor beta 3
499,talinolol,hypertensive disorder,adrenoceptor beta 1
500,cyproheptadine,atopic conjunctivitis,histamine receptor h1
501,cyproheptadine,pruritus,histamine receptor h1
502,cyproheptadine,urticaria,histamine receptor h1
503,cyproheptadine,sneeze,histamine receptor h1
504,cyproheptadine,allergic rhinitis,histamine receptor h1
505,pindolol,hypertensive disorder,adrenoceptor beta 1
506,pindolol,hypertensive disorder,adrenoceptor beta 2
507,bortezomib,mantle cell lymphoma,proteasome 20s subunit beta 5
508,bortezomib,mantle cell lymphoma,proteasome 20s subunit beta 1
509,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 5
510,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 1
511,magnesium salicylate,back pain,prostaglandin-endoperoxide synthase 1
512,magnesium salicylate,back pain,prostaglandin-endoperoxide synthase 2
513,magnesium salicylate,bursitis,prostaglandin-endoperoxide synthase 1
514,magnesium salicylate,bursitis,prostaglandin-endoperoxide synthase 2
515,magnesium salicylate,arthralgia,prostaglandin-endoperoxide synthase 1
516,magnesium salicylate,arthralgia,prostaglandin-endoperoxide synthase 2
517,magnesium salicylate,synovitis,prostaglandin-endoperoxide synthase 1
518,magnesium salicylate,synovitis,prostaglandin-endoperoxide synthase 2
519,magnesium salicylate,dysmenorrhea,prostaglandin-endoperoxide synthase 1
520,magnesium salicylate,dysmenorrhea,prostaglandin-endoperoxide synthase 2
521,magnesium salicylate,osteoarthritis,prostaglandin-endoperoxide synthase 1
522,magnesium salicylate,osteoarthritis,prostaglandin-endoperoxide synthase 2
523,magnesium salicylate,pain,prostaglandin-endoperoxide synthase 1
524,magnesium salicylate,pain,prostaglandin-endoperoxide synthase 2
525,magnesium salicylate,fever,prostaglandin-endoperoxide synthase 1
526,magnesium salicylate,fever,prostaglandin-endoperoxide synthase 2
527,magnesium salicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
528,magnesium salicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
529,magnesium salicylate,headache disorder,prostaglandin-endoperoxide synthase 1
530,magnesium salicylate,headache disorder,prostaglandin-endoperoxide synthase 2
531,baricitinib,rheumatoid arthritis,janus kinase 1
532,baricitinib,rheumatoid arthritis,janus kinase 2
533,baricitinib,rheumatoid arthritis,janus kinase 3
534,baricitinib,rheumatoid arthritis,tyrosine kinase 2
535,budesonide,crohn disease,nuclear receptor subfamily 3 group c member 1
536,budesonide,asthma,nuclear receptor subfamily 3 group c member 1
537,budesonide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
538,citalopram,depressive disorder,solute carrier family 6 member 4
539,citalopram,major depressive disorder,solute carrier family 6 member 4
540,nisoldipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
541,nisoldipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
542,vilazodone,major depressive disorder,solute carrier family 6 member 4
543,vilazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
544,etelcalcetide,secondary hyperparathyroidism,calcium sensing receptor
545,cilostazol,intermittent vascular claudication,phosphodiesterase 3a
546,diclofenamide,open-angle glaucoma,carbonic anhydrase 1
547,diclofenamide,open-angle glaucoma,carbonic anhydrase 2
548,diclofenamide,open-angle glaucoma,carbonic anhydrase 4
549,diclofenamide,open-angle glaucoma,carbonic anhydrase 7
550,diclofenamide,open-angle glaucoma,carbonic anhydrase 12
551,ethacrynic acid,edema,solute carrier family 12 member 1
552,oprelvekin,thrombocytopenia,interleukin 11 receptor subunit alpha
553,tolazoline,vascular disorder,adrenoceptor alpha 1a
554,tolazoline,vascular disorder,adrenoceptor alpha 2a
555,tolazoline,vascular disorder,adrenoceptor alpha 2b
556,tolazoline,vascular disorder,adrenoceptor alpha 2c
557,tolazoline,vascular disorder,histamine receptor h1
558,tolazoline,vascular disorder,histamine receptor h2
559,tolazoline,cerebrovascular disorder,histamine receptor h1
560,tolazoline,cerebrovascular disorder,histamine receptor h2
561,tolazoline,cerebrovascular disorder,adrenoceptor alpha 1a
562,tolazoline,cerebrovascular disorder,adrenoceptor alpha 2a
563,tolazoline,cerebrovascular disorder,adrenoceptor alpha 2b
564,tolazoline,cerebrovascular disorder,adrenoceptor alpha 2c
565,tolazoline,persistent fetal circulation syndrome,histamine receptor h1
566,tolazoline,persistent fetal circulation syndrome,histamine receptor h2
567,tolazoline,persistent fetal circulation syndrome,adrenoceptor alpha 1a
568,tolazoline,persistent fetal circulation syndrome,adrenoceptor alpha 2a
569,diclofenamide,angle-closure glaucoma,carbonic anhydrase 1
570,diclofenamide,angle-closure glaucoma,carbonic anhydrase 2
571,diclofenamide,angle-closure glaucoma,carbonic anhydrase 4
572,diclofenamide,angle-closure glaucoma,carbonic anhydrase 7
573,diclofenamide,angle-closure glaucoma,carbonic anhydrase 12
574,venetoclax,b-cell chronic lymphocytic leukemia,bcl2 apoptosis regulator
575,ketoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
576,ketoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
577,ketoprofen,rheumatoid arthritis,c-x-c motif chemokine receptor 1
578,ketoprofen,pain,prostaglandin-endoperoxide synthase 1
579,ketoprofen,pain,prostaglandin-endoperoxide synthase 2
580,ketoprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
581,ketoprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
582,clotrimazole,acne,toll like receptor 2
583,lusutrombopag,thrombocytopenia,"mpl proto-oncogene, thrombopoietin receptor"
584,levocabastine,atopic conjunctivitis,neurotensin receptor 2
585,ethosuximide,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
586,empagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
587,cimetidine,duodenal ulcer,histamine receptor h2
588,cimetidine,gastric ulcer,histamine receptor h2
589,cimetidine,zollinger-ellison syndrome,histamine receptor h2
590,cimetidine,multiple endocrine neoplasia,histamine receptor h2
591,cimetidine,dyspepsia,histamine receptor h2
592,cimetidine,gastroesophageal reflux disease,histamine receptor h2
593,cimetidine,systemic mastocytosis,histamine receptor h2
594,naloxone,opiate dependence,opioid receptor mu 1
595,naloxone,opiate dependence,opioid receptor delta 1
596,naloxone,opiate dependence,opioid receptor kappa 1
597,naloxone,pain,opioid receptor mu 1
598,naloxone,pain,opioid receptor delta 1
599,naloxone,pain,opioid receptor kappa 1
600,benzatropine,postencephalitic parkinson disease,solute carrier family 6 member 3
601,benzatropine,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
602,benzatropine,parkinsonian disorder,solute carrier family 6 member 3
603,benzatropine,parkinsonian disorder,cholinergic receptor muscarinic 1
604,benzatropine,basal ganglia disorder,solute carrier family 6 member 3
605,benzatropine,basal ganglia disorder,cholinergic receptor muscarinic 1
606,benzatropine,parkinson disease,solute carrier family 6 member 3
607,benzatropine,parkinson disease,cholinergic receptor muscarinic 1
608,imipramine,depressive disorder,solute carrier family 6 member 2
609,imipramine,depressive disorder,solute carrier family 6 member 4
610,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
611,nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
612,nifedipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
613,dantrolene,spasticity,ryanodine receptor 1
614,dantrolene,"malignant hyperthermia, susceptibility to, 1",ryanodine receptor 1
615,alimemazine,urticaria,histamine receptor h1
616,alimemazine,sneeze,histamine receptor h1
617,alimemazine,angioedema,histamine receptor h1
618,alimemazine,atopic conjunctivitis,histamine receptor h1
619,alimemazine,pruritus,histamine receptor h1
620,alimemazine,allergic rhinitis,histamine receptor h1
621,dapoxetine,premature ejaculation,solute carrier family 6 member 4
622,histrelin,precocious puberty,gonadotropin releasing hormone receptor
623,befunolol,open-angle glaucoma,adrenoceptor beta 1
624,befunolol,open-angle glaucoma,adrenoceptor beta 2
625,befunolol,ocular hypertension,adrenoceptor beta 1
626,befunolol,ocular hypertension,adrenoceptor beta 2
627,indapamide,edema,solute carrier family 12 member 3
628,indapamide,hypertensive disorder,solute carrier family 12 member 3
629,meclofenamic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
630,meclofenamic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
631,meclofenamic acid,menorrhagia,prostaglandin-endoperoxide synthase 1
632,meclofenamic acid,menorrhagia,prostaglandin-endoperoxide synthase 2
633,meclofenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 1
634,meclofenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 2
635,meclofenamic acid,pain,prostaglandin-endoperoxide synthase 1
636,meclofenamic acid,pain,prostaglandin-endoperoxide synthase 2
637,meclofenamic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
638,meclofenamic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
639,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
640,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
641,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1f
642,methyltestosterone,eunuchism,androgen receptor
643,methyltestosterone,delayed puberty,androgen receptor
644,perphenazine,schizophrenia,dopamine receptor d2
645,choline magnesium trisalicylate,fever,prostaglandin-endoperoxide synthase 1
646,choline magnesium trisalicylate,fever,prostaglandin-endoperoxide synthase 2
647,choline magnesium trisalicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
648,choline magnesium trisalicylate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
649,choline magnesium trisalicylate,osteoarthritis,prostaglandin-endoperoxide synthase 1
650,choline magnesium trisalicylate,osteoarthritis,prostaglandin-endoperoxide synthase 2
651,choline magnesium trisalicylate,pain,prostaglandin-endoperoxide synthase 1
652,choline magnesium trisalicylate,pain,prostaglandin-endoperoxide synthase 2
653,dexlansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
654,dexlansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
655,dexlansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
656,dexlansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
657,capsaicin,postherpetic neuralgia,transient receptor potential cation channel subfamily v member 1
658,capsaicin,neuralgia,transient receptor potential cation channel subfamily v member 1
659,capsaicin,back pain,transient receptor potential cation channel subfamily v member 1
660,ibrutinib,b-cell chronic lymphocytic leukemia,bruton tyrosine kinase
661,rufinamide,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
662,vindesine,melanoma,tubulin beta 1 class vi
663,vindesine,lung neoplasm,tubulin beta 1 class vi
664,vindesine,"chronic myelogenous leukemia, bcr-abl1 positive",tubulin beta 1 class vi
665,treprostinil,pulmonary arterial hypertension,prostaglandin i2 receptor
666,estramustine,prostate cancer,microtubule associated protein 2
667,estramustine,prostate cancer,microtubule associated protein 1a
668,testosterone propionate,cryptorchidism,androgen receptor
669,testosterone propionate,delayed puberty,androgen receptor
670,testosterone propionate,eunuchism,androgen receptor
671,testosterone propionate,klinefelter syndrome,androgen receptor
672,canagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
673,dexbrompheniramine,seasonal allergic rhinitis,histamine receptor h1
674,dexbrompheniramine,urticaria,histamine receptor h1
675,dexbrompheniramine,pruritus,histamine receptor h1
676,dexbrompheniramine,vasomotor rhinitis,histamine receptor h1
677,dexbrompheniramine,atopic conjunctivitis,histamine receptor h1
678,epinastine,atopic conjunctivitis,histamine receptor h1
679,epinastine,atopic conjunctivitis,histamine receptor h2
680,amantadine,basal ganglia disorder,dopamine receptor d2
681,amantadine,parkinson disease,dopamine receptor d2
682,amantadine,parkinsonian disorder,dopamine receptor d2
683,amantadine,postencephalitic parkinson disease,dopamine receptor d2
684,emedastine,urticaria,histamine receptor h1
685,emedastine,pruritus,histamine receptor h1
686,emedastine,atopic conjunctivitis,histamine receptor h1
687,tetracosactide,adrenocortical insufficiency,melanocortin 2 receptor
688,bepotastine,atopic conjunctivitis,histamine receptor h1
689,brexpiprazole,major depressive disorder,5-hydroxytryptamine receptor 2a
690,brexpiprazole,schizophrenia,5-hydroxytryptamine receptor 2a
691,enalaprilat,hypertensive disorder,angiotensin i converting enzyme
692,enalaprilat,heart failure,angiotensin i converting enzyme
693,chlorothiazide,edema,solute carrier family 12 member 3
694,imiquimod,common wart,toll like receptor 7
695,imiquimod,anogenital human papillomavirus infection,toll like receptor 7
696,imiquimod,actinic keratosis,toll like receptor 7
697,teriparatide,postmenopausal osteoporosis,parathyroid hormone 1 receptor
698,vorapaxar,stroke disorder,coagulation factor ii thrombin receptor
699,mirodenafil,erectile dysfunction,phosphodiesterase 5a
700,luseogliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
701,luseogliflozin,type 2 diabetes mellitus,solute carrier family 5 member 11
702,cromoglicic acid,allergic rhinitis,s100 calcium binding protein p
703,cromoglicic acid,systemic mastocytosis,s100 calcium binding protein p
704,cromoglicic acid,asthma,s100 calcium binding protein p
705,gabapentin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
706,bretylium,ventricular fibrillation,atpase na+/k+ transporting subunit alpha 1
707,tramadol,pain,solute carrier family 6 member 2
708,tramadol,pain,solute carrier family 6 member 4
709,tramadol,osteoarthritis,opioid receptor mu 1
710,tramadol,osteoarthritis,solute carrier family 6 member 2
711,tramadol,osteoarthritis,solute carrier family 6 member 4
712,tramadol,chronic pain,opioid receptor mu 1
713,tramadol,chronic pain,solute carrier family 6 member 2
714,tramadol,chronic pain,solute carrier family 6 member 4
715,isradipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
716,montelukast,allergic rhinitis,cysteinyl leukotriene receptor 1
717,chlophedianol,allergic rhinitis,histamine receptor h1
718,chlophedianol,rhinitis,histamine receptor h1
719,chlophedianol,vasomotor rhinitis,histamine receptor h1
720,salmeterol,pulmonary emphysema,adrenoceptor beta 2
721,azelastine,vasomotor rhinitis,histamine receptor h1
722,azelastine,vasomotor rhinitis,histamine receptor h2
723,azelastine,vasomotor rhinitis,phospholipase a2 group ib
724,azelastine,vasomotor rhinitis,leukotriene c4 synthase
725,azelastine,seasonal allergic rhinitis,histamine receptor h1
726,azelastine,seasonal allergic rhinitis,histamine receptor h2
727,azelastine,seasonal allergic rhinitis,phospholipase a2 group ib
728,azelastine,seasonal allergic rhinitis,leukotriene c4 synthase
729,azelastine,allergic rhinitis,histamine receptor h1
730,azelastine,allergic rhinitis,histamine receptor h2
731,azelastine,allergic rhinitis,phospholipase a2 group ib
732,azelastine,allergic rhinitis,leukotriene c4 synthase
733,azelastine,atopic conjunctivitis,histamine receptor h1
734,azelastine,atopic conjunctivitis,histamine receptor h2
735,azelastine,atopic conjunctivitis,phospholipase a2 group ib
736,azelastine,atopic conjunctivitis,leukotriene c4 synthase
737,ergometrine,post-partum hemorrhage,adrenoceptor alpha 1a
738,almitrine,chronic obstructive pulmonary disease,atpase na+/k+ transporting subunit alpha 1
739,acetylmethadol,opiate dependence,opioid receptor mu 1
740,pargyline,hypertensive disorder,monoamine oxidase b
741,teduglutide,short bowel syndrome,glucagon like peptide 2 receptor
742,chlorcyclizine,atopic conjunctivitis,histamine receptor h1
743,chlorcyclizine,allergic rhinitis,histamine receptor h1
744,chlorcyclizine,seasonal allergic rhinitis,histamine receptor h1
745,chlorcyclizine,sneeze,histamine receptor h1
746,chlorcyclizine,cough,histamine receptor h1
747,chlorcyclizine,vasomotor rhinitis,histamine receptor h1
748,chlorcyclizine,common cold,histamine receptor h1
749,stanozolol,pheochromocytoma,adrenoceptor alpha 1a
750,stanozolol,pheochromocytoma,adrenoceptor alpha 2a
751,stanozolol,pheochromocytoma,adrenoceptor alpha 2c
752,stanozolol,pheochromocytoma,adrenoceptor alpha 1d
753,stanozolol,pheochromocytoma,adrenoceptor alpha 1b
754,stanozolol,pheochromocytoma,adrenoceptor alpha 2b
755,nedocromil,atopic conjunctivitis,cysteinyl leukotriene receptor 2
756,nedocromil,atopic conjunctivitis,cysteinyl leukotriene receptor 1
757,nedocromil,asthma,cysteinyl leukotriene receptor 2
758,nedocromil,asthma,cysteinyl leukotriene receptor 1
759,fexofenadine,atopic conjunctivitis,histamine receptor h1
760,fexofenadine,urticaria,histamine receptor h1
761,fexofenadine,seasonal allergic rhinitis,histamine receptor h1
762,fexofenadine,sneeze,histamine receptor h1
763,fexofenadine,allergic rhinitis,histamine receptor h1
764,phenacemide,epilepsy,sodium voltage-gated channel alpha subunit 1
765,carvedilol,hypertensive disorder,adrenoceptor beta 1
766,carvedilol,hypertensive disorder,adrenoceptor alpha 1a
767,trabectedin,ovarian cancer,atp binding cassette subfamily b member 1
768,trabectedin,leiomyosarcoma,atp binding cassette subfamily b member 1
769,trabectedin,liposarcoma,atp binding cassette subfamily b member 1
770,trilostane,adrenal gland hyperfunction,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
771,trilostane,adrenal gland hyperfunction,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
772,axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 1
773,axitinib,renal cell carcinoma,kinase insert domain receptor
774,axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 4
775,trifluoperazine,schizophrenia,dopamine receptor d2
776,trifluoperazine,schizophrenia,dopamine receptor d1
777,trifluoperazine,anxiety,dopamine receptor d2
778,trifluoperazine,anxiety,dopamine receptor d1
779,glymidine,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
780,gonadorelin,amenorrhea,gonadotropin releasing hormone receptor
781,icosapent,hypertriglyceridemia,diacylglycerol o-acyltransferase 1
782,icosapent,hypertriglyceridemia,lipoprotein lipase
783,nicotinic acid,hypertriglyceridemia,diacylglycerol o-acyltransferase 1
784,nicotinic acid,hypertriglyceridemia,apolipoprotein b
785,nicotinic acid,hypertriglyceridemia,lipoprotein lipase
786,nicotinic acid,"hyperlipidemia, familial combined, lpl related",diacylglycerol o-acyltransferase 1
787,nicotinic acid,"hyperlipidemia, familial combined, lpl related",apolipoprotein b
788,nicotinic acid,"hyperlipidemia, familial combined, lpl related",apolipoprotein a1
789,nicotinic acid,hypercholesterolemia,cholesteryl ester transfer protein
790,nicotinic acid,hypercholesterolemia,apolipoprotein a1
791,nicotinic acid,hyperlipidemia,diacylglycerol o-acyltransferase 1
792,nicotinic acid,hyperlipidemia,apolipoprotein b
793,nicotinic acid,hyperlipidemia,apolipoprotein a1
794,esomeprazole,peptic esophagitis,atpase h+/k+ transporting subunit alpha
795,esomeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
796,esomeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
797,tolvaptan,hyponatremia,arginine vasopressin receptor 2
798,tolvaptan,inappropriate adh syndrome,arginine vasopressin receptor 2
799,tolvaptan,autosomal dominant polycystic kidney disease,arginine vasopressin receptor 2
800,biperiden,parkinson disease,cholinergic receptor muscarinic 1
801,biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
802,biperiden,parkinsonian disorder,cholinergic receptor muscarinic 1
803,biperiden,basal ganglia disorder,cholinergic receptor muscarinic 1
804,triiodothyronine,myxedema,thyroid hormone receptor alpha
805,triiodothyronine,myxedema,thyroid hormone receptor beta
806,triiodothyronine,hypothyroidism,thyroid hormone receptor alpha
807,triiodothyronine,hypothyroidism,thyroid hormone receptor beta
808,triiodothyronine,goiter,thyroid hormone receptor alpha
809,triiodothyronine,goiter,thyroid hormone receptor beta
810,triiodothyronine,congenital hypothyroidism,thyroid hormone receptor alpha
811,triiodothyronine,congenital hypothyroidism,thyroid hormone receptor beta
812,triiodothyronine,endemic goiter,thyroid hormone receptor alpha
813,triiodothyronine,endemic goiter,thyroid hormone receptor beta
814,travoprost,ocular hypertension,prostaglandin f receptor
815,travoprost,open-angle glaucoma,prostaglandin f receptor
816,eflornithine,human african trypanosomiasis,ornithine decarboxylase 1
817,plerixafor,plasma cell myeloma,c-x-c motif chemokine receptor 4
818,chlorpromazine,psychotic disorder,dopamine receptor d2
819,chlorpromazine,acute intermittent porphyria,dopamine receptor d2
820,chlorpromazine,schizophrenia,dopamine receptor d2
821,chlorpromazine,oppositional defiant disorder,dopamine receptor d2
822,etoposide,testicular cancer,dna topoisomerase ii alpha
823,etoposide,small cell lung carcinoma,dna topoisomerase ii alpha
824,desloratadine,seasonal allergic rhinitis,histamine receptor h1
825,desloratadine,common cold,histamine receptor h1
826,desloratadine,vasomotor rhinitis,histamine receptor h1
827,desloratadine,chronic urticaria,histamine receptor h1
828,desloratadine,allergic rhinitis,histamine receptor h1
829,desloratadine,sneeze,histamine receptor h1
830,desloratadine,atopic conjunctivitis,histamine receptor h1
831,pasireotide,adrenal gland hyperfunction,somatostatin receptor 1
832,pasireotide,adrenal gland hyperfunction,somatostatin receptor 2
833,pasireotide,adrenal gland hyperfunction,somatostatin receptor 3
834,pasireotide,adrenal gland hyperfunction,somatostatin receptor 5
835,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 5
836,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 8
837,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 1
838,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 9
839,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 2
840,carfilzomib,plasma cell myeloma,proteasome 20s subunit beta 10
841,enzalutamide,prostate cancer,androgen receptor
842,aspirin,myocardial infarction,prostaglandin-endoperoxide synthase 1
843,aspirin,myocardial infarction,prostaglandin-endoperoxide synthase 2
844,aspirin,common cold,prostaglandin-endoperoxide synthase 1
845,aspirin,common cold,prostaglandin-endoperoxide synthase 2
846,aspirin,toothache,prostaglandin-endoperoxide synthase 1
847,aspirin,toothache,prostaglandin-endoperoxide synthase 2
848,aspirin,headache disorder,prostaglandin-endoperoxide synthase 1
849,aspirin,headache disorder,prostaglandin-endoperoxide synthase 2
850,aspirin,migraine disorder,prostaglandin-endoperoxide synthase 1
851,aspirin,migraine disorder,prostaglandin-endoperoxide synthase 2
852,aspirin,back pain,prostaglandin-endoperoxide synthase 1
853,aspirin,back pain,prostaglandin-endoperoxide synthase 2
854,aspirin,osteoarthritis,prostaglandin-endoperoxide synthase 1
855,aspirin,osteoarthritis,prostaglandin-endoperoxide synthase 2
856,aspirin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
857,aspirin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
858,aspirin,arthralgia,prostaglandin-endoperoxide synthase 1
859,aspirin,arthralgia,prostaglandin-endoperoxide synthase 2
860,metaraminol,hypotensive disorder,adrenoceptor alpha 1a
861,ibandronic acid,postmenopausal osteoporosis,farnesyl diphosphate synthase
862,ibandronic acid,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
863,ibandronic acid,hypercalcemia disease,farnesyl diphosphate synthase
864,ibandronic acid,hypercalcemia disease,geranylgeranyl diphosphate synthase 1
865,lixisenatide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
866,perospirone,schizophrenia,5-hydroxytryptamine receptor 1a
867,perospirone,schizophrenia,dopamine receptor d2
868,perospirone,schizophrenia,5-hydroxytryptamine receptor 2a
869,flunisolide,asthma,nuclear receptor subfamily 3 group c member 1
870,flunisolide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
871,ropinirole,parkinson disease,dopamine receptor d2
872,ropinirole,parkinson disease,dopamine receptor d3
873,apomorphine,parkinson disease,dopamine receptor d2
874,apomorphine,parkinson disease,dopamine receptor d3
875,apomorphine,parkinson disease,dopamine receptor d4
876,modafinil,narcolepsy,solute carrier family 6 member 3
877,salicylamide,arthralgia,prostaglandin-endoperoxide synthase 1
878,salicylamide,arthralgia,prostaglandin-endoperoxide synthase 2
879,salicylamide,headache disorder,prostaglandin-endoperoxide synthase 1
880,salicylamide,headache disorder,prostaglandin-endoperoxide synthase 2
881,salicylamide,pain,prostaglandin-endoperoxide synthase 1
882,salicylamide,pain,prostaglandin-endoperoxide synthase 2
883,salicylamide,back pain,prostaglandin-endoperoxide synthase 1
884,salicylamide,back pain,prostaglandin-endoperoxide synthase 2
885,salicylamide,fever,prostaglandin-endoperoxide synthase 1
886,salicylamide,fever,prostaglandin-endoperoxide synthase 2
887,mesalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 1
888,mesalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 2
889,mesalazine,ulcerative colitis,arachidonate 5-lipoxygenase
890,mesalazine,ulcerative colitis,peroxisome proliferator activated receptor gamma
891,pimecrolimus,"dermatitis, atopic",protein phosphatase 3 catalytic subunit alpha
892,phytomenadione,hypocalcemia,bone gamma-carboxyglutamate protein
893,phytomenadione,postmenopausal osteoporosis,bone gamma-carboxyglutamate protein
894,phytomenadione,osteoporosis,bone gamma-carboxyglutamate protein
895,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 2d
896,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 1
897,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 3b
898,orphenadrine,spasticity,glutamate ionotropic receptor nmda type subunit 3a
899,asenapine,schizophrenia,5-hydroxytryptamine receptor 2a
900,asenapine,schizophrenia,dopamine receptor d2
901,ubidecarenone,heart failure,succinate dehydrogenase complex flavoprotein subunit a
902,quetiapine,schizophrenia,dopamine receptor d2
903,quetiapine,schizophrenia,5-hydroxytryptamine receptor 2a
904,imatinib,chronic eosinophilic leukemia,platelet derived growth factor receptor alpha
905,imatinib,hypereosinophilic syndrome,platelet derived growth factor receptor alpha
906,imatinib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
907,imatinib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
908,imatinib,dermatofibrosarcoma protuberans,platelet derived growth factor receptor alpha
909,dosulepin,major depressive disorder,solute carrier family 6 member 4
910,dosulepin,major depressive disorder,solute carrier family 6 member 2
911,quetiapine,bipolar disorder,solute carrier family 6 member 2
912,losartan,diabetic kidney disease,angiotensin ii receptor type 1
913,losartan,hypertensive disorder,angiotensin ii receptor type 1
914,bethanechol,urinary retention,cholinergic receptor muscarinic 2
915,mercaptopurine,acute promyelocytic leukemia,hypoxanthine phosphoribosyltransferase 1
916,mercaptopurine,acute promyelocytic leukemia,phosphoribosyl pyrophosphate amidotransferase
917,mercaptopurine,acute promyelocytic leukemia,inosine monophosphate dehydrogenase 1
918,mercaptopurine,acute promyelocytic leukemia,inosine monophosphate dehydrogenase 2
919,diamicron,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
920,pilsicainide,tachycardia,sodium voltage-gated channel alpha subunit 5
921,tropicamide,mydriasis,cholinergic receptor muscarinic 3
922,tenoxicam,arthritic joint disease,prostaglandin-endoperoxide synthase 1
923,tenoxicam,arthritic joint disease,prostaglandin-endoperoxide synthase 2
924,rotigotine,parkinson disease,dopamine receptor d3
925,rotigotine,parkinson disease,dopamine receptor d4
926,rotigotine,parkinson disease,dopamine receptor d2
927,rotigotine,parkinson disease,dopamine receptor d5
928,rotigotine,parkinson disease,dopamine receptor d1
929,rotigotine,restless legs syndrome,dopamine receptor d3
930,rotigotine,restless legs syndrome,dopamine receptor d4
931,rotigotine,restless legs syndrome,dopamine receptor d2
932,rotigotine,restless legs syndrome,dopamine receptor d5
933,rotigotine,restless legs syndrome,dopamine receptor d1
934,prasugrel,acute coronary syndrome,purinergic receptor p2y12
935,dutasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 2
936,dutasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 1
937,calcium citrate,hypocalcemia,calcium sensing receptor
938,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,histone deacetylase 2
939,theophylline,asthma,histone deacetylase 2
940,theophylline,bronchitis,histone deacetylase 2
941,theophylline,pulmonary emphysema,histone deacetylase 2
942,theophylline,bronchial disorder,histone deacetylase 2
943,dofetilide,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
944,dofetilide,atrial fibrillation,potassium two pore domain channel subfamily k member 2
945,dofetilide,atrial fibrillation,potassium inwardly rectifying channel subfamily j member 12
946,clidinium,enterocolitis,cholinergic receptor muscarinic 1
947,clidinium,irritable bowel syndrome,cholinergic receptor muscarinic 1
948,cycrimine,parkinson disease,cholinergic receptor muscarinic 1
949,insulin lispro,type 1 diabetes mellitus,insulin receptor
950,insulin lispro,type 2 diabetes mellitus,insulin receptor
951,calcium citrate,postmenopausal osteoporosis,calcium sensing receptor
952,lasofoxifene,postmenopausal osteoporosis,estrogen receptor 1
953,lasofoxifene,postmenopausal osteoporosis,estrogen receptor 2
954,brigatinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
955,brigatinib,non-small cell lung carcinoma,epidermal growth factor receptor
956,benzquinamide,postoperative nausea and vomiting,dopamine receptor d2
957,insulin glulisine,diabetes mellitus,insulin receptor
958,olodaterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
959,ripasudil,ocular hypertension,rho associated coiled-coil containing protein kinase 1
960,ripasudil,ocular hypertension,rho associated coiled-coil containing protein kinase 2
961,ripasudil,glaucoma,rho associated coiled-coil containing protein kinase 1
962,ripasudil,glaucoma,rho associated coiled-coil containing protein kinase 2
963,amcinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
964,amcinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
965,amcinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
966,amcinonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
967,amcinonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
968,amcinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
969,amcinonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
970,naltrexone,chronic pain,toll like receptor 4
971,naltrexone,alcohol abuse,opioid receptor kappa 1
972,naltrexone,alcohol abuse,opioid receptor delta 1
973,naltrexone,alcohol abuse,opioid receptor mu 1
974,piribedil,parkinsonian disorder,dopamine receptor d2
975,piribedil,parkinsonian disorder,dopamine receptor d3
976,dexibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
977,dexibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
978,dexibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
979,dexibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
980,dexibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
981,dexibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
982,dexibuprofen,fever,prostaglandin-endoperoxide synthase 1
983,dexibuprofen,fever,prostaglandin-endoperoxide synthase 2
984,dexibuprofen,pain,prostaglandin-endoperoxide synthase 1
985,dexibuprofen,pain,prostaglandin-endoperoxide synthase 2
986,dexibuprofen,headache,prostaglandin-endoperoxide synthase 1
987,dexibuprofen,headache,prostaglandin-endoperoxide synthase 2
988,dexibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
989,dexibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
990,linaclotide,irritable bowel syndrome,guanylate cyclase 2c
991,prucalopride,constipation disorder,5-hydroxytryptamine receptor 4
992,bazedoxifene,postmenopausal osteoporosis,estrogen receptor 1
993,bazedoxifene,postmenopausal osteoporosis,estrogen receptor 2
994,echothiophate,esotropia,butyrylcholinesterase
995,echothiophate,open-angle glaucoma,butyrylcholinesterase
996,echothiophate,glaucoma,butyrylcholinesterase
997,echothiophate,stargardt disease,butyrylcholinesterase
998,colecalciferol,osteoporosis,vitamin d receptor
999,colecalciferol,postmenopausal osteoporosis,vitamin d receptor
1000,colecalciferol,hypoparathyroidism,vitamin d receptor
1001,colecalciferol,vitamin d deficiency,vitamin d receptor
1002,colecalciferol,rickets,vitamin d receptor
1003,colecalciferol,hypocalcemia,vitamin d receptor
1004,pge1,pulmonary valve atresia,prostaglandin e receptor 2
1005,pge1,pulmonary artery stenosis,prostaglandin e receptor 2
1006,pge1,tricuspid atresia,prostaglandin e receptor 2
1007,pge1,aorta coarctation,prostaglandin e receptor 2
1008,pge1,erectile dysfunction,prostaglandin e receptor 2
1009,pge1,tetralogy of fallot,prostaglandin e receptor 2
1010,guanfacine,hypertensive disorder,adrenoceptor alpha 2a
1011,oxybutynin,urge incontinence,cholinergic receptor muscarinic 3
1012,oxybutynin,urge incontinence,cholinergic receptor muscarinic 2
1013,oxybutynin,urge incontinence,cholinergic receptor muscarinic 1
1014,oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 3
1015,oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 2
1016,oxybutynin,neurogenic bladder,cholinergic receptor muscarinic 1
1017,diphenylpyraline,sneeze,histamine receptor h1
1018,diphenylpyraline,pruritus,histamine receptor h1
1019,diphenylpyraline,allergic rhinitis,histamine receptor h1
1020,diphenylpyraline,atopic conjunctivitis,histamine receptor h1
1021,diphenylpyraline,vasomotor rhinitis,histamine receptor h1
1022,diphenylpyraline,urticaria,histamine receptor h1
1023,alcaftadine,atopic conjunctivitis,histamine receptor h1
1024,omarigliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
1025,azelnidipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 1
1026,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1d
1027,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1b
1028,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1f
1029,bisoprolol,hypertensive disorder,adrenoceptor beta 1
1030,dextrothyroxine,hyperlipidemia,thyroid hormone receptor alpha
1031,dextrothyroxine,hyperlipidemia,thyroid hormone receptor beta
1032,betaxolol,ocular hypertension,adrenoceptor beta 1
1033,betaxolol,open-angle glaucoma,adrenoceptor beta 1
1034,betaxolol,hypertensive disorder,adrenoceptor beta 1
1035,ketotifen,atopic conjunctivitis,histamine receptor h1
1036,ephedrine,vasomotor rhinitis,adrenoceptor alpha 1a
1037,ephedrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
1038,ephedrine,allergic rhinitis,adrenoceptor alpha 1a
1039,ephedrine,atopic conjunctivitis,adrenoceptor alpha 1a
1040,ephedrine,sneeze,adrenoceptor alpha 1a
1041,ephedrine,headache disorder,adrenoceptor alpha 1a
1042,ephedrine,bronchitis,adrenoceptor beta 2
1043,ephedrine,common cold,adrenoceptor alpha 1a
1044,ephedrine,bronchial disorder,adrenoceptor beta 2
1045,viloxazine,narcolepsy,solute carrier family 6 member 2
1046,hydroxyzine,atopic conjunctivitis,histamine receptor h1
1047,hydroxyzine,allergic rhinitis,histamine receptor h1
1048,hydroxyzine,"dermatitis, atopic",histamine receptor h1
1049,hydroxyzine,urticaria,histamine receptor h1
1050,hydroxyzine,pruritus,histamine receptor h1
1051,levorphanol,pain,opioid receptor mu 1
1052,gemfibrozil,hypertriglyceridemia,peroxisome proliferator activated receptor alpha
1053,pitavastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
1054,pitavastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
1055,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
1056,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 i
1057,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
1058,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
1059,amlodipine,angina pectoris,calcium voltage-gated channel subunit alpha1 c
1060,amlodipine,angina pectoris,calcium voltage-gated channel subunit alpha1 i
1061,amlodipine,stroke disorder,calcium voltage-gated channel subunit alpha1 c
1062,amlodipine,stroke disorder,calcium voltage-gated channel subunit alpha1 i
1063,cyclopentolate,mydriasis,cholinergic receptor muscarinic 1
1064,flecainide,atrial fibrillation,sodium voltage-gated channel alpha subunit 4
1065,flecainide,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
1066,insulin glargine,type 1 diabetes mellitus,insulin receptor
1067,insulin glargine,type 2 diabetes mellitus,insulin receptor
1068,olanzapine,schizophrenia,dopamine receptor d2
1069,olanzapine,major depressive disorder,dopamine receptor d2
1070,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2a
1071,olanzapine,bipolar disorder,dopamine receptor d2
1072,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 2a
1073,propranolol,hypertrophic cardiomyopathy,adrenoceptor beta 1
1074,propranolol,hypertrophic cardiomyopathy,adrenoceptor beta 2
1075,propranolol,angina pectoris,adrenoceptor beta 1
1076,propranolol,angina pectoris,adrenoceptor beta 2
1077,propranolol,hypertensive disorder,adrenoceptor beta 1
1078,propranolol,hypertensive disorder,adrenoceptor beta 2
1079,propranolol,hemangioma,vascular endothelial growth factor a
1080,propranolol,atrial fibrillation,adrenoceptor beta 1
1081,propranolol,atrial fibrillation,adrenoceptor beta 2
1082,propranolol,supraventricular tachycardia,adrenoceptor beta 1
1083,propranolol,supraventricular tachycardia,adrenoceptor beta 2
1084,bosentan,localized scleroderma,endothelin receptor type a
1085,bosentan,localized scleroderma,endothelin receptor type b
1086,bosentan,pulmonary hypertension,endothelin receptor type a
1087,bosentan,pulmonary hypertension,endothelin receptor type b
1088,bosentan,pulmonary arterial hypertension,endothelin receptor type a
1089,bosentan,pulmonary arterial hypertension,endothelin receptor type b
1090,testosterone propionate,hot flashes,androgen receptor
1091,diethylcarbamazine,pulmonary eosinophilia,arachidonate 5-lipoxygenase
1092,diethylcarbamazine,pulmonary eosinophilia,prostaglandin-endoperoxide synthase 1
1093,drospirenone,postmenopausal atrophic vaginitis,progesterone receptor
1094,etidronic acid,humoral hypercalcemia of malignancy,atpase h+ transporting v1 subunit a
1095,etidronic acid,bone paget disease,atpase h+ transporting v1 subunit a
1096,reboxetine,major depressive disorder,solute carrier family 6 member 2
1097,flibanserin,psychosexual disorder,5-hydroxytryptamine receptor 1a
1098,flibanserin,psychosexual disorder,5-hydroxytryptamine receptor 2a
1099,erlotinib,non-small cell lung carcinoma,epidermal growth factor receptor
1100,doxapram,respiratory failure,potassium two pore domain channel subfamily k member 3
1101,doxapram,respiratory failure,potassium two pore domain channel subfamily k member 9
1102,etodolac,pain,prostaglandin-endoperoxide synthase 2
1103,etodolac,pain,prostaglandin-endoperoxide synthase 1
1104,etodolac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1105,etodolac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1106,etodolac,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1107,etodolac,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1108,etodolac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1109,etodolac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1110,levosalbutamol,bronchial disorder,adrenoceptor beta 2
1111,tripelennamine,sneeze,histamine receptor h1
1112,tripelennamine,pruritus,histamine receptor h1
1113,tripelennamine,atopic conjunctivitis,histamine receptor h1
1114,tripelennamine,allergic rhinitis,histamine receptor h1
1115,tripelennamine,urticaria,histamine receptor h1
1116,tripelennamine,vasomotor rhinitis,histamine receptor h1
1117,nortriptyline,depressive disorder,solute carrier family 6 member 2
1118,nortriptyline,depressive disorder,solute carrier family 6 member 4
1119,triprolidine,pruritus,histamine receptor h1
1120,triprolidine,urticaria,histamine receptor h1
1121,triprolidine,allergic rhinitis,histamine receptor h1
1122,triprolidine,atopic conjunctivitis,histamine receptor h1
1123,triprolidine,common cold,histamine receptor h1
1124,triprolidine,vasomotor rhinitis,histamine receptor h1
1125,triprolidine,seasonal allergic rhinitis,histamine receptor h1
1126,pregabalin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
1127,pregabalin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
1128,glycopyrrolate,peptic ulcer disease,cholinergic receptor muscarinic 3
1129,glycopyrrolate,peptic ulcer disease,cholinergic receptor muscarinic 1
1130,glycopyrrolate,drooling,cholinergic receptor muscarinic 3
1131,glycopyrrolate,drooling,cholinergic receptor muscarinic 1
1132,glycopyrrolate,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
1133,vonoprazan,gastric ulcer,atpase h+/k+ transporting subunit alpha
1134,vonoprazan,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1135,diflorasone diacetate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1136,diflorasone diacetate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1137,diflorasone diacetate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1138,diflorasone diacetate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1139,diflorasone diacetate,exanthem,nuclear receptor subfamily 3 group c member 1
1140,diflorasone diacetate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1141,diflorasone diacetate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1142,diflorasone diacetate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1143,carmustine,diffuse large b-cell lymphoma,glutathione-disulfide reductase
1144,carmustine,plasma cell myeloma,glutathione-disulfide reductase
1145,carmustine,glioma,glutathione-disulfide reductase
1146,carmustine,classic hodgkin lymphoma,glutathione-disulfide reductase
1147,carmustine,brain cancer,glutathione-disulfide reductase
1148,carmustine,non-hodgkin lymphoma,glutathione-disulfide reductase
1149,dibucaine,pruritus,sodium voltage-gated channel alpha subunit 10
1150,dibucaine,pruritus,sodium voltage-gated channel alpha subunit 5
1151,doxazosin,hypertensive disorder,adrenoceptor alpha 1a
1152,doxazosin,hypertensive disorder,adrenoceptor alpha 1d
1153,doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1154,doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1155,loteprednol etabonate,iritis,nuclear receptor subfamily 3 group c member 1
1156,loteprednol etabonate,uveitis,nuclear receptor subfamily 3 group c member 1
1157,loteprednol etabonate,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
1158,loteprednol etabonate,iridocyclitis,nuclear receptor subfamily 3 group c member 1
1159,loteprednol etabonate,anterior uveitis,nuclear receptor subfamily 3 group c member 1
1160,apremilast,psoriatic arthritis,phosphodiesterase 4a
1161,apremilast,psoriatic arthritis,phosphodiesterase 4b
1162,apremilast,psoriatic arthritis,phosphodiesterase 4c
1163,apremilast,psoriatic arthritis,phosphodiesterase 4d
1164,levobetaxolol,open-angle glaucoma,adrenoceptor beta 1
1165,levobetaxolol,ocular hypertension,adrenoceptor beta 1
1166,nafarelin,endometriosis,gonadotropin releasing hormone receptor
1167,nafarelin,precocious puberty,gonadotropin releasing hormone receptor
1168,pethidine,labor pain,opioid receptor kappa 1
1169,pethidine,labor pain,opioid receptor mu 1
1170,pethidine,pain,opioid receptor kappa 1
1171,pethidine,pain,opioid receptor mu 1
1172,brinzolamide,ocular hypertension,carbonic anhydrase 2
1173,brinzolamide,open-angle glaucoma,carbonic anhydrase 2
1174,ezetimibe,sitosterolemia,npc1 like intracellular cholesterol transporter 1
1175,ezetimibe,hyperlipidemia,npc1 like intracellular cholesterol transporter 1
1176,ezetimibe,"hyperlipidemia, familial combined, lpl related",npc1 like intracellular cholesterol transporter 1
1177,ezetimibe,hypercholesterolemia,npc1 like intracellular cholesterol transporter 1
1178,lisinopril,myocardial infarction,angiotensin i converting enzyme
1179,lisinopril,hypertensive disorder,angiotensin i converting enzyme
1180,eptifibatide,acute coronary syndrome,integrin subunit beta 3
1181,eptifibatide,acute coronary syndrome,integrin subunit alpha 2b
1182,pantoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
1183,pantoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
1184,pantoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1185,pantoprazole,multiple endocrine neoplasia,atpase h+/k+ transporting subunit alpha
1186,gefitinib,non-small cell lung carcinoma,epidermal growth factor receptor
1187,lisuride,amenorrhea,dopamine receptor d2
1188,lisuride,acromegaly,dopamine receptor d2
1189,eprosartan,hypertensive disorder,angiotensin ii receptor type 1
1190,pemetrexed,non-small cell lung carcinoma,thymidylate synthetase
1191,pemetrexed,non-small cell lung carcinoma,dihydrofolate reductase
1192,pemetrexed,non-small cell lung carcinoma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
1193,pemetrexed,non-small cell lung carcinoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1194,tocilizumab,castleman disease,interleukin 6 receptor
1195,tocilizumab,temporal arteritis,interleukin 6 receptor
1196,tocilizumab,rheumatoid arthritis,interleukin 6 receptor
1197,tocilizumab,juvenile idiopathic arthritis,interleukin 6 receptor
1198,safinamide,parkinson disease,monoamine oxidase b
1199,opipramol,depressive disorder,sigma non-opioid intracellular receptor 1
1200,acetophenazine,psychotic disorder,dopamine receptor d2
1201,goserelin,endometriosis,gonadotropin releasing hormone receptor
1202,dromostanolone propionate,breast neoplasm,androgen receptor
1203,tetrabenazine,huntington disease,solute carrier family 18 member a2
1204,tranilast,asthma,histamine receptor h1
1205,tranilast,allergic rhinitis,histamine receptor h1
1206,tranilast,allergic rhinitis,prostaglandin-endoperoxide synthase 2
1207,tranilast,"dermatitis, atopic",histamine receptor h1
1208,tranilast,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
1209,tranilast,keloid,histamine receptor h1
1210,tranilast,"cicatrix, hypertrophic",histamine receptor h1
1211,loperamide,diarrheal disease,opioid receptor mu 1
1212,levodopa,parkinsonian disorder,dopamine receptor d1
1213,levodopa,parkinsonian disorder,dopamine receptor d5
1214,levodopa,parkinsonian disorder,dopamine receptor d2
1215,levodopa,parkinsonian disorder,dopamine receptor d3
1216,levodopa,parkinsonian disorder,dopamine receptor d4
1217,formoterol,chronic bronchitis,adrenoceptor beta 2
1218,formoterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
1219,mesuximide,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
1220,mesuximide,epilepsy,calcium voltage-gated channel subunit alpha1 g
1221,tofacitinib,rheumatoid arthritis,janus kinase 1
1222,tofacitinib,rheumatoid arthritis,janus kinase 3
1223,isoxsuprine,vascular disorder,adrenoceptor beta 2
1224,isoxsuprine,raynaud disease,adrenoceptor beta 2
1225,tenofovir alafenamide,depressive disorder,monoamine oxidase a
1226,pamidronic acid,bone paget disease,farnesyl diphosphate synthase
1227,pamidronic acid,bone paget disease,geranylgeranyl diphosphate synthase 1
1228,pamidronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
1229,pamidronic acid,humoral hypercalcemia of malignancy,geranylgeranyl diphosphate synthase 1
1230,rofecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1231,rofecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
1232,rofecoxib,migraine disorder,prostaglandin-endoperoxide synthase 2
1233,rofecoxib,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1234,rofecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1235,rofecoxib,pain,prostaglandin-endoperoxide synthase 2
1236,flumethasone pivalate,exanthem,nuclear receptor subfamily 3 group c member 1
1237,flumethasone pivalate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1238,flumethasone pivalate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1239,flumethasone pivalate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1240,flumethasone pivalate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1241,flumethasone pivalate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1242,flumethasone pivalate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1243,flumethasone pivalate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1244,flumethasone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1245,dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 3
1246,sulpiride,schizophrenia,dopamine receptor d2
1247,sulpiride,schizophrenia,dopamine receptor d3
1248,lercanidipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
1249,cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 4
1250,cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3a
1251,cisapride,gastroesophageal reflux disease,5-hydroxytryptamine receptor 2a
1252,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 1
1253,promethazine,atopic conjunctivitis,histamine receptor h1
1254,promethazine,seasonal allergic rhinitis,histamine receptor h1
1255,promethazine,vasomotor rhinitis,histamine receptor h1
1256,promethazine,urticaria,histamine receptor h1
1257,sertraline,depressive disorder,solute carrier family 6 member 4
1258,sertraline,social phobia,solute carrier family 6 member 4
1259,sertraline,premenstrual dysphoric disorder,solute carrier family 6 member 4
1260,sertraline,obsessive-compulsive disorder,solute carrier family 6 member 4
1261,sertraline,post-traumatic stress disorder,solute carrier family 6 member 4
1262,sertraline,panic disorder,solute carrier family 6 member 4
1263,penbutolol,hypertensive disorder,adrenoceptor beta 1
1264,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
1265,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
1266,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 3
1267,vorinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 6
1268,nilotinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
1269,lobeglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
1270,phentermine,hypotensive disorder,solute carrier family 6 member 2
1271,phentermine,obesity disorder,solute carrier family 6 member 2
1272,phentermine,obesity disorder,neuropeptide y
1273,methoxamine,hypotensive disorder,adrenoceptor alpha 1a
1274,methoxamine,hypotensive disorder,adrenoceptor alpha 1b
1275,pomalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
1276,pomalidomide,plasma cell myeloma,tumor necrosis factor
1277,aliskiren,hypertensive disorder,renin
1278,flurbiprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
1279,flurbiprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
1280,flurbiprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1281,flurbiprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1282,eldecalcitol,osteoporosis,vitamin d receptor
1283,camphor,back pain,transient receptor potential cation channel subfamily a member 1
1284,desvenlafaxine,major depressive disorder,solute carrier family 6 member 4
1285,desvenlafaxine,major depressive disorder,solute carrier family 6 member 2
1286,desvenlafaxine,major depressive disorder,solute carrier family 6 member 3
1287,nalbuphine,pain,opioid receptor kappa 1
1288,nalbuphine,labor pain,opioid receptor kappa 1
1289,diphenhydramine,vasomotor rhinitis,histamine receptor h1
1290,diphenhydramine,seasonal allergic rhinitis,histamine receptor h1
1291,diphenhydramine,atopic conjunctivitis,histamine receptor h1
1292,paclitaxel,ovarian cancer,tubulin beta 1 class vi
1293,paclitaxel,ovarian cancer,bcl2 apoptosis regulator
1294,paclitaxel,non-small cell lung carcinoma,tubulin beta 1 class vi
1295,paclitaxel,non-small cell lung carcinoma,bcl2 apoptosis regulator
1296,paclitaxel,breast neoplasm,tubulin beta 1 class vi
1297,paclitaxel,breast neoplasm,bcl2 apoptosis regulator
1298,paclitaxel,kaposi's sarcoma,tubulin beta 1 class vi
1299,paclitaxel,kaposi's sarcoma,bcl2 apoptosis regulator
1300,felbinac,pain,prostaglandin-endoperoxide synthase 2
1301,felbinac,pain,prostaglandin-endoperoxide synthase 1
1302,felbinac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1303,felbinac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1304,vilanterol,chronic obstructive pulmonary disease,adrenoceptor beta 2
1305,vilanterol,pulmonary emphysema,adrenoceptor beta 2
1306,vilanterol,chronic bronchitis,adrenoceptor beta 2
1307,vilanterol,asthma,adrenoceptor beta 2
1308,tranylcypromine,major depressive disorder,monoamine oxidase b
1309,tranylcypromine,major depressive disorder,monoamine oxidase a
1310,propantheline,peptic ulcer disease,cholinergic receptor muscarinic 3
1311,tacrolimus,"dermatitis, atopic",fkbp prolyl isomerase 1a
1312,methyclothiazide,edema,solute carrier family 12 member 3
1313,tolmetin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1314,tolmetin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1315,tolmetin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1316,tolmetin,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1317,tolmetin,osteoarthritis,prostaglandin-endoperoxide synthase 2
1318,tolmetin,osteoarthritis,prostaglandin-endoperoxide synthase 1
1319,candesartan,hypertensive disorder,angiotensin ii receptor type 1
1320,milnacipran,fibromyalgia,solute carrier family 6 member 4
1321,milnacipran,fibromyalgia,solute carrier family 6 member 2
1322,armodafinil,narcolepsy,solute carrier family 6 member 3
1323,alclometasone dipropionate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1324,alclometasone dipropionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1325,alclometasone dipropionate,exanthem,nuclear receptor subfamily 3 group c member 1
1326,alclometasone dipropionate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1327,alclometasone dipropionate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1328,alclometasone dipropionate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1329,alclometasone dipropionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1330,alclometasone dipropionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1331,alclometasone dipropionate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1332,vardenafil,erectile dysfunction,phosphodiesterase 5a
1333,trifluridine,colonic neoplasm,thymidylate synthetase
1334,paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 g
1335,paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 h
1336,paramethadione,absence epilepsy,calcium voltage-gated channel subunit alpha1 i
1337,paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 g
1338,paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 h
1339,paramethadione,epilepsy,calcium voltage-gated channel subunit alpha1 i
1340,meloxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1341,meloxicam,osteoarthritis,prostaglandin-endoperoxide synthase 2
1342,meloxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1343,dimethyl fumarate,psoriasis,hydroxycarboxylic acid receptor 2
1344,moxonidine,essential hypertension,adrenoceptor alpha 2a
1345,moxonidine,essential hypertension,nischarin
1346,istradefylline,parkinson disease,adenosine a2a receptor
1347,alclofenac,pain,prostaglandin-endoperoxide synthase 2
1348,reserpine,psychotic disorder,solute carrier family 18 member a2
1349,reserpine,hypertensive disorder,solute carrier family 18 member a2
1350,clomipramine,obsessive-compulsive disorder,solute carrier family 6 member 4
1351,midostaurin,systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
1352,midostaurin,acute myeloid leukemia,fms related receptor tyrosine kinase 3
1353,midostaurin,acute myeloid leukemia,"kit proto-oncogene, receptor tyrosine kinase"
1354,midostaurin,acute myeloid leukemia,protein kinase c alpha
1355,midostaurin,acute myeloid leukemia,platelet derived growth factor receptor beta
1356,midostaurin,acute myeloid leukemia,platelet derived growth factor receptor alpha
1357,midostaurin,acute myeloid leukemia,kinase insert domain receptor
1358,midostaurin,mast cell leukemia,fms related receptor tyrosine kinase 3
1359,midostaurin,mast cell leukemia,"kit proto-oncogene, receptor tyrosine kinase"
1360,midostaurin,mast cell leukemia,protein kinase c alpha
1361,midostaurin,mast cell leukemia,platelet derived growth factor receptor beta
1362,midostaurin,mast cell leukemia,platelet derived growth factor receptor alpha
1363,midostaurin,mast cell leukemia,kinase insert domain receptor
1364,phentolamine,peripheral vascular disease,adrenoceptor alpha 1b
1365,phentolamine,peripheral vascular disease,adrenoceptor alpha 1a
1366,phentolamine,peripheral vascular disease,adrenoceptor alpha 1d
1367,phentolamine,pheochromocytoma,adrenoceptor alpha 1b
1368,phentolamine,pheochromocytoma,adrenoceptor alpha 1a
1369,phentolamine,pheochromocytoma,adrenoceptor alpha 1d
1370,bunazosin,essential hypertension,adrenoceptor alpha 1a
1371,bunazosin,essential hypertension,adrenoceptor alpha 1d
1372,loratadine,sneeze,histamine receptor h1
1373,loratadine,vasomotor rhinitis,histamine receptor h1
1374,loratadine,seasonal allergic rhinitis,histamine receptor h1
1375,loratadine,common cold,histamine receptor h1
1376,loratadine,atopic conjunctivitis,histamine receptor h1
1377,fludarabine,b-cell chronic lymphocytic leukemia,"dna polymerase alpha 1, catalytic subunit"
1378,fludarabine,b-cell chronic lymphocytic leukemia,ribonucleotide reductase catalytic subunit m1
1379,fludarabine,b-cell chronic lymphocytic leukemia,dna primase subunit 2
1380,tiagabine,focal epilepsy,solute carrier family 6 member 1
1381,raloxifene,postmenopausal osteoporosis,estrogen receptor 1
1382,raloxifene,postmenopausal osteoporosis,estrogen receptor 2
1383,lornoxicam,pain,prostaglandin-endoperoxide synthase 1
1384,lornoxicam,pain,prostaglandin-endoperoxide synthase 2
1385,solifenacin,urge incontinence,cholinergic receptor muscarinic 3
1386,solifenacin,urge incontinence,cholinergic receptor muscarinic 2
1387,tolcapone,parkinson disease,catechol-o-methyltransferase
1388,diclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1389,diclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1390,diclofenac,actinic keratosis,prostaglandin-endoperoxide synthase 2
1391,diclofenac,actinic keratosis,prostaglandin-endoperoxide synthase 1
1392,diclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1393,diclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1394,diclofenac,pain,prostaglandin-endoperoxide synthase 2
1395,diclofenac,pain,prostaglandin-endoperoxide synthase 1
1396,diclofenac,dysmenorrhea,prostaglandin-endoperoxide synthase 1
1397,diclofenac,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1398,diclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1399,diclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1400,tolterodine,urge incontinence,cholinergic receptor muscarinic 3
1401,dihydrotachysterol,hypophosphatemia,vitamin d receptor
1402,dihydrotachysterol,hypoparathyroidism,vitamin d receptor
1403,dihydrotachysterol,hypocalcemia,vitamin d receptor
1404,dihydrotachysterol,rickets,vitamin d receptor
1405,dihydrotachysterol,tetany,vitamin d receptor
1406,molindone,schizophrenia,dopamine receptor d2
1407,somatrem,pituitary dwarfism,growth hormone receptor
1408,lesinurad,hyperuricemia,solute carrier family 22 member 12
1409,lesinurad,hyperuricemia,solute carrier family 22 member 11
1410,imrecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
1411,desmopressin,polyuria,arginine vasopressin receptor 2
1412,desmopressin,hemophilia a,arginine vasopressin receptor 2
1413,desmopressin,nocturnal enuresis,arginine vasopressin receptor 2
1414,ulobetasol propionate,pruritus ani,nuclear receptor subfamily 3 group c member 1
1415,ulobetasol propionate,exanthem,nuclear receptor subfamily 3 group c member 1
1416,ulobetasol propionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1417,ulobetasol propionate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1418,ulobetasol propionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1419,ulobetasol propionate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1420,ulobetasol propionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1421,ulobetasol propionate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1422,sulindac,tendinopathy,prostaglandin-endoperoxide synthase 1
1423,sulindac,tendinopathy,prostaglandin-endoperoxide synthase 2
1424,sulindac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1425,sulindac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1426,sulindac,gout,prostaglandin-endoperoxide synthase 1
1427,sulindac,gout,prostaglandin-endoperoxide synthase 2
1428,sulindac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1429,sulindac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1430,sulindac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1431,sulindac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1432,sulindac,bursitis,prostaglandin-endoperoxide synthase 2
1433,sulindac,bursitis,prostaglandin-endoperoxide synthase 1
1434,silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1435,silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
1436,silodosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1437,toloxatone,depressive disorder,monoamine oxidase a
1438,vinblastine,kaposi's sarcoma,tubulin alpha 1a
1439,vinblastine,kaposi's sarcoma,tubulin beta class i
1440,vinblastine,kaposi's sarcoma,tubulin delta 1
1441,vinblastine,kaposi's sarcoma,tubulin gamma 1
1442,vinblastine,kaposi's sarcoma,tubulin epsilon 1
1443,vinblastine,mycosis fungoides,tubulin alpha 1a
1444,vinblastine,mycosis fungoides,tubulin beta class i
1445,vinblastine,mycosis fungoides,tubulin delta 1
1446,vinblastine,mycosis fungoides,tubulin gamma 1
1447,vinblastine,mycosis fungoides,tubulin epsilon 1
1448,vinblastine,non-hodgkin lymphoma,tubulin alpha 1a
1449,vinblastine,non-hodgkin lymphoma,tubulin beta class i
1450,vinblastine,non-hodgkin lymphoma,tubulin delta 1
1451,vinblastine,non-hodgkin lymphoma,tubulin gamma 1
1452,vinblastine,non-hodgkin lymphoma,tubulin epsilon 1
1453,vinblastine,testicular cancer,tubulin alpha 1a
1454,vinblastine,testicular cancer,tubulin beta class i
1455,vinblastine,testicular cancer,tubulin delta 1
1456,vinblastine,testicular cancer,tubulin gamma 1
1457,vinblastine,testicular cancer,tubulin epsilon 1
1458,vinblastine,langerhans cell histiocytosis,tubulin alpha 1a
1459,vinblastine,langerhans cell histiocytosis,tubulin beta class i
1460,vinblastine,langerhans cell histiocytosis,tubulin delta 1
1461,vinblastine,langerhans cell histiocytosis,tubulin gamma 1
1462,vinblastine,langerhans cell histiocytosis,tubulin epsilon 1
1463,vinblastine,classic hodgkin lymphoma,tubulin alpha 1a
1464,vinblastine,classic hodgkin lymphoma,tubulin beta class i
1465,vinblastine,classic hodgkin lymphoma,tubulin delta 1
1466,vinblastine,classic hodgkin lymphoma,tubulin gamma 1
1467,vinblastine,classic hodgkin lymphoma,tubulin epsilon 1
1468,vinblastine,"hydatidiform mole, recurrent, 1",tubulin alpha 1a
1469,vinblastine,"hydatidiform mole, recurrent, 1",tubulin beta class i
1470,vinblastine,"hydatidiform mole, recurrent, 1",tubulin delta 1
1471,vinblastine,"hydatidiform mole, recurrent, 1",tubulin gamma 1
1472,vinblastine,"hydatidiform mole, recurrent, 1",tubulin epsilon 1
1473,sunitinib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
1474,sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 1
1475,sunitinib,gastrointestinal stromal tumor,"kit proto-oncogene, receptor tyrosine kinase"
1476,sunitinib,gastrointestinal stromal tumor,kinase insert domain receptor
1477,sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 4
1478,sunitinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 3
1479,sunitinib,gastrointestinal stromal tumor,colony stimulating factor 1 receptor
1480,sunitinib,gastrointestinal stromal tumor,platelet derived growth factor receptor alpha
1481,sunitinib,renal cell carcinoma,platelet derived growth factor receptor beta
1482,sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 1
1483,sunitinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
1484,sunitinib,renal cell carcinoma,kinase insert domain receptor
1485,sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 4
1486,sunitinib,renal cell carcinoma,fms related receptor tyrosine kinase 3
1487,sunitinib,renal cell carcinoma,colony stimulating factor 1 receptor
1488,sunitinib,renal cell carcinoma,platelet derived growth factor receptor alpha
1489,warfarin,thromboembolism,vitamin k epoxide reductase complex subunit 1
1490,warfarin,intracranial embolism,vitamin k epoxide reductase complex subunit 1
1491,warfarin,thrombophilia due to thrombin defect,vitamin k epoxide reductase complex subunit 1
1492,warfarin,thrombotic disease,vitamin k epoxide reductase complex subunit 1
1493,tipiracil,colonic neoplasm,thymidine phosphorylase
1494,sermorelin,pituitary dwarfism,growth hormone releasing hormone receptor
1495,nadolol,hypertensive disorder,adrenoceptor beta 1
1496,nadolol,angina pectoris,adrenoceptor beta 1
1497,mephentermine,hypotensive disorder,adrenoceptor alpha 1a
1498,mephentermine,hypotensive disorder,adrenoceptor alpha 1b
1499,mephentermine,hypotensive disorder,adrenoceptor alpha 1d
1500,mephentermine,hypotensive disorder,adrenoceptor beta 1
1501,albiglutide,type 2 diabetes mellitus,glucagon like peptide 1 receptor
1502,thiothixene,schizophrenia,dopamine receptor d2
1503,thiothixene,schizophrenia,5-hydroxytryptamine receptor 2a
1504,phenindamine,urticaria,histamine receptor h1
1505,phenindamine,pruritus,histamine receptor h1
1506,phenindamine,sneeze,histamine receptor h1
1507,phenindamine,allergic rhinitis,histamine receptor h1
1508,phenindamine,vasomotor rhinitis,histamine receptor h1
1509,phenindamine,atopic conjunctivitis,histamine receptor h1
1510,fluoxymesterone,delayed puberty,androgen receptor
1511,fluoxymesterone,klinefelter syndrome,androgen receptor
1512,fluoxymesterone,cryptorchidism,androgen receptor
1513,trichlormethiazide,hypertensive disorder,solute carrier family 12 member 3
1514,gemtuzumab ozogamicin,acute myeloid leukemia,cd33 molecule
1515,nitisinone,tyrosinemia,4-hydroxyphenylpyruvate dioxygenase
1516,colestipol,hypercholesterolemia,low density lipoprotein receptor
1517,colestipol,hyperlipidemia,low density lipoprotein receptor
1518,guanabenz,hypertensive disorder,adrenoceptor alpha 2a
1519,tamoxifen,breast ductal adenocarcinoma,estrogen receptor 1
1520,tamoxifen,breast ductal adenocarcinoma,estrogen receptor 2
1521,norethisterone,endometriosis,progesterone receptor
1522,norethisterone,metrorrhagia,progesterone receptor
1523,danazol,endometriosis,gonadotropin releasing hormone receptor
1524,danazol,endometriosis,androgen receptor
1525,fluorometholone,uveitis,nuclear receptor subfamily 3 group c member 1
1526,fluorometholone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
1527,fluorometholone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
1528,chlorpropamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1529,pentoxifylline,peripheral vascular disease,phosphodiesterase 3a
1530,pentoxifylline,peripheral vascular disease,phosphodiesterase 3b
1531,pentoxifylline,peripheral vascular disease,adenosine a2a receptor
1532,famotidine,gastric ulcer,histamine receptor h2
1533,famotidine,gastroesophageal reflux disease,histamine receptor h2
1534,famotidine,dyspepsia,histamine receptor h2
1535,famotidine,zollinger-ellison syndrome,histamine receptor h2
1536,famotidine,duodenal ulcer,histamine receptor h2
1537,famotidine,peptic esophagitis,histamine receptor h2
1538,carteolol,open-angle glaucoma,adrenoceptor beta 2
1539,carteolol,open-angle glaucoma,adrenoceptor beta 1
1540,carteolol,hypertensive disorder,adrenoceptor beta 2
1541,carteolol,hypertensive disorder,adrenoceptor beta 1
1542,carteolol,ocular hypertension,adrenoceptor beta 2
1543,carteolol,ocular hypertension,adrenoceptor beta 1
1544,acth,stevens-johnson syndrome,melanocortin 2 receptor
1545,acth,west syndrome,melanocortin 2 receptor
1546,bromfenac,pain,prostaglandin-endoperoxide synthase 1
1547,bromfenac,pain,prostaglandin-endoperoxide synthase 2
1548,aceclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1549,aceclofenac,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1550,aceclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1551,aceclofenac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1552,aceclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 1
1553,aceclofenac,osteoarthritis,prostaglandin-endoperoxide synthase 2
1554,aceclofenac,back pain,prostaglandin-endoperoxide synthase 1
1555,aceclofenac,back pain,prostaglandin-endoperoxide synthase 2
1556,rabeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1557,rabeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
1558,rabeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
1559,rabeprazole,systemic mastocytosis,atpase h+/k+ transporting subunit alpha
1560,rabeprazole,multiple endocrine neoplasia,atpase h+/k+ transporting subunit alpha
1561,rabeprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1562,celecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
1563,celecoxib,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1564,celecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1565,celecoxib,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1566,celecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1567,rasagiline,parkinson disease,bcl2 apoptosis regulator
1568,rasagiline,parkinson disease,monoamine oxidase b
1569,trihexyphenidyl,parkinson disease,cholinergic receptor muscarinic 1
1570,trihexyphenidyl,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
1571,trihexyphenidyl,basal ganglia disorder,cholinergic receptor muscarinic 1
1572,trihexyphenidyl,parkinsonian disorder,cholinergic receptor muscarinic 1
1573,methotrexate,head and neck neoplasm,thymidylate synthetase
1574,methotrexate,head and neck neoplasm,dihydrofolate reductase
1575,methotrexate,head and neck neoplasm,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1576,methotrexate,burkitt lymphoma,thymidylate synthetase
1577,methotrexate,burkitt lymphoma,dihydrofolate reductase
1578,methotrexate,burkitt lymphoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1579,methotrexate,lung neoplasm,thymidylate synthetase
1580,methotrexate,lung neoplasm,dihydrofolate reductase
1581,methotrexate,lung neoplasm,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1582,methotrexate,non-hodgkin lymphoma,thymidylate synthetase
1583,methotrexate,non-hodgkin lymphoma,dihydrofolate reductase
1584,methotrexate,non-hodgkin lymphoma,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1585,methotrexate,mycosis fungoides,thymidylate synthetase
1586,methotrexate,mycosis fungoides,dihydrofolate reductase
1587,methotrexate,mycosis fungoides,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1588,methotrexate,"hydatidiform mole, recurrent, 1",thymidylate synthetase
1589,methotrexate,"hydatidiform mole, recurrent, 1",dihydrofolate reductase
1590,methotrexate,"hydatidiform mole, recurrent, 1",5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
1591,maprotiline,depressive disorder,solute carrier family 6 member 2
1592,macitentan,pulmonary arterial hypertension,endothelin receptor type a
1593,macitentan,pulmonary arterial hypertension,endothelin receptor type b
1594,progesterone,metrorrhagia,progesterone receptor
1595,progesterone,endometriosis,progesterone receptor
1596,progesterone,endometrium neoplasm,progesterone receptor
1597,tapentadol,pain,opioid receptor mu 1
1598,tapentadol,pain,solute carrier family 6 member 2
1599,udenafil,erectile dysfunction,phosphodiesterase 5a
1600,tafluprost,ocular hypertension,prostaglandin f receptor
1601,tafluprost,open-angle glaucoma,prostaglandin f receptor
1602,acarbose,type 2 diabetes mellitus,amylase alpha 2a
1603,acarbose,type 2 diabetes mellitus,maltase-glucoamylase
1604,probucol,hypercholesterolemia,atp binding cassette subfamily a member 1
1605,probucol,hyperlipidemia,atp binding cassette subfamily a member 1
1606,migalastat,fabry disease,galactosidase alpha
1607,orciprenaline,asthma,adrenoceptor beta 2
1608,orciprenaline,bronchitis,adrenoceptor beta 2
1609,orciprenaline,pulmonary emphysema,adrenoceptor beta 2
1610,ibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
1611,ibuprofen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
1612,ibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
1613,ibuprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
1614,ibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
1615,ibuprofen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
1616,ibuprofen,headache disorder,prostaglandin-endoperoxide synthase 1
1617,ibuprofen,headache disorder,prostaglandin-endoperoxide synthase 2
1618,ibuprofen,fever,prostaglandin-endoperoxide synthase 1
1619,ibuprofen,fever,prostaglandin-endoperoxide synthase 2
1620,ibuprofen,patent ductus arteriosus,prostaglandin-endoperoxide synthase 1
1621,ibuprofen,patent ductus arteriosus,prostaglandin-endoperoxide synthase 2
1622,ibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1623,ibuprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1624,ibuprofen,pain,prostaglandin-endoperoxide synthase 2
1625,ibuprofen,pain,prostaglandin-endoperoxide synthase 1
1626,docetaxel,prostate cancer,tubulin beta 1 class vi
1627,docetaxel,prostate cancer,bcl2 apoptosis regulator
1628,docetaxel,non-small cell lung carcinoma,tubulin beta 1 class vi
1629,docetaxel,non-small cell lung carcinoma,bcl2 apoptosis regulator
1630,docetaxel,breast neoplasm,tubulin beta 1 class vi
1631,docetaxel,breast neoplasm,bcl2 apoptosis regulator
1632,docetaxel,head and neck neoplasm,tubulin beta 1 class vi
1633,docetaxel,head and neck neoplasm,bcl2 apoptosis regulator
1634,docetaxel,gastric neoplasm,tubulin beta 1 class vi
1635,docetaxel,gastric neoplasm,bcl2 apoptosis regulator
1636,dexamfetamine,narcolepsy,solute carrier family 6 member 2
1637,dexamfetamine,narcolepsy,solute carrier family 6 member 3
1638,dexamfetamine,narcolepsy,solute carrier family 18 member a2
1639,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
1640,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
1641,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
1642,edoxaban,pulmonary embolism,coagulation factor x
1643,edoxaban,embolism,coagulation factor x
1644,ergotamine,vascular headaches,adrenoceptor alpha 1a
1645,ergotamine,vascular headaches,adrenoceptor alpha 2a
1646,ergotamine,vascular headaches,adrenoceptor alpha 2c
1647,ergotamine,vascular headaches,adrenoceptor alpha 1d
1648,ergotamine,vascular headaches,adrenoceptor alpha 1b
1649,ergotamine,vascular headaches,adrenoceptor alpha 2b
1650,ergotamine,vascular headaches,5-hydroxytryptamine receptor 1d
1651,ergotamine,migraine disorder,adrenoceptor alpha 1a
1652,ergotamine,migraine disorder,adrenoceptor alpha 2a
1653,ergotamine,migraine disorder,adrenoceptor alpha 2c
1654,ergotamine,migraine disorder,adrenoceptor alpha 1d
1655,ergotamine,migraine disorder,adrenoceptor alpha 1b
1656,ergotamine,migraine disorder,adrenoceptor alpha 2b
1657,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1d
1658,ergotamine,cluster headache syndrome,adrenoceptor alpha 1a
1659,ergotamine,cluster headache syndrome,adrenoceptor alpha 2a
1660,ergotamine,cluster headache syndrome,adrenoceptor alpha 2c
1661,ergotamine,cluster headache syndrome,adrenoceptor alpha 1d
1662,ergotamine,cluster headache syndrome,adrenoceptor alpha 1b
1663,ergotamine,cluster headache syndrome,adrenoceptor alpha 2b
1664,ergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1d
1665,meclizine,motion sickness,histamine receptor h1
1666,meclizine,central nervous system origin vertigo,histamine receptor h1
1667,dimenhydrinate,motion sickness,histamine receptor h1
1668,dimenhydrinate,nausea,histamine receptor h1
1669,dimenhydrinate,central nervous system origin vertigo,histamine receptor h1
1670,dimenhydrinate,vomiting,histamine receptor h1
1671,hydroflumethiazide,edema,solute carrier family 12 member 3
1672,atenolol,myocardial infarction,adrenoceptor beta 1
1673,atenolol,angina pectoris,adrenoceptor beta 1
1674,atenolol,hypertensive disorder,adrenoceptor beta 1
1675,metipranolol,ocular hypertension,adrenoceptor beta 1
1676,metipranolol,ocular hypertension,adrenoceptor beta 2
1677,metipranolol,open-angle glaucoma,adrenoceptor beta 1
1678,metipranolol,open-angle glaucoma,adrenoceptor beta 2
1679,pirbuterol,bronchitis,adrenoceptor beta 2
1680,pirbuterol,asthma,adrenoceptor beta 2
1681,pirbuterol,pulmonary emphysema,adrenoceptor beta 2
1682,pirbuterol,bronchiectasis,adrenoceptor beta 2
1683,pirbuterol,lung disorder,adrenoceptor beta 2
1684,oxprenolol,angina pectoris,adrenoceptor beta 1
1685,oxprenolol,angina pectoris,adrenoceptor beta 2
1686,oxprenolol,hypertensive disorder,adrenoceptor beta 1
1687,oxprenolol,hypertensive disorder,adrenoceptor beta 2
1688,oxprenolol,anxiety,adrenoceptor beta 1
1689,oxprenolol,anxiety,adrenoceptor beta 2
1690,tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1691,tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1692,captopril,hypertensive disorder,angiotensin i converting enzyme
1693,captopril,diabetic kidney disease,angiotensin i converting enzyme
1694,sofalcone,gastric ulcer,15-hydroxyprostaglandin dehydrogenase
1695,ecallantide,hereditary angioedema,kallikrein b1
1696,ticagrelor,acute coronary syndrome,purinergic receptor p2y12
1697,ticagrelor,peripheral vascular disease,purinergic receptor p2y12
1698,tramazoline,seasonal allergic rhinitis,adrenoceptor alpha 2a
1699,tramazoline,allergic rhinitis,adrenoceptor alpha 2a
1700,tramazoline,atopic conjunctivitis,adrenoceptor alpha 2a
1701,tramazoline,sneeze,adrenoceptor alpha 2a
1702,tramazoline,vasomotor rhinitis,adrenoceptor alpha 2a
1703,tramazoline,common cold,adrenoceptor alpha 2a
1704,prazosin,hypertensive disorder,adrenoceptor alpha 1a
1705,prazosin,hypertensive disorder,adrenoceptor alpha 1b
1706,prazosin,hypertensive disorder,adrenoceptor alpha 1d
1707,methdilazine,sneeze,histamine receptor h1
1708,methdilazine,atopic conjunctivitis,histamine receptor h1
1709,methdilazine,angioedema,histamine receptor h1
1710,methdilazine,allergic rhinitis,histamine receptor h1
1711,methdilazine,pruritus,histamine receptor h1
1712,methdilazine,urticaria,histamine receptor h1
1713,mitiglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1714,parathyroid hormone,hypoparathyroidism,parathyroid hormone 1 receptor
1715,calcium acetate,hypocalcemia,calcium sensing receptor
1716,lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 10
1717,lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 9
1718,lidocaine,neuralgia,sodium voltage-gated channel alpha subunit 5
1719,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 10
1720,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 9
1721,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 5
1722,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 10
1723,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 9
1724,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 5
1725,lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 10
1726,lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 9
1727,lidocaine,postherpetic neuralgia,sodium voltage-gated channel alpha subunit 5
1728,lidocaine,pruritus,sodium voltage-gated channel alpha subunit 10
1729,lidocaine,pruritus,sodium voltage-gated channel alpha subunit 9
1730,lidocaine,pruritus,sodium voltage-gated channel alpha subunit 5
1731,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 10
1732,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 9
1733,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 5
1734,lidocaine,scabies,sodium voltage-gated channel alpha subunit 10
1735,lidocaine,scabies,sodium voltage-gated channel alpha subunit 9
1736,lidocaine,scabies,sodium voltage-gated channel alpha subunit 5
1737,lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 10
1738,lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 9
1739,lidocaine,pruritus ani,sodium voltage-gated channel alpha subunit 5
1740,nateglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1741,pseudoephedrine,common cold,adrenoceptor alpha 1a
1742,pseudoephedrine,common cold,adrenoceptor beta 2
1743,pseudoephedrine,allergic rhinitis,adrenoceptor alpha 1a
1744,pseudoephedrine,vasomotor rhinitis,adrenoceptor alpha 1a
1745,pseudoephedrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
1746,pseudoephedrine,atopic conjunctivitis,adrenoceptor alpha 1a
1747,pseudoephedrine,rhinitis,adrenoceptor alpha 1a
1748,pseudoephedrine,headache disorder,adrenoceptor alpha 1a
1749,ipragliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
1750,lansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1751,lansoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit alpha
1752,lansoprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
1753,lansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit alpha
1754,lansoprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1755,ketorolac,atopic conjunctivitis,prostaglandin-endoperoxide synthase 1
1756,ketorolac,atopic conjunctivitis,prostaglandin-endoperoxide synthase 2
1757,nizatidine,duodenal ulcer,histamine receptor h2
1758,nizatidine,gastric ulcer,histamine receptor h2
1759,nizatidine,gastroesophageal reflux disease,histamine receptor h2
1760,nizatidine,peptic esophagitis,histamine receptor h2
1761,nizatidine,peptic ulcer disease,histamine receptor h2
1762,tretinoin,acne,retinoic acid receptor alpha
1763,tretinoin,acne,retinoic acid receptor gamma
1764,tretinoin,acne,retinoic acid receptor beta
1765,tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor alpha
1766,tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor gamma
1767,tretinoin,dyschromatosis universalis hereditaria,retinoic acid receptor beta
1768,tretinoin,acute promyelocytic leukemia,retinoic acid receptor alpha
1769,tretinoin,acute promyelocytic leukemia,retinoic acid receptor gamma
1770,tretinoin,acute promyelocytic leukemia,retinoic acid receptor beta
1771,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
1772,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
1773,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
1774,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
1775,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
1776,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
1777,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
1778,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
1779,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
1780,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
1781,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
1782,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
1783,sirolimus,renal cell carcinoma,mechanistic target of rapamycin kinase
1784,aminobenzoic acid,pemphigus,monoamine oxidase a
1785,aminobenzoic acid,peyronie disease,monoamine oxidase a
1786,aminobenzoic acid,localized scleroderma,monoamine oxidase a
1787,aminobenzoic acid,dermatomyositis,monoamine oxidase a
1788,lorcaserin,obesity disorder,5-hydroxytryptamine receptor 2c
1789,ofatumumab,b-cell chronic lymphocytic leukemia,membrane spanning 4-domains a1
1790,dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
1791,dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
1792,bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
1793,bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
1794,bexarotene,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
1795,probenecid,hyperuricemia,solute carrier family 22 member 6
1796,probenecid,hyperuricemia,solute carrier family 22 member 11
1797,probenecid,hyperuricemia,solute carrier family 22 member 8
1798,probenecid,gout,solute carrier family 22 member 6
1799,probenecid,gout,solute carrier family 22 member 11
1800,probenecid,gout,solute carrier family 22 member 8
1801,rosuvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
1802,rosuvastatin,hypercholesterolemia,low density lipoprotein receptor
1803,rosuvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
1804,rosuvastatin,"hyperlipidemia, familial combined, lpl related",low density lipoprotein receptor
1805,rosuvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
1806,rosuvastatin,hyperlipoproteinemia type 3,low density lipoprotein receptor
1807,rosuvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
1808,rosuvastatin,stroke disorder,low density lipoprotein receptor
1809,rosuvastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
1810,rosuvastatin,hypertriglyceridemia,low density lipoprotein receptor
1811,rosuvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
1812,rosuvastatin,arteriosclerosis disorder,low density lipoprotein receptor
1813,glisoxepide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
1814,vildagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
1815,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 3
1816,bumetanide,edema,solute carrier family 12 member 1
1817,orlistat,obesity disorder,"lipase f, gastric type"
1818,orlistat,obesity disorder,pancreatic lipase
1819,levetiracetam,focal epilepsy,synaptic vesicle glycoprotein 2a
1820,levetiracetam,focal epilepsy,calcium voltage-gated channel subunit alpha1 b
1821,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
1822,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
1823,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
1824,aranidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
1825,insulin degludec,diabetes mellitus,insulin receptor
1826,buclizine,motion sickness,histamine receptor h1
1827,buclizine,motion sickness,cholinergic receptor muscarinic 1
1828,tolbutamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
1829,isopropamide,peptic ulcer disease,cholinergic receptor muscarinic 3
1830,romidepsin,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
1831,romidepsin,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
1832,romidepsin,mature t-cell and nk-cell non-hodgkin lymphoma,histone deacetylase 1
1833,romidepsin,mature t-cell and nk-cell non-hodgkin lymphoma,histone deacetylase 2
1834,ziconotide,chronic pain,calcium voltage-gated channel subunit alpha1 b
1835,sivelestat,acute lung injury,"elastase, neutrophil expressed"
1836,ceritinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
1837,dorzolamide,ocular hypertension,carbonic anhydrase 2
1838,dorzolamide,open-angle glaucoma,carbonic anhydrase 2
1839,dobutamine,cardiogenic shock,adrenoceptor beta 1
1840,indomethacin,tenosynovitis,prostaglandin-endoperoxide synthase 1
1841,indomethacin,tenosynovitis,prostaglandin-endoperoxide synthase 2
1842,indomethacin,bursitis,prostaglandin-endoperoxide synthase 1
1843,indomethacin,bursitis,prostaglandin-endoperoxide synthase 2
1844,indomethacin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1845,indomethacin,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1846,indomethacin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
1847,indomethacin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
1848,indomethacin,gout,prostaglandin-endoperoxide synthase 1
1849,indomethacin,gout,prostaglandin-endoperoxide synthase 2
1850,indomethacin,tendinopathy,prostaglandin-endoperoxide synthase 1
1851,indomethacin,tendinopathy,prostaglandin-endoperoxide synthase 2
1852,indomethacin,synovitis,prostaglandin-endoperoxide synthase 1
1853,indomethacin,synovitis,prostaglandin-endoperoxide synthase 2
1854,indomethacin,osteoarthritis,prostaglandin-endoperoxide synthase 1
1855,indomethacin,osteoarthritis,prostaglandin-endoperoxide synthase 2
1856,indomethacin,patent ductus arteriosus,prostaglandin-endoperoxide synthase 1
1857,indomethacin,patent ductus arteriosus,prostaglandin-endoperoxide synthase 2
1858,alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
1859,alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
1860,alfuzosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
1861,astemizole,sneeze,histamine receptor h1
1862,astemizole,atopic conjunctivitis,histamine receptor h1
1863,astemizole,chronic urticaria,histamine receptor h1
1864,astemizole,allergic rhinitis,histamine receptor h1
1865,fluocinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1866,fluocinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1867,fluocinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
1868,fluocinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1869,fluocinonide,exanthem,nuclear receptor subfamily 3 group c member 1
1870,fluocinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1871,lithium ion,bipolar disorder,inositol monophosphatase 1
1872,lithium ion,headache disorder,inositol monophosphatase 1
1873,lithium ion,pain,inositol monophosphatase 1
1874,lithium ion,osteoarthritis,inositol monophosphatase 1
1875,lithium ion,juvenile idiopathic arthritis,inositol monophosphatase 1
1876,lithium ion,rheumatoid arthritis,inositol monophosphatase 1
1877,lithium ion,dysmenorrhea,inositol monophosphatase 1
1878,lifitegrast,dry eye syndrome,integrin subunit alpha l
1879,menatetrenone,hemorrhagic disease of newborn,gamma-glutamyl carboxylase
1880,methapyrilene,urticaria,histamine receptor h1
1881,methapyrilene,vasomotor rhinitis,histamine receptor h1
1882,methapyrilene,allergic rhinitis,histamine receptor h1
1883,methapyrilene,sneeze,histamine receptor h1
1884,methapyrilene,atopic conjunctivitis,histamine receptor h1
1885,methapyrilene,pruritus,histamine receptor h1
1886,homatropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 1
1887,homatropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 5
1888,homatropine methylbromide,cough,cholinergic receptor muscarinic 2
1889,homatropine methylbromide,cough,cholinergic receptor muscarinic 3
1890,homatropine methylbromide,irritable bowel syndrome,cholinergic receptor muscarinic 2
1891,homatropine methylbromide,irritable bowel syndrome,cholinergic receptor muscarinic 3
1892,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1d
1893,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1b
1894,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1f
1895,pentostatin,hairy cell leukemia,adenosine deaminase
1896,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
1897,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
1898,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
1899,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
1900,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
1901,lorazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
1902,roxatidine acetate,gastroesophageal reflux disease,histamine receptor h2
1903,roxatidine acetate,zollinger-ellison syndrome,histamine receptor h2
1904,roxatidine acetate,gastric ulcer,histamine receptor h2
1905,levomilnacipran,major depressive disorder,solute carrier family 6 member 2
1906,levomilnacipran,major depressive disorder,solute carrier family 6 member 4
1907,pravastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
1908,pravastatin,arteriosclerosis disorder,low density lipoprotein receptor
1909,pravastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
1910,pravastatin,stroke disorder,low density lipoprotein receptor
1911,pravastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
1912,pravastatin,hyperlipoproteinemia type 3,low density lipoprotein receptor
1913,pravastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
1914,pravastatin,"hyperlipidemia, familial combined, lpl related",low density lipoprotein receptor
1915,pravastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
1916,pravastatin,hypertriglyceridemia,low density lipoprotein receptor
1917,pravastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
1918,pravastatin,hypercholesterolemia,low density lipoprotein receptor
1919,bupivacaine,pruritus,sodium voltage-gated channel alpha subunit 10
1920,dihydroergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1d
1921,dihydroergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1b
1922,dihydroergotamine,vascular headaches,5-hydroxytryptamine receptor 1d
1923,dihydroergotamine,vascular headaches,5-hydroxytryptamine receptor 1b
1924,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1d
1925,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1b
1926,pemirolast,allergic rhinitis,histamine receptor h1
1927,pemirolast,atopic conjunctivitis,histamine receptor h1
1928,pemirolast,asthma,histamine receptor h1
1929,salbutamol,bronchial disorder,adrenoceptor beta 2
1930,heparin,disseminated intravascular coagulation,coagulation factor x
1931,heparin,disseminated intravascular coagulation,serpin family c member 1
1932,heparin,thrombophilia due to thrombin defect,coagulation factor x
1933,heparin,thrombophilia due to thrombin defect,serpin family c member 1
1934,heparin,pulmonary embolism,coagulation factor x
1935,heparin,pulmonary embolism,serpin family c member 1
1936,ruxolitinib,myeloproliferative neoplasm,janus kinase 2
1937,ruxolitinib,myeloproliferative neoplasm,janus kinase 1
1938,ruxolitinib,acquired polycythemia vera,janus kinase 2
1939,ruxolitinib,acquired polycythemia vera,janus kinase 1
1940,somatropin,turner syndrome,growth hormone receptor
1941,somatropin,pituitary dwarfism,growth hormone receptor
1942,somatropin,prader-willi syndrome,growth hormone receptor
1943,pranlukast,asthma,cysteinyl leukotriene receptor 1
1944,pranlukast,allergic rhinitis,cysteinyl leukotriene receptor 1
1945,alteplase,pulmonary embolism,plasminogen
1946,methylergonovine,post-partum hemorrhage,5-hydroxytryptamine receptor 2b
1947,vincristine,rhabdomyosarcoma,tubulin beta class i
1948,vincristine,non-hodgkin lymphoma,tubulin beta class i
1949,vincristine,neuroblastoma,tubulin beta class i
1950,vincristine,burkitt lymphoma,tubulin beta class i
1951,vincristine,classic hodgkin lymphoma,tubulin beta class i
1952,vincristine,follicular lymphoma,tubulin beta class i
1953,vincristine,wilms tumor,tubulin beta class i
1954,vincristine,diffuse large b-cell lymphoma,tubulin beta class i
1955,fludroxycortide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
1956,fludroxycortide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
1957,fludroxycortide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
1958,fludroxycortide,exanthem,nuclear receptor subfamily 3 group c member 1
1959,fludroxycortide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
1960,fludroxycortide,pruritus ani,nuclear receptor subfamily 3 group c member 1
1961,fludroxycortide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
1962,fludroxycortide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
1963,fludroxycortide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
1964,iloperidone,schizophrenia,5-hydroxytryptamine receptor 2a
1965,iloperidone,schizophrenia,dopamine receptor d1
1966,ramatroban,allergic rhinitis,prostaglandin d2 receptor 2
1967,ramatroban,allergic rhinitis,thromboxane a2 receptor
1968,duloxetine,major depressive disorder,solute carrier family 6 member 2
1969,duloxetine,fibromyalgia,solute carrier family 6 member 4
1970,duloxetine,fibromyalgia,solute carrier family 6 member 2
1971,dipyridamole,atrial fibrillation,phosphodiesterase 10a
1972,dipyridamole,atrial fibrillation,phosphodiesterase 5a
1973,dipyridamole,atrial fibrillation,phosphodiesterase 4a
1974,dipyridamole,atrial fibrillation,adenosine deaminase
1975,melatonin,insomnia,melatonin receptor 1a
1976,melatonin,insomnia,melatonin receptor 1b
1977,bupropion,seasonal affective disorder,solute carrier family 6 member 2
1978,bupropion,seasonal affective disorder,solute carrier family 6 member 3
1979,bupropion,major depressive disorder,solute carrier family 6 member 2
1980,bupropion,major depressive disorder,solute carrier family 6 member 3
1981,bupropion,nicotine dependence,solute carrier family 6 member 3
1982,bupropion,nicotine dependence,cholinergic receptor nicotinic alpha 3 subunit
1983,bupropion,depressive disorder,solute carrier family 6 member 2
1984,bupropion,depressive disorder,solute carrier family 6 member 3
1985,tiaprofenic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
1986,tiaprofenic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
1987,tiaprofenic acid,pain,prostaglandin-endoperoxide synthase 2
1988,tiaprofenic acid,pain,prostaglandin-endoperoxide synthase 1
1989,tiaprofenic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
1990,tiaprofenic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
1991,crotamiton,pruritus,transient receptor potential cation channel subfamily v member 4
1992,crotamiton,scabies,transient receptor potential cation channel subfamily v member 4
1993,esomeprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
1994,esomeprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
1995,esomeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit alpha
1996,trimethobenzamide,vomiting,dopamine receptor d2
1997,trimethobenzamide,nausea,dopamine receptor d2
1998,rimexolone,uveitis,nuclear receptor subfamily 3 group c member 1
1999,dasatinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
2000,dasatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
2001,calcium gluconate,hypocalcemia,calcium sensing receptor
2002,dimethyl fumarate,relapsing-remitting multiple sclerosis,kelch like ech associated protein 1
2003,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2004,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2005,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2006,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2007,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2008,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2009,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha1
2010,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha2
2011,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha3
2012,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha4
2013,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha5
2014,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha6
2015,glucagon,hypoglycemia,glucagon receptor
2016,phenelzine,depressive disorder,monoamine oxidase b
2017,phenelzine,depressive disorder,monoamine oxidase a
2018,terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
2019,terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
2020,terazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
2021,terazosin,hypertensive disorder,adrenoceptor alpha 1a
2022,terazosin,hypertensive disorder,adrenoceptor alpha 1b
2023,terazosin,hypertensive disorder,adrenoceptor alpha 1d
2024,isocarboxazid,major depressive disorder,monoamine oxidase b
2025,isocarboxazid,major depressive disorder,monoamine oxidase a
2026,zuclopenthixol,schizophrenia,dopamine receptor d2
2027,zuclopenthixol,schizophrenia,dopamine receptor d5
2028,zuclopenthixol,schizophrenia,dopamine receptor d1
2029,pazopanib,sarcoma,platelet derived growth factor receptor beta
2030,pazopanib,sarcoma,fms related receptor tyrosine kinase 1
2031,pazopanib,sarcoma,"kit proto-oncogene, receptor tyrosine kinase"
2032,pazopanib,sarcoma,kinase insert domain receptor
2033,pazopanib,sarcoma,fms related receptor tyrosine kinase 4
2034,pazopanib,sarcoma,fms related receptor tyrosine kinase 3
2035,pazopanib,sarcoma,colony stimulating factor 1 receptor
2036,pazopanib,sarcoma,platelet derived growth factor receptor alpha
2037,pazopanib,renal cell carcinoma,platelet derived growth factor receptor beta
2038,pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 1
2039,pazopanib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
2040,pazopanib,renal cell carcinoma,kinase insert domain receptor
2041,pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 4
2042,pazopanib,renal cell carcinoma,fms related receptor tyrosine kinase 3
2043,pazopanib,renal cell carcinoma,colony stimulating factor 1 receptor
2044,pazopanib,renal cell carcinoma,platelet derived growth factor receptor alpha
2045,agomelatine,major depressive disorder,5-hydroxytryptamine receptor 2c
2046,agomelatine,major depressive disorder,melatonin receptor 1a
2047,agomelatine,major depressive disorder,melatonin receptor 1b
2048,antazoline,sneeze,histamine receptor h1
2049,antazoline,urticaria,histamine receptor h1
2050,antazoline,pruritus,histamine receptor h1
2051,antazoline,allergic rhinitis,histamine receptor h1
2052,antazoline,atopic conjunctivitis,histamine receptor h1
2053,cetuximab,colonic neoplasm,epidermal growth factor receptor
2054,risedronate,bone paget disease,atpase h+ transporting v1 subunit a
2055,risedronate,osteoporosis,atpase h+ transporting v1 subunit a
2056,risedronate,postmenopausal osteoporosis,atpase h+ transporting v1 subunit a
2057,hydromorphone,pain,opioid receptor mu 1
2058,lenalidomide,plasma cell myeloma,tumor necrosis factor
2059,lenalidomide,mantle cell lymphoma,tumor necrosis factor
2060,clocortolone pivalate,exanthem,nuclear receptor subfamily 3 group c member 1
2061,clocortolone pivalate,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2062,clocortolone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2063,clocortolone pivalate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2064,clocortolone pivalate,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2065,clocortolone pivalate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2066,clocortolone pivalate,pruritus ani,nuclear receptor subfamily 3 group c member 1
2067,clocortolone pivalate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2068,pirfenidone,acute interstitial pneumonia,tumor necrosis factor
2069,obinutuzumab,b-cell chronic lymphocytic leukemia,membrane spanning 4-domains a1
2070,5-fluorouracil,actinic keratosis,thymidylate synthetase
2071,5-fluorouracil,gastric neoplasm,thymidylate synthetase
2072,5-fluorouracil,colonic neoplasm,thymidylate synthetase
2073,medroxyprogesterone,endometrium neoplasm,progesterone receptor
2074,medroxyprogesterone,endometriosis,progesterone receptor
2075,medroxyprogesterone,metrorrhagia,progesterone receptor
2076,telmisartan,hypertensive disorder,angiotensin ii receptor type 1
2077,telmisartan,hypertensive disorder,peroxisome proliferator activated receptor gamma
2078,telmisartan,stroke disorder,angiotensin ii receptor type 1
2079,telmisartan,stroke disorder,peroxisome proliferator activated receptor gamma
2080,vernakalant,atrial fibrillation,potassium voltage-gated channel subfamily a member 5
2081,vernakalant,atrial fibrillation,potassium voltage-gated channel subfamily d member 3
2082,metoprolol,hypertensive disorder,adrenoceptor beta 1
2083,metoprolol,myocardial infarction,adrenoceptor beta 1
2084,metoprolol,acute coronary syndrome,adrenoceptor beta 1
2085,metoprolol,angina pectoris,adrenoceptor beta 1
2086,chlorpheniramine,atopic conjunctivitis,histamine receptor h1
2087,chlorpheniramine,seasonal allergic rhinitis,histamine receptor h1
2088,chlorpheniramine,sneeze,histamine receptor h1
2089,chlorpheniramine,vasomotor rhinitis,histamine receptor h1
2090,chlorpheniramine,pruritus,histamine receptor h1
2091,chlorpheniramine,allergic rhinitis,histamine receptor h1
2092,chlorpheniramine,urticaria,histamine receptor h1
2093,cabozantinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
2094,cabozantinib,renal cell carcinoma,kinase insert domain receptor
2095,cabozantinib,renal cell carcinoma,ret proto-oncogene
2096,cabozantinib,medullary thyroid gland carcinoma,"met proto-oncogene, receptor tyrosine kinase"
2097,cabozantinib,medullary thyroid gland carcinoma,kinase insert domain receptor
2098,cabozantinib,medullary thyroid gland carcinoma,ret proto-oncogene
2099,perazine,anxiety,dopamine receptor d2
2100,perazine,schizophrenia,dopamine receptor d2
2101,halcinonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2102,halcinonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2103,halcinonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2104,halcinonide,exanthem,nuclear receptor subfamily 3 group c member 1
2105,halcinonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2106,halcinonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
2107,halcinonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2108,halcinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2109,halcinonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2110,colchicine,gout,tubulin beta class i
2111,colchicine,familial mediterranean fever,tubulin beta class i
2112,masoprocol,actinic keratosis,mechanistic target of rapamycin kinase
2113,cetirizine,allergic rhinitis,histamine receptor h1
2114,cetirizine,sneeze,histamine receptor h1
2115,cetirizine,vasomotor rhinitis,histamine receptor h1
2116,cetirizine,chronic urticaria,histamine receptor h1
2117,cetirizine,common cold,histamine receptor h1
2118,cetirizine,seasonal allergic rhinitis,histamine receptor h1
2119,cetirizine,atopic conjunctivitis,histamine receptor h1
2120,benzocaine,pharyngitis,sodium voltage-gated channel alpha subunit 10
2121,benzocaine,cough,sodium voltage-gated channel alpha subunit 10
2122,benzocaine,pruritus,sodium voltage-gated channel alpha subunit 10
2123,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 10
2124,piroxicam,osteoarthritis,prostaglandin-endoperoxide synthase 1
2125,piroxicam,osteoarthritis,prostaglandin-endoperoxide synthase 2
2126,piroxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2127,piroxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2128,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 1
2129,acetyldigitoxin,heart failure,atpase na+/k+ transporting subunit alpha 1
2130,zoledronic acid,postmenopausal osteoporosis,farnesyl diphosphate synthase
2131,zoledronic acid,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
2132,zoledronic acid,bone paget disease,farnesyl diphosphate synthase
2133,zoledronic acid,bone paget disease,geranylgeranyl diphosphate synthase 1
2134,zoledronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
2135,zoledronic acid,humoral hypercalcemia of malignancy,geranylgeranyl diphosphate synthase 1
2136,zoledronic acid,osteoporosis,farnesyl diphosphate synthase
2137,zoledronic acid,osteoporosis,geranylgeranyl diphosphate synthase 1
2138,escitalopram,major depressive disorder,solute carrier family 6 member 4
2139,sertindole,schizophrenia,dopamine receptor d2
2140,sertindole,schizophrenia,5-hydroxytryptamine receptor 2c
2141,sertindole,schizophrenia,5-hydroxytryptamine receptor 2a
2142,sertindole,schizophrenia,adrenoceptor alpha 1b
2143,sertindole,schizophrenia,adrenoceptor alpha 1a
2144,sertindole,schizophrenia,adrenoceptor alpha 1d
2145,zaleplon,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
2146,salicylic acid,synovitis,prostaglandin-endoperoxide synthase 1
2147,salicylic acid,synovitis,prostaglandin-endoperoxide synthase 2
2148,salicylic acid,pain,prostaglandin-endoperoxide synthase 1
2149,salicylic acid,pain,prostaglandin-endoperoxide synthase 2
2150,salicylic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2151,salicylic acid,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2152,salicylic acid,tinea pedis,prostaglandin-endoperoxide synthase 1
2153,salicylic acid,tinea pedis,prostaglandin-endoperoxide synthase 2
2154,salicylic acid,acne,prostaglandin-endoperoxide synthase 1
2155,salicylic acid,acne,prostaglandin-endoperoxide synthase 2
2156,salicylic acid,common cold,prostaglandin-endoperoxide synthase 1
2157,salicylic acid,common cold,prostaglandin-endoperoxide synthase 2
2158,salicylic acid,fever,prostaglandin-endoperoxide synthase 1
2159,salicylic acid,fever,prostaglandin-endoperoxide synthase 2
2160,salicylic acid,osteoarthritis,prostaglandin-endoperoxide synthase 1
2161,salicylic acid,osteoarthritis,prostaglandin-endoperoxide synthase 2
2162,salicylic acid,allergic rhinitis,prostaglandin-endoperoxide synthase 1
2163,salicylic acid,allergic rhinitis,prostaglandin-endoperoxide synthase 2
2164,salicylic acid,seborrheic dermatitis,prostaglandin-endoperoxide synthase 1
2165,salicylic acid,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
2166,glipizide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
2167,glipizide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
2168,clofazimine,pyoderma gangrenosum,potassium voltage-gated channel subfamily a member 3
2169,torsemide,hypertensive disorder,solute carrier family 12 member 1
2170,torsemide,edema,solute carrier family 12 member 1
2171,conjugated estrogens,hot flashes,estrogen receptor 1
2172,conjugated estrogens,hot flashes,estrogen receptor 2
2173,conjugated estrogens,psychologic dyspareunia,estrogen receptor 1
2174,conjugated estrogens,psychologic dyspareunia,estrogen receptor 2
2175,dicumarol,intracranial embolism,vitamin k epoxide reductase complex subunit 1
2176,dicumarol,thromboembolism,vitamin k epoxide reductase complex subunit 1
2177,dicumarol,myocardial infarction,vitamin k epoxide reductase complex subunit 1
2178,dicumarol,thrombotic disease,vitamin k epoxide reductase complex subunit 1
2179,conivaptan,hyponatremia,arginine vasopressin receptor 1a
2180,conivaptan,hyponatremia,arginine vasopressin receptor 2
2181,doxylamine,sneeze,histamine receptor h1
2182,doxylamine,atopic conjunctivitis,histamine receptor h1
2183,doxylamine,urticaria,histamine receptor h1
2184,doxylamine,vasomotor rhinitis,histamine receptor h1
2185,doxylamine,common cold,histamine receptor h1
2186,doxylamine,seasonal allergic rhinitis,histamine receptor h1
2187,doxylamine,pruritus,histamine receptor h1
2188,fluvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
2189,fluvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
2190,fluvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
2191,lurasidone,bipolar disorder,dopamine receptor d2
2192,lurasidone,bipolar disorder,5-hydroxytryptamine receptor 2a
2193,lurasidone,schizophrenia,dopamine receptor d2
2194,lurasidone,schizophrenia,5-hydroxytryptamine receptor 2a
2195,diltiazem,angina pectoris,calcium voltage-gated channel subunit alpha1 c
2196,diltiazem,angina pectoris,calcium voltage-gated channel auxiliary subunit gamma 1
2197,diltiazem,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
2198,diltiazem,prinzmetal angina,calcium voltage-gated channel auxiliary subunit gamma 1
2199,diltiazem,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
2200,diltiazem,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
2201,diltiazem,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
2202,diltiazem,atrial fibrillation,calcium voltage-gated channel auxiliary subunit gamma 1
2203,polmacoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
2204,repaglinide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
2205,bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor gamma
2206,bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor alpha
2207,bezafibrate,hypercholesterolemia,peroxisome proliferator activated receptor delta
2208,bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor gamma
2209,bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
2210,bezafibrate,hyperlipidemia,peroxisome proliferator activated receptor delta
2211,mefenamic acid,pain,prostaglandin-endoperoxide synthase 1
2212,mefenamic acid,pain,prostaglandin-endoperoxide synthase 2
2213,mefenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 1
2214,mefenamic acid,dysmenorrhea,prostaglandin-endoperoxide synthase 2
2215,clofibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
2216,frovatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
2217,frovatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
2218,desipramine,depressive disorder,solute carrier family 6 member 2
2219,fluspirilene,schizophrenia,dopamine receptor d2
2220,naftopidil,benign prostatic hyperplasia,adrenoceptor alpha 1d
2221,fenoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2222,fenoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2223,fenoprofen,pain,prostaglandin-endoperoxide synthase 1
2224,fenoprofen,pain,prostaglandin-endoperoxide synthase 2
2225,fenoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
2226,fenoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
2227,tadalafil,erectile dysfunction,phosphodiesterase 5a
2228,tadalafil,pulmonary hypertension,phosphodiesterase 5a
2229,loxoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2230,loxoprofen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2231,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1d
2232,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1b
2233,haloperidol,tourette syndrome,dopamine receptor d2
2234,haloperidol,psychotic disorder,dopamine receptor d2
2235,sumatriptan,cluster headache syndrome,5-hydroxytryptamine receptor 1d
2236,sumatriptan,cluster headache syndrome,5-hydroxytryptamine receptor 1b
2237,gliquidone,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
2238,quinestrol,hot flashes,estrogen receptor 1
2239,quinestrol,postmenopausal atrophic vaginitis,estrogen receptor 1
2240,cyclosporin a,dry eye syndrome,peptidylprolyl isomerase a
2241,cyclosporin a,xerophthalmia,peptidylprolyl isomerase a
2242,cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase a
2243,protriptyline,depressive disorder,solute carrier family 6 member 4
2244,protriptyline,depressive disorder,solute carrier family 6 member 2
2245,phenprocoumon,thrombotic disease,vitamin k epoxide reductase complex subunit 1
2246,phenprocoumon,myocardial infarction,vitamin k epoxide reductase complex subunit 1
2247,phenprocoumon,thromboembolism,vitamin k epoxide reductase complex subunit 1
2248,riociguat,pulmonary arterial hypertension,guanylate cyclase 1 soluble subunit alpha 2
2249,megestrol,endometrium neoplasm,progesterone receptor
2250,azatadine,sneeze,histamine receptor h1
2251,azatadine,seasonal allergic rhinitis,histamine receptor h1
2252,azatadine,pruritus,histamine receptor h1
2253,azatadine,common cold,histamine receptor h1
2254,azatadine,urticaria,histamine receptor h1
2255,azatadine,vasomotor rhinitis,histamine receptor h1
2256,azatadine,allergic rhinitis,histamine receptor h1
2257,azatadine,atopic conjunctivitis,histamine receptor h1
2258,bilastine,allergic rhinitis,histamine receptor h1
2259,bilastine,urticaria,histamine receptor h1
2260,rilmenidine,hypertensive disorder,nischarin
2261,olmutinib,non-small cell lung carcinoma,epidermal growth factor receptor
2262,flutamide,prostate cancer,androgen receptor
2263,fluphenazine,psychotic disorder,dopamine receptor d2
2264,furosemide,edema,solute carrier family 12 member 1
2265,furosemide,hypertensive disorder,solute carrier family 12 member 1
2266,voglibose,type 2 diabetes mellitus,maltase-glucoamylase
2267,voglibose,type 2 diabetes mellitus,alpha glucosidase
2268,voglibose,type 2 diabetes mellitus,sucrase-isomaltase
2269,oxymetholone,aplastic anemia,androgen receptor
2270,oxymetholone,diamond-blackfan anemia,androgen receptor
2271,insulin aspart,diabetes mellitus,insulin receptor
2272,mianserin,major depressive disorder,5-hydroxytryptamine receptor 2a
2273,mianserin,major depressive disorder,5-hydroxytryptamine receptor 2c
2274,mianserin,major depressive disorder,solute carrier family 6 member 2
2275,mianserin,major depressive disorder,adrenoceptor alpha 2a
2276,mianserin,major depressive disorder,adrenoceptor alpha 2c
2277,mianserin,major depressive disorder,histamine receptor h1
2278,blonanserin,schizophrenia,dopamine receptor d2
2279,blonanserin,schizophrenia,dopamine receptor d3
2280,blonanserin,schizophrenia,5-hydroxytryptamine receptor 2a
2281,paroxetine,post-traumatic stress disorder,solute carrier family 6 member 4
2282,paroxetine,premenstrual dysphoric disorder,solute carrier family 6 member 4
2283,paroxetine,hot flashes,solute carrier family 6 member 4
2284,paroxetine,panic disorder,solute carrier family 6 member 4
2285,paroxetine,obsessive-compulsive disorder,solute carrier family 6 member 4
2286,paroxetine,major depressive disorder,solute carrier family 6 member 4
2287,paroxetine,social phobia,solute carrier family 6 member 4
2288,paroxetine,depressive disorder,solute carrier family 6 member 4
2289,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2290,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2291,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2292,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2293,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2294,phenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2295,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha1
2296,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha2
2297,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha3
2298,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha4
2299,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha5
2300,phenobarbital,vascular headaches,gamma-aminobutyric acid type a receptor subunit alpha6
2301,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2302,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2303,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2304,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2305,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2306,phenobarbital,visual epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2307,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
2308,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
2309,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
2310,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
2311,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
2312,phenobarbital,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
2313,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
2314,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
2315,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
2316,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
2317,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
2318,phenobarbital,cluster headache syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
2319,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha1
2320,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha2
2321,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha3
2322,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha4
2323,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha5
2324,phenobarbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha6
2325,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
2326,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
2327,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
2328,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
2329,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
2330,phenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
2331,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
2332,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
2333,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
2334,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
2335,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
2336,phenobarbital,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
2337,amiloride,hypertensive disorder,sodium channel epithelial 1 subunit gamma
2338,amiloride,hypertensive disorder,sodium channel epithelial 1 subunit alpha
2339,amiloride,hypertensive disorder,sodium channel epithelial 1 subunit beta
2340,amiloride,edema,sodium channel epithelial 1 subunit gamma
2341,amiloride,edema,sodium channel epithelial 1 subunit alpha
2342,amiloride,edema,sodium channel epithelial 1 subunit beta
2343,nefazodone,major depressive disorder,solute carrier family 6 member 4
2344,nefazodone,major depressive disorder,solute carrier family 6 member 2
2345,nefazodone,major depressive disorder,5-hydroxytryptamine receptor 2a
2346,nefazodone,major depressive disorder,5-hydroxytryptamine receptor 2c
2347,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 4
2348,dronedarone,atrial fibrillation,potassium inwardly rectifying channel subfamily j member 2
2349,alogliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
2350,nicorandil,angina pectoris,atp binding cassette subfamily c member 9
2351,reproterol,asthma,adrenoceptor beta 2
2352,allopurinol,gout,xanthine dehydrogenase
2353,allopurinol,hyperuricemia,xanthine dehydrogenase
2354,ebastine,allergic rhinitis,histamine receptor h1
2355,ebastine,chronic urticaria,histamine receptor h1
2356,efonidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
2357,efonidipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
2358,dopamine,decreased cardiac output,adrenoceptor beta 1
2359,mitoxantrone,relapsing-remitting multiple sclerosis,dna topoisomerase ii alpha
2360,mitoxantrone,acute myeloid leukemia,dna topoisomerase ii alpha
2361,dezocine,pain,opioid receptor mu 1
2362,dezocine,pain,opioid receptor kappa 1
2363,piretanide,hypertensive disorder,solute carrier family 12 member 1
2364,piretanide,edema,solute carrier family 12 member 1
2365,fluticasone,asthma,nuclear receptor subfamily 3 group c member 1
2366,fluticasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2367,icotinib,non-small cell lung carcinoma,epidermal growth factor receptor
2368,fluvoxamine,social phobia,solute carrier family 6 member 4
2369,fluvoxamine,obsessive-compulsive disorder,solute carrier family 6 member 4
2370,paracetamol,tension-type headache,prostaglandin-endoperoxide synthase 1
2371,paracetamol,tension-type headache,prostaglandin-endoperoxide synthase 2
2372,paracetamol,tension-type headache,prostaglandin e synthase 3
2373,paracetamol,migraine disorder,prostaglandin-endoperoxide synthase 1
2374,paracetamol,migraine disorder,prostaglandin-endoperoxide synthase 2
2375,paracetamol,migraine disorder,prostaglandin e synthase 3
2376,paracetamol,toothache,prostaglandin-endoperoxide synthase 1
2377,paracetamol,toothache,prostaglandin-endoperoxide synthase 2
2378,paracetamol,toothache,prostaglandin e synthase 3
2379,paracetamol,headache disorder,prostaglandin-endoperoxide synthase 1
2380,paracetamol,headache disorder,prostaglandin-endoperoxide synthase 2
2381,paracetamol,headache disorder,prostaglandin e synthase 3
2382,paracetamol,arthralgia,prostaglandin-endoperoxide synthase 1
2383,paracetamol,arthralgia,prostaglandin-endoperoxide synthase 2
2384,paracetamol,arthralgia,prostaglandin e synthase 3
2385,paracetamol,common cold,prostaglandin-endoperoxide synthase 1
2386,paracetamol,common cold,prostaglandin-endoperoxide synthase 2
2387,paracetamol,common cold,prostaglandin e synthase 3
2388,paracetamol,allergic rhinitis,prostaglandin-endoperoxide synthase 1
2389,paracetamol,allergic rhinitis,prostaglandin-endoperoxide synthase 2
2390,paracetamol,allergic rhinitis,prostaglandin e synthase 3
2391,alpha-methyltyrosine,pheochromocytoma,tyrosine hydroxylase
2392,captodiame,anxiety disorder,5-hydroxytryptamine receptor 2c
2393,captodiame,anxiety disorder,sigma non-opioid intracellular receptor 1
2394,fluoxetine,bipolar disorder,solute carrier family 6 member 4
2395,fluoxetine,panic disorder,solute carrier family 6 member 4
2396,fluoxetine,premenstrual dysphoric disorder,solute carrier family 6 member 4
2397,fluoxetine,depressive disorder,solute carrier family 6 member 4
2398,fluoxetine,bulimia nervosa,solute carrier family 6 member 4
2399,fluoxetine,major depressive disorder,solute carrier family 6 member 4
2400,fluoxetine,obsessive-compulsive disorder,solute carrier family 6 member 4
2401,topotecan,ovarian cancer,dna topoisomerase i
2402,topotecan,small cell lung carcinoma,dna topoisomerase i
2403,cyclizine,motion sickness,histamine receptor h1
2404,cyclizine,sneeze,histamine receptor h1
2405,cyclizine,seasonal allergic rhinitis,histamine receptor h1
2406,cyclizine,allergic rhinitis,histamine receptor h1
2407,cyclizine,common cold,histamine receptor h1
2408,cyclizine,atopic conjunctivitis,histamine receptor h1
2409,cyclizine,vasomotor rhinitis,histamine receptor h1
2410,cyclizine,cough,histamine receptor h1
2411,methyl salicylate,back pain,prostaglandin-endoperoxide synthase 1
2412,methyl salicylate,back pain,prostaglandin-endoperoxide synthase 2
2413,carbinoxamine,allergic rhinitis,histamine receptor h1
2414,carbinoxamine,common cold,histamine receptor h1
2415,carbinoxamine,pruritus,histamine receptor h1
2416,carbinoxamine,seasonal allergic rhinitis,histamine receptor h1
2417,carbinoxamine,urticaria,histamine receptor h1
2418,carbinoxamine,vasomotor rhinitis,histamine receptor h1
2419,gemigliptin,type 2 diabetes mellitus,dipeptidyl peptidase 4
2420,oxymorphone,chronic pain,opioid receptor mu 1
2421,oxymorphone,labor pain,opioid receptor mu 1
2422,oxymorphone,pain,opioid receptor mu 1
2423,ranitidine,duodenal ulcer,histamine receptor h2
2424,ranitidine,gastric ulcer,histamine receptor h2
2425,ranitidine,gastroesophageal reflux disease,histamine receptor h2
2426,ranitidine,dyspepsia,histamine receptor h2
2427,ranitidine,zollinger-ellison syndrome,histamine receptor h2
2428,trazodone,major depressive disorder,solute carrier family 6 member 4
2429,diethylpropion,obesity disorder,solute carrier family 6 member 2
2430,diethylpropion,obesity disorder,solute carrier family 6 member 3
2431,risperidone,autism spectrum disorder,dopamine receptor d2
2432,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 2a
2433,risperidone,schizophrenia,dopamine receptor d2
2434,risperidone,schizophrenia,5-hydroxytryptamine receptor 2a
2435,salsalate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2436,salsalate,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2437,salsalate,osteoarthritis,prostaglandin-endoperoxide synthase 1
2438,salsalate,osteoarthritis,prostaglandin-endoperoxide synthase 2
2439,tolazamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
2440,tolazamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
2441,trimetazidine,angina pectoris,acetyl-coa acyltransferase 2
2442,benoxaprofen,rheumatoid arthritis,arachidonate 5-lipoxygenase
2443,flufenamic acid,pain,prostaglandin-endoperoxide synthase 1
2444,flufenamic acid,pain,prostaglandin-endoperoxide synthase 2
2445,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 2a
2446,methimazole,hyperthyroidism,thyroid peroxidase
2447,anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 1
2448,anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 2
2449,anisotropine methylbromide,peptic ulcer disease,cholinergic receptor muscarinic 3
2450,anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 1
2451,anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 2
2452,anisotropine methylbromide,gastric ulcer,cholinergic receptor muscarinic 3
2453,perampanel,focal epilepsy,glutamate ionotropic receptor ampa type subunit 1
2454,atorvastatin,angina pectoris,3-hydroxy-3-methylglutaryl-coa reductase
2455,atorvastatin,prinzmetal angina,3-hydroxy-3-methylglutaryl-coa reductase
2456,atorvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
2457,atorvastatin,hypercholesterolemia,3-hydroxy-3-methylglutaryl-coa reductase
2458,atorvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
2459,atorvastatin,"hyperlipidemia, familial combined, lpl related",lipoprotein lipase
2460,atorvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
2461,atorvastatin,hyperlipoproteinemia type 3,lipoprotein lipase
2462,atorvastatin,hypertriglyceridemia,lipoprotein lipase
2463,atorvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
2464,hydroquinone,dyschromatosis universalis hereditaria,tyrosinase
2465,fluticasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2466,fluticasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2467,fluticasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2468,fluticasone,exanthem,nuclear receptor subfamily 3 group c member 1
2469,fluticasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2470,fluticasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2471,fluticasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2472,fluticasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2473,fluticasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2474,fluticasone,pulmonary emphysema,nuclear receptor subfamily 3 group c member 1
2475,phenylephrine,common cold,adrenoceptor alpha 1a
2476,phenylephrine,common cold,adrenoceptor alpha 1b
2477,phenylephrine,common cold,adrenoceptor alpha 1d
2478,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1a
2479,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1b
2480,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 1d
2481,phenylephrine,cough,adrenoceptor alpha 1a
2482,phenylephrine,cough,adrenoceptor alpha 1b
2483,phenylephrine,cough,adrenoceptor alpha 1d
2484,phenylephrine,fever,adrenoceptor alpha 1a
2485,phenylephrine,fever,adrenoceptor alpha 1b
2486,phenylephrine,fever,adrenoceptor alpha 1d
2487,phenylephrine,headache disorder,adrenoceptor alpha 1a
2488,phenylephrine,headache disorder,adrenoceptor alpha 1b
2489,phenylephrine,headache disorder,adrenoceptor alpha 1d
2490,phenylephrine,hemorrhoid,adrenoceptor alpha 1a
2491,phenylephrine,hemorrhoid,adrenoceptor alpha 1b
2492,phenylephrine,hemorrhoid,adrenoceptor alpha 1d
2493,phenylephrine,proctitis,adrenoceptor alpha 1a
2494,phenylephrine,proctitis,adrenoceptor alpha 1b
2495,phenylephrine,proctitis,adrenoceptor alpha 1d
2496,phenylephrine,pruritus ani,adrenoceptor alpha 1a
2497,phenylephrine,pruritus ani,adrenoceptor alpha 1b
2498,phenylephrine,pruritus ani,adrenoceptor alpha 1d
2499,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1a
2500,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1b
2501,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 1d
2502,phenylephrine,allergic rhinitis,adrenoceptor alpha 1a
2503,phenylephrine,allergic rhinitis,adrenoceptor alpha 1b
2504,phenylephrine,allergic rhinitis,adrenoceptor alpha 1d
2505,phenylephrine,rhinitis,adrenoceptor alpha 1a
2506,phenylephrine,rhinitis,adrenoceptor alpha 1b
2507,phenylephrine,rhinitis,adrenoceptor alpha 1d
2508,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1a
2509,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1b
2510,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 1d
2511,phenylephrine,sneeze,adrenoceptor alpha 1a
2512,phenylephrine,sneeze,adrenoceptor alpha 1b
2513,phenylephrine,sneeze,adrenoceptor alpha 1d
2514,incadronic acid,osteoporosis,farnesyl diphosphate synthase
2515,incadronic acid,humoral hypercalcemia of malignancy,farnesyl diphosphate synthase
2516,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
2517,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
2518,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
2519,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
2520,pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,dihydrofolate reductase
2521,pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,thymidylate synthetase
2522,ixazomib,plasma cell myeloma,proteasome 20s subunit beta 5
2523,ixazomib,plasma cell myeloma,proteasome 20s subunit beta 1
2524,caffeine,back pain,adenosine a2a receptor
2525,caffeine,back pain,adenosine a2b receptor
2526,caffeine,cluster headache syndrome,adenosine a2a receptor
2527,caffeine,cluster headache syndrome,adenosine a2b receptor
2528,caffeine,headache disorder,adenosine a2a receptor
2529,caffeine,headache disorder,adenosine a2b receptor
2530,caffeine,migraine disorder,adenosine a2a receptor
2531,caffeine,migraine disorder,adenosine a2b receptor
2532,caffeine,pain,adenosine a2a receptor
2533,caffeine,pain,adenosine a2b receptor
2534,caffeine,tension-type headache,adenosine a2a receptor
2535,caffeine,tension-type headache,adenosine a2b receptor
2536,caffeine,vascular headaches,adenosine a2a receptor
2537,caffeine,vascular headaches,adenosine a2b receptor
2538,desonide,asthma,nuclear receptor subfamily 3 group c member 1
2539,desonide,crohn disease,nuclear receptor subfamily 3 group c member 1
2540,desonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2541,desonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2542,desonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2543,desonide,exanthem,nuclear receptor subfamily 3 group c member 1
2544,desonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2545,desonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2546,desonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2547,desonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2548,desonide,otitis externa,nuclear receptor subfamily 3 group c member 1
2549,desonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
2550,desonide,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2551,doxorubicin,kaposi's sarcoma,dna topoisomerase ii alpha
2552,doxorubicin,breast neoplasm,dna topoisomerase ii alpha
2553,doxorubicin,burkitt lymphoma,dna topoisomerase ii alpha
2554,doxorubicin,classic hodgkin lymphoma,dna topoisomerase ii alpha
2555,doxorubicin,acute myeloid leukemia,dna topoisomerase ii alpha
2556,doxorubicin,lung neoplasm,dna topoisomerase ii alpha
2557,doxorubicin,follicular lymphoma,dna topoisomerase ii alpha
2558,doxorubicin,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
2559,doxorubicin,non-hodgkin lymphoma,dna topoisomerase ii alpha
2560,doxorubicin,plasma cell myeloma,dna topoisomerase ii alpha
2561,doxorubicin,neuroblastoma,dna topoisomerase ii alpha
2562,doxorubicin,ovarian cancer,dna topoisomerase ii alpha
2563,doxorubicin,small cell lung carcinoma,dna topoisomerase ii alpha
2564,doxorubicin,wilms tumor,dna topoisomerase ii alpha
2565,cortisol,acne,nuclear receptor subfamily 3 group c member 1
2566,cortisol,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2567,cortisol,angioedema,nuclear receptor subfamily 3 group c member 1
2568,cortisol,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
2569,cortisol,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
2570,cortisol,corneal ulcer,nuclear receptor subfamily 3 group c member 1
2571,cortisol,crohn disease,nuclear receptor subfamily 3 group c member 1
2572,cortisol,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2573,cortisol,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2574,cortisol,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2575,cortisol,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2576,cortisol,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2577,cortisol,iritis,nuclear receptor subfamily 3 group c member 1
2578,cortisol,keratitis,nuclear receptor subfamily 3 group c member 1
2579,cortisol,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2580,cortisol,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2581,cortisol,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2582,cortisol,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2583,cortisol,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2584,cortisol,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2585,cortisol,otitis externa,nuclear receptor subfamily 3 group c member 1
2586,cortisol,proctitis,nuclear receptor subfamily 3 group c member 1
2587,cortisol,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2588,cortisol,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2589,cortisol,rosacea,nuclear receptor subfamily 3 group c member 1
2590,cortisol,canker sore,nuclear receptor subfamily 3 group c member 1
2591,cortisol,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2592,cortisol,tinea pedis,nuclear receptor subfamily 3 group c member 1
2593,cortisol,trichinellosis,nuclear receptor subfamily 3 group c member 1
2594,cortisol,uveitis,nuclear receptor subfamily 3 group c member 1
2595,naproxen,arthralgia,prostaglandin-endoperoxide synthase 1
2596,naproxen,arthralgia,prostaglandin-endoperoxide synthase 2
2597,naproxen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
2598,naproxen,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
2599,naproxen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
2600,naproxen,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
2601,naproxen,bursitis,prostaglandin-endoperoxide synthase 1
2602,naproxen,bursitis,prostaglandin-endoperoxide synthase 2
2603,naproxen,dysmenorrhea,prostaglandin-endoperoxide synthase 1
2604,naproxen,dysmenorrhea,prostaglandin-endoperoxide synthase 2
2605,naproxen,fever,prostaglandin-endoperoxide synthase 1
2606,naproxen,fever,prostaglandin-endoperoxide synthase 2
2607,naproxen,gout,prostaglandin-endoperoxide synthase 1
2608,naproxen,gout,prostaglandin-endoperoxide synthase 2
2609,naproxen,headache disorder,prostaglandin-endoperoxide synthase 1
2610,naproxen,headache disorder,prostaglandin-endoperoxide synthase 2
2611,naproxen,migraine disorder,prostaglandin-endoperoxide synthase 1
2612,naproxen,migraine disorder,prostaglandin-endoperoxide synthase 2
2613,naproxen,myalgia,prostaglandin-endoperoxide synthase 1
2614,naproxen,myalgia,prostaglandin-endoperoxide synthase 2
2615,naproxen,osteoarthritis,prostaglandin-endoperoxide synthase 1
2616,naproxen,osteoarthritis,prostaglandin-endoperoxide synthase 2
2617,naproxen,pain,prostaglandin-endoperoxide synthase 1
2618,naproxen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
2619,naproxen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
2620,naproxen,tendinopathy,prostaglandin-endoperoxide synthase 1
2621,naproxen,tendinopathy,prostaglandin-endoperoxide synthase 2
2622,naproxen,toothache,prostaglandin-endoperoxide synthase 1
2623,naproxen,toothache,prostaglandin-endoperoxide synthase 2
2624,pheniramine,common cold,histamine receptor h1
2625,pheniramine,atopic conjunctivitis,histamine receptor h1
2626,pheniramine,cough,histamine receptor h1
2627,pheniramine,fever,histamine receptor h1
2628,pheniramine,headache disorder,histamine receptor h1
2629,pheniramine,pharyngitis,histamine receptor h1
2630,pheniramine,pruritus,histamine receptor h1
2631,pheniramine,allergic rhinitis,histamine receptor h1
2632,pheniramine,seasonal allergic rhinitis,histamine receptor h1
2633,pheniramine,sneeze,histamine receptor h1
2634,pheniramine,urticaria,histamine receptor h1
2635,pheniramine,vasomotor rhinitis,histamine receptor h1
2636,levoketoconazole,adrenal gland hyperfunction,cytochrome p450 family 17 subfamily a member 1
2637,methylprednisolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2638,methylprednisolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2639,methylprednisolone,angioedema,nuclear receptor subfamily 3 group c member 1
2640,methylprednisolone,gout,nuclear receptor subfamily 3 group c member 1
2641,methylprednisolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2642,methylprednisolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2643,methylprednisolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2644,methylprednisolone,asthma,nuclear receptor subfamily 3 group c member 1
2645,methylprednisolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2646,methylprednisolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2647,methylprednisolone,brain edema,nuclear receptor subfamily 3 group c member 1
2648,methylprednisolone,bursitis,nuclear receptor subfamily 3 group c member 1
2649,methylprednisolone,crohn disease,nuclear receptor subfamily 3 group c member 1
2650,methylprednisolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2651,methylprednisolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2652,methylprednisolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2653,methylprednisolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2654,methylprednisolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2655,methylprednisolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2656,methylprednisolone,exanthem,nuclear receptor subfamily 3 group c member 1
2657,methylprednisolone,eye disorder,nuclear receptor subfamily 3 group c member 1
2658,methylprednisolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2659,methylprednisolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2660,methylprednisolone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
2661,methylprednisolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2662,methylprednisolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2663,methylprednisolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2664,methylprednisolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2665,methylprednisolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2666,methylprednisolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2667,methylprednisolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2668,methylprednisolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2669,methylprednisolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2670,methylprednisolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2671,methylprednisolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2672,methylprednisolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2673,methylprednisolone,pemphigus,nuclear receptor subfamily 3 group c member 1
2674,methylprednisolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2675,methylprednisolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2676,methylprednisolone,psoriasis,nuclear receptor subfamily 3 group c member 1
2677,methylprednisolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2678,methylprednisolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2679,methylprednisolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2680,methylprednisolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2681,methylprednisolone,serum sickness,nuclear receptor subfamily 3 group c member 1
2682,methylprednisolone,skin disorder,nuclear receptor subfamily 3 group c member 1
2683,methylprednisolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2684,methylprednisolone,synovitis,nuclear receptor subfamily 3 group c member 1
2685,methylprednisolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2686,methylprednisolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2687,methylprednisolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2688,methylprednisolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2689,methylprednisolone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2690,methylprednisolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2691,triamcinolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2692,triamcinolone,angioedema,nuclear receptor subfamily 3 group c member 1
2693,triamcinolone,gout,nuclear receptor subfamily 3 group c member 1
2694,triamcinolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2695,triamcinolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2696,triamcinolone,asthma,nuclear receptor subfamily 3 group c member 1
2697,triamcinolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2698,triamcinolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2699,triamcinolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2700,triamcinolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2701,triamcinolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2702,triamcinolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
2703,triamcinolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2704,triamcinolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2705,triamcinolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2706,triamcinolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2707,triamcinolone,sympathetic ophthalmia,nuclear receptor subfamily 3 group c member 1
2708,triamcinolone,psoriasis,nuclear receptor subfamily 3 group c member 1
2709,triamcinolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2710,triamcinolone,serum sickness,nuclear receptor subfamily 3 group c member 1
2711,triamcinolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2712,triamcinolone,synovitis,nuclear receptor subfamily 3 group c member 1
2713,triamcinolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2714,triamcinolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2715,triamcinolone,bursitis,nuclear receptor subfamily 3 group c member 1
2716,triamcinolone,cutaneous candidiasis,nuclear receptor subfamily 3 group c member 1
2717,triamcinolone,exanthem,nuclear receptor subfamily 3 group c member 1
2718,triamcinolone,eye disorder,nuclear receptor subfamily 3 group c member 1
2719,triamcinolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
2720,triamcinolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2721,triamcinolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2722,triamcinolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2723,triamcinolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2724,triamcinolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2725,triamcinolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2726,triamcinolone,seasonal allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2727,triamcinolone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2728,triamcinolone,canker sore,nuclear receptor subfamily 3 group c member 1
2729,triamcinolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2730,triamcinolone,uveitis,nuclear receptor subfamily 3 group c member 1
2731,triamcinolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2732,triamcinolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2733,triamcinolone,brain edema,nuclear receptor subfamily 3 group c member 1
2734,triamcinolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2735,triamcinolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2736,triamcinolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2737,triamcinolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2738,triamcinolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2739,triamcinolone,pemphigus,nuclear receptor subfamily 3 group c member 1
2740,triamcinolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2741,triamcinolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2742,triamcinolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2743,triamcinolone,skin disorder,nuclear receptor subfamily 3 group c member 1
2744,triamcinolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2745,triamcinolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2746,triamcinolone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2747,triamcinolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2748,triamcinolone,diffuse alopecia areata,nuclear receptor subfamily 3 group c member 1
2749,triamcinolone,keloid,nuclear receptor subfamily 3 group c member 1
2750,triamcinolone,lichen planus,nuclear receptor subfamily 3 group c member 1
2751,triamcinolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2752,triamcinolone,necrobiosis lipoidica,nuclear receptor subfamily 3 group c member 1
2753,triamcinolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2754,cortisone,acne,nuclear receptor subfamily 3 group c member 1
2755,cortisone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2756,cortisone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2757,cortisone,angioedema,nuclear receptor subfamily 3 group c member 1
2758,cortisone,gout,nuclear receptor subfamily 3 group c member 1
2759,cortisone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2760,cortisone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2761,cortisone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2762,cortisone,asthma,nuclear receptor subfamily 3 group c member 1
2763,cortisone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2764,cortisone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2765,cortisone,brain edema,nuclear receptor subfamily 3 group c member 1
2766,cortisone,bursitis,nuclear receptor subfamily 3 group c member 1
2767,cortisone,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
2768,cortisone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
2769,cortisone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
2770,cortisone,crohn disease,nuclear receptor subfamily 3 group c member 1
2771,cortisone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2772,cortisone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2773,cortisone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2774,cortisone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2775,cortisone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2776,cortisone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2777,cortisone,exanthem,nuclear receptor subfamily 3 group c member 1
2778,cortisone,eye disorder,nuclear receptor subfamily 3 group c member 1
2779,cortisone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2780,cortisone,hemorrhoid,nuclear receptor subfamily 3 group c member 1
2781,cortisone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2782,cortisone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
2783,cortisone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2784,cortisone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2785,cortisone,iritis,nuclear receptor subfamily 3 group c member 1
2786,cortisone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2787,cortisone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2788,cortisone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2789,cortisone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2790,cortisone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2791,cortisone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2792,cortisone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2793,cortisone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2794,cortisone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2795,cortisone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2796,cortisone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2797,cortisone,otitis externa,nuclear receptor subfamily 3 group c member 1
2798,cortisone,pemphigus,nuclear receptor subfamily 3 group c member 1
2799,cortisone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2800,cortisone,proctitis,nuclear receptor subfamily 3 group c member 1
2801,cortisone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2802,cortisone,psoriasis,nuclear receptor subfamily 3 group c member 1
2803,cortisone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2804,cortisone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2805,cortisone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2806,cortisone,rosacea,nuclear receptor subfamily 3 group c member 1
2807,cortisone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2808,cortisone,serum sickness,nuclear receptor subfamily 3 group c member 1
2809,cortisone,skin disorder,nuclear receptor subfamily 3 group c member 1
2810,cortisone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2811,cortisone,canker sore,nuclear receptor subfamily 3 group c member 1
2812,cortisone,synovitis,nuclear receptor subfamily 3 group c member 1
2813,cortisone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2814,cortisone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2815,cortisone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2816,cortisone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2817,cortisone,tinea pedis,nuclear receptor subfamily 3 group c member 1
2818,cortisone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2819,cortisone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2820,cortisone,uveitis,nuclear receptor subfamily 3 group c member 1
2821,prednisolone,hypersensitivity pneumonitis,nuclear receptor subfamily 3 group c member 1
2822,prednisolone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2823,prednisolone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
2824,prednisolone,angioedema,nuclear receptor subfamily 3 group c member 1
2825,prednisolone,gout,nuclear receptor subfamily 3 group c member 1
2826,prednisolone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2827,prednisolone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2828,prednisolone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2829,prednisolone,allergic bronchopulmonary aspergillosis,nuclear receptor subfamily 3 group c member 1
2830,prednisolone,asthma,nuclear receptor subfamily 3 group c member 1
2831,prednisolone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2832,prednisolone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2833,prednisolone,brain edema,nuclear receptor subfamily 3 group c member 1
2834,prednisolone,bursitis,nuclear receptor subfamily 3 group c member 1
2835,prednisolone,ulcerative colitis,nuclear receptor subfamily 3 group c member 1
2836,prednisolone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
2837,prednisolone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
2838,prednisolone,crohn disease,nuclear receptor subfamily 3 group c member 1
2839,prednisolone,dacryocystitis,nuclear receptor subfamily 3 group c member 1
2840,prednisolone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2841,prednisolone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2842,prednisolone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2843,prednisolone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
2844,prednisolone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2845,prednisolone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2846,prednisolone,exanthem,nuclear receptor subfamily 3 group c member 1
2847,prednisolone,eye disorder,nuclear receptor subfamily 3 group c member 1
2848,prednisolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
2849,prednisolone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2850,prednisolone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2851,prednisolone,humoral hypercalcemia of malignancy,cytochrome p450 family 27 subfamily b member 1
2852,prednisolone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2853,prednisolone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2854,prednisolone,iritis,nuclear receptor subfamily 3 group c member 1
2855,prednisolone,keratitis,nuclear receptor subfamily 3 group c member 1
2856,prednisolone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2857,prednisolone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2858,prednisolone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2859,prednisolone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2860,prednisolone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2861,prednisolone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2862,prednisolone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2863,prednisolone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2864,prednisolone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2865,prednisolone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2866,prednisolone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2867,prednisolone,sympathetic ophthalmia,nuclear receptor subfamily 3 group c member 1
2868,prednisolone,pemphigus,nuclear receptor subfamily 3 group c member 1
2869,prednisolone,aspiration pneumonia,nuclear receptor subfamily 3 group c member 1
2870,prednisolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
2871,prednisolone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2872,prednisolone,psoriasis,nuclear receptor subfamily 3 group c member 1
2873,prednisolone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
2874,prednisolone,pulmonary fibrosis,nuclear receptor subfamily 3 group c member 1
2875,prednisolone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
2876,prednisolone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2877,prednisolone,rosacea,nuclear receptor subfamily 3 group c member 1
2878,prednisolone,serum sickness,nuclear receptor subfamily 3 group c member 1
2879,prednisolone,sjogren syndrome,nuclear receptor subfamily 3 group c member 1
2880,prednisolone,skin disorder,nuclear receptor subfamily 3 group c member 1
2881,prednisolone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2882,prednisolone,stevens-johnson syndrome,nuclear receptor subfamily 3 group c member 1
2883,prednisolone,synovitis,nuclear receptor subfamily 3 group c member 1
2884,prednisolone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2885,prednisolone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2886,prednisolone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
2887,prednisolone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2888,prednisolone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2889,prednisolone,uveitis,nuclear receptor subfamily 3 group c member 1
2890,betamethasone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
2891,betamethasone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
2892,betamethasone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2893,betamethasone,asthma,nuclear receptor subfamily 3 group c member 1
2894,betamethasone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
2895,betamethasone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
2896,betamethasone,brain edema,nuclear receptor subfamily 3 group c member 1
2897,betamethasone,bursitis,nuclear receptor subfamily 3 group c member 1
2898,betamethasone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2899,betamethasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2900,betamethasone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
2901,betamethasone,eye disorder,nuclear receptor subfamily 3 group c member 1
2902,betamethasone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2903,betamethasone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
2904,betamethasone,laryngeal edema,nuclear receptor subfamily 3 group c member 1
2905,betamethasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2906,betamethasone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2907,betamethasone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
2908,betamethasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2909,betamethasone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
2910,betamethasone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
2911,betamethasone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
2912,betamethasone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
2913,betamethasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2914,betamethasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2915,betamethasone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
2916,betamethasone,scalp dermatosis,nuclear receptor subfamily 3 group c member 1
2917,betamethasone,serum sickness,nuclear receptor subfamily 3 group c member 1
2918,betamethasone,skin disorder,nuclear receptor subfamily 3 group c member 1
2919,betamethasone,tendinopathy,nuclear receptor subfamily 3 group c member 1
2920,betamethasone,epicondylitis,nuclear receptor subfamily 3 group c member 1
2921,betamethasone,thyroiditis,nuclear receptor subfamily 3 group c member 1
2922,betamethasone,tinea pedis,nuclear receptor subfamily 3 group c member 1
2923,betamethasone,trichinellosis,nuclear receptor subfamily 3 group c member 1
2924,betamethasone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
2925,betamethasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2926,betamethasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2927,fluocinolone acetonide,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2928,fluocinolone acetonide,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2929,fluocinolone acetonide,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2930,fluocinolone acetonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
2931,fluocinolone acetonide,pruritus ani,nuclear receptor subfamily 3 group c member 1
2932,fluocinolone acetonide,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2933,fluocinolone acetonide,exanthem,nuclear receptor subfamily 3 group c member 1
2934,fluocinolone acetonide,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
2935,fluocinolone acetonide,neurodermatitis,nuclear receptor subfamily 3 group c member 1
2936,fluocinolone acetonide,choroiditis,nuclear receptor subfamily 3 group c member 1
2937,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
2938,eliglustat,gaucher disease,udp-glucose ceramide glucosyltransferase
2939,hydroxyurea,ovarian cancer,ribonucleotide reductase catalytic subunit m1
2940,hydroxyurea,head and neck neoplasm,ribonucleotide reductase catalytic subunit m1
2941,hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",ribonucleotide reductase catalytic subunit m1
2942,hydroxyurea,melanoma,ribonucleotide reductase catalytic subunit m1
2943,hydroxyurea,sickle cell anemia,ribonucleotide reductase catalytic subunit m1
2944,everolimus,renal cell carcinoma,mechanistic target of rapamycin kinase
2945,everolimus,breast neoplasm,mechanistic target of rapamycin kinase
2946,everolimus,sebaceous adenoma,mechanistic target of rapamycin kinase
2947,acetazolamide,absence epilepsy,carbonic anhydrase 2
2948,acetazolamide,open-angle glaucoma,carbonic anhydrase 1
2949,acetazolamide,open-angle glaucoma,carbonic anhydrase 14
2950,acetazolamide,open-angle glaucoma,carbonic anhydrase 3
2951,acetazolamide,open-angle glaucoma,carbonic anhydrase 2
2952,acetazolamide,open-angle glaucoma,carbonic anhydrase 4
2953,acetazolamide,open-angle glaucoma,carbonic anhydrase 7
2954,acetazolamide,open-angle glaucoma,carbonic anhydrase 12
2955,acetazolamide,edema,carbonic anhydrase 1
2956,acetazolamide,edema,carbonic anhydrase 14
2957,acetazolamide,edema,carbonic anhydrase 3
2958,acetazolamide,edema,carbonic anhydrase 2
2959,acetazolamide,edema,carbonic anhydrase 4
2960,acetazolamide,edema,carbonic anhydrase 7
2961,acetazolamide,edema,carbonic anhydrase 12
2962,acetazolamide,angle-closure glaucoma,carbonic anhydrase 1
2963,acetazolamide,angle-closure glaucoma,carbonic anhydrase 14
2964,acetazolamide,angle-closure glaucoma,carbonic anhydrase 3
2965,acetazolamide,angle-closure glaucoma,carbonic anhydrase 2
2966,acetazolamide,angle-closure glaucoma,carbonic anhydrase 4
2967,acetazolamide,angle-closure glaucoma,carbonic anhydrase 7
2968,acetazolamide,angle-closure glaucoma,carbonic anhydrase 12
2969,acetazolamide,altitude sickness,carbonic anhydrase 1
2970,acetazolamide,altitude sickness,carbonic anhydrase 14
2971,acetazolamide,altitude sickness,carbonic anhydrase 3
2972,acetazolamide,altitude sickness,carbonic anhydrase 2
2973,acetazolamide,altitude sickness,carbonic anhydrase 4
2974,acetazolamide,altitude sickness,carbonic anhydrase 7
2975,acetazolamide,altitude sickness,carbonic anhydrase 12
2976,diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 1
2977,diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 2
2978,diphenidol,central nervous system origin vertigo,cholinergic receptor muscarinic 3
2979,acebutolol,hypertensive disorder,adrenoceptor beta 1
2980,dexamethasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
2981,dexamethasone,psoriasis,nuclear receptor subfamily 3 group c member 1
2982,dexamethasone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
2983,dexamethasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
2984,dexamethasone,crohn disease,nuclear receptor subfamily 3 group c member 1
2985,dexamethasone,iridocyclitis,nuclear receptor subfamily 3 group c member 1
2986,dexamethasone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
2987,dexamethasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
2988,dexamethasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
2989,dexamethasone,keloid,nuclear receptor subfamily 3 group c member 1
2990,dexamethasone,keratitis,nuclear receptor subfamily 3 group c member 1
2991,dexamethasone,uveitis,nuclear receptor subfamily 3 group c member 1
2992,dexamethasone,bursitis,nuclear receptor subfamily 3 group c member 1
2993,dexamethasone,iritis,nuclear receptor subfamily 3 group c member 1
2994,dexamethasone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
2995,dexamethasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
2996,dexamethasone,asthma,nuclear receptor subfamily 3 group c member 1
2997,dexamethasone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
2998,dexamethasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
2999,dexamethasone,epicondylitis,nuclear receptor subfamily 3 group c member 1
3000,dexamethasone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
3001,dexamethasone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
3002,dexamethasone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
3003,dexamethasone,thyroiditis,nuclear receptor subfamily 3 group c member 1
3004,dexamethasone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
3005,dexamethasone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
3006,dexamethasone,pemphigus,nuclear receptor subfamily 3 group c member 1
3007,dexamethasone,classic hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3008,dexamethasone,trichinellosis,nuclear receptor subfamily 3 group c member 1
3009,dexamethasone,miliary tuberculosis,nuclear receptor subfamily 3 group c member 1
3010,dexamethasone,otitis externa,nuclear receptor subfamily 3 group c member 1
3011,dexamethasone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
3012,dexamethasone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
3013,dexamethasone,rosacea,nuclear receptor subfamily 3 group c member 1
3014,dexamethasone,atopic conjunctivitis,nuclear receptor subfamily 3 group c member 1
3015,dexamethasone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
3016,dexamethasone,exanthem,nuclear receptor subfamily 3 group c member 1
3017,dexamethasone,anterior uveitis,nuclear receptor subfamily 3 group c member 1
3018,dexamethasone,gout,nuclear receptor subfamily 3 group c member 1
3019,dexamethasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
3020,dexamethasone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
3021,dexamethasone,burkitt lymphoma,nuclear receptor subfamily 3 group c member 1
3022,dexamethasone,pulmonary eosinophilia,nuclear receptor subfamily 3 group c member 1
3023,dexamethasone,neurodermatitis,nuclear receptor subfamily 3 group c member 1
3024,dexamethasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3025,dexamethasone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
3026,dexamethasone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
3027,dexamethasone,diffuse large b-cell lymphoma,nuclear receptor subfamily 3 group c member 1
3028,dexamethasone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3029,dexamethasone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
3030,dexamethasone,serum sickness,nuclear receptor subfamily 3 group c member 1
3031,dexamethasone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3032,dexamethasone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
3033,dexamethasone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
3034,dexamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
3035,dexamethasone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3036,selumetinib,neurofibromatosis 1,structural maintenance of chromosomes 1a
3037,selumetinib,neurofibromatosis 1,structural maintenance of chromosomes 2
3038,selumetinib,neurofibromatosis 1,mitogen-activated protein kinase kinase 1
3039,selumetinib,neurofibromatosis 1,mitogen-activated protein kinase kinase 2
3040,ethinylestradiol,atrophic vulva,estrogen receptor 1
3041,ethinylestradiol,atrophic vulva,sex hormone binding globulin
3042,drospirenone,atrophic vulva,nuclear receptor subfamily 3 group c member 2
3043,drospirenone,atrophic vulva,progesterone receptor
3044,norethisterone,atrophic vulva,sex hormone binding globulin
3045,norethisterone,atrophic vulva,progesterone receptor
3046,norgestimate,atrophic vulva,estrogen receptor 1
3047,norgestimate,atrophic vulva,progesterone receptor
3048,estradiol valerate,atrophic vulva,estrogen related receptor beta
3049,estradiol valerate,atrophic vulva,estrogen receptor 1
3050,estradiol valerate,atrophic vulva,sex hormone binding globulin
3051,estradiol valerate,atrophic vulva,estrogen related receptor alpha
3052,ospemifene,atrophic vulva,estrogen receptor 1
3053,nizatidine,multiple endocrine neoplasia,histamine receptor h2
3054,duloxetine,generalized anxiety disorder,solute carrier family 6 member 4
3055,duloxetine,generalized anxiety disorder,solute carrier family 6 member 2
3056,duloxetine,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
3057,paroxetine,generalized anxiety disorder,solute carrier family 6 member 4
3058,paroxetine,generalized anxiety disorder,solute carrier family 6 member 2
3059,paroxetine,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
3060,pregabalin,generalized anxiety disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
3061,pregabalin,generalized anxiety disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 2
3062,escitalopram,generalized anxiety disorder,solute carrier family 6 member 4
3063,escitalopram,generalized anxiety disorder,solute carrier family 6 member 2
3064,buspirone,generalized anxiety disorder,5-hydroxytryptamine receptor 1a
3065,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha5
3066,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha3
3067,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha2
3068,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit alpha1
3069,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit gamma2
3070,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit beta2
3071,alprazolam,generalized anxiety disorder,gamma-aminobutyric acid type a receptor subunit beta3
3072,venlafaxine,generalized anxiety disorder,solute carrier family 6 member 2
3073,venlafaxine,generalized anxiety disorder,solute carrier family 6 member 4
3074,desvenlafaxine,generalized anxiety disorder,solute carrier family 6 member 2
3075,desvenlafaxine,generalized anxiety disorder,solute carrier family 6 member 4
3076,citalopram,generalized anxiety disorder,solute carrier family 6 member 2
3077,citalopram,generalized anxiety disorder,solute carrier family 6 member 4
3078,hydroxychloroquine,plasmodium malariae malaria,toll like receptor 7
3079,hydroxychloroquine,plasmodium malariae malaria,toll like receptor 9
3080,hydroxychloroquine,plasmodium malariae malaria,transmembrane protein 97
3081,chloroquine,plasmodium malariae malaria,toll like receptor 9
3082,chloroquine,plasmodium malariae malaria,transmembrane protein 97
3083,biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
3084,biperiden,postencephalitic parkinson disease,cholinergic receptor muscarinic 4
3085,benzatropine,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
3086,procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 2
3087,procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 4
3088,procyclidine,postencephalitic parkinson disease,cholinergic receptor muscarinic 1
3089,carbidopa,postencephalitic parkinson disease,dopa decarboxylase
3090,bromocriptine,postencephalitic parkinson disease,5-hydroxytryptamine receptor 6
3091,bromocriptine,postencephalitic parkinson disease,dopamine receptor d1
3092,levodopa,postencephalitic parkinson disease,dopa decarboxylase
3093,levodopa,postencephalitic parkinson disease,dopamine receptor d2
3094,levodopa,postencephalitic parkinson disease,dopamine receptor d1
3095,levodopa,postencephalitic parkinson disease,dopamine receptor d3
3096,amantadine,postencephalitic parkinson disease,dopa decarboxylase
3097,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2b
3098,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 3b
3099,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2c
3100,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2a
3101,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 1
3102,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 2d
3103,amantadine,postencephalitic parkinson disease,glutamate ionotropic receptor nmda type subunit 3a
3104,dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3105,dextromethorphan,major depressive disorder,solute carrier family 6 member 4
3106,dextromethorphan,major depressive disorder,atp binding cassette subfamily b member 1
3107,dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3108,dextromethorphan,major depressive disorder,solute carrier family 6 member 2
3109,dextromethorphan,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3110,vilazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3111,vilazodone,major depressive disorder,dopamine receptor d2
3112,vilazodone,major depressive disorder,5-hydroxytryptamine receptor 7
3113,mianserin,major depressive disorder,5-hydroxytryptamine receptor 6
3114,mianserin,major depressive disorder,solute carrier family 6 member 3
3115,mianserin,major depressive disorder,dopamine receptor d3
3116,mianserin,major depressive disorder,5-hydroxytryptamine receptor 2b
3117,mianserin,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3118,mianserin,major depressive disorder,5-hydroxytryptamine receptor 1a
3119,mianserin,major depressive disorder,5-hydroxytryptamine receptor 7
3120,mianserin,major depressive disorder,solute carrier family 6 member 4
3121,mianserin,major depressive disorder,5-hydroxytryptamine receptor 1d
3122,mianserin,major depressive disorder,dopamine receptor d2
3123,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 3a
3124,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 6
3125,olanzapine,major depressive disorder,dopamine receptor d3
3126,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 7
3127,olanzapine,major depressive disorder,dopamine receptor d4
3128,olanzapine,major depressive disorder,atp binding cassette subfamily b member 1
3129,olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3130,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1b
3131,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1a
3132,olanzapine,major depressive disorder,albumin
3133,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2b
3134,olanzapine,major depressive disorder,histamine receptor h1
3135,olanzapine,major depressive disorder,h1.0 linker histone
3136,olanzapine,major depressive disorder,adrenoceptor alpha 2c
3137,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 2c
3138,olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3139,olanzapine,major depressive disorder,dopamine receptor d5
3140,olanzapine,major depressive disorder,adrenoceptor alpha 1a
3141,olanzapine,major depressive disorder,5-hydroxytryptamine receptor 1d
3142,olanzapine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3143,olanzapine,major depressive disorder,cholinergic receptor muscarinic 2
3144,olanzapine,major depressive disorder,adrenoceptor alpha 2a
3145,olanzapine,major depressive disorder,cholinergic receptor muscarinic 3
3146,paroxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3147,paroxetine,major depressive disorder,atp binding cassette subfamily b member 1
3148,paroxetine,major depressive disorder,cholinergic receptor muscarinic 3
3149,paroxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3150,paroxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3151,paroxetine,major depressive disorder,solute carrier family 6 member 3
3152,paroxetine,major depressive disorder,cholinergic receptor muscarinic 2
3153,paroxetine,major depressive disorder,solute carrier family 6 member 2
3154,paroxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
3155,paroxetine,major depressive disorder,adrenoceptor alpha 2a
3156,paroxetine,major depressive disorder,adrenoceptor alpha 1a
3157,ketamine,major depressive disorder,dopamine receptor d2
3158,ketamine,major depressive disorder,atp binding cassette subfamily b member 1
3159,ketamine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3160,ketamine,major depressive disorder,solute carrier family 6 member 2
3161,fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3162,fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3163,fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3164,fluoxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3165,fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
3166,fluoxetine,major depressive disorder,albumin
3167,fluoxetine,major depressive disorder,solute carrier family 6 member 2
3168,fluoxetine,major depressive disorder,atp binding cassette subfamily b member 1
3169,fluoxetine,major depressive disorder,adrenoceptor alpha 2a
3170,fluoxetine,major depressive disorder,solute carrier family 6 member 3
3171,fluoxetine,major depressive disorder,histamine receptor h1
3172,fluoxetine,major depressive disorder,5-hydroxytryptamine receptor 2b
3173,fluoxetine,major depressive disorder,adrenoceptor alpha 1a
3174,fluoxetine,major depressive disorder,cholinergic receptor muscarinic 2
3175,fluoxetine,major depressive disorder,cholinergic receptor muscarinic 3
3176,bupropion,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3177,bupropion,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3178,bupropion,major depressive disorder,adrenoceptor alpha 1a
3179,bupropion,major depressive disorder,solute carrier family 6 member 4
3180,duloxetine,major depressive disorder,solute carrier family 6 member 3
3181,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3182,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 6
3183,duloxetine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3184,duloxetine,major depressive disorder,neuropeptide y receptor y1
3185,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
3186,duloxetine,major depressive disorder,adrenoceptor alpha 1a
3187,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 7
3188,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 2b
3189,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1d
3190,duloxetine,major depressive disorder,cholinergic receptor muscarinic 2
3191,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
3192,duloxetine,major depressive disorder,5-hydroxytryptamine receptor 1b
3193,duloxetine,major depressive disorder,histamine receptor h1
3194,duloxetine,major depressive disorder,adrenoceptor alpha 2a
3195,selegiline,major depressive disorder,atp binding cassette subfamily b member 1
3196,selegiline,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3197,selegiline,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3198,selegiline,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3199,escitalopram,major depressive disorder,histamine receptor h1
3200,escitalopram,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3201,escitalopram,major depressive disorder,5-hydroxytryptamine receptor 2c
3202,escitalopram,major depressive disorder,solute carrier family 6 member 3
3203,escitalopram,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3204,escitalopram,major depressive disorder,adrenoceptor alpha 1a
3205,escitalopram,major depressive disorder,solute carrier family 6 member 2
3206,citalopram,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3207,citalopram,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3208,citalopram,major depressive disorder,solute carrier family 6 member 2
3209,citalopram,major depressive disorder,solute carrier family 6 member 3
3210,citalopram,major depressive disorder,atp binding cassette subfamily b member 1
3211,citalopram,major depressive disorder,adrenoceptor alpha 1a
3212,citalopram,major depressive disorder,histamine receptor h1
3213,citalopram,major depressive disorder,5-hydroxytryptamine receptor 2c
3214,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 2a
3215,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 6
3216,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 1b
3217,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 3a
3218,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 2c
3219,vortioxetine,major depressive disorder,histamine receptor h1
3220,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 7
3221,vortioxetine,major depressive disorder,solute carrier family 6 member 4
3222,vortioxetine,major depressive disorder,5-hydroxytryptamine receptor 1a
3223,nefazodone,major depressive disorder,atp binding cassette subfamily b member 1
3224,nefazodone,major depressive disorder,solute carrier family 6 member 3
3225,nefazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
3226,nefazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3227,nefazodone,major depressive disorder,adrenoceptor alpha 2a
3228,nefazodone,major depressive disorder,adrenoceptor alpha 1a
3229,nefazodone,major depressive disorder,dopamine receptor d2
3230,venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3231,venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3232,venlafaxine,major depressive disorder,neuropeptide y receptor y1
3233,venlafaxine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3234,venlafaxine,major depressive disorder,atp binding cassette subfamily b member 1
3235,venlafaxine,major depressive disorder,adrenoceptor alpha 2a
3236,venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 6
3237,venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 2c
3238,venlafaxine,major depressive disorder,5-hydroxytryptamine receptor 2a
3239,venlafaxine,major depressive disorder,cholinergic receptor muscarinic 2
3240,trazodone,major depressive disorder,histamine receptor h1
3241,trazodone,major depressive disorder,adrenoceptor alpha 2a
3242,trazodone,major depressive disorder,atp binding cassette subfamily b member 1
3243,trazodone,major depressive disorder,5-hydroxytryptamine receptor 2c
3244,trazodone,major depressive disorder,adrenoceptor alpha 1a
3245,trazodone,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3246,trazodone,major depressive disorder,5-hydroxytryptamine receptor 1a
3247,trazodone,major depressive disorder,5-hydroxytryptamine receptor 2b
3248,trazodone,major depressive disorder,5-hydroxytryptamine receptor 2a
3249,trazodone,major depressive disorder,solute carrier family 6 member 3
3250,trazodone,major depressive disorder,dopamine receptor d2
3251,trazodone,major depressive disorder,solute carrier family 6 member 2
3252,tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3253,tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily c member 19
3254,tranylcypromine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3255,tranylcypromine,major depressive disorder,solute carrier family 6 member 3
3256,tranylcypromine,major depressive disorder,solute carrier family 6 member 2
3257,tranylcypromine,major depressive disorder,5-hydroxytryptamine receptor 1a
3258,mirtazapine,major depressive disorder,solute carrier family 6 member 4
3259,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2c
3260,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 1a
3261,mirtazapine,major depressive disorder,dopamine receptor d2
3262,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2a
3263,mirtazapine,major depressive disorder,dopamine receptor d3
3264,mirtazapine,major depressive disorder,dopamine receptor d4
3265,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 2b
3266,mirtazapine,major depressive disorder,adrenoceptor alpha 2c
3267,mirtazapine,major depressive disorder,adrenoceptor alpha 1a
3268,mirtazapine,major depressive disorder,histamine receptor h1
3269,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 3a
3270,mirtazapine,major depressive disorder,cytochrome p450 family 2 subfamily d member 6
3271,mirtazapine,major depressive disorder,solute carrier family 6 member 2
3272,mirtazapine,major depressive disorder,5-hydroxytryptamine receptor 7
3273,mirtazapine,major depressive disorder,cytochrome p450 family 2 subfamily c member 9
3274,mirtazapine,major depressive disorder,adrenoceptor alpha 2a
3275,mirtazapine,major depressive disorder,solute carrier family 6 member 3
3276,gepirone,major depressive disorder,5-hydroxytryptamine receptor 2a
3277,gepirone,major depressive disorder,dopamine receptor d2
3278,hydroxocobalamin,methylmalonic acidemia,5-methyltetrahydrofolate-homocysteine methyltransferase
3279,hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated b
3280,hydroxocobalamin,methylmalonic acidemia,methylmalonyl-coa mutase
3281,hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated a
3282,hydroxocobalamin,methylmalonic acidemia,metabolism of cobalamin associated c
3283,hydroxocobalamin,methylmalonic acidemia,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
3284,sirolimus,lymphangioma,fkbp prolyl isomerase 1a
3285,sirolimus,lymphangioma,eukaryotic translation initiation factor 4e
3286,sirolimus,lymphangioma,fkbp prolyl isomerase 1b
3287,sirolimus,lymphangioma,fkbp prolyl isomerase 5
3288,nortriptyline,depressive disorder,histamine receptor h1
3289,nortriptyline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3290,nortriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3291,nortriptyline,depressive disorder,5-hydroxytryptamine receptor 1a
3292,nortriptyline,depressive disorder,5-hydroxytryptamine receptor 2c
3293,nortriptyline,depressive disorder,albumin
3294,nortriptyline,depressive disorder,5-hydroxytryptamine receptor 2a
3295,nortriptyline,depressive disorder,dopamine receptor d2
3296,nortriptyline,depressive disorder,cholinergic receptor muscarinic 2
3297,nortriptyline,depressive disorder,solute carrier family 6 member 3
3298,nortriptyline,depressive disorder,adrenoceptor alpha 2a
3299,trimipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3300,trimipramine,depressive disorder,solute carrier family 6 member 3
3301,trimipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3302,trimipramine,depressive disorder,solute carrier family 6 member 4
3303,trimipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3304,trimipramine,depressive disorder,5-hydroxytryptamine receptor 3a
3305,trimipramine,depressive disorder,5-hydroxytryptamine receptor 1a
3306,trimipramine,depressive disorder,adrenoceptor alpha 2b
3307,trimipramine,depressive disorder,atp binding cassette subfamily b member 1
3308,trimipramine,depressive disorder,solute carrier family 6 member 2
3309,trimipramine,depressive disorder,5-hydroxytryptamine receptor 1d
3310,trimipramine,depressive disorder,histamine receptor h1
3311,trimipramine,depressive disorder,adrenoceptor alpha 2a
3312,trimipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3313,trimipramine,depressive disorder,dopamine receptor d2
3314,amoxapine,depressive disorder,5-hydroxytryptamine receptor 2a
3315,amoxapine,depressive disorder,dopamine receptor d3
3316,amoxapine,depressive disorder,5-hydroxytryptamine receptor 2c
3317,amoxapine,depressive disorder,5-hydroxytryptamine receptor 3a
3318,amoxapine,depressive disorder,gamma-aminobutyric acid type a receptor subunit alpha1
3319,amoxapine,depressive disorder,solute carrier family 6 member 3
3320,amoxapine,depressive disorder,5-hydroxytryptamine receptor 1a
3321,amoxapine,depressive disorder,dopamine receptor d2
3322,amoxapine,depressive disorder,5-hydroxytryptamine receptor 1b
3323,amoxapine,depressive disorder,solute carrier family 6 member 2
3324,amoxapine,depressive disorder,histamine receptor h1
3325,amoxapine,depressive disorder,adrenoceptor alpha 2a
3326,amoxapine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3327,amoxapine,depressive disorder,5-hydroxytryptamine receptor 7
3328,amoxapine,depressive disorder,dopamine receptor d4
3329,fluvoxamine,depressive disorder,sigma non-opioid intracellular receptor 1
3330,fluvoxamine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3331,fluvoxamine,depressive disorder,solute carrier family 6 member 4
3332,fluvoxamine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3333,fluvoxamine,depressive disorder,solute carrier family 6 member 3
3334,fluvoxamine,depressive disorder,atp binding cassette subfamily b member 1
3335,fluvoxamine,depressive disorder,solute carrier family 6 member 2
3336,imipramine,depressive disorder,cholinergic receptor muscarinic 2
3337,imipramine,depressive disorder,histamine receptor h1
3338,imipramine,depressive disorder,dopamine receptor d2
3339,imipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3340,imipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3341,imipramine,depressive disorder,solute carrier family 6 member 3
3342,imipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3343,imipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3344,imipramine,depressive disorder,atp binding cassette subfamily b member 1
3345,imipramine,depressive disorder,5-hydroxytryptamine receptor 1a
3346,imipramine,depressive disorder,5-hydroxytryptamine receptor 7
3347,imipramine,depressive disorder,dopamine receptor d3
3348,imipramine,depressive disorder,adrenoceptor alpha 2a
3349,protriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3350,protriptyline,depressive disorder,atp binding cassette subfamily b member 1
3351,protriptyline,depressive disorder,solute carrier family 6 member 3
3352,fluoxetine,depressive disorder,5-hydroxytryptamine receptor 2a
3353,fluoxetine,depressive disorder,sigma non-opioid intracellular receptor 1
3354,fluoxetine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3355,fluoxetine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3356,fluoxetine,depressive disorder,5-hydroxytryptamine receptor 2c
3357,fluoxetine,depressive disorder,albumin
3358,fluoxetine,depressive disorder,solute carrier family 6 member 2
3359,fluoxetine,depressive disorder,atp binding cassette subfamily b member 1
3360,fluoxetine,depressive disorder,adrenoceptor alpha 2a
3361,fluoxetine,depressive disorder,solute carrier family 6 member 3
3362,fluoxetine,depressive disorder,histamine receptor h1
3363,fluoxetine,depressive disorder,cholinergic receptor muscarinic 2
3364,citalopram,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3365,citalopram,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3366,citalopram,depressive disorder,solute carrier family 6 member 2
3367,citalopram,depressive disorder,solute carrier family 6 member 3
3368,citalopram,depressive disorder,atp binding cassette subfamily b member 1
3369,citalopram,depressive disorder,histamine receptor h1
3370,citalopram,depressive disorder,5-hydroxytryptamine receptor 2c
3371,sertraline,depressive disorder,atp binding cassette subfamily b member 1
3372,sertraline,depressive disorder,sigma non-opioid intracellular receptor 1
3373,sertraline,depressive disorder,monoamine oxidase b
3374,sertraline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3375,sertraline,depressive disorder,solute carrier family 6 member 2
3376,sertraline,depressive disorder,solute carrier family 6 member 3
3377,sertraline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3378,sertraline,depressive disorder,monoamine oxidase a
3379,lofepramine,depressive disorder,dopamine receptor d2
3380,lofepramine,depressive disorder,cholinergic receptor muscarinic 2
3381,lofepramine,depressive disorder,solute carrier family 6 member 2
3382,lofepramine,depressive disorder,5-hydroxytryptamine receptor 2c
3383,lofepramine,depressive disorder,5-hydroxytryptamine receptor 1a
3384,lofepramine,depressive disorder,adrenoceptor alpha 2a
3385,lofepramine,depressive disorder,histamine receptor h1
3386,lofepramine,depressive disorder,solute carrier family 6 member 4
3387,moclobemide,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3388,moclobemide,depressive disorder,monoamine oxidase a
3389,moclobemide,depressive disorder,monoamine oxidase b
3390,moclobemide,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3391,moclobemide,depressive disorder,5-hydroxytryptamine receptor 1a
3392,clomipramine,depressive disorder,adrenoceptor alpha 2a
3393,clomipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3394,clomipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3395,clomipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3396,clomipramine,depressive disorder,solute carrier family 6 member 2
3397,clomipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3398,clomipramine,depressive disorder,atp binding cassette subfamily b member 1
3399,clomipramine,depressive disorder,solute carrier family 6 member 4
3400,clomipramine,depressive disorder,albumin
3401,clomipramine,depressive disorder,dopamine receptor d3
3402,clomipramine,depressive disorder,dopamine receptor d2
3403,clomipramine,depressive disorder,solute carrier family 6 member 3
3404,clomipramine,depressive disorder,dopamine receptor d1
3405,doxepin,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3406,doxepin,depressive disorder,adrenoceptor alpha 2a
3407,doxepin,depressive disorder,5-hydroxytryptamine receptor 2a
3408,doxepin,depressive disorder,5-hydroxytryptamine receptor 2c
3409,doxepin,depressive disorder,atp binding cassette subfamily b member 1
3410,doxepin,depressive disorder,solute carrier family 6 member 2
3411,doxepin,depressive disorder,adrenoceptor alpha 2c
3412,doxepin,depressive disorder,histamine receptor h1
3413,doxepin,depressive disorder,dopamine receptor d2
3414,doxepin,depressive disorder,adrenoceptor alpha 2b
3415,doxepin,depressive disorder,solute carrier family 6 member 4
3416,doxepin,depressive disorder,5-hydroxytryptamine receptor 1a
3417,doxepin,depressive disorder,cholinergic receptor muscarinic 2
3418,doxepin,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3419,desipramine,depressive disorder,5-hydroxytryptamine receptor 2c
3420,desipramine,depressive disorder,cholinergic receptor muscarinic 2
3421,desipramine,depressive disorder,atp binding cassette subfamily b member 1
3422,desipramine,depressive disorder,5-hydroxytryptamine receptor 1a
3423,desipramine,depressive disorder,adrenoceptor beta 1
3424,desipramine,depressive disorder,5-hydroxytryptamine receptor 2a
3425,desipramine,depressive disorder,dopamine receptor d2
3426,desipramine,depressive disorder,solute carrier family 6 member 3
3427,desipramine,depressive disorder,solute carrier family 6 member 4
3428,desipramine,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3429,desipramine,depressive disorder,histamine receptor h1
3430,desipramine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3431,desipramine,depressive disorder,sphingomyelin phosphodiesterase 1
3432,desipramine,depressive disorder,dopamine receptor d1
3433,desipramine,depressive disorder,albumin
3434,desipramine,depressive disorder,adrenoceptor alpha 2a
3435,toloxatone,depressive disorder,monoamine oxidase b
3436,methylphenidate,depressive disorder,solute carrier family 6 member 4
3437,methylphenidate,depressive disorder,solute carrier family 6 member 3
3438,methylphenidate,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3439,methylphenidate,depressive disorder,solute carrier family 6 member 2
3440,paroxetine,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3441,paroxetine,depressive disorder,tachykinin receptor 1
3442,paroxetine,depressive disorder,atp binding cassette subfamily b member 1
3443,paroxetine,depressive disorder,5-hydroxytryptamine receptor 2a
3444,paroxetine,depressive disorder,solute carrier family 6 member 3
3445,paroxetine,depressive disorder,cholinergic receptor muscarinic 2
3446,paroxetine,depressive disorder,solute carrier family 6 member 2
3447,paroxetine,depressive disorder,5-hydroxytryptamine receptor 1a
3448,paroxetine,depressive disorder,adrenoceptor alpha 2a
3449,paroxetine,depressive disorder,g protein-coupled receptor kinase 2
3450,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1a
3451,amitriptyline,depressive disorder,solute carrier family 6 member 4
3452,amitriptyline,depressive disorder,neurotrophic receptor tyrosine kinase 2
3453,amitriptyline,depressive disorder,albumin
3454,amitriptyline,depressive disorder,dopamine receptor d2
3455,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1d
3456,amitriptyline,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3457,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 2c
3458,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 2a
3459,amitriptyline,depressive disorder,opioid receptor mu 1
3460,amitriptyline,depressive disorder,opioid receptor kappa 1
3461,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 1b
3462,amitriptyline,depressive disorder,atp binding cassette subfamily b member 1
3463,amitriptyline,depressive disorder,cholinergic receptor muscarinic 2
3464,amitriptyline,depressive disorder,histamine receptor h1
3465,amitriptyline,depressive disorder,dopamine receptor d3
3466,amitriptyline,depressive disorder,solute carrier family 6 member 2
3467,amitriptyline,depressive disorder,5-hydroxytryptamine receptor 7
3468,amitriptyline,depressive disorder,cytochrome p450 family 2 subfamily c member 19
3469,amitriptyline,depressive disorder,sigma non-opioid intracellular receptor 1
3470,amitriptyline,depressive disorder,adrenoceptor alpha 2a
3471,amitriptyline,depressive disorder,solute carrier family 6 member 3
3472,amitriptyline,depressive disorder,dopamine receptor d1
3473,amitriptyline,depressive disorder,dopamine receptor d5
3474,bupropion,depressive disorder,cytochrome p450 family 2 subfamily d member 6
3475,bupropion,depressive disorder,solute carrier family 6 member 4
3476,prednisolone,musculoskeletal system disorder,serpin family a member 6
3477,triamcinolone,musculoskeletal system disorder,serpin family a member 6
3478,cortisol,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3479,cortisol,musculoskeletal system disorder,sex hormone binding globulin
3480,cortisol,musculoskeletal system disorder,serpin family a member 6
3481,prednisone,musculoskeletal system disorder,nuclear receptor subfamily 3 group c member 1
3482,phenytoin,status epilepticus,atp binding cassette subfamily c member 2
3483,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 3
3484,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 1
3485,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 5
3486,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 2
3487,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 8
3488,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 4
3489,phenytoin,status epilepticus,sodium voltage-gated channel alpha subunit 9
3490,levetiracetam,status epilepticus,calcium voltage-gated channel subunit alpha1 b
3491,levetiracetam,status epilepticus,atp binding cassette subfamily c member 2
3492,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
3493,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
3494,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma3
3495,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3496,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
3497,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
3498,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3499,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3500,diazepam,status epilepticus,gamma-aminobutyric acid type a receptor subunit delta
3501,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3502,secobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3503,secobarbital,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
3504,phenobarbital,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
3505,phenobarbital,status epilepticus,atp binding cassette subfamily c member 2
3506,phenobarbital,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3507,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3508,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
3509,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
3510,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
3511,pentobarbitone,status epilepticus,glutamate ionotropic receptor ampa type subunit 2
3512,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3513,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
3514,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
3515,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3516,pentobarbitone,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
3517,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha1
3518,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha6
3519,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit delta
3520,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma3
3521,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta2
3522,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha5
3523,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit beta3
3524,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit gamma2
3525,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha4
3526,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha2
3527,midazolam,status epilepticus,gamma-aminobutyric acid type a receptor subunit alpha3
3528,cortisol,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3529,cortisol,adrenocortical insufficiency,sex hormone binding globulin
3530,cortisol,adrenocortical insufficiency,serpin family a member 6
3531,triamcinolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3532,triamcinolone,adrenocortical insufficiency,serpin family a member 6
3533,prednisone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3534,betamethasone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3535,prednisolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3536,prednisolone,adrenocortical insufficiency,serpin family a member 6
3537,methylprednisolone,adrenocortical insufficiency,nuclear receptor subfamily 3 group c member 1
3538,vasopressin,nocturnal enuresis,arginine vasopressin receptor 2
3539,medroxyprogesterone,precocious puberty,nuclear receptor subfamily 3 group c member 1
3540,progesterone,precocious puberty,nuclear receptor subfamily 3 group c member 1
3541,danazol,precocious puberty,gonadotropin releasing hormone receptor
3542,amiodarone,ventricular fibrillation,potassium voltage-gated channel subfamily h member 2
3543,"1,25-dihydroxyvitamin d3",hypophosphatemia,gc vitamin d binding protein
3544,"1,25-dihydroxyvitamin d3",hypophosphatemia,cytochrome p450 family 3 subfamily a member 4
3545,calcifediol,hypophosphatemia,vitamin d receptor
3546,calcifediol,hypophosphatemia,cytochrome p450 family 27 subfamily b member 1
3547,pralatrexate,mature t-cell and nk-cell non-hodgkin lymphoma,solute carrier family 19 member 1
3548,biotin,nutritional biotin deficiency,solute carrier family 5 member 6
3549,biotin,nutritional biotin deficiency,holocarboxylase synthetase
3550,isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
3551,isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
3552,isotretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
3553,tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
3554,tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
3555,tretinoin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
3556,acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor gamma
3557,acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor beta
3558,acitretin,primary cutaneous t-cell non-hodgkin lymphoma,retinoid x receptor alpha
3559,mometasone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3560,prednisone,primary cutaneous t-cell non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
3561,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 6
3562,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 1
3563,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 2
3564,panobinostat,primary cutaneous t-cell non-hodgkin lymphoma,histone deacetylase 3
3565,bupropion,seasonal affective disorder,solute carrier family 6 member 4
3566,fluoxetine,seasonal affective disorder,5-hydroxytryptamine receptor 2a
3567,fluoxetine,seasonal affective disorder,solute carrier family 6 member 4
3568,fluoxetine,seasonal affective disorder,5-hydroxytryptamine receptor 2c
3569,fluoxetine,seasonal affective disorder,solute carrier family 6 member 2
3570,fluoxetine,seasonal affective disorder,solute carrier family 6 member 3
3571,sertraline,seasonal affective disorder,solute carrier family 6 member 4
3572,sertraline,seasonal affective disorder,solute carrier family 6 member 2
3573,sertraline,seasonal affective disorder,solute carrier family 6 member 3
3574,phenprocoumon,thrombotic disease,albumin
3575,warfarin,thrombotic disease,cytochrome p450 family 2 subfamily c member 19
3576,warfarin,thrombotic disease,albumin
3577,dicumarol,thrombotic disease,g protein-coupled receptor 35
3578,ceftriaxone,endometritis,synuclein alpha
3579,5-fluorouracil,small intestine cancer,thymidylate synthetase
3580,oxaliplatin,gastric cancer,glutathione s-transferase pi 1
3581,oxaliplatin,gastric cancer,metallothionein 2a
3582,oxaliplatin,gastric cancer,glutathione s-transferase theta 1
3583,oxaliplatin,gastric cancer,glutathione s-transferase mu 1
3584,tipiracil,gastric cancer,thymidine phosphorylase
3585,capecitabine,gastric cancer,thymidine phosphorylase
3586,capecitabine,gastric cancer,dihydropyrimidine dehydrogenase
3587,capecitabine,gastric cancer,thymidylate synthetase
3588,docetaxel,gastric cancer,epidermal growth factor receptor
3589,docetaxel,gastric cancer,tubulin beta 6 class v
3590,docetaxel,gastric cancer,tubulin beta 2b class iib
3591,docetaxel,gastric cancer,tubulin beta 2a class iia
3592,docetaxel,gastric cancer,tubulin beta class i
3593,docetaxel,gastric cancer,tubulin beta 3 class iii
3594,docetaxel,gastric cancer,tubulin beta 1 class vi
3595,docetaxel,gastric cancer,tubulin beta 4a class iva
3596,docetaxel,gastric cancer,tubulin beta 4b class ivb
3597,docetaxel,gastric cancer,tubulin beta 8 class viii
3598,5-fluorouracil,gastric cancer,cytochrome p450 family 2 subfamily a member 6
3599,5-fluorouracil,gastric cancer,thymidine phosphorylase
3600,5-fluorouracil,gastric cancer,albumin
3601,5-fluorouracil,gastric cancer,thymidylate synthetase
3602,5-fluorouracil,gastric cancer,methylenetetrahydrofolate reductase
3603,5-fluorouracil,gastric cancer,dihydropyrimidine dehydrogenase
3604,5-fluorouracil,gastric cancer,uridine monophosphate synthetase
3605,trifluridine,gastric cancer,thymidylate synthetase
3606,trifluridine,gastric cancer,thymidine phosphorylase
3607,ergocalciferol,osteomalacia,cytochrome p450 family 2 subfamily r member 1
3608,ergocalciferol,osteomalacia,vitamin d receptor
3609,ergocalciferol,osteomalacia,cytochrome p450 family 27 subfamily b member 1
3610,ceftriaxone,acute gonococcal cervicitis,synuclein alpha
3611,esomeprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
3612,pantoprazole,gastric ulcer,atpase h+/k+ transporting subunit alpha
3613,pantoprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
3614,cimetidine,gastric ulcer,solute carrier family 47 member 1
3615,lansoprazole,gastric ulcer,atpase h+/k+ transporting subunit beta
3616,famotidine,gastric ulcer,solute carrier family 47 member 1
3617,fenoldopam,malignant essential hypertension,dopamine receptor d1
3618,5-fluorouracil,urinary bladder cancer,thymidine phosphorylase
3619,5-fluorouracil,urinary bladder cancer,thymidylate synthetase
3620,5-fluorouracil,urinary bladder cancer,methylenetetrahydrofolate reductase
3621,mitomycin c,urinary bladder cancer,cytochrome p450 oxidoreductase
3622,carboplatin,urinary bladder cancer,glutathione s-transferase theta 1
3623,carboplatin,urinary bladder cancer,metallothionein 1a
3624,carboplatin,urinary bladder cancer,metallothionein 2a
3625,carboplatin,urinary bladder cancer,myeloperoxidase
3626,carboplatin,urinary bladder cancer,glutathione s-transferase pi 1
3627,carboplatin,urinary bladder cancer,glutathione s-transferase mu 1
3628,gemcitabine,urinary bladder cancer,ribonucleotide reductase regulatory subunit m2
3629,gemcitabine,urinary bladder cancer,thymidylate synthetase
3630,prednisolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3631,prednisolone,acquired thrombocytopenia,serpin family a member 6
3632,prednisone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3633,methylprednisolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3634,betamethasone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3635,cortisol,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3636,cortisol,acquired thrombocytopenia,sex hormone binding globulin
3637,cortisol,acquired thrombocytopenia,serpin family a member 6
3638,triamcinolone,acquired thrombocytopenia,nuclear receptor subfamily 3 group c member 1
3639,triamcinolone,acquired thrombocytopenia,serpin family a member 6
3640,"1,25-dihydroxyvitamin d3",hypoparathyroidism,gc vitamin d binding protein
3641,alfacalcidol,hypoparathyroidism,cytochrome p450 family 27 subfamily b member 1
3642,alfacalcidol,hypoparathyroidism,gc vitamin d binding protein
3643,alfacalcidol,hypoparathyroidism,vitamin d receptor
3644,ergocalciferol,hypoparathyroidism,vitamin d receptor
3645,ergocalciferol,hypoparathyroidism,cytochrome p450 family 27 subfamily b member 1
3646,sertraline,social phobia,solute carrier family 6 member 2
3647,sertraline,social phobia,solute carrier family 6 member 3
3648,desvenlafaxine,social phobia,solute carrier family 6 member 2
3649,desvenlafaxine,social phobia,solute carrier family 6 member 4
3650,desvenlafaxine,social phobia,solute carrier family 6 member 3
3651,fluvoxamine,social phobia,solute carrier family 6 member 3
3652,fluvoxamine,social phobia,solute carrier family 6 member 2
3653,paroxetine,social phobia,solute carrier family 6 member 3
3654,paroxetine,social phobia,solute carrier family 6 member 2
3655,ceftriaxone,streptococcal meningitis,synuclein alpha
3656,bimatoprost,hypertrichosis of eyelid,prostaglandin f receptor
3657,theophylline,bronchial disorder,phosphodiesterase 4c
3658,theophylline,bronchial disorder,phosphodiesterase 4a
3659,theophylline,bronchial disorder,phosphodiesterase 4d
3660,theophylline,bronchial disorder,phosphodiesterase 4b
3661,triamcinolone,thyroiditis,serpin family a member 6
3662,prednisone,thyroiditis,nuclear receptor subfamily 3 group c member 1
3663,cortisol,thyroiditis,nuclear receptor subfamily 3 group c member 1
3664,cortisol,thyroiditis,sex hormone binding globulin
3665,cortisol,thyroiditis,serpin family a member 6
3666,prednisolone,thyroiditis,serpin family a member 6
3667,duloxetine,female stress incontinence,solute carrier family 6 member 4
3668,duloxetine,female stress incontinence,solute carrier family 6 member 2
3669,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha3
3670,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit gamma2
3671,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha2
3672,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit beta3
3673,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha1
3674,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit beta2
3675,chlordiazepoxide,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha5
3676,lansoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3677,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 5
3678,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 4
3679,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 2
3680,pirenzepine,peptic ulcer disease,cholinergic receptor muscarinic 3
3681,pantoprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3682,rabeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3683,esomeprazole,peptic ulcer disease,atpase h+/k+ transporting subunit beta
3684,atropine,peptic ulcer disease,cholinergic receptor muscarinic 5
3685,atropine,peptic ulcer disease,cholinergic receptor muscarinic 4
3686,atropine,peptic ulcer disease,cholinergic receptor muscarinic 3
3687,atropine,peptic ulcer disease,cholinergic receptor muscarinic 2
3688,atropine,peptic ulcer disease,cholinergic receptor muscarinic 1
3689,ceftriaxone,acute gonococcal endometritis,synuclein alpha
3690,ceftriaxone,gonorrhea,synuclein alpha
3691,diazoxide,hyperinsulinism,atp binding cassette subfamily c member 8
3692,magnesium sulfate,constipation disorder,calcium voltage-gated channel subunit alpha1 s
3693,magnesium sulfate,constipation disorder,calcium voltage-gated channel subunit alpha1 c
3694,nizatidine,dyspepsia,histamine receptor h2
3695,lovastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
3696,simvastatin,arteriosclerosis disorder,3-hydroxy-3-methylglutaryl-coa reductase
3697,cortisol,blepharoconjunctivitis,nuclear receptor subfamily 3 group c member 1
3698,cortisol,blepharoconjunctivitis,sex hormone binding globulin
3699,cortisol,blepharoconjunctivitis,serpin family a member 6
3700,prednisolone,blepharoconjunctivitis,nuclear receptor subfamily 3 group c member 1
3701,prednisolone,blepharoconjunctivitis,serpin family a member 6
3702,cromoglicic acid,vernal conjunctivitis,g protein-coupled receptor 35
3703,cinnarizine,central nervous system origin vertigo,calcium voltage-gated channel subunit alpha1 c
3704,cinnarizine,central nervous system origin vertigo,calcium voltage-gated channel subunit alpha1 g
3705,everolimus,sebaceous adenoma,fkbp prolyl isomerase 1a
3706,sirolimus,sebaceous adenoma,fkbp prolyl isomerase 1a
3707,sirolimus,sebaceous adenoma,eukaryotic translation initiation factor 4e
3708,sirolimus,sebaceous adenoma,mechanistic target of rapamycin kinase
3709,sirolimus,sebaceous adenoma,fkbp prolyl isomerase 1b
3710,sirolimus,sebaceous adenoma,fkbp prolyl isomerase 5
3711,indomethacin,synovitis,c-x-c motif chemokine ligand 8
3712,indomethacin,synovitis,aldo-keto reductase family 1 member c3
3713,betamethasone,synovitis,prostaglandin-endoperoxide synthase 2
3714,betamethasone,synovitis,nuclear receptor subfamily 3 group c member 1
3715,triamcinolone,synovitis,prostaglandin-endoperoxide synthase 2
3716,triamcinolone,synovitis,serpin family a member 6
3717,cortisol,synovitis,nuclear receptor subfamily 3 group c member 1
3718,cortisol,synovitis,sex hormone binding globulin
3719,cortisol,synovitis,serpin family a member 6
3720,prednisolone,synovitis,serpin family a member 6
3721,lidocaine,dermatitis,epidermal growth factor receptor
3722,clobetasol propionate,dermatitis,nuclear receptor subfamily 3 group c member 1
3723,cortisol,dermatitis,nuclear receptor subfamily 3 group c member 1
3724,tandospirone,bruxism,5-hydroxytryptamine receptor 1a
3725,tandospirone,bruxism,dopamine receptor d4
3726,progesterone,endometrial carcinoma,progesterone receptor
3727,progesterone,endometrial carcinoma,sex hormone binding globulin
3728,progesterone,endometrial carcinoma,estrogen receptor 1
3729,progesterone,endometrial carcinoma,serpin family a member 6
3730,paclitaxel,endometrial carcinoma,cytochrome p450 family 19 subfamily a member 1
3731,tamoxifen,endometrial carcinoma,estrogen receptor 2
3732,tamoxifen,endometrial carcinoma,cytochrome p450 family 19 subfamily a member 1
3733,tamoxifen,endometrial carcinoma,estrogen receptor 1
3734,megestrol,endometrial carcinoma,progesterone receptor
3735,lenvatinib,endometrial carcinoma,kinase insert domain receptor
3736,lenvatinib,endometrial carcinoma,receptor interacting serine/threonine kinase 2
3737,lenvatinib,endometrial carcinoma,ret proto-oncogene
3738,medroxyprogesterone,endometrial carcinoma,aldo-keto reductase family 1 member c3
3739,medroxyprogesterone,endometrial carcinoma,sex hormone binding globulin
3740,medroxyprogesterone,endometrial carcinoma,progesterone receptor
3741,medroxyprogesterone,endometrial carcinoma,estrogen receptor 1
3742,triamcinolone,bursitis,prostaglandin-endoperoxide synthase 2
3743,triamcinolone,bursitis,serpin family a member 6
3744,etodolac,bursitis,prostaglandin-endoperoxide synthase 1
3745,etodolac,bursitis,prostaglandin-endoperoxide synthase 2
3746,prednisolone,bursitis,serpin family a member 6
3747,naproxen,bursitis,aldo-keto reductase family 1 member c3
3748,indomethacin,bursitis,c-x-c motif chemokine ligand 8
3749,indomethacin,bursitis,aldo-keto reductase family 1 member c3
3750,diclofenac,bursitis,prostaglandin-endoperoxide synthase 2
3751,diclofenac,bursitis,prostaglandin-endoperoxide synthase 1
3752,diclofenac,bursitis,c-x-c motif chemokine ligand 8
3753,cortisol,bursitis,nuclear receptor subfamily 3 group c member 1
3754,cortisol,bursitis,sex hormone binding globulin
3755,cortisol,bursitis,serpin family a member 6
3756,betamethasone,bursitis,prostaglandin-endoperoxide synthase 2
3757,carmustine,brain glioblastoma,glutathione-disulfide reductase
3758,chlorhexidine,gingivitis,solute carrier family 47 member 1
3759,chlorhexidine,gingivitis,solute carrier family 22 member 1
3760,chlorhexidine,gingivitis,solute carrier family 47 member 2
3761,chlorhexidine,gingivitis,solute carrier family 22 member 3
3762,chlorhexidine,gingivitis,solute carrier family 22 member 2
3763,pexidartinib,tenosynovial giant cell tumor,protein kinase c theta
3764,betamethasone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3765,cortisol,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3766,cortisol,aspiration pneumonitis,sex hormone binding globulin
3767,cortisol,aspiration pneumonitis,serpin family a member 6
3768,triamcinolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3769,triamcinolone,aspiration pneumonitis,serpin family a member 6
3770,methylprednisolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3771,prednisolone,aspiration pneumonitis,nuclear receptor subfamily 3 group c member 1
3772,prednisolone,aspiration pneumonitis,serpin family a member 6
3773,ifosfamide,bone osteosarcoma,cytochrome p450 family 3 subfamily a member 4
3774,epirubicin,bone osteosarcoma,dna topoisomerase ii alpha
3775,etoposide,bone osteosarcoma,glutathione s-transferase pi 1
3776,etoposide,bone osteosarcoma,dna topoisomerase ii alpha
3777,etoposide,bone osteosarcoma,cytochrome p450 family 3 subfamily a member 4
3778,floxuridine,liver cancer,thymidylate synthetase
3779,prednisolone,pulmonary fibrosis,serpin family a member 6
3780,butenafine,dermatophytosis of groin and perianal area,squalene epoxidase
3781,betamethasone,dermatophytosis of groin and perianal area,nuclear receptor subfamily 3 group c member 1
3782,clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
3783,clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 17 subfamily a member 1
3784,clotrimazole,dermatophytosis of groin and perianal area,cytochrome p450 family 51 subfamily a member 1
3785,clotrimazole,dermatophytosis of groin and perianal area,potassium calcium-activated channel subfamily n member 4
3786,cortisol,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 2
3787,cortisol,dermatophytosis of groin and perianal area,nuclear receptor subfamily 3 group c member 1
3788,cortisol,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
3789,cortisol,dermatophytosis of groin and perianal area,sex hormone binding globulin
3790,cortisol,dermatophytosis of groin and perianal area,serpin family a member 6
3791,miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 51 subfamily a member 1
3792,miconazole,dermatophytosis of groin and perianal area,potassium calcium-activated channel subfamily n member 4
3793,miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 17 subfamily a member 1
3794,miconazole,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 1
3795,ethinylestradiol,postmenopausal atrophic vaginitis,estrogen receptor 2
3796,medroxyprogesterone,postmenopausal atrophic vaginitis,progesterone receptor
3797,medroxyprogesterone,postmenopausal atrophic vaginitis,estrogen receptor 1
3798,norgestimate,postmenopausal atrophic vaginitis,estrogen receptor 1
3799,norgestimate,postmenopausal atrophic vaginitis,progesterone receptor
3800,norethisterone,postmenopausal atrophic vaginitis,progesterone receptor
3801,progesterone,postmenopausal atrophic vaginitis,progesterone receptor
3802,progesterone,postmenopausal atrophic vaginitis,estrogen receptor 1
3803,butenafine,tinea corporis,squalene epoxidase
3804,cortisol,tinea corporis,cytochrome p450 family 11 subfamily b member 2
3805,cortisol,tinea corporis,nuclear receptor subfamily 3 group c member 1
3806,cortisol,tinea corporis,cytochrome p450 family 11 subfamily b member 1
3807,cortisol,tinea corporis,sex hormone binding globulin
3808,cortisol,tinea corporis,serpin family a member 6
3809,betamethasone,tinea corporis,nuclear receptor subfamily 3 group c member 1
3810,clotrimazole,tinea corporis,cytochrome p450 family 11 subfamily b member 1
3811,clotrimazole,tinea corporis,cytochrome p450 family 17 subfamily a member 1
3812,clotrimazole,tinea corporis,cytochrome p450 family 51 subfamily a member 1
3813,clotrimazole,tinea corporis,potassium calcium-activated channel subfamily n member 4
3814,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 11
3815,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 5
3816,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 10
3817,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 9
3818,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 3
3819,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 7
3820,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 2
3821,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 8
3822,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 1
3823,benzocaine,tinea corporis,sodium voltage-gated channel alpha subunit 4
3824,miconazole,tinea corporis,cytochrome p450 family 51 subfamily a member 1
3825,miconazole,tinea corporis,potassium calcium-activated channel subfamily n member 4
3826,miconazole,tinea corporis,cytochrome p450 family 17 subfamily a member 1
3827,miconazole,tinea corporis,cytochrome p450 family 11 subfamily b member 1
3828,loteprednol etabonate,punctate epithelial keratoconjunctivitis,nuclear receptor subfamily 3 group c member 1
3829,ethacrynic acid,hypercalcemia disease,solute carrier family 12 member 1
3830,bumetanide,hypercalcemia disease,solute carrier family 12 member 1
3831,furosemide,hypercalcemia disease,solute carrier family 12 member 1
3832,danazol,gynecomastia disorder,androgen receptor
3833,danazol,gynecomastia disorder,cytochrome p450 family 19 subfamily a member 1
3834,danazol,gynecomastia disorder,gonadotropin releasing hormone receptor
3835,chloroquine,plasmodium ovale malaria,toll like receptor 9
3836,chloroquine,plasmodium ovale malaria,transmembrane protein 97
3837,hydroxychloroquine,plasmodium ovale malaria,toll like receptor 7
3838,hydroxychloroquine,plasmodium ovale malaria,toll like receptor 9
3839,hydroxychloroquine,plasmodium ovale malaria,transmembrane protein 97
3840,morphine,diarrheal disease,opioid receptor mu 1
3841,morphine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3842,clonidine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3843,clonidine,diarrheal disease,solute carrier family 22 member 5
3844,diphenoxylate,diarrheal disease,opioid receptor mu 1
3845,difenoxin,diarrheal disease,opioid receptor mu 1
3846,loperamide,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3847,loperamide,diarrheal disease,calcium voltage-gated channel subunit alpha1 a
3848,codeine,diarrheal disease,cytochrome p450 family 3 subfamily a member 4
3849,codeine,diarrheal disease,opioid receptor mu 1
3850,alfacalcidol,hyperparathyroidism,cytochrome p450 family 27 subfamily b member 1
3851,alfacalcidol,hyperparathyroidism,vitamin d receptor
3852,diclofenamide,angle-closure glaucoma,carbonic anhydrase 14
3853,diclofenamide,angle-closure glaucoma,carbonic anhydrase 3
3854,acetazolamide,angle-closure glaucoma,carbonic anhydrase 11
3855,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 2
3856,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 3
3857,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 5
3858,prilocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 1
3859,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 2
3860,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 3
3861,lidocaine,premature ejaculation,sodium voltage-gated channel alpha subunit 4
3862,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 2
3863,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 9
3864,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 3
3865,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 5
3866,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 10
3867,lidocaine,pthirus pubis infestation,sodium voltage-gated channel alpha subunit 4
3868,ceftriaxone,chancroid,synuclein alpha
3869,flibanserin,hypoactive sexual desire disorder,5-hydroxytryptamine receptor 1a
3870,lisuride,amenorrhea,5-hydroxytryptamine receptor 2b
3871,lisuride,amenorrhea,dopamine receptor d4
3872,lisuride,amenorrhea,dopamine receptor d5
3873,norethisterone,amenorrhea,sex hormone binding globulin
3874,ethinylestradiol,amenorrhea,sex hormone binding globulin
3875,desogestrel,amenorrhea,sex hormone binding globulin
3876,estradiol valerate,amenorrhea,sex hormone binding globulin
3877,estrone,amenorrhea,sex hormone binding globulin
3878,triamcinolone,epicondylitis,serpin family a member 6
3879,prednisolone,epicondylitis,serpin family a member 6
3880,prednisone,epicondylitis,nuclear receptor subfamily 3 group c member 1
3881,clomiphene,oligospermia,estrogen receptor 1
3882,ceftriaxone,rhinoscleroma,synuclein alpha
3883,ivermectin,strongyloidiasis,glycine receptor alpha 3
3884,betamethasone,tinea pedis,prostaglandin-endoperoxide synthase 2
3885,sertaconazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
3886,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 11
3887,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 5
3888,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 9
3889,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 3
3890,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 7
3891,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 2
3892,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 8
3893,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 1
3894,benzocaine,tinea pedis,sodium voltage-gated channel alpha subunit 4
3895,cortisol,tinea pedis,cytochrome p450 family 11 subfamily b member 2
3896,cortisol,tinea pedis,cytochrome p450 family 11 subfamily b member 1
3897,cortisol,tinea pedis,sex hormone binding globulin
3898,cortisol,tinea pedis,serpin family a member 6
3899,miconazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
3900,miconazole,tinea pedis,potassium calcium-activated channel subfamily n member 4
3901,miconazole,tinea pedis,cytochrome p450 family 17 subfamily a member 1
3902,miconazole,tinea pedis,cytochrome p450 family 11 subfamily b member 1
3903,clotrimazole,tinea pedis,cytochrome p450 family 11 subfamily b member 1
3904,clotrimazole,tinea pedis,cytochrome p450 family 17 subfamily a member 1
3905,clotrimazole,tinea pedis,cytochrome p450 family 51 subfamily a member 1
3906,clotrimazole,tinea pedis,potassium calcium-activated channel subfamily n member 4
3907,azelastine,vasomotor rhinitis,adrenoceptor alpha 1b
3908,azelastine,vasomotor rhinitis,adrenoceptor alpha 1a
3909,dextromethorphan,vasomotor rhinitis,solute carrier family 6 member 2
3910,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 4
3911,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 5
3912,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 2
3913,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 3
3914,promethazine,vasomotor rhinitis,adrenoceptor alpha 1a
3915,promethazine,vasomotor rhinitis,cholinergic receptor muscarinic 1
3916,chlorpheniramine,vasomotor rhinitis,solute carrier family 6 member 2
3917,pseudoephedrine,vasomotor rhinitis,adrenoceptor alpha 2a
3918,pseudoephedrine,vasomotor rhinitis,solute carrier family 6 member 2
3919,pseudoephedrine,vasomotor rhinitis,adrenoceptor beta 2
3920,ephedrine,vasomotor rhinitis,solute carrier family 6 member 2
3921,ephedrine,vasomotor rhinitis,adrenoceptor beta 2
3922,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 1
3923,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 5
3924,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 2
3925,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 3
3926,n-methyl scopolamine,vasomotor rhinitis,cholinergic receptor muscarinic 4
3927,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 2
3928,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 4
3929,diphenhydramine,vasomotor rhinitis,solute carrier family 6 member 2
3930,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 1
3931,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 5
3932,diphenhydramine,vasomotor rhinitis,cholinergic receptor muscarinic 3
3933,beclometasone,vasomotor rhinitis,nuclear receptor subfamily 3 group c member 1
3934,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 4
3935,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 2
3936,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 5
3937,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 3
3938,brompheniramine,vasomotor rhinitis,cholinergic receptor muscarinic 1
3939,clemastine,vasomotor rhinitis,adrenoceptor alpha 2a
3940,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 4
3941,clemastine,vasomotor rhinitis,transmembrane protein 97
3942,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 3
3943,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 5
3944,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 1
3945,clemastine,vasomotor rhinitis,cholinergic receptor muscarinic 2
3946,phenylephrine,vasomotor rhinitis,adrenoceptor alpha 2a
3947,doxylamine,vasomotor rhinitis,cholinergic receptor muscarinic 1
3948,imiquimod,superficial multifocal basal cell carcinoma,toll like receptor 7
3949,5-fluorouracil,superficial multifocal basal cell carcinoma,thymidylate synthetase
3950,paclitaxel,cervical cancer,tubulin beta class i
3951,5-fluorouracil,cervical cancer,methylenetetrahydrofolate reductase
3952,topotecan,cervical cancer,dna topoisomerase i mitochondrial
3953,spironolactone,hyperaldosteronism,nuclear receptor subfamily 3 group c member 1
3954,spironolactone,hyperaldosteronism,cytochrome p450 family 11 subfamily b member 2
3955,spironolactone,hyperaldosteronism,cytochrome p450 family 11 subfamily b member 1
3956,dextromethorphan,rhinitis,opioid receptor mu 1
3957,dextromethorphan,rhinitis,solute carrier family 6 member 2
3958,beclometasone,rhinitis,nuclear receptor subfamily 3 group c member 1
3959,hydrocodone,rhinitis,opioid receptor mu 1
3960,ephedrine,rhinitis,adrenoceptor alpha 1a
3961,ephedrine,rhinitis,solute carrier family 6 member 2
3962,ephedrine,rhinitis,adrenoceptor beta 2
3963,pseudoephedrine,rhinitis,solute carrier family 6 member 2
3964,pseudoephedrine,rhinitis,adrenoceptor beta 2
3965,codeine,rhinitis,opioid receptor mu 1
3966,triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit beta
3967,triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit gamma
3968,triamterene,potassium deficiency disease,sodium channel epithelial 1 subunit alpha
3969,cortisol,keratitis,annexin a1
3970,cortisol,keratitis,sex hormone binding globulin
3971,cortisol,keratitis,serpin family a member 6
3972,prednisolone,keratitis,serpin family a member 6
3973,propylthiouracil,hyperthyroidism,iodothyronine deiodinase 1
3974,carbimazole,hyperthyroidism,thyroid peroxidase
3975,lidocaine,scabies,sodium voltage-gated channel alpha subunit 2
3976,lidocaine,scabies,sodium voltage-gated channel alpha subunit 3
3977,lidocaine,scabies,sodium voltage-gated channel alpha subunit 4
3978,everolimus,kidney angiomyolipoma,fkbp prolyl isomerase 1a
3979,fluorometholone,corneal ulcer,nuclear receptor subfamily 3 group c member 1
3980,fluorometholone,corneal ulcer,serpin family a member 6
3981,prednisolone,corneal ulcer,serpin family a member 6
3982,cortisol,corneal ulcer,sex hormone binding globulin
3983,cortisol,corneal ulcer,serpin family a member 6
3984,mupirocin,impetigo,isoleucyl-trna synthetase 1
3985,ceftriaxone,bacterial pneumonia,synuclein alpha
3986,hydroxocobalamin,homocystinuria,5-methyltetrahydrofolate-homocysteine methyltransferase
3987,hydroxocobalamin,homocystinuria,metabolism of cobalamin associated a
3988,hydroxocobalamin,homocystinuria,metabolism of cobalamin associated c
3989,hydroxocobalamin,homocystinuria,methylenetetrahydrofolate reductase
3990,hydroxocobalamin,homocystinuria,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
3991,montelukast,intrinsic asthma,cysteinyl leukotriene receptor 1
3992,montelukast,intrinsic asthma,arachidonate 5-lipoxygenase
3993,mometasone,intrinsic asthma,nuclear receptor subfamily 3 group c member 1
3994,salmeterol,intrinsic asthma,adrenoceptor beta 2
3995,fluticasone,intrinsic asthma,nuclear receptor subfamily 3 group c member 1
3996,zileuton,intrinsic asthma,arachidonate 5-lipoxygenase
3997,zileuton,intrinsic asthma,epoxide hydrolase 2
3998,formoterol,intrinsic asthma,adrenoceptor beta 2
3999,fluorometholone,iridocyclitis,serpin family a member 6
4000,cortisol,iridocyclitis,sex hormone binding globulin
4001,cortisol,iridocyclitis,serpin family a member 6
4002,prednisolone,iridocyclitis,serpin family a member 6
4003,fluticasone,allergic asthma,nuclear receptor subfamily 3 group c member 1
4004,montelukast,allergic asthma,cysteinyl leukotriene receptor 1
4005,montelukast,allergic asthma,arachidonate 5-lipoxygenase
4006,formoterol,allergic asthma,adrenoceptor beta 2
4007,zileuton,allergic asthma,arachidonate 5-lipoxygenase
4008,zileuton,allergic asthma,epoxide hydrolase 2
4009,mometasone,allergic asthma,nuclear receptor subfamily 3 group c member 1
4010,salmeterol,allergic asthma,adrenoceptor beta 2
4011,fluorometholone,otitis externa,nuclear receptor subfamily 3 group c member 1
4012,fluorometholone,otitis externa,serpin family a member 6
4013,prednisolone,otitis externa,nuclear receptor subfamily 3 group c member 1
4014,prednisolone,otitis externa,serpin family a member 6
4015,cortisol,otitis externa,sex hormone binding globulin
4016,cortisol,otitis externa,serpin family a member 6
4017,terbutaline,bronchiectasis,adrenoceptor beta 2
4018,terbutaline,bronchiectasis,adrenoceptor beta 1
4019,5-fluorouracil,oral mucosa leukoplakia,thymidylate synthetase
4020,formoterol,pulmonary emphysema,cytochrome p450 family 2 subfamily a member 6
4021,formoterol,pulmonary emphysema,adrenoceptor beta 1
4022,formoterol,pulmonary emphysema,adrenoceptor beta 3
4023,salmeterol,pulmonary emphysema,adrenoceptor beta 3
4024,salmeterol,pulmonary emphysema,adrenoceptor beta 1
4025,dyphylline,pulmonary emphysema,adenosine a1 receptor
4026,dyphylline,pulmonary emphysema,adenosine a2a receptor
4027,dyphylline,pulmonary emphysema,phosphodiesterase 3a
4028,terbutaline,pulmonary emphysema,adrenoceptor beta 1
4029,theophylline,pulmonary emphysema,adenosine a2a receptor
4030,theophylline,pulmonary emphysema,adenosine a2b receptor
4031,theophylline,pulmonary emphysema,phosphodiesterase 4c
4032,theophylline,pulmonary emphysema,phosphodiesterase 4a
4033,theophylline,pulmonary emphysema,phosphodiesterase 3a
4034,theophylline,pulmonary emphysema,phosphodiesterase 4d
4035,theophylline,pulmonary emphysema,phosphodiesterase 4b
4036,theophylline,pulmonary emphysema,adenosine a1 receptor
4037,theophylline,pulmonary emphysema,adenosine a3 receptor
4038,cortisol,tenosynovitis,sex hormone binding globulin
4039,cortisol,tenosynovitis,serpin family a member 6
4040,indomethacin,tenosynovitis,c-x-c motif chemokine ligand 8
4041,indomethacin,tenosynovitis,aldo-keto reductase family 1 member c3
4042,diclofenac,tenosynovitis,prostaglandin-endoperoxide synthase 2
4043,diclofenac,tenosynovitis,prostaglandin-endoperoxide synthase 1
4044,diclofenac,tenosynovitis,c-x-c motif chemokine ligand 8
4045,betamethasone,tenosynovitis,prostaglandin-endoperoxide synthase 2
4046,betamethasone,tenosynovitis,nuclear receptor subfamily 3 group c member 1
4047,triamcinolone,tenosynovitis,prostaglandin-endoperoxide synthase 2
4048,triamcinolone,tenosynovitis,serpin family a member 6
4049,salicylic acid,tenosynovitis,prostaglandin-endoperoxide synthase 1
4050,salicylic acid,tenosynovitis,prostaglandin-endoperoxide synthase 2
4051,prednisolone,tenosynovitis,serpin family a member 6
4052,betamethasone,tendinitis,prostaglandin-endoperoxide synthase 2
4053,betamethasone,tendinitis,nuclear receptor subfamily 3 group c member 1
4054,sulindac,tendinitis,prostaglandin-endoperoxide synthase 1
4055,sulindac,tendinitis,prostaglandin-endoperoxide synthase 2
4056,triamcinolone,tendinitis,nuclear receptor subfamily 3 group c member 1
4057,triamcinolone,tendinitis,prostaglandin-endoperoxide synthase 2
4058,triamcinolone,tendinitis,serpin family a member 6
4059,salicylic acid,tendinitis,prostaglandin-endoperoxide synthase 1
4060,salicylic acid,tendinitis,prostaglandin-endoperoxide synthase 2
4061,diclofenac,tendinitis,prostaglandin-endoperoxide synthase 2
4062,diclofenac,tendinitis,prostaglandin-endoperoxide synthase 1
4063,diclofenac,tendinitis,c-x-c motif chemokine ligand 8
4064,cortisol,tendinitis,nuclear receptor subfamily 3 group c member 1
4065,cortisol,tendinitis,sex hormone binding globulin
4066,cortisol,tendinitis,serpin family a member 6
4067,methylprednisolone,tendinitis,nuclear receptor subfamily 3 group c member 1
4068,naproxen,tendinitis,prostaglandin-endoperoxide synthase 1
4069,naproxen,tendinitis,aldo-keto reductase family 1 member c3
4070,naproxen,tendinitis,prostaglandin-endoperoxide synthase 2
4071,indomethacin,tendinitis,c-x-c motif chemokine ligand 8
4072,indomethacin,tendinitis,prostaglandin-endoperoxide synthase 1
4073,indomethacin,tendinitis,prostaglandin-endoperoxide synthase 2
4074,indomethacin,tendinitis,aldo-keto reductase family 1 member c3
4075,prednisolone,tendinitis,nuclear receptor subfamily 3 group c member 1
4076,prednisolone,tendinitis,serpin family a member 6
4077,etodolac,tendinitis,prostaglandin-endoperoxide synthase 1
4078,etodolac,tendinitis,prostaglandin-endoperoxide synthase 2
4079,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 2
4080,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 3
4081,lidocaine,hemorrhoid,sodium voltage-gated channel alpha subunit 4
4082,cortisol,hemorrhoid,nuclear receptor subfamily 3 group c member 1
4083,cortisol,hemorrhoid,sex hormone binding globulin
4084,cortisol,hemorrhoid,serpin family a member 6
4085,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 2
4086,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 9
4087,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 3
4088,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 5
4089,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 10
4090,lidocaine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 4
4091,terbutaline,bronchitis,adrenoceptor beta 1
4092,theophylline,bronchitis,adenosine a2a receptor
4093,theophylline,bronchitis,adenosine a2b receptor
4094,theophylline,bronchitis,phosphodiesterase 4a
4095,theophylline,bronchitis,phosphodiesterase 3a
4096,theophylline,bronchitis,phosphodiesterase 4b
4097,theophylline,bronchitis,adenosine a1 receptor
4098,theophylline,bronchitis,adenosine a3 receptor
4099,ephedrine,bronchitis,adrenoceptor alpha 1a
4100,minocycline,bronchitis,vascular endothelial growth factor a
4101,methylprednisolone,bronchitis,nuclear receptor subfamily 3 group c member 1
4102,betamethasone,bronchitis,nuclear receptor subfamily 3 group c member 1
4103,prednisolone,bronchitis,nuclear receptor subfamily 3 group c member 1
4104,triamcinolone,bronchitis,nuclear receptor subfamily 3 group c member 1
4105,betahistine,meniere disease,histamine receptor h3
4106,betahistine,meniere disease,histamine receptor h1
4107,cinnarizine,motion sickness,calcium voltage-gated channel subunit alpha1 c
4108,clotrimazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
4109,clotrimazole,vulvovaginal candidiasis,potassium calcium-activated channel subfamily n member 4
4110,tioconazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
4111,miconazole,vulvovaginal candidiasis,cytochrome p450 family 51 subfamily a member 1
4112,miconazole,vulvovaginal candidiasis,potassium calcium-activated channel subfamily n member 4
4113,amlodipine,prinzmetal angina,atp binding cassette subfamily b member 1
4114,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4115,amlodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4116,diltiazem,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4117,diltiazem,prinzmetal angina,atp binding cassette subfamily b member 1
4118,nifedipine,prinzmetal angina,atp binding cassette subfamily b member 1
4119,nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4120,nifedipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4121,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 f
4122,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4123,verapamil,prinzmetal angina,atp binding cassette subfamily b member 1
4124,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 i
4125,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4126,verapamil,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
4127,felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4128,felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
4129,felodipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 s
4130,felodipine,prinzmetal angina,atp binding cassette subfamily b member 1
4131,nicardipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 d
4132,nicardipine,prinzmetal angina,atp binding cassette subfamily b member 1
4133,nicardipine,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
4134,irinotecan,pancreatic adenocarcinoma,dna topoisomerase i
4135,gemcitabine,pancreatic adenocarcinoma,ribonucleotide reductase regulatory subunit m2
4136,gemcitabine,pancreatic adenocarcinoma,ribonucleotide reductase catalytic subunit m1
4137,gemcitabine,pancreatic adenocarcinoma,"dna polymerase epsilon, catalytic subunit"
4138,gemcitabine,pancreatic adenocarcinoma,"dna polymerase delta 1, catalytic subunit"
4139,gemcitabine,pancreatic adenocarcinoma,"dna polymerase alpha 1, catalytic subunit"
4140,gemcitabine,pancreatic adenocarcinoma,thymidylate synthetase
4141,5-fluorouracil,pancreatic adenocarcinoma,thymidylate synthetase
4142,capecitabine,pancreatic adenocarcinoma,thymidylate synthetase
4143,erlotinib,pancreatic adenocarcinoma,mitogen-activated protein kinase kinase kinase 19
4144,erlotinib,pancreatic adenocarcinoma,serine/threonine kinase 10
4145,erlotinib,pancreatic adenocarcinoma,ste20 like kinase
4146,erlotinib,pancreatic adenocarcinoma,solute carrier organic anion transporter family member 2b1
4147,erlotinib,pancreatic adenocarcinoma,epidermal growth factor receptor
4148,erlotinib,pancreatic adenocarcinoma,cyclin g associated kinase
4149,aminosalicylic acid,pulmonary tuberculosis,prostaglandin-endoperoxide synthase 1
4150,aminosalicylic acid,pulmonary tuberculosis,prostaglandin-endoperoxide synthase 2
4151,daunorubicin,wilms tumor,nuclear receptor subfamily 5 group a member 1
4152,daunorubicin,wilms tumor,dna topoisomerase ii alpha
4153,vincristine,wilms tumor,nuclear receptor subfamily 0 group b member 1
4154,bosutinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
4155,bosutinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
4156,imatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 1, non-receptor tyrosine kinase"
4157,imatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
4158,dasatinib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
4159,sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 1a
4160,sirolimus,lung lymphangioleiomyomatosis,eukaryotic translation initiation factor 4e
4161,sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 1b
4162,sirolimus,lung lymphangioleiomyomatosis,fkbp prolyl isomerase 5
4163,propranolol,hemangioma,adrenoceptor beta 2
4164,propranolol,hemangioma,adrenoceptor beta 1
4165,desloratadine,allergic urticaria,histamine receptor h1
4166,prednisolone,erythema multiforme,serpin family a member 6
4167,triamcinolone,erythema multiforme,serpin family a member 6
4168,prednisone,erythema multiforme,nuclear receptor subfamily 3 group c member 1
4169,cortisol,erythema multiforme,nuclear receptor subfamily 3 group c member 1
4170,cortisol,erythema multiforme,sex hormone binding globulin
4171,cortisol,erythema multiforme,serpin family a member 6
4172,cortisol,exanthem,nuclear receptor subfamily 3 group c member 1
4173,cortisol,exanthem,sex hormone binding globulin
4174,cortisol,exanthem,serpin family a member 6
4175,prednisolone,exanthem,serpin family a member 6
4176,fluocinolone acetonide,exanthem,serpin family a member 6
4177,betamethasone,exanthem,nuclear receptor subfamily 3 group c member 1
4178,mometasone,exanthem,nuclear receptor subfamily 3 group c member 1
4179,triamcinolone,exanthem,serpin family a member 6
4180,amcinonide,exanthem,nuclear receptor subfamily 3 group c member 1
4181,flumethasone pivalate,exanthem,serpin family a member 6
4182,fluticasone,exanthem,serpin family a member 6
4183,alclometasone dipropionate,exanthem,serpin family a member 6
4184,fluocinolone acetonide,granuloma annulare,serpin family a member 6
4185,prednisolone,granuloma annulare,serpin family a member 6
4186,triamcinolone,granuloma annulare,serpin family a member 6
4187,alclometasone dipropionate,granuloma annulare,serpin family a member 6
4188,mometasone,granuloma annulare,nuclear receptor subfamily 3 group c member 1
4189,fluticasone,granuloma annulare,serpin family a member 6
4190,cortisol,granuloma annulare,sex hormone binding globulin
4191,cortisol,granuloma annulare,serpin family a member 6
4192,clocortolone pivalate,granuloma annulare,nuclear receptor subfamily 3 group c member 1
4193,flumethasone pivalate,granuloma annulare,serpin family a member 6
4194,amcinonide,granuloma annulare,nuclear receptor subfamily 3 group c member 1
4195,prednisolone,pemphigus,serpin family a member 6
4196,betamethasone,pemphigus,nuclear receptor subfamily 3 group c member 1
4197,triamcinolone,pemphigus,serpin family a member 6
4198,prednisone,pemphigus,nuclear receptor subfamily 3 group c member 1
4199,cortisol,pemphigus,nuclear receptor subfamily 3 group c member 1
4200,cortisol,pemphigus,sex hormone binding globulin
4201,cortisol,pemphigus,serpin family a member 6
4202,cortisol,rosacea,sex hormone binding globulin
4203,cortisol,rosacea,serpin family a member 6
4204,prednisolone,rosacea,serpin family a member 6
4205,loteprednol etabonate,rosacea,nuclear receptor subfamily 3 group c member 1
4206,fluorometholone,rosacea,nuclear receptor subfamily 3 group c member 1
4207,fluorometholone,rosacea,serpin family a member 6
4208,clobetasol propionate,scalp dermatosis,nuclear receptor subfamily 3 group c member 1
4209,fluticasone,seborrheic dermatitis,serpin family a member 6
4210,betamethasone,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
4211,prednisolone,seborrheic dermatitis,serpin family a member 6
4212,cortisol,seborrheic dermatitis,cytochrome p450 family 11 subfamily b member 2
4213,cortisol,seborrheic dermatitis,cytochrome p450 family 11 subfamily b member 1
4214,cortisol,seborrheic dermatitis,sex hormone binding globulin
4215,cortisol,seborrheic dermatitis,serpin family a member 6
4216,alclometasone dipropionate,seborrheic dermatitis,serpin family a member 6
4217,triamcinolone,seborrheic dermatitis,prostaglandin-endoperoxide synthase 2
4218,triamcinolone,seborrheic dermatitis,serpin family a member 6
4219,clobetasol propionate,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
4220,flumethasone pivalate,seborrheic dermatitis,serpin family a member 6
4221,fluocinolone acetonide,seborrheic dermatitis,serpin family a member 6
4222,mometasone,seborrheic dermatitis,nuclear receptor subfamily 3 group c member 1
4223,metyrapone,adrenal gland hyperfunction,cytochrome p450 family 11 subfamily b member 1
4224,metyrapone,adrenal gland hyperfunction,cytochrome p450 family 11 subfamily b member 2
4225,prednisolone,bacterial conjunctivitis,nuclear receptor subfamily 3 group c member 1
4226,prednisolone,bacterial conjunctivitis,serpin family a member 6
4227,ceftriaxone,bacterial meningitis,synuclein alpha
4228,minoxidil,alopecia,potassium inwardly rectifying channel subfamily j member 11
4229,minoxidil,alopecia,atp binding cassette subfamily c member 9
4230,prednisolone,dacryocystitis,serpin family a member 6
4231,prednisone,b-cell chronic lymphocytic leukemia,nuclear receptor subfamily 3 group c member 1
4232,acalabrutinib,b-cell chronic lymphocytic leukemia,bruton tyrosine kinase
4233,acalabrutinib,b-cell chronic lymphocytic leukemia,txk tyrosine kinase
4234,acalabrutinib,b-cell chronic lymphocytic leukemia,bmx non-receptor tyrosine kinase
4235,acalabrutinib,b-cell chronic lymphocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
4236,acalabrutinib,b-cell chronic lymphocytic leukemia,tec protein tyrosine kinase
4237,venetoclax,b-cell chronic lymphocytic leukemia,bcl2 like 2
4238,venetoclax,b-cell chronic lymphocytic leukemia,bcl2 like 1
4239,ibrutinib,b-cell chronic lymphocytic leukemia,bmx non-receptor tyrosine kinase
4240,ibrutinib,b-cell chronic lymphocytic leukemia,tec protein tyrosine kinase
4241,ibrutinib,b-cell chronic lymphocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
4242,ibrutinib,b-cell chronic lymphocytic leukemia,txk tyrosine kinase
4243,carmustine,hodgkins lymphoma,glutathione-disulfide reductase
4244,vincristine,hodgkins lymphoma,atp binding cassette subfamily b member 1
4245,vincristine,hodgkins lymphoma,tubulin beta 8 class viii
4246,vincristine,hodgkins lymphoma,tubulin beta 3 class iii
4247,vincristine,hodgkins lymphoma,tubulin beta class i
4248,vincristine,hodgkins lymphoma,tubulin beta 1 class vi
4249,vincristine,hodgkins lymphoma,tubulin beta 4a class iva
4250,vincristine,hodgkins lymphoma,tubulin beta 2a class iia
4251,vincristine,hodgkins lymphoma,tubulin beta 2b class iib
4252,vincristine,hodgkins lymphoma,tubulin beta 4b class ivb
4253,vincristine,hodgkins lymphoma,tubulin beta 6 class v
4254,prednisolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4255,prednisolone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4256,prednisolone,hodgkins lymphoma,serpin family a member 6
4257,cortisol,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4258,cortisol,hodgkins lymphoma,atp binding cassette subfamily b member 1
4259,cortisol,hodgkins lymphoma,sex hormone binding globulin
4260,cortisol,hodgkins lymphoma,serpin family a member 6
4261,etoposide,hodgkins lymphoma,glutathione s-transferase pi 1
4262,etoposide,hodgkins lymphoma,dna topoisomerase ii alpha
4263,etoposide,hodgkins lymphoma,udp glucuronosyltransferase family 1 member a1
4264,etoposide,hodgkins lymphoma,atp binding cassette subfamily b member 1
4265,betamethasone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4266,betamethasone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4267,triamcinolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4268,triamcinolone,hodgkins lymphoma,serpin family a member 6
4269,chlorambucil,hodgkins lymphoma,glutathione s-transferase pi 1
4270,epirubicin,hodgkins lymphoma,dna topoisomerase ii alpha
4271,vinblastine,hodgkins lymphoma,tubulin beta 4a class iva
4272,vinblastine,hodgkins lymphoma,tubulin gamma 1
4273,vinblastine,hodgkins lymphoma,tubulin beta 1 class vi
4274,vinblastine,hodgkins lymphoma,tubulin beta 8 class viii
4275,vinblastine,hodgkins lymphoma,atp binding cassette subfamily b member 1
4276,vinblastine,hodgkins lymphoma,tubulin alpha 1a
4277,vinblastine,hodgkins lymphoma,tubulin beta 2b class iib
4278,vinblastine,hodgkins lymphoma,tubulin beta 4b class ivb
4279,vinblastine,hodgkins lymphoma,tubulin beta class i
4280,vinblastine,hodgkins lymphoma,tubulin beta 2a class iia
4281,vinblastine,hodgkins lymphoma,tubulin beta 3 class iii
4282,vinblastine,hodgkins lymphoma,tubulin delta 1
4283,vinblastine,hodgkins lymphoma,tubulin beta 6 class v
4284,vinblastine,hodgkins lymphoma,tubulin epsilon 1
4285,prednisone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4286,prednisone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4287,cyclophosphamide,hodgkins lymphoma,atp binding cassette subfamily b member 1
4288,methylprednisolone,hodgkins lymphoma,nuclear receptor subfamily 3 group c member 1
4289,methylprednisolone,hodgkins lymphoma,atp binding cassette subfamily b member 1
4290,tamoxifen,invasive ductal breast carcinoma,ebp cholestenol delta-isomerase
4291,tamoxifen,invasive ductal breast carcinoma,7-dehydrocholesterol reductase
4292,tamoxifen,invasive ductal breast carcinoma,ebp like
4293,tamoxifen,invasive ductal breast carcinoma,estrogen receptor 1
4294,prednisolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4295,prednisolone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4296,prednisolone,acute lymphoblastic leukemia,serpin family a member 6
4297,cytarabine,acute lymphoblastic leukemia,"dna polymerase alpha 1, catalytic subunit"
4298,cytarabine,acute lymphoblastic leukemia,"dna polymerase delta 1, catalytic subunit"
4299,cytarabine,acute lymphoblastic leukemia,"dna polymerase epsilon, catalytic subunit"
4300,daunorubicin,acute lymphoblastic leukemia,cytochrome p450 family 1 subfamily b member 1
4301,daunorubicin,acute lymphoblastic leukemia,dna topoisomerase ii alpha
4302,daunorubicin,acute lymphoblastic leukemia,cytochrome p450 family 1 subfamily a member 2
4303,daunorubicin,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4304,mercaptopurine,acute lymphoblastic leukemia,phosphoribosyl pyrophosphate amidotransferase
4305,cyclophosphamide,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4306,cyclophosphamide,acute lymphoblastic leukemia,cytochrome p450 family 2 subfamily c member 8
4307,cortisol,acute lymphoblastic leukemia,cytochrome p450 family 2 subfamily c member 8
4308,cortisol,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4309,cortisol,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4310,cortisol,acute lymphoblastic leukemia,sex hormone binding globulin
4311,cortisol,acute lymphoblastic leukemia,serpin family a member 6
4312,prednisone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4313,prednisone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4314,vincristine,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4315,vincristine,acute lymphoblastic leukemia,tubulin beta 8 class viii
4316,vincristine,acute lymphoblastic leukemia,tubulin beta 3 class iii
4317,vincristine,acute lymphoblastic leukemia,tubulin beta class i
4318,vincristine,acute lymphoblastic leukemia,tubulin beta 1 class vi
4319,vincristine,acute lymphoblastic leukemia,tubulin beta 4a class iva
4320,vincristine,acute lymphoblastic leukemia,tubulin beta 2a class iia
4321,vincristine,acute lymphoblastic leukemia,tubulin beta 2b class iib
4322,vincristine,acute lymphoblastic leukemia,tubulin beta 4b class ivb
4323,vincristine,acute lymphoblastic leukemia,tubulin beta 6 class v
4324,teniposide,acute lymphoblastic leukemia,dna topoisomerase ii alpha
4325,clofarabine,acute lymphoblastic leukemia,ribonucleotide reductase catalytic subunit m1
4326,clofarabine,acute lymphoblastic leukemia,"dna polymerase alpha 1, catalytic subunit"
4327,clofarabine,acute lymphoblastic leukemia,ribonucleotide reductase regulatory subunit m2
4328,triamcinolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4329,triamcinolone,acute lymphoblastic leukemia,serpin family a member 6
4330,betamethasone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4331,betamethasone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4332,methylprednisolone,acute lymphoblastic leukemia,nuclear receptor subfamily 3 group c member 1
4333,methylprednisolone,acute lymphoblastic leukemia,atp binding cassette subfamily b member 1
4334,galantamine,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
4335,galantamine,alzheimer disease,cholinergic receptor nicotinic alpha 4 subunit
4336,galantamine,alzheimer disease,cholinergic receptor nicotinic beta 2 subunit
4337,galantamine,alzheimer disease,butyrylcholinesterase
4338,galantamine,alzheimer disease,cholinergic receptor nicotinic alpha 7 subunit
4339,rivastigmine,alzheimer disease,butyrylcholinesterase
4340,rivastigmine,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
4341,donepezil,alzheimer disease,cytochrome p450 family 2 subfamily d member 6
4342,donepezil,alzheimer disease,5-hydroxytryptamine receptor 2a
4343,donepezil,alzheimer disease,butyrylcholinesterase
4344,terbutaline,asthma,adrenoceptor beta 1
4345,betamethasone,asthma,prostaglandin-endoperoxide synthase 2
4346,theophylline,asthma,adenosine a2a receptor
4347,theophylline,asthma,adenosine a2b receptor
4348,theophylline,asthma,phosphodiesterase 4c
4349,theophylline,asthma,phosphodiesterase 4a
4350,theophylline,asthma,phosphodiesterase 3a
4351,theophylline,asthma,phosphodiesterase 4d
4352,theophylline,asthma,phosphodiesterase 4b
4353,theophylline,asthma,adenosine deaminase
4354,theophylline,asthma,adenosine a1 receptor
4355,theophylline,asthma,adenosine a3 receptor
4356,prednisone,asthma,nuclear receptor subfamily 3 group c member 1
4357,prednisone,asthma,albumin
4358,beclometasone,asthma,serpin family a member 6
4359,beclometasone,asthma,nuclear receptor subfamily 3 group c member 1
4360,mometasone,asthma,nuclear receptor subfamily 3 group c member 1
4361,triamcinolone,asthma,prostaglandin-endoperoxide synthase 2
4362,triamcinolone,asthma,serpin family a member 6
4363,indacaterol,asthma,adrenoceptor beta 2
4364,indacaterol,asthma,adrenoceptor beta 1
4365,indacaterol,asthma,cholinergic receptor muscarinic 3
4366,nedocromil,asthma,prostaglandin d2 receptor
4367,flunisolide,asthma,serpin family a member 6
4368,zafirlukast,asthma,cysteinyl leukotriene receptor 1
4369,zafirlukast,asthma,cysteinyl leukotriene receptor 2
4370,zafirlukast,asthma,prostaglandin-endoperoxide synthase 1
4371,zafirlukast,asthma,leukotriene b4 receptor
4372,prednisolone,asthma,serpin family a member 6
4373,fluticasone,asthma,serpin family a member 6
4374,fluticasone,asthma,phospholipase a2 group iva
4375,cortisol,asthma,nuclear receptor subfamily 3 group c member 1
4376,cortisol,asthma,sex hormone binding globulin
4377,cortisol,asthma,serpin family a member 6
4378,dyphylline,asthma,adenosine a1 receptor
4379,dyphylline,asthma,adenosine a2a receptor
4380,dyphylline,asthma,phosphodiesterase 3a
4381,prednisolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4382,prednisolone,atopic eczema,serpin family a member 6
4383,triamcinolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4384,triamcinolone,atopic eczema,serpin family a member 6
4385,methylprednisolone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4386,betamethasone,atopic eczema,nuclear receptor subfamily 3 group c member 1
4387,dronedarone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4388,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
4389,dronedarone,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
4390,dronedarone,atrial fibrillation,potassium two pore domain channel subfamily k member 2
4391,dronedarone,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
4392,dronedarone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4393,dronedarone,atrial fibrillation,sodium voltage-gated channel alpha subunit 1
4394,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 1
4395,dronedarone,atrial fibrillation,adrenoceptor beta 1
4396,dronedarone,atrial fibrillation,hyperpolarization activated cyclic nucleotide gated potassium channel 3
4397,dronedarone,atrial fibrillation,calcium voltage-gated channel auxiliary subunit beta 2
4398,dronedarone,atrial fibrillation,atp binding cassette subfamily b member 1
4399,flecainide,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4400,propranolol,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4401,propranolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4402,propranolol,atrial fibrillation,atp binding cassette subfamily b member 1
4403,digoxin,atrial fibrillation,fxyd domain containing ion transport regulator 2
4404,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 1
4405,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 3
4406,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 3
4407,digoxin,atrial fibrillation,atp binding cassette subfamily b member 1
4408,digoxin,atrial fibrillation,solute carrier organic anion transporter family member 4a1
4409,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 1
4410,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 2
4411,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 2
4412,digoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 4
4413,rivaroxaban,atrial fibrillation,atp binding cassette subfamily b member 1
4414,rivaroxaban,atrial fibrillation,coagulation factor x
4415,metoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4416,metoprolol,atrial fibrillation,atp binding cassette subfamily b member 1
4417,metoprolol,atrial fibrillation,adrenoceptor beta 2
4418,metoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4419,metoprolol,atrial fibrillation,adrenoceptor beta 1
4420,benazepril,atrial fibrillation,methylenetetrahydrofolate reductase
4421,benazepril,atrial fibrillation,angiotensin i converting enzyme
4422,clopidogrel,atrial fibrillation,atp binding cassette subfamily b member 1
4423,clopidogrel,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4424,clopidogrel,atrial fibrillation,purinergic receptor p2y12
4425,quinapril,atrial fibrillation,angiotensin i converting enzyme
4426,losartan,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4427,losartan,atrial fibrillation,angiotensin i converting enzyme
4428,losartan,atrial fibrillation,atp binding cassette subfamily b member 1
4429,losartan,atrial fibrillation,solute carrier family 2 member 9
4430,perindopril,atrial fibrillation,angiotensin i converting enzyme
4431,perindopril,atrial fibrillation,atp binding cassette subfamily b member 1
4432,ramipril,atrial fibrillation,angiotensin i converting enzyme
4433,carvedilol,atrial fibrillation,selectin e
4434,carvedilol,atrial fibrillation,adrenoceptor beta 2
4435,carvedilol,atrial fibrillation,natriuretic peptide b
4436,carvedilol,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4437,carvedilol,atrial fibrillation,atp binding cassette subfamily b member 1
4438,carvedilol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4439,carvedilol,atrial fibrillation,adrenoceptor beta 1
4440,telmisartan,atrial fibrillation,atp binding cassette subfamily b member 1
4441,telmisartan,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4442,telmisartan,atrial fibrillation,angiotensin i converting enzyme
4443,bisoprolol,atrial fibrillation,adrenoceptor beta 2
4444,bisoprolol,atrial fibrillation,adrenoceptor beta 1
4445,bisoprolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4446,trandolapril,atrial fibrillation,angiotensin i converting enzyme
4447,diltiazem,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4448,diltiazem,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
4449,diltiazem,atrial fibrillation,atp binding cassette subfamily b member 1
4450,diltiazem,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4451,diltiazem,atrial fibrillation,potassium voltage-gated channel subfamily a member 5
4452,amiodarone,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4453,amiodarone,atrial fibrillation,adrenoceptor beta 1
4454,amiodarone,atrial fibrillation,atp binding cassette subfamily b member 1
4455,amiodarone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4456,amiodarone,atrial fibrillation,thyroid hormone receptor beta
4457,amiodarone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4458,nebivolol,atrial fibrillation,adrenoceptor beta 2
4459,nebivolol,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4460,nebivolol,atrial fibrillation,adrenoceptor beta 1
4461,dipyridamole,atrial fibrillation,phosphodiesterase 3b
4462,dipyridamole,atrial fibrillation,phosphodiesterase 2a
4463,dipyridamole,atrial fibrillation,phosphodiesterase 1b
4464,dipyridamole,atrial fibrillation,phosphodiesterase 7a
4465,dipyridamole,atrial fibrillation,phosphodiesterase 1c
4466,dipyridamole,atrial fibrillation,phosphodiesterase 3a
4467,dipyridamole,atrial fibrillation,phosphodiesterase 7b
4468,dipyridamole,atrial fibrillation,atp binding cassette subfamily b member 1
4469,dipyridamole,atrial fibrillation,phosphodiesterase 8a
4470,dipyridamole,atrial fibrillation,prune exopolyphosphatase 1
4471,dipyridamole,atrial fibrillation,phosphodiesterase 6d
4472,dipyridamole,atrial fibrillation,phosphodiesterase 6b
4473,dipyridamole,atrial fibrillation,phosphodiesterase 11a
4474,dipyridamole,atrial fibrillation,phosphodiesterase 6c
4475,dipyridamole,atrial fibrillation,phosphodiesterase 6a
4476,dipyridamole,atrial fibrillation,phosphodiesterase 1a
4477,dipyridamole,atrial fibrillation,phosphodiesterase 6g
4478,dipyridamole,atrial fibrillation,phosphodiesterase 6h
4479,dipyridamole,atrial fibrillation,phosphodiesterase 8b
4480,captopril,atrial fibrillation,atp binding cassette subfamily b member 1
4481,captopril,atrial fibrillation,angiotensin i converting enzyme
4482,captopril,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4483,verapamil,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4484,verapamil,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4485,verapamil,atrial fibrillation,atp binding cassette subfamily b member 1
4486,verapamil,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4487,verapamil,atrial fibrillation,calcium voltage-gated channel subunit alpha1 s
4488,verapamil,atrial fibrillation,calcium voltage-gated channel auxiliary subunit beta 2
4489,verapamil,atrial fibrillation,calcium voltage-gated channel subunit alpha1 c
4490,verapamil,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
4491,candesartan,atrial fibrillation,atp binding cassette subfamily b member 1
4492,propafenone,atrial fibrillation,adrenoceptor beta 1
4493,propafenone,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
4494,propafenone,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4495,propafenone,atrial fibrillation,atp binding cassette subfamily b member 1
4496,propafenone,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4497,irbesartan,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4498,esmolol,atrial fibrillation,adrenoceptor beta 1
4499,esmolol,atrial fibrillation,adrenoceptor beta 2
4500,quinine,atrial fibrillation,potassium voltage-gated channel subfamily h member 2
4501,quinine,atrial fibrillation,cytochrome p450 family 2 subfamily d member 6
4502,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 3
4503,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 1
4504,quinine,atrial fibrillation,atp binding cassette subfamily b member 1
4505,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 5
4506,quinine,atrial fibrillation,sodium voltage-gated channel alpha subunit 2
4507,quinine,atrial fibrillation,cytochrome p450 family 2 subfamily c member 19
4508,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 4
4509,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 2
4510,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 2
4511,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 1
4512,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit alpha 3
4513,acetyldigitoxin,atrial fibrillation,fxyd domain containing ion transport regulator 2
4514,acetyldigitoxin,atrial fibrillation,atpase na+/k+ transporting subunit beta 3
4515,atenolol,atrial fibrillation,adrenoceptor beta 1
4516,atenolol,atrial fibrillation,adrenoceptor beta 2
4517,atenolol,atrial fibrillation,atp binding cassette subfamily b member 1
4518,lisinopril,atrial fibrillation,atp binding cassette subfamily b member 1
4519,lisinopril,atrial fibrillation,angiotensin i converting enzyme
4520,ziprasidone,bipolar disorder,h1.0 linker histone
4521,ziprasidone,bipolar disorder,dopamine receptor d1
4522,ziprasidone,bipolar disorder,adrenoceptor alpha 1a
4523,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 2c
4524,ziprasidone,bipolar disorder,adrenoceptor alpha 2c
4525,ziprasidone,bipolar disorder,dopamine receptor d2
4526,ziprasidone,bipolar disorder,dopamine receptor d4
4527,ziprasidone,bipolar disorder,dopamine receptor d5
4528,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 6
4529,ziprasidone,bipolar disorder,solute carrier family 6 member 4
4530,ziprasidone,bipolar disorder,cholinergic receptor muscarinic 2
4531,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 2a
4532,ziprasidone,bipolar disorder,histamine receptor h1
4533,ziprasidone,bipolar disorder,dopamine receptor d3
4534,ziprasidone,bipolar disorder,cholinergic receptor muscarinic 3
4535,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1e
4536,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1b
4537,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 3a
4538,ziprasidone,bipolar disorder,5-hydroxytryptamine receptor 1a
4539,ziprasidone,bipolar disorder,tachykinin precursor 1
4540,ziprasidone,bipolar disorder,adrenoceptor beta 2
4541,risperidone,bipolar disorder,dopamine receptor d2
4542,risperidone,bipolar disorder,5-hydroxytryptamine receptor 1b
4543,risperidone,bipolar disorder,h1.0 linker histone
4544,risperidone,bipolar disorder,dopamine receptor d4
4545,risperidone,bipolar disorder,5-hydroxytryptamine receptor 2a
4546,risperidone,bipolar disorder,adrenoceptor alpha 2c
4547,risperidone,bipolar disorder,adrenoceptor alpha 1a
4548,risperidone,bipolar disorder,5-hydroxytryptamine receptor 2c
4549,risperidone,bipolar disorder,dopamine receptor d1
4550,risperidone,bipolar disorder,dopamine receptor d3
4551,risperidone,bipolar disorder,5-hydroxytryptamine receptor 1a
4552,risperidone,bipolar disorder,histamine receptor h1
4553,risperidone,bipolar disorder,atp binding cassette subfamily b member 1
4554,risperidone,bipolar disorder,5-hydroxytryptamine receptor 1e
4555,risperidone,bipolar disorder,cholinergic receptor muscarinic 2
4556,risperidone,bipolar disorder,tachykinin precursor 1
4557,risperidone,bipolar disorder,dopamine receptor d5
4558,risperidone,bipolar disorder,solute carrier family 6 member 4
4559,risperidone,bipolar disorder,5-hydroxytryptamine receptor 6
4560,risperidone,bipolar disorder,adrenoceptor beta 2
4561,cariprazine,bipolar disorder,histamine receptor h1
4562,cariprazine,bipolar disorder,vitamin d receptor
4563,cariprazine,bipolar disorder,dopamine receptor d3
4564,cariprazine,bipolar disorder,5-hydroxytryptamine receptor 2a
4565,cariprazine,bipolar disorder,dopamine receptor d5
4566,cariprazine,bipolar disorder,dopamine receptor d4
4567,cariprazine,bipolar disorder,5-hydroxytryptamine receptor 1a
4568,cariprazine,bipolar disorder,5-hydroxytryptamine receptor 2c
4569,cariprazine,bipolar disorder,dopamine receptor d1
4570,cariprazine,bipolar disorder,dopamine receptor d2
4571,loxapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4572,loxapine,bipolar disorder,5-hydroxytryptamine receptor 5a
4573,loxapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4574,loxapine,bipolar disorder,cholinergic receptor muscarinic 3
4575,loxapine,bipolar disorder,dopamine receptor d4
4576,loxapine,bipolar disorder,dopamine receptor d5
4577,loxapine,bipolar disorder,dopamine receptor d1
4578,loxapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4579,loxapine,bipolar disorder,adrenoceptor alpha 1a
4580,loxapine,bipolar disorder,cholinergic receptor muscarinic 2
4581,loxapine,bipolar disorder,histamine receptor h1
4582,loxapine,bipolar disorder,5-hydroxytryptamine receptor 3a
4583,loxapine,bipolar disorder,5-hydroxytryptamine receptor 6
4584,loxapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4585,loxapine,bipolar disorder,solute carrier family 6 member 2
4586,loxapine,bipolar disorder,adrenoceptor alpha 2c
4587,loxapine,bipolar disorder,dopamine receptor d3
4588,loxapine,bipolar disorder,solute carrier family 6 member 4
4589,loxapine,bipolar disorder,solute carrier family 6 member 3
4590,paliperidone,bipolar disorder,dopamine receptor d2
4591,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1a
4592,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 2c
4593,paliperidone,bipolar disorder,dopamine receptor d3
4594,paliperidone,bipolar disorder,adrenoceptor alpha 1a
4595,paliperidone,bipolar disorder,dopamine receptor d1
4596,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 2a
4597,paliperidone,bipolar disorder,histamine receptor h1
4598,paliperidone,bipolar disorder,adrenoceptor alpha 2c
4599,paliperidone,bipolar disorder,dopamine receptor d4
4600,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1b
4601,paliperidone,bipolar disorder,5-hydroxytryptamine receptor 1e
4602,paliperidone,bipolar disorder,adrenoceptor beta 2
4603,paliperidone,bipolar disorder,cholinergic receptor muscarinic 2
4604,paliperidone,bipolar disorder,tachykinin precursor 1
4605,quetiapine,bipolar disorder,adrenoceptor alpha 1a
4606,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4607,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 3a
4608,quetiapine,bipolar disorder,dopamine receptor d5
4609,quetiapine,bipolar disorder,histamine receptor h1
4610,quetiapine,bipolar disorder,adrenoceptor alpha 2c
4611,quetiapine,bipolar disorder,dopamine receptor d3
4612,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4613,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4614,quetiapine,bipolar disorder,atp binding cassette subfamily b member 1
4615,quetiapine,bipolar disorder,dopamine receptor d4
4616,quetiapine,bipolar disorder,cholinergic receptor muscarinic 3
4617,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 2a
4618,quetiapine,bipolar disorder,cholinergic receptor muscarinic 2
4619,quetiapine,bipolar disorder,h1.0 linker histone
4620,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4621,quetiapine,bipolar disorder,5-hydroxytryptamine receptor 6
4622,quetiapine,bipolar disorder,dopamine receptor d1
4623,quetiapine,bipolar disorder,dopamine receptor d2
4624,quetiapine,bipolar disorder,tachykinin precursor 1
4625,quetiapine,bipolar disorder,solute carrier family 6 member 4
4626,quetiapine,bipolar disorder,adrenoceptor beta 2
4627,carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 4
4628,carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 5
4629,carbamazepine,bipolar disorder,atp binding cassette subfamily b member 1
4630,carbamazepine,bipolar disorder,sodium voltage-gated channel alpha subunit 9
4631,carbamazepine,bipolar disorder,solute carrier family 6 member 4
4632,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 3a
4633,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 6
4634,olanzapine,bipolar disorder,dopamine receptor d3
4635,olanzapine,bipolar disorder,dopamine receptor d4
4636,olanzapine,bipolar disorder,atp binding cassette subfamily b member 1
4637,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4638,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4639,olanzapine,bipolar disorder,dopamine receptor d1
4640,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4641,olanzapine,bipolar disorder,histamine receptor h1
4642,olanzapine,bipolar disorder,h1.0 linker histone
4643,olanzapine,bipolar disorder,adrenoceptor alpha 2c
4644,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 5a
4645,olanzapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4646,olanzapine,bipolar disorder,dopamine receptor d5
4647,olanzapine,bipolar disorder,adrenoceptor alpha 1a
4648,olanzapine,bipolar disorder,cholinergic receptor muscarinic 2
4649,olanzapine,bipolar disorder,cholinergic receptor muscarinic 3
4650,asenapine,bipolar disorder,dopamine receptor d4
4651,asenapine,bipolar disorder,5-hydroxytryptamine receptor 2a
4652,asenapine,bipolar disorder,dopamine receptor d1
4653,asenapine,bipolar disorder,solute carrier family 6 member 4
4654,asenapine,bipolar disorder,adrenoceptor alpha 1a
4655,asenapine,bipolar disorder,5-hydroxytryptamine receptor 1b
4656,asenapine,bipolar disorder,5-hydroxytryptamine receptor 1a
4657,asenapine,bipolar disorder,adrenoceptor alpha 2c
4658,asenapine,bipolar disorder,dopamine receptor d3
4659,asenapine,bipolar disorder,5-hydroxytryptamine receptor 1e
4660,asenapine,bipolar disorder,histamine receptor h1
4661,asenapine,bipolar disorder,dopamine receptor d2
4662,asenapine,bipolar disorder,5-hydroxytryptamine receptor 5a
4663,asenapine,bipolar disorder,5-hydroxytryptamine receptor 2c
4664,asenapine,bipolar disorder,adrenoceptor beta 2
4665,asenapine,bipolar disorder,5-hydroxytryptamine receptor 6
4666,asenapine,bipolar disorder,cholinergic receptor muscarinic 2
4667,asenapine,bipolar disorder,tachykinin precursor 1
4668,aripiprazole,bipolar disorder,adrenoceptor alpha 2c
4669,aripiprazole,bipolar disorder,cholinergic receptor muscarinic 3
4670,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1e
4671,aripiprazole,bipolar disorder,h1.0 linker histone
4672,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 2c
4673,aripiprazole,bipolar disorder,cholinergic receptor muscarinic 2
4674,aripiprazole,bipolar disorder,dopamine receptor d5
4675,aripiprazole,bipolar disorder,histamine receptor h1
4676,aripiprazole,bipolar disorder,atp binding cassette subfamily b member 1
4677,aripiprazole,bipolar disorder,dopamine receptor d3
4678,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1a
4679,aripiprazole,bipolar disorder,dopamine receptor d4
4680,aripiprazole,bipolar disorder,dopamine receptor d1
4681,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 6
4682,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 3a
4683,aripiprazole,bipolar disorder,solute carrier family 6 member 4
4684,aripiprazole,bipolar disorder,adrenoceptor alpha 1a
4685,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 1b
4686,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 2a
4687,aripiprazole,bipolar disorder,dopamine receptor d2
4688,aripiprazole,bipolar disorder,solute carrier family 6 member 2
4689,aripiprazole,bipolar disorder,adrenoceptor beta 2
4690,aripiprazole,bipolar disorder,5-hydroxytryptamine receptor 5a
4691,aripiprazole,bipolar disorder,solute carrier family 6 member 3
4692,docetaxel,breast carcinoma,epidermal growth factor receptor
4693,docetaxel,breast carcinoma,tubulin beta 6 class v
4694,docetaxel,breast carcinoma,tubulin beta 2b class iib
4695,docetaxel,breast carcinoma,tubulin beta 2a class iia
4696,docetaxel,breast carcinoma,tubulin beta class i
4697,docetaxel,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4698,docetaxel,breast carcinoma,tubulin beta 3 class iii
4699,docetaxel,breast carcinoma,bcl2 apoptosis regulator
4700,docetaxel,breast carcinoma,tubulin beta 1 class vi
4701,docetaxel,breast carcinoma,atp binding cassette subfamily b member 1
4702,docetaxel,breast carcinoma,tubulin beta 4a class iva
4703,docetaxel,breast carcinoma,tubulin beta 4b class ivb
4704,docetaxel,breast carcinoma,tubulin beta 8 class viii
4705,docetaxel,breast carcinoma,cytochrome p450 family 1 subfamily b member 1
4706,epirubicin,breast carcinoma,aurora kinase a
4707,epirubicin,breast carcinoma,phospholipase a2 group iva
4708,epirubicin,breast carcinoma,dna topoisomerase ii alpha
4709,paclitaxel,breast carcinoma,tubulin beta 2b class iib
4710,paclitaxel,breast carcinoma,bcl2 apoptosis regulator
4711,paclitaxel,breast carcinoma,cytochrome p450 family 19 subfamily a member 1
4712,paclitaxel,breast carcinoma,atp binding cassette subfamily b member 1
4713,paclitaxel,breast carcinoma,tubulin beta 1 class vi
4714,paclitaxel,breast carcinoma,tubulin beta 6 class v
4715,paclitaxel,breast carcinoma,tubulin beta class i
4716,paclitaxel,breast carcinoma,tubulin beta 3 class iii
4717,paclitaxel,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4718,paclitaxel,breast carcinoma,tubulin beta 8 class viii
4719,paclitaxel,breast carcinoma,cytochrome p450 family 1 subfamily b member 1
4720,paclitaxel,breast carcinoma,tubulin beta 4a class iva
4721,paclitaxel,breast carcinoma,tubulin beta 2a class iia
4722,paclitaxel,breast carcinoma,tubulin beta 4b class ivb
4723,paclitaxel,breast carcinoma,solute carrier organic anion transporter family member 1b1
4724,5-fluorouracil,breast carcinoma,thymidylate synthetase
4725,5-fluorouracil,breast carcinoma,methylenetetrahydrofolate reductase
4726,5-fluorouracil,breast carcinoma,dihydropyrimidine dehydrogenase
4727,5-fluorouracil,breast carcinoma,uridine monophosphate synthetase
4728,cyclophosphamide,breast carcinoma,atp binding cassette subfamily b member 1
4729,cyclophosphamide,breast carcinoma,cytochrome p450 family 2 subfamily d member 6
4730,cyclophosphamide,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4731,everolimus,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4732,everolimus,breast carcinoma,fkbp prolyl isomerase 1a
4733,ixabepilone,breast carcinoma,tubulin beta class i
4734,ixabepilone,breast carcinoma,cytochrome p450 family 3 subfamily a member 4
4735,ixabepilone,breast carcinoma,tubulin beta 1 class vi
4736,ixabepilone,breast carcinoma,tubulin beta 2a class iia
4737,ixabepilone,breast carcinoma,tubulin beta 4a class iva
4738,ixabepilone,breast carcinoma,tubulin beta 8 class viii
4739,ixabepilone,breast carcinoma,tubulin beta 2b class iib
4740,ixabepilone,breast carcinoma,tubulin beta 4b class ivb
4741,ixabepilone,breast carcinoma,tubulin beta 3 class iii
4742,ixabepilone,breast carcinoma,tubulin beta 6 class v
4743,ixabepilone,breast carcinoma,bcl2 apoptosis regulator
4744,methylprednisolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4745,methylprednisolone,chronic obstructive pulmonary disease,glucose-6-phosphate dehydrogenase
4746,formoterol,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily a member 6
4747,fluticasone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4748,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 5
4749,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 1
4750,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 4
4751,aclidinium,chronic obstructive pulmonary disease,cholinergic receptor muscarinic 2
4752,triamcinolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4753,triamcinolone,chronic obstructive pulmonary disease,prostaglandin-endoperoxide synthase 2
4754,salbutamol,chronic obstructive pulmonary disease,adrenoceptor beta 2
4755,prednisolone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4756,prednisolone,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily a member 6
4757,prednisolone,chronic obstructive pulmonary disease,solute carrier organic anion transporter family member 1a2
4758,prednisone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4759,prednisone,chronic obstructive pulmonary disease,solute carrier organic anion transporter family member 1a2
4760,prednisone,chronic obstructive pulmonary disease,albumin
4761,betamethasone,chronic obstructive pulmonary disease,prostaglandin-endoperoxide synthase 2
4762,betamethasone,chronic obstructive pulmonary disease,nuclear receptor subfamily 3 group c member 1
4763,losartan,congestive heart failure,angiotensin i converting enzyme
4764,losartan,congestive heart failure,albumin
4765,losartan,congestive heart failure,angiotensin ii receptor type 1
4766,metoprolol,congestive heart failure,adrenoceptor beta 1
4767,metoprolol,congestive heart failure,adrenoceptor beta 3
4768,ramipril,congestive heart failure,butyrylcholinesterase
4769,ramipril,congestive heart failure,angiotensin i converting enzyme
4770,nebivolol,congestive heart failure,adrenoceptor beta 1
4771,valsartan,congestive heart failure,albumin
4772,valsartan,congestive heart failure,angiotensin ii receptor type 1
4773,isosorbide mononitrate,congestive heart failure,guanylate cyclase 1 soluble subunit beta 1
4774,isosorbide dinitrate,congestive heart failure,guanylate cyclase 1 soluble subunit beta 1
4775,isosorbide dinitrate,congestive heart failure,natriuretic peptide receptor 1
4776,irbesartan,congestive heart failure,endothelin receptor type a
4777,irbesartan,congestive heart failure,prostaglandin-endoperoxide synthase 1
4778,irbesartan,congestive heart failure,angiotensin ii receptor type 1
4779,benazepril,congestive heart failure,angiotensin i converting enzyme
4780,olmesartan,congestive heart failure,angiotensin ii receptor type 1
4781,dipyridamole,congestive heart failure,phosphodiesterase 11a
4782,digoxin,congestive heart failure,fxyd domain containing ion transport regulator 2
4783,digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 1
4784,digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 3
4785,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 3
4786,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 1
4787,digoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 2
4788,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 2
4789,digoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 4
4790,lisinopril,congestive heart failure,angiotensin i converting enzyme
4791,bisoprolol,congestive heart failure,adrenoceptor beta 1
4792,bisoprolol,congestive heart failure,adrenoceptor beta 3
4793,quinapril,congestive heart failure,angiotensin i converting enzyme
4794,enalapril,congestive heart failure,angiotensin i converting enzyme
4795,trandolapril,congestive heart failure,angiotensin i converting enzyme
4796,atenolol,congestive heart failure,adrenoceptor beta 1
4797,atenolol,congestive heart failure,adrenoceptor beta 3
4798,candesartan,congestive heart failure,angiotensin ii receptor type 1
4799,candesartan,congestive heart failure,prostaglandin-endoperoxide synthase 1
4800,eprosartan,congestive heart failure,angiotensin ii receptor type 1
4801,levosimendan,congestive heart failure,"troponin c1, slow skeletal and cardiac type"
4802,carvedilol,congestive heart failure,vascular endothelial growth factor a
4803,carvedilol,congestive heart failure,natriuretic peptide b
4804,carvedilol,congestive heart failure,xanthine dehydrogenase
4805,carvedilol,congestive heart failure,adrenoceptor alpha 2c
4806,carvedilol,congestive heart failure,hypoxia inducible factor 1 subunit alpha
4807,carvedilol,congestive heart failure,adrenoceptor beta 3
4808,carvedilol,congestive heart failure,prostaglandin-endoperoxide synthase 1
4809,carvedilol,congestive heart failure,adrenoceptor beta 1
4810,telmisartan,congestive heart failure,peroxisome proliferator activated receptor gamma
4811,telmisartan,congestive heart failure,angiotensin ii receptor type 1
4812,telmisartan,congestive heart failure,angiotensin i converting enzyme
4813,spironolactone,congestive heart failure,nuclear receptor subfamily 3 group c member 2
4814,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 1
4815,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 4
4816,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 2
4817,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 2
4818,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 1
4819,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit alpha 3
4820,acetyldigitoxin,congestive heart failure,fxyd domain containing ion transport regulator 2
4821,acetyldigitoxin,congestive heart failure,atpase na+/k+ transporting subunit beta 3
4822,captopril,congestive heart failure,renin
4823,captopril,congestive heart failure,albumin
4824,captopril,congestive heart failure,angiotensin i converting enzyme
4825,captopril,congestive heart failure,prostaglandin-endoperoxide synthase 2
4826,captopril,congestive heart failure,prostaglandin-endoperoxide synthase 1
4827,hydrochlorothiazide,congestive heart failure,albumin
4828,perindopril,congestive heart failure,butyrylcholinesterase
4829,perindopril,congestive heart failure,angiotensin i converting enzyme
4830,prednisone,crohn disease,nuclear receptor subfamily 3 group c member 1
4831,prednisone,crohn disease,albumin
4832,prednisone,crohn disease,atp binding cassette subfamily b member 1
4833,sulfasalazine,crohn disease,prostaglandin-endoperoxide synthase 2
4834,sulfasalazine,crohn disease,solute carrier family 7 member 11
4835,sulfasalazine,crohn disease,acetyl-coa acetyltransferase 1
4836,sulfasalazine,crohn disease,peroxisome proliferator activated receptor gamma
4837,betamethasone,crohn disease,prostaglandin-endoperoxide synthase 2
4838,betamethasone,crohn disease,atp binding cassette subfamily b member 1
4839,aminosalicylic acid,crohn disease,phospholipase a2 group iie
4840,aminosalicylic acid,crohn disease,myeloperoxidase
4841,aminosalicylic acid,crohn disease,prostaglandin-endoperoxide synthase 2
4842,mesalazine,crohn disease,prostaglandin-endoperoxide synthase 2
4843,mesalazine,crohn disease,peroxisome proliferator activated receptor gamma
4844,mesalazine,crohn disease,myeloperoxidase
4845,prednisolone,crohn disease,atp binding cassette subfamily b member 1
4846,prednisolone,crohn disease,serpin family a member 6
4847,methylprednisolone,crohn disease,atp binding cassette subfamily b member 1
4848,triamcinolone,crohn disease,prostaglandin-endoperoxide synthase 2
4849,triamcinolone,crohn disease,serpin family a member 6
4850,cortisol,crohn disease,atp binding cassette subfamily b member 1
4851,cortisol,crohn disease,sex hormone binding globulin
4852,cortisol,crohn disease,serpin family a member 6
4853,salicylic acid,crohn disease,albumin
4854,salicylic acid,crohn disease,prostaglandin-endoperoxide synthase 2
4855,salicylic acid,crohn disease,atp binding cassette subfamily b member 1
4856,ramipril,diabetic kidney disease,angiotensin i converting enzyme
4857,perindopril,diabetic kidney disease,angiotensin i converting enzyme
4858,telmisartan,diabetic kidney disease,peroxisome proliferator activated receptor gamma
4859,telmisartan,diabetic kidney disease,angiotensin ii receptor type 1
4860,telmisartan,diabetic kidney disease,angiotensin i converting enzyme
4861,captopril,diabetic kidney disease,albumin
4862,quinapril,diabetic kidney disease,angiotensin i converting enzyme
4863,valsartan,diabetic kidney disease,albumin
4864,valsartan,diabetic kidney disease,angiotensin ii receptor type 1
4865,benazepril,diabetic kidney disease,angiotensin i converting enzyme
4866,losartan,diabetic kidney disease,angiotensin i converting enzyme
4867,losartan,diabetic kidney disease,albumin
4868,candesartan,diabetic kidney disease,angiotensin ii receptor type 1
4869,lisinopril,diabetic kidney disease,angiotensin i converting enzyme
4870,lisinopril,diabetic kidney disease,angiotensin converting enzyme 2
4871,trandolapril,diabetic kidney disease,angiotensin i converting enzyme
4872,eprosartan,diabetic kidney disease,angiotensin ii receptor type 1
4873,phenytoin,epilepsy,atp binding cassette subfamily c member 2
4874,phenytoin,epilepsy,albumin
4875,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 3
4876,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 1
4877,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 5
4878,phenytoin,epilepsy,cytochrome p450 family 2 subfamily c member 19
4879,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 2
4880,phenytoin,epilepsy,atp binding cassette subfamily b member 1
4881,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 8
4882,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 4
4883,phenytoin,epilepsy,sodium voltage-gated channel alpha subunit 9
4884,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta3
4885,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
4886,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit pi
4887,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma3
4888,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit epsilon
4889,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
4890,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit theta
4891,diazepam,epilepsy,cytochrome p450 family 2 subfamily c member 19
4892,diazepam,epilepsy,albumin
4893,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
4894,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
4895,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma1
4896,diazepam,epilepsy,atp binding cassette subfamily b member 1
4897,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
4898,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta1
4899,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
4900,diazepam,epilepsy,gamma-aminobutyric acid type a receptor subunit delta
4901,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
4902,thiopental,epilepsy,glutamate ionotropic receptor kainate type subunit 2
4903,thiopental,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
4904,thiopental,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
4905,thiopental,epilepsy,glutamate ionotropic receptor ampa type subunit 2
4906,thiopental,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
4907,thiopental,epilepsy,fatty acid amide hydrolase
4908,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 1
4909,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 9
4910,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 8
4911,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 4
4912,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 3
4913,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 5
4914,lamotrigine,epilepsy,atp binding cassette subfamily b member 1
4915,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 10
4916,lamotrigine,epilepsy,sodium voltage-gated channel alpha subunit 2
4917,trimethadione,epilepsy,cytochrome p450 family 2 subfamily c member 19
4918,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
4919,methylphenobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
4920,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
4921,methylphenobarbital,epilepsy,cytochrome p450 family 2 subfamily c member 19
4922,methylphenobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
4923,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
4924,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
4925,methylphenobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
4926,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
4927,methylphenobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
4928,methylphenobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
4929,acetazolamide,epilepsy,carbonic anhydrase 4
4930,acetazolamide,epilepsy,carbonic anhydrase 13
4931,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
4932,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
4933,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
4934,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
4935,pentobarbitone,epilepsy,glutamate ionotropic receptor ampa type subunit 2
4936,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
4937,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
4938,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta3
4939,pentobarbitone,epilepsy,cytochrome p450 family 2 subfamily c member 19
4940,pentobarbitone,epilepsy,glutamate ionotropic receptor kainate type subunit 2
4941,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
4942,pentobarbitone,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
4943,pentobarbitone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
4944,pentobarbitone,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
4945,phenobarbital,epilepsy,atp binding cassette subfamily b member 1
4946,phenobarbital,epilepsy,cytochrome p450 family 2 subfamily c member 19
4947,phenobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
4948,phenobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
4949,phenobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
4950,phenobarbital,epilepsy,atp binding cassette subfamily c member 2
4951,phenobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
4952,valproic acid,epilepsy,aldehyde dehydrogenase 5 family member a1
4953,valproic acid,epilepsy,4-aminobutyrate aminotransferase
4954,valproic acid,epilepsy,acyl-coa dehydrogenase short/branched chain
4955,valproic acid,epilepsy,cytochrome p450 family 2 subfamily c member 19
4956,secobarbital,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
4957,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
4958,secobarbital,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
4959,secobarbital,epilepsy,glutamate ionotropic receptor kainate type subunit 2
4960,secobarbital,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
4961,secobarbital,epilepsy,glutamate ionotropic receptor ampa type subunit 2
4962,felbamate,epilepsy,glutamate ionotropic receptor nmda type subunit 2a
4963,felbamate,epilepsy,glutamate ionotropic receptor nmda type subunit 2b
4964,felbamate,epilepsy,cytochrome p450 family 2 subfamily c member 19
4965,carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 4
4966,carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 5
4967,carbamazepine,epilepsy,cytochrome p450 family 2 subfamily c member 19
4968,carbamazepine,epilepsy,atp binding cassette subfamily b member 1
4969,carbamazepine,epilepsy,sodium voltage-gated channel alpha subunit 9
4970,carbamazepine,epilepsy,atp binding cassette subfamily c member 2
4971,carbamazepine,epilepsy,solute carrier family 6 member 4
4972,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
4973,primidone,epilepsy,cytochrome p450 family 2 subfamily c member 19
4974,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
4975,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
4976,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
4977,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
4978,primidone,epilepsy,cholinergic receptor nicotinic alpha 7 subunit
4979,primidone,epilepsy,glutamate ionotropic receptor kainate type subunit 2
4980,primidone,epilepsy,cholinergic receptor nicotinic alpha 4 subunit
4981,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
4982,primidone,epilepsy,glutamate ionotropic receptor ampa type subunit 2
4983,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
4984,primidone,epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
4985,anagrelide,essential thrombocythemia,phosphodiesterase 3a
4986,lenvatinib,thyroid gland follicular carcinoma,kinase insert domain receptor
4987,lenvatinib,thyroid gland follicular carcinoma,receptor interacting serine/threonine kinase 2
4988,acetylcholine,glaucoma,cholinergic receptor muscarinic 3
4989,bisoprolol,hypertensive disorder,adrenoceptor beta 2
4990,bisoprolol,hypertensive disorder,adrenoceptor beta 3
4991,ketanserin,hypertensive disorder,adrenoceptor alpha 2b
4992,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 1b
4993,ketanserin,hypertensive disorder,adrenoceptor alpha 2a
4994,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 2b
4995,ketanserin,hypertensive disorder,solute carrier family 18 member a2
4996,ketanserin,hypertensive disorder,5-hydroxytryptamine receptor 7
4997,ketanserin,hypertensive disorder,dopamine receptor d4
4998,ketanserin,hypertensive disorder,dopamine receptor d2
4999,ketanserin,hypertensive disorder,adrenoceptor alpha 1a
5000,trandolapril,hypertensive disorder,angiotensin i converting enzyme
5001,bumetanide,hypertensive disorder,solute carrier family 12 member 2
5002,bumetanide,hypertensive disorder,prostaglandin-endoperoxide synthase 2
5003,bumetanide,hypertensive disorder,solute carrier family 12 member 1
5004,bumetanide,hypertensive disorder,carbonic anhydrase 9
5005,bumetanide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5006,bumetanide,hypertensive disorder,carbonic anhydrase 2
5007,paclitaxel,hypertensive disorder,tubulin beta 2b class iib
5008,paclitaxel,hypertensive disorder,bcl2 apoptosis regulator
5009,paclitaxel,hypertensive disorder,cytochrome p450 family 19 subfamily a member 1
5010,paclitaxel,hypertensive disorder,atp binding cassette subfamily b member 1
5011,paclitaxel,hypertensive disorder,tubulin beta 1 class vi
5012,paclitaxel,hypertensive disorder,tubulin beta 6 class v
5013,paclitaxel,hypertensive disorder,tubulin beta class i
5014,paclitaxel,hypertensive disorder,tubulin beta 3 class iii
5015,paclitaxel,hypertensive disorder,tubulin beta 8 class viii
5016,paclitaxel,hypertensive disorder,tubulin beta 4a class iva
5017,paclitaxel,hypertensive disorder,tubulin beta 2a class iia
5018,paclitaxel,hypertensive disorder,tubulin beta 4b class ivb
5019,paclitaxel,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5020,paclitaxel,hypertensive disorder,paraoxonase 1
5021,prazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5022,prazosin,hypertensive disorder,atp binding cassette subfamily b member 1
5023,prazosin,hypertensive disorder,adrenoceptor alpha 2b
5024,prazosin,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5025,prazosin,hypertensive disorder,adrenoceptor alpha 2a
5026,prazosin,hypertensive disorder,adrenoceptor alpha 2c
5027,prazosin,hypertensive disorder,dopamine receptor d4
5028,indapamide,hypertensive disorder,carbonic anhydrase 2
5029,indapamide,hypertensive disorder,potassium voltage-gated channel subfamily q member 1
5030,indapamide,hypertensive disorder,carbonic anhydrase 9
5031,nicardipine,hypertensive disorder,adrenoceptor alpha 1b
5032,nicardipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5033,nicardipine,hypertensive disorder,adrenoceptor alpha 1d
5034,nicardipine,hypertensive disorder,adrenoceptor alpha 1a
5035,nicardipine,hypertensive disorder,calmodulin 2
5036,nicardipine,hypertensive disorder,atp binding cassette subfamily b member 1
5037,nicardipine,hypertensive disorder,calmodulin 1
5038,captopril,hypertensive disorder,leukotriene a4 hydrolase
5039,captopril,hypertensive disorder,matrix metallopeptidase 9
5040,captopril,hypertensive disorder,"coagulation factor ii, thrombin"
5041,captopril,hypertensive disorder,renin
5042,captopril,hypertensive disorder,atp binding cassette subfamily b member 1
5043,captopril,hypertensive disorder,albumin
5044,captopril,hypertensive disorder,matrix metallopeptidase 2
5045,captopril,hypertensive disorder,prostaglandin-endoperoxide synthase 2
5046,captopril,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5047,perindopril,hypertensive disorder,angiotensin i converting enzyme
5048,perindopril,hypertensive disorder,atp binding cassette subfamily b member 1
5049,acebutolol,hypertensive disorder,adrenoceptor beta 2
5050,acebutolol,hypertensive disorder,atp binding cassette subfamily b member 1
5051,acebutolol,hypertensive disorder,adrenoceptor beta 3
5052,hydralazine,hypertensive disorder,ryanodine receptor 2
5053,hydralazine,hypertensive disorder,amine oxidase copper containing 3
5054,hydralazine,hypertensive disorder,glutamic-oxaloacetic transaminase 1
5055,amlodipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5056,amlodipine,hypertensive disorder,atp binding cassette subfamily b member 1
5057,amlodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5058,amlodipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5059,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5060,amlodipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5061,amlodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5062,amlodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
5063,diltiazem,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5064,diltiazem,hypertensive disorder,atp binding cassette subfamily b member 1
5065,diltiazem,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5066,diltiazem,hypertensive disorder,potassium voltage-gated channel subfamily a member 5
5067,isotretinoin,hypertensive disorder,retinoic acid receptor beta
5068,hydrochlorothiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
5069,hydrochlorothiazide,hypertensive disorder,carbonic anhydrase 9
5070,hydrochlorothiazide,hypertensive disorder,carbonic anhydrase 2
5071,hydrochlorothiazide,hypertensive disorder,albumin
5072,amiloride,hypertensive disorder,amine oxidase copper containing 1
5073,amiloride,hypertensive disorder,solute carrier family 9 member a1
5074,amiloride,hypertensive disorder,solute carrier family 22 member 4
5075,amiloride,hypertensive disorder,acid sensing ion channel subunit 1
5076,telmisartan,hypertensive disorder,atp binding cassette subfamily b member 1
5077,telmisartan,hypertensive disorder,cytochrome p450 family 2 subfamily j member 2
5078,telmisartan,hypertensive disorder,angiotensin i converting enzyme
5079,metoprolol,hypertensive disorder,atp binding cassette subfamily b member 1
5080,metoprolol,hypertensive disorder,adrenoceptor beta 2
5081,metoprolol,hypertensive disorder,adrenoceptor beta 3
5082,clonidine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5083,clonidine,hypertensive disorder,solute carrier family 22 member 4
5084,clonidine,hypertensive disorder,adrenoceptor alpha 1d
5085,clonidine,hypertensive disorder,adrenoceptor alpha 1b
5086,clonidine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5087,clonidine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5088,clonidine,hypertensive disorder,atp binding cassette subfamily b member 1
5089,clonidine,hypertensive disorder,nischarin
5090,clonidine,hypertensive disorder,solute carrier family 6 member 2
5091,clonidine,hypertensive disorder,adrenoceptor alpha 1a
5092,olmesartan,hypertensive disorder,angiotensin ii receptor type 1
5093,verapamil,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5094,verapamil,hypertensive disorder,cytochrome p450 family 2 subfamily c member 18
5095,verapamil,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5096,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 g
5097,verapamil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 11
5098,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 f
5099,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5100,verapamil,hypertensive disorder,atp binding cassette subfamily b member 1
5101,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 i
5102,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
5103,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5104,verapamil,hypertensive disorder,solute carrier family 6 member 4
5105,verapamil,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 1
5106,verapamil,hypertensive disorder,solute carrier family 22 member 4
5107,verapamil,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5108,verapamil,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5109,verapamil,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
5110,lisinopril,hypertensive disorder,atp binding cassette subfamily b member 1
5111,lisinopril,hypertensive disorder,angiotensin converting enzyme 2
5112,hydroflumethiazide,hypertensive disorder,solute carrier family 12 member 3
5113,hydroflumethiazide,hypertensive disorder,solute carrier family 12 member 1
5114,hydroflumethiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
5115,hydroflumethiazide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5116,hydroflumethiazide,hypertensive disorder,carbonic anhydrase 2
5117,hydroflumethiazide,hypertensive disorder,carbonic anhydrase 9
5118,cilazapril,hypertensive disorder,atp binding cassette subfamily b member 1
5119,benazepril,hypertensive disorder,methylenetetrahydrofolate reductase
5120,benazepril,hypertensive disorder,angiotensin i converting enzyme
5121,felodipine,hypertensive disorder,atp binding cassette subfamily b member 1
5122,felodipine,hypertensive disorder,calmodulin 2
5123,felodipine,hypertensive disorder,nuclear receptor subfamily 3 group c member 2
5124,felodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5125,felodipine,hypertensive disorder,calmodulin 1
5126,felodipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
5127,felodipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5128,felodipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
5129,reserpine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5130,reserpine,hypertensive disorder,atp binding cassette subfamily b member 1
5131,reserpine,hypertensive disorder,solute carrier family 18 member a1
5132,reserpine,hypertensive disorder,dopamine receptor d3
5133,reserpine,hypertensive disorder,dopamine receptor d2
5134,reserpine,hypertensive disorder,solute carrier family 6 member 4
5135,guanfacine,hypertensive disorder,nischarin
5136,guanfacine,hypertensive disorder,adrenoceptor alpha 2b
5137,guanfacine,hypertensive disorder,adrenoceptor alpha 2c
5138,irbesartan,hypertensive disorder,endothelin receptor type a
5139,irbesartan,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5140,irbesartan,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5141,irbesartan,hypertensive disorder,"jun proto-oncogene, ap-1 transcription factor subunit"
5142,atenolol,hypertensive disorder,adrenoceptor beta 2
5143,atenolol,hypertensive disorder,atp binding cassette subfamily b member 1
5144,atenolol,hypertensive disorder,adrenoceptor beta 3
5145,candesartan,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5146,candesartan,hypertensive disorder,atp binding cassette subfamily b member 1
5147,labetalol,hypertensive disorder,adrenoceptor beta 1
5148,labetalol,hypertensive disorder,adrenoceptor beta 3
5149,labetalol,hypertensive disorder,adrenoceptor beta 2
5150,chlorothiazide,hypertensive disorder,solute carrier family 12 member 3
5151,chlorothiazide,hypertensive disorder,carbonic anhydrase 2
5152,losartan,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5153,losartan,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5154,losartan,hypertensive disorder,angiotensin i converting enzyme
5155,losartan,hypertensive disorder,atp binding cassette subfamily b member 1
5156,losartan,hypertensive disorder,albumin
5157,losartan,hypertensive disorder,angiotensin ii receptor type 2
5158,nisoldipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5159,nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5160,nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5161,nisoldipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 c
5162,nisoldipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5163,nisoldipine,hypertensive disorder,atp binding cassette subfamily b member 1
5164,furosemide,hypertensive disorder,albumin
5165,furosemide,hypertensive disorder,carbonic anhydrase 9
5166,furosemide,hypertensive disorder,carbonic anhydrase 2
5167,furosemide,hypertensive disorder,paraoxonase 1
5168,terazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5169,terazosin,hypertensive disorder,atp binding cassette subfamily b member 1
5170,terazosin,hypertensive disorder,adrenoceptor alpha 2c
5171,terazosin,hypertensive disorder,adrenoceptor alpha 2b
5172,terazosin,hypertensive disorder,adrenoceptor alpha 2a
5173,bendroflumethiazide,hypertensive disorder,carbonic anhydrase 2
5174,bendroflumethiazide,hypertensive disorder,solute carrier family 12 member 3
5175,bendroflumethiazide,hypertensive disorder,potassium calcium-activated channel subfamily m alpha 1
5176,propranolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5177,propranolol,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5178,propranolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5179,propranolol,hypertensive disorder,atp binding cassette subfamily b member 1
5180,propranolol,hypertensive disorder,5-hydroxytryptamine receptor 1b
5181,propranolol,hypertensive disorder,adrenoceptor beta 3
5182,propranolol,hypertensive disorder,albumin
5183,guanadrel,hypertensive disorder,solute carrier family 6 member 2
5184,ethacrynic acid,hypertensive disorder,solute carrier family 12 member 1
5185,ethacrynic acid,hypertensive disorder,albumin
5186,ethacrynic acid,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5187,ethacrynic acid,hypertensive disorder,glutathione s-transferase alpha 2
5188,betaxolol,hypertensive disorder,adrenoceptor beta 2
5189,betaxolol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5190,timolol,hypertensive disorder,atp binding cassette subfamily b member 1
5191,timolol,hypertensive disorder,adrenoceptor beta 3
5192,timolol,hypertensive disorder,adrenoceptor beta 1
5193,timolol,hypertensive disorder,adrenoceptor beta 2
5194,doxazosin,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5195,doxazosin,hypertensive disorder,adrenoceptor alpha 1b
5196,doxazosin,hypertensive disorder,atp binding cassette subfamily b member 1
5197,doxazosin,hypertensive disorder,adrenoceptor alpha 2a
5198,doxazosin,hypertensive disorder,adrenoceptor alpha 2c
5199,valsartan,hypertensive disorder,albumin
5200,valsartan,hypertensive disorder,angiotensin ii receptor type 1
5201,valsartan,hypertensive disorder,angiotensin ii receptor type 2
5202,spironolactone,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
5203,spironolactone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 2
5204,spironolactone,hypertensive disorder,androgen receptor
5205,spironolactone,hypertensive disorder,atp binding cassette subfamily b member 1
5206,spironolactone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 1
5207,minoxidil,hypertensive disorder,potassium inwardly rectifying channel subfamily j member 11
5208,minoxidil,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5209,minoxidil,hypertensive disorder,atp binding cassette subfamily c member 9
5210,triamterene,hypertensive disorder,sodium channel epithelial 1 subunit beta
5211,triamterene,hypertensive disorder,sodium channel epithelial 1 subunit gamma
5212,triamterene,hypertensive disorder,sodium channel epithelial 1 subunit alpha
5213,triamterene,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5214,torsemide,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5215,trichlormethiazide,hypertensive disorder,atpase na+/k+ transporting subunit alpha 1
5216,trichlormethiazide,hypertensive disorder,solute carrier family 12 member 1
5217,trichlormethiazide,hypertensive disorder,carbonic anhydrase 9
5218,trichlormethiazide,hypertensive disorder,carbonic anhydrase 2
5219,metolazone,hypertensive disorder,carbonic anhydrase 9
5220,metolazone,hypertensive disorder,solute carrier family 12 member 1
5221,metolazone,hypertensive disorder,carbonic anhydrase 2
5222,pindolol,hypertensive disorder,adrenoceptor beta 3
5223,pindolol,hypertensive disorder,5-hydroxytryptamine receptor 1b
5224,pindolol,hypertensive disorder,5-hydroxytryptamine receptor 2a
5225,pindolol,hypertensive disorder,5-hydroxytryptamine receptor 2b
5226,guanethidine,hypertensive disorder,solute carrier family 6 member 2
5227,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 h
5228,nifedipine,hypertensive disorder,atp binding cassette subfamily b member 1
5229,nifedipine,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5230,nifedipine,hypertensive disorder,calmodulin 1
5231,nifedipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5232,nifedipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit beta 2
5233,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 d
5234,nifedipine,hypertensive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 1
5235,nifedipine,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5236,nifedipine,hypertensive disorder,calcium voltage-gated channel subunit alpha1 s
5237,nifedipine,hypertensive disorder,calmodulin 2
5238,enalapril,hypertensive disorder,atp binding cassette subfamily b member 1
5239,enalapril,hypertensive disorder,angiotensin i converting enzyme
5240,eplerenone,hypertensive disorder,cytochrome p450 family 11 subfamily b member 2
5241,eplerenone,hypertensive disorder,cytochrome p450 family 3 subfamily a member 5
5242,eplerenone,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
5243,guanabenz,hypertensive disorder,nischarin
5244,guanabenz,hypertensive disorder,adrenoceptor alpha 2b
5245,guanabenz,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5246,guanabenz,hypertensive disorder,adrenoceptor alpha 2c
5247,nebivolol,hypertensive disorder,adrenoceptor beta 2
5248,nebivolol,hypertensive disorder,macrophage migration inhibitory factor
5249,quinapril,hypertensive disorder,angiotensin i converting enzyme
5250,spirapril,hypertensive disorder,angiotensin i converting enzyme
5251,carvedilol,hypertensive disorder,adrenoceptor alpha 2b
5252,carvedilol,hypertensive disorder,adrenoceptor alpha 1b
5253,carvedilol,hypertensive disorder,vascular endothelial growth factor a
5254,carvedilol,hypertensive disorder,selectin e
5255,carvedilol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 1
5256,carvedilol,hypertensive disorder,adrenoceptor beta 2
5257,carvedilol,hypertensive disorder,natriuretic peptide b
5258,carvedilol,hypertensive disorder,potassium voltage-gated channel subfamily h member 2
5259,carvedilol,hypertensive disorder,atp binding cassette subfamily b member 1
5260,carvedilol,hypertensive disorder,xanthine dehydrogenase
5261,carvedilol,hypertensive disorder,adrenoceptor alpha 2c
5262,carvedilol,hypertensive disorder,cytochrome p450 family 1 subfamily a member 2
5263,carvedilol,hypertensive disorder,adrenoceptor alpha 2a
5264,carvedilol,hypertensive disorder,hypoxia inducible factor 1 subunit alpha
5265,carvedilol,hypertensive disorder,adrenoceptor beta 3
5266,carvedilol,hypertensive disorder,gap junction protein alpha 1
5267,carvedilol,hypertensive disorder,adrenoceptor alpha 1d
5268,carvedilol,hypertensive disorder,vascular cell adhesion molecule 1
5269,carvedilol,hypertensive disorder,prostaglandin-endoperoxide synthase 1
5270,ramipril,hypertensive disorder,angiotensin i converting enzyme
5271,n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 1
5272,n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 2
5273,n-methyl scopolamine,irritable bowel syndrome,cholinergic receptor muscarinic 3
5274,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
5275,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
5276,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
5277,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit beta3
5278,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
5279,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit beta2
5280,chlordiazepoxide,irritable bowel syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
5281,dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 2
5282,dicyclomine,irritable bowel syndrome,cholinergic receptor muscarinic 1
5283,atropine,irritable bowel syndrome,cholinergic receptor muscarinic 3
5284,atropine,irritable bowel syndrome,cholinergic receptor muscarinic 2
5285,atropine,irritable bowel syndrome,cholinergic receptor muscarinic 1
5286,etoposide,kaposi's sarcoma,dna topoisomerase ii alpha
5287,etoposide,kaposi's sarcoma,atp binding cassette subfamily b member 1
5288,vinblastine,kaposi's sarcoma,tubulin beta 4a class iva
5289,vinblastine,kaposi's sarcoma,tubulin beta 1 class vi
5290,vinblastine,kaposi's sarcoma,tubulin beta 8 class viii
5291,vinblastine,kaposi's sarcoma,atp binding cassette subfamily b member 1
5292,vinblastine,kaposi's sarcoma,tubulin beta 2b class iib
5293,vinblastine,kaposi's sarcoma,tubulin beta 4b class ivb
5294,vinblastine,kaposi's sarcoma,tubulin beta 2a class iia
5295,vinblastine,kaposi's sarcoma,tubulin beta 3 class iii
5296,vinblastine,kaposi's sarcoma,tubulin beta 6 class v
5297,paclitaxel,kaposi's sarcoma,tubulin beta 2b class iib
5298,paclitaxel,kaposi's sarcoma,atp binding cassette subfamily b member 1
5299,paclitaxel,kaposi's sarcoma,tubulin beta 6 class v
5300,paclitaxel,kaposi's sarcoma,tubulin beta class i
5301,paclitaxel,kaposi's sarcoma,tubulin beta 3 class iii
5302,paclitaxel,kaposi's sarcoma,tubulin beta 8 class viii
5303,paclitaxel,kaposi's sarcoma,tubulin beta 4a class iva
5304,paclitaxel,kaposi's sarcoma,tubulin beta 2a class iia
5305,paclitaxel,kaposi's sarcoma,tubulin beta 4b class ivb
5306,daunorubicin,kaposi's sarcoma,dna topoisomerase ii alpha
5307,daunorubicin,kaposi's sarcoma,atp binding cassette subfamily b member 1
5308,vinorelbine,kaposi's sarcoma,tubulin beta 2b class iib
5309,vinorelbine,kaposi's sarcoma,tubulin beta 6 class v
5310,vinorelbine,kaposi's sarcoma,tubulin beta 1 class vi
5311,vinorelbine,kaposi's sarcoma,tubulin beta 2a class iia
5312,vinorelbine,kaposi's sarcoma,tubulin beta 4a class iva
5313,vinorelbine,kaposi's sarcoma,atp binding cassette subfamily b member 1
5314,vinorelbine,kaposi's sarcoma,tubulin beta class i
5315,vinorelbine,kaposi's sarcoma,tubulin beta 4b class ivb
5316,vinorelbine,kaposi's sarcoma,tubulin beta 8 class viii
5317,vinorelbine,kaposi's sarcoma,tubulin beta 3 class iii
5318,eribulin,liposarcoma,tubulin beta 1 class vi
5319,eribulin,liposarcoma,tubulin beta 2b class iib
5320,eribulin,liposarcoma,tubulin beta 8 class viii
5321,eribulin,liposarcoma,tubulin beta 4b class ivb
5322,eribulin,liposarcoma,tubulin beta 2a class iia
5323,eribulin,liposarcoma,tubulin beta 6 class v
5324,eribulin,liposarcoma,tubulin beta 3 class iii
5325,eribulin,liposarcoma,tubulin beta class i
5326,eribulin,liposarcoma,tubulin beta 4a class iva
5327,dicumarol,myocardial infarction,g protein-coupled receptor 35
5328,nitroglycerin,myocardial infarction,guanylate cyclase 1 soluble subunit alpha 1
5329,nitroglycerin,myocardial infarction,guanylate cyclase 1 soluble subunit beta 1
5330,nitroglycerin,myocardial infarction,aldehyde dehydrogenase 2 family member
5331,aspirin,myocardial infarction,endothelin receptor type a
5332,aspirin,myocardial infarction,tumor protein p53
5333,cyclophosphamide,neuroblastoma,atp binding cassette subfamily b member 1
5334,etoposide,neuroblastoma,dna topoisomerase ii alpha
5335,etoposide,neuroblastoma,atp binding cassette subfamily b member 1
5336,vincristine,neuroblastoma,atp binding cassette subfamily b member 1
5337,vincristine,neuroblastoma,tubulin beta 8 class viii
5338,vincristine,neuroblastoma,tubulin beta 3 class iii
5339,vincristine,neuroblastoma,tubulin beta 1 class vi
5340,vincristine,neuroblastoma,tubulin beta 4a class iva
5341,vincristine,neuroblastoma,tubulin beta 2a class iia
5342,vincristine,neuroblastoma,tubulin beta 2b class iib
5343,vincristine,neuroblastoma,tubulin beta 4b class ivb
5344,vincristine,neuroblastoma,tubulin beta 6 class v
5345,daunorubicin,neuroblastoma,dna topoisomerase ii alpha
5346,daunorubicin,neuroblastoma,atp binding cassette subfamily b member 1
5347,teniposide,neuroblastoma,dna topoisomerase ii alpha
5348,vinblastine,neuroblastoma,tubulin beta 4a class iva
5349,vinblastine,neuroblastoma,tubulin beta 1 class vi
5350,vinblastine,neuroblastoma,tubulin beta 8 class viii
5351,vinblastine,neuroblastoma,atp binding cassette subfamily b member 1
5352,vinblastine,neuroblastoma,tubulin beta 2b class iib
5353,vinblastine,neuroblastoma,tubulin beta 4b class ivb
5354,vinblastine,neuroblastoma,tubulin beta class i
5355,vinblastine,neuroblastoma,tubulin beta 2a class iia
5356,vinblastine,neuroblastoma,tubulin beta 3 class iii
5357,vinblastine,neuroblastoma,tubulin beta 6 class v
5358,lenvatinib,thyroid gland papillary carcinoma,kinase insert domain receptor
5359,lenvatinib,thyroid gland papillary carcinoma,receptor interacting serine/threonine kinase 2
5360,minocycline,periodontitis,interleukin 1 beta
5361,minocycline,periodontitis,matrix metallopeptidase 9
5362,prednisolone,psoriasis,serpin family a member 6
5363,triamcinolone,psoriasis,serpin family a member 6
5364,cortisol,psoriasis,nuclear receptor subfamily 3 group c member 1
5365,cortisol,psoriasis,sex hormone binding globulin
5366,cortisol,psoriasis,serpin family a member 6
5367,calcipotriol,psoriasis,vitamin d receptor
5368,betamethasone,psoriasis,nuclear receptor subfamily 3 group c member 1
5369,prednisone,psoriasis,nuclear receptor subfamily 3 group c member 1
5370,lenvatinib,renal cell carcinoma,traf2 and nck interacting kinase
5371,lenvatinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5372,lenvatinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5373,lenvatinib,renal cell carcinoma,ste20 like kinase
5374,lenvatinib,renal cell carcinoma,kinase insert domain receptor
5375,lenvatinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5376,lenvatinib,renal cell carcinoma,serine/threonine kinase 10
5377,lenvatinib,renal cell carcinoma,aurora kinase b
5378,cabozantinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5379,cabozantinib,renal cell carcinoma,aurora kinase a
5380,cabozantinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5381,cabozantinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5382,cabozantinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5383,sunitinib,renal cell carcinoma,serine/threonine kinase 33
5384,sunitinib,renal cell carcinoma,myosin light chain kinase family member 4
5385,sunitinib,renal cell carcinoma,leucine rich repeat kinase 2
5386,sunitinib,renal cell carcinoma,fibroblast growth factor receptor 1
5387,sunitinib,renal cell carcinoma,homeodomain interacting protein kinase 4
5388,sunitinib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5389,sunitinib,renal cell carcinoma,death associated protein kinase 3
5390,sunitinib,renal cell carcinoma,serine/threonine kinase 17a
5391,sunitinib,renal cell carcinoma,cdc like kinase 4
5392,sunitinib,renal cell carcinoma,cdc like kinase 2
5393,sunitinib,renal cell carcinoma,ribosomal protein s6 kinase a2
5394,sunitinib,renal cell carcinoma,cdc like kinase 1
5395,sunitinib,renal cell carcinoma,death associated protein kinase 1
5396,sunitinib,renal cell carcinoma,alk receptor tyrosine kinase
5397,sunitinib,renal cell carcinoma,homeodomain interacting protein kinase 2
5398,sunitinib,renal cell carcinoma,ribosomal protein s6 kinase a5
5399,sunitinib,renal cell carcinoma,il2 inducible t cell kinase
5400,sunitinib,renal cell carcinoma,ste20 like kinase
5401,sunitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5402,sunitinib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
5403,sunitinib,renal cell carcinoma,bmp2 inducible kinase
5404,sunitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5405,sunitinib,renal cell carcinoma,checkpoint kinase 2
5406,sunitinib,renal cell carcinoma,myosin light chain kinase
5407,sunitinib,renal cell carcinoma,ret proto-oncogene
5408,sunitinib,renal cell carcinoma,phosphorylase kinase catalytic subunit gamma 2
5409,sunitinib,renal cell carcinoma,phosphorylase kinase catalytic subunit gamma 1
5410,sunitinib,renal cell carcinoma,serine/threonine kinase 4
5411,sunitinib,renal cell carcinoma,serine/threonine kinase 11
5412,sunitinib,renal cell carcinoma,serine/threonine kinase 10
5413,sunitinib,renal cell carcinoma,polo like kinase 4
5414,sunitinib,renal cell carcinoma,axl receptor tyrosine kinase
5415,sunitinib,renal cell carcinoma,aurora kinase c
5416,sunitinib,renal cell carcinoma,traf2 and nck interacting kinase
5417,sunitinib,renal cell carcinoma,myosin light chain kinase 3
5418,sunitinib,renal cell carcinoma,cyclin g associated kinase
5419,sunitinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
5420,sunitinib,renal cell carcinoma,"src proto-oncogene, non-receptor tyrosine kinase"
5421,sunitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 1
5422,sunitinib,renal cell carcinoma,casein kinase 1 delta
5423,sunitinib,renal cell carcinoma,bub1 mitotic checkpoint serine/threonine kinase
5424,sunitinib,renal cell carcinoma,delta like non-canonical notch ligand 1
5425,sunitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5426,sunitinib,renal cell carcinoma,ap2 associated kinase 1
5427,sunitinib,renal cell carcinoma,misshapen like kinase 1
5428,sunitinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5429,sunitinib,renal cell carcinoma,fibroblast growth factor receptor 3
5430,sunitinib,renal cell carcinoma,aurora kinase b
5431,sunitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 2
5432,sunitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5433,sunitinib,renal cell carcinoma,aurora kinase a
5434,sirolimus,renal cell carcinoma,fkbp prolyl isomerase 1a
5435,sirolimus,renal cell carcinoma,eukaryotic translation initiation factor 4e
5436,sirolimus,renal cell carcinoma,fkbp prolyl isomerase 1b
5437,sirolimus,renal cell carcinoma,fkbp prolyl isomerase 5
5438,everolimus,renal cell carcinoma,fkbp prolyl isomerase 1a
5439,sorafenib,renal cell carcinoma,fibroblast growth factor receptor 1
5440,sorafenib,renal cell carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
5441,sorafenib,renal cell carcinoma,epoxide hydrolase 2
5442,sorafenib,renal cell carcinoma,serine/threonine kinase 10
5443,sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 3
5444,sorafenib,renal cell carcinoma,ret proto-oncogene
5445,sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 1
5446,sorafenib,renal cell carcinoma,fms related receptor tyrosine kinase 4
5447,sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5448,sorafenib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
5449,sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 20
5450,sorafenib,renal cell carcinoma,aurora kinase c
5451,sorafenib,renal cell carcinoma,kinase insert domain receptor
5452,sorafenib,renal cell carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
5453,sorafenib,renal cell carcinoma,homeodomain interacting protein kinase 4
5454,sorafenib,renal cell carcinoma,platelet derived growth factor receptor alpha
5455,sorafenib,renal cell carcinoma,platelet derived growth factor receptor beta
5456,sorafenib,renal cell carcinoma,colony stimulating factor 1 receptor
5457,sorafenib,renal cell carcinoma,homeodomain interacting protein kinase 2
5458,sorafenib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5459,sorafenib,renal cell carcinoma,polo like kinase 4
5460,sorafenib,renal cell carcinoma,aurora kinase b
5461,sorafenib,renal cell carcinoma,axl receptor tyrosine kinase
5462,sorafenib,renal cell carcinoma,traf2 and nck interacting kinase
5463,sorafenib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5464,sorafenib,renal cell carcinoma,ste20 like kinase
5465,sorafenib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5466,sorafenib,renal cell carcinoma,serine/threonine kinase 33
5467,sorafenib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5468,sorafenib,renal cell carcinoma,cdc like kinase 1
5469,sorafenib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5470,sorafenib,renal cell carcinoma,eph receptor b2
5471,sorafenib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5472,sorafenib,renal cell carcinoma,myosin light chain kinase 3
5473,sorafenib,renal cell carcinoma,tek receptor tyrosine kinase
5474,sorafenib,renal cell carcinoma,fibroblast growth factor receptor 3
5475,pazopanib,renal cell carcinoma,aurora kinase c
5476,pazopanib,renal cell carcinoma,il2 inducible t cell kinase
5477,pazopanib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5478,pazopanib,renal cell carcinoma,fibroblast growth factor receptor 1
5479,pazopanib,renal cell carcinoma,serine/threonine kinase 10
5480,pazopanib,renal cell carcinoma,polo like kinase 4
5481,pazopanib,renal cell carcinoma,fibroblast growth factor receptor 3
5482,pazopanib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5483,pazopanib,renal cell carcinoma,bmp2 inducible kinase
5484,pazopanib,renal cell carcinoma,tek receptor tyrosine kinase
5485,pazopanib,renal cell carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
5486,pazopanib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5487,pazopanib,renal cell carcinoma,"src proto-oncogene, non-receptor tyrosine kinase"
5488,pazopanib,renal cell carcinoma,ste20 like kinase
5489,pazopanib,renal cell carcinoma,ret proto-oncogene
5490,pazopanib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5491,pazopanib,renal cell carcinoma,aurora kinase a
5492,pazopanib,renal cell carcinoma,cyclin g associated kinase
5493,pazopanib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
5494,pazopanib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5495,pazopanib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5496,pazopanib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
5497,pazopanib,renal cell carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
5498,pazopanib,renal cell carcinoma,traf2 and nck interacting kinase
5499,pazopanib,renal cell carcinoma,ap2 associated kinase 1
5500,pazopanib,renal cell carcinoma,alk receptor tyrosine kinase
5501,pazopanib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5502,axitinib,renal cell carcinoma,leucine rich repeat kinase 2
5503,axitinib,renal cell carcinoma,aurora kinase b
5504,axitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 2
5505,axitinib,renal cell carcinoma,traf2 and nck interacting kinase
5506,axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 19
5507,axitinib,renal cell carcinoma,colony stimulating factor 1 receptor
5508,axitinib,renal cell carcinoma,ap2 associated kinase 1
5509,axitinib,renal cell carcinoma,misshapen like kinase 1
5510,axitinib,renal cell carcinoma,"mer proto-oncogene, tyrosine kinase"
5511,axitinib,renal cell carcinoma,platelet derived growth factor receptor alpha
5512,axitinib,renal cell carcinoma,unc-51 like autophagy activating kinase 2
5513,axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase 20
5514,axitinib,renal cell carcinoma,discoidin domain receptor tyrosine kinase 1
5515,axitinib,renal cell carcinoma,tek receptor tyrosine kinase
5516,axitinib,renal cell carcinoma,polo like kinase 4
5517,axitinib,renal cell carcinoma,serine/threonine kinase 4
5518,axitinib,renal cell carcinoma,cyclin g associated kinase
5519,axitinib,renal cell carcinoma,aurora kinase c
5520,axitinib,renal cell carcinoma,interleukin 1 receptor associated kinase 1
5521,axitinib,renal cell carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
5522,axitinib,renal cell carcinoma,bmp2 inducible kinase
5523,axitinib,renal cell carcinoma,aurora kinase a
5524,axitinib,renal cell carcinoma,myosin light chain kinase 3
5525,axitinib,renal cell carcinoma,serine/threonine kinase 10
5526,axitinib,renal cell carcinoma,fibroblast growth factor receptor 1
5527,axitinib,renal cell carcinoma,il2 inducible t cell kinase
5528,axitinib,renal cell carcinoma,receptor interacting serine/threonine kinase 2
5529,axitinib,renal cell carcinoma,ste20 like kinase
5530,axitinib,renal cell carcinoma,platelet derived growth factor receptor beta
5531,axitinib,renal cell carcinoma,mitogen-activated protein kinase kinase kinase kinase 1
5532,axitinib,renal cell carcinoma,fms related receptor tyrosine kinase 3
5533,axitinib,renal cell carcinoma,ret proto-oncogene
5534,axitinib,renal cell carcinoma,"lck proto-oncogene, src family tyrosine kinase"
5535,axitinib,renal cell carcinoma,axl receptor tyrosine kinase
5536,axitinib,renal cell carcinoma,"met proto-oncogene, receptor tyrosine kinase"
5537,axitinib,renal cell carcinoma,fibroblast growth factor receptor 3
5538,pazopanib,sarcoma,bone morphogenetic protein receptor type 1b
5539,pazopanib,sarcoma,tek receptor tyrosine kinase
5540,pazopanib,sarcoma,"raf-1 proto-oncogene, serine/threonine kinase"
5541,pazopanib,sarcoma,"src proto-oncogene, non-receptor tyrosine kinase"
5542,pazopanib,sarcoma,"b-raf proto-oncogene, serine/threonine kinase"
5543,paliperidone,schizophrenia,dopamine receptor d2
5544,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1d
5545,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1a
5546,paliperidone,schizophrenia,adrenoceptor alpha 2a
5547,paliperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5548,paliperidone,schizophrenia,5-hydroxytryptamine receptor 2c
5549,paliperidone,schizophrenia,dopamine receptor d3
5550,paliperidone,schizophrenia,adrenoceptor alpha 1a
5551,paliperidone,schizophrenia,dopamine receptor d1
5552,paliperidone,schizophrenia,5-hydroxytryptamine receptor 2a
5553,paliperidone,schizophrenia,adrenoceptor alpha 1b
5554,paliperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5555,paliperidone,schizophrenia,histamine receptor h1
5556,paliperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5557,paliperidone,schizophrenia,dopamine receptor d4
5558,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1b
5559,paliperidone,schizophrenia,5-hydroxytryptamine receptor 1e
5560,paliperidone,schizophrenia,cholinergic receptor muscarinic 2
5561,paliperidone,schizophrenia,tachykinin precursor 1
5562,prochlorperazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5563,prochlorperazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5564,prochlorperazine,schizophrenia,histamine receptor h1
5565,prochlorperazine,schizophrenia,dopamine receptor d2
5566,prochlorperazine,schizophrenia,cholinergic receptor muscarinic 2
5567,prochlorperazine,schizophrenia,dopamine receptor d3
5568,prochlorperazine,schizophrenia,5-hydroxytryptamine receptor 2c
5569,prochlorperazine,schizophrenia,adrenoceptor alpha 1a
5570,prochlorperazine,schizophrenia,5-hydroxytryptamine receptor 1a
5571,prochlorperazine,schizophrenia,adrenoceptor alpha 2a
5572,prochlorperazine,schizophrenia,dopamine receptor d4
5573,fluphenazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5574,fluphenazine,schizophrenia,cytochrome p450 family 2 subfamily e member 1
5575,fluphenazine,schizophrenia,adrenoceptor alpha 2a
5576,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 2c
5577,fluphenazine,schizophrenia,atp binding cassette subfamily b member 1
5578,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 6
5579,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 1a
5580,fluphenazine,schizophrenia,dopamine receptor d3
5581,fluphenazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5582,fluphenazine,schizophrenia,histamine receptor h1
5583,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 2a
5584,fluphenazine,schizophrenia,calmodulin 1
5585,fluphenazine,schizophrenia,adrenoceptor alpha 1a
5586,fluphenazine,schizophrenia,5-hydroxytryptamine receptor 7
5587,fluphenazine,schizophrenia,cholinergic receptor muscarinic 2
5588,fluphenazine,schizophrenia,dopamine receptor d4
5589,fluphenazine,schizophrenia,dopamine receptor d5
5590,cariprazine,schizophrenia,histamine receptor h1
5591,cariprazine,schizophrenia,vitamin d receptor
5592,cariprazine,schizophrenia,dopamine receptor d3
5593,cariprazine,schizophrenia,5-hydroxytryptamine receptor 7
5594,cariprazine,schizophrenia,5-hydroxytryptamine receptor 2a
5595,cariprazine,schizophrenia,dopamine receptor d5
5596,cariprazine,schizophrenia,dopamine receptor d4
5597,cariprazine,schizophrenia,5-hydroxytryptamine receptor 1a
5598,cariprazine,schizophrenia,5-hydroxytryptamine receptor 2c
5599,cariprazine,schizophrenia,dopamine receptor d1
5600,cariprazine,schizophrenia,dopamine receptor d2
5601,ziprasidone,schizophrenia,h1.0 linker histone
5602,ziprasidone,schizophrenia,dopamine receptor d1
5603,ziprasidone,schizophrenia,cholinergic receptor muscarinic 5
5604,ziprasidone,schizophrenia,adrenoceptor alpha 2a
5605,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 7
5606,ziprasidone,schizophrenia,adrenoceptor alpha 1a
5607,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 2c
5608,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1d
5609,ziprasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5610,ziprasidone,schizophrenia,cholinergic receptor muscarinic 1
5611,ziprasidone,schizophrenia,potassium voltage-gated channel subfamily h member 2
5612,ziprasidone,schizophrenia,dopamine receptor d4
5613,ziprasidone,schizophrenia,dopamine receptor d5
5614,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 6
5615,ziprasidone,schizophrenia,adrenoceptor alpha 1b
5616,ziprasidone,schizophrenia,solute carrier family 6 member 4
5617,ziprasidone,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5618,ziprasidone,schizophrenia,cholinergic receptor muscarinic 2
5619,ziprasidone,schizophrenia,histamine receptor h1
5620,ziprasidone,schizophrenia,dopamine receptor d3
5621,ziprasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5622,ziprasidone,schizophrenia,cholinergic receptor muscarinic 4
5623,ziprasidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5624,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1e
5625,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1b
5626,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 3a
5627,ziprasidone,schizophrenia,5-hydroxytryptamine receptor 1a
5628,ziprasidone,schizophrenia,tachykinin precursor 1
5629,haloperidol,schizophrenia,atp binding cassette subfamily b member 1
5630,haloperidol,schizophrenia,5-hydroxytryptamine receptor 2a
5631,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1b
5632,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1d
5633,haloperidol,schizophrenia,ebp cholestenol delta-isomerase
5634,haloperidol,schizophrenia,histamine receptor h1
5635,haloperidol,schizophrenia,dopamine receptor d4
5636,haloperidol,schizophrenia,dopamine receptor d2
5637,haloperidol,schizophrenia,dopamine receptor d1
5638,haloperidol,schizophrenia,dopamine receptor d3
5639,haloperidol,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5640,haloperidol,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5641,haloperidol,schizophrenia,glutamate ionotropic receptor nmda type subunit 2b
5642,haloperidol,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5643,haloperidol,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5644,haloperidol,schizophrenia,potassium voltage-gated channel subfamily h member 2
5645,haloperidol,schizophrenia,h1.0 linker histone
5646,haloperidol,schizophrenia,sigma non-opioid intracellular receptor 1
5647,haloperidol,schizophrenia,5-hydroxytryptamine receptor 6
5648,haloperidol,schizophrenia,cholinergic receptor muscarinic 1
5649,haloperidol,schizophrenia,solute carrier family 6 member 2
5650,haloperidol,schizophrenia,"major histocompatibility complex, class i, a"
5651,haloperidol,schizophrenia,adrenoceptor alpha 2a
5652,haloperidol,schizophrenia,opioid receptor mu 1
5653,haloperidol,schizophrenia,5-hydroxytryptamine receptor 2c
5654,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1a
5655,haloperidol,schizophrenia,adrenoceptor alpha 1a
5656,haloperidol,schizophrenia,transmembrane protein 97
5657,haloperidol,schizophrenia,solute carrier family 6 member 4
5658,haloperidol,schizophrenia,dopamine receptor d5
5659,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1f
5660,haloperidol,schizophrenia,5-hydroxytryptamine receptor 7
5661,haloperidol,schizophrenia,tachykinin precursor 1
5662,haloperidol,schizophrenia,5-hydroxytryptamine receptor 1e
5663,chlorpromazine,schizophrenia,adrenoceptor alpha 1b
5664,chlorpromazine,schizophrenia,dopamine receptor d5
5665,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 1a
5666,chlorpromazine,schizophrenia,calmodulin 1
5667,chlorpromazine,schizophrenia,adrenoceptor alpha 1a
5668,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 7
5669,chlorpromazine,schizophrenia,adrenoceptor alpha 2a
5670,chlorpromazine,schizophrenia,cytochrome p450 family 2 subfamily e member 1
5671,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 2a
5672,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 6
5673,chlorpromazine,schizophrenia,histamine receptor h1
5674,chlorpromazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5675,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 1
5676,chlorpromazine,schizophrenia,dopamine receptor d3
5677,chlorpromazine,schizophrenia,dopamine receptor d4
5678,chlorpromazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5679,chlorpromazine,schizophrenia,dopamine receptor d1
5680,chlorpromazine,schizophrenia,atp binding cassette subfamily b member 1
5681,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 2
5682,chlorpromazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5683,chlorpromazine,schizophrenia,5-hydroxytryptamine receptor 2c
5684,chlorpromazine,schizophrenia,potassium voltage-gated channel subfamily h member 2
5685,chlorpromazine,schizophrenia,solute carrier family 6 member 4
5686,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 4
5687,chlorpromazine,schizophrenia,cholinergic receptor muscarinic 5
5688,mesoridazine,schizophrenia,histamine receptor h1
5689,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 6
5690,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 2c
5691,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 2a
5692,mesoridazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5693,mesoridazine,schizophrenia,5-hydroxytryptamine receptor 1a
5694,mesoridazine,schizophrenia,dopamine receptor d2
5695,mesoridazine,schizophrenia,cholinergic receptor muscarinic 2
5696,mesoridazine,schizophrenia,potassium voltage-gated channel subfamily h member 2
5697,mesoridazine,schizophrenia,dopamine receptor d3
5698,mesoridazine,schizophrenia,cholinergic receptor muscarinic 5
5699,mesoridazine,schizophrenia,adrenoceptor alpha 1a
5700,mesoridazine,schizophrenia,adrenoceptor alpha 2a
5701,mesoridazine,schizophrenia,dopamine receptor d4
5702,mesoridazine,schizophrenia,cholinergic receptor muscarinic 4
5703,mesoridazine,schizophrenia,cholinergic receptor muscarinic 1
5704,risperidone,schizophrenia,5-hydroxytryptamine receptor 1b
5705,risperidone,schizophrenia,adrenoceptor alpha 1b
5706,risperidone,schizophrenia,h1.0 linker histone
5707,risperidone,schizophrenia,dopamine receptor d4
5708,risperidone,schizophrenia,5-hydroxytryptamine receptor 1d
5709,risperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5710,risperidone,schizophrenia,adrenoceptor alpha 1a
5711,risperidone,schizophrenia,5-hydroxytryptamine receptor 2c
5712,risperidone,schizophrenia,potassium voltage-gated channel subfamily h member 2
5713,risperidone,schizophrenia,dopamine receptor d1
5714,risperidone,schizophrenia,dopamine receptor d3
5715,risperidone,schizophrenia,5-hydroxytryptamine receptor 7
5716,risperidone,schizophrenia,5-hydroxytryptamine receptor 1a
5717,risperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5718,risperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5719,risperidone,schizophrenia,adrenoceptor alpha 2a
5720,risperidone,schizophrenia,histamine receptor h1
5721,risperidone,schizophrenia,atp binding cassette subfamily b member 1
5722,risperidone,schizophrenia,cholinergic receptor muscarinic 1
5723,risperidone,schizophrenia,5-hydroxytryptamine receptor 1e
5724,risperidone,schizophrenia,cholinergic receptor muscarinic 2
5725,risperidone,schizophrenia,5-hydroxytryptamine receptor 1f
5726,risperidone,schizophrenia,tachykinin precursor 1
5727,risperidone,schizophrenia,dopamine receptor d5
5728,risperidone,schizophrenia,sigma non-opioid intracellular receptor 1
5729,risperidone,schizophrenia,solute carrier family 6 member 4
5730,risperidone,schizophrenia,cholinergic receptor muscarinic 4
5731,risperidone,schizophrenia,5-hydroxytryptamine receptor 6
5732,aripiprazole,schizophrenia,adrenoceptor alpha 2a
5733,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1e
5734,aripiprazole,schizophrenia,h1.0 linker histone
5735,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 2c
5736,aripiprazole,schizophrenia,cholinergic receptor muscarinic 2
5737,aripiprazole,schizophrenia,cholinergic receptor muscarinic 1
5738,aripiprazole,schizophrenia,dopamine receptor d5
5739,aripiprazole,schizophrenia,histamine receptor h1
5740,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 7
5741,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1d
5742,aripiprazole,schizophrenia,atp binding cassette subfamily b member 1
5743,aripiprazole,schizophrenia,dopamine receptor d3
5744,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1a
5745,aripiprazole,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5746,aripiprazole,schizophrenia,dopamine receptor d4
5747,aripiprazole,schizophrenia,dopamine receptor d1
5748,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 6
5749,aripiprazole,schizophrenia,adrenoceptor alpha 1b
5750,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 3a
5751,aripiprazole,schizophrenia,potassium voltage-gated channel subfamily h member 2
5752,aripiprazole,schizophrenia,cholinergic receptor muscarinic 4
5753,aripiprazole,schizophrenia,solute carrier family 6 member 4
5754,aripiprazole,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5755,aripiprazole,schizophrenia,adrenoceptor alpha 1a
5756,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 1b
5757,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 2a
5758,aripiprazole,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5759,aripiprazole,schizophrenia,dopamine receptor d2
5760,aripiprazole,schizophrenia,cholinergic receptor muscarinic 5
5761,aripiprazole,schizophrenia,solute carrier family 6 member 2
5762,aripiprazole,schizophrenia,5-hydroxytryptamine receptor 5a
5763,aripiprazole,schizophrenia,solute carrier family 6 member 3
5764,mosapramine,schizophrenia,dopamine receptor d4
5765,trifluoperazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5766,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 6
5767,trifluoperazine,schizophrenia,sigma non-opioid intracellular receptor 1
5768,trifluoperazine,schizophrenia,adrenoceptor alpha 1a
5769,trifluoperazine,schizophrenia,atp binding cassette subfamily b member 1
5770,trifluoperazine,schizophrenia,cholinergic receptor muscarinic 2
5771,trifluoperazine,schizophrenia,histamine receptor h1
5772,trifluoperazine,schizophrenia,calmodulin 1
5773,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 1a
5774,trifluoperazine,schizophrenia,ebp like
5775,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 2a
5776,trifluoperazine,schizophrenia,ebp cholestenol delta-isomerase
5777,trifluoperazine,schizophrenia,calcyon neuron specific vesicular protein
5778,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 2c
5779,trifluoperazine,schizophrenia,adrenoceptor alpha 2a
5780,trifluoperazine,schizophrenia,dopamine receptor d3
5781,trifluoperazine,schizophrenia,5-hydroxytryptamine receptor 7
5782,trifluoperazine,schizophrenia,dopamine receptor d4
5783,iloperidone,schizophrenia,adrenoceptor alpha 2a
5784,iloperidone,schizophrenia,cytochrome p450 family 2 subfamily e member 1
5785,iloperidone,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5786,iloperidone,schizophrenia,histamine receptor h1
5787,iloperidone,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5788,iloperidone,schizophrenia,5-hydroxytryptamine receptor 1a
5789,iloperidone,schizophrenia,dopamine receptor d2
5790,iloperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5791,iloperidone,schizophrenia,sigma non-opioid intracellular receptor 1
5792,iloperidone,schizophrenia,adrenoceptor alpha 1a
5793,iloperidone,schizophrenia,5-hydroxytryptamine receptor 7
5794,iloperidone,schizophrenia,5-hydroxytryptamine receptor 2c
5795,iloperidone,schizophrenia,5-hydroxytryptamine receptor 1d
5796,iloperidone,schizophrenia,5-hydroxytryptamine receptor 6
5797,iloperidone,schizophrenia,dopamine receptor d3
5798,iloperidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5799,iloperidone,schizophrenia,dopamine receptor d4
5800,iloperidone,schizophrenia,cholinergic receptor muscarinic 1
5801,iloperidone,schizophrenia,solute carrier family 6 member 3
5802,iloperidone,schizophrenia,solute carrier family 6 member 2
5803,iloperidone,schizophrenia,cholinergic receptor muscarinic 2
5804,iloperidone,schizophrenia,cholinergic receptor muscarinic 4
5805,iloperidone,schizophrenia,dopamine receptor d5
5806,asenapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5807,asenapine,schizophrenia,histamine receptor h2
5808,asenapine,schizophrenia,dopamine receptor d4
5809,asenapine,schizophrenia,dopamine receptor d1
5810,asenapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5811,asenapine,schizophrenia,solute carrier family 6 member 4
5812,asenapine,schizophrenia,adrenoceptor alpha 1a
5813,asenapine,schizophrenia,5-hydroxytryptamine receptor 1b
5814,asenapine,schizophrenia,5-hydroxytryptamine receptor 1a
5815,asenapine,schizophrenia,5-hydroxytryptamine receptor 1d
5816,asenapine,schizophrenia,adrenoceptor alpha 2a
5817,asenapine,schizophrenia,dopamine receptor d3
5818,asenapine,schizophrenia,5-hydroxytryptamine receptor 1e
5819,asenapine,schizophrenia,histamine receptor h1
5820,asenapine,schizophrenia,5-hydroxytryptamine receptor 5a
5821,asenapine,schizophrenia,5-hydroxytryptamine receptor 2c
5822,asenapine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5823,asenapine,schizophrenia,5-hydroxytryptamine receptor 7
5824,asenapine,schizophrenia,5-hydroxytryptamine receptor 6
5825,asenapine,schizophrenia,cholinergic receptor muscarinic 2
5826,asenapine,schizophrenia,tachykinin precursor 1
5827,zuclopenthixol,schizophrenia,histamine receptor h1
5828,zuclopenthixol,schizophrenia,5-hydroxytryptamine receptor 6
5829,zuclopenthixol,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5830,zuclopenthixol,schizophrenia,5-hydroxytryptamine receptor 2a
5831,zuclopenthixol,schizophrenia,adrenoceptor alpha 1a
5832,zuclopenthixol,schizophrenia,adrenoceptor alpha 2a
5833,sertindole,schizophrenia,5-hydroxytryptamine receptor 1d
5834,sertindole,schizophrenia,solute carrier family 6 member 4
5835,sertindole,schizophrenia,dopamine receptor d3
5836,sertindole,schizophrenia,adrenoceptor alpha 2a
5837,sertindole,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5838,sertindole,schizophrenia,5-hydroxytryptamine receptor 1e
5839,sertindole,schizophrenia,potassium voltage-gated channel subfamily h member 2
5840,sertindole,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5841,sertindole,schizophrenia,5-hydroxytryptamine receptor 1b
5842,sertindole,schizophrenia,histamine receptor h1
5843,sertindole,schizophrenia,5-hydroxytryptamine receptor 1f
5844,sertindole,schizophrenia,dopamine receptor d4
5845,sertindole,schizophrenia,5-hydroxytryptamine receptor 1a
5846,sertindole,schizophrenia,5-hydroxytryptamine receptor 6
5847,sertindole,schizophrenia,dopamine receptor d1
5848,sertindole,schizophrenia,tachykinin precursor 1
5849,sertindole,schizophrenia,cholinergic receptor muscarinic 2
5850,sertindole,schizophrenia,5-hydroxytryptamine receptor 7
5851,quetiapine,schizophrenia,adrenoceptor alpha 1a
5852,quetiapine,schizophrenia,cytochrome p450 family 3 subfamily a member 5
5853,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1e
5854,quetiapine,schizophrenia,5-hydroxytryptamine receptor 7
5855,quetiapine,schizophrenia,5-hydroxytryptamine receptor 3a
5856,quetiapine,schizophrenia,adrenoceptor alpha 1d
5857,quetiapine,schizophrenia,dopamine receptor d5
5858,quetiapine,schizophrenia,cholinergic receptor muscarinic 4
5859,quetiapine,schizophrenia,histamine receptor h1
5860,quetiapine,schizophrenia,adrenoceptor alpha 2a
5861,quetiapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5862,quetiapine,schizophrenia,cholinergic receptor muscarinic 5
5863,quetiapine,schizophrenia,cholinergic receptor muscarinic 1
5864,quetiapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5865,quetiapine,schizophrenia,dopamine receptor d3
5866,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1b
5867,quetiapine,schizophrenia,adrenoceptor alpha 1b
5868,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1a
5869,quetiapine,schizophrenia,atp binding cassette subfamily b member 1
5870,quetiapine,schizophrenia,dopamine receptor d4
5871,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1d
5872,quetiapine,schizophrenia,cholinergic receptor muscarinic 2
5873,quetiapine,schizophrenia,h1.0 linker histone
5874,quetiapine,schizophrenia,5-hydroxytryptamine receptor 2c
5875,quetiapine,schizophrenia,5-hydroxytryptamine receptor 6
5876,quetiapine,schizophrenia,dopamine receptor d1
5877,quetiapine,schizophrenia,5-hydroxytryptamine receptor 1f
5878,quetiapine,schizophrenia,tachykinin precursor 1
5879,quetiapine,schizophrenia,solute carrier family 6 member 4
5880,quetiapine,schizophrenia,potassium voltage-gated channel subfamily h member 2
5881,lurasidone,schizophrenia,5-hydroxytryptamine receptor 1a
5882,lurasidone,schizophrenia,adrenoceptor alpha 2a
5883,lurasidone,schizophrenia,5-hydroxytryptamine receptor 7
5884,lurasidone,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5885,lurasidone,schizophrenia,dopamine receptor d4
5886,spiperone,schizophrenia,"major histocompatibility complex, class i, a"
5887,spiperone,schizophrenia,cholinergic receptor muscarinic 2
5888,spiperone,schizophrenia,adrenoceptor alpha 1b
5889,spiperone,schizophrenia,dopamine receptor d5
5890,spiperone,schizophrenia,dopamine receptor d1
5891,spiperone,schizophrenia,5-hydroxytryptamine receptor 6
5892,spiperone,schizophrenia,dopamine receptor d2
5893,spiperone,schizophrenia,5-hydroxytryptamine receptor 5a
5894,spiperone,schizophrenia,5-hydroxytryptamine receptor 1a
5895,spiperone,schizophrenia,5-hydroxytryptamine receptor 1b
5896,spiperone,schizophrenia,adrenoceptor alpha 1a
5897,spiperone,schizophrenia,5-hydroxytryptamine receptor 7
5898,spiperone,schizophrenia,dopamine receptor d4
5899,spiperone,schizophrenia,histamine receptor h1
5900,spiperone,schizophrenia,5-hydroxytryptamine receptor 2c
5901,spiperone,schizophrenia,5-hydroxytryptamine receptor 1f
5902,spiperone,schizophrenia,dopamine receptor d3
5903,spiperone,schizophrenia,adrenoceptor alpha 2a
5904,spiperone,schizophrenia,sigma non-opioid intracellular receptor 1
5905,spiperone,schizophrenia,5-hydroxytryptamine receptor 1d
5906,spiperone,schizophrenia,5-hydroxytryptamine receptor 2a
5907,spiperone,schizophrenia,5-hydroxytryptamine receptor 1e
5908,spiperone,schizophrenia,adrenoceptor alpha 1d
5909,sulpiride,schizophrenia,carbonic anhydrase 2
5910,sulpiride,schizophrenia,dopamine receptor d4
5911,loxapine,schizophrenia,5-hydroxytryptamine receptor 1e
5912,loxapine,schizophrenia,5-hydroxytryptamine receptor 5a
5913,loxapine,schizophrenia,5-hydroxytryptamine receptor 1a
5914,loxapine,schizophrenia,cholinergic receptor muscarinic 5
5915,loxapine,schizophrenia,dopamine receptor d4
5916,loxapine,schizophrenia,histamine receptor h2
5917,loxapine,schizophrenia,dopamine receptor d5
5918,loxapine,schizophrenia,dopamine receptor d1
5919,loxapine,schizophrenia,adrenoceptor alpha 2a
5920,loxapine,schizophrenia,5-hydroxytryptamine receptor 2c
5921,loxapine,schizophrenia,cholinergic receptor muscarinic 1
5922,loxapine,schizophrenia,adrenoceptor alpha 1a
5923,loxapine,schizophrenia,cholinergic receptor muscarinic 2
5924,loxapine,schizophrenia,5-hydroxytryptamine receptor 7
5925,loxapine,schizophrenia,5-hydroxytryptamine receptor 1d
5926,loxapine,schizophrenia,histamine receptor h1
5927,loxapine,schizophrenia,adrenoceptor alpha 1b
5928,loxapine,schizophrenia,5-hydroxytryptamine receptor 3a
5929,loxapine,schizophrenia,5-hydroxytryptamine receptor 6
5930,loxapine,schizophrenia,5-hydroxytryptamine receptor 1b
5931,loxapine,schizophrenia,cholinergic receptor muscarinic 4
5932,loxapine,schizophrenia,solute carrier family 6 member 2
5933,loxapine,schizophrenia,dopamine receptor d3
5934,loxapine,schizophrenia,solute carrier family 6 member 4
5935,loxapine,schizophrenia,solute carrier family 6 member 3
5936,olanzapine,schizophrenia,5-hydroxytryptamine receptor 3a
5937,olanzapine,schizophrenia,adrenoceptor alpha 1b
5938,olanzapine,schizophrenia,5-hydroxytryptamine receptor 6
5939,olanzapine,schizophrenia,cholinergic receptor muscarinic 5
5940,olanzapine,schizophrenia,dopamine receptor d3
5941,olanzapine,schizophrenia,cholinergic receptor muscarinic 1
5942,olanzapine,schizophrenia,5-hydroxytryptamine receptor 7
5943,olanzapine,schizophrenia,dopamine receptor d4
5944,olanzapine,schizophrenia,atp binding cassette subfamily b member 1
5945,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1b
5946,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1a
5947,olanzapine,schizophrenia,dopamine receptor d1
5948,olanzapine,schizophrenia,cholinergic receptor muscarinic 4
5949,olanzapine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5950,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1e
5951,olanzapine,schizophrenia,histamine receptor h1
5952,olanzapine,schizophrenia,h1.0 linker histone
5953,olanzapine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5954,olanzapine,schizophrenia,5-hydroxytryptamine receptor 2a
5955,olanzapine,schizophrenia,5-hydroxytryptamine receptor 5a
5956,olanzapine,schizophrenia,5-hydroxytryptamine receptor 2c
5957,olanzapine,schizophrenia,histamine receptor h2
5958,olanzapine,schizophrenia,dopamine receptor d5
5959,olanzapine,schizophrenia,adrenoceptor alpha 1a
5960,olanzapine,schizophrenia,5-hydroxytryptamine receptor 1d
5961,olanzapine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5962,olanzapine,schizophrenia,cholinergic receptor muscarinic 2
5963,olanzapine,schizophrenia,adrenoceptor alpha 2a
5964,perphenazine,schizophrenia,5-hydroxytryptamine receptor 1a
5965,perphenazine,schizophrenia,dopamine receptor d1
5966,perphenazine,schizophrenia,5-hydroxytryptamine receptor 2c
5967,perphenazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5968,perphenazine,schizophrenia,histamine receptor h1
5969,perphenazine,schizophrenia,calmodulin 1
5970,perphenazine,schizophrenia,5-hydroxytryptamine receptor 2a
5971,perphenazine,schizophrenia,5-hydroxytryptamine receptor 6
5972,perphenazine,schizophrenia,cytochrome p450 family 2 subfamily d member 6
5973,perphenazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5974,perphenazine,schizophrenia,5-hydroxytryptamine receptor 7
5975,perphenazine,schizophrenia,adrenoceptor alpha 2a
5976,perphenazine,schizophrenia,adrenoceptor alpha 1a
5977,perphenazine,schizophrenia,cholinergic receptor muscarinic 2
5978,perphenazine,schizophrenia,dopamine receptor d3
5979,perphenazine,schizophrenia,dopamine receptor d4
5980,promazine,schizophrenia,dopamine receptor d4
5981,promazine,schizophrenia,adrenoceptor alpha 1a
5982,promazine,schizophrenia,adrenoceptor alpha 1b
5983,promazine,schizophrenia,5-hydroxytryptamine receptor 2c
5984,promazine,schizophrenia,cytochrome p450 family 3 subfamily a member 4
5985,promazine,schizophrenia,cholinergic receptor muscarinic 5
5986,promazine,schizophrenia,adrenoceptor alpha 2a
5987,promazine,schizophrenia,5-hydroxytryptamine receptor 2a
5988,promazine,schizophrenia,dopamine receptor d2
5989,promazine,schizophrenia,cholinergic receptor muscarinic 1
5990,promazine,schizophrenia,adrenoceptor alpha 1d
5991,promazine,schizophrenia,cytochrome p450 family 1 subfamily a member 2
5992,promazine,schizophrenia,cholinergic receptor muscarinic 4
5993,promazine,schizophrenia,dopamine receptor d1
5994,promazine,schizophrenia,histamine receptor h1
5995,promazine,schizophrenia,cholinergic receptor muscarinic 2
5996,promazine,schizophrenia,dopamine receptor d3
5997,betamethasone,skin disorder,prostaglandin-endoperoxide synthase 2
5998,prednisolone,skin disorder,serpin family a member 6
5999,prednisone,skin disorder,nuclear receptor subfamily 3 group c member 1
6000,prednisone,skin disorder,albumin
6001,triamcinolone,skin disorder,prostaglandin-endoperoxide synthase 2
6002,triamcinolone,skin disorder,serpin family a member 6
6003,lovastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
6004,simvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
6005,rosuvastatin,stroke disorder,albumin
6006,ramipril,stroke disorder,angiotensin i converting enzyme
6007,fluvastatin,stroke disorder,3-hydroxy-3-methylglutaryl-coa reductase
6008,telmisartan,stroke disorder,angiotensin i converting enzyme
6009,nimodipine,subarachnoid hemorrhage,calcium voltage-gated channel subunit alpha1 c
6010,mesalazine,ulcerative colitis,myeloperoxidase
6011,sulfasalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6012,sulfasalazine,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6013,sulfasalazine,ulcerative colitis,peroxisome proliferator activated receptor gamma
6014,prednisolone,ulcerative colitis,atp binding cassette subfamily b member 1
6015,prednisolone,ulcerative colitis,serpin family a member 6
6016,cortisol,ulcerative colitis,atp binding cassette subfamily b member 1
6017,cortisol,ulcerative colitis,sex hormone binding globulin
6018,cortisol,ulcerative colitis,serpin family a member 6
6019,aminosalicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6020,aminosalicylic acid,ulcerative colitis,phospholipase a2 group iie
6021,aminosalicylic acid,ulcerative colitis,myeloperoxidase
6022,aminosalicylic acid,ulcerative colitis,arachidonate 5-lipoxygenase
6023,aminosalicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6024,balsalazide,ulcerative colitis,peroxisome proliferator activated receptor gamma
6025,balsalazide,ulcerative colitis,arachidonate 5-lipoxygenase
6026,balsalazide,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6027,balsalazide,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6028,tofacitinib,ulcerative colitis,doublecortin like kinase 3
6029,tofacitinib,ulcerative colitis,ribosomal protein s6 kinase a2
6030,tofacitinib,ulcerative colitis,janus kinase 3
6031,tofacitinib,ulcerative colitis,calcium/calmodulin dependent protein kinase ii alpha
6032,tofacitinib,ulcerative colitis,janus kinase 1
6033,tofacitinib,ulcerative colitis,ribosomal protein s6 kinase a6
6034,tofacitinib,ulcerative colitis,tyrosine kinase 2
6035,tofacitinib,ulcerative colitis,bmp2 inducible kinase
6036,tofacitinib,ulcerative colitis,janus kinase 2
6037,salicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 1
6038,salicylic acid,ulcerative colitis,albumin
6039,salicylic acid,ulcerative colitis,prostaglandin-endoperoxide synthase 2
6040,salicylic acid,ulcerative colitis,atp binding cassette subfamily b member 1
6041,hydroxyurea,melanoma,ribonucleotide reductase regulatory subunit m2
6042,darunavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6043,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 43
6044,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6045,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6046,zalcitabine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6047,zalcitabine,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6048,zalcitabine,hiv infectious disease,albumin
6049,efavirenz,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6050,efavirenz,hiv infectious disease,cytochrome p450 family 46 subfamily a member 1
6051,lopinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6052,delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6053,delavirdine,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6054,delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6055,delavirdine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6056,nevirapine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6057,nevirapine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6058,fosamprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6059,atazanavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6060,saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6061,saquinavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6062,saquinavir,hiv infectious disease,albumin
6063,saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6064,saquinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6065,abacavir,hiv infectious disease,albumin
6066,zidovudine,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6067,zidovudine,hiv infectious disease,albumin
6068,amprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6069,amprenavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6070,nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6071,nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6072,nelfinavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6073,nelfinavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6074,tipranavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6075,lamivudine,hiv infectious disease,albumin
6076,emtricitabine,hiv infectious disease,albumin
6077,raltegravir,hiv infectious disease,c-c motif chemokine receptor 1
6078,ritonavir,hiv infectious disease,solute carrier family 47 member 1
6079,ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 4
6080,ritonavir,hiv infectious disease,cyp3a7-cyp3a51p readthrough
6081,ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 5
6082,ritonavir,hiv infectious disease,cytochrome p450 family 3 subfamily a member 7
6083,pemetrexed,malignant pleural mesothelioma,dihydrofolate reductase
6084,pemetrexed,malignant pleural mesothelioma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
6085,pemetrexed,malignant pleural mesothelioma,solute carrier family 46 member 1
6086,pemetrexed,malignant pleural mesothelioma,thymidylate synthetase
6087,dapsone,leprosy,myeloperoxidase
6088,danazol,endometriosis,estrogen receptor 1
6089,danazol,endometriosis,progesterone receptor
6090,danazol,endometriosis,cytochrome p450 family 19 subfamily a member 1
6091,danazol,endometriosis,sex hormone binding globulin
6092,progesterone,endometriosis,androgen receptor
6093,progesterone,endometriosis,nuclear receptor subfamily 3 group c member 2
6094,progesterone,endometriosis,sex hormone binding globulin
6095,progesterone,endometriosis,nuclear receptor subfamily 3 group c member 1
6096,progesterone,endometriosis,estrogen receptor 1
6097,progesterone,endometriosis,serpin family a member 6
6098,medroxyprogesterone,endometriosis,aldo-keto reductase family 1 member c3
6099,medroxyprogesterone,endometriosis,nuclear receptor subfamily 3 group c member 1
6100,medroxyprogesterone,endometriosis,sex hormone binding globulin
6101,medroxyprogesterone,endometriosis,estrogen receptor 1
6102,medroxyprogesterone,endometriosis,androgen receptor
6103,norethisterone,endometriosis,sex hormone binding globulin
6104,levonorgestrel,endometriosis,steroid 5 alpha-reductase 1
6105,levonorgestrel,endometriosis,cytochrome p450 family 19 subfamily a member 1
6106,levonorgestrel,endometriosis,androgen receptor
6107,levonorgestrel,endometriosis,progesterone receptor
6108,levonorgestrel,endometriosis,sex hormone binding globulin
6109,levonorgestrel,endometriosis,estrogen receptor 1
6110,mestranol,endometriosis,estrogen receptor 1
6111,quinine,malaria,cytochrome p450 family 2 subfamily d member 6
6112,quinine,malaria,sodium voltage-gated channel alpha subunit 3
6113,quinine,malaria,sodium voltage-gated channel alpha subunit 1
6114,quinine,malaria,sodium voltage-gated channel alpha subunit 5
6115,quinine,malaria,sodium voltage-gated channel alpha subunit 2
6116,pyrimethamine,malaria,dihydrofolate reductase
6117,pyrimethamine,malaria,cytochrome p450 family 2 subfamily d member 6
6118,citalopram,post-traumatic stress disorder,solute carrier family 6 member 4
6119,fluoxetine,post-traumatic stress disorder,solute carrier family 6 member 4
6120,escitalopram,post-traumatic stress disorder,solute carrier family 6 member 4
6121,venlafaxine,post-traumatic stress disorder,solute carrier family 6 member 4
6122,fluvoxamine,post-traumatic stress disorder,solute carrier family 6 member 4
6123,mirtazapine,post-traumatic stress disorder,solute carrier family 6 member 4
6124,amitriptyline,post-traumatic stress disorder,solute carrier family 6 member 4
6125,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 4
6126,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 1
6127,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 11
6128,dapagliflozin,type 1 diabetes mellitus,solute carrier family 5 member 2
6129,glimepiride,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
6130,nateglinide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6131,nateglinide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6132,nateglinide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6133,nateglinide,type 2 diabetes mellitus,albumin
6134,sitagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6135,troglitazone,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6136,alogliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6137,acarbose,type 2 diabetes mellitus,amylase alpha 1c
6138,acarbose,type 2 diabetes mellitus,alpha glucosidase
6139,acarbose,type 2 diabetes mellitus,amylase alpha 1b
6140,acarbose,type 2 diabetes mellitus,sucrase-isomaltase
6141,acarbose,type 2 diabetes mellitus,amylase alpha 1a
6142,pioglitazone,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6143,pioglitazone,type 2 diabetes mellitus,cdgsh iron sulfur domain 1
6144,canagliflozin,type 2 diabetes mellitus,albumin
6145,canagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
6146,canagliflozin,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
6147,canagliflozin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6148,glibenclamide,type 2 diabetes mellitus,albumin
6149,glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
6150,glibenclamide,type 2 diabetes mellitus,carnitine palmitoyltransferase 1a
6151,glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily b member 11
6152,glibenclamide,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
6153,glibenclamide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6154,glibenclamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6155,glibenclamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
6156,glibenclamide,type 2 diabetes mellitus,cdgsh iron sulfur domain 1
6157,glibenclamide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6158,linagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6159,metformin,type 2 diabetes mellitus,solute carrier family 22 member 3
6160,metformin,type 2 diabetes mellitus,ndufa4 mitochondrial complex associated like 2
6161,metformin,type 2 diabetes mellitus,ndufa4 mitochondrial complex associated
6162,tolazamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
6163,glipizide,type 2 diabetes mellitus,peroxisome proliferator activated receptor gamma
6164,glipizide,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6165,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 4
6166,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 1
6167,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 11
6168,dapagliflozin,type 2 diabetes mellitus,solute carrier family 5 member 2
6169,dapagliflozin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6170,dapagliflozin,type 2 diabetes mellitus,cytochrome p450 family 1 subfamily a member 2
6171,saxagliptin,type 2 diabetes mellitus,cytochrome p450 family 3 subfamily a member 4
6172,saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 8
6173,saxagliptin,type 2 diabetes mellitus,dipeptidyl peptidase 9
6174,chlorpropamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6175,chlorpropamide,type 2 diabetes mellitus,albumin
6176,tolbutamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 1
6177,tolbutamide,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
6178,tolbutamide,type 2 diabetes mellitus,albumin
6179,glymidine,type 2 diabetes mellitus,atp binding cassette subfamily c member 8
6180,diclofenac,actinic keratosis,c-x-c motif chemokine receptor 1
6181,diclofenac,actinic keratosis,c-x-c motif chemokine ligand 8
6182,masoprocol,actinic keratosis,leukotriene b4 receptor
6183,meclofenamic acid,osteoarthritis,arachidonate 5-lipoxygenase
6184,meclofenamic acid,osteoarthritis,aldo-keto reductase family 1 member c3
6185,tolmetin,osteoarthritis,c-x-c motif chemokine ligand 8
6186,lumiracoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
6187,lumiracoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6188,celecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6189,diclofenac,osteoarthritis,c-x-c motif chemokine receptor 1
6190,diclofenac,osteoarthritis,arachidonate 5-lipoxygenase
6191,diclofenac,osteoarthritis,c-x-c motif chemokine ligand 8
6192,duloxetine,osteoarthritis,solute carrier family 6 member 4
6193,duloxetine,osteoarthritis,solute carrier family 6 member 2
6194,duloxetine,osteoarthritis,histamine receptor h1
6195,nabumetone,osteoarthritis,prostaglandin-endoperoxide synthase 1
6196,nabumetone,osteoarthritis,prostaglandin-endoperoxide synthase 2
6197,ketoprofen,osteoarthritis,c-x-c motif chemokine ligand 8
6198,ketoprofen,osteoarthritis,c-x-c motif chemokine receptor 1
6199,ketoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 2
6200,ketoprofen,osteoarthritis,prostaglandin-endoperoxide synthase 1
6201,histamine,osteoarthritis,histamine receptor h4
6202,histamine,osteoarthritis,histamine receptor h1
6203,indomethacin,osteoarthritis,c-x-c motif chemokine ligand 8
6204,indomethacin,osteoarthritis,peroxisome proliferator activated receptor gamma
6205,indomethacin,osteoarthritis,aldo-keto reductase family 1 member c3
6206,salicylic acid,osteoarthritis,aldo-keto reductase family 1 member c1
6207,rofecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6208,ibuprofen,osteoarthritis,c-x-c motif chemokine ligand 8
6209,ibuprofen,osteoarthritis,peroxisome proliferator activated receptor gamma
6210,aspirin,osteoarthritis,aldo-keto reductase family 1 member c1
6211,naproxen,osteoarthritis,aldo-keto reductase family 1 member c3
6212,meloxicam,osteoarthritis,prostaglandin-endoperoxide synthase 1
6213,valdecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 1
6214,valdecoxib,osteoarthritis,prostaglandin-endoperoxide synthase 2
6215,pimavanserin,parkinson disease,5-hydroxytryptamine receptor 2a
6216,levodopa,parkinson disease,dopa decarboxylase
6217,levodopa,parkinson disease,dopamine receptor d2
6218,levodopa,parkinson disease,dopamine receptor d5
6219,levodopa,parkinson disease,dopamine receptor d1
6220,levodopa,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6221,levodopa,parkinson disease,dopamine receptor d4
6222,levodopa,parkinson disease,dopamine receptor d3
6223,amantadine,parkinson disease,dopa decarboxylase
6224,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2b
6225,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 3b
6226,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2c
6227,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2a
6228,amantadine,parkinson disease,monoamine oxidase b
6229,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 1
6230,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 2d
6231,amantadine,parkinson disease,atp binding cassette subfamily b member 1
6232,amantadine,parkinson disease,glutamate ionotropic receptor nmda type subunit 3a
6233,pramipexole,parkinson disease,adrenoceptor alpha 2b
6234,pramipexole,parkinson disease,dopamine receptor d5
6235,pramipexole,parkinson disease,5-hydroxytryptamine receptor 1a
6236,pramipexole,parkinson disease,dopamine receptor d1
6237,pramipexole,parkinson disease,adrenoceptor alpha 2a
6238,pramipexole,parkinson disease,5-hydroxytryptamine receptor 2a
6239,pramipexole,parkinson disease,adrenoceptor alpha 2c
6240,pramipexole,parkinson disease,5-hydroxytryptamine receptor 7
6241,benzatropine,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6242,benzatropine,parkinson disease,cholinergic receptor muscarinic 2
6243,rasagiline,parkinson disease,5-hydroxytryptamine receptor 6
6244,rasagiline,parkinson disease,monoamine oxidase a
6245,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 6
6246,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 1a
6247,bromocriptine,parkinson disease,dopamine receptor d1
6248,bromocriptine,parkinson disease,adrenoceptor alpha 2a
6249,bromocriptine,parkinson disease,dopamine receptor d4
6250,bromocriptine,parkinson disease,adrenoceptor alpha 1b
6251,bromocriptine,parkinson disease,atp binding cassette subfamily b member 1
6252,bromocriptine,parkinson disease,adrenoceptor alpha 1d
6253,bromocriptine,parkinson disease,adrenoceptor alpha 1a
6254,bromocriptine,parkinson disease,dopamine receptor d5
6255,bromocriptine,parkinson disease,adrenoceptor alpha 2b
6256,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 7
6257,bromocriptine,parkinson disease,5-hydroxytryptamine receptor 2a
6258,bromocriptine,parkinson disease,adrenoceptor beta 1
6259,bromocriptine,parkinson disease,adrenoceptor alpha 2c
6260,bromocriptine,parkinson disease,adrenoceptor beta 2
6261,apomorphine,parkinson disease,adrenoceptor alpha 2c
6262,apomorphine,parkinson disease,adrenoceptor alpha 2a
6263,apomorphine,parkinson disease,adrenoceptor alpha 2b
6264,apomorphine,parkinson disease,adrenoceptor alpha 1d
6265,apomorphine,parkinson disease,dopamine receptor d5
6266,apomorphine,parkinson disease,5-hydroxytryptamine receptor 2a
6267,apomorphine,parkinson disease,dopamine receptor d1
6268,apomorphine,parkinson disease,5-hydroxytryptamine receptor 1a
6269,apomorphine,parkinson disease,adrenoceptor alpha 1b
6270,apomorphine,parkinson disease,adrenoceptor alpha 1a
6271,droxidopa,parkinson disease,adrenoceptor alpha 2b
6272,droxidopa,parkinson disease,adrenoceptor beta 3
6273,droxidopa,parkinson disease,adrenoceptor beta 2
6274,droxidopa,parkinson disease,adrenoceptor alpha 1d
6275,droxidopa,parkinson disease,adrenoceptor alpha 1b
6276,droxidopa,parkinson disease,adrenoceptor alpha 2a
6277,droxidopa,parkinson disease,adrenoceptor alpha 1a
6278,droxidopa,parkinson disease,adrenoceptor beta 1
6279,droxidopa,parkinson disease,dopa decarboxylase
6280,droxidopa,parkinson disease,adrenoceptor alpha 2c
6281,carbidopa,parkinson disease,dopa decarboxylase
6282,selegiline,parkinson disease,atp binding cassette subfamily b member 1
6283,selegiline,parkinson disease,cytochrome p450 family 2 subfamily e member 1
6284,selegiline,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6285,procyclidine,parkinson disease,cholinergic receptor muscarinic 2
6286,procyclidine,parkinson disease,cholinergic receptor muscarinic 4
6287,procyclidine,parkinson disease,cholinergic receptor muscarinic 1
6288,ropinirole,parkinson disease,dopamine receptor d1
6289,ropinirole,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6290,ropinirole,parkinson disease,dopamine receptor d4
6291,ropinirole,parkinson disease,adrenoceptor alpha 2a
6292,ropinirole,parkinson disease,5-hydroxytryptamine receptor 2a
6293,ropinirole,parkinson disease,adrenoceptor alpha 2c
6294,ropinirole,parkinson disease,5-hydroxytryptamine receptor 1a
6295,ropinirole,parkinson disease,dopamine receptor d5
6296,ropinirole,parkinson disease,adrenoceptor alpha 2b
6297,ropinirole,parkinson disease,5-hydroxytryptamine receptor 7
6298,biperiden,parkinson disease,atp binding cassette subfamily b member 1
6299,biperiden,parkinson disease,cholinergic receptor muscarinic 2
6300,biperiden,parkinson disease,cytochrome p450 family 2 subfamily d member 6
6301,biperiden,parkinson disease,cholinergic receptor muscarinic 4
6302,dabrafenib,metastatic melanoma,salt inducible kinase 1
6303,dabrafenib,metastatic melanoma,"fyn proto-oncogene, src family tyrosine kinase"
6304,dabrafenib,metastatic melanoma,cyclin dependent kinase 6
6305,vincristine,rhabdomyosarcoma,tubulin beta 8 class viii
6306,vincristine,rhabdomyosarcoma,tubulin beta 3 class iii
6307,vincristine,rhabdomyosarcoma,tubulin beta 1 class vi
6308,vincristine,rhabdomyosarcoma,tubulin beta 4a class iva
6309,vincristine,rhabdomyosarcoma,tubulin beta 2a class iia
6310,vincristine,rhabdomyosarcoma,tubulin beta 2b class iib
6311,vincristine,rhabdomyosarcoma,tubulin beta 4b class ivb
6312,vincristine,rhabdomyosarcoma,tubulin beta 6 class v
6313,danazol,breast fibrocystic disease,androgen receptor
6314,danazol,breast fibrocystic disease,progesterone receptor
6315,danazol,breast fibrocystic disease,sex hormone binding globulin
6316,danazol,breast fibrocystic disease,gonadotropin releasing hormone receptor
6317,etoposide,non-small cell lung carcinoma,glutathione s-transferase pi 1
6318,etoposide,non-small cell lung carcinoma,cytochrome p450 family 2 subfamily e member 1
6319,etoposide,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6320,vinblastine,non-small cell lung carcinoma,tubulin beta 4a class iva
6321,vinblastine,non-small cell lung carcinoma,tubulin beta 1 class vi
6322,vinblastine,non-small cell lung carcinoma,tubulin beta 8 class viii
6323,vinblastine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6324,vinblastine,non-small cell lung carcinoma,tubulin beta 2b class iib
6325,vinblastine,non-small cell lung carcinoma,tubulin beta 4b class ivb
6326,vinblastine,non-small cell lung carcinoma,tubulin beta class i
6327,vinblastine,non-small cell lung carcinoma,tubulin beta 2a class iia
6328,vinblastine,non-small cell lung carcinoma,tubulin beta 3 class iii
6329,vinblastine,non-small cell lung carcinoma,tubulin beta 6 class v
6330,carboplatin,non-small cell lung carcinoma,glutathione s-transferase pi 1
6331,gemcitabine,non-small cell lung carcinoma,ribonucleotide reductase regulatory subunit m2
6332,gemcitabine,non-small cell lung carcinoma,ribonucleotide reductase catalytic subunit m1
6333,gemcitabine,non-small cell lung carcinoma,"dna polymerase epsilon, catalytic subunit"
6334,gemcitabine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6335,gemcitabine,non-small cell lung carcinoma,"dna polymerase delta 1, catalytic subunit"
6336,gemcitabine,non-small cell lung carcinoma,cytidine/uridine monophosphate kinase 1
6337,gemcitabine,non-small cell lung carcinoma,"dna polymerase alpha 1, catalytic subunit"
6338,gemcitabine,non-small cell lung carcinoma,thymidylate synthetase
6339,ifosfamide,non-small cell lung carcinoma,cytochrome p450 family 2 subfamily a member 6
6340,gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6341,gefitinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6342,gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
6343,gefitinib,non-small cell lung carcinoma,serine/threonine kinase 10
6344,gefitinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6345,gefitinib,non-small cell lung carcinoma,ste20 like kinase
6346,gefitinib,non-small cell lung carcinoma,nuak family kinase 2
6347,gefitinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6348,gefitinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6349,gefitinib,non-small cell lung carcinoma,eph receptor b6
6350,gefitinib,non-small cell lung carcinoma,cyclin g associated kinase
6351,gefitinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6352,gefitinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6353,gefitinib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
6354,gefitinib,non-small cell lung carcinoma,erb-b2 receptor tyrosine kinase 2
6355,docetaxel,non-small cell lung carcinoma,epidermal growth factor receptor
6356,docetaxel,non-small cell lung carcinoma,tubulin beta 6 class v
6357,docetaxel,non-small cell lung carcinoma,tubulin beta 2b class iib
6358,docetaxel,non-small cell lung carcinoma,tubulin beta 2a class iia
6359,docetaxel,non-small cell lung carcinoma,tubulin beta class i
6360,docetaxel,non-small cell lung carcinoma,tubulin beta 3 class iii
6361,docetaxel,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6362,docetaxel,non-small cell lung carcinoma,tubulin beta 4a class iva
6363,docetaxel,non-small cell lung carcinoma,tubulin beta 4b class ivb
6364,docetaxel,non-small cell lung carcinoma,tubulin beta 8 class viii
6365,paclitaxel,non-small cell lung carcinoma,tubulin beta 2b class iib
6366,paclitaxel,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6367,paclitaxel,non-small cell lung carcinoma,tubulin beta 6 class v
6368,paclitaxel,non-small cell lung carcinoma,tubulin beta class i
6369,paclitaxel,non-small cell lung carcinoma,tubulin beta 3 class iii
6370,paclitaxel,non-small cell lung carcinoma,tubulin beta 8 class viii
6371,paclitaxel,non-small cell lung carcinoma,tubulin beta 4a class iva
6372,paclitaxel,non-small cell lung carcinoma,tubulin beta 2a class iia
6373,paclitaxel,non-small cell lung carcinoma,tubulin beta 4b class ivb
6374,pemetrexed,non-small cell lung carcinoma,solute carrier family 46 member 1
6375,irinotecan,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6376,irinotecan,non-small cell lung carcinoma,dna topoisomerase i
6377,ceritinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6378,ceritinib,non-small cell lung carcinoma,protein tyrosine kinase 2
6379,ceritinib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
6380,ceritinib,non-small cell lung carcinoma,cdc like kinase 1
6381,ceritinib,non-small cell lung carcinoma,fer tyrosine kinase
6382,ceritinib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
6383,ceritinib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
6384,ceritinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6385,vinorelbine,non-small cell lung carcinoma,tubulin beta 2b class iib
6386,vinorelbine,non-small cell lung carcinoma,tubulin beta 6 class v
6387,vinorelbine,non-small cell lung carcinoma,tubulin beta 1 class vi
6388,vinorelbine,non-small cell lung carcinoma,tubulin beta 2a class iia
6389,vinorelbine,non-small cell lung carcinoma,tubulin beta 4a class iva
6390,vinorelbine,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6391,vinorelbine,non-small cell lung carcinoma,tubulin beta class i
6392,vinorelbine,non-small cell lung carcinoma,tubulin beta 4b class ivb
6393,vinorelbine,non-small cell lung carcinoma,tubulin beta 8 class viii
6394,vinorelbine,non-small cell lung carcinoma,tubulin beta 3 class iii
6395,mitomycin c,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6396,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6397,nintedanib,non-small cell lung carcinoma,alk receptor tyrosine kinase
6398,nintedanib,non-small cell lung carcinoma,fibroblast growth factor receptor 3
6399,nintedanib,non-small cell lung carcinoma,kinase insert domain receptor
6400,nintedanib,non-small cell lung carcinoma,cdc like kinase 1
6401,nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 3
6402,nintedanib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6403,nintedanib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6404,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 1
6405,nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 1
6406,nintedanib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
6407,nintedanib,non-small cell lung carcinoma,nuak family kinase 2
6408,nintedanib,non-small cell lung carcinoma,insulin receptor related receptor
6409,nintedanib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
6410,nintedanib,non-small cell lung carcinoma,cyclin dependent kinase 16
6411,nintedanib,non-small cell lung carcinoma,eph receptor b6
6412,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 16
6413,nintedanib,non-small cell lung carcinoma,rio kinase 1
6414,nintedanib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
6415,nintedanib,non-small cell lung carcinoma,ste20 like kinase
6416,nintedanib,non-small cell lung carcinoma,platelet derived growth factor receptor beta
6417,nintedanib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
6418,nintedanib,non-small cell lung carcinoma,maternal embryonic leucine zipper kinase
6419,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 2
6420,nintedanib,non-small cell lung carcinoma,cdc like kinase 4
6421,nintedanib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
6422,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 11
6423,nintedanib,non-small cell lung carcinoma,srsf protein kinase 3
6424,nintedanib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
6425,nintedanib,non-small cell lung carcinoma,testis specific serine kinase 1b
6426,nintedanib,non-small cell lung carcinoma,ttk protein kinase
6427,nintedanib,non-small cell lung carcinoma,platelet derived growth factor receptor alpha
6428,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 4
6429,nintedanib,non-small cell lung carcinoma,protein kinase cgmp-dependent 1
6430,nintedanib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
6431,nintedanib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6432,nintedanib,non-small cell lung carcinoma,bmp2 inducible kinase
6433,nintedanib,non-small cell lung carcinoma,ret proto-oncogene
6434,nintedanib,non-small cell lung carcinoma,pre-mrna processing factor kinase prp4k
6435,nintedanib,non-small cell lung carcinoma,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
6436,nintedanib,non-small cell lung carcinoma,protein tyrosine kinase 2
6437,nintedanib,non-small cell lung carcinoma,serine/threonine kinase 10
6438,nintedanib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
6439,nintedanib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6440,nintedanib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6441,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 7
6442,nintedanib,non-small cell lung carcinoma,fibroblast growth factor receptor 1
6443,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6444,nintedanib,non-small cell lung carcinoma,fer tyrosine kinase
6445,nintedanib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
6446,nintedanib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6447,nintedanib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
6448,crizotinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6449,crizotinib,non-small cell lung carcinoma,serine/threonine kinase 4
6450,crizotinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6451,crizotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6452,crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6453,crizotinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6454,crizotinib,non-small cell lung carcinoma,ste20 like kinase
6455,crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 1
6456,crizotinib,non-small cell lung carcinoma,"fes proto-oncogene, tyrosine kinase"
6457,crizotinib,non-small cell lung carcinoma,serine/threonine kinase 10
6458,crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6459,crizotinib,non-small cell lung carcinoma,insulin receptor related receptor
6460,crizotinib,non-small cell lung carcinoma,bmp2 inducible kinase
6461,crizotinib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
6462,crizotinib,non-small cell lung carcinoma,fer tyrosine kinase
6463,crizotinib,non-small cell lung carcinoma,nuak family kinase 2
6464,crizotinib,non-small cell lung carcinoma,eph receptor b6
6465,crizotinib,non-small cell lung carcinoma,protein tyrosine kinase 2 beta
6466,crizotinib,non-small cell lung carcinoma,protein tyrosine kinase 2
6467,crizotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 2
6468,crizotinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6469,crizotinib,non-small cell lung carcinoma,srsf protein kinase 3
6470,crizotinib,non-small cell lung carcinoma,ret proto-oncogene
6471,crizotinib,non-small cell lung carcinoma,fibroblast growth factor receptor 3
6472,crizotinib,non-small cell lung carcinoma,epidermal growth factor receptor
6473,crizotinib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
6474,crizotinib,non-small cell lung carcinoma,rio kinase 1
6475,crizotinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6476,crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 3
6477,crizotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
6478,crizotinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
6479,crizotinib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
6480,crizotinib,non-small cell lung carcinoma,interleukin 1 receptor associated kinase 3
6481,crizotinib,non-small cell lung carcinoma,macrophage stimulating 1 receptor
6482,crizotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 7
6483,lorlatinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6484,lorlatinib,non-small cell lung carcinoma,neurotrophic receptor tyrosine kinase 2
6485,lorlatinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
6486,alectinib,non-small cell lung carcinoma,"ros proto-oncogene 1, receptor tyrosine kinase"
6487,alectinib,non-small cell lung carcinoma,acyl-coa oxidase 1
6488,alectinib,non-small cell lung carcinoma,cyclin g associated kinase
6489,alectinib,non-small cell lung carcinoma,fer tyrosine kinase
6490,alectinib,non-small cell lung carcinoma,cdc like kinase 1
6491,erlotinib,non-small cell lung carcinoma,tyrosine kinase non receptor 1
6492,erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 19
6493,erlotinib,non-small cell lung carcinoma,serine/threonine kinase 10
6494,erlotinib,non-small cell lung carcinoma,ste20 like kinase
6495,erlotinib,non-small cell lung carcinoma,solute carrier organic anion transporter family member 2b1
6496,erlotinib,non-small cell lung carcinoma,atp binding cassette subfamily b member 1
6497,erlotinib,non-small cell lung carcinoma,leukocyte receptor tyrosine kinase
6498,erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase 5
6499,erlotinib,non-small cell lung carcinoma,alk receptor tyrosine kinase
6500,erlotinib,non-small cell lung carcinoma,g protein-coupled receptor kinase 4
6501,erlotinib,non-small cell lung carcinoma,discoidin domain receptor tyrosine kinase 1
6502,erlotinib,non-small cell lung carcinoma,platelet derived growth factor receptor beta
6503,erlotinib,non-small cell lung carcinoma,ttk protein kinase
6504,erlotinib,non-small cell lung carcinoma,cyclin g associated kinase
6505,erlotinib,non-small cell lung carcinoma,mitogen-activated protein kinase kinase kinase 2
6506,erlotinib,non-small cell lung carcinoma,erb-b2 receptor tyrosine kinase 2
6507,erlotinib,non-small cell lung carcinoma,fibroblast growth factor receptor 2
6508,erlotinib,non-small cell lung carcinoma,axl receptor tyrosine kinase
6509,erlotinib,non-small cell lung carcinoma,ret proto-oncogene
6510,erlotinib,non-small cell lung carcinoma,eph receptor b6
6511,erlotinib,non-small cell lung carcinoma,platelet derived growth factor receptor alpha
6512,erlotinib,non-small cell lung carcinoma,bmp2 inducible kinase
6513,erlotinib,non-small cell lung carcinoma,"mer proto-oncogene, tyrosine kinase"
6514,erlotinib,non-small cell lung carcinoma,srsf protein kinase 3
6515,erlotinib,non-small cell lung carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
6516,erlotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 4
6517,erlotinib,non-small cell lung carcinoma,"met proto-oncogene, receptor tyrosine kinase"
6518,erlotinib,non-small cell lung carcinoma,fms related receptor tyrosine kinase 1
6519,erlotinib,non-small cell lung carcinoma,kinase insert domain receptor
6520,cefmetazole,pneumonia,albumin
6521,minocycline,pneumonia,caspase 1
6522,minocycline,pneumonia,interleukin 1 beta
6523,cefalotin,pneumonia,albumin
6524,tetracycline,pneumonia,albumin
6525,ofloxacin,pneumonia,albumin
6526,cefonicid,pneumonia,albumin
6527,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1d
6528,aripiprazole,autism spectrum disorder,dopamine receptor d3
6529,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1a
6530,aripiprazole,autism spectrum disorder,dopamine receptor d1
6531,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 3a
6532,aripiprazole,autism spectrum disorder,cholinergic receptor muscarinic 4
6533,aripiprazole,autism spectrum disorder,solute carrier family 6 member 4
6534,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 1b
6535,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 2a
6536,aripiprazole,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
6537,aripiprazole,autism spectrum disorder,dopamine receptor d2
6538,aripiprazole,autism spectrum disorder,adrenoceptor beta 2
6539,aripiprazole,autism spectrum disorder,5-hydroxytryptamine receptor 5a
6540,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1b
6541,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1d
6542,risperidone,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
6543,risperidone,autism spectrum disorder,dopamine receptor d1
6544,risperidone,autism spectrum disorder,dopamine receptor d3
6545,risperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1a
6546,risperidone,autism spectrum disorder,solute carrier family 6 member 4
6547,risperidone,autism spectrum disorder,cholinergic receptor muscarinic 4
6548,risperidone,autism spectrum disorder,neutrophil cytosolic factor 1
6549,risperidone,autism spectrum disorder,adrenoceptor beta 2
6550,paliperidone,autism spectrum disorder,dopamine receptor d2
6551,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1d
6552,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1a
6553,paliperidone,autism spectrum disorder,dopamine receptor d3
6554,paliperidone,autism spectrum disorder,dopamine receptor d1
6555,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 2a
6556,paliperidone,autism spectrum disorder,cytochrome p450 family 2 subfamily d member 6
6557,paliperidone,autism spectrum disorder,5-hydroxytryptamine receptor 1b
6558,paliperidone,autism spectrum disorder,adrenoceptor beta 2
6559,triamcinolone,inflammatory bowel disease,prostaglandin-endoperoxide synthase 2
6560,triamcinolone,inflammatory bowel disease,serpin family a member 6
6561,betamethasone,inflammatory bowel disease,prostaglandin-endoperoxide synthase 2
6562,betamethasone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6563,cortisol,inflammatory bowel disease,atp binding cassette subfamily b member 1
6564,cortisol,inflammatory bowel disease,sex hormone binding globulin
6565,cortisol,inflammatory bowel disease,serpin family a member 6
6566,prednisone,inflammatory bowel disease,nuclear receptor subfamily 3 group c member 1
6567,prednisone,inflammatory bowel disease,albumin
6568,prednisone,inflammatory bowel disease,hydroxysteroid 11-beta dehydrogenase 1
6569,prednisone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6570,methylprednisolone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6571,cromoglicic acid,inflammatory bowel disease,g protein-coupled receptor 35
6572,prednisolone,inflammatory bowel disease,atp binding cassette subfamily b member 1
6573,prednisolone,inflammatory bowel disease,serpin family a member 6
6574,theophylline,lung disorder,adenosine a2a receptor
6575,theophylline,lung disorder,adenosine a2b receptor
6576,theophylline,lung disorder,phosphodiesterase 4a
6577,theophylline,lung disorder,histone deacetylase 2
6578,theophylline,lung disorder,phosphodiesterase 3a
6579,theophylline,lung disorder,adenosine a1 receptor
6580,theophylline,lung disorder,adenosine a3 receptor
6581,phenazone,migraine disorder,prostaglandin-endoperoxide synthase 1
6582,phenazone,migraine disorder,prostaglandin-endoperoxide synthase 2
6583,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha6
6584,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha2
6585,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha1
6586,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha4
6587,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit gamma2
6588,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha3
6589,butalbital,migraine disorder,gamma-aminobutyric acid type a receptor subunit alpha5
6590,naratriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6591,caffeine,migraine disorder,phosphodiesterase 4b
6592,caffeine,migraine disorder,adenosine a1 receptor
6593,caffeine,migraine disorder,atm serine/threonine kinase
6594,diphenhydramine,migraine disorder,prostaglandin-endoperoxide synthase 1
6595,diphenhydramine,migraine disorder,solute carrier family 6 member 4
6596,lisuride,migraine disorder,adrenoceptor alpha 2c
6597,lisuride,migraine disorder,5-hydroxytryptamine receptor 1a
6598,lisuride,migraine disorder,5-hydroxytryptamine receptor 2b
6599,lisuride,migraine disorder,5-hydroxytryptamine receptor 2c
6600,lisuride,migraine disorder,5-hydroxytryptamine receptor 1d
6601,lisuride,migraine disorder,5-hydroxytryptamine receptor 2a
6602,lisuride,migraine disorder,dopamine receptor d4
6603,lisuride,migraine disorder,5-hydroxytryptamine receptor 1b
6604,lisuride,migraine disorder,adrenoceptor alpha 1b
6605,lisuride,migraine disorder,dopamine receptor d5
6606,lisuride,migraine disorder,adrenoceptor alpha 2b
6607,lisuride,migraine disorder,adrenoceptor alpha 2a
6608,lisuride,migraine disorder,adrenoceptor alpha 1d
6609,zolmitriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6610,paracetamol,migraine disorder,transient receptor potential cation channel subfamily v member 1
6611,paracetamol,migraine disorder,cannabinoid receptor 1
6612,rofecoxib,migraine disorder,prostaglandin-endoperoxide synthase 1
6613,aspirin,migraine disorder,endothelin receptor type a
6614,aspirin,migraine disorder,tumor protein p53
6615,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1e
6616,eletriptan,migraine disorder,5-hydroxytryptamine receptor 2b
6617,eletriptan,migraine disorder,5-hydroxytryptamine receptor 1f
6618,eletriptan,migraine disorder,prostaglandin-endoperoxide synthase 1
6619,eletriptan,migraine disorder,5-hydroxytryptamine receptor 7
6620,ergotamine,migraine disorder,5-hydroxytryptamine receptor 2c
6621,ergotamine,migraine disorder,5-hydroxytryptamine receptor 2a
6622,ergotamine,migraine disorder,5-hydroxytryptamine receptor 2b
6623,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1e
6624,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1b
6625,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1f
6626,ergotamine,migraine disorder,5-hydroxytryptamine receptor 1a
6627,ergotamine,migraine disorder,5-hydroxytryptamine receptor 5a
6628,rizatriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6629,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 1a
6630,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 6
6631,dihydroergotamine,migraine disorder,adrenoceptor alpha 2a
6632,dihydroergotamine,migraine disorder,5-hydroxytryptamine receptor 2b
6633,naproxen,migraine disorder,aldo-keto reductase family 1 member c3
6634,olanzapine,migraine disorder,5-hydroxytryptamine receptor 3a
6635,olanzapine,migraine disorder,adrenoceptor alpha 1b
6636,olanzapine,migraine disorder,5-hydroxytryptamine receptor 6
6637,olanzapine,migraine disorder,5-hydroxytryptamine receptor 7
6638,olanzapine,migraine disorder,dopamine receptor d4
6639,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1b
6640,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1a
6641,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1e
6642,olanzapine,migraine disorder,5-hydroxytryptamine receptor 2b
6643,olanzapine,migraine disorder,adrenoceptor alpha 2b
6644,olanzapine,migraine disorder,adrenoceptor alpha 2c
6645,olanzapine,migraine disorder,5-hydroxytryptamine receptor 2a
6646,olanzapine,migraine disorder,5-hydroxytryptamine receptor 5a
6647,olanzapine,migraine disorder,5-hydroxytryptamine receptor 2c
6648,olanzapine,migraine disorder,dopamine receptor d5
6649,olanzapine,migraine disorder,adrenoceptor alpha 1a
6650,olanzapine,migraine disorder,5-hydroxytryptamine receptor 1d
6651,olanzapine,migraine disorder,adrenoceptor alpha 2a
6652,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1f
6653,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 3a
6654,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1a
6655,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 2c
6656,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 2a
6657,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 7
6658,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 1e
6659,sumatriptan,migraine disorder,5-hydroxytryptamine receptor 6
6660,prochlorperazine,migraine disorder,5-hydroxytryptamine receptor 2c
6661,prochlorperazine,migraine disorder,adrenoceptor alpha 1a
6662,prochlorperazine,migraine disorder,5-hydroxytryptamine receptor 1a
6663,prochlorperazine,migraine disorder,adrenoceptor alpha 2a
6664,prochlorperazine,migraine disorder,dopamine receptor d4
6665,dabigatran etexilate,pulmonary embolism,"coagulation factor ii, thrombin"
6666,rivaroxaban,pulmonary embolism,coagulation factor x
6667,phentolamine,peripheral vascular disease,adrenoceptor alpha 2a
6668,phentolamine,peripheral vascular disease,adrenoceptor alpha 2c
6669,phentolamine,peripheral vascular disease,adrenoceptor alpha 2b
6670,papaverine,peripheral vascular disease,phosphodiesterase 3b
6671,papaverine,peripheral vascular disease,phosphodiesterase 3a
6672,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 2
6673,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 3
6674,lidocaine,urethritis,sodium voltage-gated channel alpha subunit 4
6675,ergocalciferol,osteoporosis,cytochrome p450 family 24 subfamily a member 1
6676,ergocalciferol,osteoporosis,cytochrome p450 family 27 subfamily a member 1
6677,ergocalciferol,osteoporosis,vitamin d receptor
6678,benzocaine,osteoporosis,sodium voltage-gated channel alpha subunit 4
6679,zoledronic acid,osteoporosis,carbonic anhydrase 2
6680,dapagliflozin,chronic kidney disease,solute carrier family 5 member 4
6681,dapagliflozin,chronic kidney disease,cytochrome p450 family 1 subfamily a member 1
6682,dapagliflozin,chronic kidney disease,solute carrier family 5 member 11
6683,dapagliflozin,chronic kidney disease,solute carrier family 5 member 2
6684,dapagliflozin,chronic kidney disease,cytochrome p450 family 3 subfamily a member 4
6685,dapagliflozin,chronic kidney disease,atp binding cassette subfamily b member 1
6686,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 5
6687,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 3
6688,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 3
6689,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 3
6690,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 4
6691,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 3
6692,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 5
6693,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 4
6694,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 2
6695,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily v member 2
6696,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily b member 1
6697,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 2
6698,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 1
6699,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 2
6700,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 2
6701,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 6
6702,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 4
6703,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 4
6704,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 1
6705,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 7
6706,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 8
6707,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 6
6708,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 1
6709,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 5
6710,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily q member 2
6711,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily b member 2
6712,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 4
6713,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily f member 1
6714,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily d member 1
6715,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily v member 1
6716,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 10
6717,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily c member 3
6718,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 1
6719,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 3
6720,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 7
6721,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily h member 1
6722,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily g member 2
6723,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 3
6724,fampridine,multiple sclerosis,potassium voltage-gated channel modifier subfamily s member 1
6725,fampridine,multiple sclerosis,potassium voltage-gated channel subfamily a member 2
6726,prednisolone,multiple sclerosis,serpin family a member 6
6727,triamcinolone,multiple sclerosis,butyrylcholinesterase
6728,triamcinolone,multiple sclerosis,serpin family a member 6
6729,prednisone,multiple sclerosis,nuclear receptor subfamily 3 group c member 1
6730,prednisone,multiple sclerosis,albumin
6731,betamethasone,multiple sclerosis,progesterone receptor
6732,cortisol,multiple sclerosis,sex hormone binding globulin
6733,cortisol,multiple sclerosis,serpin family a member 6
6734,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6735,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6736,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6737,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6738,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6739,nortriptyline,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6740,clonidine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6741,carbamazepine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6742,desipramine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6743,desipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6744,desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6745,desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6746,desipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6747,desipramine,"attention deficit hyperactivity disorder, inattentive type",sphingomyelin phosphodiesterase 1
6748,desipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d1
6749,desipramine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6750,dexmethylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6751,guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6752,guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
6753,guanfacine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
6754,amphetamine,"attention deficit hyperactivity disorder, inattentive type",monoamine oxidase b
6755,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6756,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6757,amphetamine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6758,amphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6759,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6760,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 1b
6761,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6762,atomoxetine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6763,dexamfetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
6764,methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6765,methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6766,methylphenidate,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6767,imipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d2
6768,imipramine,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2a
6769,imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6770,imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6771,imipramine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6772,imipramine,"attention deficit hyperactivity disorder, inattentive type",potassium voltage-gated channel subfamily d member 2
6773,imipramine,"attention deficit hyperactivity disorder, inattentive type",dopamine receptor d3
6774,imipramine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6775,bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 2
6776,bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 3
6777,bupropion,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6778,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2a
6779,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",trace amine associated receptor 1
6780,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 18 member a2
6781,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2c
6782,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",adrenoceptor alpha 2b
6783,methamphetamine,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 6 member 4
6784,diclofenac,ankylosing spondylitis,c-x-c motif chemokine receptor 1
6785,diclofenac,ankylosing spondylitis,c-x-c motif chemokine ligand 8
6786,ketoprofen,ankylosing spondylitis,c-x-c motif chemokine ligand 8
6787,ketoprofen,ankylosing spondylitis,c-x-c motif chemokine receptor 1
6788,ketoprofen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6789,ketoprofen,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6790,cortisol,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
6791,cortisol,ankylosing spondylitis,sex hormone binding globulin
6792,cortisol,ankylosing spondylitis,serpin family a member 6
6793,meloxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6794,meloxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6795,prednisolone,ankylosing spondylitis,serpin family a member 6
6796,nabumetone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6797,nabumetone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6798,celecoxib,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6799,etodolac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6800,etodolac,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6801,triamcinolone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6802,triamcinolone,ankylosing spondylitis,serpin family a member 6
6803,oxaprozin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6804,oxaprozin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6805,indomethacin,ankylosing spondylitis,c-x-c motif chemokine ligand 8
6806,indomethacin,ankylosing spondylitis,aldo-keto reductase family 1 member c3
6807,tolmetin,ankylosing spondylitis,c-x-c motif chemokine ligand 8
6808,tolmetin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6809,tolmetin,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6810,prednisone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
6811,naproxen,ankylosing spondylitis,aldo-keto reductase family 1 member c3
6812,meclofenamic acid,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6813,meclofenamic acid,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6814,meclofenamic acid,ankylosing spondylitis,aldo-keto reductase family 1 member c3
6815,betamethasone,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6816,betamethasone,ankylosing spondylitis,nuclear receptor subfamily 3 group c member 1
6817,piroxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 1
6818,piroxicam,ankylosing spondylitis,prostaglandin-endoperoxide synthase 2
6819,cladribine,relapsing-remitting multiple sclerosis,ribonucleotide reductase catalytic subunit m1
6820,mitoxantrone,relapsing-remitting multiple sclerosis,solute carrier family 47 member 2
6821,mitoxantrone,relapsing-remitting multiple sclerosis,solute carrier family 47 member 1
6822,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 3
6823,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 5
6824,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 1
6825,fingolimod,relapsing-remitting multiple sclerosis,sphingosine-1-phosphate receptor 4
6826,azelastine,seasonal allergic rhinitis,adrenoceptor alpha 1b
6827,azelastine,seasonal allergic rhinitis,adrenoceptor alpha 1a
6828,pseudoephedrine,seasonal allergic rhinitis,adrenoceptor alpha 2a
6829,methylprednisolone,seasonal allergic rhinitis,nuclear receptor subfamily 3 group c member 1
6830,promethazine,seasonal allergic rhinitis,adrenoceptor alpha 1a
6831,phenylephrine,seasonal allergic rhinitis,adrenoceptor alpha 2a
6832,triamcinolone,eye disorder,serpin family a member 6
6833,cortisol,eye disorder,nuclear receptor subfamily 3 group c member 1
6834,cortisol,eye disorder,sex hormone binding globulin
6835,cortisol,eye disorder,serpin family a member 6
6836,prednisolone,eye disorder,serpin family a member 6
6837,bimatoprost,open-angle glaucoma,prostaglandin f receptor
6838,pilocarpine,open-angle glaucoma,cholinergic receptor muscarinic 3
6839,betaxolol,open-angle glaucoma,adrenoceptor beta 2
6840,brinzolamide,open-angle glaucoma,carbonic anhydrase 12
6841,brinzolamide,open-angle glaucoma,carbonic anhydrase 14
6842,brinzolamide,open-angle glaucoma,carbonic anhydrase 7
6843,brinzolamide,open-angle glaucoma,carbonic anhydrase 1
6844,brinzolamide,open-angle glaucoma,carbonic anhydrase 4
6845,brinzolamide,open-angle glaucoma,carbonic anhydrase 3
6846,physostigmine,open-angle glaucoma,butyrylcholinesterase
6847,diclofenamide,open-angle glaucoma,carbonic anhydrase 14
6848,diclofenamide,open-angle glaucoma,carbonic anhydrase 3
6849,dipivefrine,open-angle glaucoma,adrenoceptor alpha 1a
6850,dipivefrine,open-angle glaucoma,adrenoceptor alpha 2a
6851,dipivefrine,open-angle glaucoma,adrenoceptor beta 2
6852,dipivefrine,open-angle glaucoma,adrenoceptor alpha 2b
6853,dipivefrine,open-angle glaucoma,butyrylcholinesterase
6854,dipivefrine,open-angle glaucoma,adrenoceptor alpha 2c
6855,dorzolamide,open-angle glaucoma,carbonic anhydrase 7
6856,dorzolamide,open-angle glaucoma,carbonic anhydrase 12
6857,dorzolamide,open-angle glaucoma,carbonic anhydrase 14
6858,dorzolamide,open-angle glaucoma,carbonic anhydrase 4
6859,dorzolamide,open-angle glaucoma,carbonic anhydrase 1
6860,dorzolamide,open-angle glaucoma,carbonic anhydrase 3
6861,apraclonidine,open-angle glaucoma,adrenoceptor alpha 2c
6862,apraclonidine,open-angle glaucoma,adrenoceptor alpha 2b
6863,apraclonidine,open-angle glaucoma,adrenoceptor alpha 1a
6864,clonidine,open-angle glaucoma,adrenoceptor alpha 1d
6865,clonidine,open-angle glaucoma,adrenoceptor alpha 1b
6866,clonidine,open-angle glaucoma,adrenoceptor alpha 1a
6867,paclitaxel,open-angle glaucoma,tubulin beta 2b class iib
6868,paclitaxel,open-angle glaucoma,tubulin beta 1 class vi
6869,paclitaxel,open-angle glaucoma,tubulin beta 6 class v
6870,paclitaxel,open-angle glaucoma,tubulin beta class i
6871,paclitaxel,open-angle glaucoma,tubulin beta 3 class iii
6872,paclitaxel,open-angle glaucoma,tubulin beta 8 class viii
6873,paclitaxel,open-angle glaucoma,cytochrome p450 family 1 subfamily b member 1
6874,paclitaxel,open-angle glaucoma,tubulin beta 4a class iva
6875,paclitaxel,open-angle glaucoma,tubulin beta 2a class iia
6876,paclitaxel,open-angle glaucoma,tubulin beta 4b class ivb
6877,timolol,open-angle glaucoma,adrenoceptor beta 1
6878,timolol,open-angle glaucoma,adrenoceptor beta 2
6879,acetazolamide,open-angle glaucoma,carbonic anhydrase 11
6880,vismodegib,skin basal cell carcinoma,"smoothened, frizzled class receptor"
6881,vismodegib,skin basal cell carcinoma,sonic hedgehog signaling molecule
6882,sonidegib,skin basal cell carcinoma,"smoothened, frizzled class receptor"
6883,fenofibrate,hypertriglyceridemia,peroxisome proliferator activated receptor alpha
6884,simvastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
6885,epa,hypertriglyceridemia,peroxisome proliferator activated receptor gamma
6886,nicotinic acid,hypertriglyceridemia,hydroxycarboxylic acid receptor 2
6887,nicotinic acid,hypertriglyceridemia,hydroxycarboxylic acid receptor 3
6888,lovastatin,hypertriglyceridemia,3-hydroxy-3-methylglutaryl-coa reductase
6889,budesonide,eosinophilic esophagitis,nuclear receptor subfamily 3 group c member 1
6890,tadalafil,erectile dysfunction,phosphodiesterase 11a
6891,vardenafil,erectile dysfunction,phosphodiesterase 11a
6892,pge1,erectile dysfunction,prostaglandin e receptor 1
6893,carbimazole,graves disease,thyroid peroxidase
6894,clomiphene,male infertility,cytochrome p450 family 19 subfamily a member 1
6895,clomiphene,male infertility,estrogen receptor 1
6896,clomiphene,male infertility,cytochrome p450 family 1 subfamily a member 1
6897,prednisolone,nephrotic syndrome,serpin family a member 6
6898,triamcinolone,nephrotic syndrome,serpin family a member 6
6899,cortisol,nephrotic syndrome,sex hormone binding globulin
6900,cortisol,nephrotic syndrome,serpin family a member 6
6901,prednisone,nephrotic syndrome,nuclear receptor subfamily 3 group c member 1
6902,prednisone,nephrotic syndrome,albumin
6903,alendronate,bone paget disease,farnesyl diphosphate synthase
6904,alendronate,bone paget disease,atpase h+ transporting v1 subunit a
6905,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
6906,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
6907,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
6908,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
6909,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
6910,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
6911,chlordiazepoxide,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
6912,escitalopram,panic disorder,solute carrier family 6 member 4
6913,escitalopram,panic disorder,solute carrier family 6 member 2
6914,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
6915,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
6916,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
6917,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
6918,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
6919,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
6920,alprazolam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
6921,venlafaxine,panic disorder,adrenoceptor alpha 2a
6922,venlafaxine,panic disorder,5-hydroxytryptamine receptor 2a
6923,paroxetine,panic disorder,5-hydroxytryptamine receptor 2a
6924,paroxetine,panic disorder,solute carrier family 6 member 2
6925,paroxetine,panic disorder,5-hydroxytryptamine receptor 1a
6926,paroxetine,panic disorder,adrenoceptor alpha 2a
6927,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta3
6928,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
6929,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
6930,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
6931,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha5
6932,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
6933,diazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
6934,desvenlafaxine,panic disorder,solute carrier family 6 member 2
6935,desvenlafaxine,panic disorder,solute carrier family 6 member 4
6936,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha1
6937,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit beta2
6938,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha3
6939,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit gamma2
6940,clonazepam,panic disorder,gamma-aminobutyric acid type a receptor subunit alpha2
6941,clomipramine,panic disorder,adrenoceptor alpha 2a
6942,clomipramine,panic disorder,5-hydroxytryptamine receptor 2a
6943,clomipramine,panic disorder,solute carrier family 6 member 2
6944,clomipramine,panic disorder,solute carrier family 6 member 4
6945,desipramine,panic disorder,5-hydroxytryptamine receptor 1a
6946,desipramine,panic disorder,5-hydroxytryptamine receptor 2a
6947,desipramine,panic disorder,solute carrier family 6 member 4
6948,desipramine,panic disorder,solute carrier family 6 member 2
6949,desipramine,panic disorder,adrenoceptor alpha 2a
6950,citalopram,panic disorder,solute carrier family 6 member 2
6951,citalopram,panic disorder,solute carrier family 6 member 4
6952,sertraline,panic disorder,solute carrier family 6 member 2
6953,sertraline,panic disorder,monoamine oxidase a
6954,fluoxetine,panic disorder,5-hydroxytryptamine receptor 2a
6955,fluoxetine,panic disorder,solute carrier family 6 member 2
6956,fluoxetine,panic disorder,adrenoceptor alpha 2a
6957,imipramine,panic disorder,5-hydroxytryptamine receptor 2a
6958,imipramine,panic disorder,solute carrier family 6 member 2
6959,imipramine,panic disorder,solute carrier family 6 member 4
6960,imipramine,panic disorder,5-hydroxytryptamine receptor 1a
6961,imipramine,panic disorder,5-hydroxytryptamine receptor 7
6962,imipramine,panic disorder,adrenoceptor alpha 2a
6963,oxcarbazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 5
6964,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 3
6965,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 1
6966,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 5
6967,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 2
6968,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 8
6969,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 4
6970,phenytoin,focal epilepsy,sodium voltage-gated channel alpha subunit 9
6971,carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 4
6972,carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 5
6973,carbamazepine,focal epilepsy,sodium voltage-gated channel alpha subunit 9
6974,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha1
6975,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit beta2
6976,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha4
6977,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
6978,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha6
6979,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha5
6980,primidone,focal epilepsy,glutamate ionotropic receptor ampa type subunit 2
6981,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit alpha2
6982,primidone,focal epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
6983,ropinirole,restless legs syndrome,dopamine receptor d1
6984,ropinirole,restless legs syndrome,dopamine receptor d4
6985,ropinirole,restless legs syndrome,dopamine receptor d2
6986,ropinirole,restless legs syndrome,dopamine receptor d3
6987,ropinirole,restless legs syndrome,dopamine receptor d5
6988,pramipexole,restless legs syndrome,dopamine receptor d5
6989,pramipexole,restless legs syndrome,dopamine receptor d1
6990,levodopa,restless legs syndrome,dopamine receptor d2
6991,levodopa,restless legs syndrome,dopamine receptor d5
6992,levodopa,restless legs syndrome,dopamine receptor d1
6993,levodopa,restless legs syndrome,dopamine receptor d4
6994,levodopa,restless legs syndrome,dopamine receptor d3
6995,gabapentin,restless legs syndrome,calcium voltage-gated channel auxiliary subunit alpha2delta 2
6996,indomethacin,gout,solute carrier family 22 member 11
6997,indomethacin,gout,c-x-c motif chemokine ligand 8
6998,indomethacin,gout,solute carrier family 22 member 6
6999,indomethacin,gout,aldo-keto reductase family 1 member c3
7000,indomethacin,gout,solute carrier family 22 member 8
7001,phenylbutazone,gout,prostaglandin-endoperoxide synthase 2
7002,phenylbutazone,gout,solute carrier family 22 member 8
7003,phenylbutazone,gout,solute carrier family 22 member 6
7004,phenylbutazone,gout,solute carrier family 22 member 11
7005,phenylbutazone,gout,prostaglandin-endoperoxide synthase 1
7006,triamcinolone,gout,prostaglandin-endoperoxide synthase 2
7007,triamcinolone,gout,serpin family a member 6
7008,sulindac,gout,solute carrier family 22 member 6
7009,ketoprofen,gout,c-x-c motif chemokine ligand 8
7010,ketoprofen,gout,solute carrier family 22 member 8
7011,ketoprofen,gout,solute carrier family 22 member 6
7012,ketoprofen,gout,solute carrier family 22 member 11
7013,ketoprofen,gout,prostaglandin-endoperoxide synthase 2
7014,ketoprofen,gout,prostaglandin-endoperoxide synthase 1
7015,prednisone,gout,nuclear receptor subfamily 3 group c member 1
7016,naproxen,gout,aldo-keto reductase family 1 member c3
7017,naproxen,gout,solute carrier family 22 member 6
7018,prednisolone,gout,serpin family a member 6
7019,allopurinol,gout,solute carrier family 22 member 8
7020,probenecid,gout,solute carrier family 2 member 9
7021,probenecid,gout,solute carrier family 22 member 12
7022,cortisol,gout,nuclear receptor subfamily 3 group c member 1
7023,cortisol,gout,sex hormone binding globulin
7024,cortisol,gout,serpin family a member 6
7025,betamethasone,gout,prostaglandin-endoperoxide synthase 2
7026,betamethasone,gout,nuclear receptor subfamily 3 group c member 1
7027,etodolac,gout,prostaglandin-endoperoxide synthase 1
7028,etodolac,gout,solute carrier family 22 member 6
7029,etodolac,gout,prostaglandin-endoperoxide synthase 2
7030,cimetidine,duodenal ulcer,solute carrier family 47 member 1
7031,famotidine,duodenal ulcer,solute carrier family 47 member 1
7032,esomeprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7033,rabeprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7034,pantoprazole,duodenal ulcer,atpase h+/k+ transporting subunit alpha
7035,pantoprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7036,lansoprazole,duodenal ulcer,atpase h+/k+ transporting subunit beta
7037,gemcitabine,testicular cancer,atp binding cassette subfamily b member 1
7038,vinblastine,testicular cancer,tubulin beta 4a class iva
7039,vinblastine,testicular cancer,tubulin beta 1 class vi
7040,vinblastine,testicular cancer,tubulin beta 8 class viii
7041,vinblastine,testicular cancer,atp binding cassette subfamily b member 1
7042,vinblastine,testicular cancer,tubulin beta 2b class iib
7043,vinblastine,testicular cancer,tubulin beta 4b class ivb
7044,vinblastine,testicular cancer,tubulin beta 2a class iia
7045,vinblastine,testicular cancer,tubulin beta 3 class iii
7046,vinblastine,testicular cancer,tubulin beta 6 class v
7047,paclitaxel,testicular cancer,tubulin beta 2b class iib
7048,paclitaxel,testicular cancer,atp binding cassette subfamily b member 1
7049,paclitaxel,testicular cancer,tubulin beta 1 class vi
7050,paclitaxel,testicular cancer,tubulin beta 6 class v
7051,paclitaxel,testicular cancer,tubulin beta class i
7052,paclitaxel,testicular cancer,tubulin beta 3 class iii
7053,paclitaxel,testicular cancer,tubulin beta 8 class viii
7054,paclitaxel,testicular cancer,tubulin beta 4a class iva
7055,paclitaxel,testicular cancer,tubulin beta 2a class iia
7056,paclitaxel,testicular cancer,tubulin beta 4b class ivb
7057,etoposide,testicular cancer,atp binding cassette subfamily b member 1
7058,amitriptyline,bulimia nervosa,solute carrier family 6 member 4
7059,imipramine,bulimia nervosa,solute carrier family 6 member 4
7060,desipramine,bulimia nervosa,solute carrier family 6 member 4
7061,pentamidine,human african trypanosomiasis,amine oxidase copper containing 1
7062,pentamidine,human african trypanosomiasis,s100 calcium binding protein b
7063,suramin,human african trypanosomiasis,sirtuin 1
7064,dopamine,hypotensive disorder,dopamine receptor d2
7065,dopamine,hypotensive disorder,solute carrier family 6 member 2
7066,dopamine,hypotensive disorder,monoamine oxidase b
7067,dopamine,hypotensive disorder,dopamine receptor d1
7068,dopamine,hypotensive disorder,monoamine oxidase a
7069,dopamine,hypotensive disorder,adrenoceptor beta 1
7070,dopamine,hypotensive disorder,adrenoceptor alpha 1a
7071,phenylephrine,hypotensive disorder,adrenoceptor alpha 1a
7072,phenylephrine,hypotensive disorder,monoamine oxidase a
7073,phenylephrine,hypotensive disorder,adrenoceptor alpha 1b
7074,phenylephrine,hypotensive disorder,adrenoceptor alpha 1d
7075,phenylephrine,hypotensive disorder,adrenoceptor alpha 2a
7076,phentermine,hypotensive disorder,monoamine oxidase a
7077,phentermine,hypotensive disorder,monoamine oxidase b
7078,methoxamine,hypotensive disorder,adrenoceptor alpha 1d
7079,midodrine,orthostatic hypotension,adrenoceptor alpha 1a
7080,droxidopa,orthostatic hypotension,adrenoceptor alpha 1a
7081,magnesium sulfate,torsades de pointes,calcium voltage-gated channel subunit alpha1 c
7082,fluocinolone acetonide,contact dermatitis,serpin family a member 6
7083,clobetasol propionate,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7084,clobetasol propionate,contact dermatitis,cytochrome p450 family 1 subfamily a member 1
7085,flumethasone pivalate,contact dermatitis,serpin family a member 6
7086,mometasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7087,triamcinolone,contact dermatitis,serpin family a member 6
7088,alclometasone dipropionate,contact dermatitis,serpin family a member 6
7089,prednisolone,contact dermatitis,serpin family a member 6
7090,cortisol,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7091,cortisol,contact dermatitis,sex hormone binding globulin
7092,cortisol,contact dermatitis,serpin family a member 6
7093,betamethasone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7094,fluticasone,contact dermatitis,serpin family a member 6
7095,methylprednisolone,contact dermatitis,glucose-6-phosphate dehydrogenase
7096,prednisone,contact dermatitis,nuclear receptor subfamily 3 group c member 1
7097,acetophenazine,psychotic disorder,dopamine receptor d1
7098,triflupromazine,psychotic disorder,atp binding cassette subfamily b member 1
7099,promazine,psychotic disorder,dopamine receptor d4
7100,promazine,psychotic disorder,5-hydroxytryptamine receptor 2a
7101,promazine,psychotic disorder,dopamine receptor d2
7102,promazine,psychotic disorder,cholinergic receptor muscarinic 1
7103,promazine,psychotic disorder,dopamine receptor d1
7104,promazine,psychotic disorder,cholinergic receptor muscarinic 2
7105,fluphenazine,psychotic disorder,atp binding cassette subfamily b member 1
7106,fluphenazine,psychotic disorder,dopamine receptor d1
7107,fluphenazine,psychotic disorder,5-hydroxytryptamine receptor 2a
7108,fluphenazine,psychotic disorder,cholinergic receptor muscarinic 2
7109,fluphenazine,psychotic disorder,dopamine receptor d4
7110,fluphenazine,psychotic disorder,dopamine receptor d5
7111,paliperidone,psychotic disorder,dopamine receptor d2
7112,paliperidone,psychotic disorder,dopamine receptor d1
7113,paliperidone,psychotic disorder,5-hydroxytryptamine receptor 2a
7114,paliperidone,psychotic disorder,dopamine receptor d4
7115,paliperidone,psychotic disorder,5-hydroxytryptamine receptor 1b
7116,paliperidone,psychotic disorder,cholinergic receptor muscarinic 2
7117,chlorpromazine,psychotic disorder,dopamine receptor d5
7118,chlorpromazine,psychotic disorder,5-hydroxytryptamine receptor 2a
7119,chlorpromazine,psychotic disorder,cholinergic receptor muscarinic 1
7120,chlorpromazine,psychotic disorder,dopamine receptor d4
7121,chlorpromazine,psychotic disorder,dopamine receptor d1
7122,chlorpromazine,psychotic disorder,atp binding cassette subfamily b member 1
7123,chlorpromazine,psychotic disorder,5-hydroxytryptamine receptor 2b
7124,chlorpromazine,psychotic disorder,cholinergic receptor muscarinic 2
7125,chlorpromazine,psychotic disorder,potassium voltage-gated channel subfamily h member 2
7126,reserpine,psychotic disorder,atp binding cassette subfamily b member 1
7127,reserpine,psychotic disorder,solute carrier family 18 member a1
7128,reserpine,psychotic disorder,dopamine receptor d2
7129,reserpine,psychotic disorder,dopamine receptor d1
7130,haloperidol,psychotic disorder,atp binding cassette subfamily b member 1
7131,haloperidol,psychotic disorder,5-hydroxytryptamine receptor 2a
7132,haloperidol,psychotic disorder,5-hydroxytryptamine receptor 1b
7133,haloperidol,psychotic disorder,dopamine receptor d4
7134,haloperidol,psychotic disorder,dopamine receptor d1
7135,haloperidol,psychotic disorder,5-hydroxytryptamine receptor 2b
7136,haloperidol,psychotic disorder,potassium voltage-gated channel subfamily h member 2
7137,haloperidol,psychotic disorder,cholinergic receptor muscarinic 1
7138,haloperidol,psychotic disorder,opioid receptor mu 1
7139,haloperidol,psychotic disorder,transmembrane protein 97
7140,haloperidol,psychotic disorder,dopamine receptor d5
7141,paliperidone,schizoaffective disorder,dopamine receptor d2
7142,paliperidone,schizoaffective disorder,5-hydroxytryptamine receptor 2a
7143,paliperidone,schizoaffective disorder,5-hydroxytryptamine receptor 1b
7144,cyproheptadine,urticaria,5-hydroxytryptamine receptor 2a
7145,cyproheptadine,urticaria,dopamine receptor d2
7146,promethazine,urticaria,dopamine receptor d2
7147,promethazine,urticaria,5-hydroxytryptamine receptor 2a
7148,clemastine,urticaria,transmembrane protein 97
7149,loratadine,urticaria,histamine receptor h1
7150,astemizole,urticaria,histamine receptor h1
7151,astemizole,urticaria,transmembrane protein 97
7152,hydroxyzine,urticaria,5-hydroxytryptamine receptor 2a
7153,hydroxyzine,urticaria,dopamine receptor d2
7154,promazine,urticaria,5-hydroxytryptamine receptor 2a
7155,promazine,urticaria,dopamine receptor d2
7156,promazine,urticaria,histamine receptor h1
7157,cetirizine,urticaria,histamine receptor h1
7158,calcifediol,rickets,vitamin d receptor
7159,calcifediol,rickets,cytochrome p450 family 27 subfamily b member 1
7160,calcifediol,rickets,cytochrome p450 family 24 subfamily a member 1
7161,"1,25-dihydroxyvitamin d3",rickets,gc vitamin d binding protein
7162,"1,25-dihydroxyvitamin d3",rickets,vitamin d receptor
7163,"1,25-dihydroxyvitamin d3",rickets,cytochrome p450 family 24 subfamily a member 1
7164,ergocalciferol,rickets,cytochrome p450 family 2 subfamily r member 1
7165,ergocalciferol,rickets,cytochrome p450 family 24 subfamily a member 1
7166,ergocalciferol,rickets,vitamin d receptor
7167,ergocalciferol,rickets,cytochrome p450 family 27 subfamily b member 1
7168,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit beta3
7169,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha2
7170,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit gamma3
7171,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit gamma2
7172,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha3
7173,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha5
7174,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit alpha1
7175,diazepam,tetanus,gamma-aminobutyric acid type a receptor subunit beta2
7176,naloxone,opiate dependence,atp binding cassette subfamily b member 1
7177,buprenorphine,opiate dependence,opioid related nociceptin receptor 1
7178,buprenorphine,opiate dependence,opioid receptor delta 1
7179,buprenorphine,opiate dependence,atp binding cassette subfamily b member 1
7180,cortisol,proctitis,sex hormone binding globulin
7181,cortisol,proctitis,serpin family a member 6
7182,esmolol,acute coronary syndrome,adrenoceptor beta 1
7183,heparin,acute coronary syndrome,serpin family c member 1
7184,verapamil,acute coronary syndrome,calcium voltage-gated channel subunit alpha1 c
7185,fondaparinux,acute coronary syndrome,serpin family c member 1
7186,cortisol,brain edema,nuclear receptor subfamily 3 group c member 1
7187,terbutaline,dry eye syndrome,adrenoceptor beta 2
7188,terbutaline,dry eye syndrome,adrenoceptor beta 3
7189,cyclosporin a,dry eye syndrome,protein phosphatase 3 catalytic subunit alpha
7190,cyclosporin a,dry eye syndrome,fkbp prolyl isomerase 1b
7191,cyclosporin a,dry eye syndrome,fkbp prolyl isomerase 4
7192,cyclosporin a,dry eye syndrome,atp binding cassette subfamily b member 11
7193,cyclosporin a,dry eye syndrome,solute carrier organic anion transporter family member 1b1
7194,cyclosporin a,dry eye syndrome,peptidylprolyl isomerase d
7195,cyclosporin a,dry eye syndrome,peptidylprolyl isomerase b
7196,cyclosporin a,dry eye syndrome,solute carrier organic anion transporter family member 1b3
7197,diclofenac,frozen shoulder,prostaglandin-endoperoxide synthase 2
7198,dicumarol,intracranial embolism,g protein-coupled receptor 35
7199,cortisol,iritis,sex hormone binding globulin
7200,cortisol,iritis,serpin family a member 6
7201,fluorometholone,iritis,nuclear receptor subfamily 3 group c member 1
7202,fluorometholone,iritis,serpin family a member 6
7203,prednisolone,iritis,serpin family a member 6
7204,ceftriaxone,arthropathy,synuclein alpha
7205,fluoxymesterone,klinefelter syndrome,sex hormone binding globulin
7206,methyltestosterone,klinefelter syndrome,androgen receptor
7207,methyltestosterone,klinefelter syndrome,sex hormone binding globulin
7208,timolol,ocular hypertension,adrenoceptor beta 1
7209,timolol,ocular hypertension,adrenoceptor beta 2
7210,pilocarpine,ocular hypertension,cholinergic receptor muscarinic 3
7211,clonidine,ocular hypertension,adrenoceptor alpha 2a
7212,clonidine,ocular hypertension,adrenoceptor alpha 2b
7213,clonidine,ocular hypertension,adrenoceptor alpha 2c
7214,apraclonidine,ocular hypertension,adrenoceptor alpha 2c
7215,apraclonidine,ocular hypertension,adrenoceptor alpha 2b
7216,apraclonidine,ocular hypertension,adrenoceptor alpha 2a
7217,paclitaxel,ocular hypertension,tubulin beta 2b class iib
7218,paclitaxel,ocular hypertension,tubulin beta 1 class vi
7219,paclitaxel,ocular hypertension,tubulin beta 6 class v
7220,paclitaxel,ocular hypertension,tubulin beta class i
7221,paclitaxel,ocular hypertension,tubulin beta 3 class iii
7222,paclitaxel,ocular hypertension,tubulin beta 8 class viii
7223,paclitaxel,ocular hypertension,tubulin beta 4a class iva
7224,paclitaxel,ocular hypertension,tubulin beta 2a class iia
7225,paclitaxel,ocular hypertension,tubulin beta 4b class ivb
7226,betaxolol,ocular hypertension,adrenoceptor beta 2
7227,bimatoprost,ocular hypertension,prostaglandin f receptor
7228,esomeprazole,peptic esophagitis,atpase h+/k+ transporting subunit beta
7229,famotidine,peptic esophagitis,solute carrier family 47 member 1
7230,trimetaphan,pulmonary edema,cholinergic receptor nicotinic alpha 10 subunit
7231,trimetaphan,pulmonary edema,cholinergic receptor nicotinic alpha 3 subunit
7232,trimetaphan,pulmonary edema,cholinergic receptor nicotinic beta 4 subunit
7233,norfloxacin,pyelonephritis,dna topoisomerase ii alpha
7234,ofloxacin,pyelonephritis,dna topoisomerase ii alpha
7235,dihydrotachysterol,renal osteodystrophy,vitamin d receptor
7236,calcifediol,renal osteodystrophy,vitamin d receptor
7237,calcifediol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
7238,alfacalcidol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
7239,alfacalcidol,renal osteodystrophy,gc vitamin d binding protein
7240,alfacalcidol,renal osteodystrophy,vitamin d receptor
7241,"1,25-dihydroxyvitamin d3",renal osteodystrophy,gc vitamin d binding protein
7242,ergocalciferol,renal osteodystrophy,vitamin d receptor
7243,ergocalciferol,renal osteodystrophy,cytochrome p450 family 27 subfamily b member 1
7244,prednisolone,rheumatic heart disease,serpin family a member 6
7245,cortisol,rheumatic heart disease,sex hormone binding globulin
7246,cortisol,rheumatic heart disease,serpin family a member 6
7247,betamethasone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
7248,prednisone,rheumatic heart disease,nuclear receptor subfamily 3 group c member 1
7249,triamcinolone,rheumatic heart disease,serpin family a member 6
7250,propylthiouracil,thyroid crisis,iodothyronine deiodinase 1
7251,methimazole,thyroid crisis,thyroid peroxidase
7252,gabapentin,alcohol dependence,adenosine a1 receptor
7253,acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 1
7254,acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 2a
7255,acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit beta3
7256,acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit gamma2
7257,acamprosate,alcohol dependence,glutamate ionotropic receptor nmda type subunit 2b
7258,acamprosate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit alpha1
7259,naltrexone,alcohol dependence,opioid receptor mu 1
7260,naltrexone,alcohol dependence,opioid receptor kappa 1
7261,naltrexone,alcohol dependence,opioid receptor delta 1
7262,topiramate,alcohol dependence,carbonic anhydrase 2
7263,topiramate,alcohol dependence,glutamate ionotropic receptor kainate type subunit 3
7264,topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit alpha1
7265,topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit beta2
7266,topiramate,alcohol dependence,gamma-aminobutyric acid type a receptor subunit gamma2
7267,topiramate,alcohol dependence,glutamate ionotropic receptor kainate type subunit 1
7268,disulfiram,alcohol dependence,cytochrome p450 family 2 subfamily e member 1
7269,disulfiram,alcohol dependence,dopamine beta-hydroxylase
7270,disulfiram,alcohol dependence,aldehyde dehydrogenase 2 family member
7271,betamethasone,autoimmune disease,prostaglandin-endoperoxide synthase 2
7272,prednisone,autoimmune disease,nuclear receptor subfamily 3 group c member 1
7273,prednisone,autoimmune disease,albumin
7274,cortisol,autoimmune disease,nuclear receptor subfamily 3 group c member 1
7275,cortisol,autoimmune disease,serpin family a member 6
7276,triamcinolone,autoimmune disease,prostaglandin-endoperoxide synthase 2
7277,triamcinolone,autoimmune disease,serpin family a member 6
7278,prednisolone,autoimmune disease,serpin family a member 6
7279,lansoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7280,famotidine,gastroesophageal reflux disease,solute carrier family 47 member 1
7281,cisapride,gastroesophageal reflux disease,dopamine receptor d2
7282,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3a
7283,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3b
7284,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3c
7285,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3e
7286,metoclopramide,gastroesophageal reflux disease,5-hydroxytryptamine receptor 3d
7287,pantoprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7288,esomeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7289,cimetidine,gastroesophageal reflux disease,solute carrier family 47 member 1
7290,rabeprazole,gastroesophageal reflux disease,atpase h+/k+ transporting subunit beta
7291,baclofen,gastroesophageal reflux disease,gamma-aminobutyric acid type b receptor subunit 2
7292,vincristine,burkitt lymphoma,tubulin beta 8 class viii
7293,vincristine,burkitt lymphoma,tubulin beta 3 class iii
7294,vincristine,burkitt lymphoma,tubulin beta 1 class vi
7295,vincristine,burkitt lymphoma,tubulin beta 4a class iva
7296,vincristine,burkitt lymphoma,tubulin beta 2a class iia
7297,vincristine,burkitt lymphoma,tubulin beta 2b class iib
7298,vincristine,burkitt lymphoma,tubulin beta 4b class ivb
7299,vincristine,burkitt lymphoma,tubulin beta 6 class v
7300,etoposide,burkitt lymphoma,dna topoisomerase ii alpha
7301,etoposide,burkitt lymphoma,cytochrome p450 family 2 subfamily e member 1
7302,carboplatin,breast cancer,glutathione s-transferase theta 1
7303,carboplatin,breast cancer,atpase copper transporting beta
7304,carboplatin,breast cancer,xanthine dehydrogenase
7305,carboplatin,breast cancer,glutathione s-transferase pi 1
7306,carboplatin,breast cancer,glutathione s-transferase mu 1
7307,dromostanolone propionate,breast cancer,cytochrome p450 family 19 subfamily a member 1
7308,dromostanolone propionate,breast cancer,sex hormone binding globulin
7309,dromostanolone propionate,breast cancer,androgen receptor
7310,cabozantinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7311,cabozantinib,hepatocellular carcinoma,aurora kinase a
7312,cabozantinib,hepatocellular carcinoma,kinase insert domain receptor
7313,cabozantinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7314,sorafenib,hepatocellular carcinoma,fibroblast growth factor receptor 1
7315,sorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily b member 6
7316,sorafenib,hepatocellular carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
7317,sorafenib,hepatocellular carcinoma,epoxide hydrolase 2
7318,sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 3
7319,sorafenib,hepatocellular carcinoma,ret proto-oncogene
7320,sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 1
7321,sorafenib,hepatocellular carcinoma,cytochrome p450 family 1 subfamily a member 2
7322,sorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 4
7323,sorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily c member 8
7324,sorafenib,hepatocellular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
7325,sorafenib,hepatocellular carcinoma,mitogen-activated protein kinase kinase kinase 20
7326,sorafenib,hepatocellular carcinoma,atp binding cassette subfamily b member 1
7327,sorafenib,hepatocellular carcinoma,kinase insert domain receptor
7328,sorafenib,hepatocellular carcinoma,"raf-1 proto-oncogene, serine/threonine kinase"
7329,sorafenib,hepatocellular carcinoma,homeodomain interacting protein kinase 4
7330,sorafenib,hepatocellular carcinoma,platelet derived growth factor receptor alpha
7331,sorafenib,hepatocellular carcinoma,platelet derived growth factor receptor beta
7332,sorafenib,hepatocellular carcinoma,aurora kinase b
7333,sorafenib,hepatocellular carcinoma,ttk protein kinase
7334,sorafenib,hepatocellular carcinoma,axl receptor tyrosine kinase
7335,sorafenib,hepatocellular carcinoma,transforming growth factor beta receptor 2
7336,sorafenib,hepatocellular carcinoma,eph receptor a1
7337,sorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7338,sorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7339,sorafenib,hepatocellular carcinoma,cyclin dependent kinase 14
7340,sorafenib,hepatocellular carcinoma,tek receptor tyrosine kinase
7341,regorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily c member 8
7342,regorafenib,hepatocellular carcinoma,fms related receptor tyrosine kinase 4
7343,regorafenib,hepatocellular carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
7344,regorafenib,hepatocellular carcinoma,platelet derived growth factor receptor beta
7345,regorafenib,hepatocellular carcinoma,epoxide hydrolase 2
7346,regorafenib,hepatocellular carcinoma,ret proto-oncogene
7347,regorafenib,hepatocellular carcinoma,atp binding cassette subfamily b member 1
7348,regorafenib,hepatocellular carcinoma,tek receptor tyrosine kinase
7349,regorafenib,hepatocellular carcinoma,cytochrome p450 family 2 subfamily b member 6
7350,regorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7351,regorafenib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7352,regorafenib,hepatocellular carcinoma,eph receptor a1
7353,regorafenib,hepatocellular carcinoma,mitogen-activated protein kinase kinase kinase 20
7354,regorafenib,hepatocellular carcinoma,ttk protein kinase
7355,lenvatinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 1
7356,lenvatinib,hepatocellular carcinoma,discoidin domain receptor tyrosine kinase 2
7357,lenvatinib,hepatocellular carcinoma,kinase insert domain receptor
7358,lenvatinib,hepatocellular carcinoma,ret proto-oncogene
7359,lenvatinib,hepatocellular carcinoma,aurora kinase b
7360,clomipramine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
7361,clomipramine,obsessive-compulsive disorder,solute carrier family 6 member 2
7362,clomipramine,obsessive-compulsive disorder,dopamine receptor d2
7363,sertraline,obsessive-compulsive disorder,solute carrier family 6 member 2
7364,citalopram,obsessive-compulsive disorder,solute carrier family 6 member 2
7365,citalopram,obsessive-compulsive disorder,solute carrier family 6 member 4
7366,fluvoxamine,obsessive-compulsive disorder,solute carrier family 6 member 2
7367,escitalopram,obsessive-compulsive disorder,solute carrier family 6 member 4
7368,escitalopram,obsessive-compulsive disorder,solute carrier family 6 member 2
7369,fluoxetine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
7370,fluoxetine,obsessive-compulsive disorder,solute carrier family 6 member 2
7371,paroxetine,obsessive-compulsive disorder,5-hydroxytryptamine receptor 2a
7372,paroxetine,obsessive-compulsive disorder,solute carrier family 6 member 2
7373,ergocalciferol,postmenopausal osteoporosis,vitamin d receptor
7374,norgestimate,postmenopausal osteoporosis,estrogen receptor 1
7375,norgestimate,postmenopausal osteoporosis,progesterone receptor
7376,alendronate,postmenopausal osteoporosis,farnesyl diphosphate synthase
7377,alendronate,postmenopausal osteoporosis,atpase h+ transporting v1 subunit a
7378,ethinylestradiol,postmenopausal osteoporosis,estrogen receptor 2
7379,medroxyprogesterone,postmenopausal osteoporosis,progesterone receptor
7380,medroxyprogesterone,postmenopausal osteoporosis,estrogen receptor 1
7381,progesterone,postmenopausal osteoporosis,progesterone receptor
7382,progesterone,postmenopausal osteoporosis,estrogen receptor 1
7383,norethisterone,postmenopausal osteoporosis,progesterone receptor
7384,levonorgestrel,postmenopausal osteoporosis,progesterone receptor
7385,levonorgestrel,postmenopausal osteoporosis,estrogen receptor 1
7386,cisplatin,ovarian cancer,atp binding cassette subfamily b member 1
7387,cisplatin,ovarian cancer,superoxide dismutase 1
7388,cisplatin,ovarian cancer,atpase copper transporting beta
7389,docetaxel,ovarian cancer,epidermal growth factor receptor
7390,docetaxel,ovarian cancer,tubulin beta 6 class v
7391,docetaxel,ovarian cancer,tubulin beta 2b class iib
7392,docetaxel,ovarian cancer,tubulin beta 2a class iia
7393,docetaxel,ovarian cancer,tubulin beta class i
7394,docetaxel,ovarian cancer,tubulin beta 3 class iii
7395,docetaxel,ovarian cancer,tubulin beta 1 class vi
7396,docetaxel,ovarian cancer,atp binding cassette subfamily b member 1
7397,docetaxel,ovarian cancer,tubulin beta 4a class iva
7398,docetaxel,ovarian cancer,tubulin beta 4b class ivb
7399,docetaxel,ovarian cancer,tubulin beta 8 class viii
7400,docetaxel,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
7401,megestrol,ovarian cancer,atp binding cassette subfamily b member 1
7402,megestrol,ovarian cancer,progesterone receptor
7403,etoposide,ovarian cancer,dna topoisomerase ii alpha
7404,etoposide,ovarian cancer,atp binding cassette subfamily b member 1
7405,paclitaxel,ovarian cancer,tubulin beta 2b class iib
7406,paclitaxel,ovarian cancer,atp binding cassette subfamily b member 1
7407,paclitaxel,ovarian cancer,tubulin beta 6 class v
7408,paclitaxel,ovarian cancer,tubulin beta class i
7409,paclitaxel,ovarian cancer,tubulin beta 3 class iii
7410,paclitaxel,ovarian cancer,tubulin beta 8 class viii
7411,paclitaxel,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
7412,paclitaxel,ovarian cancer,tubulin beta 4a class iva
7413,paclitaxel,ovarian cancer,tubulin beta 2a class iia
7414,paclitaxel,ovarian cancer,tubulin beta 4b class ivb
7415,topotecan,ovarian cancer,atp binding cassette subfamily b member 1
7416,topotecan,ovarian cancer,dna topoisomerase i mitochondrial
7417,gemcitabine,ovarian cancer,ribonucleotide reductase regulatory subunit m2
7418,gemcitabine,ovarian cancer,ribonucleotide reductase catalytic subunit m1
7419,gemcitabine,ovarian cancer,"dna polymerase epsilon, catalytic subunit"
7420,gemcitabine,ovarian cancer,atp binding cassette subfamily b member 1
7421,gemcitabine,ovarian cancer,"dna polymerase delta 1, catalytic subunit"
7422,gemcitabine,ovarian cancer,cytidine/uridine monophosphate kinase 1
7423,gemcitabine,ovarian cancer,"dna polymerase alpha 1, catalytic subunit"
7424,gemcitabine,ovarian cancer,thymidylate synthetase
7425,carboplatin,ovarian cancer,atpase copper transporting beta
7426,carboplatin,ovarian cancer,superoxide dismutase 1
7427,capecitabine,ovarian cancer,thymidylate synthetase
7428,cyclophosphamide,ovarian cancer,atp binding cassette subfamily b member 1
7429,hydroxyurea,ovarian cancer,ribonucleotide reductase regulatory subunit m2
7430,tamoxifen,ovarian cancer,cytochrome p450 family 1 subfamily b member 1
7431,tamoxifen,ovarian cancer,atp binding cassette subfamily b member 1
7432,tamoxifen,ovarian cancer,estrogen receptor 1
7433,hydroxocobalamin,pernicious anemia,cobalamin binding intrinsic factor
7434,phentolamine,pheochromocytoma,adrenoceptor alpha 2a
7435,phentolamine,pheochromocytoma,adrenoceptor alpha 2c
7436,phentolamine,pheochromocytoma,adrenoceptor alpha 2b
7437,promazine,acute intermittent porphyria,5-hydroxytryptamine receptor 2a
7438,promazine,acute intermittent porphyria,dopamine receptor d2
7439,promazine,acute intermittent porphyria,histamine receptor h1
7440,chlorpromazine,acute intermittent porphyria,5-hydroxytryptamine receptor 2a
7441,chlorpromazine,acute intermittent porphyria,histamine receptor h1
7442,chlorpromazine,acute intermittent porphyria,atp binding cassette subfamily b member 1
7443,carbetocin,prader-willi syndrome,oxytocin receptor
7444,abiraterone acetate,prostate cancer,sulfotransferase family 2a member 1
7445,docetaxel,prostate cancer,epidermal growth factor receptor
7446,docetaxel,prostate cancer,tubulin beta 6 class v
7447,docetaxel,prostate cancer,tubulin beta 2b class iib
7448,docetaxel,prostate cancer,tubulin beta 2a class iia
7449,docetaxel,prostate cancer,tubulin beta class i
7450,docetaxel,prostate cancer,cytochrome p450 family 3 subfamily a member 4
7451,docetaxel,prostate cancer,tubulin beta 3 class iii
7452,docetaxel,prostate cancer,microtubule associated protein 2
7453,docetaxel,prostate cancer,cytochrome p450 family 3 subfamily a member 5
7454,docetaxel,prostate cancer,tubulin beta 4a class iva
7455,docetaxel,prostate cancer,tubulin beta 4b class ivb
7456,docetaxel,prostate cancer,tubulin beta 8 class viii
7457,docetaxel,prostate cancer,cytochrome p450 family 1 subfamily b member 1
7458,docetaxel,prostate cancer,paraoxonase 1
7459,enzalutamide,prostate cancer,cytochrome p450 family 3 subfamily a member 5
7460,enzalutamide,prostate cancer,cytochrome p450 family 2 subfamily c member 19
7461,enzalutamide,prostate cancer,cytochrome p450 family 3 subfamily a member 4
7462,enzalutamide,prostate cancer,cytochrome p450 family 2 subfamily c member 9
7463,enzalutamide,prostate cancer,nuclear receptor subfamily 3 group c member 1
7464,diflunisal,rheumatoid arthritis,transthyretin
7465,diflunisal,rheumatoid arthritis,albumin
7466,diflunisal,rheumatoid arthritis,dihydrofolate reductase
7467,diflunisal,rheumatoid arthritis,high mobility group box 1
7468,valdecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7469,valdecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7470,triamcinolone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7471,triamcinolone,rheumatoid arthritis,serpin family a member 6
7472,meloxicam,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7473,piroxicam,rheumatoid arthritis,albumin
7474,naproxen,rheumatoid arthritis,albumin
7475,naproxen,rheumatoid arthritis,aldo-keto reductase family 1 member c3
7476,naproxen,rheumatoid arthritis,dihydrofolate reductase
7477,penicillamine,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7478,leflunomide,rheumatoid arthritis,aryl hydrocarbon receptor
7479,tolmetin,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7480,tolmetin,rheumatoid arthritis,myeloperoxidase
7481,tolmetin,rheumatoid arthritis,albumin
7482,rofecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7483,betamethasone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7484,betamethasone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7485,tofacitinib,rheumatoid arthritis,doublecortin like kinase 3
7486,tofacitinib,rheumatoid arthritis,"lck proto-oncogene, src family tyrosine kinase"
7487,tofacitinib,rheumatoid arthritis,ribosomal protein s6 kinase a1
7488,tofacitinib,rheumatoid arthritis,mapk interacting serine/threonine kinase 2
7489,tofacitinib,rheumatoid arthritis,tyrosine kinase 2
7490,tofacitinib,rheumatoid arthritis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
7491,tofacitinib,rheumatoid arthritis,janus kinase 2
7492,celecoxib,rheumatoid arthritis,albumin
7493,celecoxib,rheumatoid arthritis,mitogen-activated protein kinase 14
7494,celecoxib,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7495,chloroquine,rheumatoid arthritis,tumor necrosis factor
7496,chloroquine,rheumatoid arthritis,toll like receptor 9
7497,chloroquine,rheumatoid arthritis,atp binding cassette subfamily b member 1
7498,chloroquine,rheumatoid arthritis,sigma non-opioid intracellular receptor 1
7499,chloroquine,rheumatoid arthritis,transmembrane protein 97
7500,salicylic acid,rheumatoid arthritis,albumin
7501,salicylic acid,rheumatoid arthritis,atp binding cassette subfamily b member 1
7502,salicylic acid,rheumatoid arthritis,high mobility group box 1
7503,hydroxychloroquine,rheumatoid arthritis,toll like receptor 7
7504,hydroxychloroquine,rheumatoid arthritis,toll like receptor 9
7505,hydroxychloroquine,rheumatoid arthritis,sigma non-opioid intracellular receptor 1
7506,hydroxychloroquine,rheumatoid arthritis,transmembrane protein 97
7507,ketoprofen,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7508,ketoprofen,rheumatoid arthritis,albumin
7509,ketoprofen,rheumatoid arthritis,paraoxonase 1
7510,aspirin,rheumatoid arthritis,albumin
7511,aspirin,rheumatoid arthritis,atp binding cassette subfamily b member 1
7512,aspirin,rheumatoid arthritis,tumor protein p53
7513,aspirin,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
7514,etodolac,rheumatoid arthritis,albumin
7515,etodolac,rheumatoid arthritis,dihydrofolate reductase
7516,ibuprofen,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7517,ibuprofen,rheumatoid arthritis,atp binding cassette subfamily b member 1
7518,ibuprofen,rheumatoid arthritis,albumin
7519,ibuprofen,rheumatoid arthritis,dihydrofolate reductase
7520,indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 3
7521,indomethacin,rheumatoid arthritis,atp binding cassette subfamily c member 2
7522,indomethacin,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7523,indomethacin,rheumatoid arthritis,albumin
7524,indomethacin,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7525,indomethacin,rheumatoid arthritis,aldo-keto reductase family 1 member c3
7526,indomethacin,rheumatoid arthritis,atp binding cassette subfamily b member 1
7527,indomethacin,rheumatoid arthritis,solute carrier organic anion transporter family member 1b3
7528,indomethacin,rheumatoid arthritis,paraoxonase 1
7529,aceclofenac,rheumatoid arthritis,transthyretin
7530,auranofin,rheumatoid arthritis,albumin
7531,auranofin,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
7532,flurbiprofen,rheumatoid arthritis,albumin
7533,cortisol,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
7534,cortisol,rheumatoid arthritis,atp binding cassette subfamily b member 1
7535,cortisol,rheumatoid arthritis,sex hormone binding globulin
7536,cortisol,rheumatoid arthritis,serpin family a member 6
7537,baricitinib,rheumatoid arthritis,ap2 associated kinase 1
7538,baricitinib,rheumatoid arthritis,septin 9
7539,baricitinib,rheumatoid arthritis,cyclin g associated kinase
7540,methylprednisolone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7541,cyclosporin a,rheumatoid arthritis,protein phosphatase 3 catalytic subunit alpha
7542,cyclosporin a,rheumatoid arthritis,fkbp prolyl isomerase 1b
7543,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily b member 1
7544,cyclosporin a,rheumatoid arthritis,fkbp prolyl isomerase 4
7545,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily c member 3
7546,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily c member 2
7547,cyclosporin a,rheumatoid arthritis,atp binding cassette subfamily b member 11
7548,cyclosporin a,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7549,cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase d
7550,cyclosporin a,rheumatoid arthritis,peptidylprolyl isomerase b
7551,cyclosporin a,rheumatoid arthritis,solute carrier organic anion transporter family member 1b3
7552,meclofenamic acid,rheumatoid arthritis,arachidonate 5-lipoxygenase
7553,meclofenamic acid,rheumatoid arthritis,aldo-keto reductase family 1 member c3
7554,meclofenamic acid,rheumatoid arthritis,transthyretin
7555,sulindac,rheumatoid arthritis,albumin
7556,sulindac,rheumatoid arthritis,complement c5
7557,diclofenac,rheumatoid arthritis,atp binding cassette subfamily b member 1
7558,diclofenac,rheumatoid arthritis,c-x-c motif chemokine receptor 1
7559,diclofenac,rheumatoid arthritis,albumin
7560,diclofenac,rheumatoid arthritis,arachidonate 5-lipoxygenase
7561,diclofenac,rheumatoid arthritis,transthyretin
7562,diclofenac,rheumatoid arthritis,c-x-c motif chemokine ligand 8
7563,diclofenac,rheumatoid arthritis,dihydrofolate reductase
7564,sulfasalazine,rheumatoid arthritis,solute carrier organic anion transporter family member 1b1
7565,sulfasalazine,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7566,sulfasalazine,rheumatoid arthritis,arachidonate 5-lipoxygenase
7567,sulfasalazine,rheumatoid arthritis,inhibitor of nuclear factor kappa b kinase subunit beta
7568,sulfasalazine,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7569,sulfasalazine,rheumatoid arthritis,atp binding cassette subfamily c member 2
7570,sulfasalazine,rheumatoid arthritis,solute carrier family 46 member 1
7571,minocycline,rheumatoid arthritis,caspase 1
7572,minocycline,rheumatoid arthritis,interleukin 1 beta
7573,minocycline,rheumatoid arthritis,matrix metallopeptidase 9
7574,minocycline,rheumatoid arthritis,vascular endothelial growth factor a
7575,minocycline,rheumatoid arthritis,arachidonate 5-lipoxygenase
7576,prednisolone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7577,prednisolone,rheumatoid arthritis,serpin family a member 6
7578,prednisone,rheumatoid arthritis,nuclear receptor subfamily 3 group c member 1
7579,prednisone,rheumatoid arthritis,albumin
7580,prednisone,rheumatoid arthritis,hydroxysteroid 11-beta dehydrogenase 1
7581,prednisone,rheumatoid arthritis,atp binding cassette subfamily b member 1
7582,nabumetone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 1
7583,nabumetone,rheumatoid arthritis,myeloperoxidase
7584,nabumetone,rheumatoid arthritis,prostaglandin-endoperoxide synthase 2
7585,oxaprozin,rheumatoid arthritis,complement c5
7586,etoposide,small cell lung carcinoma,udp glucuronosyltransferase family 1 member a1
7587,docetaxel,small cell lung carcinoma,epidermal growth factor receptor
7588,topotecan,small cell lung carcinoma,dna topoisomerase i mitochondrial
7589,irinotecan,small cell lung carcinoma,udp glucuronosyltransferase family 1 member a1
7590,irinotecan,small cell lung carcinoma,dna topoisomerase i
7591,irinotecan,small cell lung carcinoma,dna topoisomerase i mitochondrial
7592,ifosfamide,small cell lung carcinoma,cytochrome p450 family 2 subfamily a member 6
7593,progesterone,polycystic ovary syndrome,progesterone receptor
7594,progesterone,polycystic ovary syndrome,androgen receptor
7595,progesterone,polycystic ovary syndrome,sex hormone binding globulin
7596,progesterone,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
7597,progesterone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
7598,progesterone,polycystic ovary syndrome,estrogen receptor 1
7599,progesterone,polycystic ovary syndrome,cytochrome p450 family 17 subfamily a member 1
7600,estrone,polycystic ovary syndrome,estrogen receptor 1
7601,estrone,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
7602,estrone,polycystic ovary syndrome,sex hormone binding globulin
7603,letrozole,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
7604,desogestrel,polycystic ovary syndrome,sex hormone binding globulin
7605,desogestrel,polycystic ovary syndrome,progesterone receptor
7606,desogestrel,polycystic ovary syndrome,estrogen receptor 1
7607,estradiol valerate,polycystic ovary syndrome,estrogen receptor 1
7608,estradiol valerate,polycystic ovary syndrome,cytochrome p450 family 1 subfamily a member 1
7609,estradiol valerate,polycystic ovary syndrome,sex hormone binding globulin
7610,estradiol valerate,polycystic ovary syndrome,androgen receptor
7611,norgestimate,polycystic ovary syndrome,estrogen receptor 1
7612,norgestimate,polycystic ovary syndrome,progesterone receptor
7613,medroxyprogesterone,polycystic ovary syndrome,aldo-keto reductase family 1 member c3
7614,medroxyprogesterone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
7615,medroxyprogesterone,polycystic ovary syndrome,sex hormone binding globulin
7616,medroxyprogesterone,polycystic ovary syndrome,progesterone receptor
7617,medroxyprogesterone,polycystic ovary syndrome,estrogen receptor 1
7618,medroxyprogesterone,polycystic ovary syndrome,androgen receptor
7619,medroxyprogesterone,polycystic ovary syndrome,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
7620,ethynodiol diacetate,polycystic ovary syndrome,progesterone receptor
7621,ethynodiol diacetate,polycystic ovary syndrome,estrogen receptor 1
7622,levonorgestrel,polycystic ovary syndrome,steroid 5 alpha-reductase 1
7623,levonorgestrel,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
7624,levonorgestrel,polycystic ovary syndrome,androgen receptor
7625,levonorgestrel,polycystic ovary syndrome,progesterone receptor
7626,levonorgestrel,polycystic ovary syndrome,sex hormone binding globulin
7627,levonorgestrel,polycystic ovary syndrome,estrogen receptor 1
7628,drospirenone,polycystic ovary syndrome,progesterone receptor
7629,drospirenone,polycystic ovary syndrome,androgen receptor
7630,ethinylestradiol,polycystic ovary syndrome,estrogen receptor 1
7631,ethinylestradiol,polycystic ovary syndrome,sex hormone binding globulin
7632,norethisterone,polycystic ovary syndrome,sex hormone binding globulin
7633,norethisterone,polycystic ovary syndrome,progesterone receptor
7634,spironolactone,polycystic ovary syndrome,progesterone receptor
7635,spironolactone,polycystic ovary syndrome,nuclear receptor subfamily 3 group c member 1
7636,spironolactone,polycystic ovary syndrome,sex hormone binding globulin
7637,spironolactone,polycystic ovary syndrome,androgen receptor
7638,spironolactone,polycystic ovary syndrome,cytochrome p450 family 11 subfamily b member 1
7639,prednisone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
7640,prednisolone,temporal arteritis,serpin family a member 6
7641,methylprednisolone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
7642,betamethasone,temporal arteritis,nuclear receptor subfamily 3 group c member 1
7643,triamcinolone,temporal arteritis,serpin family a member 6
7644,pge1,tetralogy of fallot,prostaglandin e receptor 1
7645,acenocoumarol,thrombophilia due to thrombin defect,vitamin k epoxide reductase complex subunit 1
7646,bupropion,nicotine dependence,cytochrome p450 family 2 subfamily a member 6
7647,bupropion,nicotine dependence,solute carrier family 6 member 2
7648,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 4 subunit
7649,nicotine,nicotine dependence,cytochrome p450 family 2 subfamily a member 6
7650,nicotine,nicotine dependence,cytochrome p450 family 1 subfamily a member 1
7651,nicotine,nicotine dependence,cholinergic receptor nicotinic beta 2 subunit
7652,nicotine,nicotine dependence,cholinergic receptor nicotinic beta 4 subunit
7653,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 5 subunit
7654,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 3 subunit
7655,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 7 subunit
7656,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 2 subunit
7657,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 10 subunit
7658,nicotine,nicotine dependence,cholinergic receptor nicotinic beta 3 subunit
7659,nicotine,nicotine dependence,cholinergic receptor nicotinic alpha 6 subunit
7660,nicotine,nicotine dependence,monoamine oxidase b
7661,carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 4
7662,carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 5
7663,carbamazepine,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 9
7664,paroxetine,fibromyalgia,solute carrier family 6 member 4
7665,paroxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
7666,paroxetine,fibromyalgia,solute carrier family 6 member 2
7667,gabapentin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
7668,gabapentin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
7669,pregabalin,fibromyalgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
7670,duloxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
7671,amitriptyline,fibromyalgia,solute carrier family 6 member 4
7672,amitriptyline,fibromyalgia,5-hydroxytryptamine receptor 2a
7673,amitriptyline,fibromyalgia,solute carrier family 6 member 2
7674,tramadol,fibromyalgia,solute carrier family 6 member 2
7675,tramadol,fibromyalgia,solute carrier family 6 member 4
7676,fluoxetine,fibromyalgia,5-hydroxytryptamine receptor 2a
7677,fluoxetine,fibromyalgia,solute carrier family 6 member 4
7678,fluoxetine,fibromyalgia,solute carrier family 6 member 2
7679,cyclobenzaprine,fibromyalgia,5-hydroxytryptamine receptor 2a
7680,pramipexole,fibromyalgia,5-hydroxytryptamine receptor 2a
7681,cyclopentolate,cycloplegia,cholinergic receptor muscarinic 3
7682,cyclopentolate,cycloplegia,cholinergic receptor muscarinic 1
7683,morphine,neonatal abstinence syndrome,atp binding cassette subfamily b member 1
7684,diflunisal,arthritic joint disease,prostaglandin-endoperoxide synthase 2
7685,diflunisal,arthritic joint disease,albumin
7686,diflunisal,arthritic joint disease,prostaglandin-endoperoxide synthase 1
7687,diphenhydramine,anxiety disorder,solute carrier family 6 member 3
7688,diphenhydramine,anxiety disorder,solute carrier family 6 member 4
7689,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 2a
7690,haloperidol,anxiety disorder,dopamine receptor d2
7691,haloperidol,anxiety disorder,sigma non-opioid intracellular receptor 1
7692,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 2c
7693,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 1a
7694,haloperidol,anxiety disorder,solute carrier family 6 member 4
7695,haloperidol,anxiety disorder,5-hydroxytryptamine receptor 7
7696,5-fluorouracil,head and neck cancer,thymidylate synthetase
7697,5-fluorouracil,head and neck cancer,dihydropyrimidine dehydrogenase
7698,gemcitabine,head and neck cancer,thymidylate synthetase
7699,docetaxel,head and neck cancer,epidermal growth factor receptor
7700,docetaxel,head and neck cancer,bcl2 apoptosis regulator
7701,paclitaxel,head and neck cancer,bcl2 apoptosis regulator
7702,carboplatin,head and neck cancer,atpase copper transporting beta
7703,carboplatin,head and neck cancer,glutathione s-transferase mu 1
7704,promethazine,atopic conjunctivitis,dopamine receptor d2
7705,promethazine,atopic conjunctivitis,adrenoceptor alpha 1a
7706,promethazine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7707,diphenhydramine,atopic conjunctivitis,prostaglandin-endoperoxide synthase 1
7708,diphenhydramine,atopic conjunctivitis,solute carrier family 6 member 2
7709,azelastine,atopic conjunctivitis,adrenoceptor alpha 1b
7710,azelastine,atopic conjunctivitis,adrenoceptor alpha 1a
7711,pseudoephedrine,atopic conjunctivitis,adrenoceptor alpha 2a
7712,pseudoephedrine,atopic conjunctivitis,solute carrier family 6 member 2
7713,pseudoephedrine,atopic conjunctivitis,adrenoceptor beta 2
7714,phenylephrine,atopic conjunctivitis,adrenoceptor alpha 2a
7715,hydroxyzine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7716,hydroxyzine,atopic conjunctivitis,dopamine receptor d2
7717,cyproheptadine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7718,cyproheptadine,atopic conjunctivitis,solute carrier family 6 member 2
7719,cyproheptadine,atopic conjunctivitis,dopamine receptor d2
7720,epinastine,atopic conjunctivitis,adrenoceptor alpha 1a
7721,epinastine,atopic conjunctivitis,adrenoceptor alpha 2a
7722,epinastine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7723,cromoglicic acid,atopic conjunctivitis,s100 calcium binding protein p
7724,chlorpheniramine,atopic conjunctivitis,solute carrier family 6 member 2
7725,ephedrine,atopic conjunctivitis,solute carrier family 6 member 2
7726,ephedrine,atopic conjunctivitis,adrenoceptor beta 2
7727,prednisolone,atopic conjunctivitis,serpin family a member 6
7728,clemastine,atopic conjunctivitis,adrenoceptor alpha 2a
7729,clemastine,atopic conjunctivitis,transmembrane protein 97
7730,astemizole,atopic conjunctivitis,transmembrane protein 97
7731,fluorometholone,atopic conjunctivitis,serpin family a member 6
7732,cortisol,atopic conjunctivitis,sex hormone binding globulin
7733,cortisol,atopic conjunctivitis,serpin family a member 6
7734,promazine,atopic conjunctivitis,adrenoceptor alpha 1a
7735,promazine,atopic conjunctivitis,adrenoceptor alpha 1b
7736,promazine,atopic conjunctivitis,adrenoceptor alpha 2a
7737,promazine,atopic conjunctivitis,5-hydroxytryptamine receptor 2a
7738,promazine,atopic conjunctivitis,dopamine receptor d2
7739,promazine,atopic conjunctivitis,adrenoceptor alpha 1d
7740,promazine,atopic conjunctivitis,histamine receptor h1
7741,podophyllotoxin,anogenital human papillomavirus infection,tubulin alpha 4a
7742,bromodiphenhydramine,common cold,histamine receptor h1
7743,pseudoephedrine,common cold,adrenoceptor alpha 2a
7744,pseudoephedrine,common cold,solute carrier family 6 member 2
7745,pseudoephedrine,common cold,adrenoceptor beta 1
7746,hydromorphone,common cold,prostaglandin-endoperoxide synthase 1
7747,hydromorphone,common cold,opioid receptor mu 1
7748,phenylephrine,common cold,adrenoceptor alpha 2a
7749,mepyramine,common cold,histamine receptor h1
7750,dextromethorphan,common cold,opioid receptor mu 1
7751,dextromethorphan,common cold,solute carrier family 6 member 2
7752,codeine,common cold,opioid receptor mu 1
7753,caffeine,common cold,adenosine a2b receptor
7754,caffeine,common cold,phosphodiesterase 4b
7755,caffeine,common cold,adenosine a1 receptor
7756,caffeine,common cold,adenosine a2a receptor
7757,caffeine,common cold,adenosine a3 receptor
7758,chlorpheniramine,common cold,solute carrier family 6 member 2
7759,chlorpheniramine,common cold,histamine receptor h1
7760,doxylamine,common cold,cholinergic receptor muscarinic 1
7761,ephedrine,common cold,solute carrier family 6 member 2
7762,ephedrine,common cold,adrenoceptor beta 2
7763,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 1
7764,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 5
7765,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 2
7766,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 3
7767,n-methyl scopolamine,common cold,cholinergic receptor muscarinic 4
7768,chlophedianol,common cold,histamine receptor h1
7769,hydrocodone,common cold,opioid receptor mu 1
7770,paracetamol,common cold,transient receptor potential cation channel subfamily v member 1
7771,paracetamol,common cold,cannabinoid receptor 1
7772,prednisolone,eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
7773,prednisolone,eosinophilic pneumonia,serpin family a member 6
7774,acetazolamide,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 2
7775,acetazolamide,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 4
7776,phenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
7777,phenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
7778,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 3
7779,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
7780,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
7781,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 2
7782,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 8
7783,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
7784,phenytoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
7785,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
7786,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 8
7787,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 3
7788,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
7789,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 10
7790,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 2
7791,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 11
7792,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
7793,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
7794,ethotoin,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 7
7795,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 3
7796,topiramate,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 2
7797,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 4
7798,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 5
7799,topiramate,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
7800,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
7801,topiramate,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 1
7802,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 3
7803,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
7804,topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
7805,topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit beta2
7806,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 1
7807,topiramate,epilepsy with generalized tonic-clonic seizures,carbonic anhydrase 4
7808,topiramate,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit gamma2
7809,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 4
7810,topiramate,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 1
7811,carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 4
7812,carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 5
7813,carbamazepine,epilepsy with generalized tonic-clonic seizures,sodium voltage-gated channel alpha subunit 9
7814,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
7815,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
7816,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
7817,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
7818,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
7819,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
7820,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
7821,methylphenobarbital,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
7822,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha1
7823,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit beta2
7824,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha4
7825,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha3
7826,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha6
7827,primidone,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor kainate type subunit 2
7828,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha5
7829,primidone,epilepsy with generalized tonic-clonic seizures,glutamate ionotropic receptor ampa type subunit 2
7830,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit alpha2
7831,primidone,epilepsy with generalized tonic-clonic seizures,gamma-aminobutyric acid type a receptor subunit gamma2
7832,fluoxymesterone,eunuchism,androgen receptor
7833,cabergoline,hyperprolactinemia,dopamine receptor d3
7834,oseltamivir,influenza,solute carrier family 22 member 8
7835,prednisolone,miliary tuberculosis,serpin family a member 6
7836,triamcinolone,miliary tuberculosis,serpin family a member 6
7837,miconazole,oral candidiasis,cytochrome p450 family 51 subfamily a member 1
7838,miconazole,oral candidiasis,potassium calcium-activated channel subfamily n member 4
7839,miconazole,oral candidiasis,cytochrome p450 family 17 subfamily a member 1
7840,miconazole,oral candidiasis,cytochrome p450 family 11 subfamily b member 1
7841,clotrimazole,oral candidiasis,cytochrome p450 family 11 subfamily b member 1
7842,clotrimazole,oral candidiasis,cytochrome p450 family 17 subfamily a member 1
7843,clotrimazole,oral candidiasis,cytochrome p450 family 51 subfamily a member 1
7844,clotrimazole,oral candidiasis,potassium calcium-activated channel subfamily n member 4
7845,miconazole,pityriasis versicolor,cytochrome p450 family 51 subfamily a member 1
7846,miconazole,pityriasis versicolor,potassium calcium-activated channel subfamily n member 4
7847,miconazole,pityriasis versicolor,cytochrome p450 family 17 subfamily a member 1
7848,miconazole,pityriasis versicolor,cytochrome p450 family 11 subfamily b member 1
7849,clotrimazole,pityriasis versicolor,cytochrome p450 family 11 subfamily b member 1
7850,clotrimazole,pityriasis versicolor,cytochrome p450 family 17 subfamily a member 1
7851,clotrimazole,pityriasis versicolor,cytochrome p450 family 51 subfamily a member 1
7852,clotrimazole,pityriasis versicolor,potassium calcium-activated channel subfamily n member 4
7853,proguanil,plasmodium falciparum malaria,dihydrofolate reductase
7854,hydroxychloroquine,plasmodium falciparum malaria,toll like receptor 7
7855,hydroxychloroquine,plasmodium falciparum malaria,toll like receptor 9
7856,hydroxychloroquine,plasmodium falciparum malaria,transmembrane protein 97
7857,chloroquine,plasmodium falciparum malaria,toll like receptor 9
7858,chloroquine,plasmodium falciparum malaria,transmembrane protein 97
7859,chloroquine,plasmodium vivax malaria,toll like receptor 9
7860,chloroquine,plasmodium vivax malaria,transmembrane protein 97
7861,hydroxychloroquine,plasmodium vivax malaria,toll like receptor 7
7862,hydroxychloroquine,plasmodium vivax malaria,toll like receptor 9
7863,hydroxychloroquine,plasmodium vivax malaria,transmembrane protein 97
7864,fluoxetine,postpartum depression,solute carrier family 6 member 4
7865,azatadine,familial dermatographia,histamine receptor h1
7866,clemastine,familial dermatographia,histamine receptor h1
7867,clemastine,familial dermatographia,transmembrane protein 97
7868,brompheniramine,familial dermatographia,histamine receptor h1
7869,antazoline,familial dermatographia,histamine receptor h1
7870,diphenylpyraline,familial dermatographia,histamine receptor h1
7871,hydroxyzine,familial dermatographia,histamine receptor h1
7872,hydroxyzine,familial dermatographia,5-hydroxytryptamine receptor 2a
7873,hydroxyzine,familial dermatographia,dopamine receptor d2
7874,chlorpheniramine,familial dermatographia,histamine receptor h1
7875,mepyramine,familial dermatographia,histamine receptor h1
7876,carbinoxamine,familial dermatographia,histamine receptor h1
7877,doxylamine,familial dermatographia,histamine receptor h1
7878,promazine,familial dermatographia,5-hydroxytryptamine receptor 2a
7879,promazine,familial dermatographia,dopamine receptor d2
7880,promazine,familial dermatographia,histamine receptor h1
7881,dexbrompheniramine,familial dermatographia,histamine receptor h1
7882,cyproheptadine,familial dermatographia,5-hydroxytryptamine receptor 2a
7883,cyproheptadine,familial dermatographia,dopamine receptor d2
7884,cyproheptadine,familial dermatographia,histamine receptor h1
7885,triprolidine,familial dermatographia,histamine receptor h1
7886,methdilazine,familial dermatographia,histamine receptor h1
7887,zonisamide,lewy body dementia,sodium voltage-gated channel alpha subunit 1
7888,5-fluorouracil,esophageal cancer,cytochrome p450 family 2 subfamily a member 6
7889,5-fluorouracil,esophageal cancer,thymidine phosphorylase
7890,docetaxel,esophageal cancer,epidermal growth factor receptor
7891,docetaxel,esophageal cancer,nuclear receptor subfamily 1 group i member 2
7892,docetaxel,esophageal cancer,atp binding cassette subfamily c member 2
7893,docetaxel,esophageal cancer,bcl2 apoptosis regulator
7894,docetaxel,esophageal cancer,atp binding cassette subfamily b member 1
7895,docetaxel,esophageal cancer,cytochrome p450 family 1 subfamily b member 1
7896,clonidine,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
7897,haloperidol,tourette syndrome,5-hydroxytryptamine receptor 2a
7898,haloperidol,tourette syndrome,dopamine receptor d4
7899,haloperidol,tourette syndrome,dopamine receptor d3
7900,haloperidol,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
7901,haloperidol,tourette syndrome,transmembrane protein 97
7902,pimozide,tourette syndrome,5-hydroxytryptamine receptor 2a
7903,pimozide,tourette syndrome,cytochrome p450 family 2 subfamily d member 6
7904,pimozide,tourette syndrome,dopamine receptor d4
7905,fenofibrate,"hyperlipidemia, familial combined, lpl related",peroxisome proliferator activated receptor alpha
7906,fenofibrate,"hyperlipidemia, familial combined, lpl related",fatty acid binding protein 2
7907,nicotinic acid,"hyperlipidemia, familial combined, lpl related",hydroxycarboxylic acid receptor 2
7908,nicotinic acid,"hyperlipidemia, familial combined, lpl related",hydroxycarboxylic acid receptor 3
7909,lovastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
7910,simvastatin,"hyperlipidemia, familial combined, lpl related",3-hydroxy-3-methylglutaryl-coa reductase
7911,ezetimibe,"hyperlipidemia, familial combined, lpl related",atp binding cassette subfamily g member 8
7912,diazoxide,islet cell adenomatosis,atp binding cassette subfamily c member 8
7913,norethisterone,uterine corpus leiomyoma,sex hormone binding globulin
7914,norethisterone,uterine corpus leiomyoma,progesterone receptor
7915,ruxolitinib,vitiligo,ribosomal protein s6 kinase a2
7916,ruxolitinib,vitiligo,serine/threonine kinase 25
7917,ruxolitinib,vitiligo,homeodomain interacting protein kinase 1
7918,ezetimibe,sitosterolemia,atp binding cassette subfamily g member 8
7919,ezetimibe,sitosterolemia,atp binding cassette subfamily g member 5
7920,fluoxymesterone,cryptorchidism,sex hormone binding globulin
7921,methyltestosterone,cryptorchidism,androgen receptor
7922,methyltestosterone,cryptorchidism,sex hormone binding globulin
7923,methyltestosterone,cryptorchidism,cytochrome p450 family 19 subfamily a member 1
7924,daunorubicin,acute monocytic leukemia,dna topoisomerase ii alpha
7925,chloroquine,systemic lupus erythematosus,tumor necrosis factor
7926,chloroquine,systemic lupus erythematosus,toll like receptor 9
7927,chloroquine,systemic lupus erythematosus,transmembrane protein 97
7928,hydroxychloroquine,systemic lupus erythematosus,toll like receptor 7
7929,hydroxychloroquine,systemic lupus erythematosus,toll like receptor 9
7930,hydroxychloroquine,systemic lupus erythematosus,transmembrane protein 97
7931,prednisone,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
7932,prednisone,systemic lupus erythematosus,albumin
7933,betamethasone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
7934,cortisol,systemic lupus erythematosus,nuclear receptor subfamily 3 group c member 1
7935,cortisol,systemic lupus erythematosus,sex hormone binding globulin
7936,cortisol,systemic lupus erythematosus,serpin family a member 6
7937,triamcinolone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
7938,triamcinolone,systemic lupus erythematosus,serpin family a member 6
7939,dapsone,systemic lupus erythematosus,prostaglandin-endoperoxide synthase 2
7940,dapsone,systemic lupus erythematosus,n-acetyltransferase 2
7941,prednisolone,systemic lupus erythematosus,serpin family a member 6
7942,prednisolone,systemic lupus erythematosus,androgen receptor
7943,biotin,propionic acidemia,propionyl-coa carboxylase subunit alpha
7944,biotin,propionic acidemia,propionyl-coa carboxylase subunit beta
7945,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 33
7946,sunitinib,gastrointestinal stromal tumor,myosin light chain kinase family member 4
7947,sunitinib,gastrointestinal stromal tumor,"mer proto-oncogene, tyrosine kinase"
7948,sunitinib,gastrointestinal stromal tumor,death associated protein kinase 3
7949,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 17a
7950,sunitinib,gastrointestinal stromal tumor,cdc like kinase 4
7951,sunitinib,gastrointestinal stromal tumor,cdc like kinase 2
7952,sunitinib,gastrointestinal stromal tumor,ribosomal protein s6 kinase a2
7953,sunitinib,gastrointestinal stromal tumor,cdc like kinase 1
7954,sunitinib,gastrointestinal stromal tumor,homeodomain interacting protein kinase 2
7955,sunitinib,gastrointestinal stromal tumor,ribosomal protein s6 kinase a5
7956,sunitinib,gastrointestinal stromal tumor,mitogen-activated protein kinase kinase kinase 19
7957,sunitinib,gastrointestinal stromal tumor,interleukin 1 receptor associated kinase 1
7958,sunitinib,gastrointestinal stromal tumor,bmp2 inducible kinase
7959,sunitinib,gastrointestinal stromal tumor,mitogen-activated protein kinase kinase kinase kinase 1
7960,sunitinib,gastrointestinal stromal tumor,dual specificity tyrosine phosphorylation regulated kinase 2
7961,sunitinib,gastrointestinal stromal tumor,checkpoint kinase 2
7962,sunitinib,gastrointestinal stromal tumor,myosin light chain kinase
7963,sunitinib,gastrointestinal stromal tumor,ret proto-oncogene
7964,sunitinib,gastrointestinal stromal tumor,phosphorylase kinase catalytic subunit gamma 2
7965,sunitinib,gastrointestinal stromal tumor,phosphorylase kinase catalytic subunit gamma 1
7966,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 4
7967,sunitinib,gastrointestinal stromal tumor,serine/threonine kinase 10
7968,sunitinib,gastrointestinal stromal tumor,axl receptor tyrosine kinase
7969,sunitinib,gastrointestinal stromal tumor,traf2 and nck interacting kinase
7970,sunitinib,gastrointestinal stromal tumor,myosin light chain kinase 3
7971,sunitinib,gastrointestinal stromal tumor,cyclin g associated kinase
7972,sunitinib,gastrointestinal stromal tumor,unc-51 like autophagy activating kinase 1
7973,sunitinib,gastrointestinal stromal tumor,casein kinase 1 delta
7974,sunitinib,gastrointestinal stromal tumor,delta like non-canonical notch ligand 1
7975,sunitinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
7976,sunitinib,gastrointestinal stromal tumor,homeodomain interacting protein kinase 1
7977,sunitinib,gastrointestinal stromal tumor,ap2 associated kinase 1
7978,sunitinib,gastrointestinal stromal tumor,misshapen like kinase 1
7979,sunitinib,gastrointestinal stromal tumor,"abl proto-oncogene 2, non-receptor tyrosine kinase"
7980,sunitinib,gastrointestinal stromal tumor,unc-51 like autophagy activating kinase 2
7981,sunitinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
7982,sunitinib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
7983,imatinib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
7984,imatinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
7985,imatinib,gastrointestinal stromal tumor,colony stimulating factor 1 receptor
7986,imatinib,gastrointestinal stromal tumor,solute carrier family 47 member 1
7987,imatinib,gastrointestinal stromal tumor,"abl proto-oncogene 2, non-receptor tyrosine kinase"
7988,imatinib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
7989,imatinib,gastrointestinal stromal tumor,cdc like kinase 1
7990,imatinib,gastrointestinal stromal tumor,serine/threonine kinase 17a
7991,imatinib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
7992,imatinib,gastrointestinal stromal tumor,interleukin 1 receptor associated kinase 1
7993,imatinib,gastrointestinal stromal tumor,"b-raf proto-oncogene, serine/threonine kinase"
7994,imatinib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 3
7995,imatinib,gastrointestinal stromal tumor,cyclin g associated kinase
7996,imatinib,gastrointestinal stromal tumor,dead-box helicase 3 x-linked
7997,imatinib,gastrointestinal stromal tumor,cdc like kinase 4
7998,regorafenib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 4
7999,regorafenib,gastrointestinal stromal tumor,platelet derived growth factor receptor beta
8000,regorafenib,gastrointestinal stromal tumor,epoxide hydrolase 2
8001,regorafenib,gastrointestinal stromal tumor,"b-raf proto-oncogene, serine/threonine kinase"
8002,regorafenib,gastrointestinal stromal tumor,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8003,regorafenib,gastrointestinal stromal tumor,ret proto-oncogene
8004,regorafenib,gastrointestinal stromal tumor,fms related receptor tyrosine kinase 1
8005,regorafenib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 2
8006,regorafenib,gastrointestinal stromal tumor,kinase insert domain receptor
8007,regorafenib,gastrointestinal stromal tumor,discoidin domain receptor tyrosine kinase 1
8008,regorafenib,gastrointestinal stromal tumor,eph receptor a1
8009,regorafenib,gastrointestinal stromal tumor,cdc like kinase 1
8010,montelukast,allergic rhinitis,prostaglandin-endoperoxide synthase 1
8011,azelastine,allergic rhinitis,adrenoceptor alpha 1b
8012,azelastine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8013,azelastine,allergic rhinitis,adrenoceptor alpha 1a
8014,promazine,allergic rhinitis,adrenoceptor alpha 1a
8015,promazine,allergic rhinitis,adrenoceptor alpha 1b
8016,promazine,allergic rhinitis,cholinergic receptor muscarinic 5
8017,promazine,allergic rhinitis,adrenoceptor alpha 2a
8018,promazine,allergic rhinitis,5-hydroxytryptamine receptor 2a
8019,promazine,allergic rhinitis,dopamine receptor d2
8020,promazine,allergic rhinitis,cholinergic receptor muscarinic 1
8021,promazine,allergic rhinitis,adrenoceptor alpha 1d
8022,promazine,allergic rhinitis,cholinergic receptor muscarinic 4
8023,promazine,allergic rhinitis,histamine receptor h1
8024,promazine,allergic rhinitis,cholinergic receptor muscarinic 3
8025,promazine,allergic rhinitis,cholinergic receptor muscarinic 2
8026,mepyramine,allergic rhinitis,solute carrier family 22 member 5
8027,prednisone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8028,flunisolide,allergic rhinitis,serpin family a member 6
8029,hydrocodone,allergic rhinitis,opioid receptor mu 1
8030,fluticasone,allergic rhinitis,serpin family a member 6
8031,pseudoephedrine,allergic rhinitis,adrenoceptor alpha 2a
8032,pseudoephedrine,allergic rhinitis,solute carrier family 6 member 2
8033,pseudoephedrine,allergic rhinitis,adrenoceptor beta 2
8034,pseudoephedrine,allergic rhinitis,interleukin 2
8035,phenylephrine,allergic rhinitis,adrenoceptor alpha 2a
8036,cortisol,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8037,cortisol,allergic rhinitis,sex hormone binding globulin
8038,cortisol,allergic rhinitis,serpin family a member 6
8039,chlorpheniramine,allergic rhinitis,solute carrier family 6 member 2
8040,caffeine,allergic rhinitis,adenosine a2b receptor
8041,caffeine,allergic rhinitis,phosphodiesterase 4b
8042,caffeine,allergic rhinitis,adenosine a1 receptor
8043,caffeine,allergic rhinitis,adenosine a2a receptor
8044,caffeine,allergic rhinitis,adenosine a3 receptor
8045,clemastine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8046,clemastine,allergic rhinitis,adrenoceptor alpha 2a
8047,clemastine,allergic rhinitis,cholinergic receptor muscarinic 4
8048,clemastine,allergic rhinitis,transmembrane protein 97
8049,clemastine,allergic rhinitis,cholinergic receptor muscarinic 3
8050,clemastine,allergic rhinitis,cholinergic receptor muscarinic 5
8051,clemastine,allergic rhinitis,cholinergic receptor muscarinic 1
8052,clemastine,allergic rhinitis,cholinergic receptor muscarinic 2
8053,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 4
8054,brompheniramine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8055,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 2
8056,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 5
8057,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 3
8058,brompheniramine,allergic rhinitis,cholinergic receptor muscarinic 1
8059,mometasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8060,ephedrine,allergic rhinitis,solute carrier family 6 member 2
8061,ephedrine,allergic rhinitis,adrenoceptor beta 2
8062,hydroxyzine,allergic rhinitis,5-hydroxytryptamine receptor 2a
8063,hydroxyzine,allergic rhinitis,dopamine receptor d2
8064,fexofenadine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8065,dextromethorphan,allergic rhinitis,opioid receptor mu 1
8066,dextromethorphan,allergic rhinitis,solute carrier family 6 member 2
8067,beclometasone,allergic rhinitis,serpin family a member 6
8068,beclometasone,allergic rhinitis,nuclear receptor subfamily 3 group c member 1
8069,paracetamol,allergic rhinitis,transient receptor potential cation channel subfamily v member 1
8070,paracetamol,allergic rhinitis,sulfotransferase family 1a member 1
8071,paracetamol,allergic rhinitis,cannabinoid receptor 1
8072,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 3
8073,cyproheptadine,allergic rhinitis,5-hydroxytryptamine receptor 2a
8074,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 2
8075,cyproheptadine,allergic rhinitis,solute carrier family 6 member 2
8076,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 1
8077,cyproheptadine,allergic rhinitis,dopamine receptor d2
8078,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 5
8079,cyproheptadine,allergic rhinitis,cholinergic receptor muscarinic 4
8080,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 1
8081,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 5
8082,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 2
8083,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 3
8084,n-methyl scopolamine,allergic rhinitis,cholinergic receptor muscarinic 4
8085,dexbrompheniramine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8086,dexbrompheniramine,allergic rhinitis,histamine receptor h1
8087,prednisolone,allergic rhinitis,serpin family a member 6
8088,astemizole,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8089,astemizole,allergic rhinitis,"major histocompatibility complex, class i, a"
8090,astemizole,allergic rhinitis,transmembrane protein 97
8091,codeine,allergic rhinitis,opioid receptor mu 1
8092,betamethasone,allergic rhinitis,prostaglandin-endoperoxide synthase 2
8093,betamethasone,allergic rhinitis,phospholipase a2 group ib
8094,doxylamine,allergic rhinitis,cholinergic receptor muscarinic 1
8095,loratadine,allergic rhinitis,potassium voltage-gated channel subfamily h member 2
8096,triamcinolone,allergic rhinitis,prostaglandin-endoperoxide synthase 2
8097,triamcinolone,allergic rhinitis,serpin family a member 6
8098,ibuprofen,patent ductus arteriosus,c-x-c motif chemokine ligand 8
8099,ibuprofen,patent ductus arteriosus,albumin
8100,indomethacin,patent ductus arteriosus,c-x-c motif chemokine ligand 8
8101,indomethacin,patent ductus arteriosus,albumin
8102,indomethacin,patent ductus arteriosus,aldo-keto reductase family 1 member c3
8103,sulfasalazine,psoriatic arthritis,solute carrier family 46 member 1
8104,sulfasalazine,psoriatic arthritis,acetyl-coa acetyltransferase 1
8105,cortisol,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
8106,cortisol,psoriatic arthritis,sex hormone binding globulin
8107,cortisol,psoriatic arthritis,serpin family a member 6
8108,prednisolone,psoriatic arthritis,serpin family a member 6
8109,betamethasone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
8110,triamcinolone,psoriatic arthritis,serpin family a member 6
8111,tofacitinib,psoriatic arthritis,"fyn proto-oncogene, src family tyrosine kinase"
8112,tofacitinib,psoriatic arthritis,janus kinase 3
8113,tofacitinib,psoriatic arthritis,janus kinase 1
8114,tofacitinib,psoriatic arthritis,janus kinase 2
8115,prednisone,psoriatic arthritis,nuclear receptor subfamily 3 group c member 1
8116,imatinib,idiopathic hypereosinophilic syndrome,platelet derived growth factor receptor alpha
8117,acebutolol,anxiety,adrenoceptor beta 2
8118,acebutolol,anxiety,adrenoceptor beta 1
8119,alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8120,alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8121,alprazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8122,alprazolam,anxiety,bromodomain containing 4
8123,chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8124,chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8125,chlordiazepoxide,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8126,clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8127,clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8128,clorazepate,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8129,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8130,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8131,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8132,midazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8133,doxepin,anxiety,5-hydroxytryptamine receptor 2a
8134,doxepin,anxiety,solute carrier family 6 member 2
8135,doxepin,anxiety,histamine receptor h1
8136,doxepin,anxiety,dopamine receptor d2
8137,doxepin,anxiety,solute carrier family 6 member 4
8138,doxepin,anxiety,5-hydroxytryptamine receptor 1a
8139,trifluoperazine,anxiety,sigma non-opioid intracellular receptor 1
8140,trifluoperazine,anxiety,histamine receptor h1
8141,trifluoperazine,anxiety,5-hydroxytryptamine receptor 1a
8142,trifluoperazine,anxiety,5-hydroxytryptamine receptor 2a
8143,imipramine,anxiety,histamine receptor h1
8144,imipramine,anxiety,dopamine receptor d2
8145,imipramine,anxiety,5-hydroxytryptamine receptor 2a
8146,imipramine,anxiety,solute carrier family 6 member 2
8147,imipramine,anxiety,solute carrier family 6 member 4
8148,imipramine,anxiety,5-hydroxytryptamine receptor 1a
8149,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8150,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8151,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8152,adinazolam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8153,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8154,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8155,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8156,oxazepam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8157,methylphenobarbital,anxiety,glutamate ionotropic receptor kainate type subunit 2
8158,methylphenobarbital,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8159,methylphenobarbital,anxiety,cholinergic receptor nicotinic alpha 4 subunit
8160,clomipramine,anxiety,5-hydroxytryptamine receptor 2a
8161,clomipramine,anxiety,solute carrier family 6 member 2
8162,clomipramine,anxiety,solute carrier family 6 member 4
8163,clomipramine,anxiety,dopamine receptor d2
8164,clomipramine,anxiety,dopamine receptor d1
8165,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit beta3
8166,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit gamma2
8167,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit alpha1
8168,diazepam,anxiety,gamma-aminobutyric acid type a receptor subunit delta
8169,desipramine,anxiety,adrenoceptor beta 2
8170,desipramine,anxiety,5-hydroxytryptamine receptor 1a
8171,desipramine,anxiety,adrenoceptor beta 1
8172,desipramine,anxiety,5-hydroxytryptamine receptor 2a
8173,desipramine,anxiety,dopamine receptor d2
8174,desipramine,anxiety,solute carrier family 6 member 4
8175,desipramine,anxiety,histamine receptor h1
8176,desipramine,anxiety,solute carrier family 6 member 2
8177,desipramine,anxiety,dopamine receptor d1
8178,imatinib,dermatofibrosarcoma protuberans,"kit proto-oncogene, receptor tyrosine kinase"
8179,imatinib,dermatofibrosarcoma protuberans,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8180,imatinib,dermatofibrosarcoma protuberans,discoidin domain receptor tyrosine kinase 1
8181,imatinib,dermatofibrosarcoma protuberans,solute carrier family 47 member 1
8182,imatinib,dermatofibrosarcoma protuberans,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8183,imatinib,dermatofibrosarcoma protuberans,platelet derived growth factor receptor beta
8184,imatinib,dermatofibrosarcoma protuberans,discoidin domain receptor tyrosine kinase 2
8185,imatinib,dermatofibrosarcoma protuberans,dead-box helicase 3 x-linked
8186,cephalotaxine,"chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein l3
8187,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",discoidin domain receptor tyrosine kinase 1
8188,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",platelet derived growth factor receptor alpha
8189,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 2, non-receptor tyrosine kinase"
8190,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 9
8191,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 19
8192,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive","b-raf proto-oncogene, serine/threonine kinase"
8193,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",mitogen-activated protein kinase 14
8194,imatinib,"chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
8195,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",bcr activator of rhogef and gtpase
8196,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",platelet derived growth factor receptor alpha
8197,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","abl proto-oncogene 2, non-receptor tyrosine kinase"
8198,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",eph receptor a5
8199,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",dead-box helicase 1
8200,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 19
8201,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",mitogen-activated protein kinase 14
8202,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",cyclin dependent kinase 8
8203,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive","b-raf proto-oncogene, serine/threonine kinase"
8204,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",receptor interacting serine/threonine kinase 3
8205,ponatinib,"chronic myelogenous leukemia, bcr-abl1 positive",discoidin domain receptor tyrosine kinase 1
8206,hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",ribonucleotide reductase regulatory subunit m2
8207,hydroxyurea,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 9
8208,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit gamma2
8209,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha3
8210,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha5
8211,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha6
8212,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha1
8213,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha2
8214,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit beta2
8215,pentobarbitone,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit alpha4
8216,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit gamma2
8217,thiopental,pseudotumor cerebri,gamma-aminobutyric acid type a receptor subunit beta2
8218,biotin,biotinidase deficiency,holocarboxylase synthetase
8219,biotin,holocarboxylase synthetase deficiency,holocarboxylase synthetase
8220,methylprednisolone,mycosis fungoides,atp binding cassette subfamily b member 1
8221,triamcinolone,mycosis fungoides,serpin family a member 6
8222,prednisolone,mycosis fungoides,atp binding cassette subfamily b member 1
8223,prednisolone,mycosis fungoides,serpin family a member 6
8224,vincristine,mycosis fungoides,atp binding cassette subfamily b member 1
8225,vincristine,mycosis fungoides,tubulin beta 8 class viii
8226,vincristine,mycosis fungoides,tubulin beta 3 class iii
8227,vincristine,mycosis fungoides,tubulin beta class i
8228,vincristine,mycosis fungoides,tubulin beta 1 class vi
8229,vincristine,mycosis fungoides,tubulin beta 4a class iva
8230,vincristine,mycosis fungoides,tubulin beta 2a class iia
8231,vincristine,mycosis fungoides,tubulin beta 2b class iib
8232,vincristine,mycosis fungoides,tubulin beta 4b class ivb
8233,vincristine,mycosis fungoides,tubulin beta 6 class v
8234,cyclophosphamide,mycosis fungoides,atp binding cassette subfamily b member 1
8235,prednisone,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
8236,prednisone,mycosis fungoides,atp binding cassette subfamily b member 1
8237,betamethasone,mycosis fungoides,atp binding cassette subfamily b member 1
8238,vinblastine,mycosis fungoides,tubulin beta 4a class iva
8239,vinblastine,mycosis fungoides,tubulin beta 1 class vi
8240,vinblastine,mycosis fungoides,tubulin beta 8 class viii
8241,vinblastine,mycosis fungoides,atp binding cassette subfamily b member 1
8242,vinblastine,mycosis fungoides,tubulin beta 2b class iib
8243,vinblastine,mycosis fungoides,tubulin beta 4b class ivb
8244,vinblastine,mycosis fungoides,tubulin beta 2a class iia
8245,vinblastine,mycosis fungoides,tubulin beta 3 class iii
8246,vinblastine,mycosis fungoides,tubulin beta 6 class v
8247,cortisol,mycosis fungoides,nuclear receptor subfamily 3 group c member 1
8248,cortisol,mycosis fungoides,atp binding cassette subfamily b member 1
8249,cortisol,mycosis fungoides,sex hormone binding globulin
8250,cortisol,mycosis fungoides,serpin family a member 6
8251,ruxolitinib,primary myelofibrosis,mitogen-activated protein kinase kinase kinase 19
8252,ruxolitinib,primary myelofibrosis,death associated protein kinase 2
8253,ruxolitinib,primary myelofibrosis,janus kinase 1
8254,ruxolitinib,primary myelofibrosis,death associated protein kinase 3
8255,ruxolitinib,primary myelofibrosis,bmp2 inducible kinase
8256,ruxolitinib,primary myelofibrosis,doublecortin like kinase 3
8257,ruxolitinib,primary myelofibrosis,janus kinase 2
8258,ruxolitinib,primary myelofibrosis,serine/threonine kinase 16
8259,ruxolitinib,primary myelofibrosis,cyclin g associated kinase
8260,ruxolitinib,primary myelofibrosis,death associated protein kinase 1
8261,betamethasone,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8262,betamethasone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8263,panobinostat,plasma cell myeloma,histone deacetylase 6
8264,panobinostat,plasma cell myeloma,histone deacetylase 10
8265,panobinostat,plasma cell myeloma,histone deacetylase 11
8266,panobinostat,plasma cell myeloma,histone deacetylase 9
8267,panobinostat,plasma cell myeloma,histone deacetylase 7
8268,panobinostat,plasma cell myeloma,histone deacetylase 1
8269,panobinostat,plasma cell myeloma,histone deacetylase 2
8270,panobinostat,plasma cell myeloma,histone deacetylase 3
8271,panobinostat,plasma cell myeloma,histone deacetylase 4
8272,panobinostat,plasma cell myeloma,histone deacetylase 8
8273,panobinostat,plasma cell myeloma,histone deacetylase 5
8274,methylprednisolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8275,lenalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8276,lenalidomide,plasma cell myeloma,cereblon
8277,triamcinolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8278,triamcinolone,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8279,etoposide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8280,etoposide,plasma cell myeloma,dna topoisomerase ii alpha
8281,etoposide,plasma cell myeloma,glutathione s-transferase theta 1
8282,prednisone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8283,pomalidomide,plasma cell myeloma,cereblon
8284,prednisolone,plasma cell myeloma,nuclear receptor subfamily 3 group c member 1
8285,bortezomib,plasma cell myeloma,proteasome 20s subunit alpha 1
8286,bortezomib,plasma cell myeloma,cathepsin g
8287,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 2
8288,bortezomib,plasma cell myeloma,proteasome 20s subunit beta 8
8289,bortezomib,plasma cell myeloma,chymotrypsinogen b1
8290,thalidomide,plasma cell myeloma,tumor necrosis factor
8291,thalidomide,plasma cell myeloma,cereblon
8292,thalidomide,plasma cell myeloma,prostaglandin-endoperoxide synthase 2
8293,prednisolone,sjogren syndrome,serpin family a member 6
8294,cortisol,angioedema,sex hormone binding globulin
8295,cortisol,angioedema,serpin family a member 6
8296,prednisone,angioedema,nuclear receptor subfamily 3 group c member 1
8297,prednisone,angioedema,albumin
8298,prednisolone,angioedema,serpin family a member 6
8299,betamethasone,angioedema,nuclear receptor subfamily 3 group c member 1
8300,triamcinolone,angioedema,serpin family a member 6
8301,promazine,angioedema,5-hydroxytryptamine receptor 2a
8302,promazine,angioedema,dopamine receptor d2
8303,promazine,angioedema,histamine receptor h1
8304,vasopressin,hemophilia a,arginine vasopressin receptor 1b
8305,vasopressin,hemophilia a,arginine vasopressin receptor 1a
8306,vasopressin,hemophilia a,arginine vasopressin receptor 2
8307,desmopressin,hemophilia a,arginine vasopressin receptor 1a
8308,desmopressin,hemophilia a,arginine vasopressin receptor 1b
8309,ergocalciferol,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 2 subfamily r member 1
8310,ergocalciferol,x-linked dominant hypophosphatemic rickets,vitamin d receptor
8311,ergocalciferol,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 27 subfamily b member 1
8312,"1,25-dihydroxyvitamin d3",x-linked dominant hypophosphatemic rickets,vitamin d receptor
8313,l-citrulline,ornithine carbamoyltransferase deficiency,ornithine transcarbamylase
8314,finasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 2
8315,finasteride,benign prostatic hyperplasia,steroid 5 alpha-reductase 1
8316,tadalafil,benign prostatic hyperplasia,phosphodiesterase 5a
8317,tamsulosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
8318,prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
8319,prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1a
8320,prazosin,benign prostatic hyperplasia,adrenoceptor alpha 1d
8321,doxazosin,benign prostatic hyperplasia,adrenoceptor alpha 1b
8322,prasugrel,cerebrovascular disorder,purinergic receptor p2y12
8323,prasugrel,cerebrovascular disorder,albumin
8324,caffeine,obesity disorder,cytochrome p450 family 1 subfamily b member 1
8325,caffeine,obesity disorder,cytochrome p450 family 2 subfamily e member 1
8326,lorcaserin,obesity disorder,5-hydroxytryptamine receptor 2a
8327,lorcaserin,obesity disorder,solute carrier family 6 member 4
8328,sibutramine,obesity disorder,solute carrier family 6 member 3
8329,sibutramine,obesity disorder,solute carrier family 6 member 4
8330,sibutramine,obesity disorder,solute carrier family 6 member 2
8331,fenfluramine,obesity disorder,5-hydroxytryptamine receptor 2c
8332,fenfluramine,obesity disorder,5-hydroxytryptamine receptor 2a
8333,methamphetamine,obesity disorder,solute carrier family 6 member 2
8334,methamphetamine,obesity disorder,trace amine associated receptor 1
8335,methamphetamine,obesity disorder,solute carrier family 22 member 3
8336,methamphetamine,obesity disorder,solute carrier family 18 member a2
8337,methamphetamine,obesity disorder,solute carrier family 6 member 3
8338,methamphetamine,obesity disorder,solute carrier family 6 member 4
8339,bupropion,obesity disorder,solute carrier family 6 member 2
8340,bupropion,obesity disorder,solute carrier family 6 member 3
8341,bupropion,obesity disorder,cytochrome p450 family 2 subfamily e member 1
8342,bupropion,obesity disorder,adrenoceptor alpha 1a
8343,bupropion,obesity disorder,solute carrier family 6 member 4
8344,benzphetamine,obesity disorder,solute carrier family 18 member a2
8345,benzphetamine,obesity disorder,solute carrier family 6 member 3
8346,benzphetamine,obesity disorder,solute carrier family 6 member 2
8347,phentermine,obesity disorder,solute carrier family 6 member 4
8348,phentermine,obesity disorder,solute carrier family 6 member 3
8349,rimonabant,obesity disorder,cannabinoid receptor 2
8350,rimonabant,obesity disorder,cannabinoid receptor 1
8351,naltrexone,obesity disorder,opioid receptor mu 1
8352,naltrexone,obesity disorder,opioid receptor kappa 1
8353,naltrexone,obesity disorder,opioid receptor delta 1
8354,dexfenfluramine,obesity disorder,solute carrier family 6 member 4
8355,dexfenfluramine,obesity disorder,5-hydroxytryptamine receptor 2c
8356,dexfenfluramine,obesity disorder,cytochrome p450 family 2 subfamily e member 1
8357,phenmetrazine,obesity disorder,solute carrier family 6 member 3
8358,phenmetrazine,obesity disorder,solute carrier family 6 member 2
8359,amphetamine,obesity disorder,solute carrier family 22 member 3
8360,amphetamine,obesity disorder,solute carrier family 6 member 4
8361,amphetamine,obesity disorder,solute carrier family 6 member 2
8362,amphetamine,obesity disorder,dopamine receptor d2
8363,amphetamine,obesity disorder,solute carrier family 6 member 3
8364,secobarbital,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8365,zolpidem,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8366,zolpidem,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8367,choline,insomnia,adenosine a2a receptor
8368,eszopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8369,zaleplon,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8370,triazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8371,triazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8372,melatonin,insomnia,calreticulin
8373,nitrazepam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8374,nitrazepam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8375,midazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8376,midazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8377,pentobarbitone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8378,pentobarbitone,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8379,flurazepam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8380,flurazepam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8381,zopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8382,zopiclone,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8383,alprazolam,insomnia,gamma-aminobutyric acid type a receptor subunit alpha1
8384,alprazolam,insomnia,gamma-aminobutyric acid type a receptor subunit beta3
8385,betamethasone,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
8386,betamethasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8387,cetirizine,"dermatitis, atopic",histamine receptor h1
8388,mometasone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8389,doxepin,"dermatitis, atopic",histamine receptor h1
8390,doxepin,"dermatitis, atopic",histamine receptor h2
8391,clobetasol propionate,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8392,triamcinolone,"dermatitis, atopic",prostaglandin-endoperoxide synthase 2
8393,prednisone,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8394,cortisol,"dermatitis, atopic",nuclear receptor subfamily 3 group c member 1
8395,l-glutamine,sickle cell anemia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
8396,hydroxyurea,sickle cell anemia,ribonucleotide reductase regulatory subunit m2
8397,prednisolone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8398,prednisolone,juvenile idiopathic arthritis,serpin family a member 6
8399,etodolac,juvenile idiopathic arthritis,dihydrofolate reductase
8400,methylprednisolone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8401,meloxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8402,salicylic acid,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8403,salicylic acid,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8404,salicylic acid,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8405,salicylic acid,juvenile idiopathic arthritis,high mobility group box 1
8406,naproxen,juvenile idiopathic arthritis,aldo-keto reductase family 1 member c3
8407,naproxen,juvenile idiopathic arthritis,dihydrofolate reductase
8408,celecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8409,chloroquine,juvenile idiopathic arthritis,tumor necrosis factor
8410,chloroquine,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8411,prednisone,juvenile idiopathic arthritis,nuclear receptor subfamily 3 group c member 1
8412,prednisone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8413,betamethasone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8414,betamethasone,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8415,tolmetin,juvenile idiopathic arthritis,c-x-c motif chemokine ligand 8
8416,triamcinolone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8417,triamcinolone,juvenile idiopathic arthritis,serpin family a member 6
8418,nabumetone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8419,nabumetone,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8420,sulfasalazine,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8421,sulfasalazine,juvenile idiopathic arthritis,arachidonate 5-lipoxygenase
8422,sulfasalazine,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8423,sulfasalazine,juvenile idiopathic arthritis,solute carrier family 46 member 1
8424,rofecoxib,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8425,ibuprofen,juvenile idiopathic arthritis,c-x-c motif chemokine ligand 8
8426,ibuprofen,juvenile idiopathic arthritis,atp binding cassette subfamily b member 1
8427,ibuprofen,juvenile idiopathic arthritis,dihydrofolate reductase
8428,piroxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 1
8429,piroxicam,juvenile idiopathic arthritis,prostaglandin-endoperoxide synthase 2
8430,spironolactone,acne,progesterone receptor
8431,spironolactone,acne,nuclear receptor subfamily 3 group c member 1
8432,spironolactone,acne,sex hormone binding globulin
8433,spironolactone,acne,androgen receptor
8434,spironolactone,acne,cytochrome p450 family 11 subfamily b member 1
8435,dapsone,acne,prostaglandin-endoperoxide synthase 2
8436,dapsone,acne,prostaglandin-endoperoxide synthase 1
8437,ethinylestradiol,acne,estrogen receptor 2
8438,ethinylestradiol,acne,sex hormone binding globulin
8439,estradiol valerate,acne,sex hormone binding globulin
8440,estradiol valerate,acne,androgen receptor
8441,azelaic acid,acne,tyrosinase
8442,drospirenone,acne,progesterone receptor
8443,drospirenone,acne,prostaglandin-endoperoxide synthase 2
8444,drospirenone,acne,androgen receptor
8445,tretinoin,acne,retinoid x receptor beta
8446,cortisol,acne,cytochrome p450 family 11 subfamily b member 1
8447,cortisol,acne,sex hormone binding globulin
8448,norethisterone,acne,sex hormone binding globulin
8449,norethisterone,acne,progesterone receptor
8450,minocycline,acne,interleukin 1 beta
8451,adapalene,acne,retinoid x receptor beta
8452,adapalene,acne,retinoic acid receptor beta
8453,adapalene,acne,retinoic acid receptor alpha
8454,adapalene,acne,retinoic acid receptor gamma
8455,levonorgestrel,acne,androgen receptor
8456,levonorgestrel,acne,progesterone receptor
8457,levonorgestrel,acne,sex hormone binding globulin
8458,levonorgestrel,acne,estrogen receptor 1
8459,norgestimate,acne,estrogen receptor 1
8460,norgestimate,acne,progesterone receptor
8461,estrone,acne,estrogen receptor 1
8462,estrone,acne,estrogen receptor 2
8463,estrone,acne,sex hormone binding globulin
8464,tretinoin,acute promyelocytic leukemia,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
8465,cytarabine,acute promyelocytic leukemia,"dna polymerase alpha 1, catalytic subunit"
8466,cytarabine,acute promyelocytic leukemia,"dna polymerase delta 1, catalytic subunit"
8467,cytarabine,acute promyelocytic leukemia,dna polymerase beta
8468,cytarabine,acute promyelocytic leukemia,"dna polymerase epsilon, catalytic subunit"
8469,tamibarotene,acute promyelocytic leukemia,retinoic acid receptor alpha
8470,tamibarotene,acute promyelocytic leukemia,retinoic acid receptor beta
8471,daunorubicin,acute promyelocytic leukemia,dna topoisomerase ii alpha
8472,lovastatin,hypoalphalipoproteinemia,3-hydroxy-3-methylglutaryl-coa reductase
8473,fenofibrate,hypoalphalipoproteinemia,peroxisome proliferator activated receptor alpha
8474,simvastatin,hypoalphalipoproteinemia,3-hydroxy-3-methylglutaryl-coa reductase
8475,gemfibrozil,hypoalphalipoproteinemia,peroxisome proliferator activated receptor alpha
8476,prednisolone,hypersensitivity pneumonitis,serpin family a member 6
8477,ceftriaxone,meningococcal meningitis,synuclein alpha
8478,acth,west syndrome,melanocortin 3 receptor
8479,vemurafenib,erdheim-chester disease,"b-raf proto-oncogene, serine/threonine kinase"
8480,vandetanib,thyroid gland carcinoma,ret proto-oncogene
8481,vandetanib,thyroid gland carcinoma,ste20 like kinase
8482,sorafenib,thyroid gland carcinoma,"b-raf proto-oncogene, serine/threonine kinase"
8483,sorafenib,thyroid gland carcinoma,ret proto-oncogene
8484,sorafenib,thyroid gland carcinoma,ste20 like kinase
8485,triamcinolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8486,triamcinolone,chronic primary adrenal insufficiency,serpin family a member 6
8487,prednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8488,prednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8489,prednisolone,chronic primary adrenal insufficiency,serpin family a member 6
8490,prednisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8491,cortisol,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8492,cortisol,chronic primary adrenal insufficiency,sex hormone binding globulin
8493,cortisol,chronic primary adrenal insufficiency,serpin family a member 6
8494,cortisol,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8495,methylprednisolone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8496,betamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8497,betamethasone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8498,fludrocortisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 2
8499,fludrocortisone,chronic primary adrenal insufficiency,nuclear receptor subfamily 3 group c member 1
8500,prednisolone,dermatitis herpetiformis,serpin family a member 6
8501,triamcinolone,dermatitis herpetiformis,serpin family a member 6
8502,prednisone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
8503,dapsone,dermatitis herpetiformis,myeloperoxidase
8504,cortisol,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
8505,cortisol,dermatitis herpetiformis,sex hormone binding globulin
8506,cortisol,dermatitis herpetiformis,serpin family a member 6
8507,betamethasone,dermatitis herpetiformis,nuclear receptor subfamily 3 group c member 1
8508,imatinib,chronic eosinophilic leukemia,"kit proto-oncogene, receptor tyrosine kinase"
8509,imatinib,chronic eosinophilic leukemia,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8510,imatinib,chronic eosinophilic leukemia,discoidin domain receptor tyrosine kinase 1
8511,imatinib,chronic eosinophilic leukemia,solute carrier family 47 member 1
8512,imatinib,chronic eosinophilic leukemia,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8513,imatinib,chronic eosinophilic leukemia,platelet derived growth factor receptor beta
8514,imatinib,chronic eosinophilic leukemia,discoidin domain receptor tyrosine kinase 2
8515,imatinib,chronic eosinophilic leukemia,dead-box helicase 3 x-linked
8516,imatinib,myeloid neoplasm associated with pdgfra rearrangement,platelet derived growth factor receptor alpha
8517,cortisol,adrenogenital syndrome,cytochrome p450 family 11 subfamily b member 1
8518,nitric oxide,pulmonary arterial hypertension,guanylate cyclase 1 soluble subunit alpha 2
8519,pge1,pulmonary arterial hypertension,prostaglandin e receptor 1
8520,pge1,pulmonary arterial hypertension,prostaglandin e receptor 2
8521,pge1,pulmonary arterial hypertension,prostaglandin i2 receptor
8522,iloprost,pulmonary arterial hypertension,prostaglandin i2 receptor
8523,iloprost,pulmonary arterial hypertension,prostaglandin e receptor 1
8524,iloprost,pulmonary arterial hypertension,prostaglandin e receptor 4
8525,iloprost,pulmonary arterial hypertension,prostaglandin e receptor 2
8526,tadalafil,pulmonary arterial hypertension,phosphodiesterase 5a
8527,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 2
8528,nintedanib,interstitial lung disease,fibroblast growth factor receptor 3
8529,nintedanib,interstitial lung disease,kinase insert domain receptor
8530,nintedanib,interstitial lung disease,cdc like kinase 1
8531,nintedanib,interstitial lung disease,axl receptor tyrosine kinase
8532,nintedanib,interstitial lung disease,discoidin domain receptor tyrosine kinase 1
8533,nintedanib,interstitial lung disease,nuak family kinase 2
8534,nintedanib,interstitial lung disease,insulin receptor related receptor
8535,nintedanib,interstitial lung disease,fms related receptor tyrosine kinase 1
8536,nintedanib,interstitial lung disease,cyclin dependent kinase 16
8537,nintedanib,interstitial lung disease,serine/threonine kinase 16
8538,nintedanib,interstitial lung disease,rio kinase 1
8539,nintedanib,interstitial lung disease,"mer proto-oncogene, tyrosine kinase"
8540,nintedanib,interstitial lung disease,ste20 like kinase
8541,nintedanib,interstitial lung disease,platelet derived growth factor receptor beta
8542,nintedanib,interstitial lung disease,g protein-coupled receptor kinase 4
8543,nintedanib,interstitial lung disease,maternal embryonic leucine zipper kinase
8544,nintedanib,interstitial lung disease,cdc like kinase 4
8545,nintedanib,interstitial lung disease,serine/threonine kinase 11
8546,nintedanib,interstitial lung disease,srsf protein kinase 3
8547,nintedanib,interstitial lung disease,ttk protein kinase
8548,nintedanib,interstitial lung disease,platelet derived growth factor receptor alpha
8549,nintedanib,interstitial lung disease,serine/threonine kinase 4
8550,nintedanib,interstitial lung disease,protein kinase cgmp-dependent 1
8551,nintedanib,interstitial lung disease,bmp2 inducible kinase
8552,nintedanib,interstitial lung disease,pre-mrna processing factor kinase prp4k
8553,nintedanib,interstitial lung disease,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
8554,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 7
8555,nintedanib,interstitial lung disease,fibroblast growth factor receptor 1
8556,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase kinase 19
8557,nintedanib,interstitial lung disease,mitogen-activated protein kinase kinase 5
8558,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma2
8559,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit alpha1
8560,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta2
8561,nitrazepam,early myoclonic encephalopathy,sodium voltage-gated channel alpha subunit 1
8562,nitrazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta3
8563,clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit alpha1
8564,clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit beta2
8565,clonazepam,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma2
8566,mexiletine,myotonic syndrome,sodium voltage-gated channel alpha subunit 4
8567,prednisolone,allergic bronchopulmonary aspergillosis,serpin family a member 6
8568,triamcinolone,diamond-blackfan anemia,serpin family a member 6
8569,cortisol,diamond-blackfan anemia,sex hormone binding globulin
8570,cortisol,diamond-blackfan anemia,serpin family a member 6
8571,prednisolone,diamond-blackfan anemia,serpin family a member 6
8572,prednisolone,diamond-blackfan anemia,androgen receptor
8573,prednisone,diamond-blackfan anemia,nuclear receptor subfamily 3 group c member 1
8574,triamcinolone,chronic beryllium disease,serpin family a member 6
8575,cortisol,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
8576,cortisol,chronic beryllium disease,sex hormone binding globulin
8577,cortisol,chronic beryllium disease,serpin family a member 6
8578,prednisone,chronic beryllium disease,nuclear receptor subfamily 3 group c member 1
8579,prednisolone,chronic beryllium disease,serpin family a member 6
8580,vandetanib,medullary thyroid gland carcinoma,ret proto-oncogene
8581,vandetanib,medullary thyroid gland carcinoma,kinase insert domain receptor
8582,vandetanib,medullary thyroid gland carcinoma,tek receptor tyrosine kinase
8583,vandetanib,medullary thyroid gland carcinoma,fms related receptor tyrosine kinase 3
8584,vandetanib,medullary thyroid gland carcinoma,axl receptor tyrosine kinase
8585,vandetanib,medullary thyroid gland carcinoma,"met proto-oncogene, receptor tyrosine kinase"
8586,vandetanib,medullary thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
8587,vandetanib,medullary thyroid gland carcinoma,"kit proto-oncogene, receptor tyrosine kinase"
8588,cabozantinib,medullary thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
8589,lisuride,acromegaly,dopamine receptor d3
8590,lisuride,acromegaly,5-hydroxytryptamine receptor 2b
8591,lisuride,acromegaly,dopamine receptor d4
8592,lisuride,acromegaly,dopamine receptor d5
8593,bromocriptine,acromegaly,5-hydroxytryptamine receptor 6
8594,bromocriptine,acromegaly,dopamine receptor d4
8595,bromocriptine,acromegaly,5-hydroxytryptamine receptor 2b
8596,bromocriptine,acromegaly,dopamine receptor d5
8597,octreotide,acromegaly,somatostatin receptor 1
8598,octreotide,acromegaly,somatostatin receptor 3
8599,octreotide,acromegaly,somatostatin receptor 4
8600,octreotide,acromegaly,somatostatin receptor 5
8601,octreotide,acromegaly,somatostatin receptor 2
8602,nicotine,pellagra,cholinergic receptor nicotinic alpha 4 subunit
8603,nicotine,pellagra,cholinergic receptor nicotinic beta 2 subunit
8604,nicotine,pellagra,cholinergic receptor nicotinic alpha 2 subunit
8605,nicotine,pellagra,cholinergic receptor nicotinic beta 3 subunit
8606,nicotine,pellagra,cholinergic receptor nicotinic alpha 6 subunit
8607,ruxolitinib,myeloproliferative neoplasm,janus kinase 3
8608,ruxolitinib,myeloproliferative neoplasm,"kit proto-oncogene, receptor tyrosine kinase"
8609,ruxolitinib,myeloproliferative neoplasm,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8610,prednisolone,autoimmune hemolytic anemia,serpin family a member 6
8611,cortisol,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
8612,cortisol,autoimmune hemolytic anemia,sex hormone binding globulin
8613,cortisol,autoimmune hemolytic anemia,serpin family a member 6
8614,triamcinolone,autoimmune hemolytic anemia,serpin family a member 6
8615,prednisone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
8616,betamethasone,autoimmune hemolytic anemia,nuclear receptor subfamily 3 group c member 1
8617,prednisolone,uveitis,serpin family a member 6
8618,fluorometholone,uveitis,serpin family a member 6
8619,triamcinolone,uveitis,serpin family a member 6
8620,cortisol,uveitis,sex hormone binding globulin
8621,cortisol,uveitis,serpin family a member 6
8622,cyclopentolate,uveitis,cholinergic receptor muscarinic 3
8623,cyclopentolate,uveitis,cholinergic receptor muscarinic 1
8624,azacitidine,chronic myelomonocytic leukemia,dna methyltransferase 3 alpha
8625,azacitidine,chronic myelomonocytic leukemia,dna methyltransferase 1
8626,azacitidine,chronic myelomonocytic leukemia,cytidine deaminase
8627,midostaurin,aggressive systemic mastocytosis,microtubule affinity regulating kinase 3
8628,midostaurin,aggressive systemic mastocytosis,protein kinase n1
8629,midostaurin,aggressive systemic mastocytosis,tank binding kinase 1
8630,midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 9
8631,midostaurin,aggressive systemic mastocytosis,calcium/calmodulin dependent protein kinase ii alpha
8632,midostaurin,aggressive systemic mastocytosis,"kit proto-oncogene, receptor tyrosine kinase"
8633,midostaurin,aggressive systemic mastocytosis,serine/threonine kinase 4
8634,midostaurin,aggressive systemic mastocytosis,pre-mrna splicing tri-snrnp complex factor prpf4
8635,midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 11
8636,midostaurin,aggressive systemic mastocytosis,fms related receptor tyrosine kinase 3
8637,midostaurin,aggressive systemic mastocytosis,protein kinase n2
8638,midostaurin,aggressive systemic mastocytosis,tankyrase 2
8639,midostaurin,aggressive systemic mastocytosis,mitogen-activated protein kinase kinase kinase 19
8640,midostaurin,mast cell leukemia,microtubule affinity regulating kinase 3
8641,midostaurin,mast cell leukemia,protein kinase n1
8642,midostaurin,mast cell leukemia,tank binding kinase 1
8643,midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 9
8644,midostaurin,mast cell leukemia,calcium/calmodulin dependent protein kinase ii alpha
8645,midostaurin,mast cell leukemia,serine/threonine kinase 4
8646,midostaurin,mast cell leukemia,pre-mrna splicing tri-snrnp complex factor prpf4
8647,midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 11
8648,midostaurin,mast cell leukemia,protein kinase n2
8649,midostaurin,mast cell leukemia,tankyrase 2
8650,midostaurin,mast cell leukemia,mitogen-activated protein kinase kinase kinase 19
8651,carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 4
8652,carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 5
8653,carbamazepine,glossopharyngeal neuralgia,sodium voltage-gated channel alpha subunit 9
8654,glibenclamide,neonatal diabetes mellitus,atp binding cassette subfamily c member 8
8655,glibenclamide,neonatal diabetes mellitus,potassium inwardly rectifying channel subfamily j member 11
8656,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 3
8657,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
8658,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8659,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 2
8660,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 8
8661,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
8662,phenytoin,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
8663,felbamate,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 2a
8664,felbamate,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 2b
8665,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
8666,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
8667,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 8
8668,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
8669,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 3
8670,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8671,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 10
8672,lamotrigine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 2
8673,phenobarbital,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
8674,phenobarbital,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
8675,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 3
8676,topiramate,lennox-gastaut syndrome,carbonic anhydrase 2
8677,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 4
8678,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 5
8679,topiramate,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8680,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
8681,topiramate,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 1
8682,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 3
8683,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
8684,topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8685,topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8686,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 1
8687,topiramate,lennox-gastaut syndrome,carbonic anhydrase 4
8688,topiramate,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8689,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 4
8690,topiramate,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 1
8691,carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 4
8692,carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
8693,carbamazepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 9
8694,clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8695,clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8696,clobazam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8697,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8698,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8699,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
8700,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8701,clonazepam,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
8702,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
8703,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit beta2
8704,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
8705,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha3
8706,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
8707,primidone,lennox-gastaut syndrome,glutamate ionotropic receptor kainate type subunit 2
8708,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
8709,primidone,lennox-gastaut syndrome,glutamate ionotropic receptor ampa type subunit 2
8710,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
8711,primidone,lennox-gastaut syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
8712,sapropterin,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,phenylalanine hydroxylase
8713,nizatidine,systemic mastocytosis,histamine receptor h2
8714,rabeprazole,systemic mastocytosis,atpase h+/k+ transporting subunit beta
8715,cimetidine,systemic mastocytosis,solute carrier family 47 member 1
8716,imatinib,systemic mastocytosis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
8717,imatinib,systemic mastocytosis,discoidin domain receptor tyrosine kinase 1
8718,imatinib,systemic mastocytosis,solute carrier family 47 member 1
8719,imatinib,systemic mastocytosis,"abl proto-oncogene 2, non-receptor tyrosine kinase"
8720,imatinib,systemic mastocytosis,platelet derived growth factor receptor beta
8721,imatinib,systemic mastocytosis,discoidin domain receptor tyrosine kinase 2
8722,imatinib,systemic mastocytosis,dead-box helicase 3 x-linked
8723,acth,stevens-johnson syndrome,melanocortin 3 receptor
8724,prednisolone,stevens-johnson syndrome,serpin family a member 6
8725,ezetimibe,homozygous familial hypercholesterolemia,atp binding cassette subfamily g member 8
8726,ezetimibe,homozygous familial hypercholesterolemia,atp binding cassette subfamily g member 5
8727,simvastatin,hyperlipoproteinemia type 3,3-hydroxy-3-methylglutaryl-coa reductase
8728,methylprednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
8729,triamcinolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
8730,triamcinolone,congenital adrenal hyperplasia,serpin family a member 6
8731,prednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
8732,prednisolone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
8733,prednisolone,congenital adrenal hyperplasia,serpin family a member 6
8734,betamethasone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
8735,betamethasone,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
8736,cortisol,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 1
8737,cortisol,congenital adrenal hyperplasia,cytochrome p450 family 11 subfamily b member 1
8738,cortisol,congenital adrenal hyperplasia,sex hormone binding globulin
8739,cortisol,congenital adrenal hyperplasia,serpin family a member 6
8740,cortisol,congenital adrenal hyperplasia,nuclear receptor subfamily 3 group c member 2
8741,dantrolene,malignant hyperthermia of anesthesia,ryanodine receptor 1
8742,dantrolene,malignant hyperthermia of anesthesia,ryanodine receptor 3
8743,thalidomide,pyoderma gangrenosum,tumor necrosis factor
8744,thalidomide,pyoderma gangrenosum,nuclear factor kappa b subunit 1
8745,cytarabine,acute myeloid leukemia,"dna polymerase alpha 1, catalytic subunit"
8746,cytarabine,acute myeloid leukemia,"dna polymerase delta 1, catalytic subunit"
8747,cytarabine,acute myeloid leukemia,dna polymerase beta
8748,cytarabine,acute myeloid leukemia,"dna polymerase epsilon, catalytic subunit"
8749,daunorubicin,acute myeloid leukemia,dna topoisomerase ii beta
8750,daunorubicin,acute myeloid leukemia,dna topoisomerase ii alpha
8751,etoposide,acute myeloid leukemia,dna topoisomerase ii beta
8752,etoposide,acute myeloid leukemia,dna topoisomerase ii alpha
8753,fludarabine,acute myeloid leukemia,"dna polymerase alpha 1, catalytic subunit"
8754,mercaptopurine,acute myeloid leukemia,hypoxanthine phosphoribosyltransferase 1
8755,midostaurin,acute myeloid leukemia,microtubule affinity regulating kinase 3
8756,midostaurin,acute myeloid leukemia,protein kinase n1
8757,midostaurin,acute myeloid leukemia,tank binding kinase 1
8758,midostaurin,acute myeloid leukemia,death associated protein kinase 1
8759,midostaurin,acute myeloid leukemia,axl receptor tyrosine kinase
8760,midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 9
8761,midostaurin,acute myeloid leukemia,calcium/calmodulin dependent protein kinase ii alpha
8762,midostaurin,acute myeloid leukemia,"mer proto-oncogene, tyrosine kinase"
8763,midostaurin,acute myeloid leukemia,serine/threonine kinase 4
8764,midostaurin,acute myeloid leukemia,"pim-2 proto-oncogene, serine/threonine kinase"
8765,midostaurin,acute myeloid leukemia,pre-mrna splicing tri-snrnp complex factor prpf4
8766,midostaurin,acute myeloid leukemia,unc-51 like kinase 3
8767,midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 11
8768,midostaurin,acute myeloid leukemia,polo like kinase 4
8769,midostaurin,acute myeloid leukemia,protein kinase n2
8770,midostaurin,acute myeloid leukemia,neurotrophic receptor tyrosine kinase 3
8771,midostaurin,acute myeloid leukemia,cyclin g associated kinase
8772,midostaurin,acute myeloid leukemia,interleukin 1 receptor associated kinase 3
8773,midostaurin,acute myeloid leukemia,janus kinase 2
8774,midostaurin,acute myeloid leukemia,tankyrase 2
8775,midostaurin,acute myeloid leukemia,janus kinase 1
8776,midostaurin,acute myeloid leukemia,"met proto-oncogene, receptor tyrosine kinase"
8777,midostaurin,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 19
8778,midostaurin,acute myeloid leukemia,ap2 associated kinase 1
8779,midostaurin,acute myeloid leukemia,colony stimulating factor 1 receptor
8780,venetoclax,acute myeloid leukemia,bcl2 apoptosis regulator
8781,venetoclax,acute myeloid leukemia,bcl2 like 2
8782,venetoclax,acute myeloid leukemia,bcl2 like 1
8783,mitoxantrone,acute myeloid leukemia,solute carrier family 47 member 2
8784,mitoxantrone,acute myeloid leukemia,solute carrier family 47 member 1
8785,quizartinib,acute myeloid leukemia,neurotrophic receptor tyrosine kinase 3
8786,quizartinib,acute myeloid leukemia,"kit proto-oncogene, receptor tyrosine kinase"
8787,quizartinib,acute myeloid leukemia,kinase insert domain receptor
8788,quizartinib,acute myeloid leukemia,fms related receptor tyrosine kinase 3
8789,quizartinib,acute myeloid leukemia,platelet derived growth factor receptor beta
8790,quizartinib,acute myeloid leukemia,platelet derived growth factor receptor alpha
8791,quizartinib,acute myeloid leukemia,myosin heavy chain 10
8792,quizartinib,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 19
8793,quizartinib,acute myeloid leukemia,colony stimulating factor 1 receptor
8794,thioguanine,acute myeloid leukemia,hypoxanthine phosphoribosyltransferase 1
8795,thioguanine,acute myeloid leukemia,inosine monophosphate dehydrogenase 2
8796,thioguanine,acute myeloid leukemia,inosine monophosphate dehydrogenase 1
8797,azacitidine,acute myeloid leukemia,dna methyltransferase 3 alpha
8798,azacitidine,acute myeloid leukemia,dna methyltransferase 1
8799,histamine,acute myeloid leukemia,histamine receptor h4
8800,histamine,acute myeloid leukemia,histamine receptor h1
8801,gilteritinib,acute myeloid leukemia,cyclin g associated kinase
8802,gilteritinib,acute myeloid leukemia,"ran, member ras oncogene family"
8803,gilteritinib,acute myeloid leukemia,solute carrier family 25 member 6
8804,gilteritinib,acute myeloid leukemia,"tu translation elongation factor, mitochondrial"
8805,gilteritinib,acute myeloid leukemia,24-dehydrocholesterol reductase
8806,gilteritinib,acute myeloid leukemia,interleukin 1 receptor associated kinase 3
8807,gilteritinib,acute myeloid leukemia,polo like kinase 4
8808,gilteritinib,acute myeloid leukemia,solute carrier family 25 member 5
8809,gilteritinib,acute myeloid leukemia,protein kinase c alpha
8810,gilteritinib,acute myeloid leukemia,acyl-coa synthetase long chain family member 5
8811,gilteritinib,acute myeloid leukemia,cytochrome c1
8812,gilteritinib,acute myeloid leukemia,fms related receptor tyrosine kinase 3
8813,gilteritinib,acute myeloid leukemia,unc-51 like kinase 3
8814,gilteritinib,acute myeloid leukemia,ap2 associated kinase 1
8815,gilteritinib,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase 11
8816,gilteritinib,acute myeloid leukemia,platelet derived growth factor receptor beta
8817,vincristine,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
8818,epirubicin,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
8819,etoposide,diffuse large b-cell lymphoma,dna topoisomerase ii alpha
8820,etoposide,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
8821,prednisone,diffuse large b-cell lymphoma,nuclear receptor subfamily 3 group c member 1
8822,prednisone,diffuse large b-cell lymphoma,atp binding cassette subfamily b member 1
8823,lenalidomide,follicular lymphoma,cereblon
8824,teniposide,follicular lymphoma,dna topoisomerase ii alpha
8825,mitoxantrone,follicular lymphoma,dna topoisomerase ii alpha
8826,prednisone,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
8827,cortisol,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
8828,betamethasone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
8829,prednisone,non-hodgkin lymphoma,nuclear receptor subfamily 3 group c member 1
8830,ivermectin,onchocerciasis,glycine receptor alpha 3
8831,thalidomide,poems syndrome,cereblon
8832,ibrutinib,marginal zone lymphoma,erb-b2 receptor tyrosine kinase 2
8833,cladribine,hairy cell leukemia,ribonucleotide reductase catalytic subunit m1
8834,vinblastine,gestational trophoblastic neoplasm,tubulin beta 4a class iva
8835,vinblastine,gestational trophoblastic neoplasm,tubulin beta 1 class vi
8836,vinblastine,gestational trophoblastic neoplasm,tubulin beta 8 class viii
8837,vinblastine,gestational trophoblastic neoplasm,atp binding cassette subfamily b member 1
8838,vinblastine,gestational trophoblastic neoplasm,tubulin beta 2b class iib
8839,vinblastine,gestational trophoblastic neoplasm,tubulin beta 4b class ivb
8840,vinblastine,gestational trophoblastic neoplasm,tubulin beta class i
8841,vinblastine,gestational trophoblastic neoplasm,tubulin beta 2a class iia
8842,vinblastine,gestational trophoblastic neoplasm,tubulin beta 3 class iii
8843,vinblastine,gestational trophoblastic neoplasm,tubulin beta 6 class v
8844,methyltestosterone,noonan syndrome,androgen receptor
8845,fluoxymesterone,noonan syndrome,androgen receptor
8846,tafamidis,amyloidosis,transthyretin
8847,prednisone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8848,methylprednisolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8849,triamcinolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8850,triamcinolone,idiopathic acute eosinophilic pneumonia,serpin family a member 6
8851,prednisolone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8852,prednisolone,idiopathic acute eosinophilic pneumonia,serpin family a member 6
8853,cortisol,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8854,cortisol,idiopathic acute eosinophilic pneumonia,sex hormone binding globulin
8855,cortisol,idiopathic acute eosinophilic pneumonia,serpin family a member 6
8856,betamethasone,idiopathic acute eosinophilic pneumonia,nuclear receptor subfamily 3 group c member 1
8857,prednisolone,sympathetic ophthalmia,serpin family a member 6
8858,triamcinolone,sympathetic ophthalmia,serpin family a member 6
8859,sapropterin,classic phenylketonuria,phenylalanine hydroxylase
8860,triamcinolone,sarcoidosis,serpin family a member 6
8861,cortisol,sarcoidosis,nuclear receptor subfamily 3 group c member 1
8862,cortisol,sarcoidosis,sex hormone binding globulin
8863,cortisol,sarcoidosis,serpin family a member 6
8864,prednisone,sarcoidosis,nuclear receptor subfamily 3 group c member 1
8865,prednisolone,sarcoidosis,serpin family a member 6
8866,bosentan,scleroderma,endothelin receptor type a
8867,bosentan,scleroderma,endothelin receptor type b
8868,tafamidis,attrv122i amyloidosis,transthyretin
8869,prednisone,trichinellosis,nuclear receptor subfamily 3 group c member 1
8870,triamcinolone,trichinellosis,serpin family a member 6
8871,cortisol,trichinellosis,sex hormone binding globulin
8872,cortisol,trichinellosis,serpin family a member 6
8873,mometasone,discoid lupus erythematosus,nuclear receptor subfamily 3 group c member 1
8874,chloroquine,discoid lupus erythematosus,toll like receptor 9
8875,hydroxychloroquine,discoid lupus erythematosus,toll like receptor 7
8876,hydroxychloroquine,discoid lupus erythematosus,toll like receptor 9
8877,vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 1b
8878,vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 1a
8879,vasopressin,hereditary von willebrand disease,arginine vasopressin receptor 2
8880,desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 1a
8881,desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 1b
8882,desmopressin,hereditary von willebrand disease,arginine vasopressin receptor 2
8883,hydroxocobalamin,vitamin b12 deficiency,cubilin
8884,hydroxocobalamin,vitamin b12 deficiency,cobalamin binding intrinsic factor
8885,hydroxocobalamin,vitamin b12 deficiency,amnion associated transmembrane protein
8886,ciprofloxacin,escherichia coli infection,atp binding cassette subfamily b member 1
8887,oxaliplatin,malignant colon neoplasm,glutathione s-transferase pi 1
8888,oxaliplatin,malignant colon neoplasm,solute carrier family 22 member 1
8889,oxaliplatin,malignant colon neoplasm,glutathione s-transferase mu 1
8890,oxaliplatin,malignant colon neoplasm,atpase copper transporting alpha
8891,trifluridine,malignant colon neoplasm,thymidylate synthetase
8892,trifluridine,malignant colon neoplasm,thymidine phosphorylase
8893,tipiracil,malignant colon neoplasm,thymidine phosphorylase
8894,5-fluorouracil,malignant colon neoplasm,thymidine phosphorylase
8895,5-fluorouracil,malignant colon neoplasm,thymidylate synthetase
8896,5-fluorouracil,malignant colon neoplasm,methylenetetrahydrofolate reductase
8897,5-fluorouracil,malignant colon neoplasm,dihydropyrimidine dehydrogenase
8898,5-fluorouracil,malignant colon neoplasm,uridine monophosphate synthetase
8899,biperiden,parkinsonian disorder,cholinergic receptor muscarinic 2
8900,biperiden,parkinsonian disorder,cholinergic receptor muscarinic 4
8901,carbidopa,parkinsonian disorder,dopa decarboxylase
8902,procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 2
8903,procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 4
8904,procyclidine,parkinsonian disorder,cholinergic receptor muscarinic 1
8905,pergolide,parkinsonian disorder,dopamine receptor d1
8906,pergolide,parkinsonian disorder,dopamine receptor d5
8907,pergolide,parkinsonian disorder,dopamine receptor d3
8908,pergolide,parkinsonian disorder,dopamine receptor d2
8909,pergolide,parkinsonian disorder,dopamine receptor d4
8910,methixene,parkinsonian disorder,cholinergic receptor muscarinic 4
8911,methixene,parkinsonian disorder,cholinergic receptor muscarinic 2
8912,methixene,parkinsonian disorder,cholinergic receptor muscarinic 1
8913,amantadine,parkinsonian disorder,dopa decarboxylase
8914,amantadine,parkinsonian disorder,monoamine oxidase b
8915,amantadine,parkinsonian disorder,sigma non-opioid intracellular receptor 1
8916,levodopa,parkinsonian disorder,dopa decarboxylase
8917,benzatropine,parkinsonian disorder,cholinergic receptor muscarinic 2
8918,orphenadrine,parkinsonian disorder,sodium voltage-gated channel alpha subunit 9
8919,orphenadrine,parkinsonian disorder,sodium voltage-gated channel alpha subunit 1
8920,orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 2
8921,orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 4
8922,orphenadrine,parkinsonian disorder,cholinergic receptor muscarinic 1
8923,methylphenidate,narcolepsy,solute carrier family 6 member 3
8924,methylphenidate,narcolepsy,solute carrier family 6 member 2
8925,dexamfetamine,narcolepsy,trace amine associated receptor 1
8926,amphetamine,narcolepsy,solute carrier family 6 member 2
8927,amphetamine,narcolepsy,solute carrier family 6 member 3
8928,imipramine,narcolepsy,5-hydroxytryptamine receptor 2a
8929,imipramine,narcolepsy,solute carrier family 6 member 3
8930,imipramine,narcolepsy,solute carrier family 6 member 2
8931,clomiphene,female infertility,cytochrome p450 family 19 subfamily a member 1
8932,clomiphene,female infertility,estrogen receptor 1
8933,caffeine,headache disorder,phosphodiesterase 4b
8934,haloperidol,headache disorder,histamine receptor h1
8935,haloperidol,headache disorder,adrenoceptor alpha 1a
8936,icosapent,hyperlipidemia,diacylglycerol o-acyltransferase 1
8937,lovastatin,hyperlipidemia,3-hydroxy-3-methylglutaryl-coa reductase
8938,nicotine,hyperlipidemia,cytochrome p450 family 19 subfamily a member 1
8939,ezetimibe,hyperlipidemia,atp binding cassette subfamily g member 8
8940,ezetimibe,hyperlipidemia,atp binding cassette subfamily g member 5
8941,nicotinic acid,hyperlipidemia,hydroxycarboxylic acid receptor 3
8942,bezafibrate,hyperlipidemia,3-hydroxy-3-methylglutaryl-coa reductase
8943,fenofibrate,hyperlipidemia,peroxisome proliferator activated receptor alpha
8944,estramustine,prostate neoplasm,cytochrome p450 family 3 subfamily a member 4
8945,estramustine,prostate neoplasm,estrogen receptor 1
8946,estramustine,prostate neoplasm,estrogen receptor 2
8947,flutamide,prostate neoplasm,cytochrome p450 family 1 subfamily b member 1
8948,flutamide,prostate neoplasm,cytochrome p450 family 1 subfamily a member 1
8949,flutamide,prostate neoplasm,cytochrome p450 family 2 subfamily c member 19
8950,flutamide,prostate neoplasm,cytochrome p450 family 3 subfamily a member 5
8951,flutamide,prostate neoplasm,androgen receptor
8952,flutamide,prostate neoplasm,aryl hydrocarbon receptor
8953,flutamide,prostate neoplasm,cytochrome p450 family 3 subfamily a member 4
8954,paclitaxel,neoplasm of esophagus,bcl2 apoptosis regulator
8955,paclitaxel,neoplasm of esophagus,cytochrome p450 family 19 subfamily a member 1
8956,paclitaxel,neoplasm of esophagus,atp binding cassette subfamily b member 1
8957,paclitaxel,neoplasm of esophagus,nuclear receptor subfamily 1 group i member 2
8958,clozapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8959,clozapine,manic bipolar affective disorder,dopamine receptor d1
8960,aripiprazole,manic bipolar affective disorder,dopamine receptor d5
8961,aripiprazole,manic bipolar affective disorder,dopamine receptor d1
8962,aripiprazole,manic bipolar affective disorder,solute carrier family 6 member 4
8963,aripiprazole,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8964,carbamazepine,manic bipolar affective disorder,solute carrier family 6 member 4
8965,risperidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8966,risperidone,manic bipolar affective disorder,dopamine receptor d1
8967,risperidone,manic bipolar affective disorder,tachykinin precursor 1
8968,risperidone,manic bipolar affective disorder,dopamine receptor d5
8969,risperidone,manic bipolar affective disorder,solute carrier family 6 member 4
8970,asenapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8971,asenapine,manic bipolar affective disorder,dopamine receptor d1
8972,asenapine,manic bipolar affective disorder,solute carrier family 6 member 4
8973,asenapine,manic bipolar affective disorder,tachykinin precursor 1
8974,paliperidone,manic bipolar affective disorder,dopamine receptor d1
8975,paliperidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8976,paliperidone,manic bipolar affective disorder,tachykinin precursor 1
8977,ziprasidone,manic bipolar affective disorder,dopamine receptor d1
8978,ziprasidone,manic bipolar affective disorder,dopamine receptor d5
8979,ziprasidone,manic bipolar affective disorder,solute carrier family 6 member 4
8980,ziprasidone,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8981,ziprasidone,manic bipolar affective disorder,tachykinin precursor 1
8982,olanzapine,manic bipolar affective disorder,dopamine receptor d1
8983,olanzapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8984,olanzapine,manic bipolar affective disorder,dopamine receptor d5
8985,promazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8986,promazine,manic bipolar affective disorder,dopamine receptor d1
8987,quetiapine,manic bipolar affective disorder,dopamine receptor d5
8988,quetiapine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8989,quetiapine,manic bipolar affective disorder,dopamine receptor d1
8990,quetiapine,manic bipolar affective disorder,tachykinin precursor 1
8991,quetiapine,manic bipolar affective disorder,solute carrier family 6 member 4
8992,cariprazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8993,cariprazine,manic bipolar affective disorder,dopamine receptor d5
8994,cariprazine,manic bipolar affective disorder,dopamine receptor d1
8995,chlorpromazine,manic bipolar affective disorder,dopamine receptor d5
8996,chlorpromazine,manic bipolar affective disorder,5-hydroxytryptamine receptor 2a
8997,chlorpromazine,manic bipolar affective disorder,dopamine receptor d1
8998,chlorpromazine,manic bipolar affective disorder,solute carrier family 6 member 4
8999,doxepin,bipolar depression,5-hydroxytryptamine receptor 2a
9000,doxepin,bipolar depression,solute carrier family 6 member 4
9001,doxepin,bipolar depression,5-hydroxytryptamine receptor 1a
9002,primidone,bipolar depression,glutamate ionotropic receptor kainate type subunit 2
9003,sertraline,bipolar depression,solute carrier family 6 member 4
9004,sertraline,bipolar depression,monoamine oxidase a
9005,paroxetine,bipolar depression,tachykinin receptor 1
9006,paroxetine,bipolar depression,solute carrier family 6 member 4
9007,paroxetine,bipolar depression,5-hydroxytryptamine receptor 2a
9008,paroxetine,bipolar depression,5-hydroxytryptamine receptor 1a
9009,quetiapine,bipolar depression,dopamine receptor d5
9010,quetiapine,bipolar depression,5-hydroxytryptamine receptor 1a
9011,quetiapine,bipolar depression,5-hydroxytryptamine receptor 2a
9012,quetiapine,bipolar depression,dopamine receptor d1
9013,quetiapine,bipolar depression,tachykinin precursor 1
9014,quetiapine,bipolar depression,solute carrier family 6 member 4
9015,lurasidone,bipolar depression,5-hydroxytryptamine receptor 1a
9016,lurasidone,bipolar depression,5-hydroxytryptamine receptor 2a
9017,carbamazepine,bipolar depression,solute carrier family 6 member 4
9018,escitalopram,bipolar depression,solute carrier family 6 member 4
9019,phenobarbital,bipolar depression,glutamate ionotropic receptor kainate type subunit 2
9020,bupropion,bipolar depression,solute carrier family 6 member 4
9021,nefazodone,bipolar depression,5-hydroxytryptamine receptor 1a
9022,nefazodone,bipolar depression,5-hydroxytryptamine receptor 2a
9023,nefazodone,bipolar depression,solute carrier family 6 member 4
9024,citalopram,bipolar depression,solute carrier family 6 member 4
9025,risperidone,bipolar depression,5-hydroxytryptamine receptor 2a
9026,risperidone,bipolar depression,dopamine receptor d1
9027,risperidone,bipolar depression,5-hydroxytryptamine receptor 1a
9028,risperidone,bipolar depression,tachykinin precursor 1
9029,risperidone,bipolar depression,dopamine receptor d5
9030,risperidone,bipolar depression,solute carrier family 6 member 4
9031,fluvoxamine,bipolar depression,solute carrier family 6 member 4
9032,ziprasidone,bipolar depression,dopamine receptor d1
9033,ziprasidone,bipolar depression,dopamine receptor d5
9034,ziprasidone,bipolar depression,solute carrier family 6 member 4
9035,ziprasidone,bipolar depression,5-hydroxytryptamine receptor 2a
9036,ziprasidone,bipolar depression,5-hydroxytryptamine receptor 1a
9037,ziprasidone,bipolar depression,tachykinin precursor 1
9038,olanzapine,bipolar depression,5-hydroxytryptamine receptor 1a
9039,olanzapine,bipolar depression,dopamine receptor d1
9040,olanzapine,bipolar depression,5-hydroxytryptamine receptor 2a
9041,olanzapine,bipolar depression,dopamine receptor d5
9042,fluoxetine,bipolar depression,5-hydroxytryptamine receptor 2a
9043,fluoxetine,bipolar depression,solute carrier family 6 member 4
9044,paliperidone,bipolar depression,5-hydroxytryptamine receptor 1a
9045,paliperidone,bipolar depression,dopamine receptor d1
9046,paliperidone,bipolar depression,5-hydroxytryptamine receptor 2a
9047,paliperidone,bipolar depression,tachykinin precursor 1
9048,diazoxide,pancreatic insulinoma,atp binding cassette subfamily c member 8
9049,cimetidine,zollinger-ellison syndrome,solute carrier family 47 member 1
9050,rabeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9051,lansoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9052,nizatidine,zollinger-ellison syndrome,histamine receptor h2
9053,pantoprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9054,famotidine,zollinger-ellison syndrome,solute carrier family 47 member 1
9055,esomeprazole,zollinger-ellison syndrome,atpase h+/k+ transporting subunit beta
9056,betamethasone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9057,prednisolone,polymyalgia rheumatica,serpin family a member 6
9058,methylprednisolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9059,triamcinolone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9060,triamcinolone,polymyalgia rheumatica,serpin family a member 6
9061,prednisone,polymyalgia rheumatica,nuclear receptor subfamily 3 group c member 1
9062,ergotamine,cluster headache syndrome,5-hydroxytryptamine receptor 1b
9063,dihydroergotamine,cluster headache syndrome,adrenoceptor alpha 2a
9064,caffeine,cluster headache syndrome,phosphodiesterase 4b
9065,prednisone,serum sickness,nuclear receptor subfamily 3 group c member 1
9066,prednisone,serum sickness,albumin
9067,cortisol,serum sickness,nuclear receptor subfamily 3 group c member 1
9068,haloperidol,delirium,dopamine receptor d2
9069,haloperidol,delirium,dopamine receptor d3
9070,oxycodone,neuralgia,opioid receptor mu 1
9071,phenytoin,neuralgia,sodium voltage-gated channel alpha subunit 5
9072,phenytoin,neuralgia,sodium voltage-gated channel alpha subunit 9
9073,gabapentin,neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
9074,trimipramine,neuralgia,5-hydroxytryptamine receptor 2c
9075,naltrexone,neuralgia,opioid receptor mu 1
9076,desipramine,neuralgia,5-hydroxytryptamine receptor 2c
9077,carbamazepine,neuralgia,sodium voltage-gated channel alpha subunit 5
9078,carbamazepine,neuralgia,sodium voltage-gated channel alpha subunit 9
9079,amitriptyline,neuralgia,5-hydroxytryptamine receptor 2c
9080,amitriptyline,neuralgia,opioid receptor mu 1
9081,amitriptyline,neuralgia,neurotrophic receptor tyrosine kinase 1
9082,imipramine,neuralgia,5-hydroxytryptamine receptor 2c
9083,venlafaxine,neuralgia,5-hydroxytryptamine receptor 2c
9084,nortriptyline,neuralgia,5-hydroxytryptamine receptor 2c
9085,morphine,neuralgia,opioid receptor mu 1
9086,tramadol,neuralgia,opioid receptor mu 1
9087,tramadol,neuralgia,5-hydroxytryptamine receptor 2c
9088,lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 9
9089,lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 5
9090,lamotrigine,neuralgia,sodium voltage-gated channel alpha subunit 10
9091,ibrutinib,waldenstrom macroglobulinemia,bmx non-receptor tyrosine kinase
9092,ibrutinib,waldenstrom macroglobulinemia,tec protein tyrosine kinase
9093,ibrutinib,waldenstrom macroglobulinemia,"blk proto-oncogene, src family tyrosine kinase"
9094,ibrutinib,waldenstrom macroglobulinemia,txk tyrosine kinase
9095,carmustine,malignant glioma,glutathione-disulfide reductase
9096,phenobarbital,hyperbilirubinemia,atp binding cassette subfamily c member 2
9097,phenobarbital,hyperbilirubinemia,atp binding cassette subfamily b member 11
9098,riboflavin,vitamin deficiency disorder,riboflavin kinase
9099,methylprednisolone,perennial allergic rhinitis,nuclear receptor subfamily 3 group c member 1
9100,gabapentin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
9101,pregabalin,postherpetic neuralgia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
9102,calcifediol,vitamin d deficiency,vitamin d receptor
9103,"1,25-dihydroxyvitamin d3",vitamin d deficiency,vitamin d receptor
9104,ergocalciferol,vitamin d deficiency,vitamin d receptor
9105,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 2
9106,nintedanib,interstitial lung disease 2,dual specificity tyrosine phosphorylation regulated kinase 1b
9107,nintedanib,interstitial lung disease 2,fibroblast growth factor receptor 3
9108,nintedanib,interstitial lung disease 2,kinase insert domain receptor
9109,nintedanib,interstitial lung disease 2,cdc like kinase 1
9110,nintedanib,interstitial lung disease 2,doublecortin like kinase 1
9111,nintedanib,interstitial lung disease 2,axl receptor tyrosine kinase
9112,nintedanib,interstitial lung disease 2,txk tyrosine kinase
9113,nintedanib,interstitial lung disease 2,discoidin domain receptor tyrosine kinase 1
9114,nintedanib,interstitial lung disease 2,nuak family kinase 2
9115,nintedanib,interstitial lung disease 2,insulin receptor related receptor
9116,nintedanib,interstitial lung disease 2,fms related receptor tyrosine kinase 1
9117,nintedanib,interstitial lung disease 2,cyclin dependent kinase 16
9118,nintedanib,interstitial lung disease 2,serine/threonine kinase 16
9119,nintedanib,interstitial lung disease 2,rio kinase 1
9120,nintedanib,interstitial lung disease 2,"mer proto-oncogene, tyrosine kinase"
9121,nintedanib,interstitial lung disease 2,platelet derived growth factor receptor beta
9122,nintedanib,interstitial lung disease 2,g protein-coupled receptor kinase 4
9123,nintedanib,interstitial lung disease 2,maternal embryonic leucine zipper kinase
9124,nintedanib,interstitial lung disease 2,cdc like kinase 4
9125,nintedanib,interstitial lung disease 2,serine/threonine kinase 11
9126,nintedanib,interstitial lung disease 2,srsf protein kinase 3
9127,nintedanib,interstitial lung disease 2,ribosomal protein s6 kinase a2
9128,nintedanib,interstitial lung disease 2,ttk protein kinase
9129,nintedanib,interstitial lung disease 2,platelet derived growth factor receptor alpha
9130,nintedanib,interstitial lung disease 2,serine/threonine kinase 4
9131,nintedanib,interstitial lung disease 2,protein kinase cgmp-dependent 1
9132,nintedanib,interstitial lung disease 2,"hck proto-oncogene, src family tyrosine kinase"
9133,nintedanib,interstitial lung disease 2,bmp2 inducible kinase
9134,nintedanib,interstitial lung disease 2,ret proto-oncogene
9135,nintedanib,interstitial lung disease 2,eph receptor a3
9136,nintedanib,interstitial lung disease 2,pre-mrna processing factor kinase prp4k
9137,nintedanib,interstitial lung disease 2,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
9138,nintedanib,interstitial lung disease 2,unc-51 like autophagy activating kinase 1
9139,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 7
9140,nintedanib,interstitial lung disease 2,"yes proto-oncogene 1, src family tyrosine kinase"
9141,nintedanib,interstitial lung disease 2,fibroblast growth factor receptor 1
9142,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 19
9143,nintedanib,interstitial lung disease 2,mitogen-activated protein kinase kinase 5
9144,nintedanib,interstitial lung disease 2,activin a receptor type 1
9145,chlorpromazine,disruptive behavior disorder,dopamine receptor d4
9146,promazine,disruptive behavior disorder,dopamine receptor d4
9147,prednisone,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
9148,cortisol,exfoliative dermatitis,nuclear receptor subfamily 3 group c member 1
9149,methylprednisolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9150,betamethasone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9151,prednisone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9152,prednisolone,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9153,cortisol,humoral hypercalcemia of malignancy,nuclear receptor subfamily 3 group c member 1
9154,clonazepam,absence epilepsy,gamma-aminobutyric acid type a receptor subunit gamma2
9155,rivaroxaban,embolism,coagulation factor x
9156,terbutaline,premature obstetric labor,adrenoceptor beta 2
9157,imatinib,"leukemia, myeloid, chronic-phase","abl proto-oncogene 1, non-receptor tyrosine kinase"
9158,haloperidol,chronic schizophrenia,cytochrome p450 family 3 subfamily a member 4
9159,haloperidol,chronic schizophrenia,cholinergic receptor muscarinic 1
9160,mometasone,pruritus ani,nuclear receptor subfamily 3 group c member 1
9161,cortisol,pruritus ani,nuclear receptor subfamily 3 group c member 1
9162,caffeine,vascular headaches,phosphodiesterase 4b
9163,dihydroergotamine,vascular headaches,adrenoceptor alpha 2a
9164,ergotamine,vascular headaches,5-hydroxytryptamine receptor 1b
9165,trospium chloride,urge incontinence,cholinergic receptor muscarinic 2
9166,trospium chloride,urge incontinence,cholinergic receptor muscarinic 1
9167,trospium chloride,urge incontinence,cholinergic receptor muscarinic 3
9168,darifenacin,urge incontinence,cholinergic receptor muscarinic 2
9169,darifenacin,urge incontinence,cholinergic receptor muscarinic 1
9170,tolterodine,urge incontinence,cholinergic receptor muscarinic 2
9171,tolterodine,urge incontinence,cholinergic receptor muscarinic 1
9172,drospirenone,premenstrual dysphoric disorder,nuclear receptor subfamily 3 group c member 2
9173,ethinylestradiol,premenstrual dysphoric disorder,estrogen receptor 2
9174,ivacaftor,pulmonary cystic fibrosis,cf transmembrane conductance regulator
9175,tafamidis,"familial amyloid neuropathy, portuguese type",transthyretin
9176,doxepin,severe major depression with psychotic features,5-hydroxytryptamine receptor 2a
9177,pralidoxime,poisoning of animals with phosphate salts,butyrylcholinesterase
9178,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4c
9179,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4a
9180,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4d
9181,theophylline,asthma-chronic obstructive pulmonary disease overlap syndrome,phosphodiesterase 4b
9182,nilotinib,alcohol dependence,"blk proto-oncogene, src family tyrosine kinase"
9183,plerixafor,hyperbilirubinemia,electron transfer flavoprotein dehydrogenase
9184,colecalciferol,cerebrovascular disorder,calcium voltage-gated channel subunit alpha1 i
9185,oxycodone,tricuspid atresia,sodium channel epithelial 1 subunit gamma
9186,azilsartan medoxomil,postoperative nausea and vomiting,phosphodiesterase 7a
9187,clotrimazole,streptococcal pneumonia,cytochrome p450 family 51 subfamily a member 1
9188,mirtazapine,vascular headaches,"abl proto-oncogene 2, non-receptor tyrosine kinase"
9189,ciprofloxacin,tricuspid atresia,"ros proto-oncogene 1, receptor tyrosine kinase"
9190,gliquidone,pulmonary artery stenosis,cytochrome p450 family 2 subfamily d member 6
9191,metyrapone,acquired thrombocytopenia,eph receptor a1
9192,primidone,duodenal ulcer,structural maintenance of chromosomes 1a
9193,penicillamine,mydriasis,"jun proto-oncogene, ap-1 transcription factor subunit"
9194,dicumarol,gonorrhea,carbonic anhydrase 4
9195,venlafaxine,musculoskeletal system disorder,solute carrier family 22 member 4
9196,benzquinamide,ovarian cancer,atpase copper transporting beta
9197,benoxaprofen,myotonic syndrome,glutathione-disulfide reductase
9198,mitiglinide,anxiety,dopamine receptor d2
9199,pimecrolimus,thyroiditis,methylenetetrahydrofolate reductase
9200,mebendazole,non-small cell lung carcinoma,fer tyrosine kinase
9201,methoxamine,bacterial conjunctivitis,cobalamin binding intrinsic factor
9202,amantadine,hemorrhagic disease of newborn,pre-mrna processing factor kinase prp4k
9203,prucalopride,blepharoconjunctivitis,eukaryotic translation initiation factor 4e
9204,sulindac,central nervous system origin vertigo,cytochrome p450 family 51 subfamily a member 1
9205,floctafenine,pulmonary eosinophilia,eph receptor a1
9206,nicorandil,obesity disorder,transforming growth factor beta receptor 2
9207,carbimazole,neuroblastoma,high mobility group box 1
9208,clofarabine,hyponatremia,prostaglandin e receptor 4
9209,pentoxifylline,bacterial meningitis,protein kinase c alpha
9210,modafinil,endometrium neoplasm,potassium voltage-gated channel subfamily a member 3
9211,loratadine,hyperbilirubinemia,serine/threonine kinase 25
9212,carbinoxamine,otitis externa,microtubule associated protein 1a
9213,dextrothyroxine,urticaria,potassium voltage-gated channel subfamily b member 1
9214,clozapine,melanoma,protein kinase cgmp-dependent 1
9215,somatropin,asthma-chronic obstructive pulmonary disease overlap syndrome,solute carrier family 25 member 6
9216,crisaborole,altitude sickness,thromboxane a2 receptor
9217,rivaroxaban,phenylketonuria,gamma-aminobutyric acid type a receptor subunit alpha5
9218,dextromethorphan,glaucoma,angiotensin i converting enzyme
9219,tramadol,malignant glioma,phenylalanine hydroxylase
9220,clomiphene,social phobia,potassium voltage-gated channel subfamily h member 8
9221,fluspirilene,punctate epithelial keratoconjunctivitis,potassium voltage-gated channel subfamily c member 2
9222,cabozantinib,delayed puberty,dopamine receptor d3
9223,dapsone,vascular headaches,sodium voltage-gated channel alpha subunit 2
9224,losartan,premature obstetric labor,dopamine receptor d1
9225,tirofiban,peyronie disease,phosphodiesterase 5a
9226,everolimus,decreased cardiac output,cytochrome p450 family 2 subfamily c member 9
9227,prednisolone,chronic kidney disease,adrenoceptor beta 2
9228,candesartan,duodenal ulcer,potassium voltage-gated channel modifier subfamily s member 1
9229,reproterol,postoperative nausea and vomiting,proteasome 20s subunit beta 5
9230,migalastat,panic disorder,androgen receptor
9231,floxuridine,restless legs syndrome,phospholipase a2 group iva
9232,lixisenatide,urge incontinence,dna methyltransferase 3 alpha
9233,tadalafil,chronic primary adrenal insufficiency,5-hydroxytryptamine receptor 2a
9234,paclitaxel,hyponatremia,neurotrophic receptor tyrosine kinase 2
9235,propantheline,mydriasis,potassium voltage-gated channel subfamily b member 2
9236,bilastine,proctitis,fer tyrosine kinase
9237,carbachol,acidosis disorder,"met proto-oncogene, receptor tyrosine kinase"
9238,vardenafil,hypoactive sexual desire disorder,salt inducible kinase 1
9239,leuprolide,lennox-gastaut syndrome,axl receptor tyrosine kinase
9240,solifenacin,strongyloidiasis,potassium voltage-gated channel subfamily a member 7
9241,modafinil,diffuse alopecia areata,cyclin dependent kinase 6
9242,fentanyl,dysmenorrhea,solute carrier family 22 member 3
9243,loteprednol etabonate,thrombotic disease,solute carrier family 6 member 1
9244,tranylcypromine,medullary thyroid gland carcinoma,15-hydroxyprostaglandin dehydrogenase
9245,ketorolac,chronic myelomonocytic leukemia,5-hydroxytryptamine receptor 4
9246,trifluridine,lung lymphangioleiomyomatosis,growth hormone releasing hormone receptor
9247,cytarabine,humoral hypercalcemia of malignancy,amine oxidase copper containing 3
9248,terguride,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",phenylalanine hydroxylase
9249,azelastine,seborrheic dermatitis,serpin family a member 6
9250,ruxolitinib,thyroid gland carcinoma,annexin a1
9251,promazine,contact dermatitis,calcitonin receptor
9252,olmutinib,type 2 diabetes mellitus,mitogen-activated protein kinase kinase kinase kinase 1
9253,carfilzomib,thrombocytopenia,dopamine receptor d3
9254,teniposide,postpartum depression,polo like kinase 4
9255,viloxazine,toothache,cytochrome p450 family 11 subfamily b member 2
9256,prednisolone,follicular lymphoma,serine/threonine kinase 33
9257,phendimetrazine,peyronie disease,gamma-aminobutyric acid type a receptor subunit alpha1
9258,oxaprozin,oral mucosa leukoplakia,potassium voltage-gated channel subfamily h member 2
9259,bosutinib,heart failure,dipeptidyl peptidase 9
9260,antazoline,adrenocortical insufficiency,glutamate ionotropic receptor ampa type subunit 1
9261,metoprolol,hepatic veno-occlusive disease,oxytocin receptor
9262,metoprolol,acromegaly,cytochrome p450 family 2 subfamily d member 6
9263,armodafinil,atrial fibrillation,riboflavin kinase
9264,crisaborole,altitude sickness,angiotensin ii receptor type 2
9265,tacrolimus,bacterial endocarditis,gc vitamin d binding protein
9266,levomethadyl acetate,intermittent vascular claudication,death associated protein kinase 2
9267,ospemifene,goiter,n-acylsphingosine amidohydrolase 1
9268,methotrexate,"hydatidiform mole, recurrent, 1",mitogen-activated protein kinase kinase kinase 7
9269,raltegravir,plasmodium malariae malaria,mitogen-activated protein kinase kinase kinase 7
9270,chlorpropamide,canker sore,atpase h+/k+ transporting subunit alpha
9271,olmesartan,neuralgia,leukotriene a4 hydrolase
9272,glycopyrrolate,respiratory syncytial virus infectious disease,interleukin 1 beta
9273,talinolol,aspiration pneumonitis,serine/threonine kinase 25
9274,oxcarbazepine,cardiac arrest,potassium voltage-gated channel subfamily h member 6
9275,anakinra,mycosis fungoides,inosine monophosphate dehydrogenase 1
9276,riociguat,chronic hepatitis c virus infection,tyrosinase
9277,darunavir,exfoliative dermatitis,cobalamin binding intrinsic factor
9278,lorlatinib,delirium,melanocortin 3 receptor
9279,glutethimide,intermittent vascular claudication,cholinergic receptor nicotinic alpha 6 subunit
9280,indapamide,biotinidase deficiency,discoidin domain receptor tyrosine kinase 2
9281,hydroxocobalamin,tyrosinemia,succinate dehydrogenase complex flavoprotein subunit a
9282,simvastatin,bruxism,5-hydroxytryptamine receptor 3b
9283,trichlormethiazide,homocystinuria,solute carrier family 12 member 3
9284,cariprazine,seborrheic dermatitis,insulin receptor related receptor
9285,istradefylline,phenylketonuria,cytochrome p450 family 19 subfamily a member 1
9286,tolbutamide,early myoclonic encephalopathy,amnion associated transmembrane protein
9287,flibanserin,pellagra,3-hydroxy-3-methylglutaryl-coa reductase
9288,dexibuprofen,pulmonary fibrosis,solute carrier family 9 member a1
9289,dihydroergotamine,urinary retention,kallikrein b1
9290,omacetaxine mepesuccinate,secondary hyperparathyroidism,ryanodine receptor 2
9291,capsaicin,laryngeal edema,"coagulation factor ii, thrombin"
9292,clorazepate,toxic shock syndrome,amine oxidase copper containing 3
9293,anakinra,malignant essential hypertension,sodium voltage-gated channel alpha subunit 5
9294,lenalidomide,thrombotic disease,tubulin beta 6 class v
9295,carbachol,subarachnoid hemorrhage,amine oxidase copper containing 1
9296,avanafil,essential hypertension,tubulin beta 4a class iva
9297,aranidipine,b-cell chronic lymphocytic leukemia,phospholipase a2 group iie
9298,oxybutynin,hodgkins lymphoma,tyrosinase
9299,fosamprenavir,vomiting,bub1 mitotic checkpoint serine/threonine kinase
9300,dapsone,angle-closure glaucoma,phosphodiesterase 3b
9301,nadolol,postherpetic neuralgia,atp binding cassette subfamily b member 11
9302,olaparib,visual epilepsy,phosphodiesterase 5a
9303,linaclotide,hypertrophic cardiomyopathy,gamma-aminobutyric acid type a receptor subunit alpha5
9304,clidinium,malignant essential hypertension,prostaglandin e receptor 2
9305,cyproheptadine,peripheral vascular disease,dopamine receptor d3
9306,budesonide,"leukemia, myeloid, chronic-phase",prostaglandin e synthase 3
9307,imipramine,bacterial pneumonia,gamma-aminobutyric acid type a receptor subunit alpha5
9308,abiraterone acetate,ventricular fibrillation,metallothionein 2a
9309,benzocaine,tinea corporis,arachidonate 5-lipoxygenase
9310,bumetanide,back pain,glutamate ionotropic receptor nmda type subunit 2b
9311,teriflunomide,open-angle glaucoma,dipeptidase 1
9312,digoxin,prostate neoplasm,carbonic anhydrase 9
9313,sibutramine,lichen planus,nuclear receptor subfamily 0 group b member 1
9314,montelukast,thromboembolism,structural maintenance of chromosomes 2
9315,abacavir,urinary bladder cancer,prostaglandin d2 receptor 2
9316,dofetilide,chancroid,progesterone receptor
9317,triprolidine,hypoalphalipoproteinemia,calcium voltage-gated channel subunit alpha1 c
9318,bisoprolol,urge incontinence,"b-raf proto-oncogene, serine/threonine kinase"
9319,captodiame,intracranial embolism,ebp cholestenol delta-isomerase
9320,mitomycin c,myocardial infarction,cytochrome p450 family 11 subfamily b member 1
9321,clemastine,hypoalphalipoproteinemia,protein kinase n2
9322,toloxatone,ascariasis,tubulin alpha 4a
9323,beclometasone,postpartum depression,potassium voltage-gated channel subfamily a member 2
9324,sermorelin,anxiety disorder,endothelin receptor type b
9325,nicotinic acid,dysmenorrhea,dopamine beta-hydroxylase
9326,plerixafor,ulcerative colitis,mapk interacting serine/threonine kinase 2
9327,perindopril,vascular headaches,"kras proto-oncogene, gtpase"
9328,abiraterone acetate,biotinidase deficiency,"blk proto-oncogene, src family tyrosine kinase"
9329,udenafil,diabetes mellitus,protein tyrosine kinase 2 beta
9330,luseogliflozin,open-angle glaucoma,adenosine a1 receptor
9331,methylphenobarbital,dermatophytosis of groin and perianal area,ornithine decarboxylase 1
9332,guanfacine,anogenital human papillomavirus infection,calcium voltage-gated channel auxiliary subunit alpha2delta 1
9333,doxylamine,angle-closure glaucoma,guanylate cyclase 1 soluble subunit alpha 2
9334,tocilizumab,gingivitis,glutathione s-transferase theta 1
9335,paclitaxel,cervical cancer,discoidin domain receptor tyrosine kinase 2
9336,ethinylestradiol,vascular disorder,solute carrier family 6 member 2
9337,tetracycline,plasmodium malariae malaria,vitamin d receptor
9338,vorapaxar,discoid lupus erythematosus,potassium two pore domain channel subfamily k member 3
9339,triazolam,dyspepsia,death associated protein kinase 1
9340,vortioxetine,epilepsy,squalene epoxidase
9341,testosterone propionate,alcohol dependence,interleukin 1 receptor associated kinase 3
9342,cetirizine,miliary tuberculosis,sirtuin 1
9343,radotinib,hyperglycemia,interleukin 1 receptor associated kinase 1
9344,dexmethylphenidate,chronic eosinophilic leukemia,cart prepropeptide
9345,fludarabine,angioedema,vascular cell adhesion molecule 1
9346,suramin,head and neck neoplasm,mitogen-activated protein kinase kinase kinase 19
9347,cisapride,pyoderma gangrenosum,tank binding kinase 1
9348,estrone sulphate,hemorrhagic disease of newborn,follicle stimulating hormone receptor
9349,colecalciferol,"familial amyloid neuropathy, portuguese type",5-methyltetrahydrofolate-homocysteine methyltransferase reductase
9350,fluvastatin,intermittent vascular claudication,gamma-glutamyl carboxylase
9351,tamibarotene,intermittent vascular claudication,ap2 associated kinase 1
9352,eszopiclone,superficial multifocal basal cell carcinoma,potassium voltage-gated channel subfamily b member 2
9353,fluvoxamine,thyroiditis,proteasome 20s subunit beta 2
9354,enzalutamide,chronic schizophrenia,acetyl-coa acetyltransferase 1
9355,terfenadine,epilepsy with generalized tonic-clonic seizures,dopa decarboxylase
9356,methylergonovine,angioedema,dopamine receptor d3
9357,bethanechol,prinzmetal angina,phospholipase a2 group iva
9358,esmolol,malignant essential hypertension,serine/threonine kinase 25
9359,homatropine methylbromide,sympathetic ophthalmia,platelet derived growth factor receptor beta
9360,bisoprolol,xerophthalmia,histone deacetylase 9
9361,chlorpropamide,anxiety disorder,"dna polymerase delta 1, catalytic subunit"
9362,pethidine,abdominal infection,low density lipoprotein receptor
9363,lidocaine,tinea pedis,structural maintenance of chromosomes 1a
9364,papaverine,female stress incontinence,ryanodine receptor 3
9365,famotidine,bacterial conjunctivitis,leukotriene a4 hydrolase
9366,valdecoxib,metrorrhagia,propionyl-coa carboxylase subunit alpha
9367,naloxone,congenital adrenal hyperplasia,gamma-aminobutyric acid type a receptor subunit alpha3
9368,phentermine,strongyloidiasis,fkbp prolyl isomerase 4
9369,dromostanolone propionate,plasmodium vivax malaria,prostaglandin d2 receptor
9370,empagliflozin,langerhans cell histiocytosis,inosine monophosphate dehydrogenase 1
9371,meclofenamic acid,fabry disease,calcium voltage-gated channel auxiliary subunit alpha2delta 1
9372,glisoxepide,otitis externa,propionyl-coa carboxylase subunit alpha
9373,oxymetazoline,eosinophilic esophagitis,sodium voltage-gated channel alpha subunit 7
9374,fsh,abdominal abscess,opioid receptor delta 1
9375,doxapram,gingivitis,estrogen receptor 2
9376,guanfacine,mast cell leukemia,solute carrier organic anion transporter family member 1b1
9377,insulin degludec,psoriasis,mapk interacting serine/threonine kinase 2
9378,oxybutynin,sympathetic ophthalmia,cytochrome p450 family 19 subfamily a member 1
9379,isocarboxazid,endometriosis,somatostatin receptor 5
9380,olmesartan,invasive ductal breast carcinoma,atp binding cassette subfamily c member 3
9381,levomilnacipran,multiple sclerosis,progesterone receptor
9382,befunolol,hodgkins lymphoma,tec protein tyrosine kinase
9383,oxazepam,heart failure,g protein-coupled receptor kinase 4
9384,rivastigmine,dermatomyositis,cyclin dependent kinase 6
9385,adapalene,hyperbilirubinemia,adrenoceptor beta 1
9386,ziprasidone,bacterial pneumonia,mitogen-activated protein kinase kinase kinase kinase 1
9387,iloprost,x-linked dominant hypophosphatemic rickets,interleukin 11 receptor subunit alpha
9388,cilazapril,pancreatic insulinoma,ryanodine receptor 2
9389,lafutidine,hyperaldosteronism,hypoxia inducible factor 1 subunit alpha
9390,calcium acetate,acquired polycythemia vera,potassium voltage-gated channel subfamily h member 8
9391,ticagrelor,chronic bronchitis,sodium voltage-gated channel alpha subunit 9
9392,quinestrol,gynecomastia disorder,kinase insert domain receptor
9393,celiprolol,tendinitis,steroid 5 alpha-reductase 1
9394,dasatinib,colonic neoplasm,tubulin beta 2a class iia
9395,imatinib,renal osteodystrophy,calcium voltage-gated channel subunit alpha1 b
9396,orphenadrine,uveitis,ndufa4 mitochondrial complex associated
9397,midostaurin,psoriatic arthritis,gamma-aminobutyric acid type a receptor subunit alpha6
9398,morphine,streptococcal meningitis,tachykinin precursor 1
9399,goserelin,type 1 diabetes mellitus,toll like receptor 7
9400,hydroxyzine,rosacea,carnitine palmitoyltransferase 1a
9401,icatibant,hypereosinophilic syndrome,dna topoisomerase ii alpha
9402,sofalcone,influenza,potassium voltage-gated channel subfamily a member 5
9403,promazine,tenosynovitis,solute carrier family 5 member 6
9404,ixazomib,hot flashes,potassium voltage-gated channel modifier subfamily g member 4
9405,dibucaine,bipolar disorder,maltase-glucoamylase
9406,phendimetrazine,hodgkins lymphoma,estrogen receptor 1
9407,diamicron,mantle cell lymphoma,glucose-6-phosphate dehydrogenase
9408,ticagrelor,bone osteosarcoma,npc1 like intracellular cholesterol transporter 1
9409,buspirone,hepatocellular carcinoma,carbonic anhydrase 12
9410,fludrocortisone,diffuse alopecia areata,"raf-1 proto-oncogene, serine/threonine kinase"
9411,perospirone,autism spectrum disorder,cytochrome p450 family 2 subfamily a member 6
9412,gepirone,metrorrhagia,integrin subunit alpha 2b
9413,loxoprofen,post-operative pain,mitogen-activated protein kinase kinase 1
9414,anastrozole,postmenopausal atrophic vaginitis,cytochrome c1
9415,sumatriptan,x-linked dominant hypophosphatemic rickets,solute carrier family 22 member 6
9416,floctafenine,acquired thrombocytopenia,monoamine oxidase b
9417,tulobuterol,lennox-gastaut syndrome,glutamate ionotropic receptor nmda type subunit 3a
9418,prazosin,postherpetic neuralgia,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
9419,losartan,trigeminal neuralgia,sodium voltage-gated channel alpha subunit 5
9420,riociguat,hairy cell leukemia,"plasminogen activator, tissue type"
9421,ketoprofen,idiopathic hypereosinophilic syndrome,cytochrome p450 family 2 subfamily c member 9
9422,homatropine methylbromide,allergic rhinitis,n-acylsphingosine amidohydrolase 1
9423,fluocinonide,plasma cell myeloma,"glucosidase alpha, neutral c"
9424,phenytoin,respiratory syncytial virus infectious disease,cdc like kinase 1
9425,travoprost,thyroid gland follicular carcinoma,calcium voltage-gated channel auxiliary subunit alpha2delta 1
9426,afamelanotide,vernal conjunctivitis,hydroxysteroid 11-beta dehydrogenase 1
9427,omarigliptin,brain edema,"abl proto-oncogene 2, non-receptor tyrosine kinase"
9428,nisoldipine,cutaneous candidiasis,"lck proto-oncogene, src family tyrosine kinase"
9429,tamsulosin,erythropoietic protoporphyria,microtubule affinity regulating kinase 3
9430,aminoglutethimide,otitis externa,dna topoisomerase ii beta
9431,emtricitabine,pulmonary fibrosis,cytochrome p450 family 11 subfamily b member 2
9432,empagliflozin,otitis externa,glucosidase ii alpha subunit
9433,dicumarol,postmenopausal osteoporosis,solute carrier family 12 member 2
9434,dehydroepiandrosterone,bone paget disease,transforming growth factor beta receptor 2
9435,ipragliflozin,toothache,5-hydroxytryptamine receptor 4
9436,amiodarone,headache disorder,glutamate ionotropic receptor nmda type subunit 2c
9437,norfloxacin,ankylosing spondylitis,annexin a1
9438,prednicarbate,hypereosinophilic syndrome,acid sensing ion channel subunit 1
9439,cisapride,adrenal gland hyperfunction,transient receptor potential cation channel subfamily v member 4
9440,naftopidil,hot flashes,carbonic anhydrase 14
9441,bromfenac,chronic primary adrenal insufficiency,mitogen-activated protein kinase kinase kinase 7
9442,mepyramine,respiratory failure,cytochrome p450 family 2 subfamily c member 8
9443,pentobarbitone,onchocerciasis,dna primase subunit 2
9444,carmofur,chronic primary adrenal insufficiency,platelet derived growth factor receptor beta
9445,quinapril,dyspnea,tec protein tyrosine kinase
9446,viloxazine,chronic eosinophilic leukemia,galactosidase alpha
9447,methyclothiazide,male infertility,"abl proto-oncogene 1, non-receptor tyrosine kinase"
9448,methixene,orthostatic hypotension,proteasome 20s subunit beta 1
9449,flutamide,fibromyalgia,rio kinase 1
9450,atenolol,"hydatidiform mole, recurrent, 1",phosphodiesterase 8a
9451,benzquinamide,lewy body dementia,receptor interacting serine/threonine kinase 3
9452,spironolactone,cluster headache syndrome,protein kinase c theta
9453,rilmenidine,anogenital human papillomavirus infection,peroxisome proliferator activated receptor gamma
9454,estradiol valerate,premature obstetric labor,neuropeptide y
9455,omacetaxine mepesuccinate,back pain,high mobility group box 1
9456,letrozole,myeloid neoplasm associated with pdgfra rearrangement,potassium voltage-gated channel subfamily d member 3
9457,acarbose,postmenopausal atrophic vaginitis,tubulin beta 2b class iib
9458,heparin,pyelonephritis,growth hormone receptor
9459,perphenazine,proctitis,carbonic anhydrase 14
9460,celiprolol,tension-type headache,serpin family e member 1
9461,vinblastine,hypotensive disorder,potassium voltage-gated channel subfamily h member 3
9462,mupirocin,tinea pedis,succinate dehydrogenase complex flavoprotein subunit a
9463,pyridostigmine,respiratory failure,myristoylated alanine rich protein kinase c substrate
9464,homatropine methylbromide,hypoparathyroidism,thyroid hormone receptor beta
9465,eldecalcitol,hypercalcemia disease,tubulin beta 4b class ivb
9466,sertaconazole,intermittent vascular claudication,atp binding cassette subfamily c member 8
9467,testosterone propionate,hyperaldosteronism,melatonin receptor 1b
9468,pranlukast,vomiting,misshapen like kinase 1
9469,molindone,otitis externa,prostaglandin e receptor 1
9470,eplerenone,skin basal cell carcinoma,acetyl-coa acyltransferase 2
9471,stanozolol,erythropoietic protoporphyria,gamma-aminobutyric acid type a receptor subunit gamma3
9472,ketoprofen,neuroblastoma,cytochrome p450 family 17 subfamily a member 1
9473,riluzole,mydriasis,dna topoisomerase i mitochondrial
9474,diethylcarbamazine,inflammatory bowel disease,phospholipase a2 group iva
9475,medrysone,temporal arteritis,5-hydroxytryptamine receptor 1f
9476,valbenazine,breast cancer,coagulation factor x
9477,dabrafenib,plasmodium malariae malaria,s100 calcium binding protein b
9478,pargyline,short bowel syndrome,monoamine oxidase a
9479,ibrutinib,acute myeloid leukemia,somatostatin receptor 4
9480,befunolol,head and neck cancer,"fes proto-oncogene, tyrosine kinase"
9481,frovatriptan,hyperaldosteronism,prune exopolyphosphatase 1
9482,doxepin,onchocerciasis,progesterone receptor
9483,isocarboxazid,thrombotic disease,ornithine transcarbamylase
9484,escitalopram,tyrosinemia,kinase insert domain receptor
9485,entacapone,pulmonary eosinophilia,glutamate ionotropic receptor nmda type subunit 3a
9486,dezocine,"hyperlipidemia, familial combined, lpl related",fxyd domain containing ion transport regulator 2
9487,cromoglicic acid,"familial amyloid neuropathy, portuguese type",butyrylcholinesterase
9488,ebastine,thyroid tumor,bub1 mitotic checkpoint serine/threonine kinase
9489,valrubicin,esotropia,solute carrier family 22 member 3
9490,choline,seasonal allergic rhinitis,cytochrome p450 family 2 subfamily c member 18
9491,diclofenamide,tetany,septin 9
9492,miglitol,castleman disease,epidermal growth factor receptor
9493,sertraline,laryngeal edema,complement c5
9494,cortisol,erdheim-chester disease,gonadotropin releasing hormone receptor
9495,dorzolamide,thyroid gland follicular carcinoma,5-hydroxytryptamine receptor 3a
9496,bromfenac,aorta coarctation,"elastase, neutrophil expressed"
9497,vorapaxar,urge incontinence,aldo-keto reductase family 1 member c3
9498,diphenoxylate,congestive heart failure,renin
9499,nifedipine,short bowel syndrome,unc-51 like autophagy activating kinase 1
9500,bepotastine,acute intermittent porphyria,vascular cell adhesion molecule 1
9501,methdilazine,rhabdomyosarcoma,erb-b2 receptor tyrosine kinase 2
9502,chlordiazepoxide,hyperlipoproteinemia type 3,aldehyde dehydrogenase 2 family member
9503,tropicamide,scabies,tyrosinase
9504,biotin,autoimmune disease,thromboxane a2 receptor
9505,methotrexate,aspiration pneumonia,potassium voltage-gated channel modifier subfamily s member 3
9506,canagliflozin,ventricular fibrillation,carbonic anhydrase 1
9507,valdecoxib,breast cancer,fms related receptor tyrosine kinase 4
9508,darunavir,uterine corpus leiomyoma,bruton tyrosine kinase
9509,progesterone,hemangioma,interleukin 6 receptor
9510,icosapent,leiomyosarcoma,maternal embryonic leucine zipper kinase
9511,tacrolimus,premature ventricular contraction,phosphodiesterase 6g
9512,molindone,cardiogenic shock,sodium channel epithelial 1 subunit beta
9513,valbenazine,gaucher disease,solute carrier family 22 member 4
9514,naproxen,hypoalphalipoproteinemia,cytochrome p450 family 11 subfamily b member 2
9515,olodaterol,disseminated intravascular coagulation,atp binding cassette subfamily b member 11
9516,cytarabine,urethritis,cholinergic receptor muscarinic 1
9517,atazanavir,absence epilepsy,carbonic anhydrase 7
9518,galantamine,rheumatic heart disease,melatonin receptor 1b
9519,diphenidol,hereditary angioedema,acyl-coa dehydrogenase short/branched chain
9520,dimenhydrinate,intrinsic asthma,rho associated coiled-coil containing protein kinase 2
9521,perampanel,pulmonary eosinophilia,tumor protein p53
9522,armodafinil,hiv infectious disease,protein kinase n2
9523,triamterene,fever,dopamine receptor d2
9524,gonadorelin,trichuriasis,bone gamma-carboxyglutamate protein
9525,conivaptan,diabetes mellitus,potassium voltage-gated channel subfamily d member 3
9526,topiramate,depressive disorder,dopamine receptor d4
9527,asenapine,edema,amylase alpha 1a
9528,reproterol,vitiligo,"fyn proto-oncogene, src family tyrosine kinase"
9529,treprostinil,pruritus,estrogen related receptor beta
9530,pentobarbitone,idiopathic acute eosinophilic pneumonia,inosine monophosphate dehydrogenase 1
9531,hydrochlorothiazide,angle-closure glaucoma,atp binding cassette subfamily b member 1
9532,thiothixene,mature t-cell and nk-cell non-hodgkin lymphoma,leukotriene b4 receptor
9533,mitiglinide,allergic asthma,dna methyltransferase 1
9534,bazedoxifene,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 3 subfamily a member 43
9535,metolazone,hypophosphatemia,5-hydroxytryptamine receptor 6
9536,methotrexate,eosinophilic pneumonia,adrenoceptor alpha 1a
9537,tranexamic acid,erythema multiforme,eph receptor a1
9538,metipranolol,sickle cell anemia,low density lipoprotein receptor
9539,vinpocetine,rheumatic heart disease,atpase copper transporting alpha
9540,estramustine,motion sickness,integrin subunit alpha l
9541,eflornithine,choroiditis,prostaglandin e receptor 4
9542,sunitinib,methylmalonic acidemia,casein kinase 1 delta
9543,gemfibrozil,skin disorder,"raf-1 proto-oncogene, serine/threonine kinase"
9544,dimenhydrinate,phenylketonuria,pre-mrna splicing tri-snrnp complex factor prpf4
9545,rufinamide,tyrosinemia,solute carrier family 22 member 12
9546,alimemazine,breast fibrocystic disease,metabolism of cobalamin associated a
9547,dyphylline,medullary thyroid gland carcinoma,"dna polymerase alpha 1, catalytic subunit"
9548,bisoprolol,pityriasis versicolor,solute carrier family 47 member 2
9549,olaparib,toxic shock syndrome,unc-51 like autophagy activating kinase 2
9550,indapamide,aspiration pneumonitis,interleukin 1 receptor type 1
9551,nalbuphine,sneeze,solute carrier family 19 member 1
9552,naproxen,ascariasis,mapk interacting serine/threonine kinase 2
9553,clemastine,type 2 diabetes mellitus,dopamine receptor d5
9554,budesonide,prostate neoplasm,estrogen related receptor alpha
9555,teriparatide,sebaceous adenoma,ret proto-oncogene
9556,bretylium,human african trypanosomiasis,acetyl-coa acyltransferase 2
9557,pexidartinib,malaria,carnitine palmitoyltransferase 1a
9558,masoprocol,urethritis,5-hydroxytryptamine receptor 3a
9559,gabapentin,heart failure,atpase h+ transporting v1 subunit a
9560,solifenacin,raynaud disease,bmx non-receptor tyrosine kinase
9561,umeclidinium,diffuse large b-cell lymphoma,bromodomain containing 4
9562,lansoprazole,keratitis,"ros proto-oncogene 1, receptor tyrosine kinase"
9563,levobetaxolol,idiopathic hypereosinophilic syndrome,rho associated coiled-coil containing protein kinase 1
9564,gilteritinib,seasonal affective disorder,transforming growth factor beta receptor 2
9565,zaleplon,hyperaldosteronism,mitogen-activated protein kinase kinase kinase 20
9566,imatinib,"dermatitis, atopic",opioid related nociceptin receptor 1
9567,fludrocortisone,subarachnoid hemorrhage,coagulation factor x
9568,ponatinib,bacterial conjunctivitis,calcium voltage-gated channel subunit alpha1 f
9569,diclofenac,polyuria,solute carrier family 47 member 2
9570,ergometrine,strongyloidiasis,solute carrier organic anion transporter family member 2b1
9571,dexmethylphenidate,absence epilepsy,testis specific serine kinase 1b
9572,diflorasone diacetate,lennox-gastaut syndrome,serine/threonine kinase 11
9573,sirolimus,shock,phosphodiesterase 6d
9574,tamoxifen,pthirus pubis infestation,carbonic anhydrase 1
9575,losartan,myxedema,myristoylated alanine rich protein kinase c substrate
9576,epa,trichinellosis,ornithine decarboxylase 1
9577,fingolimod,mast cell leukemia,metabolism of cobalamin associated b
9578,tazarotene,hot flashes,coagulation factor ii thrombin receptor
9579,methamphetamine,hiv infectious disease,histone deacetylase 7
9580,sulpiride,poems syndrome,solute carrier family 5 member 2
9581,alprazolam,rhinoscleroma,gamma-aminobutyric acid type a receptor subunit beta1
9582,perindopril,ovarian epithelial tumor,sulfotransferase family 2a member 1
9583,flumethasone pivalate,diarrheal disease,progesterone receptor
9584,lamivudine,congestive heart failure,adenosine a2a receptor
9585,lenalidomide,migraine disorder,phosphodiesterase 7a
9586,tazarotene,pruritus ani,atpase na+/k+ transporting subunit beta 1
9587,acenocoumarol,dermatitis herpetiformis,salt inducible kinase 1
9588,gefitinib,discoid lupus erythematosus,unc-51 like kinase 3
9589,atazanavir,hypocalcemia,mitogen-activated protein kinase kinase kinase 11
9590,eptifibatide,persistent fetal circulation syndrome,potassium voltage-gated channel modifier subfamily g member 1
9591,norfloxacin,metastatic melanoma,atp binding cassette subfamily b member 1
9592,sufentanil,thyroid gland follicular carcinoma,prostaglandin-endoperoxide synthase 1
9593,floctafenine,serum sickness,gamma-aminobutyric acid type a receptor subunit alpha6
9594,teniposide,amyotrophic lateral sclerosis,nuak family kinase 2
9595,nelfinavir,islet cell adenomatosis,protein kinase c theta
9596,cortisol,bronchial disorder,sodium voltage-gated channel alpha subunit 4
9597,histamine,castleman disease,atpase na+/k+ transporting subunit alpha 3
9598,hydroxychloroquine,leprosy,cdc like kinase 2
9599,tolcapone,aplastic anemia,acetyl-coa acyltransferase 2
9600,eliglustat,asthma-chronic obstructive pulmonary disease overlap syndrome,sphingosine-1-phosphate receptor 1
9601,diphenylpyraline,ornithine carbamoyltransferase deficiency,glutathione-disulfide reductase
9602,halcinonide,hyperbilirubinemia,cannabinoid receptor 1
9603,lofepramine,vitamin b12 deficiency,interleukin 1 receptor associated kinase 1
9604,paclitaxel,erectile dysfunction,somatostatin receptor 4
9605,carvedilol,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",cholinergic receptor muscarinic 3
9606,molindone,pain,unc-51 like kinase 3
9607,nadolol,humoral hypercalcemia of malignancy,protein kinase c alpha
9608,landiolol,dermatitis,phosphodiesterase 5a
9609,crotamiton,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,microtubule affinity regulating kinase 3
9610,imrecoxib,acute coronary syndrome,"dna polymerase epsilon, catalytic subunit"
9611,tocilizumab,respiratory failure,steroid 5 alpha-reductase 1
9612,tolazamide,trigeminal neuralgia,estrogen related receptor alpha
9613,carbachol,psoriasis,arachidonate 5-lipoxygenase
9614,udenafil,leprosy,glutamate ionotropic receptor kainate type subunit 4
9615,nilotinib,hyperlipidemia,kelch like ech associated protein 1
9616,imatinib,lichen planus,tubulin alpha 1a
9617,ciprofloxacin,seasonal affective disorder,histone deacetylase 8
9618,betamethasone,ovarian epithelial tumor,death associated protein kinase 1
9619,methamphetamine,wilms tumor,glutathione-disulfide reductase
9620,dipyridamole,langerhans cell histiocytosis,retinoic acid receptor alpha
9621,aclidinium,peripheral vascular disease,toll like receptor 4
9622,dibucaine,vitamin b12 deficiency,5-hydroxytryptamine receptor 1d
9623,tamibarotene,arthritic joint disease,protein kinase n1
9624,topotecan,small cell lung carcinoma,platelet derived growth factor receptor beta
9625,sertraline,hepatic veno-occlusive disease,estrogen receptor 2
9626,mizolastine,neoplasm of esophagus,srsf protein kinase 3
9627,clozapine,exfoliative dermatitis,potassium voltage-gated channel subfamily a member 4
9628,nafarelin,dacryocystitis,dna methyltransferase 1
9629,nebivolol,angle-closure glaucoma,atpase na+/k+ transporting subunit alpha 2
9630,dromostanolone propionate,pseudotumor cerebri,solute carrier organic anion transporter family member 4a1
9631,alendronate,obesity disorder,phosphodiesterase 4a
9632,pinacidil,bronchial disorder,calcium voltage-gated channel auxiliary subunit gamma 1
9633,topiroxostat,meningococcal meningitis,fibroblast growth factor receptor 1
9634,pralatrexate,eosinophilic pneumonia,interleukin 2
9635,cisplatin,toothache,calcium voltage-gated channel subunit alpha1 a
9636,terbutaline,thrombotic disease,guanylate cyclase 1 soluble subunit beta 1
9637,leflunomide,early myoclonic encephalopathy,ebp like
9638,desogestrel,scleroderma,thyroid hormone receptor alpha
9639,vindesine,langerhans cell histiocytosis,structural maintenance of chromosomes 1a
9640,ponatinib,myasthenia gravis,unc-51 like kinase 3
9641,ritonavir,restless legs syndrome,bone gamma-carboxyglutamate protein
9642,vildagliptin,dementia,arginine vasopressin receptor 1b
9643,prednicarbate,pernicious anemia,cytochrome p450 family 27 subfamily a member 1
9644,vindesine,urticaria,tubulin alpha 4a
9645,febuxostat,periodontitis,atp binding cassette subfamily g member 8
9646,aceclofenac,thyroiditis,dopamine receptor d2
9647,brigatinib,onchocerciasis,metabolism of cobalamin associated a
9648,oxazepam,hyperuricemia,sodium voltage-gated channel alpha subunit 7
9649,methyltestosterone,oppositional defiant disorder,histone deacetylase 5
9650,betaxolol,hiv infectious disease,prostaglandin-endoperoxide synthase 2
9651,irbesartan,vascular headaches,7-dehydrocholesterol reductase
9652,nizatidine,renal osteodystrophy,amylase alpha 2a
9653,topiroxostat,lichen planus,retinoic acid receptor beta
9654,norethisterone,chronic urticaria,integrin subunit alpha l
9655,butenafine,angina pectoris,adrenoceptor alpha 2c
9656,benoxaprofen,tinea corporis,dead-box helicase 1
9657,bupivacaine,pulmonary eosinophilia,homeodomain interacting protein kinase 2
9658,fenofibrate,torsades de pointes,prostaglandin e receptor 4
9659,gliquidone,discoid lupus erythematosus,phosphodiesterase 6d
9660,thalidomide,cardiogenic shock,interleukin 11 receptor subunit alpha
9661,triprolidine,alzheimer disease,eph receptor a5
9662,parathyroid hormone,granuloma annulare,high mobility group box 1
9663,hydroxychloroquine,holocarboxylase synthetase deficiency,matrix metallopeptidase 9
9664,sulindac,cardiogenic shock,growth hormone releasing hormone receptor
9665,ziconotide,oligospermia,protein kinase n1
9666,lurasidone,nicotine dependence,potassium voltage-gated channel subfamily c member 4
9667,anakinra,inflammatory bowel disease,hyperpolarization activated cyclic nucleotide gated potassium channel 4
9668,chlorpropamide,pulmonary fibrosis,c-x-c motif chemokine ligand 8
9669,bazedoxifene,glioma,pre-mrna splicing tri-snrnp complex factor prpf4
9670,niraparib,adrenocortical insufficiency,potassium voltage-gated channel subfamily a member 7
9671,aminoglutethimide,motion sickness,solute carrier organic anion transporter family member 1b3
9672,dantrolene,visual epilepsy,calcitonin receptor
9673,clobazam,urinary bladder cancer,annexin a1
9674,clobetasone,gout,phosphodiesterase 6c
9675,roxatidine acetate,hereditary von willebrand disease,unc-51 like autophagy activating kinase 2
9676,enalapril,dermatophytosis of groin and perianal area,solute carrier family 5 member 1
9677,rasagiline,absence epilepsy,phospholipase a2 group iva
9678,diclofenamide,"dermatitis, atopic",tumor necrosis factor
9679,zonisamide,torsades de pointes,calcium voltage-gated channel auxiliary subunit beta 2
9680,daunorubicin,eosinophilic esophagitis,sphingosine-1-phosphate receptor 4
9681,bexarotene,allergic asthma,potassium voltage-gated channel subfamily q member 5
9682,budesonide,neurogenic bladder,5-hydroxytryptamine receptor 3b
9683,reboxetine,homozygous familial hypercholesterolemia,solute carrier organic anion transporter family member 4a1
9684,metoprolol,acute monocytic leukemia,gamma-aminobutyric acid type a receptor subunit gamma2
9685,ceftriaxone,ascites,dopamine receptor d3
9686,bromfenac,postmenopausal osteoporosis,sodium voltage-gated channel alpha subunit 1
9687,lisinopril,autism spectrum disorder,bmx non-receptor tyrosine kinase
9688,isosorbide dinitrate,non-small cell lung carcinoma,melanocortin 3 receptor
9689,levoketoconazole,chronic hepatitis c virus infection,phosphodiesterase 8b
9690,ulobetasol propionate,anxiety,potassium inwardly rectifying channel subfamily j member 1
9691,pilocarpine,tenosynovitis,solute carrier family 9 member a1
9692,dopamine,alopecia,metallothionein 2a
9693,anakinra,pheochromocytoma,myeloperoxidase
9694,goserelin,chronic eosinophilic leukemia,protein kinase n1
9695,l-citrulline,psychologic dyspareunia,ribosomal protein s6 kinase a2
9696,astemizole,mast cell leukemia,atp binding cassette subfamily b member 1
9697,moclobemide,autoimmune hemolytic anemia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
9698,bromfenac,type 1 diabetes mellitus,electron transfer flavoprotein dehydrogenase
9699,phenazone,ovarian epithelial tumor,gamma-aminobutyric acid type a receptor subunit gamma3
9700,miglitol,labor pain,ndufa4 mitochondrial complex associated
9701,benzbromarone,chronic primary adrenal insufficiency,somatostatin receptor 5
9702,phentolamine,gonorrhea,tyrosine kinase non receptor 2
9703,guanfacine,hemorrhagic disease of newborn,membrane spanning 4-domains a1
9704,gemtuzumab ozogamicin,pulmonary eosinophilia,glutamate ionotropic receptor ampa type subunit 2
9705,fluvastatin,burkitt lymphoma,interleukin 2
9706,duloxetine,malignant colon neoplasm,"kras proto-oncogene, gtpase"
9707,orciprenaline,ornithine carbamoyltransferase deficiency,"dna polymerase epsilon, catalytic subunit"
9708,vardenafil,rickets,carbonic anhydrase 14
9709,apraclonidine,breast cancer,atpase copper transporting alpha
9710,befunolol,bursitis,leukotriene b4 receptor
9711,polythiazide,oral candidiasis,sodium channel epithelial 1 subunit alpha
9712,rotigotine,urinary retention,calcium voltage-gated channel auxiliary subunit beta 2
9713,anagrelide,vasomotor rhinitis,phosphodiesterase 6c
9714,gemcitabine,postpartum depression,glutamic-oxaloacetic transaminase 1
9715,tandospirone,ascariasis,s100 calcium binding protein p
9716,vinorelbine,male infertility,estrogen related receptor alpha
9717,etelcalcetide,zollinger-ellison syndrome,aurora kinase b
9718,leuprolide,discoid lupus erythematosus,cytochrome p450 family 17 subfamily a member 1
9719,olanzapine,headache disorder,myosin light chain kinase 3
9720,biperiden,intermittent vascular claudication,solute carrier family 22 member 3
9721,methdilazine,premature ventricular contraction,cytochrome p450 family 27 subfamily a member 1
9722,sorafenib,urticaria,peptidylprolyl isomerase a
9723,albiglutide,idiopathic hypereosinophilic syndrome,cholinergic receptor nicotinic alpha 3 subunit
9724,perampanel,lymphangioma,solute carrier family 22 member 3
9725,treprostinil,neonatal diabetes mellitus,glutamate ionotropic receptor ampa type subunit 2
9726,"1,25-dihydroxyvitamin d3",dermatitis,cholinergic receptor nicotinic alpha 4 subunit
9727,mesalazine,phenylketonuria,potassium voltage-gated channel subfamily q member 2
9728,aripiprazole,alopecia,calcyon neuron specific vesicular protein
9729,bazedoxifene,thrombotic disease,sodium voltage-gated channel alpha subunit 4
9730,clonidine,postherpetic neuralgia,histone deacetylase 10
9731,ifosfamide,drooling,glutamate ionotropic receptor ampa type subunit 4
9732,fenfluramine,melanoma,gamma-aminobutyric acid type a receptor subunit alpha1
9733,tetracosactide,disruptive behavior disorder,aldehyde dehydrogenase 5 family member a1
9734,carbachol,arthritic joint disease,solute carrier family 18 member a1
9735,oxprenolol,idiopathic acute eosinophilic pneumonia,atp binding cassette subfamily b member 11
9736,hydroxocobalamin,potassium deficiency disease,pre-mrna processing factor kinase prp4k
9737,ketamine,psoriasis,polo like kinase 4
9738,gepirone,gonorrhea,ebp like
9739,esmolol,"chronic myelogenous leukemia, bcr-abl1 positive",leukocyte receptor tyrosine kinase
9740,diflunisal,secondary hyperparathyroidism,proteasome 20s subunit beta 10
9741,lisuride,lung neoplasm,prostaglandin d2 receptor 2
9742,amantadine,periodontitis,cytochrome p450 family 2 subfamily d member 6
9743,zoledronic acid,asthma,phosphorylase kinase catalytic subunit gamma 1
9744,5-fluorouracil,lewy body dementia,cytidine deaminase
9745,ulobetasol propionate,dacryocystitis,cytochrome p450 family 11 subfamily b member 2
9746,progesterone,kaposi's sarcoma,"dna polymerase epsilon, catalytic subunit"
9747,emtricitabine,acromegaly,bub1 mitotic checkpoint serine/threonine kinase
9748,landiolol,premenstrual dysphoric disorder,sodium voltage-gated channel alpha subunit 4
9749,celecoxib,ovarian cancer,calcium voltage-gated channel auxiliary subunit beta 1
9750,lopinavir,hepatic veno-occlusive disease,retinoid x receptor beta
9751,asenapine,anterior uveitis,hyperpolarization activated cyclic nucleotide gated potassium channel 3
9752,homatropine methylbromide,pyelonephritis,5-hydroxytryptamine receptor 4
9753,treprostinil,malignant colon neoplasm,aryl hydrocarbon receptor
9754,methixene,west syndrome,leucine rich repeat kinase 2
9755,frovatriptan,post-traumatic stress disorder,ribonucleotide reductase regulatory subunit m2
9756,dimethyl fumarate,plasma cell myeloma,bone gamma-carboxyglutamate protein
9757,acitretin,endometrium neoplasm,gamma-aminobutyric acid type a receptor subunit gamma3
9758,ripasudil,pyoderma gangrenosum,potassium inwardly rectifying channel subfamily j member 2
9759,sertindole,non-small cell lung carcinoma,protein tyrosine kinase 2
9760,baclofen,chronic beryllium disease,macrophage migration inhibitory factor
9761,dantrolene,phenylketonuria,low density lipoprotein receptor
9762,linagliptin,peripheral vascular disease,atm serine/threonine kinase
9763,teduglutide,mycosis fungoides,g protein-coupled receptor kinase 4
9764,codeine,endometrial carcinoma,glucagon like peptide 2 receptor
9765,toloxatone,necrobiosis lipoidica,solute carrier family 5 member 2
9766,eszopiclone,dermatophytosis of groin and perianal area,serine/threonine kinase 16
9767,cyclophosphamide,dermatofibrosarcoma protuberans,aurora kinase a
9768,desmopressin,enterocolitis,cyclin dependent kinase 19
9769,mirtazapine,biotinidase deficiency,carbonic anhydrase 14
9770,cephalotaxine,sjogren syndrome,solute carrier family 47 member 2
9771,insulin aspart,vernal conjunctivitis,solute carrier family 18 member a1
9772,probenecid,pulmonary artery stenosis,phosphodiesterase 4a
9773,oxytocin,mature t-cell and nk-cell non-hodgkin lymphoma,peroxisome proliferator activated receptor delta
9774,talinolol,malignant hyperthermia of anesthesia,potassium voltage-gated channel modifier subfamily s member 1
9775,camphor,b-cell chronic lymphocytic leukemia,maltase-glucoamylase
9776,insulin lispro,liposarcoma,mapk interacting serine/threonine kinase 2
9777,rilmenidine,asthma-chronic obstructive pulmonary disease overlap syndrome,electron transfer flavoprotein dehydrogenase
9778,dronedarone,pulmonary embolism,microtubule affinity regulating kinase 3
9779,aliskiren,onchocerciasis,amine oxidase copper containing 1
9780,sertindole,bipolar depression,estrogen receptor 2
9781,nitrazepam,bronchial disorder,tyrosine kinase 2
9782,moxonidine,strongyloidiasis,phospholipase a2 group ib
9783,fludroxycortide,urinary bladder cancer,microtubule associated protein 1a
9784,vasopressin,anogenital human papillomavirus infection,somatostatin receptor 3
9785,icatibant,vulvovaginal candidiasis,sulfotransferase family 1a member 1
9786,nortriptyline,mast cell leukemia,chymotrypsinogen b1
9787,mitomycin c,stargardt disease,monoamine oxidase a
9788,camphor,pulmonary edema,amylase alpha 1c
9789,bepotastine,myocardial infarction,sulfotransferase family 2a member 1
9790,zidovudine,brain glioblastoma,ribosomal protein s6 kinase a6
9791,lercanidipine,enterobiasis,potassium voltage-gated channel subfamily d member 1
9792,almitrine,prostate neoplasm,dipeptidyl peptidase 9
9793,molindone,nutritional biotin deficiency,carnitine palmitoyltransferase 1a
9794,fenoprofen,parkinsonian disorder,epidermal growth factor receptor
9795,galantamine,myasthenia gravis,solute carrier family 5 member 11
9796,oxymorphone,ascites,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
9797,reboxetine,multiple endocrine neoplasia,potassium voltage-gated channel modifier subfamily v member 2
9798,apomorphine,bulimia nervosa,gap junction protein alpha 1
9799,megestrol,parkinson disease,proteasome 20s subunit beta 10
9800,diflunisal,diabetic kidney disease,"dna polymerase alpha 1, catalytic subunit"
9801,ephedrine,dementia,atp binding cassette subfamily b member 11
9802,tranexamic acid,major depressive disorder,glutamate ionotropic receptor nmda type subunit 2c
9803,vindesine,peptic esophagitis,potassium voltage-gated channel subfamily h member 8
9804,brompheniramine,brain glioblastoma,phospholipase a2 group iie
9805,dronedarone,osteoarthritis,parathyroid hormone 1 receptor
9806,nisoldipine,metastatic melanoma,somatostatin receptor 3
9807,roxatidine acetate,thromboangiitis obliterans,calcium voltage-gated channel auxiliary subunit alpha2delta 1
9808,befunolol,postpartum depression,potassium voltage-gated channel subfamily d member 1
9809,levetiracetam,acute pain,growth hormone receptor
9810,ezetimibe,erectile dysfunction,g protein-coupled receptor kinase 2
9811,valrubicin,myeloid neoplasm associated with pdgfra rearrangement,cytochrome p450 family 2 subfamily a member 6
9812,valbenazine,seborrheic dermatitis,solute carrier family 22 member 8
9813,choline,dacryocystitis,cytochrome p450 family 27 subfamily a member 1
9814,capsaicin,langerhans cell histiocytosis,aryl hydrocarbon receptor
9815,sonidegib,central nervous system origin vertigo,solute carrier organic anion transporter family member 4a1
9816,leuprolide,toothache,solute carrier family 46 member 1
9817,silodosin,thromboangiitis obliterans,sodium channel epithelial 1 subunit alpha
9818,aliskiren,musculoskeletal system disorder,pre-mrna processing factor kinase prp4k
9819,miglitol,diffuse large b-cell lymphoma,histone deacetylase 10
9820,carbimazole,edema,cholinergic receptor nicotinic alpha 4 subunit
9821,phentolamine,anxiety,macrophage stimulating 1 receptor
9822,gemcitabine,homozygous familial hypercholesterolemia,guanylate cyclase 1 soluble subunit alpha 2
9823,vinpocetine,iridocyclitis,matrix metallopeptidase 2
9824,pravastatin,pulmonary artery stenosis,sodium voltage-gated channel alpha subunit 7
9825,cyclobenzaprine,hot flashes,neuropeptide y receptor y1
9826,dromostanolone propionate,rhabdomyosarcoma,sucrase-isomaltase
9827,tolcapone,familial dermatographia,transient receptor potential cation channel subfamily a member 1
9828,propantheline,pain,eph receptor b6
9829,vincristine,focal epilepsy,caspase 1
9830,ripasudil,decreased cardiac output,platelet derived growth factor receptor alpha
9831,teniposide,ascites,dna methyltransferase 1
9832,nintedanib,oppositional defiant disorder,myosin light chain kinase
9833,meclofenamic acid,tardive dyskinesia,aurora kinase a
9834,stanozolol,iridocyclitis,c-x-c motif chemokine receptor 4
9835,azatadine,dyschromatosis universalis hereditaria,solute carrier family 22 member 4
9836,diazepam,systemic lupus erythematosus,melatonin receptor 1a
9837,bazedoxifene,pulmonary edema,cytochrome p450 family 2 subfamily j member 2
9838,tetracycline,allergic bronchopulmonary aspergillosis,glutamate ionotropic receptor nmda type subunit 2b
9839,gepirone,peripheral vascular disease,aldo-keto reductase family 1 member c1
9840,lenalidomide,holocarboxylase synthetase deficiency,histamine receptor h3
9841,flumethasone pivalate,ornithine carbamoyltransferase deficiency,atp binding cassette subfamily b member 11
9842,colestipol,manic bipolar affective disorder,acetyl-coa acetyltransferase 1
9843,triiodothyronine,multiple sclerosis,atpase na+/k+ transporting subunit alpha 4
9844,repaglinide,dacryocystitis,cannabinoid receptor 1
9845,allopurinol,rhinitis,estrogen receptor 2
9846,pemirolast,delayed puberty,toll like receptor 9
9847,primidone,rhabdomyosarcoma,rho associated coiled-coil containing protein kinase 1
9848,ibuprofen,acquired polycythemia vera,potassium inwardly rectifying channel subfamily j member 11
9849,toloxatone,acute promyelocytic leukemia,atp binding cassette subfamily a member 1
9850,desmopressin,diabetic kidney disease,cytochrome p450 family 2 subfamily b member 6
9851,magnesium salicylate,thrombocytopenia,serine/threonine kinase 16
9852,glycopyrrolate,juvenile idiopathic arthritis,bcr activator of rhogef and gtpase
9853,cycrimine,colonic neoplasm,fkbp prolyl isomerase 5
9854,amcinonide,postherpetic neuralgia,death associated protein kinase 3
9855,nilotinib,pulmonary valve atresia,somatostatin receptor 5
9856,anisotropine methylbromide,social phobia,bcr activator of rhogef and gtpase
9857,miglitol,acute monocytic leukemia,neurotrophic receptor tyrosine kinase 1
9858,dabrafenib,dermatitis herpetiformis,ryanodine receptor 2
9859,diphenidol,abdominal infection,leucine rich repeat kinase 2
9860,moxonidine,humoral hypercalcemia of malignancy,glutamate ionotropic receptor nmda type subunit 3b
9861,metformin,essential thrombocythemia,interleukin 6 receptor
9862,oprelvekin,breast cancer,prostaglandin e receptor 1
9863,linagliptin,b-cell chronic lymphocytic leukemia,gonadotropin releasing hormone receptor
9864,leuprolide,strongyloidiasis,solute carrier organic anion transporter family member 1b3
9865,meclofenamic acid,pellagra,5-hydroxytryptamine receptor 5a
9866,tenofovir alafenamide,anxiety,mitogen-activated protein kinase kinase kinase 19
9867,nicorandil,oral mucosa leukoplakia,homeodomain interacting protein kinase 1
9868,delavirdine,acute monocytic leukemia,sodium voltage-gated channel alpha subunit 5
9869,ethynodiol diacetate,b-cell chronic lymphocytic leukemia,solute carrier organic anion transporter family member 4a1
9870,esmolol,chancroid,diacylglycerol o-acyltransferase 1
9871,protriptyline,miliary tuberculosis,phosphodiesterase 4c
9872,bunazosin,neoplasm of esophagus,adrenoceptor alpha 2b
9873,lusutrombopag,eosinophilic pneumonia,glutamate ionotropic receptor ampa type subunit 1
9874,sertaconazole,renal osteodystrophy,solute carrier family 6 member 1
9875,ziconotide,scalp dermatosis,receptor interacting serine/threonine kinase 2
9876,nelfinavir,cutaneous candidiasis,cholinergic receptor nicotinic alpha 5 subunit
9877,anisotropine methylbromide,pulmonary valve atresia,"ros proto-oncogene 1, receptor tyrosine kinase"
9878,alimemazine,frozen shoulder,fer tyrosine kinase
9879,alprazolam,focal epilepsy,somatostatin receptor 3
9880,theophylline,malignant hyperthermia of anesthesia,adrenoceptor alpha 1b
9881,trimetaphan,tachycardia,g protein-coupled receptor kinase 4
9882,fluticasone,trichinellosis,tachykinin precursor 1
9883,isocarboxazid,anaphylaxis,dna polymerase beta
9884,prazosin,eye disorder,potassium voltage-gated channel subfamily d member 2
9885,dihydroergotamine,arteriosclerosis disorder,glutathione s-transferase pi 1
9886,tamoxifen,migraine disorder,potassium voltage-gated channel subfamily h member 8
9887,diazepam,oligospermia,c-x-c motif chemokine receptor 4
9888,hydralazine,pruritus ani,hypoxia inducible factor 1 subunit alpha
9889,tioconazole,mycosis fungoides,holocarboxylase synthetase
9890,vorapaxar,small cell lung carcinoma,cholinergic receptor nicotinic beta 4 subunit
9891,triamterene,tendinopathy,sphingosine-1-phosphate receptor 3
9892,dexmethylphenidate,brain cancer,"src proto-oncogene, non-receptor tyrosine kinase"
9893,pilocarpine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",kelch like ech associated protein 1
9894,guanfacine,erectile dysfunction,plasminogen
9895,luseogliflozin,marginal zone lymphoma,fer tyrosine kinase
9896,bepotastine,menorrhagia,atp binding cassette subfamily a member 1
9897,olodaterol,lung disorder,fibroblast growth factor receptor 1
9898,hydroxyzine,precocious puberty,"plasminogen activator, tissue type"
9899,cariprazine,psychologic dyspareunia,protein tyrosine kinase 2
9900,eszopiclone,anterior uveitis,melanocortin 1 receptor
9901,pilocarpine,nephrotic syndrome,unc-51 like autophagy activating kinase 2
9902,moxonidine,inappropriate adh syndrome,lipoprotein lipase
9903,nilotinib,atopic conjunctivitis,somatostatin receptor 3
9904,atazanavir,plasmodium falciparum malaria,prostaglandin e synthase 3
9905,vandetanib,dermatitis,acid sensing ion channel subunit 1
9906,alfacalcidol,autosomal dominant polycystic kidney disease,calcium sensing receptor
9907,cyclophosphamide,ocular hypertension,solute carrier family 6 member 1
9908,everolimus,vitamin d deficiency,histone deacetylase 7
9909,alectinib,diffuse large b-cell lymphoma,platelet derived growth factor receptor alpha
9910,oxymorphone,opiate dependence,melatonin receptor 1a
9911,fenoldopam,bipolar depression,matrix metallopeptidase 2
9912,methdilazine,thrombophilia due to thrombin defect,calcium voltage-gated channel subunit alpha1 g
9913,felbamate,malignant essential hypertension,hyperpolarization activated cyclic nucleotide gated potassium channel 4
9914,norfloxacin,hyperinsulinism,eph receptor a3
9915,vigabatrin,allergic asthma,bmx non-receptor tyrosine kinase
9916,pirenzepine,social phobia,cholinergic receptor nicotinic beta 3 subunit
9917,levosalbutamol,vasomotor rhinitis,homeodomain interacting protein kinase 1
9918,blonanserin,hypertriglyceridemia,dopamine beta-hydroxylase
9919,perazine,goiter,mechanistic target of rapamycin kinase
9920,montelukast,short bowel syndrome,estrogen receptor 1
9921,cisapride,cutaneous candidiasis,c-x-c motif chemokine ligand 8
9922,cefmetazole,psychosexual disorder,ribosomal protein s6 kinase a5
9923,azilsartan medoxomil,mantle cell lymphoma,sulfotransferase family 1a member 1
9924,orphenadrine,autoimmune disease,glutamate ionotropic receptor nmda type subunit 1
9925,maprotiline,keloid,nuclear factor kappa b subunit 1
9926,tiagabine,drooling,fkbp prolyl isomerase 4
9927,phenacemide,eosinophilic esophagitis,ribonucleotide reductase regulatory subunit m2
9928,reserpine,subarachnoid hemorrhage,growth hormone receptor
9929,colestipol,follicular lymphoma,c-c motif chemokine receptor 1
9930,reproterol,homocystinuria,calcium voltage-gated channel subunit alpha1 i
9931,etoposide,waldenstrom macroglobulinemia,oxytocin receptor
9932,felodipine,ulcerative colitis,mitogen-activated protein kinase kinase 2
9933,apomorphine,persistent fetal circulation syndrome,g protein-coupled receptor kinase 2
9934,phenmetrazine,scalp dermatosis,ryanodine receptor 3
9935,lisinopril,pneumonia,interleukin 1 beta
9936,saquinavir,basal ganglia disorder,phosphodiesterase 1b
9937,brinzolamide,basal ganglia disorder,gamma-aminobutyric acid type a receptor subunit alpha6
9938,icatibant,temporal arteritis,mitogen-activated protein kinase kinase 1
9939,escitalopram,ulcerative colitis,calcium voltage-gated channel auxiliary subunit alpha2delta 2
9940,nimodipine,erythropoietic protoporphyria,phosphodiesterase 6d
9941,propafenone,primary ovarian failure,calcium voltage-gated channel auxiliary subunit beta 1
9942,lenalidomide,asthma,unc-51 like autophagy activating kinase 1
9943,sertindole,tendinitis,c-x-c motif chemokine receptor 4
9944,candesartan,early myoclonic encephalopathy,fms related receptor tyrosine kinase 4
9945,carbidopa,heart failure,gamma-aminobutyric acid type a receptor subunit gamma1
9946,sotalol,hyperlipidemia,atm serine/threonine kinase
9947,cimetidine,ulcerative colitis,potassium voltage-gated channel subfamily a member 3
9948,dibucaine,liposarcoma,calcitonin receptor
9949,moxonidine,bruxism,neuropeptide y receptor y1
9950,lenalidomide,endometrial carcinoma,potassium voltage-gated channel subfamily b member 2
9951,miconazole,diffuse large b-cell lymphoma,phosphodiesterase 4b
9952,cefalotin,myalgia,potassium voltage-gated channel subfamily q member 3
9953,somatrem,anogenital human papillomavirus infection,peroxisome proliferator activated receptor alpha
9954,secobarbital,allergic rhinitis,tyrosine kinase 2
9955,axitinib,xerophthalmia,adrenoceptor alpha 2c
9956,dexibuprofen,gingivitis,potassium voltage-gated channel subfamily h member 3
9957,promethazine,post-partum hemorrhage,phosphodiesterase 10a
9958,landiolol,tricuspid atresia,potassium voltage-gated channel modifier subfamily s member 1
9959,dimethyl fumarate,lichen planus,potassium voltage-gated channel subfamily c member 1
9960,ivermectin,plasmodium falciparum malaria,dipeptidase 1
9961,dobutamine,bacterial pneumonia,"met proto-oncogene, receptor tyrosine kinase"
9962,paramethadione,drooling,amylase alpha 1a
9963,hydroflumethiazide,seasonal allergic rhinitis,interleukin 2
9964,insulin aspart,mydriasis,cysteinyl leukotriene receptor 2
9965,mizolastine,malignant colon neoplasm,calmodulin 2
9966,tafamidis,manic bipolar affective disorder,ryanodine receptor 2
9967,pioglitazone,myxedema,txk tyrosine kinase
9968,vorinostat,cough,hypoxanthine phosphoribosyltransferase 1
9969,probenecid,tachycardia,high mobility group box 1
9970,dabrafenib,common cold,mitogen-activated protein kinase kinase 1
9971,dexmethylphenidate,hypereosinophilic syndrome,melatonin receptor 1a
9972,butorphanol,arthropathy,atpase na+/k+ transporting subunit alpha 2
9973,diphenhydramine,postencephalitic parkinson disease,histone deacetylase 8
9974,darunavir,duodenal ulcer,tyrosine kinase non receptor 2
9975,rufinamide,zollinger-ellison syndrome,gamma-aminobutyric acid type b receptor subunit 2
9976,phentolamine,exfoliative dermatitis,gamma-aminobutyric acid type a receptor subunit alpha2
9977,procyclidine,sneeze,cart prepropeptide
9978,levomilnacipran,sneeze,mitogen-activated protein kinase kinase 2
9979,teriflunomide,small intestine cancer,g protein-coupled receptor 35
9980,acrivastine,peptic ulcer disease,atp binding cassette subfamily g member 8
9981,lesinurad,humoral hypercalcemia of malignancy,metallothionein 1a
9982,clonidine,nephrotic syndrome,phosphodiesterase 5a
9983,lafutidine,rheumatic heart disease,phosphoribosyl pyrophosphate amidotransferase
9984,dihydroergotamine,actinic keratosis,neurotrophic receptor tyrosine kinase 2
9985,bunolol,obsessive-compulsive disorder,dopamine receptor d2
9986,progesterone,obsessive-compulsive disorder,inosine monophosphate dehydrogenase 1
9987,amantadine,ascariasis,il2 inducible t cell kinase
9988,metaraminol,familial mediterranean fever,peptidylprolyl isomerase b
9989,ezetimibe,juvenile idiopathic arthritis,ornithine transcarbamylase
9990,astemizole,streptococcal meningitis,holocarboxylase synthetase
9991,icosapent,tyrosinemia,solute carrier family 22 member 5
9992,diethylcarbamazine,classic hodgkin lymphoma,thyroid hormone receptor beta
9993,bromodiphenhydramine,perennial allergic rhinitis,atpase na+/k+ transporting subunit alpha 2
9994,fentanyl,mycosis fungoides,sonic hedgehog signaling molecule
9995,megestrol,dermatitis herpetiformis,guanylate cyclase 1 soluble subunit beta 1
9996,ciprofloxacin,superficial multifocal basal cell carcinoma,plasminogen
9997,amantadine,dacryocystitis,adenosine a3 receptor
9998,phendimetrazine,rickets,glucagon like peptide 2 receptor
9999,levosimendan,diabetes mellitus,metabolism of cobalamin associated c
10000,emtricitabine,manic bipolar affective disorder,potassium calcium-activated channel subfamily m alpha 1
10001,carbimazole,leprosy,hydroxycarboxylic acid receptor 3
10002,midazolam,strongyloidiasis,"glucosidase alpha, neutral c"
10003,ketotifen,ventricular fibrillation,ribonucleotide reductase catalytic subunit m1
10004,dofetilide,acute myeloid leukemia,mitogen-activated protein kinase kinase kinase kinase 1
10005,felodipine,chronic kidney disease,geranylgeranyl diphosphate synthase 1
10006,zaleplon,lung neoplasm,interleukin 6 receptor
10007,rilmenidine,allergic bronchopulmonary aspergillosis,serine/threonine kinase 10
10008,miglitol,hypocalcemia,mitogen-activated protein kinase kinase kinase 9
10009,vindesine,zollinger-ellison syndrome,potassium voltage-gated channel subfamily h member 8
10010,cortisone,ascariasis,s100 calcium binding protein p
10011,methylprednisolone,endometritis,myosin heavy chain 10
10012,linagliptin,ovarian cancer,potassium voltage-gated channel modifier subfamily s member 3
10013,calcium acetate,"hydatidiform mole, recurrent, 1",thromboxane a2 receptor
10014,alclometasone dipropionate,chronic kidney disease,phosphodiesterase 11a
10015,chlorthalidone,pseudotumor cerebri,5-hydroxytryptamine receptor 4
10016,dutasteride,diarrheal disease,isoleucyl-trna synthetase 1
10017,gemigliptin,gastric neoplasm,protein tyrosine kinase 2 beta
10018,teniposide,"attention deficit hyperactivity disorder, inattentive type",tubulin beta 2a class iia
10019,perindopril,tendinopathy,calcium voltage-gated channel subunit alpha1 h
10020,clobetasone,melanoma,peptidylprolyl isomerase a
10021,omarigliptin,tetralogy of fallot,"mpl proto-oncogene, thrombopoietin receptor"
10022,finasteride,enterocolitis,gamma-aminobutyric acid type a receptor subunit alpha3
10023,imrecoxib,myeloproliferative neoplasm,neuropeptide y
10024,lusutrombopag,hypoalphalipoproteinemia,glutamic-oxaloacetic transaminase 1
10025,molindone,fabry disease,myristoylated alanine rich protein kinase c substrate
10026,venlafaxine,intermittent vascular claudication,dipeptidyl peptidase 8
10027,megestrol,heart failure,fkbp prolyl isomerase 1a
10028,trospium chloride,juvenile idiopathic arthritis,fibroblast growth factor receptor 3
10029,pergolide,severe major depression with psychotic features,cytochrome p450 family 1 subfamily a member 1
10030,ecallantide,necrobiosis lipoidica,myosin heavy chain 10
10031,meloxicam,impetigo,sphingomyelin phosphodiesterase 1
10032,diltiazem,west syndrome,c-c motif chemokine receptor 1
10033,oxycodone,otitis externa,nuclear receptor subfamily 0 group b member 1
10034,tipiracil,myxedema,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
10035,vasopressin,dermatofibrosarcoma protuberans,solute carrier family 47 member 2
10036,diphenhydramine,islet cell adenomatosis,adrenoceptor alpha 1d
10037,vemurafenib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",ribosomal protein s6 kinase a6
10038,esomeprazole,hypersensitivity pneumonitis,mapk interacting serine/threonine kinase 2
10039,pralatrexate,goiter,myeloperoxidase
10040,citalopram,tinea pedis,thyroid stimulating hormone receptor
10041,dezocine,idiopathic acute eosinophilic pneumonia,peptidylprolyl isomerase b
10042,bupropion,human african trypanosomiasis,bcl2 like 1
10043,conjugated estrogens,hereditary von willebrand disease,potassium voltage-gated channel subfamily a member 6
10044,amiodarone,polymyalgia rheumatica,atpase na+/k+ transporting subunit beta 1
10045,entacapone,rhinitis,ryanodine receptor 1
10046,benzocaine,dacryocystitis,proteasome 20s subunit beta 8
10047,furosemide,sarcoidosis,potassium voltage-gated channel subfamily h member 5
10048,isosorbide mononitrate,focal epilepsy,potassium voltage-gated channel subfamily h member 3
10049,prednisone,marginal zone lymphoma,estrogen related receptor alpha
10050,dihydroergotamine,atrial fibrillation,potassium voltage-gated channel subfamily d member 1
10051,tolvaptan,breast neoplasm,solute carrier family 27 member 2
10052,nortriptyline,hereditary angioedema,phosphodiesterase 1a
10053,lorazepam,angina pectoris,sodium channel epithelial 1 subunit alpha
10054,tramadol,post-traumatic stress disorder,cholinergic receptor muscarinic 3
10055,tetrabenazine,epicondylitis,transient receptor potential cation channel subfamily v member 1
10056,trimetazidine,pernicious anemia,adenosine a2a receptor
10057,trimipramine,kaposi's sarcoma,sodium voltage-gated channel alpha subunit 7
10058,terbutaline,acute coronary syndrome,adenosine a2b receptor
10059,triflupromazine,iridocyclitis,glucose-6-phosphate dehydrogenase
10060,iloperidone,trichinellosis,potassium voltage-gated channel subfamily b member 2
10061,diazepam,chronic obstructive pulmonary disease,colony stimulating factor 1 receptor
10062,entacapone,punctate epithelial keratoconjunctivitis,catechol-o-methyltransferase
10063,nizatidine,essential hypertension,dna topoisomerase i
10064,aceclofenac,myalgia,sirtuin 1
10065,regorafenib,vitamin deficiency disorder,fibroblast growth factor receptor 1
10066,oxprenolol,"familial amyloid neuropathy, portuguese type",solute carrier family 2 member 9
10067,selegiline,tachycardia,"kras proto-oncogene, gtpase"
10068,emtricitabine,phenylketonuria,atp binding cassette subfamily c member 8
10069,ospemifene,esotropia,atpase h+/k+ transporting subunit beta
10070,zidovudine,sarcoma,calcium voltage-gated channel subunit alpha1 s
10071,eletriptan,acquired thrombocytopenia,discoidin domain receptor tyrosine kinase 1
10072,dexamethasone,holocarboxylase synthetase deficiency,histone deacetylase 7
10073,ibandronic acid,hyponatremia,solute carrier family 12 member 3
10074,vardenafil,lichen planus,gap junction protein alpha 1
10075,methylphenobarbital,waldenstrom macroglobulinemia,selectin e
10076,acamprosate,nocturnal enuresis,dopa decarboxylase
10077,pasireotide,"attention deficit hyperactivity disorder, inattentive type",dead-box helicase 3 x-linked
10078,orphenadrine,respiratory failure,bruton tyrosine kinase
10079,doxorubicin,plasmodium falciparum malaria,cart prepropeptide
10080,parathyroid hormone,langerhans cell histiocytosis,bromodomain containing 4
10081,felbinac,head and neck cancer,potassium inwardly rectifying channel subfamily j member 1
10082,clozapine,scabies,calcium voltage-gated channel subunit alpha1 b
10083,candesartan,oral mucosa leukoplakia,metabolism of cobalamin associated a
10084,gilteritinib,type 2 diabetes mellitus,retinoic acid receptor gamma
10085,trabectedin,tinea corporis,mitogen-activated protein kinase kinase kinase 2
10086,risedronate,graves disease,propionyl-coa carboxylase subunit alpha
10087,prochlorperazine,bone paget disease,dipeptidyl peptidase 9
10088,lisinopril,thrombocytopenia,melanocortin 1 receptor
10089,perazine,bipolar disorder,growth hormone receptor
10090,tranilast,chronic myelomonocytic leukemia,peroxisome proliferator activated receptor alpha
10091,anastrozole,turner syndrome,toll like receptor 2
10092,methapyrilene,diabetic kidney disease,neurotrophic receptor tyrosine kinase 2
10093,carboplatin,tenosynovial giant cell tumor,gamma-aminobutyric acid type b receptor subunit 2
10094,hydroquinone,gastroesophageal reflux disease,bradykinin receptor b2
10095,phenmetrazine,severe major depression with psychotic features,phosphodiesterase 5a
10096,romidepsin,pulmonary eosinophilia,alk receptor tyrosine kinase
10097,imatinib,atopic eczema,peroxisome proliferator activated receptor alpha
10098,melatonin,lung neoplasm,microtubule associated protein 1a
10099,phenylephrine,peripheral vascular disease,5-hydroxytryptamine receptor 7
10100,desipramine,acidosis disorder,tank binding kinase 1
10101,pomalidomide,bacterial pneumonia,cytochrome p450 family 2 subfamily c member 8
10102,amantadine,myotonic syndrome,kallikrein b1
10103,pentostatin,tourette syndrome,androgen receptor
10104,anagrelide,rhinitis,annexin a1
10105,alclometasone dipropionate,plasmodium vivax malaria,estrogen receptor 2
10106,cetuximab,cutaneous candidiasis,solute carrier family 27 member 2
10107,promazine,postmenopausal atrophic vaginitis,potassium voltage-gated channel subfamily b member 2
10108,fesoterodine,pulmonary artery stenosis,histone deacetylase 6
10109,tazarotene,orthostatic hypotension,histone deacetylase 11
10110,avanafil,toothache,protein kinase c alpha
10111,bunazosin,nausea,potassium voltage-gated channel subfamily h member 6
10112,bortezomib,tinea corporis,cholinergic receptor nicotinic alpha 10 subunit
10113,fluphenazine,constipation disorder,natriuretic peptide b
10114,pilsicainide,acidosis disorder,cytochrome p450 family 2 subfamily r member 1
10115,prednisone,lennox-gastaut syndrome,5-methyltetrahydrofolate-homocysteine methyltransferase
10116,indomethacin,trichuriasis,prostaglandin i2 receptor
10117,glymidine,otitis externa,ndufa4 mitochondrial complex associated like 2
10118,saquinavir,hypereosinophilic syndrome,cytochrome p450 family 3 subfamily a member 5
10119,incadronic acid,discoid lupus erythematosus,glutamate ionotropic receptor kainate type subunit 5
10120,diclofenac,chronic obstructive pulmonary disease,coagulation factor ii thrombin receptor
10121,alclometasone dipropionate,postherpetic neuralgia,sucrase-isomaltase
10122,moxonidine,acute monocytic leukemia,solute carrier family 22 member 8
10123,dabigatran etexilate,autosomal dominant polycystic kidney disease,cytochrome c1
10124,benzphetamine,amenorrhea,phospholipase a2 group ib
10125,ibandronic acid,arthralgia,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
10126,dapagliflozin,anxiety disorder,sodium channel epithelial 1 subunit gamma
10127,fondaparinux,hiv infectious disease,"major histocompatibility complex, class i, a"
10128,loteprednol etabonate,asthma-chronic obstructive pulmonary disease overlap syndrome,cytochrome p450 family 2 subfamily c member 19
10129,cyclobenzaprine,x-linked dominant hypophosphatemic rickets,tachykinin receptor 1
10130,edoxaban,marginal zone lymphoma,phosphodiesterase 3a
10131,cyclosporin a,dermatitis,fms related receptor tyrosine kinase 1
10132,zolmitriptan,tenosynovitis,potassium voltage-gated channel subfamily q member 5
10133,codeine,"leukemia, myeloid, chronic-phase",interleukin 1 receptor type 1
10134,dibucaine,urticaria,amylase alpha 1b
10135,valdecoxib,eosinophilic pneumonia,phosphodiesterase 7b
10136,naratriptan,premature ejaculation,proteasome 20s subunit beta 2
10137,voglibose,ovarian epithelial tumor,glutamate ionotropic receptor kainate type subunit 3
10138,penbutolol,plasmodium vivax malaria,interleukin 6 receptor
10139,calcium citrate,osteoarthritis,fkbp prolyl isomerase 4
10140,chlordiazepoxide,tinea corporis,solute carrier family 18 member a1
10141,isocarboxazid,heart failure,diacylglycerol o-acyltransferase 1
10142,donepezil,dermatitis herpetiformis,tubulin gamma 1
10143,rivastigmine,atopic eczema,microtubule associated protein 2
10144,mefenamic acid,cryptorchidism,natriuretic peptide receptor 1
10145,clemastine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",gc vitamin d binding protein
10146,tretinoin,opiate dependence,melatonin receptor 1a
10147,beclometasone,eye disorder,neurotrophic receptor tyrosine kinase 1
10148,aminosalicylic acid,osteomalacia,doublecortin like kinase 1
10149,oxcarbazepine,angle-closure glaucoma,platelet derived growth factor receptor alpha
10150,ritonavir,uveitis,solute carrier family 22 member 2
10151,clorazepate,generalized anxiety disorder,myeloperoxidase
10152,tazarotene,liposarcoma,glucagon like peptide 1 receptor
10153,venetoclax,glaucoma,5-hydroxytryptamine receptor 3b
10154,trimipramine,"cicatrix, hypertrophic","coagulation factor ii, thrombin"
10155,ponatinib,scalp dermatosis,solute carrier family 18 member a1
10156,flutamide,urethritis,delta like non-canonical notch ligand 1
10157,efonidipine,intrinsic asthma,solute carrier family 5 member 2
10158,floctafenine,thyroid gland follicular carcinoma,mitogen-activated protein kinase kinase 1
10159,norethisterone,lung neoplasm,glutathione-disulfide reductase
10160,dexamethasone,systemic lupus erythematosus,glycine receptor alpha 3
10161,benzatropine,rhabdomyosarcoma,ste20 like kinase
10162,probucol,mantle cell lymphoma,transient receptor potential cation channel subfamily v member 4
10163,tramazoline,opiate dependence,cysteinyl leukotriene receptor 2
10164,duloxetine,aorta coarctation,interleukin 1 receptor type 1
10165,mephentermine,head and neck cancer,tyrosine kinase 2
10166,plerixafor,acute monocytic leukemia,cannabinoid receptor 1
10167,dexamethasone,post-traumatic stress disorder,ornithine transcarbamylase
10168,dipyridamole,female infertility,carbonic anhydrase 14
10169,enalaprilat,otitis externa,cytochrome p450 family 3 subfamily a member 5
10170,metaraminol,hypercalcemia disease,traf2 and nck interacting kinase
10171,lasofoxifene,myalgia,opioid receptor mu 1
10172,desogestrel,severe major depression with psychotic features,solute carrier family 22 member 4
10173,vincristine,short bowel syndrome,selectin e
10174,incadronic acid,neoplasm of esophagus,cdgsh iron sulfur domain 1
10175,carteolol,trigeminal neuralgia,calcium voltage-gated channel subunit alpha1 s
10176,ketorolac,toxic shock syndrome,cholinergic receptor nicotinic alpha 7 subunit
10177,niraparib,tetanus,amnion associated transmembrane protein
10178,alendronate,benign prostatic hyperplasia,transient receptor potential cation channel subfamily v member 4
10179,udenafil,arthralgia,tankyrase 2
10180,progesterone,polycystic ovary syndrome,5-hydroxytryptamine receptor 1a
10181,bupropion,hepatocellular carcinoma,"troponin c1, slow skeletal and cardiac type"
10182,apremilast,diamond-blackfan anemia,riboflavin kinase
10183,abiraterone acetate,streptococcal pneumonia,cytochrome p450 family 2 subfamily c member 8
10184,iloprost,atrioventricular block,histamine receptor h3
10185,"1,25-dihydroxyvitamin d3",ulcerative colitis,ndufa4 mitochondrial complex associated like 2
10186,gemfibrozil,acute myeloid leukemia,5-hydroxytryptamine receptor 2b
10187,lobeglitazone,inappropriate adh syndrome,salt inducible kinase 1
10188,lorcaserin,acute myeloid leukemia,estrogen receptor 2
10189,lenalidomide,premenstrual dysphoric disorder,synaptic vesicle glycoprotein 2a
10190,rivastigmine,chronic bronchitis,cholinergic receptor nicotinic alpha 2 subunit
10191,tranylcypromine,tetanus,atpase na+/k+ transporting subunit alpha 1
10192,calcium citrate,fabry disease,diacylglycerol o-acyltransferase 1
10193,rupatadine,hyponatremia,glutamic-oxaloacetic transaminase 1
10194,riboflavin,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",hyperpolarization activated cyclic nucleotide gated potassium channel 3
10195,fentanyl,pyelonephritis,insulin receptor
10196,mercaptopurine,hemangioma,dihydropyrimidine dehydrogenase
10197,donepezil,bone osteosarcoma,protein kinase c theta
10198,octreotide,altitude sickness,tubulin gamma 1
10199,befunolol,otitis externa,insulin receptor
10200,fingolimod,sarcoidosis,ornithine decarboxylase 1
10201,amoxapine,acute coronary syndrome,potassium voltage-gated channel subfamily a member 5
10202,perampanel,brain cancer,checkpoint kinase 2
10203,lasofoxifene,prinzmetal angina,tubulin alpha 1a
10204,nitrazepam,migraine disorder,solute carrier organic anion transporter family member 1a2
10205,mesalazine,burkitt lymphoma,tubulin gamma 1
10206,crizotinib,vitamin d deficiency,cytochrome p450 family 11 subfamily b member 2
10207,isopropamide,aplastic anemia,dual specificity tyrosine phosphorylation regulated kinase 2
10208,triamterene,interstitial lung disease 2,arginine vasopressin receptor 1a
10209,tocilizumab,vernal conjunctivitis,nuclear receptor subfamily 0 group b member 1
10210,olaparib,erdheim-chester disease,acyl-coa dehydrogenase short/branched chain
10211,trifluridine,malignant glioma,tubulin beta 3 class iii
10212,acetazolamide,dermatitis herpetiformis,cytochrome p450 family 1 subfamily a member 1
10213,pravastatin,persistent fetal circulation syndrome,testis specific serine kinase 1b
10214,trifluridine,leprosy,arginine vasopressin receptor 2
10215,carbimazole,humoral hypercalcemia of malignancy,peroxisome proliferator activated receptor alpha
10216,mesoridazine,pediculus humanus capitis infestation,transforming growth factor beta receptor 2
10217,oxymetazoline,migraine disorder,npc1 like intracellular cholesterol transporter 1
10218,fludroxycortide,delirium,solute carrier family 18 member a2
10219,regorafenib,"blast phase chronic myelogenous leukemia, bcr-abl1 positive","protein phosphatase 3 regulatory subunit b, alpha"
10220,amitriptyline,prostate cancer,atpase na+/k+ transporting subunit alpha 3
10221,crotamiton,biotinidase deficiency,transient receptor potential cation channel subfamily v member 3
10222,ergometrine,pernicious anemia,platelet derived growth factor receptor alpha
10223,vinpocetine,meningococcal meningitis,solute carrier family 5 member 1
10224,alcaftadine,idiopathic hypereosinophilic syndrome,potassium voltage-gated channel subfamily a member 2
10225,raloxifene,short bowel syndrome,melatonin receptor 1b
10226,cortisone,urge incontinence,glutathione s-transferase mu 1
10227,tropicamide,primary myelofibrosis,histone deacetylase 1
10228,chloroquine,ovarian cancer,proteasome 20s subunit beta 5
10229,azelastine,langerhans cell histiocytosis,solute carrier family 47 member 1
10230,rimexolone,basal ganglia disorder,dipeptidyl peptidase 8
10231,azacitidine,diffuse large b-cell lymphoma,doublecortin like kinase 1
10232,floctafenine,diffuse large b-cell lymphoma,ribosomal protein s6 kinase a1
10233,piroxicam,"malignant hyperthermia, susceptibility to, 1",homeodomain interacting protein kinase 4
10234,etoposide,bronchiectasis,"b-raf proto-oncogene, serine/threonine kinase"
10235,etodolac,hypotensive disorder,solute carrier family 22 member 2
10236,benzquinamide,breast ductal adenocarcinoma,calcium voltage-gated channel subunit alpha1 a
10237,chlorothiazide,pulmonary artery stenosis,leukotriene a4 hydrolase
10238,gabapentin,allergic asthma,aurora kinase a
10239,balsalazide,urinary bladder cancer,glutamic-oxaloacetic transaminase 1
10240,befunolol,melanoma,phosphoribosyl pyrophosphate amidotransferase
10241,talinolol,acute intermittent porphyria,histone deacetylase 9
10242,diphenidol,patent ductus arteriosus,interleukin 1 receptor type 1
10243,quinestrol,uveitis,atp binding cassette subfamily c member 3
10244,lifitegrast,ovarian cancer,cereblon
10245,carteolol,hypophosphatemia,calcium voltage-gated channel subunit alpha1 i
10246,dopamine,sitosterolemia,doublecortin like kinase 1
10247,calcipotriol,endemic goiter,amylase alpha 2a
10248,histrelin,postmenopausal osteoporosis,endothelin receptor type a
10249,dofetilide,bipolar depression,myristoylated alanine rich protein kinase c substrate
10250,etoposide,hypercholesterolemia,dna methyltransferase 3 alpha
10251,phentolamine,skin disorder,potassium voltage-gated channel modifier subfamily g member 3
10252,midodrine,female infertility,potassium inwardly rectifying channel subfamily j member 12
10253,imipramine,cutaneous candidiasis,"b-raf proto-oncogene, serine/threonine kinase"
10254,doxapram,peripheral vascular disease,5-hydroxytryptamine receptor 1a
10255,epa,ovarian cancer,transthyretin
10256,ritonavir,methylmalonic acidemia,tyrosinase
10257,hydroflumethiazide,premenstrual dysphoric disorder,glucagon receptor
10258,ruxolitinib,cycloplegia,thymidylate synthetase
10259,donepezil,follicular lymphoma,gamma-aminobutyric acid type a receptor subunit delta
10260,isoxsuprine,epilepsy,gamma-aminobutyric acid type a receptor subunit alpha3
10261,viloxazine,manic bipolar affective disorder,hyperpolarization activated cyclic nucleotide gated potassium channel 4
10262,diphenidol,short bowel syndrome,sex hormone binding globulin
10263,vindesine,"hydatidiform mole, recurrent, 1",phosphodiesterase 1c
10264,emedastine,interstitial lung disease 2,histone deacetylase 10
10265,safinamide,peptic ulcer disease,solute carrier organic anion transporter family member 1b1
10266,fampridine,vernal conjunctivitis,bmx non-receptor tyrosine kinase
10267,cisapride,tricuspid atresia,phosphodiesterase 8a
10268,cetuximab,tyrosinemia,proteasome 20s subunit beta 9
10269,afamelanotide,raynaud disease,serine/threonine kinase 16
10270,tulobuterol,gestational trophoblastic neoplasm,ribonucleotide reductase catalytic subunit m1
10271,hydrochlorothiazide,keratitis,sphingosine-1-phosphate receptor 3
10272,sertindole,back pain,purinergic receptor p2y12
10273,salicylamide,plasmodium vivax malaria,tubulin beta 2a class iia
10274,nevirapine,huntington disease,fms related receptor tyrosine kinase 3
10275,dehydroepiandrosterone,diffuse large b-cell lymphoma,potassium voltage-gated channel subfamily q member 3
10276,phenindamine,osteomalacia,kallikrein b1
10277,astemizole,scalp dermatosis,melanocortin 3 receptor
10278,methylphenobarbital,thyroid gland papillary carcinoma,il2 inducible t cell kinase
10279,letrozole,postencephalitic parkinson disease,unc-51 like autophagy activating kinase 2
10280,lumiracoxib,nocturnal enuresis,adenosine a2a receptor
10281,pentoxifylline,thyroiditis,superoxide dismutase 1
10282,midodrine,breast cancer,potassium voltage-gated channel subfamily a member 6
10283,bethanechol,hyperglycemia,solute carrier family 27 member 2
10284,olaparib,neuroblastoma,propionyl-coa carboxylase subunit alpha
10285,cariprazine,anxiety disorder,potassium voltage-gated channel subfamily d member 2
10286,mephentermine,pharyngitis,potassium voltage-gated channel subfamily c member 4
10287,vindesine,migraine disorder,solute carrier family 12 member 2
10288,vinblastine,premenstrual dysphoric disorder,sphingosine-1-phosphate receptor 1
10289,betahistine,cardiac arrest,5-hydroxytryptamine receptor 1f
10290,desonide,supraventricular tachycardia,cytochrome p450 family 2 subfamily j member 2
10291,methylergonovine,x-linked dominant hypophosphatemic rickets,protein phosphatase 3 catalytic subunit alpha
10292,codeine,ornithine carbamoyltransferase deficiency,mechanistic target of rapamycin kinase
10293,fluoxetine,spasticity,microtubule associated protein 2
10294,camphor,alcohol dependence,glutamate ionotropic receptor kainate type subunit 4
10295,ivermectin,langerhans cell histiocytosis,aurora kinase c
10296,sertindole,depressive disorder,serine/threonine kinase 33
10297,estramustine,myocardial infarction,gamma-aminobutyric acid type a receptor subunit alpha1
10298,iloprost,gastrointestinal stromal tumor,solute carrier organic anion transporter family member 1a2
10299,lifitegrast,nausea,myosin light chain kinase family member 4
10300,isosorbide dinitrate,prostate neoplasm,atpase na+/k+ transporting subunit alpha 2
10301,phenylbutazone,pulmonary emphysema,receptor interacting serine/threonine kinase 3
10302,edoxaban,"leukemia, myeloid, chronic-phase",angiotensin ii receptor type 1
10303,alteplase,chronic primary adrenal insufficiency,sulfotransferase family 1a member 1
10304,acrivastine,myocardial infarction,tubulin beta 2b class iib
10305,nizatidine,early myoclonic encephalopathy,bcl2 like 1
10306,trihexyphenidyl,hyperaldosteronism,sodium channel epithelial 1 subunit gamma
10307,levonorgestrel,urethritis,cholinergic receptor muscarinic 2
10308,carbenoxolone,vascular disorder,gc vitamin d binding protein
10309,goserelin,hereditary angioedema,microtubule associated protein 1a
10310,riluzole,esophageal cancer,inositol monophosphatase 1
10311,chloroquine,primary myelofibrosis,potassium voltage-gated channel subfamily b member 1
10312,fluspirilene,fever,acetyl-coa acyltransferase 2
10313,icatibant,premature ventricular contraction,phosphodiesterase 8a
10314,fluocinonide,goiter,4-hydroxyphenylpyruvate dioxygenase
10315,clobazam,attrv122i amyloidosis,eph receptor a3
10316,methoxamine,thyroiditis,atpase na+/k+ transporting subunit beta 3
10317,chlorothiazide,meniere disease,guanylate cyclase 1 soluble subunit beta 1
10318,cimetidine,chronic pain,metallothionein 1a
10319,dexamfetamine,shock,prostaglandin e receptor 4
10320,lithium ion,malignant colon neoplasm,potassium voltage-gated channel subfamily a member 7
10321,miglitol,peptic esophagitis,homeodomain interacting protein kinase 2
10322,metolazone,nausea,bmx non-receptor tyrosine kinase
10323,etelcalcetide,pulmonary valve atresia,tubulin alpha 1a
10324,tranylcypromine,brain glioblastoma,potassium inwardly rectifying channel subfamily j member 1
10325,oxazepam,malignant colon neoplasm,calcium voltage-gated channel subunit alpha1 c
10326,blonanserin,localized scleroderma,death associated protein kinase 3
10327,bitolterol,oral mucosa leukoplakia,cholinergic receptor nicotinic alpha 6 subunit
10328,pazopanib,sympathetic ophthalmia,calcium/calmodulin dependent protein kinase ii alpha
10329,fluocinolone acetonide,decreased cardiac output,isoleucyl-trna synthetase 1
10330,methimazole,postpartum depression,histone deacetylase 7
10331,pazopanib,enterocolitis,potassium voltage-gated channel subfamily c member 4
10332,medroxyprogesterone,shock,cdc like kinase 2
10333,dimenhydrinate,essential thrombocythemia,calcium voltage-gated channel subunit alpha1 s
10334,dyphylline,pulmonary edema,"troponin c1, slow skeletal and cardiac type"
10335,nadolol,nicotine dependence,aldo-keto reductase family 1 member c1
10336,valsartan,sebaceous adenoma,5-hydroxytryptamine receptor 1e
10337,buprenorphine,pancreatic insulinoma,cubilin
10338,vildagliptin,streptococcal pneumonia,peptidylprolyl isomerase b
10339,pge1,psychologic dyspareunia,transmembrane protein 97
10340,ketorolac,brain cancer,cdc like kinase 4
10341,mercaptopurine,hairy cell leukemia,acid sensing ion channel subunit 1
10342,diphenoxylate,inappropriate adh syndrome,acyl-coa dehydrogenase short/branched chain
10343,conivaptan,juvenile idiopathic arthritis,neurotrophic receptor tyrosine kinase 3
10344,carmustine,pulmonary valve atresia,solute carrier family 6 member 3
10345,mesalazine,skin disorder,sodium voltage-gated channel alpha subunit 10
10346,methapyrilene,hypoparathyroidism,bmx non-receptor tyrosine kinase
10347,pyridostigmine,ocular hypertension,nuclear receptor subfamily 0 group b member 1
10348,loxoprofen,anogenital human papillomavirus infection,thymidine phosphorylase
10349,probenecid,pseudotumor cerebri,ryanodine receptor 3
10350,lusutrombopag,prader-willi syndrome,cytochrome p450 family 2 subfamily c member 8
10351,benzquinamide,hypereosinophilic syndrome,sigma non-opioid intracellular receptor 1
10352,dobutamine,alzheimer disease,vitamin d receptor
10353,icatibant,nausea,dopamine receptor d1
10354,tafamidis,breast ductal adenocarcinoma,tank binding kinase 1
10355,hydrocodone,"cicatrix, hypertrophic",tyrosine kinase non receptor 2
10356,pyrimethamine,homocystinuria,superoxide dismutase 1
10357,clofarabine,neonatal diabetes mellitus,sulfotransferase family 2a member 1
10358,tadalafil,premature obstetric labor,ribosomal protein l3
10359,carfilzomib,delayed puberty,potassium inwardly rectifying channel subfamily j member 11
10360,raltegravir,gastrointestinal stromal tumor,cytochrome c1
10361,rivaroxaban,vomiting,amnion associated transmembrane protein
10362,eszopiclone,interstitial lung disease 2,neuropeptide y
10363,miglitol,endometrial carcinoma,neutrophil cytosolic factor 1
10364,eletriptan,kidney angiomyolipoma,retinoid x receptor beta
10365,dimethyl fumarate,hyponatremia,phosphodiesterase 11a
10366,vandetanib,systemic mastocytosis,tubulin gamma 1
10367,zolmitriptan,burkitt lymphoma,proteasome 20s subunit beta 2
10368,bupivacaine,poisoning of animals with phosphate salts,sodium voltage-gated channel alpha subunit 9
10369,tranylcypromine,influenza,amnion associated transmembrane protein
10370,tamsulosin,congestive heart failure,potassium voltage-gated channel subfamily h member 8
10371,pentoxifylline,crohn disease,tyrosine kinase non receptor 2
10372,dasatinib,mast cell leukemia,cannabinoid receptor 1
10373,selumetinib,peptic ulcer disease,dipeptidyl peptidase 9
10374,ketotifen,zollinger-ellison syndrome,calcyon neuron specific vesicular protein
10375,neostigmine,polyuria,doublecortin like kinase 3
10376,fexofenadine,biotinidase deficiency,membrane spanning 4-domains a1
10377,nevirapine,bruxism,sonic hedgehog signaling molecule
10378,pemetrexed,onchocerciasis,"yes proto-oncogene 1, src family tyrosine kinase"
10379,methylphenidate,bruxism,3-hydroxy-3-methylglutaryl-coa reductase
10380,pimozide,neurogenic bladder,metallothionein 2a
10381,spironolactone,thyroid gland papillary carcinoma,amylase alpha 2a
10382,fluticasone,premature ventricular contraction,cytochrome p450 family 2 subfamily c member 8
10383,saxagliptin,skin basal cell carcinoma,cytochrome p450 family 11 subfamily b member 2
10384,dextromethorphan,invasive ductal breast carcinoma,gamma-aminobutyric acid type a receptor subunit gamma1
10385,eprosartan,zollinger-ellison syndrome,nuclear receptor subfamily 5 group a member 1
10386,buclizine,sebaceous adenoma,peroxisome proliferator activated receptor gamma
10387,rasagiline,arthralgia,glutamate ionotropic receptor kainate type subunit 2
10388,ambenonium,pyelonephritis,atpase na+/k+ transporting subunit alpha 4
10389,acetazolamide,drooling,c-x-c motif chemokine receptor 4
10390,hydromorphone,abdominal abscess,metabolism of cobalamin associated c
10391,verapamil,gastric cancer,"lck proto-oncogene, src family tyrosine kinase"
10392,paramethadione,lichen planus,calcium voltage-gated channel subunit alpha1 a
10393,carbamazepine,impetigo,vitamin d receptor
10394,befunolol,non-hodgkin lymphoma,potassium voltage-gated channel subfamily h member 7
10395,oprelvekin,edema,potassium voltage-gated channel subfamily h member 1
10396,amiodarone,localized scleroderma,hyperpolarization activated cyclic nucleotide gated potassium channel 1
10397,phytomenadione,hiv infectious disease,retinoic acid receptor alpha
10398,guanethidine,bronchiectasis,potassium voltage-gated channel subfamily h member 8
10399,perazine,abdominal infection,atpase h+/k+ transporting subunit beta
10400,clomipramine,bipolar disorder,monoamine oxidase b
10401,bumetanide,hemangioma,phosphodiesterase 8b
10402,levosimendan,psychosexual disorder,proteasome 20s subunit beta 5
10403,abiraterone acetate,myocardial infarction,5-hydroxytryptamine receptor 1d
10404,safinamide,postoperative nausea and vomiting,butyrylcholinesterase
10405,pazopanib,scabies,calcium voltage-gated channel subunit alpha1 a
10406,armodafinil,pancreatic adenocarcinoma,cytochrome p450 family 3 subfamily a member 43
10407,balsalazide,cerebrovascular disorder,serine/threonine kinase 4
10408,bepotastine,oligospermia,gamma-aminobutyric acid type a receptor subunit alpha2
10409,testosterone propionate,dacryocystitis,fkbp prolyl isomerase 1b
10410,fludarabine,cryopyrin-associated periodic syndrome,solute carrier family 5 member 1
10411,nintedanib,dermatitis,proteasome 20s subunit beta 1
10412,aranidipine,ventricular fibrillation,ndufa4 mitochondrial complex associated
10413,hydroflumethiazide,glossopharyngeal neuralgia,glutamate ionotropic receptor nmda type subunit 2d
10414,nebivolol,diarrheal disease,sodium voltage-gated channel alpha subunit 7
10415,travoprost,psoriatic arthritis,interleukin 1 receptor associated kinase 1
10416,tacrolimus,breast carcinoma,cytochrome p450 family 2 subfamily c member 19
10417,tipranavir,delirium,atpase na+/k+ transporting subunit beta 1
10418,pravastatin,pancreatic insulinoma,c-x-c motif chemokine receptor 1
10419,eszopiclone,malignant glioma,leucine rich repeat kinase 2
10420,repaglinide,hypereosinophilic syndrome,calcium voltage-gated channel subunit alpha1 s
10421,diclofenamide,brain glioblastoma,potassium voltage-gated channel subfamily c member 4
10422,darunavir,iridocyclitis,ornithine transcarbamylase
10423,quinestrol,allergic bronchopulmonary aspergillosis,protein tyrosine kinase 2 beta
10424,spiperone,lewy body dementia,tubulin beta 1 class vi
10425,chlorpromazine,peptic esophagitis,sodium voltage-gated channel alpha subunit 5
10426,dipyridamole,aspiration pneumonitis,potassium voltage-gated channel subfamily d member 1
10427,raloxifene,human african trypanosomiasis,somatostatin receptor 5
10428,lafutidine,chronic obstructive pulmonary disease,holocarboxylase synthetase
10429,lithium ion,non-hodgkin lymphoma,5-hydroxytryptamine receptor 2b
10430,trimetazidine,crohn disease,gamma-aminobutyric acid type a receptor subunit alpha6
10431,flunisolide,vitiligo,txk tyrosine kinase
10432,glisoxepide,trigeminal neuralgia,guanylate cyclase 1 soluble subunit beta 1
10433,paliperidone,rheumatoid arthritis,cholesteryl ester transfer protein
10434,acetophenazine,b-cell chronic lymphocytic leukemia,phosphodiesterase 6d
10435,aceclofenac,gonorrhea,dopamine beta-hydroxylase
10436,almitrine,persistent fetal circulation syndrome,amylase alpha 1a
10437,letrozole,stargardt disease,estrogen receptor 2
10438,promethazine,postpartum depression,interleukin 2
10439,pentoxifylline,brain cancer,inhibitor of nuclear factor kappa b kinase subunit beta
10440,nimodipine,tinea corporis,neurotrophic receptor tyrosine kinase 2
10441,mupirocin,insomnia,carbonic anhydrase 14
10442,azatadine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",g protein-coupled receptor kinase 4
10443,levodopa,disruptive behavior disorder,cysteinyl leukotriene receptor 2
10444,lorlatinib,pemphigus,gamma-aminobutyric acid type a receptor subunit theta
10445,metoclopramide,autoimmune hemolytic anemia,potassium voltage-gated channel subfamily a member 2
10446,dronedarone,prostate cancer,ret proto-oncogene
10447,pimecrolimus,hot flashes,tubulin alpha 4a
10448,amprenavir,breast carcinoma,dipeptidase 1
10449,triamterene,chronic schizophrenia,"lipase f, gastric type"
10450,dromostanolone propionate,eosinophilic pneumonia,prostaglandin d2 receptor
10451,bosentan,dacryocystitis,5-hydroxytryptamine receptor 2b
10452,pentoxifylline,dyspnea,5-hydroxytryptamine receptor 2a
10453,lamotrigine,testicular cancer,glutamate ionotropic receptor nmda type subunit 1
10454,levorphanol,hypertrichosis of eyelid,solute carrier family 7 member 11
10455,cariprazine,congestive heart failure,histamine receptor h1
10456,pramipexole,hypophosphatemia,solute carrier family 6 member 3
10457,pindolol,allergic urticaria,bromodomain containing 4
10458,epirubicin,premature ventricular contraction,structural maintenance of chromosomes 2
10459,dexbrompheniramine,xerophthalmia,ribosomal protein s6 kinase a2
10460,nateglinide,small cell lung carcinoma,arginine vasopressin receptor 2
10461,cariprazine,drooling,h1.0 linker histone
10462,desloratadine,cervical cancer,solute carrier family 47 member 2
10463,timolol,chronic schizophrenia,phosphodiesterase 1a
10464,cortisone,superficial multifocal basal cell carcinoma,sodium channel epithelial 1 subunit gamma
10465,dapagliflozin,rhinitis,adrenoceptor beta 1
10466,famotidine,diabetic kidney disease,histone deacetylase 7
10467,cetirizine,amyotrophic lateral sclerosis,tubulin gamma 1
10468,meclizine,postherpetic neuralgia,ste20 like kinase
10469,colestipol,hyperglycemia,gamma-aminobutyric acid type a receptor subunit epsilon
10470,glibenclamide,mantle cell lymphoma,s100 calcium binding protein b
10471,dezocine,bipolar disorder,thyroid hormone receptor beta
10472,methamphetamine,classic phenylketonuria,histamine receptor h2
10473,lenalidomide,ascites,prostaglandin i2 receptor
10474,cetirizine,tardive dyskinesia,cytochrome p450 family 2 subfamily r member 1
10475,ziconotide,phenylketonuria,adrenoceptor beta 1
10476,aranidipine,respiratory failure,"yes proto-oncogene 1, src family tyrosine kinase"
10477,tamoxifen,malaria,epidermal growth factor receptor
10478,emtricitabine,urge incontinence,atp binding cassette subfamily c member 8
10479,imatinib,onchocerciasis,5-hydroxytryptamine receptor 1d
10480,cisplatin,vernal conjunctivitis,fatty acid amide hydrolase
10481,raltegravir,"hydatidiform mole, recurrent, 1",fms related receptor tyrosine kinase 4
10482,insulin aspart,sjogren syndrome,"hck proto-oncogene, src family tyrosine kinase"
10483,prucalopride,female infertility,solute carrier family 5 member 2
10484,pindolol,hypercalcemia disease,nuclear receptor subfamily 3 group c member 2
10485,camphor,pneumonia,5-hydroxytryptamine receptor 1a
10486,acth,tourette syndrome,cytochrome p450 family 51 subfamily a member 1
10487,esomeprazole,acute coronary syndrome,potassium voltage-gated channel subfamily a member 4
10488,valrubicin,abdominal infection,glucose-6-phosphate dehydrogenase
10489,primidone,osteoarthritis,potassium voltage-gated channel subfamily q member 2
10490,spirapril,lung lymphangioleiomyomatosis,"smoothened, frizzled class receptor"
10491,bepridil,thrombophilia due to thrombin defect,cytidine/uridine monophosphate kinase 1
10492,zileuton,postherpetic neuralgia,death associated protein kinase 2
10493,l-glutamine,depressive disorder,amylase alpha 1a
10494,phenacemide,bruxism,eph receptor a5
10495,alprazolam,tenosynovial giant cell tumor,cytochrome p450 family 46 subfamily a member 1
10496,gemigliptin,oral candidiasis,retinoic acid receptor beta
10497,imiquimod,brain glioblastoma,sodium voltage-gated channel alpha subunit 5
10498,methylergonovine,streptococcal pneumonia,atpase h+/k+ transporting subunit beta
10499,bunazosin,perennial allergic rhinitis,potassium voltage-gated channel subfamily a member 5
10500,atazanavir,vitamin deficiency disorder,phosphodiesterase 8a
10501,anastrozole,cough,lipoprotein lipase
10502,cyclosporin a,hypertrophic cardiomyopathy,fatty acid amide hydrolase
10503,stanozolol,peptic ulcer disease,gamma-aminobutyric acid type a receptor subunit alpha4
10504,pentostatin,meningococcal meningitis,toll like receptor 9
10505,echothiophate,idiopathic acute eosinophilic pneumonia,"mer proto-oncogene, tyrosine kinase"
10506,cyclobenzaprine,gastric cancer,arginine vasopressin receptor 1a
10507,buprenorphine,chronic hepatitis c virus infection,solute carrier family 6 member 2
10508,captodiame,early myoclonic encephalopathy,axl receptor tyrosine kinase
10509,icatibant,malignant essential hypertension,mitogen-activated protein kinase kinase 1
10510,furosemide,thyroid tumor,butyrylcholinesterase
10511,icotinib,renal cell carcinoma,g protein-coupled receptor 35
10512,dexibuprofen,classic phenylketonuria,tubulin beta 4b class ivb
10513,baricitinib,liver cancer,carbonic anhydrase 9
10514,selegiline,ankylosing spondylitis,retinoid x receptor gamma
10515,clonidine,menorrhagia,transient receptor potential cation channel subfamily a member 1
10516,calcium acetate,hyperglycemia,atpase copper transporting alpha
10517,vinorelbine,peripheral vascular disease,glutathione s-transferase mu 1
10518,levoketoconazole,leprosy,albumin
10519,desvenlafaxine,eosinophilic esophagitis,tek receptor tyrosine kinase
10520,alclofenac,pulmonary emphysema,inositol monophosphatase 1
10521,medrysone,tyrosinemia,sodium voltage-gated channel alpha subunit 7
10522,dasatinib,relapsing-remitting multiple sclerosis,atpase h+/k+ transporting subunit alpha
10523,benzquinamide,delirium,steroid 5 alpha-reductase 1
10524,bretylium,"attention deficit hyperactivity disorder, inattentive type",5-hydroxytryptamine receptor 2b
10525,sertaconazole,head and neck neoplasm,solute carrier family 6 member 3
10526,buclizine,phenylketonuria,cyclin dependent kinase 19
10527,fenoprofen,brain glioblastoma,protein kinase n1
10528,methylphenobarbital,hypertrichosis of eyelid,phosphodiesterase 6c
10529,tranilast,benign prostatic hyperplasia,synaptic vesicle glycoprotein 2a
10530,aclidinium,fever,angiotensin converting enzyme 2
10531,tolbutamide,psychologic dyspareunia,potassium voltage-gated channel subfamily d member 1
10532,romidepsin,bronchitis,calcium voltage-gated channel auxiliary subunit alpha2delta 2
10533,tolmetin,migraine disorder,tubulin beta 1 class vi
10534,brexpiprazole,raynaud disease,adrenoceptor alpha 1d
10535,aminoglutethimide,west syndrome,cdgsh iron sulfur domain 1
10536,heparin,periodontitis,thromboxane a2 receptor
10537,paliperidone,enterobiasis,"kit proto-oncogene, receptor tyrosine kinase"
10538,ethinylestradiol,essential thrombocythemia,cytochrome p450 family 2 subfamily a member 6
10539,dibucaine,psychotic disorder,eph receptor a5
10540,tetracosactide,amyloidosis,carbonic anhydrase 1
10541,mosapramine,hypercalcemia disease,potassium two pore domain channel subfamily k member 2
10542,nitroglycerin,sneeze,fibroblast growth factor receptor 1
10543,gemfibrozil,scalp dermatosis,opioid receptor mu 1
10544,anakinra,interstitial lung disease,atp binding cassette subfamily c member 9
10545,fludrocortisone,postherpetic neuralgia,calcium voltage-gated channel subunit alpha1 g
10546,cisapride,tetralogy of fallot,potassium voltage-gated channel subfamily c member 2
10547,dasatinib,trichinellosis,potassium voltage-gated channel modifier subfamily v member 1
10548,ribavirin,pain,5-hydroxytryptamine receptor 4
10549,rabeprazole,nicotine dependence,ribosomal protein s6 kinase a5
10550,isradipine,sebaceous adenoma,nuclear receptor subfamily 1 group i member 2
10551,escitalopram,status epilepticus,peroxisome proliferator activated receptor gamma
10552,efonidipine,hypotensive disorder,homeodomain interacting protein kinase 2
10553,cetuximab,manic bipolar affective disorder,"abl proto-oncogene 1, non-receptor tyrosine kinase"
10554,miglitol,allergic urticaria,cytochrome p450 family 2 subfamily c member 9
10555,tipiracil,interstitial lung disease 2,sulfotransferase family 2a member 1
10556,amprenavir,rhinitis,sucrase-isomaltase
10557,lobeglitazone,hereditary von willebrand disease,glutathione s-transferase theta 1
10558,vorapaxar,castleman disease,cart prepropeptide
10559,darifenacin,humoral hypercalcemia of malignancy,potassium voltage-gated channel subfamily q member 1
10560,dexlansoprazole,asthma-chronic obstructive pulmonary disease overlap syndrome,neuropeptide y receptor y1
10561,progesterone,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 2 subfamily c member 9
10562,sotalol,patent ductus arteriosus,sphingosine-1-phosphate receptor 3
10563,ethosuximide,enterocolitis,transient receptor potential cation channel subfamily v member 4
10564,celiprolol,malignant pleural mesothelioma,death associated protein kinase 1
10565,rivastigmine,nicotine dependence,"smoothened, frizzled class receptor"
10566,tramadol,allergic contact dermatitis,phosphodiesterase 7b
10567,perazine,neoplasm of esophagus,retinoic acid receptor beta
10568,cabergoline,eunuchism,peptidylprolyl isomerase d
10569,simvastatin,sitosterolemia,sulfotransferase family 1a member 1
10570,loxoprofen,eosinophilic pneumonia,g protein-coupled receptor kinase 2
10571,l-citrulline,bronchial disorder,adenosine a2b receptor
10572,amoxapine,gynecomastia disorder,cytochrome p450 family 51 subfamily a member 1
10573,rivastigmine,mydriasis,calcium voltage-gated channel auxiliary subunit beta 2
10574,phenmetrazine,medullary thyroid gland carcinoma,cholinergic receptor muscarinic 5
10575,anagliptin,dermatophytosis of groin and perianal area,5-hydroxytryptamine receptor 7
10576,metoclopramide,depressive disorder,retinoid x receptor gamma
10577,pseudoephedrine,tetralogy of fallot,bcr activator of rhogef and gtpase
10578,tadalafil,bacterial pneumonia,guanylate cyclase 1 soluble subunit alpha 2
10579,fentanyl,peripheral vascular disease,retinoid x receptor gamma
10580,metoclopramide,musculoskeletal system disorder,atpase na+/k+ transporting subunit beta 2
10581,dorzolamide,cycloplegia,gamma-aminobutyric acid type a receptor subunit gamma1
10582,vortioxetine,prostate cancer,carbonic anhydrase 9
10583,repaglinide,secondary hyperparathyroidism,potassium voltage-gated channel subfamily a member 7
10584,norethisterone,eosinophilic esophagitis,gamma-aminobutyric acid type a receptor subunit alpha6
10585,perphenazine,neurofibromatosis 1,peptidylprolyl isomerase b
10586,colecalciferol,eosinophilic pneumonia,propionyl-coa carboxylase subunit beta
10587,flecainide,labor pain,"fyn proto-oncogene, src family tyrosine kinase"
10588,bromocriptine,abdominal infection,cholinergic receptor muscarinic 5
10589,valdecoxib,waldenstrom macroglobulinemia,retinoic acid receptor gamma
10590,fluoxetine,vitamin deficiency disorder,tubulin beta 4a class iva
10591,alectinib,malignant pleural mesothelioma,cholinergic receptor nicotinic alpha 5 subunit
10592,treprostinil,head and neck cancer,sucrase-isomaltase
10593,nilotinib,chancroid,peroxisome proliferator activated receptor gamma
10594,enzalutamide,bipolar disorder,sodium voltage-gated channel alpha subunit 3
10595,cycrimine,mantle cell lymphoma,glutamate ionotropic receptor nmda type subunit 1
10596,carmofur,breast fibrocystic disease,potassium voltage-gated channel subfamily a member 4
10597,salsalate,multiple sclerosis,ribonucleotide reductase catalytic subunit m1
10598,ibandronic acid,hypocalcemia,5-hydroxytryptamine receptor 2a
10599,clofarabine,b-cell chronic lymphocytic leukemia,discoidin domain receptor tyrosine kinase 2
10600,estrone sulphate,chronic eosinophilic leukemia,dna primase subunit 2
10601,phentermine,arthralgia,24-dehydrocholesterol reductase
10602,flumethasone pivalate,postherpetic neuralgia,macrophage stimulating 1 receptor
10603,vinpocetine,polymyalgia rheumatica,cdc like kinase 2
10604,lusutrombopag,central nervous system origin vertigo,histone deacetylase 1
10605,selumetinib,zollinger-ellison syndrome,myeloperoxidase
10606,norgestimate,heart failure,solute carrier family 22 member 1
10607,carbimazole,basal ganglia disorder,membrane spanning 4-domains a1
10608,rimonabant,amenorrhea,tubulin alpha 4a
10609,dipivefrine,manic bipolar affective disorder,5-hydroxytryptamine receptor 5a
10610,dexamethasone,basal ganglia disorder,aurora kinase c
10611,eribulin,orthostatic hypotension,cf transmembrane conductance regulator
10612,carbetocin,benign prostatic hyperplasia,serpin family a member 6
10613,macitentan,myasthenia gravis,atpase h+ transporting v1 subunit a
10614,midodrine,seasonal affective disorder,potassium calcium-activated channel subfamily n member 4
10615,pergolide,primary cutaneous t-cell non-hodgkin lymphoma,acid sensing ion channel subunit 1
10616,tulobuterol,early myoclonic encephalopathy,potassium voltage-gated channel subfamily h member 6
10617,mizolastine,disseminated intravascular coagulation,"lipase f, gastric type"
10618,amitriptyline,migraine disorder,atpase na+/k+ transporting subunit beta 2
10619,clobazam,pneumonia,"coagulation factor ii, thrombin"
10620,penbutolol,torsades de pointes,oxytocin receptor
10621,dexibuprofen,intracranial embolism,potassium voltage-gated channel subfamily q member 5
10622,dobutamine,bursitis,death associated protein kinase 2
10623,aminobenzoic acid,vulvovaginal candidiasis,hydroxycarboxylic acid receptor 3
10624,magnesium sulfate,short bowel syndrome,transmembrane protein 97
10625,capecitabine,non-hodgkin lymphoma,aldo-keto reductase family 1 member c3
10626,dipivefrine,schizoaffective disorder,thymidylate synthetase
10627,cisapride,allergic asthma,atpase na+/k+ transporting subunit alpha 2
10628,clobetasol propionate,keratitis,cf transmembrane conductance regulator
10629,warfarin,rhinoscleroma,atp binding cassette subfamily b member 11
10630,sonidegib,lung neoplasm,bone morphogenetic protein receptor type 1b
10631,raltegravir,rheumatoid arthritis,hyperpolarization activated cyclic nucleotide gated potassium channel 4
10632,ketorolac,hypocalcemia,potassium voltage-gated channel subfamily q member 5
10633,bazedoxifene,trichuriasis,potassium voltage-gated channel subfamily c member 1
10634,flunisolide,opiate dependence,cholinergic receptor nicotinic beta 2 subunit
10635,thalidomide,open-angle glaucoma,histone deacetylase 5
10636,chlorothiazide,anxiety disorder,mechanistic target of rapamycin kinase
10637,dexbrompheniramine,respiratory failure,maltase-glucoamylase
10638,dexbrompheniramine,hypophosphatemia,cytochrome p450 family 27 subfamily a member 1
10639,mepyramine,diamond-blackfan anemia,amylase alpha 1c
10640,pravastatin,canker sore,receptor interacting serine/threonine kinase 3
10641,azelastine,myotonic syndrome,prostaglandin e receptor 1
10642,rofecoxib,polymyalgia rheumatica,nuak family kinase 2
10643,voclosporin,hemophilia a,solute carrier family 19 member 1
10644,meclizine,parkinsonian disorder,amylase alpha 1b
10645,vinblastine,rosacea,neurotrophic receptor tyrosine kinase 1
10646,methapyrilene,sarcoidosis,dead-box helicase 3 x-linked
10647,dofetilide,periodontitis,atm serine/threonine kinase
10648,tolbutamide,amyloidosis,tubulin beta 8 class viii
10649,lenalidomide,temporal arteritis,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
10650,riociguat,dermatomyositis,phosphodiesterase 10a
10651,bosutinib,pulmonary artery stenosis,solute carrier family 2 member 9
10652,cefonicid,glaucoma,cdc like kinase 4
10653,rofecoxib,congestive heart failure,colony stimulating factor 1 receptor
10654,alpha-methyltyrosine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",kallikrein b1
10655,zonisamide,proctitis,protein kinase c alpha
10656,citalopram,dermatophytosis of groin and perianal area,thymidine phosphorylase
10657,sildenafil,hyperthyroidism,phospholipase a2 group iie
10658,efavirenz,autosomal dominant polycystic kidney disease,serine/threonine kinase 16
10659,azilsartan medoxomil,urinary retention,homeodomain interacting protein kinase 2
10660,flutamide,meniere disease,ornithine decarboxylase 1
10661,sumatriptan,tenosynovial giant cell tumor,endothelin receptor type a
10662,imiquimod,acute intermittent porphyria,vascular endothelial growth factor a
10663,ramipril,testicular cancer,retinoic acid receptor beta
10664,rabeprazole,chronic obstructive pulmonary disease,janus kinase 1
10665,gepirone,dermatophytosis of groin and perianal area,carbonic anhydrase 11
10666,mesoridazine,castleman disease,phosphodiesterase 6g
10667,triazolam,ventricular fibrillation,axl receptor tyrosine kinase
10668,quinine,iritis,atpase na+/k+ transporting subunit beta 2
10669,tandospirone,myotonic syndrome,neurotrophic receptor tyrosine kinase 1
10670,terfenadine,hypoalphalipoproteinemia,interleukin 1 beta
10671,fludrocortisone,seborrheic dermatitis,potassium voltage-gated channel subfamily h member 7
10672,aliskiren,inflammatory bowel disease,cholesteryl ester transfer protein
10673,formoterol,pheochromocytoma,calmodulin 2
10674,allopurinol,migraine disorder,hyperpolarization activated cyclic nucleotide gated potassium channel 1
10675,pargyline,arthritic joint disease,death associated protein kinase 2
10676,pomalidomide,hypophosphatemia,mitogen-activated protein kinase kinase kinase kinase 1
10677,tipranavir,adrenal gland hyperfunction,histamine receptor h2
10678,eprosartan,liposarcoma,tankyrase 2
10679,drospirenone,sickle cell anemia,eph receptor b2
10680,sunitinib,cardiac arrest,receptor interacting serine/threonine kinase 2
10681,voglibose,hemorrhagic disease of newborn,unc-51 like autophagy activating kinase 1
10682,bunolol,psoriatic arthritis,fkbp prolyl isomerase 4
10683,pseudoephedrine,marginal zone lymphoma,thyroid hormone receptor beta
10684,dextropropoxyphene,post-partum hemorrhage,serine/threonine kinase 25
10685,mitomycin c,breast neoplasm,potassium voltage-gated channel subfamily d member 1
10686,chlorpheniramine,glaucoma,mapk interacting serine/threonine kinase 2
10687,tramadol,plasmodium malariae malaria,thymidylate synthetase
10688,pitavastatin,tardive dyskinesia,n-acetyltransferase 2
10689,tandospirone,asthma-chronic obstructive pulmonary disease overlap syndrome,histamine receptor h3
10690,levomilnacipran,dry eye syndrome,somatostatin receptor 3
10691,apomorphine,stroke disorder,galactosidase alpha
10692,fosamprenavir,tetanus,calcium voltage-gated channel subunit alpha1 d
10693,cefonicid,follicular lymphoma,colony stimulating factor 1 receptor
10694,sirolimus,hyperinsulinism,amine oxidase copper containing 3
10695,alectinib,arthropathy,metabolism of cobalamin associated c
10696,tranylcypromine,fibromyalgia,gonadotropin releasing hormone receptor
10697,diazoxide,renal osteodystrophy,"hck proto-oncogene, src family tyrosine kinase"
10698,lesinurad,common wart,hyperpolarization activated cyclic nucleotide gated potassium channel 3
10699,oxytocin,huntington disease,acid sensing ion channel subunit 1
10700,cephalotaxine,rickets,unc-51 like kinase 3
10701,metoclopramide,neonatal abstinence syndrome,opioid related nociceptin receptor 1
10702,escitalopram,hyperthyroidism,cathepsin g
10703,pralidoxime,bronchial disorder,toll like receptor 7
10704,digoxin,parkinson disease,acetyl-coa acetyltransferase 1
10705,aminobenzoic acid,vulvovaginal candidiasis,catechol-o-methyltransferase
10706,quinine,head and neck cancer,cytochrome p450 family 2 subfamily a member 6
10707,nitroglycerin,gastrointestinal stromal tumor,cytochrome p450 family 24 subfamily a member 1
10708,dextropropoxyphene,pneumonia,potassium voltage-gated channel subfamily h member 4
10709,levoketoconazole,acute coronary syndrome,5-hydroxytryptamine receptor 5a
10710,isoprenaline,enterocolitis,calcium voltage-gated channel subunit alpha1 a
10711,mirodenafil,actinic keratosis,"src proto-oncogene, non-receptor tyrosine kinase"
10712,colestipol,localized scleroderma,"dna polymerase alpha 1, catalytic subunit"
10713,phenazone,inappropriate adh syndrome,ribonucleotide reductase regulatory subunit m2
10714,glycopyrrolate,necrobiosis lipoidica,histone deacetylase 10
10715,imrecoxib,graves disease,"dna polymerase alpha 1, catalytic subunit"
10716,insulin detemir,tenosynovitis,fms related receptor tyrosine kinase 1
10717,saxagliptin,pernicious anemia,potassium voltage-gated channel modifier subfamily g member 1
10718,methyltestosterone,acromegaly,atpase na+/k+ transporting subunit beta 3
10719,levodopa,ornithine carbamoyltransferase deficiency,pre-mrna splicing tri-snrnp complex factor prpf4
10720,menatetrenone,intrinsic asthma,potassium voltage-gated channel subfamily d member 2
10721,docetaxel,chronic eosinophilic leukemia,protein kinase c theta
10722,ivacaftor,musculoskeletal system disorder,androgen receptor
10723,zopiclone,melanoma,endothelin receptor type b
10724,tafamidis,hypertrophic cardiomyopathy,endothelin receptor type b
10725,ofloxacin,lennox-gastaut syndrome,ribosomal protein s6 kinase a1
10726,chlorpheniramine,temporal arteritis,carbonic anhydrase 11
10727,proguanil,atopic conjunctivitis,diacylglycerol o-acyltransferase 1
10728,rivaroxaban,pityriasis versicolor,tubulin epsilon 1
10729,olodaterol,delirium,gamma-aminobutyric acid type a receptor subunit beta3
10730,phentolamine,small intestine cancer,"abl proto-oncogene 1, non-receptor tyrosine kinase"
10731,dipyridamole,postencephalitic parkinson disease,dna topoisomerase ii alpha
10732,frovatriptan,amyotrophic lateral sclerosis,homeodomain interacting protein kinase 2
10733,methylprednisolone,vulvovaginal candidiasis,ribonucleotide reductase catalytic subunit m1
10734,ruxolitinib,myocardial infarction,"coagulation factor ii, thrombin"
10735,phytomenadione,head and neck neoplasm,ribosomal protein s6 kinase a5
10736,pantoprazole,sarcoidosis,neurotensin receptor 2
10737,tolterodine,nicotine dependence,prostaglandin e synthase 3
10738,leuprolide,endometritis,fkbp prolyl isomerase 4
10739,sofalcone,uterine corpus leiomyoma,potassium voltage-gated channel subfamily q member 2
10740,chlophedianol,canker sore,fer tyrosine kinase
10741,irbesartan,hyperthyroidism,calcium voltage-gated channel auxiliary subunit alpha2delta 2
10742,physostigmine,uveitis,succinate dehydrogenase complex flavoprotein subunit a
10743,procyclidine,multiple sclerosis,cholinergic receptor nicotinic alpha 6 subunit
10744,ofatumumab,head and neck neoplasm,atp binding cassette subfamily g member 5
10745,ethosuximide,lung lymphangioleiomyomatosis,cytochrome p450 family 2 subfamily r member 1
10746,glisoxepide,migraine disorder,solute carrier organic anion transporter family member 4a1
10747,fenoldopam,labor pain,dna topoisomerase ii beta
10748,indomethacin,"cicatrix, hypertrophic",tubulin beta 4a class iva
10749,ipragliflozin,bacterial endocarditis,aldo-keto reductase family 1 member c1
10750,irinotecan,spasticity,cubilin
10751,bosentan,ovarian epithelial tumor,udp-glucose ceramide glucosyltransferase
10752,lobeglitazone,polymyalgia rheumatica,fkbp prolyl isomerase 1a
10753,amlodipine,diamond-blackfan anemia,unc-51 like kinase 3
10754,bupropion,myeloproliferative neoplasm,cyclin g associated kinase
10755,cabozantinib,erectile dysfunction,gamma-aminobutyric acid type a receptor subunit alpha5
10756,quinestrol,serum sickness,atp binding cassette subfamily b member 1
10757,epa,epilepsy,potassium voltage-gated channel modifier subfamily v member 2
10758,duloxetine,atopic eczema,potassium voltage-gated channel subfamily a member 2
10759,clofarabine,endometrial carcinoma,solute carrier family 22 member 2
10760,methotrexate,dry eye syndrome,solute carrier family 22 member 5
10761,ketotifen,breast fibrocystic disease,solute carrier organic anion transporter family member 1b1
10762,brompheniramine,prinzmetal angina,potassium inwardly rectifying channel subfamily j member 1
10763,nevirapine,pityriasis versicolor,leucine rich repeat kinase 2
10764,guanethidine,pancreatic adenocarcinoma,monoamine oxidase b
10765,cisapride,oral mucosa leukoplakia,serine/threonine kinase 4
10766,valproic acid,mast cell leukemia,5-hydroxytryptamine receptor 3a
10767,pregabalin,thrombotic disease,traf2 and nck interacting kinase
10768,chlorthalidone,acne,5-hydroxytryptamine receptor 3e
10769,naratriptan,hyperglycemia,serpin family e member 1
10770,conjugated estrogens,myotonic syndrome,"raf-1 proto-oncogene, serine/threonine kinase"
10771,droxidopa,cervical cancer,calcium voltage-gated channel auxiliary subunit beta 1
10772,carmofur,aorta coarctation,angiotensin converting enzyme 2
10773,docetaxel,pulmonary hypertension,farnesyl diphosphate synthase
10774,eprosartan,cryptorchidism,"lipase f, gastric type"
10775,pranlukast,early myoclonic encephalopathy,chymotrypsinogen b1
10776,valbenazine,pityriasis versicolor,superoxide dismutase 1
10777,acetyldigitoxin,headache disorder,cytochrome p450 family 3 subfamily a member 4
10778,pilocarpine,glaucoma,calcium voltage-gated channel auxiliary subunit gamma 1
10779,pioglitazone,streptococcal meningitis,5-hydroxytryptamine receptor 7
10780,carteolol,ocular hypertension,c-x-c motif chemokine receptor 1
10781,phenacemide,angina pectoris,potassium voltage-gated channel subfamily h member 3
10782,fexofenadine,hyperprolactinemia,xanthine dehydrogenase
10783,propylthiouracil,arthralgia,neurotensin receptor 2
10784,midodrine,chronic eosinophilic leukemia,adrenoceptor beta 3
10785,octreotide,adrenal gland hyperfunction,transient receptor potential cation channel subfamily m member 8
10786,amiloride,chronic schizophrenia,protein tyrosine kinase 2
10787,glibenclamide,ovarian cancer,matrix metallopeptidase 2
10788,brigatinib,hyperlipoproteinemia type 3,nuclear receptor subfamily 5 group a member 1
10789,isoprenaline,diffuse alopecia areata,retinoic acid receptor gamma
10790,clobazam,acute coronary syndrome,"ran, member ras oncogene family"
10791,dopamine,central nervous system origin vertigo,janus kinase 2
10792,nalbuphine,dacryocystitis,platelet derived growth factor receptor beta
10793,glipizide,choroiditis,toll like receptor 7
10794,levodopa,"cicatrix, hypertrophic",ryanodine receptor 3
10795,diflorasone diacetate,chronic beryllium disease,bmx non-receptor tyrosine kinase
10796,landiolol,focal epilepsy,cyclin dependent kinase 6
10797,quinapril,testicular cancer,dopamine receptor d1
10798,vonoprazan,neurogenic bladder,cyp3a7-cyp3a51p readthrough
10799,perazine,langerhans cell histiocytosis,integrin subunit beta 3
10800,carbetocin,type 1 diabetes mellitus,adenosine deaminase
10801,lamotrigine,schizophrenia,cytochrome p450 family 1 subfamily a member 1
10802,entacapone,absence epilepsy,dead-box helicase 1
10803,acebutolol,breast neoplasm,prostaglandin e synthase 3
10804,tolterodine,west syndrome,bcr activator of rhogef and gtpase
10805,valproic acid,sympathetic ophthalmia,atp binding cassette subfamily g member 8
10806,atazanavir,central nervous system origin vertigo,selectin e
10807,tolmetin,hepatocellular carcinoma,dna primase subunit 2
10808,imatinib,hypoalphalipoproteinemia,fibroblast growth factor receptor 2
10809,roxatidine acetate,angle-closure glaucoma,cholinergic receptor muscarinic 2
10810,sufentanil,nocturnal enuresis,farnesyl diphosphate synthase
10811,ripasudil,malignant colon neoplasm,proteasome 20s subunit beta 1
10812,goserelin,chronic schizophrenia,sodium channel epithelial 1 subunit alpha
10813,benazepril,aorta coarctation,tubulin beta 4a class iva
10814,abiraterone acetate,decreased cardiac output,tubulin beta 4b class ivb
10815,opipramol,endometritis,potassium voltage-gated channel subfamily d member 2
10816,enalapril,prostate neoplasm,glutathione s-transferase theta 1
10817,vemurafenib,hypoparathyroidism,potassium two pore domain channel subfamily k member 9
10818,terguride,bruxism,serpin family c member 1
10819,fenoprofen,myeloproliferative neoplasm,tachykinin precursor 1
10820,chlorcyclizine,phenylketonuria,bmx non-receptor tyrosine kinase
10821,fluvoxamine,idiopathic acute eosinophilic pneumonia,metabolism of cobalamin associated c
10822,silodosin,scabies,histone deacetylase 9
10823,riociguat,embolism,janus kinase 3
10824,bimatoprost,atrial fibrillation,calcium voltage-gated channel subunit alpha1 a
10825,zidovudine,duodenal ulcer,"tu translation elongation factor, mitochondrial"
10826,bepridil,seasonal affective disorder,interleukin 6 receptor
10827,quinestrol,allergic rhinitis,glutathione-disulfide reductase
10828,tafluprost,cough,protein kinase c theta
10829,thioguanine,pseudotumor cerebri,interleukin 1 receptor associated kinase 1
10830,ambenonium,hypertrophic cardiomyopathy,amylase alpha 2a
10831,ofatumumab,acute intermittent porphyria,gamma-aminobutyric acid type a receptor subunit alpha3
10832,pergolide,tetany,unc-51 like autophagy activating kinase 1
10833,promethazine,xerophthalmia,sodium voltage-gated channel alpha subunit 11
10834,phenytoin,headache disorder,peroxisome proliferator activated receptor delta
10835,zafirlukast,myasthenia gravis,prostaglandin e receptor 2
10836,heparin,hyperglycemia,pre-mrna processing factor kinase prp4k
10837,ivacaftor,panic disorder,glutamate ionotropic receptor kainate type subunit 5
10838,calcium citrate,uterine corpus leiomyoma,transient receptor potential cation channel subfamily v member 4
10839,tiaprofenic acid,aspiration pneumonitis,potassium calcium-activated channel subfamily m alpha 1
10840,acamprosate,disseminated intravascular coagulation,potassium voltage-gated channel subfamily c member 2
10841,lesinurad,rhabdomyosarcoma,tubulin beta 2b class iib
10842,atazanavir,sickle cell anemia,solute carrier family 12 member 1
10843,eflornithine,metrorrhagia,diacylglycerol o-acyltransferase 1
10844,vismodegib,arthropathy,eph receptor a1
10845,leuprolide,tyrosinemia,cytochrome p450 family 2 subfamily r member 1
10846,nisoldipine,pituitary dwarfism,histone deacetylase 2
10847,safinamide,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",dead-box helicase 1
10848,imrecoxib,waldenstrom macroglobulinemia,matrix metallopeptidase 2
10849,ibandronic acid,classic hodgkin lymphoma,gamma-aminobutyric acid type a receptor subunit alpha5
10850,bepotastine,polycystic ovary syndrome,inosine monophosphate dehydrogenase 2
10851,alfuzosin,type 2 diabetes mellitus,pancreatic lipase
10852,repaglinide,liver cancer,platelet activating factor receptor
10853,clobetasol propionate,pulmonary tuberculosis,potassium voltage-gated channel subfamily h member 7
10854,valrubicin,nutritional biotin deficiency,glutamate ionotropic receptor ampa type subunit 4
10855,secobarbital,headache,aldo-keto reductase family 1 member c3
10856,sonidegib,migraine disorder,metabolism of cobalamin associated a
10857,meloxicam,rhinoscleroma,solute carrier family 25 member 5
10858,pheniramine,nutritional biotin deficiency,potassium voltage-gated channel subfamily q member 1
10859,pheniramine,chronic pain,"mer proto-oncogene, tyrosine kinase"
10860,benoxaprofen,head and neck neoplasm,solute carrier family 22 member 11
10861,sermorelin,keratitis,potassium voltage-gated channel subfamily a member 10
10862,pentoxifylline,aorta coarctation,axl receptor tyrosine kinase
10863,tipranavir,sitosterolemia,cd33 molecule
10864,butenafine,pneumonia,thromboxane a2 receptor
10865,betamethasone,female infertility,"dna polymerase delta 1, catalytic subunit"
10866,chlorpheniramine,peptic ulcer disease,butyrylcholinesterase
10867,clonidine,eye disorder,metallothionein 1a
10868,pheniramine,chronic eosinophilic leukemia,glutamate ionotropic receptor ampa type subunit 1
10869,pregabalin,aplastic anemia,interleukin 11 receptor subunit alpha
10870,trichlormethiazide,common wart,potassium voltage-gated channel subfamily a member 10
10871,protriptyline,pulmonary valve atresia,melatonin receptor 1b
10872,olmesartan,streptococcal meningitis,phosphodiesterase 6h
10873,lofepramine,arthralgia,sigma non-opioid intracellular receptor 1
10874,meclizine,seasonal affective disorder,leukotriene c4 synthase
10875,paroxetine,enterocolitis,phosphodiesterase 3b
10876,pimozide,contact dermatitis,tachykinin precursor 1
10877,bepridil,mast cell leukemia,homeodomain interacting protein kinase 1
10878,lercanidipine,postencephalitic parkinson disease,histone deacetylase 8
10879,diazoxide,myocardial infarction,hyperpolarization activated cyclic nucleotide gated potassium channel 4
10880,vismodegib,pulmonary emphysema,"fes proto-oncogene, tyrosine kinase"
10881,rivaroxaban,decreased cardiac output,calcium voltage-gated channel subunit alpha1 b
10882,gemigliptin,synovitis,plasminogen
10883,dofetilide,turner syndrome,ttk protein kinase
10884,tadalafil,urge incontinence,gamma-aminobutyric acid type a receptor subunit alpha3
10885,neostigmine,follicular lymphoma,cytochrome p450 family 2 subfamily c member 19
10886,clofarabine,keloid,potassium voltage-gated channel modifier subfamily g member 2
10887,papaverine,crohn disease,glutamate ionotropic receptor kainate type subunit 4
10888,ziconotide,epilepsy with generalized tonic-clonic seizures,ribosomal protein l3
10889,lenvatinib,mature t-cell and nk-cell non-hodgkin lymphoma,nuclear factor kappa b subunit 1
10890,pge1,neoplasm of esophagus,bone morphogenetic protein receptor type 1b
10891,tulobuterol,post-traumatic stress disorder,prostaglandin d2 receptor 2
10892,oxprenolol,thyroid gland follicular carcinoma,sodium voltage-gated channel alpha subunit 5
10893,dihydroergotamine,postoperative nausea and vomiting,"yes proto-oncogene 1, src family tyrosine kinase"
10894,rofecoxib,testicular cancer,5-hydroxytryptamine receptor 2c
10895,betamethasone,ovarian epithelial tumor,7-dehydrocholesterol reductase
10896,calcifediol,asthma-chronic obstructive pulmonary disease overlap syndrome,aldo-keto reductase family 1 member c1
10897,cisapride,dyschromatosis universalis hereditaria,dopamine receptor d5
10898,ziprasidone,hyperlipidemia,estrogen receptor 2
10899,calcipotriol,"attention deficit hyperactivity disorder, inattentive type",transient receptor potential cation channel subfamily v member 4
10900,pargyline,langerhans cell histiocytosis,solute carrier organic anion transporter family member 1a2
10901,clemastine,tourette syndrome,solute carrier family 12 member 3
10902,alectinib,pulmonary emphysema,glutathione-disulfide reductase
10903,benzquinamide,vasomotor rhinitis,potassium inwardly rectifying channel subfamily j member 11
10904,tamibarotene,vascular headaches,cytochrome p450 family 21 subfamily a member 2
10905,fluocinonide,sympathetic ophthalmia,death associated protein kinase 2
10906,raltegravir,islet cell adenomatosis,sphingosine-1-phosphate receptor 1
10907,pasireotide,arteriosclerosis disorder,propionyl-coa carboxylase subunit alpha
10908,trichlormethiazide,parkinsonian disorder,histone deacetylase 5
10909,glibenclamide,malignant colon neoplasm,solute carrier organic anion transporter family member 4a1
10910,vincristine,aspiration pneumonitis,ornithine decarboxylase 1
10911,acebutolol,"hyperlipidemia, familial combined, lpl related",sodium voltage-gated channel alpha subunit 11
10912,cladribine,psoriatic arthritis,potassium two pore domain channel subfamily k member 3
10913,sermorelin,oligospermia,cytochrome p450 family 24 subfamily a member 1
10914,prednisolone,trigeminal neuralgia,phosphodiesterase 6g
10915,piribedil,female stress incontinence,"plasminogen activator, tissue type"
10916,pyrimethamine,familial dermatographia,serine/threonine kinase 10
10917,dipivefrine,epilepsy,melanocortin 3 receptor
10918,ziprasidone,benign prostatic hyperplasia,protein kinase c alpha
10919,chlorothiazide,systemic mastocytosis,cholinergic receptor muscarinic 1
10920,bosentan,ankylosing spondylitis,histone deacetylase 11
10921,guanadrel,urinary retention,eph receptor a3
10922,dexfenfluramine,dyschromatosis universalis hereditaria,calcium voltage-gated channel auxiliary subunit beta 2
10923,methyltestosterone,hyperprolactinemia,tubulin alpha 4a
10924,pexidartinib,angle-closure glaucoma,carbonic anhydrase 3
10925,capecitabine,ascariasis,gamma-aminobutyric acid type a receptor subunit gamma1
10926,pseudoephedrine,lewy body dementia,potassium voltage-gated channel modifier subfamily g member 3
10927,l-citrulline,waldenstrom macroglobulinemia,somatostatin receptor 1
10928,maprotiline,bacterial pneumonia,glutathione s-transferase theta 1
10929,raloxifene,malignant pleural mesothelioma,riboflavin kinase
10930,lisinopril,esophageal cancer,cytochrome p450 family 2 subfamily d member 6
10931,lifitegrast,streptococcal pneumonia,angiotensin ii receptor type 2
10932,carbenoxolone,trichinellosis,interleukin 2
10933,lorlatinib,bronchitis,inosine monophosphate dehydrogenase 2
10934,estrone,glossopharyngeal neuralgia,cytochrome p450 family 2 subfamily e member 1
10935,opipramol,migraine disorder,geranylgeranyl diphosphate synthase 1
10936,etoposide,graves disease,fer tyrosine kinase
10937,valrubicin,thrombotic disease,solute carrier family 12 member 2
10938,isopropamide,acute coronary syndrome,peptidylprolyl isomerase a
10939,biperiden,narcolepsy,prostaglandin e receptor 1
10940,hydroxyzine,hyperaldosteronism,diacylglycerol o-acyltransferase 1
10941,verapamil,marginal zone lymphoma,adenosine deaminase
10942,floxuridine,chronic pain,sphingosine-1-phosphate receptor 1
10943,flumethasone pivalate,torsades de pointes,dna primase subunit 2
10944,phenytoin,alcohol dependence,epidermal growth factor receptor
10945,levomethadyl acetate,subarachnoid hemorrhage,ste20 like kinase
10946,disulfiram,"familial amyloid neuropathy, portuguese type",potassium voltage-gated channel subfamily h member 4
10947,valbenazine,endemic goiter,atpase na+/k+ transporting subunit alpha 1
10948,voclosporin,tinea corporis,solute carrier family 47 member 2
10949,loratadine,autoimmune hemolytic anemia,5-hydroxytryptamine receptor 1b
10950,clofazimine,glossopharyngeal neuralgia,prostaglandin e receptor 4
10951,tamibarotene,potassium deficiency disease,protein kinase cgmp-dependent 1
10952,silodosin,gastroesophageal reflux disease,aurora kinase b
10953,lornoxicam,proctitis,toll like receptor 2
10954,nitroglycerin,bacterial meningitis,tank binding kinase 1
10955,ponatinib,diffuse large b-cell lymphoma,protein kinase n1
10956,acth,migraine disorder,methylenetetrahydrofolate reductase
10957,aliskiren,basal ganglia disorder,atp binding cassette subfamily c member 9
10958,amlodipine,"hyperlipidemia, familial combined, lpl related",cholinergic receptor nicotinic alpha 10 subunit
10959,megestrol,wilms tumor,apolipoprotein a1
10960,salsalate,hyperthyroidism,cytochrome p450 family 3 subfamily a member 4
10961,gabapentin,pulmonary edema,homeodomain interacting protein kinase 2
10962,nefazodone,primary ovarian failure,inositol monophosphatase 1
10963,ebastine,pediculus humanus capitis infestation,5-hydroxytryptamine receptor 3d
10964,oxcarbazepine,thyroid gland papillary carcinoma,bruton tyrosine kinase
10965,"1,25-dihydroxyvitamin d3",attrv122i amyloidosis,potassium voltage-gated channel subfamily b member 2
10966,prednisone,aorta coarctation,sodium voltage-gated channel alpha subunit 3
10967,pentostatin,bacterial pneumonia,tubulin beta 2a class iia
10968,dimethyl fumarate,lewy body dementia,solute carrier organic anion transporter family member 1b3
10969,mizolastine,intracranial embolism,atp binding cassette subfamily c member 8
10970,proguanil,ovarian epithelial tumor,macrophage stimulating 1 receptor
10971,flurbiprofen,alopecia,thromboxane a2 receptor
10972,isoprenaline,thyroid gland follicular carcinoma,carbonic anhydrase 7
10973,cobicistat,pemphigus,calcium voltage-gated channel subunit alpha1 f
10974,rilmenidine,tricuspid atresia,sphingosine-1-phosphate receptor 3
10975,dipyridamole,dermatitis herpetiformis,potassium voltage-gated channel subfamily a member 2
10976,docetaxel,oral mucosa leukoplakia,proteasome 20s subunit beta 1
10977,venlafaxine,urge incontinence,5-hydroxytryptamine receptor 2a
10978,brigatinib,acquired polycythemia vera,adrenoceptor alpha 1b
10979,methapyrilene,perennial allergic rhinitis,phospholipase a2 group iva
10980,lornoxicam,breast cancer,nuclear receptor subfamily 5 group a member 1
10981,doxazosin,myotonic syndrome,cytochrome p450 family 11 subfamily b member 1
10982,clofibrate,synovitis,interleukin 1 receptor associated kinase 3
10983,cabergoline,esophageal cancer,casein kinase 1 delta
10984,codeine,hyperlipoproteinemia type 3,potassium inwardly rectifying channel subfamily j member 12
10985,cilastatin,erythema multiforme,bone gamma-carboxyglutamate protein
10986,oxaprozin,vitamin d deficiency,sphingosine-1-phosphate receptor 5
10987,sufentanil,type 2 diabetes mellitus,aldo-keto reductase family 1 member c3
10988,indacaterol,type 2 diabetes mellitus,potassium voltage-gated channel subfamily c member 4
10989,aspirin,autosomal dominant polycystic kidney disease,farnesyl diphosphate synthase
10990,daunorubicin,fever,atpase na+/k+ transporting subunit alpha 3
10991,phytomenadione,secondary hyperparathyroidism,phosphodiesterase 4b
10992,valsartan,neurofibromatosis 1,gc vitamin d binding protein
10993,bromodiphenhydramine,hodgkins lymphoma,prostaglandin e synthase 3
10994,benzocaine,bacterial conjunctivitis,erb-b2 receptor tyrosine kinase 2
10995,tofacitinib,malignant pleural mesothelioma,complement c5
10996,ketamine,metastatic melanoma,melatonin receptor 1b
10997,n-methyl scopolamine,lung disorder,potassium voltage-gated channel subfamily q member 4
10998,pazopanib,diffuse alopecia areata,phosphodiesterase 6a
10999,mesalazine,obesity disorder,phenylalanine hydroxylase
11000,rofecoxib,premature obstetric labor,gamma-aminobutyric acid type a receptor subunit alpha5
11001,carmustine,malignant colon neoplasm,4-hydroxyphenylpyruvate dioxygenase
11002,dapsone,head and neck cancer,solute carrier organic anion transporter family member 1b1
11003,phenazone,propionic acidemia,sodium channel epithelial 1 subunit beta
11004,diclofenamide,nocturnal enuresis,transmembrane protein 97
11005,bunolol,migraine disorder,proteasome 20s subunit beta 2
11006,terfenadine,relapsing-remitting multiple sclerosis,myosin heavy chain 10
11007,hydroxyzine,localized scleroderma,glutathione-disulfide reductase
11008,ketanserin,chronic hepatitis c virus infection,opioid related nociceptin receptor 1
11009,celecoxib,bone paget disease,potassium voltage-gated channel subfamily d member 1
11010,solifenacin,delirium,eph receptor b2
11011,tiagabine,female stress incontinence,neutrophil cytosolic factor 1
11012,dexbrompheniramine,bipolar depression,serpin family e member 1
11013,pilocarpine,acute promyelocytic leukemia,arginine vasopressin receptor 1b
11014,roxatidine acetate,plasma cell myeloma,phosphodiesterase 4c
11015,propantheline,glioma,phosphodiesterase 7a
11016,tolterodine,ulcerative colitis,adenosine a2a receptor
11017,desvenlafaxine,toothache,nuclear receptor subfamily 0 group b member 1
11018,irinotecan,diabetes mellitus,potassium voltage-gated channel subfamily h member 6
11019,febuxostat,headache,hydroxycarboxylic acid receptor 2
11020,tiagabine,keloid,solute carrier family 47 member 1
11021,bunolol,stargardt disease,misshapen like kinase 1
11022,levocabastine,pernicious anemia,atp binding cassette subfamily g member 8
11023,omarigliptin,edema,death associated protein kinase 3
11024,hydroxyzine,erdheim-chester disease,cart prepropeptide
11025,mesalazine,dermatofibrosarcoma protuberans,peroxisome proliferator activated receptor gamma
11026,pirenzepine,seasonal allergic rhinitis,serpin family a member 6
11027,triprolidine,ankylosing spondylitis,glutathione-disulfide reductase
11028,clozapine,serum sickness,solute carrier family 22 member 2
11029,crotamiton,hypoalphalipoproteinemia,amylase alpha 2a
11030,fenfluramine,anterior uveitis,cytochrome p450 oxidoreductase
11031,oseltamivir,tendinitis,cytochrome c1
11032,tolvaptan,non-hodgkin lymphoma,somatostatin receptor 3
11033,fluocinolone acetonide,pulmonary fibrosis,mitogen-activated protein kinase kinase kinase 11
11034,testosterone propionate,angle-closure glaucoma,adrenoceptor beta 1
11035,ziconotide,medullary thyroid gland carcinoma,potassium voltage-gated channel subfamily h member 1
11036,bepotastine,tenosynovitis,retinoid x receptor beta
11037,nevirapine,impetigo,toll like receptor 4
11038,sildenafil,hypoactive sexual desire disorder,sodium voltage-gated channel alpha subunit 1
11039,methyclothiazide,vomiting,nuclear receptor subfamily 1 group i member 2
11040,ceftriaxone,osteoporosis,histone deacetylase 10
11041,febuxostat,bipolar disorder,phosphodiesterase 6d
11042,levorphanol,osteoarthritis,dna methyltransferase 3 alpha
11043,vonoprazan,tardive dyskinesia,cytochrome p450 family 2 subfamily r member 1
11044,fsh,myxedema,glutamate ionotropic receptor nmda type subunit 3b
11045,ketanserin,scleroderma,somatostatin receptor 4
11046,thioguanine,acquired thrombocytopenia,platelet activating factor receptor
11047,leflunomide,pruritus ani,calcium voltage-gated channel subunit alpha1 i
11048,carfilzomib,bipolar depression,cytochrome p450 family 3 subfamily a member 5
11049,levomethadyl acetate,interstitial lung disease 2,potassium voltage-gated channel subfamily c member 2
11050,clofibrate,essential thrombocythemia,carbonic anhydrase 11
11051,carbachol,classic hodgkin lymphoma,growth hormone receptor
11052,olodaterol,polyuria,cytochrome p450 family 3 subfamily a member 5
11053,rosuvastatin,chronic pain,gc vitamin d binding protein
11054,ivacaftor,scalp dermatosis,prostaglandin-endoperoxide synthase 2
11055,isoxsuprine,dysmenorrhea,cytochrome p450 family 11 subfamily b member 1
11056,nitroglycerin,poems syndrome,traf2 and nck interacting kinase
11057,aclidinium,anxiety,dihydropyrimidine dehydrogenase
11058,bromocriptine,dyschromatosis universalis hereditaria,phosphodiesterase 1a
11059,bunolol,synovitis,potassium voltage-gated channel modifier subfamily s member 3
11060,almitrine,dermatomyositis,phosphodiesterase 11a
11061,amoxapine,hyperthyroidism,cdc like kinase 2
11062,tretinoin,temporal arteritis,cholinergic receptor nicotinic alpha 3 subunit
11063,verapamil,vernal conjunctivitis,insulin receptor
11064,nicotinic acid,invasive ductal breast carcinoma,5-hydroxytryptamine receptor 4
11065,ibuprofen,rheumatoid arthritis,polo like kinase 4
11066,tandospirone,endometritis,myosin light chain kinase 3
11067,clozapine,poems syndrome,toll like receptor 7
11068,mirodenafil,erythropoietic protoporphyria,calmodulin 1
11069,naloxone,sympathetic ophthalmia,potassium voltage-gated channel subfamily q member 4
11070,dexfenfluramine,myeloproliferative neoplasm,cdc like kinase 4
11071,tretinoin,back pain,"met proto-oncogene, receptor tyrosine kinase"
11072,crizotinib,panic disorder,histone deacetylase 2
11073,bumetanide,acute monocytic leukemia,bcl2 like 1
11074,pamidronic acid,diabetic kidney disease,janus kinase 1
11075,mitoxantrone,epilepsy,atpase na+/k+ transporting subunit alpha 1
11076,isosorbide dinitrate,angioedema,potassium inwardly rectifying channel subfamily j member 1
11077,terfenadine,thyroid crisis,solute carrier family 9 member a1
11078,lenvatinib,"cicatrix, hypertrophic",solute carrier family 12 member 2
11079,befunolol,cough,myosin light chain kinase 3
11080,tolazoline,toothache,"plasminogen activator, tissue type"
11081,selexipag,primary cutaneous t-cell non-hodgkin lymphoma,24-dehydrocholesterol reductase
11082,limaprost,opiate dependence,janus kinase 2
11083,tenoxicam,thrombophilia due to thrombin defect,adrenoceptor alpha 2a
11084,guanethidine,scleroderma,cytochrome p450 family 3 subfamily a member 43
11085,reboxetine,ovarian epithelial tumor,solute carrier family 27 member 2
11086,estrone sulphate,x-linked dominant hypophosphatemic rickets,phosphodiesterase 6h
11087,benzatropine,cryptorchidism,kinase insert domain receptor
11088,desipramine,hereditary von willebrand disease,monoamine oxidase b
11089,topiroxostat,brain edema,tumor necrosis factor
11090,diflunisal,trichinellosis,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
11091,galantamine,exanthem,dna topoisomerase i
11092,lidocaine,orthostatic hypotension,5-hydroxytryptamine receptor 1b
11093,ofatumumab,malignant hyperthermia of anesthesia,cytidine/uridine monophosphate kinase 1
11094,galantamine,chronic bronchitis,growth hormone receptor
11095,capsaicin,hyperparathyroidism,"kit proto-oncogene, receptor tyrosine kinase"
11096,dexamethasone,thyroid tumor,tubulin beta class i
11097,glycopyrrolate,obsessive-compulsive disorder,peroxisome proliferator activated receptor delta
11098,montelukast,pernicious anemia,endothelin receptor type a
11099,prednisolone,polymyalgia rheumatica,cysteinyl leukotriene receptor 2
11100,mebendazole,urticaria,solute carrier family 9 member a1
11101,ivermectin,opiate dependence,cholinergic receptor nicotinic alpha 2 subunit
11102,delavirdine,zollinger-ellison syndrome,"fyn proto-oncogene, src family tyrosine kinase"
11103,escitalopram,persistent fetal circulation syndrome,solute carrier family 5 member 1
11104,pirenzepine,classic hodgkin lymphoma,calcium voltage-gated channel subunit alpha1 h
11105,pralatrexate,pthirus pubis infestation,cytochrome p450 family 3 subfamily a member 5
11106,radotinib,dysmenorrhea,retinoic acid receptor alpha
11107,benzocaine,subarachnoid hemorrhage,cytochrome p450 family 2 subfamily a member 6
11108,fomepizole,myasthenia gravis,solute carrier organic anion transporter family member 1b1
11109,ripasudil,ascites,opioid receptor mu 1
11110,carbetocin,acquired polycythemia vera,homeodomain interacting protein kinase 4
11111,ritonavir,"dermatitis, atopic",atpase copper transporting alpha
11112,irbesartan,proctitis,phosphorylase kinase catalytic subunit gamma 2
11113,baclofen,hypoactive sexual desire disorder,androgen receptor
11114,colchicine,blepharoconjunctivitis,high mobility group box 1
11115,modafinil,pancreatic insulinoma,adenosine a2b receptor
11116,triiodothyronine,tenosynovitis,il2 inducible t cell kinase
11117,dihydrotachysterol,atopic conjunctivitis,ribosomal protein s6 kinase a1
11118,ulobetasol propionate,eosinophilic pneumonia,solute carrier family 5 member 1
11119,acalabrutinib,tendinitis,cyp3a7-cyp3a51p readthrough
11120,dihydroergotamine,amenorrhea,cubilin
11121,raloxifene,supraventricular tachycardia,phosphorylase kinase catalytic subunit gamma 1
11122,levonorgestrel,hereditary angioedema,ret proto-oncogene
11123,moxonidine,amyotrophic lateral sclerosis,cereblon
11124,etodolac,abdominal abscess,death associated protein kinase 3
11125,vortioxetine,breast carcinoma,carbonic anhydrase 9
11126,diclofenac,pharyngitis,solute carrier family 6 member 2
11127,ethacrynic acid,periodontitis,prostaglandin e receptor 2
11128,fsh,follicular lymphoma,phosphodiesterase 6c
11129,levosalbutamol,back pain,5-hydroxytryptamine receptor 3b
11130,travoprost,type 2 diabetes mellitus,atp binding cassette subfamily g member 8
11131,digoxin,uveitis,serine/threonine kinase 11
11132,tramazoline,nausea,phosphodiesterase 4d
11133,estradiol valerate,influenza,tachykinin receptor 1
11134,conjugated estrogens,familial mediterranean fever,platelet derived growth factor receptor beta
11135,iloperidone,wilms tumor,inosine monophosphate dehydrogenase 2
11136,dipivefrine,chronic urticaria,glutamate ionotropic receptor ampa type subunit 3
11137,terbutaline,wilms tumor,neurotrophic receptor tyrosine kinase 3
11138,daunorubicin,psoriatic arthritis,"raf-1 proto-oncogene, serine/threonine kinase"
11139,vincristine,ventricular fibrillation,histone deacetylase 11
11140,pregabalin,punctate epithelial keratoconjunctivitis,glutamate ionotropic receptor ampa type subunit 2
11141,oxytocin,allergic contact dermatitis,methylmalonyl-coa mutase
11142,ivacaftor,hyperthyroidism,bradykinin receptor b2
11143,apremilast,hairy cell leukemia,histone deacetylase 6
11144,oxymetazoline,hepatic veno-occlusive disease,retinoic acid receptor gamma
11145,riociguat,polycystic ovary syndrome,gamma-aminobutyric acid type a receptor subunit alpha5
11146,vemurafenib,tardive dyskinesia,glutamate ionotropic receptor nmda type subunit 3b
11147,lorcaserin,hypoactive sexual desire disorder,5-hydroxytryptamine receptor 1e
11148,darunavir,bruxism,estrogen related receptor alpha
11149,fluvastatin,myeloproliferative neoplasm,prostaglandin i2 receptor
11150,atenolol,epilepsy with generalized tonic-clonic seizures,oxytocin receptor
11151,isosorbide dinitrate,neuralgia,gamma-aminobutyric acid type a receptor subunit alpha3
11152,clotrimazole,hypophosphatemia,phosphodiesterase 1a
11153,chlorcyclizine,exfoliative dermatitis,sodium voltage-gated channel alpha subunit 4
11154,lansoprazole,focal epilepsy,sirtuin 1
11155,cyclopentolate,huntington disease,sigma non-opioid intracellular receptor 1
11156,teniposide,gastrointestinal stromal tumor,dopamine receptor d3
11157,crisaborole,hyperinsulinism,cysteinyl leukotriene receptor 1
11158,simvastatin,neurodermatitis,potassium inwardly rectifying channel subfamily j member 8
11159,captodiame,chronic bronchitis,solute carrier family 6 member 1
11160,bosentan,sitosterolemia,atm serine/threonine kinase
11161,mosapramine,tourette syndrome,5-hydroxytryptamine receptor 1a
11162,venlafaxine,scleroderma,adrenoceptor alpha 1d
11163,fenoldopam,malignant glioma,potassium two pore domain channel subfamily k member 3
11164,l-citrulline,sympathetic ophthalmia,cholinergic receptor nicotinic alpha 6 subunit
11165,diethylcarbamazine,head and neck neoplasm,hyperpolarization activated cyclic nucleotide gated potassium channel 4
11166,pranlukast,contact dermatitis,phosphodiesterase 2a
11167,isotretinoin,alzheimer disease,npc1 like intracellular cholesterol transporter 1
11168,lenalidomide,perennial allergic rhinitis,glutamate ionotropic receptor nmda type subunit 1
11169,tadalafil,eosinophilic esophagitis,protein kinase n1
11170,imipramine,tendinitis,butyrylcholinesterase
11171,incadronic acid,actinic keratosis,gamma-aminobutyric acid type a receptor subunit alpha5
11172,acarbose,gingivitis,prostaglandin-endoperoxide synthase 1
11173,flibanserin,central nervous system origin vertigo,phosphodiesterase 4b
11174,emedastine,hypertrichosis of eyelid,growth hormone receptor
11175,chlorothiazide,hypoactive sexual desire disorder,opioid receptor delta 1
11176,cyclosporin a,rheumatoid arthritis,doublecortin like kinase 3
11177,verapamil,myocardial infarction,potassium calcium-activated channel subfamily m alpha 1
11178,febuxostat,sneeze,cholinergic receptor nicotinic alpha 7 subunit
11179,glymidine,postherpetic neuralgia,cytochrome p450 family 11 subfamily b member 1
11180,pentostatin,oral candidiasis,solute carrier family 12 member 2
11181,fampridine,phenylketonuria,tubulin beta 8 class viii
11182,diethylcarbamazine,erectile dysfunction,melatonin receptor 1b
11183,methamphetamine,x-linked dominant hypophosphatemic rickets,calcium voltage-gated channel auxiliary subunit gamma 1
11184,pantoprazole,castleman disease,cytochrome p450 family 3 subfamily a member 43
11185,phentolamine,holocarboxylase synthetase deficiency,dual specificity tyrosine phosphorylation regulated kinase 1b
11186,medroxyprogesterone,ovarian epithelial tumor,leukotriene b4 receptor
11187,cilostazol,diabetic kidney disease,cannabinoid receptor 1
11188,isocarboxazid,acute coronary syndrome,structural maintenance of chromosomes 1a
11189,celiprolol,social phobia,janus kinase 3
11190,bunolol,temporal arteritis,tubulin beta 2b class iib
11191,loratadine,malignant hyperthermia of anesthesia,s100 calcium binding protein b
11192,daunorubicin,vitamin deficiency disorder,peptidylprolyl isomerase b
11193,amcinonide,cardiogenic shock,hyperpolarization activated cyclic nucleotide gated potassium channel 4
11194,pargyline,atrioventricular block,cathepsin g
11195,clonidine,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,synuclein alpha
11196,isosorbide dinitrate,bursitis,transient receptor potential cation channel subfamily v member 4
11197,icatibant,multiple endocrine neoplasia,sodium voltage-gated channel alpha subunit 2
11198,desvenlafaxine,nocturnal enuresis,gonadotropin releasing hormone receptor
11199,meloxicam,hypertensive disorder,pancreatic lipase
11200,escitalopram,poisoning of animals with phosphate salts,5-hydroxytryptamine receptor 5a
11201,bretylium,fibromyalgia,glutamate ionotropic receptor nmda type subunit 2d
11202,methotrexate,tinea pedis,phosphodiesterase 1c
11203,ceftriaxone,iridocyclitis,solute carrier family 6 member 3
11204,ethosuximide,supraventricular tachycardia,gamma-aminobutyric acid type a receptor subunit gamma3
11205,ketoprofen,pthirus pubis infestation,solute carrier family 5 member 11
11206,thiothixene,ovarian epithelial tumor,atm serine/threonine kinase
11207,mosapramine,renal cell carcinoma,estrogen receptor 2
11208,nelfinavir,endemic goiter,calreticulin
11209,nimodipine,myalgia,succinate dehydrogenase complex flavoprotein subunit a
11210,glucagon,vulvovaginal candidiasis,potassium voltage-gated channel modifier subfamily v member 2
11211,frovatriptan,bacterial meningitis,tubulin beta 2b class iib
11212,auranofin,myocardial infarction,caspase 1
11213,cortisone,"malignant hyperthermia, susceptibility to, 1",gamma-aminobutyric acid type a receptor subunit alpha3
11214,obinutuzumab,hyponatremia,fatty acid amide hydrolase
11215,mitomycin c,periodontitis,potassium voltage-gated channel subfamily c member 4
11216,dezocine,noonan syndrome,matrix metallopeptidase 9
11217,pralatrexate,tenosynovitis,phosphodiesterase 6d
11218,vinblastine,polymyalgia rheumatica,melatonin receptor 1b
11219,carmofur,aggressive systemic mastocytosis,cholinergic receptor nicotinic alpha 7 subunit
11220,brinzolamide,hodgkins lymphoma,serine/threonine kinase 17a
11221,omacetaxine mepesuccinate,blepharoconjunctivitis,dna methyltransferase 3 alpha
11222,clofazimine,pernicious anemia,cdc like kinase 2
11223,bepotastine,autism spectrum disorder,atpase h+/k+ transporting subunit beta
11224,trimipramine,type 1 diabetes mellitus,mitogen-activated protein kinase kinase kinase 7
11225,amlodipine,pernicious anemia,"abl proto-oncogene 1, non-receptor tyrosine kinase"
11226,linagliptin,brain edema,solute carrier family 22 member 6
11227,bepridil,disruptive behavior disorder,dopamine beta-hydroxylase
11228,azelaic acid,pellagra,potassium voltage-gated channel subfamily h member 7
11229,dromostanolone propionate,hypereosinophilic syndrome,cytochrome p450 family 3 subfamily a member 43
11230,pirfenidone,psoriatic arthritis,epoxide hydrolase 2
11231,lisuride,endometritis,transient receptor potential cation channel subfamily v member 3
11232,albiglutide,neurofibromatosis 1,acyl-coa synthetase long chain family member 5
11233,tadalafil,sarcoidosis,gamma-aminobutyric acid type a receptor subunit pi
11234,insulin glargine,torsades de pointes,unc-51 like kinase 3
11235,trimethadione,type 1 diabetes mellitus,ebp cholestenol delta-isomerase
11236,hydroxyurea,toothache,calcium voltage-gated channel subunit alpha1 d
11237,cephalotaxine,pulmonary tuberculosis,phosphodiesterase 7b
11238,nelfinavir,vernal conjunctivitis,sodium voltage-gated channel alpha subunit 7
11239,dronedarone,scleroderma,glutamate ionotropic receptor nmda type subunit 1
11240,loteprednol etabonate,breast neoplasm,cytochrome p450 family 27 subfamily b member 1
11241,hydroquinone,obsessive-compulsive disorder,g protein-coupled receptor 35
11242,gemigliptin,disruptive behavior disorder,dna topoisomerase ii beta
11243,dosulepin,abdominal abscess,5-hydroxytryptamine receptor 1f
11244,linaclotide,cycloplegia,tachykinin precursor 1
11245,escitalopram,rhabdomyosarcoma,estrogen receptor 2
11246,lorazepam,sickle cell anemia,5-hydroxytryptamine receptor 1d
11247,umeclidinium,sarcoma,solute carrier family 18 member a2
11248,dofetilide,premenstrual dysphoric disorder,5-hydroxytryptamine receptor 1e
11249,rimexolone,hepatocellular carcinoma,fatty acid binding protein 2
11250,rilmenidine,type 1 diabetes mellitus,5-hydroxytryptamine receptor 1b
11251,fentanyl,poisoning of animals with phosphate salts,coagulation factor ii thrombin receptor
11252,tetrabenazine,prostate cancer,peptidylprolyl isomerase a
11253,flurbiprofen,dyspnea,discoidin domain receptor tyrosine kinase 2
11254,phenindamine,pellagra,sirtuin 1
11255,selumetinib,hairy cell leukemia,histone deacetylase 2
11256,dexbrompheniramine,postoperative nausea and vomiting,atp binding cassette subfamily a member 1
11257,naproxen,temporal arteritis,delta like non-canonical notch ligand 1
11258,progesterone,idiopathic acute eosinophilic pneumonia,squalene epoxidase
11259,digoxin,thyroid crisis,potassium voltage-gated channel subfamily h member 1
11260,romidepsin,polycystic ovary syndrome,doublecortin like kinase 3
11261,chlorpheniramine,back pain,tubulin beta 6 class v
11262,chlorambucil,kaposi's sarcoma,calcium voltage-gated channel subunit alpha1 f
11263,bezafibrate,pulmonary hypertension,potassium voltage-gated channel subfamily a member 5
11264,pentostatin,sickle cell anemia,potassium voltage-gated channel modifier subfamily f member 1
11265,chlorpheniramine,acute promyelocytic leukemia,gamma-aminobutyric acid type a receptor subunit delta
11266,canagliflozin,thyroid gland papillary carcinoma,albumin
11267,aclidinium,cerebrovascular disorder,cholinergic receptor nicotinic beta 3 subunit
11268,difenoxin,congenital hypothyroidism,doublecortin like kinase 3
11269,phenindamine,actinic keratosis,macrophage stimulating 1 receptor
11270,cyclizine,diamond-blackfan anemia,atp binding cassette subfamily g member 8
11271,eribulin,male infertility,janus kinase 2
11272,ramatroban,sneeze,sphingosine-1-phosphate receptor 5
11273,fenoldopam,altitude sickness,microtubule associated protein 2
11274,entacapone,dermatofibrosarcoma protuberans,atp binding cassette subfamily b member 1
11275,amoxapine,peptic esophagitis,dopamine receptor d4
11276,asenapine,rheumatic heart disease,nuclear receptor subfamily 0 group b member 1
11277,chlophedianol,hyperlipidemia,cobalamin binding intrinsic factor
11278,safinamide,acute intermittent porphyria,histone deacetylase 5
11279,bretylium,hyperglycemia,solute carrier family 25 member 6
11280,flufenamic acid,psoriatic arthritis,solute carrier family 46 member 1
11281,darifenacin,amenorrhea,"smoothened, frizzled class receptor"
11282,ciprofloxacin,bulimia nervosa,methylmalonyl-coa mutase
11283,lifitegrast,generalized anxiety disorder,propionyl-coa carboxylase subunit beta
11284,isocarboxazid,male infertility,homeodomain interacting protein kinase 4
11285,trimethobenzamide,dry eye syndrome,gamma-aminobutyric acid type a receptor subunit gamma1
11286,nedocromil,anterior uveitis,serine/threonine kinase 17a
11287,polythiazide,tenosynovitis,opioid receptor kappa 1
11288,brexpiprazole,schizophrenia,dna polymerase beta
11289,nifedipine,fibromyalgia,fkbp prolyl isomerase 1a
11290,etoposide,graves disease,aldehyde dehydrogenase 5 family member a1
11291,vonoprazan,holocarboxylase synthetase deficiency,bmp2 inducible kinase
11292,nevirapine,melanoma,"lipase f, gastric type"
11293,acenocoumarol,inflammatory bowel disease,cdc like kinase 4
11294,methyltestosterone,peripheral vascular disease,bub1 mitotic checkpoint serine/threonine kinase
11295,vinpocetine,rosacea,adrenoceptor alpha 1d
11296,paracetamol,discoid lupus erythematosus,phospholipase a2 group iva
11297,fenoldopam,breast neoplasm,solute carrier family 46 member 1
11298,darunavir,social phobia,carbonic anhydrase 9
11299,bazedoxifene,myasthenia gravis,protein kinase n1
11300,triiodothyronine,atrioventricular block,solute carrier family 22 member 11
11301,anagrelide,diffuse large b-cell lymphoma,glutathione s-transferase mu 1
11302,pentoxifylline,chronic bronchitis,neurotrophic receptor tyrosine kinase 2
11303,ecallantide,nasal congestion,paraoxonase 1
11304,rivaroxaban,"familial amyloid neuropathy, portuguese type","major histocompatibility complex, class i, a"
11305,acitretin,osteomalacia,"protein phosphatase 3 regulatory subunit b, alpha"
11306,etidronic acid,cryptorchidism,septin 9
11307,daunorubicin,sebaceous adenoma,adenosine deaminase
11308,perospirone,uveitis,macrophage stimulating 1 receptor
11309,dipivefrine,shock,nuclear factor kappa b subunit 1
11310,chlorpropamide,essential thrombocythemia,phenylalanine hydroxylase
11311,lumiracoxib,medullary thyroid gland carcinoma,glutamate ionotropic receptor nmda type subunit 2a
11312,pinacidil,inappropriate adh syndrome,mitogen-activated protein kinase kinase 5
11313,tandospirone,urinary bladder cancer,toll like receptor 9
11314,carbetocin,thrombotic disease,annexin a1
11315,capsaicin,langerhans cell histiocytosis,melatonin receptor 1a
11316,salicylic acid,tourette syndrome,dopamine receptor d1
11317,felbamate,abdominal abscess,"met proto-oncogene, receptor tyrosine kinase"
11318,pyrimethamine,stroke disorder,potassium voltage-gated channel subfamily a member 6
11319,flibanserin,esotropia,serpin family e member 1
11320,tetracosactide,nutritional biotin deficiency,5-hydroxytryptamine receptor 4
11321,pyrimethamine,hot flashes,potassium two pore domain channel subfamily k member 3
11322,eflornithine,attrv122i amyloidosis,s100 calcium binding protein p
11323,olmesartan,parkinsonian disorder,neutrophil cytosolic factor 1
11324,promazine,diffuse large b-cell lymphoma,opioid related nociceptin receptor 1
11325,morphine,mature t-cell and nk-cell non-hodgkin lymphoma,epidermal growth factor receptor
11326,gefitinib,mast cell leukemia,potassium voltage-gated channel subfamily b member 2
11327,bezafibrate,testicular cancer,atpase na+/k+ transporting subunit alpha 1
11328,olmesartan,anxiety,angiotensin ii receptor type 1
11329,silodosin,epilepsy with generalized tonic-clonic seizures,calcium voltage-gated channel auxiliary subunit beta 1
11330,tenofovir alafenamide,frozen shoulder,activin a receptor type 1
11331,betamethasone,fabry disease,n-acylsphingosine amidohydrolase 1
11332,niraparib,patent ductus arteriosus,transient receptor potential cation channel subfamily m member 8
11333,naloxone,hypersensitivity pneumonitis,retinoic acid receptor gamma
11334,aminobenzoic acid,head and neck cancer,guanylate cyclase 2c
11335,mitoxantrone,bacterial endocarditis,ryanodine receptor 2
11336,acebutolol,sickle cell anemia,cytochrome p450 family 1 subfamily a member 2
11337,triflupromazine,blepharoconjunctivitis,trace amine associated receptor 1
11338,insulin glulisine,atrophic vulva,"src proto-oncogene, non-receptor tyrosine kinase"
11339,etoposide,post-operative pain,paraoxonase 1
11340,salsalate,atopic eczema,"hck proto-oncogene, src family tyrosine kinase"
11341,saquinavir,hypoglycemia,potassium inwardly rectifying channel subfamily j member 12
11342,lixisenatide,bacterial endocarditis,adrenoceptor alpha 1a
11343,sildenafil,bipolar disorder,fms related receptor tyrosine kinase 4
11344,udenafil,tendinopathy,cytochrome p450 family 2 subfamily c member 18
11345,benoxaprofen,hepatocellular carcinoma,atpase na+/k+ transporting subunit beta 2
11346,loperamide,exfoliative dermatitis,histone deacetylase 9
11347,metaraminol,erdheim-chester disease,potassium voltage-gated channel modifier subfamily g member 3
11348,megestrol,uterine corpus leiomyoma,sodium voltage-gated channel alpha subunit 8
11349,gilteritinib,chronic beryllium disease,sodium voltage-gated channel alpha subunit 4
11350,promazine,xerophthalmia,potassium voltage-gated channel subfamily a member 6
11351,etidronic acid,punctate epithelial keratoconjunctivitis,prostaglandin-endoperoxide synthase 1
11352,perampanel,premature ejaculation,propionyl-coa carboxylase subunit beta
11353,tetracosactide,embolism,aurora kinase b
11354,reproterol,tyrosinemia,cholinergic receptor nicotinic alpha 3 subunit
11355,olaparib,thyroid gland follicular carcinoma,carbonic anhydrase 9
11356,minoxidil,neoplasm of esophagus,maternal embryonic leucine zipper kinase
11357,tolbutamide,tyrosinemia,gamma-aminobutyric acid type a receptor subunit alpha4
11358,eliglustat,oppositional defiant disorder,tubulin alpha 1a
11359,gemigliptin,premenstrual dysphoric disorder,solute carrier family 22 member 5
11360,secobarbital,medullary thyroid gland carcinoma,serine/threonine kinase 11
11361,modafinil,ventricular fibrillation,diacylglycerol o-acyltransferase 1
11362,luseogliflozin,orthostatic hypotension,cytochrome p450 family 2 subfamily a member 6
11363,promazine,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,opioid receptor mu 1
11364,etodolac,pulmonary arterial hypertension,"mer proto-oncogene, tyrosine kinase"
11365,vernakalant,abdominal abscess,hyperpolarization activated cyclic nucleotide gated potassium channel 3
11366,phytomenadione,iridocyclitis,acyl-coa synthetase long chain family member 5
11367,migalastat,tendinitis,5-hydroxytryptamine receptor 3c
11368,bupivacaine,acquired thrombocytopenia,fms related receptor tyrosine kinase 1
11369,donepezil,goiter,cytochrome p450 family 2 subfamily j member 2
11370,sulpiride,adrenogenital syndrome,gamma-aminobutyric acid type a receptor subunit alpha4
11371,protriptyline,inflammatory bowel disease,thromboxane a2 receptor
11372,travoprost,sympathetic ophthalmia,ornithine transcarbamylase
11373,medrysone,vulvovaginal candidiasis,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
11374,capsaicin,angina pectoris,atpase h+/k+ transporting subunit alpha
11375,incadronic acid,disruptive behavior disorder,glutathione s-transferase mu 1
11376,buspirone,ocular hypertension,dopamine receptor d3
11377,thiothixene,hyperinsulinism,phosphodiesterase 4d
11378,cyclizine,"leukemia, myeloid, chronic-phase",dna primase subunit 2
11379,beclometasone,pharyngitis,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
11380,mesuximide,bipolar disorder,cytochrome p450 family 2 subfamily c member 19
11381,phenylephrine,seasonal affective disorder,gamma-aminobutyric acid type a receptor subunit gamma3
11382,salicylic acid,"leukemia, myeloid, chronic-phase",atpase h+/k+ transporting subunit beta
11383,aliskiren,xerophthalmia,serine/threonine kinase 4
11384,floxuridine,asthma-chronic obstructive pulmonary disease overlap syndrome,atm serine/threonine kinase
11385,treprostinil,multiple endocrine neoplasia,solute carrier family 46 member 1
11386,estramustine,prinzmetal angina,tank binding kinase 1
11387,glibenclamide,cluster headache syndrome,udp-glucose ceramide glucosyltransferase
11388,pralatrexate,acute gonococcal endometritis,potassium voltage-gated channel subfamily h member 5
11389,nicardipine,pain,solute carrier family 5 member 6
11390,amlodipine,tetanus,follicle stimulating hormone receptor
11391,alogliptin,toothache,gamma-aminobutyric acid type a receptor subunit beta2
11392,mercaptopurine,meningococcal meningitis,carbonic anhydrase 11
11393,lenalidomide,head and neck cancer,renin
11394,voclosporin,x-linked dominant hypophosphatemic rickets,mechanistic target of rapamycin kinase
11395,lercanidipine,head and neck neoplasm,atp binding cassette subfamily g member 8
11396,haloperidol,perennial allergic rhinitis,eukaryotic translation initiation factor 4e
11397,calcium acetate,musculoskeletal system disorder,calcium voltage-gated channel subunit alpha1 a
11398,azacitidine,vulvovaginal candidiasis,monoamine oxidase a
11399,pomalidomide,type 1 diabetes mellitus,albumin
11400,fluvastatin,breast cancer,dopamine beta-hydroxylase
11401,pseudoephedrine,cough,renin
11402,prochlorperazine,schizophrenia,calcium voltage-gated channel subunit alpha1 d
11403,melatonin,serum sickness,cyclin dependent kinase 19
11404,flurbiprofen,vulvovaginal candidiasis,potassium voltage-gated channel subfamily h member 4
11405,cilostazol,tetanus,peptidylprolyl isomerase a
11406,dexlansoprazole,premenstrual dysphoric disorder,solute carrier family 5 member 4
11407,eletriptan,x-linked dominant hypophosphatemic rickets,protein kinase cgmp-dependent 1
11408,balsalazide,polymyalgia rheumatica,bmp2 inducible kinase
11409,glycopyrrolate,nausea,guanylate cyclase 1 soluble subunit beta 1
11410,chlorthalidone,myotonic syndrome,gamma-aminobutyric acid type a receptor subunit delta
11411,midodrine,alcohol abuse,potassium voltage-gated channel subfamily h member 8
11412,propranolol,endometriosis,follicle stimulating hormone receptor
11413,zonisamide,psoriasis,glutamate ionotropic receptor nmda type subunit 2c
11414,naloxone,pseudotumor cerebri,cannabinoid receptor 1
11415,alteplase,hiv infectious disease,tankyrase 2
11416,cisapride,oral mucosa leukoplakia,protein kinase cgmp-dependent 1
11417,captodiame,breast cancer,solute carrier family 2 member 9
11418,bimatoprost,aspiration pneumonitis,sodium channel epithelial 1 subunit beta
11419,danazol,dermatophytosis of groin and perianal area,potassium two pore domain channel subfamily k member 3
11420,tapentadol,islet cell adenomatosis,trace amine associated receptor 1
11421,aceclofenac,"chronic myelogenous leukemia, bcr-abl1 positive",glutamate ionotropic receptor kainate type subunit 2
11422,doxazosin,rheumatoid arthritis,melatonin receptor 1a
11423,acrivastine,gestational trophoblastic neoplasm,geranylgeranyl diphosphate synthase 1
11424,piroxicam,glaucoma,neurotrophic receptor tyrosine kinase 3
11425,clemastine,testicular cancer,nuclear receptor subfamily 3 group c member 2
11426,pranlukast,type 1 diabetes mellitus,dna topoisomerase i mitochondrial
11427,ivermectin,dementia,potassium voltage-gated channel modifier subfamily f member 1
11428,pemetrexed,acute pain,ret proto-oncogene
11429,finasteride,thromboangiitis obliterans,phosphodiesterase 4d
11430,alprazolam,endometritis,"dna polymerase epsilon, catalytic subunit"
11431,anagrelide,follicular lymphoma,epoxide hydrolase 2
11432,reboxetine,hypothyroidism,receptor interacting serine/threonine kinase 3
11433,amitriptyline,actinic keratosis,mitogen-activated protein kinase 14
11434,apraclonidine,hypothyroidism,homeodomain interacting protein kinase 2
11435,omarigliptin,nocturnal enuresis,tubulin beta 4b class ivb
11436,tamibarotene,acute promyelocytic leukemia,bcl2 apoptosis regulator
11437,diphenoxylate,parkinson disease,udp-glucose ceramide glucosyltransferase
11438,cromoglicic acid,subarachnoid hemorrhage,histone deacetylase 4
11439,warfarin,cardiogenic shock,ribonucleotide reductase regulatory subunit m2
11440,tolcapone,sebaceous adenoma,gamma-aminobutyric acid type a receptor subunit alpha5
11441,tamsulosin,thyroid crisis,phosphoribosyl pyrophosphate amidotransferase
11442,baclofen,fibromyalgia,cholinergic receptor nicotinic beta 3 subunit
11443,trichlormethiazide,adrenogenital syndrome,ribosomal protein s6 kinase a2
11444,almitrine,thrombophilia due to thrombin defect,dipeptidyl peptidase 9
11445,doxazosin,shock,glucagon like peptide 2 receptor
11446,fluphenazine,disseminated intravascular coagulation,sodium voltage-gated channel alpha subunit 2
11447,acetylcholine,neoplasm of esophagus,glutamate ionotropic receptor nmda type subunit 1
11448,ethosuximide,lichen planus,potassium voltage-gated channel modifier subfamily g member 3
11449,rotigotine,hypertensive disorder,amylase alpha 1c
11450,terguride,allergic urticaria,homeodomain interacting protein kinase 1
11451,conivaptan,myeloid neoplasm associated with pdgfra rearrangement,carbonic anhydrase 13
11452,tipranavir,dacryocystitis,hydroxycarboxylic acid receptor 3
11453,azilsartan medoxomil,pain,serine/threonine kinase 33
11454,lifitegrast,hemophilia a,proteasome 20s subunit beta 10
11455,glimepiride,waldenstrom macroglobulinemia,diacylglycerol o-acyltransferase 1
11456,candesartan,male infertility,"kit proto-oncogene, receptor tyrosine kinase"
11457,topiroxostat,methylmalonic acidemia,platelet derived growth factor receptor alpha
11458,clobetasol propionate,decreased cardiac output,potassium voltage-gated channel subfamily h member 5
11459,methylergonovine,gastric cancer,nuak family kinase 2
11460,tafluprost,lymphangioma,calcium voltage-gated channel subunit alpha1 h
11461,paramethadione,tetanus,rho associated coiled-coil containing protein kinase 1
11462,topiroxostat,premenstrual dysphoric disorder,calcium voltage-gated channel subunit alpha1 d
11463,ofloxacin,drooling,peroxisome proliferator activated receptor delta
11464,echothiophate,urticaria,angiotensin ii receptor type 2
11465,lopinavir,classic hodgkin lymphoma,ryanodine receptor 3
11466,chlordiazepoxide,dermatofibrosarcoma protuberans,gamma-aminobutyric acid type a receptor subunit beta1
11467,teriparatide,poisoning of animals with phosphate salts,interleukin 1 receptor type 1
11468,dosulepin,impetigo,maternal embryonic leucine zipper kinase
11469,canagliflozin,eunuchism,solute carrier family 6 member 1
11470,betamethasone,esotropia,calcium voltage-gated channel auxiliary subunit gamma 1
11471,adinazolam,hyponatremia,solute carrier family 22 member 3
11472,mitoxantrone,hepatocellular carcinoma,phenylalanine hydroxylase
11473,migalastat,hepatocellular carcinoma,cytochrome p450 family 46 subfamily a member 1
11474,papaverine,nicotine dependence,"abl proto-oncogene 1, non-receptor tyrosine kinase"
11475,auranofin,sarcoma,protein phosphatase 3 catalytic subunit alpha
11476,phenazone,oral mucosa leukoplakia,potassium voltage-gated channel subfamily h member 2
11477,chlordiazepoxide,parkinsonian disorder,tubulin beta 4b class ivb
11478,l-glutamine,dacryocystitis,mitogen-activated protein kinase kinase kinase 9
11479,carbinoxamine,hemangioma,colony stimulating factor 1 receptor
11480,alectinib,acute lymphoblastic leukemia,integrin subunit alpha l
11481,triazolam,polycystic ovary syndrome,dual specificity tyrosine phosphorylation regulated kinase 1b
11482,colchicine,gastric cancer,sodium voltage-gated channel alpha subunit 10
11483,pregabalin,autoimmune hemolytic anemia,cytidine deaminase
11484,cephalotaxine,shock,"major histocompatibility complex, class i, a"
11485,paracetamol,pulmonary valve atresia,gamma-aminobutyric acid type a receptor subunit gamma3
11486,thioguanine,premature ejaculation,dipeptidyl peptidase 8
11487,frovatriptan,anogenital human papillomavirus infection,solute carrier family 5 member 2
11488,moclobemide,ovarian cancer,sex hormone binding globulin
11489,phentermine,perennial allergic rhinitis,gamma-aminobutyric acid type a receptor subunit alpha2
11490,montelukast,vulvovaginal candidiasis,sodium voltage-gated channel alpha subunit 10
11491,midodrine,tetany,neurotrophic receptor tyrosine kinase 2
11492,nintedanib,angioedema,vitamin k epoxide reductase complex subunit 1
11493,lifitegrast,pulmonary embolism,bcl2 like 1
11494,imatinib,anterior uveitis,thyroid peroxidase
11495,terfenadine,tendinopathy,dipeptidyl peptidase 4
11496,lornoxicam,angle-closure glaucoma,hyperpolarization activated cyclic nucleotide gated potassium channel 1
11497,megestrol,tardive dyskinesia,homeodomain interacting protein kinase 1
11498,proguanil,arthritic joint disease,potassium voltage-gated channel modifier subfamily v member 1
11499,chlorpropamide,pruritus ani,fatty acid amide hydrolase
11500,fluticasone,iritis,fms related receptor tyrosine kinase 4
11501,indacaterol,postoperative nausea and vomiting,cdc like kinase 2
11502,dipivefrine,aspiration pneumonitis,potassium calcium-activated channel subfamily m alpha 1
11503,indomethacin,pulmonary embolism,toll like receptor 4
11504,baricitinib,spasticity,salt inducible kinase 1
11505,bimatoprost,trigeminal neuralgia,cholinergic receptor nicotinic alpha 3 subunit
11506,bupivacaine,polymyalgia rheumatica,hydroxycarboxylic acid receptor 3
11507,eletriptan,alcohol dependence,melatonin receptor 1b
11508,cetirizine,frozen shoulder,"met proto-oncogene, receptor tyrosine kinase"
11509,tetrabenazine,bronchial disorder,metabolism of cobalamin associated a
11510,daunorubicin,dyspnea,gamma-aminobutyric acid type a receptor subunit gamma2
11511,phenobarbital,common wart,serpin family c member 1
11512,bazedoxifene,pulmonary cystic fibrosis,bmx non-receptor tyrosine kinase
11513,nicardipine,breast cancer,growth hormone releasing hormone receptor
11514,linagliptin,pancreatic insulinoma,riboflavin kinase
11515,pilocarpine,sympathetic ophthalmia,somatostatin receptor 3
11516,montelukast,osteoporosis,cart prepropeptide
11517,maprotiline,anxiety,histone deacetylase 4
11518,propafenone,multiple sclerosis,cf transmembrane conductance regulator
11519,mesalazine,diabetic kidney disease,uridine monophosphate synthetase
11520,carbimazole,"dermatitis, atopic",unc-51 like autophagy activating kinase 1
11521,cetirizine,ascariasis,solute carrier family 27 member 2
11522,gliquidone,lymphangioma,g protein-coupled receptor 35
11523,pimecrolimus,psychotic disorder,solute carrier family 27 member 2
11524,dimenhydrinate,erythema multiforme,potassium voltage-gated channel modifier subfamily g member 4
11525,blonanserin,gastric cancer,calcium voltage-gated channel auxiliary subunit gamma 1
11526,acarbose,small intestine cancer,metallothionein 2a
11527,rizatriptan,sjogren syndrome,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
11528,cycrimine,sarcoidosis,cytochrome p450 family 2 subfamily c member 19
11529,ifosfamide,psoriasis,integrin subunit beta 3
11530,auranofin,acquired thrombocytopenia,"pim-2 proto-oncogene, serine/threonine kinase"
11531,dapagliflozin,insomnia,nuclear receptor subfamily 5 group a member 1
11532,nadolol,urticaria,potassium voltage-gated channel modifier subfamily s member 2
11533,salicylic acid,gaucher disease,thyroid hormone receptor beta
11534,aminobenzoic acid,dermatophytosis of groin and perianal area,cholinergic receptor nicotinic beta 2 subunit
11535,amobarbital,necrobiosis lipoidica,potassium voltage-gated channel subfamily h member 5
11536,alimemazine,alzheimer disease,calreticulin
11537,orphenadrine,lennox-gastaut syndrome,phosphodiesterase 3a
11538,enzalutamide,arthritic joint disease,atp binding cassette subfamily c member 9
11539,bethanechol,epilepsy with generalized tonic-clonic seizures,interleukin 6 receptor
11540,carbidopa,iridocyclitis,prostaglandin f receptor
11541,mometasone,waldenstrom macroglobulinemia,potassium voltage-gated channel subfamily q member 5
11542,ranitidine,epilepsy,peptidylprolyl isomerase b
11543,vincristine,nocturnal enuresis,metabolism of cobalamin associated b
11544,triiodothyronine,bruxism,adenosine a1 receptor
11545,propafenone,mature t-cell and nk-cell non-hodgkin lymphoma,fkbp prolyl isomerase 1b
11546,felodipine,b-cell chronic lymphocytic leukemia,histone deacetylase 3
11547,prilocaine,tyrosinemia,"kras proto-oncogene, gtpase"
11548,apalutamide,rheumatoid arthritis,fatty acid binding protein 2
11549,bunolol,inappropriate adh syndrome,c-c motif chemokine receptor 1
11550,liraglutide,gestational trophoblastic neoplasm,cytochrome p450 family 1 subfamily b member 1
11551,montelukast,chronic hepatitis c virus infection,amine oxidase copper containing 3
11552,methamphetamine,thromboembolism,serine/threonine kinase 33
11553,zolpidem,seasonal allergic rhinitis,atp binding cassette subfamily c member 9
11554,phenytoin,islet cell adenomatosis,"protein phosphatase 3 regulatory subunit b, alpha"
11555,naloxone,corneal ulcer,glutamic-oxaloacetic transaminase 1
11556,moxonidine,small cell lung carcinoma,peptidylprolyl isomerase d
11557,lidocaine,small intestine cancer,serine/threonine kinase 25
11558,pethidine,familial dermatographia,farnesyl diphosphate synthase
11559,insulin degludec,"cicatrix, hypertrophic",potassium voltage-gated channel modifier subfamily g member 3
11560,pirfenidone,gaucher disease,tubulin beta 2a class iia
11561,rimonabant,polyuria,potassium inwardly rectifying channel subfamily j member 11
11562,gemtuzumab ozogamicin,motion sickness,adrenoceptor alpha 2c
11563,estrone sulphate,glioma,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
11564,acamprosate,frozen shoulder,potassium voltage-gated channel subfamily b member 1
11565,parathyroid hormone,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,eph receptor b6
11566,regorafenib,lung neoplasm,angiotensin ii receptor type 2
11567,eletriptan,acquired thrombocytopenia,solute carrier family 25 member 5
11568,biotin,motion sickness,protein kinase n1
11569,ergotamine,vitiligo,hyperpolarization activated cyclic nucleotide gated potassium channel 1
11570,mupirocin,eosinophilic pneumonia,acetyl-coa acyltransferase 2
11571,cilastatin,myasthenia gravis,gc vitamin d binding protein
11572,tretinoin,scalp dermatosis,prostaglandin f receptor
11573,tranexamic acid,amyotrophic lateral sclerosis,mitogen-activated protein kinase kinase kinase 9
11574,nitric oxide,scleroderma,calcium voltage-gated channel subunit alpha1 f
11575,captodiame,pyoderma gangrenosum,potassium voltage-gated channel modifier subfamily s member 1
11576,tiaprofenic acid,thyroiditis,tyrosine kinase non receptor 1
11577,tipiracil,relapsing-remitting multiple sclerosis,glucose-6-phosphate dehydrogenase
11578,raloxifene,polymyalgia rheumatica,synuclein alpha
11579,triflupromazine,asthma-chronic obstructive pulmonary disease overlap syndrome,sodium voltage-gated channel alpha subunit 10
11580,mercaptopurine,malignant hyperthermia of anesthesia,serine/threonine kinase 10
11581,medroxyprogesterone,acute promyelocytic leukemia,neurotrophic receptor tyrosine kinase 1
11582,clocortolone pivalate,migraine disorder,phosphodiesterase 3a
11583,rimonabant,neuralgia,sphingomyelin phosphodiesterase 1
11584,apomorphine,interstitial lung disease 2,carbonic anhydrase 1
11585,sofalcone,mycosis fungoides,acid sensing ion channel subunit 1
11586,ziprasidone,thyroid gland papillary carcinoma,histone deacetylase 1
11587,mitoxantrone,essential thrombocythemia,homeodomain interacting protein kinase 4
11588,midostaurin,lung neoplasm,bradykinin receptor b2
11589,perindopril,malignant glioma,tubulin gamma 1
11590,pexidartinib,idiopathic acute eosinophilic pneumonia,activin a receptor type 1
11591,gemtuzumab ozogamicin,small cell lung carcinoma,atp binding cassette subfamily c member 8
11592,terfenadine,oppositional defiant disorder,death associated protein kinase 2
11593,icotinib,lichen planus,toll like receptor 4
11594,celecoxib,ornithine carbamoyltransferase deficiency,"blk proto-oncogene, src family tyrosine kinase"
11595,raltegravir,frozen shoulder,adenosine a2b receptor
11596,tramadol,psychologic dyspareunia,atpase copper transporting beta
11597,letrozole,seasonal affective disorder,7-dehydrocholesterol reductase
11598,chlorpropamide,seasonal allergic rhinitis,glutamate ionotropic receptor ampa type subunit 3
11599,pindolol,tetanus,vascular endothelial growth factor a
11600,dronedarone,menorrhagia,solute carrier family 5 member 2
11601,cabozantinib,cardiac arrest,solute carrier family 27 member 2
11602,clobazam,anaphylaxis,septin 9
11603,imrecoxib,tension-type headache,homeodomain interacting protein kinase 1
11604,bisoprolol,malaria,4-hydroxyphenylpyruvate dioxygenase
11605,trilostane,breast ductal adenocarcinoma,adrenoceptor alpha 2b
11606,ephedrine,aplastic anemia,mitogen-activated protein kinase kinase 2
11607,acrivastine,male infertility,phosphodiesterase 3a
11608,nilotinib,marginal zone lymphoma,cytochrome p450 family 1 subfamily b member 1
11609,cisplatin,irritable bowel syndrome,colony stimulating factor 1 receptor
11610,diclofenamide,manic bipolar affective disorder,neuropeptide y
11611,diazepam,drooling,carbonic anhydrase 1
11612,diazoxide,acute lymphoblastic leukemia,bone gamma-carboxyglutamate protein
11613,verapamil,vascular disorder,potassium voltage-gated channel modifier subfamily f member 1
11614,levomethadyl acetate,gastrointestinal stromal tumor,atpase na+/k+ transporting subunit beta 3
11615,loxoprofen,type 2 diabetes mellitus,glutamate ionotropic receptor nmda type subunit 2c
11616,edoxaban,dementia,dual specificity tyrosine phosphorylation regulated kinase 2
11617,tulobuterol,invasive ductal breast carcinoma,retinoid x receptor gamma
11618,methdilazine,endometrium neoplasm,dipeptidase 1
11619,armodafinil,myasthenia gravis,galactosidase alpha
11620,lovastatin,arthropathy,matrix metallopeptidase 2
11621,buclizine,rheumatoid arthritis,acetyl-coa acyltransferase 2
11622,tolbutamide,arthropathy,prostaglandin-endoperoxide synthase 2
11623,betahistine,aspiration pneumonitis,histone deacetylase 7
11624,azelnidipine,peptic esophagitis,"kit proto-oncogene, receptor tyrosine kinase"
11625,cetirizine,psychotic disorder,retinoid x receptor gamma
11626,n-methyl scopolamine,male infertility,glutathione s-transferase mu 1
11627,epa,fever,tankyrase 2
11628,phendimetrazine,thyroid gland follicular carcinoma,solute carrier family 22 member 1
11629,atropine,respiratory failure,solute carrier family 18 member a2
11630,mestranol,bruxism,calcium voltage-gated channel auxiliary subunit gamma 1
11631,roxatidine acetate,restless legs syndrome,srsf protein kinase 3
11632,benoxaprofen,major depressive disorder,metabolism of cobalamin associated b
11633,pamidronic acid,respiratory failure,potassium voltage-gated channel subfamily c member 3
11634,ipragliflozin,headache disorder,cytochrome p450 family 46 subfamily a member 1
11635,caffeine,hyperthyroidism,txk tyrosine kinase
11636,trabectedin,peptic esophagitis,guanylate cyclase 1 soluble subunit alpha 1
11637,chlorcyclizine,metrorrhagia,retinoic acid receptor alpha
11638,rasagiline,melanoma,txk tyrosine kinase
11639,apalutamide,chronic obstructive pulmonary disease,mitogen-activated protein kinase kinase kinase kinase 1
11640,eszopiclone,raynaud disease,myeloperoxidase
11641,sotalol,intrinsic asthma,cf transmembrane conductance regulator
11642,propafenone,wilms tumor,glutamate ionotropic receptor nmda type subunit 2a
11643,fsh,chronic bronchitis,tankyrase 2
11644,reproterol,thyroid gland carcinoma,fms related receptor tyrosine kinase 1
11645,indacaterol,polymyalgia rheumatica,il2 inducible t cell kinase
11646,cyproheptadine,hyperaldosteronism,potassium two pore domain channel subfamily k member 3
11647,magnesium salicylate,scleroderma,carnitine palmitoyltransferase 1a
11648,fludroxycortide,mydriasis,angiotensin i converting enzyme
11649,clocortolone pivalate,primary cutaneous t-cell non-hodgkin lymphoma,synuclein alpha
11650,raltegravir,vitamin d deficiency,lipoprotein lipase
11651,ranitidine,trichuriasis,glutamate ionotropic receptor kainate type subunit 1
11652,pazopanib,enterocolitis,dead-box helicase 3 x-linked
11653,omarigliptin,bipolar disorder,prostaglandin e receptor 2
11654,piroxicam,west syndrome,ribosomal protein s6 kinase a1
11655,miconazole,renal cell carcinoma,phospholipase a2 group iva
11656,salsalate,epicondylitis,matrix metallopeptidase 9
11657,doxylamine,bacterial conjunctivitis,insulin receptor
11658,milnacipran,otitis externa,bcl2 like 1
11659,baricitinib,delayed puberty,cytochrome p450 family 2 subfamily c member 19
11660,thioguanine,abdominal abscess,phosphodiesterase 4b
11661,pregabalin,diabetes mellitus,cannabinoid receptor 2
11662,idelalisib,keratitis,ndufa4 mitochondrial complex associated like 2
11663,fluorometholone,zollinger-ellison syndrome,potassium inwardly rectifying channel subfamily j member 11
11664,ibandronic acid,gastroesophageal reflux disease,cyclin dependent kinase 14
11665,oxytocin,"malignant hyperthermia, susceptibility to, 1","yes proto-oncogene 1, src family tyrosine kinase"
11666,tranylcypromine,myotonic syndrome,lipoprotein lipase
11667,balsalazide,actinic keratosis,phosphodiesterase 4d
11668,vinorelbine,abdominal abscess,aldo-keto reductase family 1 member c1
11669,perazine,nicotine dependence,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
11670,bexarotene,intracranial embolism,txk tyrosine kinase
11671,tamoxifen,hodgkins lymphoma,acid sensing ion channel subunit 1
11672,haloperidol,perennial allergic rhinitis,retinoid x receptor alpha
11673,naproxen,pain,gamma-aminobutyric acid type a receptor subunit beta1
11674,fsh,proctitis,histone deacetylase 5
11675,luseogliflozin,enterocolitis,cytochrome p450 family 11 subfamily b member 2
11676,isopropamide,eunuchism,calcium voltage-gated channel subunit alpha1 i
11677,medroxyprogesterone,nocturnal enuresis,histone deacetylase 8
11678,sofalcone,diffuse large b-cell lymphoma,iodothyronine deiodinase 1
11679,dimenhydrinate,congenital hypothyroidism,vascular cell adhesion molecule 1
11680,bunolol,bacterial meningitis,5-hydroxytryptamine receptor 2a
11681,nizatidine,dermatitis herpetiformis,5-hydroxytryptamine receptor 3c
11682,vorinostat,brain glioblastoma,calcium voltage-gated channel subunit alpha1 f
11683,bupropion,post-operative pain,potassium voltage-gated channel subfamily c member 1
11684,tacrolimus,prader-willi syndrome,metabolism of cobalamin associated b
11685,naloxone,pulmonary fibrosis,cholinergic receptor nicotinic alpha 3 subunit
11686,levobetaxolol,urethritis,kelch like ech associated protein 1
11687,salicylic acid,pancreatic insulinoma,melatonin receptor 1a
11688,ethosuximide,essential hypertension,cytochrome p450 family 27 subfamily a member 1
11689,glymidine,acromegaly,platelet derived growth factor receptor alpha
11690,gemcitabine,xerophthalmia,nuclear receptor subfamily 3 group c member 2
11691,felbamate,angina pectoris,acyl-coa oxidase 1
11692,mestranol,onchocerciasis,myosin light chain kinase family member 4
11693,bimatoprost,scleroderma,phosphodiesterase 4b
11694,vilanterol,blepharoconjunctivitis,protein tyrosine kinase 2 beta
11695,cabergoline,thromboangiitis obliterans,serine/threonine kinase 33
11696,ziprasidone,interstitial lung disease,tumor necrosis factor
11697,dapoxetine,bipolar disorder,mitogen-activated protein kinase kinase kinase 20
11698,pamidronic acid,toothache,potassium voltage-gated channel subfamily a member 10
11699,rimexolone,male infertility,phosphodiesterase 4a
11700,morphine,myocardial infarction,aldo-keto reductase family 1 member c1
11701,lorazepam,acute gonococcal endometritis,solute carrier family 6 member 1
11702,insulin lispro,synovitis,"met proto-oncogene, receptor tyrosine kinase"
11703,toloxatone,west syndrome,mitogen-activated protein kinase kinase kinase 11
11704,pioglitazone,postmenopausal osteoporosis,geranylgeranyl diphosphate synthase 1
11705,ethacrynic acid,labor pain,sphingosine-1-phosphate receptor 4
11706,dimethyl fumarate,amyotrophic lateral sclerosis,cdc like kinase 4
11707,pemetrexed,liver cancer,phosphoribosyl pyrophosphate amidotransferase
11708,pilocarpine,vernal conjunctivitis,solute carrier organic anion transporter family member 1a2
11709,desvenlafaxine,rhinoscleroma,amylase alpha 1b
11710,methyclothiazide,waldenstrom macroglobulinemia,cereblon
11711,aminosalicylic acid,keratitis,potassium voltage-gated channel subfamily q member 1
11712,romidepsin,allergic bronchopulmonary aspergillosis,"smoothened, frizzled class receptor"
11713,dihydrotachysterol,brain cancer,n-acetyltransferase 2
11714,stanozolol,insomnia,solute carrier family 9 member a1
11715,dehydroepiandrosterone,interstitial lung disease 2,calcium voltage-gated channel subunit alpha1 a
11716,dibucaine,hypertensive disorder,tubulin gamma 1
11717,aceclofenac,chronic myelomonocytic leukemia,sodium voltage-gated channel alpha subunit 1
11718,mitiglinide,diamond-blackfan anemia,cholinergic receptor muscarinic 2
11719,olmesartan,open-angle glaucoma,melanocortin 1 receptor
11720,rofecoxib,hypertrophic cardiomyopathy,cholinergic receptor muscarinic 3
11721,radotinib,holocarboxylase synthetase deficiency,retinoic acid receptor beta
11722,ixazomib,thrombocytopenia,cholinergic receptor nicotinic alpha 4 subunit
11723,tafamidis,myocardial infarction,acyl-coa dehydrogenase short/branched chain
11724,ziprasidone,"dermatitis, atopic",atp binding cassette subfamily c member 3
11725,midostaurin,diffuse large b-cell lymphoma,thromboxane a2 receptor
11726,propranolol,homozygous familial hypercholesterolemia,histone deacetylase 7
11727,olodaterol,endemic goiter,maltase-glucoamylase
11728,clofazimine,myxedema,phosphodiesterase 3a
11729,amlodipine,hypoalphalipoproteinemia,potassium voltage-gated channel subfamily c member 1
11730,prednisolone,chronic schizophrenia,tek receptor tyrosine kinase
11731,amiodarone,renal osteodystrophy,cdc like kinase 4
11732,fluvastatin,lewy body dementia,monoamine oxidase a
11733,isosorbide dinitrate,thyroid gland carcinoma,sodium voltage-gated channel alpha subunit 4
11734,cyclobenzaprine,pellagra,histone deacetylase 3
11735,isoprenaline,"dermatitis, atopic",dopamine beta-hydroxylase
11736,lofepramine,proctitis,unc-51 like kinase 3
11737,acarbose,pulmonary artery stenosis,estrogen related receptor beta
11738,fludarabine,malignant hyperthermia of anesthesia,proteasome 20s subunit beta 10
11739,vilanterol,anogenital human papillomavirus infection,natriuretic peptide receptor 1
11740,benoxaprofen,neuralgia,ndufa4 mitochondrial complex associated like 2
11741,venetoclax,primary myelofibrosis,"tu translation elongation factor, mitochondrial"
11742,mometasone,idiopathic hypereosinophilic syndrome,potassium voltage-gated channel subfamily h member 4
11743,epirubicin,hyponatremia,dual specificity tyrosine phosphorylation regulated kinase 1b
11744,risedronate,hyperprolactinemia,atpase na+/k+ transporting subunit alpha 3
11745,ofatumumab,pemphigus,phosphodiesterase 6a
11746,indacaterol,huntington disease,solute carrier family 47 member 2
11747,pioglitazone,familial mediterranean fever,prostaglandin f receptor
11748,lidocaine,erectile dysfunction,glucosidase ii alpha subunit
11749,duloxetine,acute gonococcal cervicitis,nuclear receptor subfamily 5 group a member 1
11750,oxazepam,b-cell chronic lymphocytic leukemia,5-hydroxytryptamine receptor 1d
11751,acarbose,cardiac arrest,interleukin 1 receptor associated kinase 1
11752,liraglutide,psychotic disorder,aurora kinase b
11753,eszopiclone,invasive ductal breast carcinoma,cytochrome p450 family 2 subfamily c member 9
11754,defibrotide,amenorrhea,colony stimulating factor 1 receptor
11755,acth,bronchitis,potassium two pore domain channel subfamily k member 2
11756,amphetamine,granuloma annulare,phospholipase a2 group ib
11757,valrubicin,colonic neoplasm,phosphorylase kinase catalytic subunit gamma 1
11758,pethidine,breast carcinoma,bub1 mitotic checkpoint serine/threonine kinase
11759,sulpiride,cough,platelet derived growth factor receptor alpha
11760,fexofenadine,vitamin b12 deficiency,potassium voltage-gated channel subfamily q member 1
11761,risperidone,"chronic myelogenous leukemia, bcr-abl1 positive",cholinergic receptor nicotinic beta 2 subunit
11762,pemirolast,hyperparathyroidism,cholinergic receptor nicotinic alpha 7 subunit
11763,dipivefrine,biotinidase deficiency,mitogen-activated protein kinase kinase 2
11764,nilotinib,influenza,"met proto-oncogene, receptor tyrosine kinase"
11765,propantheline,medullary thyroid gland carcinoma,"kras proto-oncogene, gtpase"
11766,desogestrel,basal ganglia disorder,caspase 1
11767,diclofenamide,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 5 member 4
11768,fludarabine,miliary tuberculosis,homeodomain interacting protein kinase 2
11769,anagrelide,hypocalcemia,dna topoisomerase i mitochondrial
11770,l-glutamine,peptic ulcer disease,cyclin g associated kinase
11771,ceritinib,sickle cell anemia,potassium voltage-gated channel subfamily c member 4
11772,bethanechol,torsades de pointes,calmodulin 2
11773,propantheline,graves disease,leukotriene a4 hydrolase
11774,mosapramine,chronic beryllium disease,potassium voltage-gated channel subfamily c member 2
11775,trabectedin,hypertrichosis of eyelid,mapk interacting serine/threonine kinase 2
11776,bepotastine,bacterial pneumonia,acyl-coa synthetase long chain family member 5
11777,armodafinil,hyperlipidemia,phosphodiesterase 10a
11778,quetiapine,acute promyelocytic leukemia,mechanistic target of rapamycin kinase
11779,obinutuzumab,abdominal abscess,potassium voltage-gated channel subfamily b member 1
11780,trimetaphan,pellagra,adenosine a2b receptor
11781,dexlansoprazole,methylmalonic acidemia,carbonic anhydrase 13
11782,tolmetin,wilms tumor,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
11783,isotretinoin,pityriasis versicolor,low density lipoprotein receptor
11784,sonidegib,bacterial conjunctivitis,serine/threonine kinase 17a
11785,lovastatin,acidosis disorder,cytochrome p450 family 27 subfamily a member 1
11786,fludroxycortide,scleroderma,"protein phosphatase 3 regulatory subunit b, alpha"
11787,bretylium,thyroid tumor,phenylalanine hydroxylase
11788,trimethadione,motion sickness,glutathione-disulfide reductase
11789,paclitaxel,phenylketonuria,fms related receptor tyrosine kinase 3
11790,amobarbital,bronchial disorder,potassium voltage-gated channel subfamily a member 1
11791,febuxostat,mydriasis,neurotensin receptor 2
11792,avanafil,pyelonephritis,transthyretin
11793,probenecid,kaposi's sarcoma,solute carrier family 22 member 8
11794,nizatidine,epicondylitis,cysteinyl leukotriene receptor 1
11795,meclofenamic acid,pancreatic insulinoma,adenosine deaminase
11796,olodaterol,leprosy,coagulation factor x
11797,pemirolast,chronic bronchitis,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
11798,nefazodone,nicotine dependence,"protein phosphatase 3 regulatory subunit b, alpha"
11799,ketanserin,prostate neoplasm,atp binding cassette subfamily c member 3
11800,pirbuterol,delirium,"coagulation factor ii, thrombin"
11801,alfuzosin,alcohol dependence,colony stimulating factor 1 receptor
11802,phentermine,hot flashes,phosphodiesterase 8b
11803,ketorolac,attrv122i amyloidosis,homeodomain interacting protein kinase 4
11804,reproterol,lung neoplasm,npc1 like intracellular cholesterol transporter 1
11805,lasofoxifene,pulmonary cystic fibrosis,neuropeptide y receptor y1
11806,vincristine,anaphylaxis,5-hydroxytryptamine receptor 3c
11807,ergocalciferol,myalgia,alpha glucosidase
11808,ranitidine,anterior uveitis,s100 calcium binding protein p
11809,fsh,glaucoma,bruton tyrosine kinase
11810,rizatriptan,testicular cancer,potassium voltage-gated channel subfamily h member 6
11811,imiquimod,thyroiditis,proteasome 20s subunit beta 10
11812,calcium citrate,hereditary von willebrand disease,sodium channel epithelial 1 subunit gamma
11813,triazolam,anaphylaxis,apolipoprotein b
11814,pirenzepine,severe major depression with psychotic features,calcium/calmodulin dependent protein kinase ii alpha
11815,octreotide,rheumatoid arthritis,5-hydroxytryptamine receptor 4
11816,tolterodine,aorta coarctation,potassium inwardly rectifying channel subfamily j member 8
11817,danazol,cough,retinoic acid receptor gamma
11818,aceclofenac,arthropathy,cholesteryl ester transfer protein
11819,tolmetin,canker sore,"fyn proto-oncogene, src family tyrosine kinase"
11820,silodosin,autism spectrum disorder,phosphodiesterase 7b
11821,salbutamol,chronic beryllium disease,tankyrase 2
11822,anisotropine methylbromide,gastric cancer,steroid 5 alpha-reductase 1
11823,goserelin,pheochromocytoma,glucosidase ii alpha subunit
11824,eliglustat,x-linked dominant hypophosphatemic rickets,butyrylcholinesterase
11825,luseogliflozin,mast cell leukemia,calcium voltage-gated channel subunit alpha1 g
11826,simvastatin,glossopharyngeal neuralgia,somatostatin receptor 5
11827,progesterone,enterocolitis,adrenoceptor alpha 2c
11828,epirubicin,cluster headache syndrome,amylase alpha 2a
11829,diazoxide,post-operative pain,calcium/calmodulin dependent protein kinase ii alpha
11830,carmustine,open-angle glaucoma,receptor interacting serine/threonine kinase 3
11831,meclizine,pruritus,cd33 molecule
11832,dantrolene,ankylosing spondylitis,phosphodiesterase 4c
11833,bunazosin,osteoarthritis,atpase na+/k+ transporting subunit beta 1
11834,quinapril,acute monocytic leukemia,carbonic anhydrase 9
11835,"1,25-dihydroxyvitamin d3",erdheim-chester disease,5-hydroxytryptamine receptor 1b
11836,trichlormethiazide,invasive ductal breast carcinoma,atp binding cassette subfamily g member 5
11837,glibenclamide,sarcoidosis,"raf-1 proto-oncogene, serine/threonine kinase"
11838,paroxetine,gastrointestinal stromal tumor,calcium sensing receptor
11839,cabozantinib,hypothyroidism,potassium voltage-gated channel subfamily b member 1
11840,linaclotide,poisoning of animals with phosphate salts,melatonin receptor 1b
11841,cyproheptadine,angina pectoris,cholinergic receptor muscarinic 2
11842,migalastat,social phobia,cholinergic receptor nicotinic alpha 3 subunit
11843,estramustine,acne,isoleucyl-trna synthetase 1
11844,megestrol,fabry disease,dead-box helicase 3 x-linked
11845,blonanserin,burkitt lymphoma,natriuretic peptide receptor 1
11846,nabumetone,toothache,growth hormone receptor
11847,leuprolide,renal osteodystrophy,cytochrome p450 family 2 subfamily c member 9
11848,propranolol,generalized anxiety disorder,potassium voltage-gated channel modifier subfamily g member 4
11849,diclofenamide,familial dermatographia,aldo-keto reductase family 1 member c1
11850,bimatoprost,diabetes mellitus,sphingosine-1-phosphate receptor 1
11851,panobinostat,rickets,"tu translation elongation factor, mitochondrial"
11852,landiolol,duodenal ulcer,cholinergic receptor muscarinic 4
11853,oxaliplatin,aspiration pneumonitis,adrenoceptor alpha 2a
11854,nitrazepam,iridocyclitis,guanylate cyclase 1 soluble subunit alpha 1
11855,clofarabine,"hyperlipidemia, familial combined, lpl related",lipoprotein lipase
11856,epinastine,pulmonary eosinophilia,potassium inwardly rectifying channel subfamily j member 12
11857,alprazolam,ascites,aurora kinase b
11858,triazolam,epicondylitis,neurotrophic receptor tyrosine kinase 3
11859,carbachol,allergic rhinitis,solute carrier organic anion transporter family member 1b1
11860,armodafinil,psychosexual disorder,dead-box helicase 1
11861,miconazole,meniere disease,phosphodiesterase 4a
11862,gliquidone,meniere disease,cyclin dependent kinase 6
11863,crizotinib,chronic kidney disease,solute carrier family 6 member 1
11864,emedastine,cardiac arrest,cytochrome p450 family 3 subfamily a member 4
11865,cyclosporin a,polycystic ovary syndrome,"smoothened, frizzled class receptor"
11866,tazarotene,orthostatic hypotension,cyclin dependent kinase 8
11867,tiagabine,basal ganglia disorder,cytochrome p450 family 2 subfamily d member 6
11868,irbesartan,sebaceous adenoma,phosphodiesterase 6b
11869,amlodipine,"dermatitis, atopic",low density lipoprotein receptor
11870,ceritinib,oral mucosa leukoplakia,homeodomain interacting protein kinase 1
11871,buprenorphine,familial dermatographia,metallothionein 1a
11872,neostigmine,hypotensive disorder,glutathione-disulfide reductase
11873,cladribine,constipation disorder,glucose-6-phosphate dehydrogenase
11874,alclometasone dipropionate,vitiligo,prune exopolyphosphatase 1
11875,anagrelide,cycloplegia,eph receptor b2
11876,bezafibrate,respiratory failure,tubulin beta 4b class ivb
11877,imiquimod,endometrium neoplasm,isoleucyl-trna synthetase 1
11878,probenecid,hairy cell leukemia,glutamate ionotropic receptor kainate type subunit 2
11879,theophylline,disseminated intravascular coagulation,fibroblast growth factor receptor 1
11880,reboxetine,endometritis,sonic hedgehog signaling molecule
11881,methoxamine,hepatic veno-occlusive disease,ornithine transcarbamylase
11882,azelnidipine,tension-type headache,interleukin 1 receptor associated kinase 1
11883,ketorolac,gout,tyrosinase
11884,mianserin,relapsing-remitting multiple sclerosis,mitogen-activated protein kinase kinase kinase 7
11885,dicyclomine,premature obstetric labor,5-hydroxytryptamine receptor 3a
11886,pirenzepine,hypercholesterolemia,vascular cell adhesion molecule 1
11887,darifenacin,prinzmetal angina,gamma-aminobutyric acid type b receptor subunit 2
11888,methyl salicylate,diabetes mellitus,cytochrome p450 family 2 subfamily j member 2
11889,tramadol,acquired polycythemia vera,phosphodiesterase 1a
11890,glimepiride,ankylosing spondylitis,adrenoceptor alpha 2b
11891,ipragliflozin,streptococcal meningitis,serpin family e member 1
11892,alendronate,thrombotic disease,kinase insert domain receptor
11893,flurazepam,cardiac arrest,myeloperoxidase
11894,azatadine,acute intermittent porphyria,paraoxonase 1
11895,pasireotide,plasmodium malariae malaria,serpin family a member 6
11896,valproic acid,crohn disease,cytochrome p450 family 2 subfamily c member 8
11897,etizolam,hot flashes,fibroblast growth factor receptor 1
11898,nizatidine,acute monocytic leukemia,atp binding cassette subfamily g member 8
11899,isradipine,localized scleroderma,prostaglandin e receptor 2
11900,carbidopa,pyelonephritis,retinoid x receptor beta
11901,sunitinib,alcohol abuse,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
11902,vortioxetine,renal cell carcinoma,metabolism of cobalamin associated a
11903,protriptyline,plasmodium falciparum malaria,calcium voltage-gated channel subunit alpha1 h
11904,chlorhexidine,opiate dependence,somatostatin receptor 1
11905,naratriptan,abdominal infection,misshapen like kinase 1
11906,tadalafil,bacterial endocarditis,potassium voltage-gated channel modifier subfamily s member 1
11907,flufenamic acid,miliary tuberculosis,protein tyrosine kinase 2 beta
11908,lofepramine,laryngeal edema,acyl-coa dehydrogenase short/branched chain
11909,goserelin,hypotensive disorder,solute carrier family 12 member 2
11910,penicillamine,toxic shock syndrome,potassium calcium-activated channel subfamily m alpha 1
11911,methixene,gaucher disease,sonic hedgehog signaling molecule
11912,ranitidine,bone osteosarcoma,protein kinase cgmp-dependent 1
11913,nafarelin,asthma,glucose-6-phosphate dehydrogenase
11914,levomilnacipran,nutritional biotin deficiency,prostaglandin-endoperoxide synthase 1
11915,thiopental,"chronic myelogenous leukemia, bcr-abl1 positive",aldehyde dehydrogenase 2 family member
11916,fludrocortisone,respiratory failure,guanylate cyclase 1 soluble subunit beta 1
11917,nabumetone,obsessive-compulsive disorder,adrenoceptor alpha 1a
11918,felbamate,uveitis,cholinergic receptor muscarinic 3
11919,pergolide,vascular headaches,angiotensin ii receptor type 1
11920,pexidartinib,gastric ulcer,solute carrier family 5 member 1
11921,buspirone,hot flashes,glucagon receptor
11922,loteprednol etabonate,scabies,bmx non-receptor tyrosine kinase
11923,pirfenidone,gestational trophoblastic neoplasm,solute carrier family 12 member 2
11924,prazosin,heart failure,sodium voltage-gated channel alpha subunit 2
11925,eflornithine,hyponatremia,glutamate ionotropic receptor nmda type subunit 3b
11926,lenvatinib,postpartum depression,proteasome 20s subunit beta 5
11927,diclofenamide,attrv122i amyloidosis,aldo-keto reductase family 1 member c3
11928,fenoprofen,pulmonary emphysema,glutamate ionotropic receptor kainate type subunit 4
11929,sermorelin,rheumatic heart disease,c-x-c motif chemokine ligand 8
11930,pexidartinib,thyroid gland carcinoma,ndufa4 mitochondrial complex associated like 2
11931,tofacitinib,pulmonary embolism,fatty acid binding protein 2
11932,nafarelin,autoimmune hemolytic anemia,h1.0 linker histone
11933,chlorpheniramine,breast ductal adenocarcinoma,metallothionein 1a
11934,avanafil,erdheim-chester disease,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
11935,dimenhydrinate,chronic hepatitis c virus infection,arginine vasopressin receptor 2
11936,carboplatin,chronic myelomonocytic leukemia,endothelin receptor type a
11937,penbutolol,small cell lung carcinoma,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
11938,camphor,gastric ulcer,vitamin d receptor
11939,lifitegrast,aggressive systemic mastocytosis,potassium voltage-gated channel modifier subfamily s member 1
11940,diphenylpyraline,tourette syndrome,interleukin 6 receptor
11941,trilostane,rickets,calcium voltage-gated channel subunit alpha1 a
11942,estradiol valerate,psychologic dyspareunia,janus kinase 2
11943,pirfenidone,adrenocortical insufficiency,potassium voltage-gated channel subfamily c member 4
11944,diphenidol,attrv122i amyloidosis,coagulation factor ii thrombin receptor
11945,aclidinium,hereditary angioedema,uridine monophosphate synthetase
11946,gemfibrozil,myocardial infarction,phosphodiesterase 3b
11947,ofloxacin,meningococcal meningitis,potassium voltage-gated channel subfamily d member 1
11948,ketamine,thrombophilia due to thrombin defect,phosphodiesterase 8b
11949,somatrem,psychosexual disorder,opioid receptor delta 1
11950,imipramine,vitamin d deficiency,fms related receptor tyrosine kinase 4
11951,bumetanide,lung disorder,somatostatin receptor 1
11952,cefalotin,hypertriglyceridemia,somatostatin receptor 1
11953,cortisol,oppositional defiant disorder,myristoylated alanine rich protein kinase c substrate
11954,voclosporin,arteriosclerosis disorder,estrogen related receptor beta
11955,calcium acetate,iridocyclitis,glutamate ionotropic receptor nmda type subunit 3b
11956,iloprost,dyschromatosis universalis hereditaria,cdc like kinase 2
11957,phenacemide,iritis,neurotrophic receptor tyrosine kinase 1
11958,chlorambucil,diffuse large b-cell lymphoma,cholinergic receptor muscarinic 3
11959,carbidopa,chronic urticaria,death associated protein kinase 2
11960,alogliptin,wilms tumor,gamma-aminobutyric acid type a receptor subunit alpha6
11961,fenfluramine,gastroesophageal reflux disease,cholinergic receptor nicotinic alpha 7 subunit
11962,orciprenaline,myotonic syndrome,gamma-aminobutyric acid type a receptor subunit alpha6
11963,calcium acetate,pulmonary artery stenosis,histamine receptor h2
11964,loteprednol etabonate,thyroid gland follicular carcinoma,catechol-o-methyltransferase
11965,dopamine,alcohol dependence,c-c motif chemokine receptor 1
11966,valbenazine,mantle cell lymphoma,metallothionein 2a
11967,captodiame,trigeminal neuralgia,4-hydroxyphenylpyruvate dioxygenase
11968,nitroglycerin,langerhans cell histiocytosis,rho associated coiled-coil containing protein kinase 1
11969,isoprenaline,west syndrome,eukaryotic translation initiation factor 4e
11970,orlistat,visual epilepsy,cannabinoid receptor 2
11971,pimavanserin,myasthenia gravis,mapk interacting serine/threonine kinase 2
11972,paramethadione,scalp dermatosis,bmp2 inducible kinase
11973,tofacitinib,delayed puberty,adrenoceptor alpha 1a
11974,oxymetholone,chronic urticaria,opioid related nociceptin receptor 1
11975,doxylamine,pheochromocytoma,7-dehydrocholesterol reductase
11976,hydroxyzine,bronchitis,glutathione s-transferase pi 1
11977,empagliflozin,familial mediterranean fever,alk receptor tyrosine kinase
11978,rabeprazole,insomnia,solute carrier family 25 member 5
11979,cilostazol,brain edema,5-methyltetrahydrofolate-homocysteine methyltransferase
11980,losartan,psychotic disorder,tubulin beta 2b class iib
11981,oxymetazoline,breast ductal adenocarcinoma,prostaglandin e synthase 3
11982,ubidecarenone,non-hodgkin lymphoma,alpha glucosidase
11983,fluticasone,premature ejaculation,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
11984,fenfluramine,oral candidiasis,holocarboxylase synthetase
11985,acarbose,myxedema,erb-b2 receptor tyrosine kinase 2
11986,eszopiclone,psychotic disorder,g protein-coupled receptor 35
11987,tenoxicam,breast ductal adenocarcinoma,peptidylprolyl isomerase a
11988,clonidine,psychologic dyspareunia,serine/threonine kinase 17a
11989,plerixafor,psoriatic arthritis,interleukin 2
11990,dimenhydrinate,potassium deficiency disease,cathepsin g
11991,pimavanserin,delayed puberty,interleukin 11 receptor subunit alpha
11992,silodosin,breast carcinoma,phosphodiesterase 6d
11993,caffeine,liposarcoma,cytochrome p450 family 1 subfamily a member 1
11994,isopropamide,tetany,udp-glucose ceramide glucosyltransferase
11995,zolpidem,autoimmune hemolytic anemia,glucose-6-phosphate dehydrogenase
11996,trimetaphan,orthostatic hypotension,phosphodiesterase 7a
11997,baclofen,pneumonia,5-hydroxytryptamine receptor 1a
11998,nilotinib,polyuria,ebp like
11999,cisapride,ovarian epithelial tumor,cholinergic receptor nicotinic beta 3 subunit
12000,dimethyl fumarate,short bowel syndrome,oxytocin receptor
12001,alpha-methyltyrosine,lichen planus,thymidine phosphorylase
12002,sildenafil,liver cancer,phosphodiesterase 6b
12003,labetalol,renal cell carcinoma,parathyroid hormone 1 receptor
12004,colestipol,absence epilepsy,"abl proto-oncogene 2, non-receptor tyrosine kinase"
12005,capecitabine,"leukemia, myeloid, chronic-phase",dopamine beta-hydroxylase
12006,vemurafenib,rhinitis,potassium voltage-gated channel subfamily b member 1
12007,glimepiride,sickle cell anemia,cholinergic receptor nicotinic alpha 2 subunit
12008,tolterodine,hyperbilirubinemia,protein phosphatase 3 catalytic subunit alpha
12009,albiglutide,influenza,bub1 mitotic checkpoint serine/threonine kinase
12010,methylphenidate,vitamin b12 deficiency,myosin light chain kinase
12011,homatropine methylbromide,hyperthyroidism,unc-51 like autophagy activating kinase 1
12012,nebivolol,sarcoidosis,protein kinase n1
12013,vorapaxar,classic phenylketonuria,"raf-1 proto-oncogene, serine/threonine kinase"
12014,acetophenazine,hypertrichosis of eyelid,tubulin alpha 1a
12015,carbimazole,atopic eczema,phosphodiesterase 4c
12016,calcipotriol,raynaud disease,gamma-aminobutyric acid type a receptor subunit beta3
12017,terguride,cutaneous candidiasis,purinergic receptor p2y12
12018,ethynodiol diacetate,aspiration pneumonia,cathepsin g
12019,diazepam,postherpetic neuralgia,gonadotropin releasing hormone receptor
12020,nicotine,arthralgia,glutathione s-transferase mu 1
12021,dimethyl fumarate,thrombophilia due to thrombin defect,fatty acid amide hydrolase
12022,nilotinib,systemic mastocytosis,arginine vasopressin receptor 2
12023,cilastatin,escherichia coli infection,solute carrier family 22 member 8
12024,proguanil,endemic goiter,atpase h+/k+ transporting subunit alpha
12025,lumiracoxib,malignant hyperthermia of anesthesia,gamma-aminobutyric acid type a receptor subunit gamma1
12026,selegiline,lewy body dementia,tubulin alpha 1a
12027,dezocine,noonan syndrome,protein kinase cgmp-dependent 1
12028,bendroflumethiazide,neoplasm of esophagus,neurotensin receptor 2
12029,saquinavir,acute interstitial pneumonia,calmodulin 2
12030,fenoprofen,sebaceous adenoma,solute carrier family 6 member 1
12031,gemfibrozil,dyspepsia,glutamate ionotropic receptor ampa type subunit 3
12032,benzquinamide,discoid lupus erythematosus,cytochrome p450 family 2 subfamily c member 8
12033,lenvatinib,eunuchism,cytochrome p450 family 2 subfamily e member 1
12034,riboflavin,tetralogy of fallot,parathyroid hormone 1 receptor
12035,sotalol,ulcerative colitis,ndufa4 mitochondrial complex associated like 2
12036,perampanel,chronic pain,solute carrier family 19 member 1
12037,glimepiride,bipolar depression,methylmalonyl-coa mutase
12038,triamcinolone,schizoaffective disorder,5-hydroxytryptamine receptor 3d
12039,estramustine,noonan syndrome,gamma-aminobutyric acid type a receptor subunit alpha1
12040,butalbital,psoriasis,tank binding kinase 1
12041,thyrotropin alfa,testicular cancer,phosphoribosyl pyrophosphate amidotransferase
12042,procyclidine,enterobiasis,glutamate ionotropic receptor kainate type subunit 1
12043,pexidartinib,allergic rhinitis,fms related receptor tyrosine kinase 4
12044,polythiazide,classic hodgkin lymphoma,tachykinin precursor 1
12045,colchicine,depressive disorder,calcium voltage-gated channel auxiliary subunit alpha2delta 2
12046,paracetamol,lung lymphangioleiomyomatosis,cytochrome p450 family 27 subfamily b member 1
12047,brinzolamide,cough,cytochrome p450 family 1 subfamily b member 1
12048,ziconotide,prader-willi syndrome,atm serine/threonine kinase
12049,pargyline,chronic myelomonocytic leukemia,solute carrier family 22 member 4
12050,atorvastatin,seasonal allergic rhinitis,5-hydroxytryptamine receptor 4
12051,pregabalin,anterior uveitis,leukotriene a4 hydrolase
12052,cimetidine,alzheimer disease,bcl2 apoptosis regulator
12053,reserpine,systemic lupus erythematosus,potassium voltage-gated channel subfamily q member 4
12054,midazolam,rhabdomyosarcoma,amnion associated transmembrane protein
12055,bortezomib,anxiety,dna polymerase beta
12056,apomorphine,acute gonococcal cervicitis,fkbp prolyl isomerase 5
12057,prednicarbate,common wart,atpase na+/k+ transporting subunit alpha 1
12058,trazodone,gastroesophageal reflux disease,plasminogen
12059,metolazone,esotropia,cyclin dependent kinase 8
12060,oxaliplatin,allergic rhinitis,glutamate ionotropic receptor nmda type subunit 2d
12061,baricitinib,insomnia,cannabinoid receptor 1
12062,valdecoxib,nausea,phosphodiesterase 4a
12063,etelcalcetide,spasticity,casein kinase 1 delta
12064,quizartinib,huntington disease,serine/threonine kinase 25
12065,benzbromarone,acute lung injury,tek receptor tyrosine kinase
12066,lixisenatide,fabry disease,cytochrome p450 family 2 subfamily c member 19
12067,viloxazine,endometrium neoplasm,eph receptor b6
12068,tolazoline,tinea corporis,solute carrier family 18 member a1
12069,triamterene,streptococcal meningitis,cytochrome p450 family 2 subfamily a member 6
12070,stanozolol,rosacea,riboflavin kinase
12071,felbamate,esotropia,renin
12072,hydroflumethiazide,chronic bronchitis,prostaglandin i2 receptor
12073,chlophedianol,neuroblastoma,transforming growth factor beta receptor 2
12074,ziconotide,potassium deficiency disease,histone deacetylase 3
12075,gabapentin,malignant essential hypertension,bmp2 inducible kinase
12076,brigatinib,chronic kidney disease,mitogen-activated protein kinase kinase 1
12077,lidocaine,skin disorder,calcium voltage-gated channel subunit alpha1 f
12078,prochlorperazine,juvenile idiopathic arthritis,gonadotropin releasing hormone receptor
12079,mefenamic acid,ankylosing spondylitis,salt inducible kinase 1
12080,azacitidine,sjogren syndrome,gamma-aminobutyric acid type b receptor subunit 2
12081,bisoprolol,invasive ductal breast carcinoma,histone deacetylase 9
12082,imatinib,male infertility,phosphorylase kinase catalytic subunit gamma 2
12083,papaverine,psychologic dyspareunia,transthyretin
12084,conjugated estrogens,plasmodium ovale malaria,oxytocin receptor
12085,diphenhydramine,premature obstetric labor,tubulin beta class i
12086,chlorpromazine,bacterial conjunctivitis,tubulin epsilon 1
12087,tioconazole,sarcoidosis,transthyretin
12088,triprolidine,oligospermia,proteasome 20s subunit beta 2
12089,cetirizine,sickle cell anemia,5-hydroxytryptamine receptor 2c
12090,oxazepam,peripheral vascular disease,aurora kinase c
12091,bosentan,periodontitis,calmodulin 1
12092,fomepizole,cerebrovascular disorder,"ran, member ras oncogene family"
12093,plerixafor,autoimmune disease,cdgsh iron sulfur domain 1
12094,famotidine,myasthenia gravis,cyclin dependent kinase 6
12095,cisplatin,pityriasis versicolor,phospholipase a2 group iie
12096,brexpiprazole,potassium deficiency disease,cytochrome p450 family 51 subfamily a member 1
12097,proguanil,idiopathic hypereosinophilic syndrome,ribosomal protein s6 kinase a5
12098,prednisone,pharyngitis,somatostatin receptor 1
12099,ethotoin,plasma cell myeloma,monoamine oxidase a
12100,zonisamide,sympathetic ophthalmia,n-acetyltransferase 2
12101,dicyclomine,pulmonary fibrosis,cannabinoid receptor 2
12102,betaxolol,hyperlipidemia,c-x-c motif chemokine ligand 8
12103,nebivolol,allergic urticaria,calcium voltage-gated channel subunit alpha1 c
12104,benzbromarone,aspiration pneumonia,"smoothened, frizzled class receptor"
12105,sertaconazole,sneeze,angiotensin ii receptor type 2
12106,oxymetholone,erdheim-chester disease,"abl proto-oncogene 2, non-receptor tyrosine kinase"
12107,fludarabine,meningococcal meningitis,platelet derived growth factor receptor alpha
12108,candesartan,bursitis,fms related receptor tyrosine kinase 3
12109,probenecid,tenosynovial giant cell tumor,arginine vasopressin receptor 2
12110,citalopram,small intestine cancer,fer tyrosine kinase
12111,loxoprofen,torsades de pointes,glutamate ionotropic receptor kainate type subunit 2
12112,lusutrombopag,altitude sickness,5-hydroxytryptamine receptor 3e
12113,guanfacine,pancreatic adenocarcinoma,bruton tyrosine kinase
12114,icatibant,osteoarthritis,gamma-aminobutyric acid type a receptor subunit alpha4
12115,hydroxocobalamin,amyotrophic lateral sclerosis,methylenetetrahydrofolate reductase
12116,alectinib,urticaria,cholinergic receptor muscarinic 5
12117,olmutinib,liposarcoma,txk tyrosine kinase
12118,tetracycline,early myoclonic encephalopathy,rho associated coiled-coil containing protein kinase 2
12119,l-glutamine,cryptorchidism,leukotriene a4 hydrolase
12120,droxidopa,pediculus humanus capitis infestation,rio kinase 1
12121,ketoprofen,chronic kidney disease,solute carrier family 22 member 5
12122,mesuximide,short bowel syndrome,prostaglandin-endoperoxide synthase 2
12123,olmutinib,toothache,oxytocin receptor
12124,methamphetamine,sarcoidosis,mitogen-activated protein kinase kinase kinase 19
12125,letrozole,pemphigus,alpha glucosidase
12126,n-methyl scopolamine,nephrotic syndrome,proteasome 20s subunit alpha 1
12127,promazine,marginal zone lymphoma,erb-b2 receptor tyrosine kinase 2
12128,anakinra,aorta coarctation,acetyl-coa acetyltransferase 1
12129,bromodiphenhydramine,ocular hypertension,transient receptor potential cation channel subfamily v member 1
12130,estrone,allergic bronchopulmonary aspergillosis,sucrase-isomaltase
12131,proguanil,myeloid neoplasm associated with pdgfra rearrangement,potassium voltage-gated channel modifier subfamily g member 3
12132,floctafenine,premature obstetric labor,atpase na+/k+ transporting subunit alpha 2
12133,esmolol,poisoning of animals with phosphate salts,glutathione s-transferase pi 1
12134,eszopiclone,hyperbilirubinemia,alpha glucosidase
12135,darifenacin,male infertility,dead-box helicase 1
12136,miconazole,autoimmune hemolytic anemia,atp binding cassette subfamily c member 3
12137,tapentadol,chronic primary adrenal insufficiency,follicle stimulating hormone receptor
12138,eprosartan,adrenal gland hyperfunction,cereblon
12139,losartan,angina pectoris,gamma-aminobutyric acid type a receptor subunit pi
12140,incadronic acid,postoperative nausea and vomiting,potassium voltage-gated channel subfamily q member 2
12141,dexmethylphenidate,rhabdomyosarcoma,5-hydroxytryptamine receptor 5a
12142,metoprolol,"malignant hyperthermia, susceptibility to, 1",5-hydroxytryptamine receptor 7
12143,fingolimod,pellagra,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
12144,eldecalcitol,cardiac arrest,phosphodiesterase 11a
12145,pargyline,gastroesophageal reflux disease,prostaglandin-endoperoxide synthase 2
12146,rosuvastatin,mycosis fungoides,solute carrier family 22 member 6
12147,cariprazine,leprosy,potassium inwardly rectifying channel subfamily j member 1
12148,famotidine,frozen shoulder,low density lipoprotein receptor
12149,lamotrigine,biotinidase deficiency,potassium voltage-gated channel subfamily a member 3
12150,sofalcone,thyroid tumor,tubulin beta 3 class iii
12151,clonazepam,hypocalcemia,estrogen related receptor alpha
12152,amcinonide,west syndrome,fibroblast growth factor receptor 3
12153,fondaparinux,hemangioma,steroid 5 alpha-reductase 1
12154,naltrexone,bronchitis,sodium voltage-gated channel alpha subunit 10
12155,phenmetrazine,burkitt lymphoma,"tu translation elongation factor, mitochondrial"
12156,miconazole,idiopathic hypereosinophilic syndrome,"glucosidase alpha, neutral c"
12157,apraclonidine,thrombotic disease,phenylalanine hydroxylase
12158,isopropamide,gestational trophoblastic neoplasm,"kras proto-oncogene, gtpase"
12159,estradiol valerate,bipolar depression,sphingomyelin phosphodiesterase 1
12160,nortriptyline,lichen planus,thymidylate synthetase
12161,lercanidipine,"leukemia, myeloid, chronic-phase",steroid 5 alpha-reductase 1
12162,heparin,toothache,progesterone receptor
12163,duloxetine,polyuria,cyclin dependent kinase 8
12164,fondaparinux,tachycardia,dna methyltransferase 3 alpha
12165,ifosfamide,turner syndrome,prostaglandin e synthase 3
12166,cetuximab,tardive dyskinesia,5-hydroxytryptamine receptor 4
12167,tafluprost,xerophthalmia,cholinergic receptor nicotinic beta 4 subunit
12168,lasofoxifene,respiratory syncytial virus infectious disease,cytochrome p450 family 19 subfamily a member 1
12169,dextromethorphan,thyroid gland carcinoma,potassium voltage-gated channel subfamily a member 6
12170,romidepsin,prinzmetal angina,potassium inwardly rectifying channel subfamily j member 1
12171,trimethadione,atrioventricular block,peroxisome proliferator activated receptor gamma
12172,limaprost,obesity disorder,cyclin g associated kinase
12173,indapamide,humoral hypercalcemia of malignancy,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
12174,camphor,"leukemia, myeloid, chronic-phase",sodium voltage-gated channel alpha subunit 4
12175,sonidegib,poems syndrome,lipoprotein lipase
12176,edoxaban,autism spectrum disorder,tumor protein p53
12177,nicardipine,polycystic ovary syndrome,cysteinyl leukotriene receptor 2
12178,dexmethylphenidate,irritable bowel syndrome,thymidylate synthetase
12179,nitric oxide,hypersensitivity pneumonitis,casein kinase 1 delta
12180,papaverine,holocarboxylase synthetase deficiency,"pim-2 proto-oncogene, serine/threonine kinase"
12181,fsh,chronic pain,death associated protein kinase 3
12182,calcium gluconate,allergic contact dermatitis,cobalamin binding intrinsic factor
12183,dapoxetine,major depressive disorder,sphingosine-1-phosphate receptor 3
12184,insulin aspart,vascular disorder,n-acylsphingosine amidohydrolase 1
12185,homatropine methylbromide,anaphylaxis,"jun proto-oncogene, ap-1 transcription factor subunit"
12186,citalopram,idiopathic hypereosinophilic syndrome,cart prepropeptide
12187,buprenorphine,hyperthyroidism,acetyl-coa acyltransferase 2
12188,reboxetine,insomnia,ste20 like kinase
12189,olmesartan,epicondylitis,opioid receptor mu 1
12190,nitisinone,anterior uveitis,tubulin beta 4b class ivb
12191,vildagliptin,seborrheic dermatitis,salt inducible kinase 1
12192,radotinib,asthma,5-hydroxytryptamine receptor 5a
12193,tacrolimus,malignant essential hypertension,atp binding cassette subfamily c member 2
12194,mirtazapine,autism spectrum disorder,fkbp prolyl isomerase 1a
12195,tolazamide,nutritional biotin deficiency,insulin receptor related receptor
12196,oxaprozin,bronchial disorder,potassium voltage-gated channel subfamily q member 2
12197,flutamide,delirium,transient receptor potential cation channel subfamily v member 4
12198,limaprost,tetany,propionyl-coa carboxylase subunit alpha
12199,cycrimine,common cold,phosphorylase kinase catalytic subunit gamma 2
12200,prucalopride,malignant colon neoplasm,structural maintenance of chromosomes 2
12201,enalaprilat,pellagra,trace amine associated receptor 1
12202,rivastigmine,holocarboxylase synthetase deficiency,sodium voltage-gated channel alpha subunit 7
12203,trimethadione,graves disease,kallikrein b1
12204,caffeine,eosinophilic pneumonia,"b-raf proto-oncogene, serine/threonine kinase"
12205,clonazepam,pruritus ani,electron transfer flavoprotein dehydrogenase
12206,galantamine,asthma-chronic obstructive pulmonary disease overlap syndrome,"dna polymerase delta 1, catalytic subunit"
12207,l-citrulline,ornithine carbamoyltransferase deficiency,neuropeptide y receptor y1
12208,pentobarbitone,"malignant hyperthermia, susceptibility to, 1",bmp2 inducible kinase
12209,luseogliflozin,rosacea,kallikrein b1
12210,paliperidone,insomnia,dipeptidyl peptidase 8
12211,teriflunomide,"dermatitis, atopic",solute carrier organic anion transporter family member 1a2
12212,ezetimibe,oligospermia,mitogen-activated protein kinase kinase kinase kinase 1
12213,salsalate,adrenocortical insufficiency,g protein-coupled receptor 35
12214,nitrazepam,amyloidosis,platelet derived growth factor receptor beta
12215,solifenacin,aspiration pneumonitis,sodium channel epithelial 1 subunit beta
12216,pargyline,human african trypanosomiasis,solute carrier organic anion transporter family member 4a1
12217,delavirdine,pancreatic insulinoma,ornithine decarboxylase 1
12218,dromostanolone propionate,noonan syndrome,potassium voltage-gated channel subfamily a member 7
12219,tolbutamide,colonic neoplasm,superoxide dismutase 1
12220,lorazepam,homocystinuria,udp glucuronosyltransferase family 1 member a1
12221,sunitinib,patent ductus arteriosus,maternal embryonic leucine zipper kinase
12222,abacavir,hyperprolactinemia,hydroxycarboxylic acid receptor 3
12223,dopamine,holocarboxylase synthetase deficiency,atp binding cassette subfamily g member 8
12224,dobutamine,dyschromatosis universalis hereditaria,cytochrome p450 family 11 subfamily b member 1
12225,trandolapril,"malignant hyperthermia, susceptibility to, 1","major histocompatibility complex, class i, a"
12226,teriflunomide,plasmodium malariae malaria,superoxide dismutase 1
12227,reboxetine,impetigo,acyl-coa oxidase 1
12228,tamsulosin,sickle cell anemia,atp binding cassette subfamily b member 1
12229,irbesartan,polycystic ovary syndrome,sirtuin 1
12230,trichlormethiazide,miliary tuberculosis,transthyretin
12231,phenmetrazine,castleman disease,"jun proto-oncogene, ap-1 transcription factor subunit"
12232,saxagliptin,hypertrophic cardiomyopathy,casein kinase 1 delta
12233,letrozole,neoplasm of esophagus,angiotensin i converting enzyme
12234,glisoxepide,turner syndrome,plasminogen
12235,pirfenidone,pulmonary eosinophilia,gamma-aminobutyric acid type a receptor subunit theta
12236,pemetrexed,ascites,acetyl-coa acetyltransferase 1
12237,nintedanib,esophageal cancer,potassium voltage-gated channel subfamily b member 2
12238,nefazodone,cycloplegia,matrix metallopeptidase 2
12239,nebivolol,malignant essential hypertension,follicle stimulating hormone receptor
12240,carbachol,tardive dyskinesia,discoidin domain receptor tyrosine kinase 2
12241,phendimetrazine,cough,solute carrier family 25 member 6
12242,reproterol,pulmonary embolism,gamma-aminobutyric acid type a receptor subunit beta3
12243,isotretinoin,cryopyrin-associated periodic syndrome,vascular endothelial growth factor a
12244,desvenlafaxine,menorrhagia,cholinergic receptor muscarinic 1
12245,rimonabant,fibromyalgia,eph receptor b6
12246,azelaic acid,oligospermia,interleukin 11 receptor subunit alpha
12247,chlorambucil,osteomalacia,hydroxycarboxylic acid receptor 3
12248,colestipol,aggressive systemic mastocytosis,5-hydroxytryptamine receptor 6
12249,triamcinolone,hemorrhoid,paraoxonase 1
12250,tolterodine,relapsing-remitting multiple sclerosis,atp binding cassette subfamily g member 5
12251,ciprofloxacin,endometrial carcinoma,dopamine beta-hydroxylase
12252,aminobenzoic acid,premature ventricular contraction,il2 inducible t cell kinase
12253,minoxidil,diabetes mellitus,dna topoisomerase ii beta
12254,balsalazide,endometritis,h1.0 linker histone
12255,umeclidinium,"cicatrix, hypertrophic",phenylalanine hydroxylase
12256,aceclofenac,tetralogy of fallot,ryanodine receptor 2
12257,histrelin,pulmonary eosinophilia,solute carrier family 47 member 2
12258,selexipag,skin basal cell carcinoma,prostaglandin i2 receptor
12259,bortezomib,gastric neoplasm,cytochrome p450 family 21 subfamily a member 2
12260,chlorthalidone,hypoglycemia,tyrosinase
12261,diltiazem,skin basal cell carcinoma,sodium voltage-gated channel alpha subunit 4
12262,fludarabine,primary cutaneous t-cell non-hodgkin lymphoma,calcium voltage-gated channel auxiliary subunit beta 2
12263,sulpiride,gonorrhea,cytochrome c1
12264,saquinavir,exanthem,epidermal growth factor receptor
12265,glipizide,plasmodium vivax malaria,cholinergic receptor nicotinic alpha 3 subunit
12266,reproterol,allergic rhinitis,cannabinoid receptor 1
12267,diphenhydramine,holocarboxylase synthetase deficiency,dopamine beta-hydroxylase
12268,fenfluramine,punctate epithelial keratoconjunctivitis,phosphodiesterase 4d
12269,azelastine,rhabdomyosarcoma,5-hydroxytryptamine receptor 1f
12270,bunazosin,medullary thyroid gland carcinoma,uridine monophosphate synthetase
12271,vorapaxar,persistent fetal circulation syndrome,purinergic receptor p2y12
12272,papaverine,pancreatic adenocarcinoma,cytochrome p450 family 17 subfamily a member 1
12273,pethidine,hypersensitivity pneumonitis,kallikrein b1
12274,aspirin,urticaria,atpase h+/k+ transporting subunit beta
12275,anagliptin,miliary tuberculosis,aldehyde dehydrogenase 5 family member a1
12276,triiodothyronine,rheumatoid arthritis,dead-box helicase 1
12277,topiramate,aorta coarctation,glutamic-oxaloacetic transaminase 1
12278,nadolol,lichen planus,histone deacetylase 5
12279,warfarin,opiate dependence,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
12280,bumetanide,anogenital human papillomavirus infection,parathyroid hormone 1 receptor
12281,methylergonovine,hypertriglyceridemia,cholinergic receptor nicotinic alpha 2 subunit
12282,trihexyphenidyl,restless legs syndrome,glutamate ionotropic receptor ampa type subunit 2
12283,bumetanide,"malignant hyperthermia, susceptibility to, 1",atp binding cassette subfamily g member 5
12284,pge1,primary ovarian failure,ndufa4 mitochondrial complex associated
12285,cabergoline,chronic urticaria,dna topoisomerase ii beta
12286,duloxetine,constipation disorder,adrenoceptor alpha 2b
12287,lasofoxifene,interstitial lung disease 2,uridine monophosphate synthetase
12288,pralatrexate,premenstrual dysphoric disorder,gonadotropin releasing hormone receptor
12289,diflorasone diacetate,hypoactive sexual desire disorder,xanthine dehydrogenase
12290,morphine,hypoalphalipoproteinemia,toll like receptor 4
12291,levorphanol,propionic acidemia,gamma-aminobutyric acid type a receptor subunit alpha2
12292,ticagrelor,malignant hyperthermia of anesthesia,cd33 molecule
12293,medrysone,pruritus ani,tubulin beta 6 class v
12294,amitriptyline,diabetes mellitus,coagulation factor ii thrombin receptor
12295,amlodipine,escherichia coli infection,cytochrome p450 family 3 subfamily a member 5
12296,alfuzosin,hypertriglyceridemia,mitogen-activated protein kinase kinase kinase 19
12297,carbinoxamine,respiratory syncytial virus infectious disease,rho associated coiled-coil containing protein kinase 1
12298,homatropine methylbromide,skin basal cell carcinoma,bone morphogenetic protein receptor type 1b
12299,almotriptan,neurofibromatosis 1,mapk interacting serine/threonine kinase 2
12300,zopiclone,vascular headaches,ribonucleotide reductase regulatory subunit m2
12301,ixazomib,sitosterolemia,metallothionein 1a
12302,bimatoprost,dermatophytosis of groin and perianal area,tubulin alpha 4a
12303,brigatinib,bruxism,glutamate ionotropic receptor nmda type subunit 2b
12304,clemastine,invasive ductal breast carcinoma,unc-51 like autophagy activating kinase 1
12305,cetuximab,endometrial carcinoma,transforming growth factor beta receptor 2
12306,mephentermine,glioma,progesterone receptor
12307,methylprednisolone,tetralogy of fallot,4-hydroxyphenylpyruvate dioxygenase
12308,promethazine,erectile dysfunction,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
12309,glibenclamide,hypercholesterolemia,arginine vasopressin receptor 2
12310,thioguanine,allergic asthma,gamma-glutamyl carboxylase
12311,digoxin,colonic neoplasm,proteasome 20s subunit beta 8
12312,flurazepam,chronic beryllium disease,histamine receptor h3
12313,sirolimus,diffuse large b-cell lymphoma,gamma-aminobutyric acid type a receptor subunit gamma2
12314,albiglutide,pyoderma gangrenosum,atp binding cassette subfamily b member 11
12315,sertaconazole,schizoaffective disorder,riboflavin kinase
12316,ifosfamide,hypophosphatemia,potassium voltage-gated channel modifier subfamily s member 2
12317,midodrine,acquired polycythemia vera,potassium voltage-gated channel subfamily q member 2
12318,enalaprilat,pulmonary emphysema,adrenoceptor alpha 2a
12319,eliglustat,vitiligo,serpin family a member 6
12320,brompheniramine,arthralgia,cytochrome p450 family 11 subfamily b member 2
12321,ripasudil,intrinsic asthma,potassium voltage-gated channel subfamily c member 3
12322,eldecalcitol,asthma,sphingosine-1-phosphate receptor 4
12323,polmacoxib,turner syndrome,apolipoprotein a1
12324,valsartan,ovarian epithelial tumor,plasminogen
12325,beclometasone,hyperprolactinemia,hypoxanthine phosphoribosyltransferase 1
12326,ceritinib,peyronie disease,delta like non-canonical notch ligand 1
12327,balsalazide,generalized anxiety disorder,5-hydroxytryptamine receptor 6
12328,carbimazole,pituitary dwarfism,homeodomain interacting protein kinase 2
12329,digoxin,diffuse large b-cell lymphoma,potassium voltage-gated channel subfamily d member 2
12330,bosutinib,short bowel syndrome,fkbp prolyl isomerase 1a
12331,ripasudil,major depressive disorder,leukotriene b4 receptor
12332,etizolam,bursitis,propionyl-coa carboxylase subunit beta
12333,sertraline,synovitis,h1.0 linker histone
12334,thalidomide,sarcoidosis,homeodomain interacting protein kinase 2
12335,dextromethorphan,postpartum depression,peptidylprolyl isomerase d
12336,baricitinib,postoperative nausea and vomiting,solute carrier family 19 member 1
12337,rosuvastatin,essential hypertension,"hck proto-oncogene, src family tyrosine kinase"
12338,histamine,precocious puberty,potassium voltage-gated channel modifier subfamily v member 1
12339,befunolol,systemic lupus erythematosus,adrenoceptor alpha 1a
12340,ergotamine,headache disorder,microtubule associated protein 2
12341,nizatidine,discoid lupus erythematosus,protein kinase n1
12342,nedocromil,tetany,potassium voltage-gated channel subfamily d member 2
12343,azatadine,restless legs syndrome,farnesyl diphosphate synthase
12344,hydralazine,scabies,atp binding cassette subfamily a member 1
12345,donepezil,constipation disorder,carbonic anhydrase 1
12346,pamidronic acid,hyperglycemia,fkbp prolyl isomerase 4
12347,linaclotide,langerhans cell histiocytosis,"kras proto-oncogene, gtpase"
12348,mesuximide,ulcerative colitis,adrenoceptor beta 2
12349,atomoxetine,systemic lupus erythematosus,adrenoceptor alpha 2c
12350,gemigliptin,renal osteodystrophy,atpase h+/k+ transporting subunit alpha
12351,olodaterol,vitiligo,s100 calcium binding protein b
12352,roxatidine acetate,neuroblastoma,dna polymerase beta
12353,desipramine,bone paget disease,phosphodiesterase 6b
12354,biotin,relapsing-remitting multiple sclerosis,sodium channel epithelial 1 subunit gamma
12355,cetirizine,erythropoietic protoporphyria,solute carrier organic anion transporter family member 1b3
12356,somatropin,aorta coarctation,hydroxycarboxylic acid receptor 3
12357,azatadine,leiomyosarcoma,interleukin 6 receptor
12358,dutasteride,pulmonary fibrosis,phosphodiesterase 6d
12359,pregabalin,pulmonary cystic fibrosis,prostaglandin e receptor 4
12360,naloxone,hypocalcemia,succinate dehydrogenase complex flavoprotein subunit a
12361,ergotamine,essential thrombocythemia,uridine monophosphate synthetase
12362,clofibrate,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",cholinergic receptor nicotinic beta 2 subunit
12363,ponatinib,hypertrichosis of eyelid,platelet activating factor receptor
12364,telmisartan,chronic beryllium disease,prostaglandin i2 receptor
12365,histamine,acute pain,neurotensin receptor 2
12366,acebutolol,sarcoma,checkpoint kinase 2
12367,incadronic acid,plasma cell myeloma,prune exopolyphosphatase 1
12368,tapentadol,secondary hyperparathyroidism,potassium voltage-gated channel subfamily q member 2
12369,dosulepin,non-hodgkin lymphoma,potassium inwardly rectifying channel subfamily j member 8
12370,pargyline,periodontitis,prostaglandin i2 receptor
12371,ritonavir,breast ductal adenocarcinoma,fms related receptor tyrosine kinase 1
12372,brinzolamide,acute lung injury,calcium voltage-gated channel subunit alpha1 d
12373,chlorthalidone,acute monocytic leukemia,"blk proto-oncogene, src family tyrosine kinase"
12374,pemirolast,allergic bronchopulmonary aspergillosis,chymotrypsinogen b1
12375,clofarabine,"dermatitis, atopic",myosin light chain kinase
12376,norfloxacin,propionic acidemia,dihydrofolate reductase
12377,somatrem,tinea pedis,potassium voltage-gated channel modifier subfamily g member 4
12378,chlorthalidone,lewy body dementia,atp binding cassette subfamily c member 8
12379,propranolol,dermatophytosis of groin and perianal area,microtubule associated protein 2
12380,isoprenaline,adrenogenital syndrome,"jun proto-oncogene, ap-1 transcription factor subunit"
12381,bitolterol,diffuse alopecia areata,cdc like kinase 2
12382,piribedil,psychosexual disorder,retinoid x receptor alpha
12383,vildagliptin,rheumatoid arthritis,n-acetyltransferase 2
12384,acetylmethadol,pulmonary cystic fibrosis,tumor protein p53
12385,aminosalicylic acid,actinic keratosis,glucagon like peptide 2 receptor
12386,bepotastine,primary myelofibrosis,potassium voltage-gated channel modifier subfamily v member 1
12387,zalcitabine,skin disorder,interleukin 2
12388,piretanide,urinary bladder cancer,phosphodiesterase 3b
12389,diphenhydramine,serum sickness,adenosine a2a receptor
12390,fluvoxamine,systemic lupus erythematosus,n-acylsphingosine amidohydrolase 1
12391,mianserin,serum sickness,serine/threonine kinase 10
12392,crotamiton,atrophic vulva,ribosomal protein s6 kinase a6
12393,lithium ion,postoperative nausea and vomiting,5-hydroxytryptamine receptor 4
12394,methotrexate,urge incontinence,gamma-aminobutyric acid type a receptor subunit alpha5
12395,antazoline,post-traumatic stress disorder,doublecortin like kinase 1
12396,thiothixene,chronic urticaria,mitogen-activated protein kinase kinase kinase 7
12397,lafutidine,nasal congestion,potassium voltage-gated channel modifier subfamily f member 1
12398,ibuprofen,propionic acidemia,renin
12399,acitretin,islet cell adenomatosis,caspase 1
12400,phytomenadione,rhabdomyosarcoma,cobalamin binding intrinsic factor
12401,escitalopram,hereditary angioedema,macrophage stimulating 1 receptor
12402,leuprolide,mycosis fungoides,cytochrome p450 family 2 subfamily c member 9
12403,treprostinil,restless legs syndrome,plasminogen
12404,budesonide,pellagra,fer tyrosine kinase
12405,vernakalant,nocturnal enuresis,interleukin 6 receptor
12406,rilmenidine,dysmenorrhea,mitogen-activated protein kinase kinase kinase 20
12407,naftopidil,intrinsic asthma,cytochrome p450 family 1 subfamily a member 1
12408,pargyline,breast carcinoma,sodium voltage-gated channel alpha subunit 8
12409,orphenadrine,corneal ulcer,myosin light chain kinase family member 4
12410,cefonicid,disseminated intravascular coagulation,cyclin dependent kinase 8
12411,reserpine,sjogren syndrome,interleukin 2
12412,dosulepin,gestational trophoblastic neoplasm,dead-box helicase 1
12413,mefenamic acid,acute pain,adrenoceptor beta 2
12414,etizolam,neurofibromatosis 1,dopa decarboxylase
12415,oxymetazoline,eosinophilic esophagitis,carnitine palmitoyltransferase 1a
12416,selexipag,stevens-johnson syndrome,tumor protein p53
12417,alclometasone dipropionate,autism spectrum disorder,structural maintenance of chromosomes 2
12418,eprosartan,chronic pain,leukocyte receptor tyrosine kinase
12419,desonide,neuroblastoma,glutamate ionotropic receptor ampa type subunit 3
12420,propantheline,urticaria,adrenoceptor beta 1
12421,dexmethylphenidate,tachycardia,carbonic anhydrase 12
12422,mitiglinide,chancroid,prostaglandin e receptor 2
12423,rimonabant,"chronic myelogenous leukemia, bcr-abl1 positive",metallothionein 1a
12424,vorinostat,cerebrovascular disorder,axl receptor tyrosine kinase
12425,saquinavir,anogenital human papillomavirus infection,peptidylprolyl isomerase b
12426,leuprolide,endemic goiter,aurora kinase c
12427,nefazodone,gastroesophageal reflux disease,bromodomain containing 4
12428,topotecan,disseminated intravascular coagulation,growth hormone receptor
12429,pilsicainide,psoriasis,fatty acid binding protein 2
12430,pindolol,cardiogenic shock,unc-51 like kinase 3
12431,capecitabine,nutritional biotin deficiency,potassium voltage-gated channel subfamily d member 2
12432,epinastine,decreased cardiac output,tec protein tyrosine kinase
12433,brexpiprazole,frozen shoulder,tubulin beta 2a class iia
12434,hydrocodone,acquired thrombocytopenia,interleukin 2
12435,dapoxetine,rickets,transforming growth factor beta receptor 2
12436,ergotamine,streptococcal pneumonia,estrogen receptor 2
12437,fenoprofen,polyuria,rio kinase 1
12438,etoposide,hypercalcemia disease,potassium voltage-gated channel modifier subfamily s member 3
12439,canagliflozin,thrombophilia due to thrombin defect,solute carrier family 12 member 3
12440,glucagon,hemorrhagic disease of newborn,solute carrier organic anion transporter family member 2b1
12441,buspirone,premature ventricular contraction,srsf protein kinase 3
12442,gemtuzumab ozogamicin,punctate epithelial keratoconjunctivitis,integrin subunit beta 3
12443,valsartan,tardive dyskinesia,tubulin beta 4b class ivb
12444,ribavirin,non-small cell lung carcinoma,proteasome 20s subunit beta 9
12445,phenmetrazine,temporal arteritis,structural maintenance of chromosomes 1a
12446,ubidecarenone,brain glioblastoma,ap2 associated kinase 1
12447,eptifibatide,pheochromocytoma,gamma-aminobutyric acid type a receptor subunit alpha4
12448,zidovudine,early myoclonic encephalopathy,solute carrier family 47 member 1
12449,histamine,peptic ulcer disease,amylase alpha 1b
12450,primidone,diamond-blackfan anemia,adenosine a2a receptor
12451,tolbutamide,atopic eczema,phosphodiesterase 1b
12452,zafirlukast,tenosynovial giant cell tumor,potassium voltage-gated channel modifier subfamily v member 2
12453,vonoprazan,postherpetic neuralgia,fibroblast growth factor receptor 1
12454,fondaparinux,urge incontinence,proteasome 20s subunit beta 8
12455,tenofovir alafenamide,malignant essential hypertension,fms related receptor tyrosine kinase 4
12456,topiroxostat,actinic keratosis,glutamate ionotropic receptor kainate type subunit 3
12457,selegiline,thrombocytopenia,eph receptor a5
12458,mometasone,pityriasis versicolor,cannabinoid receptor 2
12459,hydroxyzine,gastroesophageal reflux disease,potassium voltage-gated channel subfamily c member 3
12460,thioguanine,psoriasis,nuclear receptor subfamily 1 group i member 2
12461,penicillamine,plasma cell myeloma,glutamate ionotropic receptor kainate type subunit 4
12462,pyrimethamine,lewy body dementia,cyclin dependent kinase 19
12463,azelaic acid,tinea corporis,adenosine a2a receptor
12464,epinastine,congestive heart failure,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
12465,lidocaine,invasive ductal breast carcinoma,npc1 like intracellular cholesterol transporter 1
12466,clomipramine,sympathetic ophthalmia,atpase h+ transporting v1 subunit a
12467,mebendazole,tenosynovitis,gamma-aminobutyric acid type a receptor subunit alpha1
12468,ergometrine,duodenal ulcer,solute carrier family 2 member 9
12469,acrivastine,toothache,acetyl-coa acetyltransferase 1
12470,miconazole,huntington disease,dna topoisomerase i mitochondrial
12471,sertraline,liver cancer,solute carrier family 5 member 1
12472,phytomenadione,streptococcal pneumonia,"jun proto-oncogene, ap-1 transcription factor subunit"
12473,bezafibrate,atrioventricular block,serpin family a member 6
12474,solifenacin,hypertrichosis of eyelid,histamine receptor h2
12475,brigatinib,congenital adrenal hyperplasia,adrenoceptor beta 2
12476,ibuprofen,waldenstrom macroglobulinemia,fkbp prolyl isomerase 1a
12477,piretanide,pulmonary eosinophilia,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
12478,ergocalciferol,vitamin b12 deficiency,dead-box helicase 3 x-linked
12479,phenelzine,thyroid gland follicular carcinoma,potassium voltage-gated channel modifier subfamily s member 1
12480,sonidegib,hiv infectious disease,phospholipase a2 group iie
12481,estrone sulphate,iridocyclitis,fkbp prolyl isomerase 1b
12482,orlistat,waldenstrom macroglobulinemia,solute carrier organic anion transporter family member 1a2
12483,oxazepam,osteomalacia,calcium voltage-gated channel subunit alpha1 s
12484,lidocaine,hypereosinophilic syndrome,"smoothened, frizzled class receptor"
12485,beraprost,tardive dyskinesia,gamma-aminobutyric acid type b receptor subunit 2
12486,methylphenobarbital,non-hodgkin lymphoma,colony stimulating factor 1 receptor
12487,iloperidone,dermatomyositis,atpase na+/k+ transporting subunit alpha 3
12488,phenacemide,poisoning of animals with phosphate salts,kinase insert domain receptor
12489,axitinib,"attention deficit hyperactivity disorder, inattentive type",atpase copper transporting beta
12490,gonadorelin,sarcoidosis,calcium voltage-gated channel auxiliary subunit beta 2
12491,clonazepam,bipolar disorder,mechanistic target of rapamycin kinase
12492,fenfluramine,tetralogy of fallot,proteasome 20s subunit beta 1
12493,formoterol,uveitis,phosphodiesterase 6g
12494,levosimendan,periodontitis,solute carrier family 6 member 1
12495,telmisartan,sneeze,dopamine receptor d2
12496,nicotine,pruritus ani,kallikrein b1
12497,saquinavir,dermatitis herpetiformis,catechol-o-methyltransferase
12498,lesinurad,sebaceous adenoma,calcium voltage-gated channel auxiliary subunit alpha2delta 1
12499,phenacemide,corneal ulcer,metallothionein 1a
12500,vinorelbine,systemic lupus erythematosus,retinoid x receptor gamma
12501,tafluprost,"cicatrix, hypertrophic",natriuretic peptide b
12502,pemetrexed,pulmonary hypertension,cytochrome p450 family 17 subfamily a member 1
12503,isocarboxazid,disseminated intravascular coagulation,acyl-coa dehydrogenase short/branched chain
12504,ubidecarenone,open-angle glaucoma,parathyroid hormone 1 receptor
12505,treprostinil,plasmodium vivax malaria,bruton tyrosine kinase
12506,bexarotene,open-angle glaucoma,butyrylcholinesterase
12507,methamphetamine,ankylosing spondylitis,eukaryotic translation initiation factor 4e
12508,linaclotide,"cicatrix, hypertrophic",carbonic anhydrase 14
12509,fenoldopam,ornithine carbamoyltransferase deficiency,follicle stimulating hormone receptor
12510,dosulepin,seborrheic dermatitis,"fes proto-oncogene, tyrosine kinase"
12511,agomelatine,dermatitis,somatostatin receptor 3
12512,cabergoline,postmenopausal osteoporosis,solute carrier family 9 member a1
12513,amiloride,invasive ductal breast carcinoma,follicle stimulating hormone receptor
12514,clonidine,severe major depression with psychotic features,cholinergic receptor nicotinic alpha 6 subunit
12515,estrone,anxiety disorder,angiotensin ii receptor type 2
12516,glimepiride,waldenstrom macroglobulinemia,myosin light chain kinase
12517,dronedarone,pulmonary emphysema,peroxisome proliferator activated receptor gamma
12518,tofacitinib,osteomalacia,glucosidase ii alpha subunit
12519,isopropamide,crohn disease,transforming growth factor beta receptor 2
12520,prochlorperazine,streptococcal meningitis,calcium voltage-gated channel subunit alpha1 h
12521,nicotine,pulmonary cystic fibrosis,methylmalonyl-coa mutase
12522,orphenadrine,diabetes mellitus,melanocortin 3 receptor
12523,tamsulosin,meniere disease,serine/threonine kinase 17a
12524,balsalazide,pneumonia,squalene epoxidase
12525,flunisolide,periodontitis,cytochrome p450 family 51 subfamily a member 1
12526,ergocalciferol,aorta coarctation,npc1 like intracellular cholesterol transporter 1
12527,verapamil,psoriatic arthritis,prostaglandin e receptor 4
12528,pirenzepine,breast fibrocystic disease,eph receptor a1
12529,tamoxifen,alcohol dependence,cdc like kinase 1
12530,methamphetamine,lymphangioma,potassium voltage-gated channel modifier subfamily v member 1
12531,menatetrenone,common wart,potassium voltage-gated channel subfamily c member 4
12532,nitisinone,breast cancer,parathyroid hormone 1 receptor
12533,choline magnesium trisalicylate,tourette syndrome,potassium inwardly rectifying channel subfamily j member 8
12534,methotrexate,aspiration pneumonia,solute carrier family 2 member 9
12535,chlorpromazine,sarcoidosis,sodium voltage-gated channel alpha subunit 9
12536,lenalidomide,cluster headache syndrome,5-hydroxytryptamine receptor 4
12537,olmesartan,erectile dysfunction,ndufa4 mitochondrial complex associated like 2
12538,vilazodone,inappropriate adh syndrome,5-hydroxytryptamine receptor 4
12539,ramipril,hypercalcemia disease,cytidine/uridine monophosphate kinase 1
12540,sermorelin,psychologic dyspareunia,rho associated coiled-coil containing protein kinase 1
12541,azelaic acid,thyroid gland follicular carcinoma,structural maintenance of chromosomes 2
12542,mizolastine,pheochromocytoma,gamma-aminobutyric acid type a receptor subunit delta
12543,metyrapone,sickle cell anemia,adrenoceptor alpha 2c
12544,tafamidis,mydriasis,5-methyltetrahydrofolate-homocysteine methyltransferase
12545,hydralazine,polyuria,cholinergic receptor nicotinic alpha 3 subunit
12546,acth,thrombocytopenia,tumor protein p53
12547,ecallantide,hypertensive disorder,histone deacetylase 6
12548,bazedoxifene,cardiogenic shock,bone gamma-carboxyglutamate protein
12549,loxapine,iritis,cdgsh iron sulfur domain 1
12550,caffeine,hyperprolactinemia,cholinergic receptor nicotinic alpha 6 subunit
12551,propafenone,diffuse large b-cell lymphoma,atp binding cassette subfamily g member 5
12552,doxorubicin,endometriosis,integrin subunit alpha 2b
12553,anagliptin,meniere disease,potassium inwardly rectifying channel subfamily j member 1
12554,chlophedianol,atopic eczema,"abl proto-oncogene 2, non-receptor tyrosine kinase"
12555,docetaxel,cardiogenic shock,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
12556,efavirenz,polycystic ovary syndrome,calcyon neuron specific vesicular protein
12557,ticagrelor,hyperthyroidism,gamma-aminobutyric acid type a receptor subunit gamma2
12558,fexofenadine,cluster headache syndrome,thyroid stimulating hormone receptor
12559,amiodarone,human african trypanosomiasis,cysteinyl leukotriene receptor 1
12560,pravastatin,homocystinuria,phosphoribosyl pyrophosphate amidotransferase
12561,flufenamic acid,hypophosphatemia,bone gamma-carboxyglutamate protein
12562,anakinra,renal osteodystrophy,gamma-aminobutyric acid type a receptor subunit beta1
12563,meclizine,autoimmune hemolytic anemia,insulin receptor related receptor
12564,ixabepilone,plasmodium ovale malaria,acetyl-coa acyltransferase 2
12565,nevirapine,acute promyelocytic leukemia,cytochrome p450 oxidoreductase
12566,dextropropoxyphene,central nervous system origin vertigo,oxytocin receptor
12567,dapsone,urinary bladder neoplasm,solute carrier family 22 member 4
12568,nortriptyline,congenital hypothyroidism,solute carrier organic anion transporter family member 1b1
12569,hydroxyzine,spasticity,atp binding cassette subfamily c member 2
12570,clemastine,depressive disorder,solute carrier family 7 member 11
12571,fentanyl,endometrial carcinoma,npc1 like intracellular cholesterol transporter 1
12572,rabeprazole,tinea corporis,dipeptidyl peptidase 4
12573,vandetanib,urinary bladder neoplasm,kallikrein b1
12574,icotinib,abdominal infection,adrenoceptor alpha 1b
12575,roxatidine acetate,kaposi's sarcoma,misshapen like kinase 1
12576,obinutuzumab,abdominal abscess,cdc like kinase 4
12577,anagrelide,idiopathic hypereosinophilic syndrome,myosin light chain kinase 3
12578,milnacipran,ovarian cancer,dna methyltransferase 1
12579,eszopiclone,glioma,"troponin c1, slow skeletal and cardiac type"
12580,metipranolol,supraventricular tachycardia,transmembrane protein 97
12581,difenoxin,dysmenorrhea,adrenoceptor alpha 2c
12582,piribedil,ventricular fibrillation,neuropeptide y receptor y1
12583,aripiprazole,breast neoplasm,fkbp prolyl isomerase 4
12584,flurbiprofen,common cold,ret proto-oncogene
12585,sertaconazole,urinary retention,calcium voltage-gated channel subunit alpha1 s
12586,diethylcarbamazine,gingivitis,leukotriene b4 receptor
12587,tetracycline,myeloproliferative neoplasm,proteasome 20s subunit beta 9
12588,nicorandil,pulmonary emphysema,dopa decarboxylase
12589,diazepam,mast cell leukemia,dipeptidyl peptidase 4
12590,ergotamine,pyelonephritis,cytochrome p450 family 11 subfamily b member 1
12591,vernakalant,metastatic melanoma,phosphorylase kinase catalytic subunit gamma 1
12592,acetazolamide,cryopyrin-associated periodic syndrome,prune exopolyphosphatase 1
12593,nitric oxide,sarcoidosis,3-hydroxy-3-methylglutaryl-coa reductase
12594,prochlorperazine,tinea pedis,hydroxycarboxylic acid receptor 3
12595,axitinib,bipolar disorder,solute carrier organic anion transporter family member 2b1
12596,losartan,psychosexual disorder,acid sensing ion channel subunit 1
12597,oxazepam,nephrotic syndrome,c-x-c motif chemokine receptor 1
12598,voglibose,osteoarthritis,synaptic vesicle glycoprotein 2a
12599,selexipag,neurogenic bladder,"pim-2 proto-oncogene, serine/threonine kinase"
12600,flunisolide,actinic keratosis,cholinergic receptor muscarinic 5
12601,trimethobenzamide,psychosexual disorder,colony stimulating factor 1 receptor
12602,abiraterone acetate,adrenal gland hyperfunction,cytochrome p450 family 2 subfamily e member 1
12603,prilocaine,neurogenic bladder,eph receptor b2
12604,choline,liposarcoma,atp binding cassette subfamily g member 8
12605,rofecoxib,head and neck cancer,ryanodine receptor 2
12606,alimemazine,sitosterolemia,eph receptor b2
12607,tolmetin,gestational trophoblastic neoplasm,retinoid x receptor beta
12608,5-fluorouracil,peripheral vascular disease,cyclin dependent kinase 14
12609,bezafibrate,insomnia,unc-51 like autophagy activating kinase 2
12610,carvedilol,familial dermatographia,ornithine decarboxylase 1
12611,olmutinib,vitamin b12 deficiency,sodium channel epithelial 1 subunit alpha
12612,oxazepam,visual epilepsy,proteasome 20s subunit beta 9
12613,celecoxib,contact dermatitis,angiotensin converting enzyme 2
12614,pomalidomide,constipation disorder,angiotensin converting enzyme 2
12615,choline,aggressive systemic mastocytosis,tubulin beta 2a class iia
12616,vismodegib,thyroid gland carcinoma,purinergic receptor p2y12
12617,moxonidine,vascular disorder,"dna polymerase alpha 1, catalytic subunit"
12618,tetracosactide,absence epilepsy,"met proto-oncogene, receptor tyrosine kinase"
12619,tripelennamine,ascites,"kras proto-oncogene, gtpase"
12620,sulfasalazine,primary myelofibrosis,gamma-aminobutyric acid type a receptor subunit gamma1
12621,sonidegib,impetigo,insulin receptor related receptor
12622,bretylium,tendinitis,proteasome 20s subunit beta 5
12623,levorphanol,anxiety,solute carrier family 22 member 11
12624,tetracycline,headache disorder,s100 calcium binding protein p
12625,amcinonide,postmenopausal atrophic vaginitis,eph receptor a1
12626,lopinavir,malignant hyperthermia of anesthesia,melanocortin 3 receptor
12627,epinastine,vulvovaginal candidiasis,atp binding cassette subfamily b member 11
12628,rofecoxib,hemangioma,7-dehydrocholesterol reductase
12629,zafirlukast,postpartum depression,protein tyrosine kinase 2
12630,venlafaxine,hyperinsulinism,arginine vasopressin receptor 1a
12631,cimetidine,methylmalonic acidemia,cd33 molecule
12632,drospirenone,canker sore,amylase alpha 2a
12633,agomelatine,primary myelofibrosis,myosin heavy chain 10
12634,rofecoxib,multiple endocrine neoplasia,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
12635,sofalcone,hypereosinophilic syndrome,dna methyltransferase 1
12636,betaxolol,hot flashes,mitogen-activated protein kinase kinase kinase 7
12637,verapamil,aspiration pneumonitis,glutamate ionotropic receptor ampa type subunit 3
12638,salsalate,tenosynovial giant cell tumor,glucagon like peptide 2 receptor
12639,ribavirin,bacterial pneumonia,death associated protein kinase 1
12640,pyrimethamine,pruritus,phosphorylase kinase catalytic subunit gamma 2
12641,progesterone,pthirus pubis infestation,atpase h+/k+ transporting subunit beta
12642,methyclothiazide,breast cancer,c-x-c motif chemokine receptor 4
12643,vorapaxar,amenorrhea,amylase alpha 1b
12644,fingolimod,autoimmune disease,gamma-aminobutyric acid type a receptor subunit alpha2
12645,radotinib,"attention deficit hyperactivity disorder, inattentive type",calcium voltage-gated channel auxiliary subunit alpha2delta 1
12646,travoprost,psoriasis,srsf protein kinase 3
12647,amobarbital,primary myelofibrosis,fkbp prolyl isomerase 5
12648,apomorphine,asthma-chronic obstructive pulmonary disease overlap syndrome,atpase na+/k+ transporting subunit beta 3
12649,melatonin,labor pain,aldehyde dehydrogenase 5 family member a1
12650,spironolactone,pheochromocytoma,histone deacetylase 5
12651,bendroflumethiazide,poems syndrome,potassium inwardly rectifying channel subfamily j member 2
12652,cyclizine,acute gonococcal cervicitis,tyrosine kinase non receptor 1
12653,ifosfamide,renal osteodystrophy,histone deacetylase 8
12654,riboflavin,central nervous system origin vertigo,"lck proto-oncogene, src family tyrosine kinase"
12655,ergocalciferol,allergic asthma,potassium voltage-gated channel subfamily h member 3
12656,metolazone,chronic eosinophilic leukemia,colony stimulating factor 1 receptor
12657,bepotastine,b-cell chronic lymphocytic leukemia,5-hydroxytryptamine receptor 2b
12658,midazolam,familial dermatographia,somatostatin receptor 1
12659,tolmetin,congestive heart failure,phosphodiesterase 11a
12660,ethosuximide,schizophrenia,janus kinase 3
12661,physostigmine,psychosexual disorder,potassium two pore domain channel subfamily k member 3
12662,riluzole,atrioventricular block,adrenoceptor alpha 2b
12663,bromocriptine,propionic acidemia,gamma-aminobutyric acid type a receptor subunit alpha1
12664,levoketoconazole,neurogenic bladder,potassium voltage-gated channel subfamily h member 4
12665,drospirenone,tourette syndrome,phosphodiesterase 5a
12666,pyrimethamine,dermatomyositis,cannabinoid receptor 1
12667,insulin lispro,myocardial infarction,g protein-coupled receptor kinase 2
12668,diphenidol,actinic keratosis,"hck proto-oncogene, src family tyrosine kinase"
12669,levosalbutamol,"dermatitis, atopic",phosphodiesterase 6c
12670,amphetamine,strongyloidiasis,death associated protein kinase 2
12671,salicylamide,uveitis,transient receptor potential cation channel subfamily a member 1
12672,suramin,postoperative nausea and vomiting,aldo-keto reductase family 1 member c3
12673,escitalopram,follicular lymphoma,cyclin dependent kinase 14
12674,nimodipine,back pain,cyp3a7-cyp3a51p readthrough
12675,ergotamine,sarcoidosis,coagulation factor ii thrombin receptor
12676,pemetrexed,respiratory syncytial virus infectious disease,prune exopolyphosphatase 1
12677,minoxidil,migraine disorder,purinergic receptor p2y12
12678,sufentanil,vitamin b12 deficiency,phosphodiesterase 3b
12679,vildagliptin,leprosy,glucose-6-phosphate dehydrogenase
12680,glipizide,dyspepsia,gamma-glutamyl carboxylase
12681,beraprost,anterior uveitis,metabolism of cobalamin associated a
12682,lamivudine,acidosis disorder,cytochrome p450 family 2 subfamily c member 9
12683,nilotinib,hepatic veno-occlusive disease,cytochrome p450 family 2 subfamily r member 1
12684,insulin detemir,glossopharyngeal neuralgia,potassium voltage-gated channel modifier subfamily g member 1
12685,cyproheptadine,migraine disorder,myosin light chain kinase
12686,rizatriptan,orthostatic hypotension,sodium channel epithelial 1 subunit beta
12687,clobazam,esophageal cancer,hypoxia inducible factor 1 subunit alpha
12688,secobarbital,noonan syndrome,5-hydroxytryptamine receptor 1a
12689,acalabrutinib,neurogenic bladder,arachidonate 5-lipoxygenase
12690,cabergoline,pruritus ani,farnesyl diphosphate synthase
12691,cilazapril,nocturnal enuresis,potassium voltage-gated channel modifier subfamily v member 2
12692,cinnarizine,eosinophilic esophagitis,epoxide hydrolase 2
12693,clozapine,eosinophilic esophagitis,dopamine beta-hydroxylase
12694,ergocalciferol,urinary bladder cancer,tubulin beta 1 class vi
12695,dapoxetine,female infertility,cholinergic receptor nicotinic alpha 10 subunit
12696,aclidinium,hyperuricemia,cholinergic receptor muscarinic 4
12697,topotecan,adrenocortical insufficiency,atpase na+/k+ transporting subunit beta 2
12698,sertindole,dacryocystitis,proteasome 20s subunit beta 1
12699,flibanserin,"chronic myelogenous leukemia, bcr-abl1 positive",potassium voltage-gated channel subfamily h member 7
12700,eptifibatide,localized scleroderma,cytochrome p450 family 11 subfamily b member 1
12701,imatinib,open-angle glaucoma,delta like non-canonical notch ligand 1
12702,romidepsin,endometrium neoplasm,histamine receptor h2
12703,terguride,autoimmune disease,ribosomal protein s6 kinase a1
12704,bortezomib,cough,calmodulin 2
12705,ribavirin,fabry disease,"coagulation factor ii, thrombin"
12706,lopinavir,ornithine carbamoyltransferase deficiency,histone deacetylase 2
12707,echothiophate,premature ventricular contraction,phosphorylase kinase catalytic subunit gamma 1
12708,warfarin,hyperbilirubinemia,potassium voltage-gated channel subfamily a member 4
12709,treprostinil,exanthem,adrenoceptor beta 1
12710,sulfasalazine,labor pain,neurotrophic receptor tyrosine kinase 1
12711,reboxetine,menorrhagia,carbonic anhydrase 1
12712,darifenacin,interstitial lung disease,aldo-keto reductase family 1 member c1
12713,teniposide,subarachnoid hemorrhage,calcium sensing receptor
12714,vinorelbine,severe major depression with psychotic features,phosphodiesterase 6a
12715,clofarabine,bone paget disease,serine/threonine kinase 16
12716,raltegravir,autoimmune disease,mitogen-activated protein kinase kinase kinase 19
12717,prasugrel,superficial multifocal basal cell carcinoma,potassium voltage-gated channel subfamily c member 4
12718,insulin aspart,mast cell leukemia,cholinergic receptor nicotinic alpha 2 subunit
12719,phenazone,tetralogy of fallot,histamine receptor h3
12720,pemetrexed,skin basal cell carcinoma,myosin light chain kinase family member 4
12721,isoprenaline,phenylketonuria,doublecortin like kinase 1
12722,nifedipine,anaphylaxis,somatostatin receptor 2
12723,clobetasone,gastric cancer,cytochrome p450 family 2 subfamily c member 9
12724,icotinib,hodgkins lymphoma,tyrosine hydroxylase
12725,fluspirilene,lung disorder,cytochrome p450 family 2 subfamily c member 8
12726,gonadorelin,vulvovaginal candidiasis,histone deacetylase 11
12727,captopril,ornithine carbamoyltransferase deficiency,"troponin c1, slow skeletal and cardiac type"
12728,desipramine,brain glioblastoma,opioid receptor mu 1
12729,bunolol,brain glioblastoma,solute carrier family 12 member 1
12730,dipyridamole,tendinopathy,matrix metallopeptidase 9
12731,etelcalcetide,anogenital human papillomavirus infection,cytochrome p450 family 3 subfamily a member 5
12732,goserelin,respiratory syncytial virus infectious disease,melatonin receptor 1b
12733,haloperidol,oligospermia,integrin subunit alpha l
12734,diazepam,alcohol dependence,histone deacetylase 6
12735,cetirizine,hiv infectious disease,mapk interacting serine/threonine kinase 2
12736,dexibuprofen,biotinidase deficiency,potassium voltage-gated channel subfamily c member 4
12737,lusutrombopag,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",potassium voltage-gated channel subfamily c member 3
12738,ramatroban,hemorrhagic disease of newborn,endothelin receptor type b
12739,benzatropine,bacterial meningitis,bruton tyrosine kinase
12740,etodolac,trigeminal neuralgia,adenosine a3 receptor
12741,cisplatin,female stress incontinence,glucagon like peptide 2 receptor
12742,oxybutynin,hyperlipidemia,gap junction protein alpha 1
12743,dorzolamide,inappropriate adh syndrome,sodium voltage-gated channel alpha subunit 3
12744,chlorthalidone,decreased cardiac output,rho associated coiled-coil containing protein kinase 1
12745,sulindac,trichinellosis,solute carrier family 12 member 2
12746,trabectedin,actinic keratosis,dopa decarboxylase
12747,propranolol,intracranial embolism,fkbp prolyl isomerase 1b
12748,sapropterin,pityriasis versicolor,glutamate ionotropic receptor kainate type subunit 5
12749,ulobetasol propionate,acute intermittent porphyria,insulin receptor
12750,irinotecan,synovitis,potassium voltage-gated channel subfamily h member 6
12751,zuclopenthixol,diabetes mellitus,solute carrier family 22 member 2
12752,tamoxifen,hemorrhagic disease of newborn,hyperpolarization activated cyclic nucleotide gated potassium channel 4
12753,cortisol,gestational trophoblastic neoplasm,selectin e
12754,isoprenaline,tardive dyskinesia,cytochrome p450 oxidoreductase
12755,metolazone,urethritis,solute carrier organic anion transporter family member 1b1
12756,pregabalin,raynaud disease,mitogen-activated protein kinase kinase 5
12757,ergometrine,breast cancer,somatostatin receptor 3
12758,duloxetine,eunuchism,tubulin alpha 4a
12759,clofarabine,pulmonary cystic fibrosis,"major histocompatibility complex, class i, a"
12760,fesoterodine,zollinger-ellison syndrome,calcium voltage-gated channel subunit alpha1 i
12761,tenofovir alafenamide,localized scleroderma,calcium voltage-gated channel auxiliary subunit alpha2delta 2
12762,tulobuterol,acute coronary syndrome,"smoothened, frizzled class receptor"
12763,lasofoxifene,neuroblastoma,sulfotransferase family 1a member 1
12764,ergocalciferol,postherpetic neuralgia,cytochrome p450 family 24 subfamily a member 1
12765,gonadorelin,pityriasis versicolor,protein kinase n1
12766,procyclidine,tinea corporis,solute carrier family 6 member 1
12767,dofetilide,aggressive systemic mastocytosis,gamma-aminobutyric acid type a receptor subunit pi
12768,mestranol,altitude sickness,solute carrier organic anion transporter family member 1b1
12769,tretinoin,diffuse large b-cell lymphoma,calcium voltage-gated channel subunit alpha1 i
12770,warfarin,vitamin deficiency disorder,gc vitamin d binding protein
12771,nedocromil,west syndrome,sphingosine-1-phosphate receptor 5
12772,tamsulosin,ovarian epithelial tumor,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
12773,clidinium,autism spectrum disorder,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
12774,lorazepam,eunuchism,holocarboxylase synthetase
12775,isopropamide,metastatic melanoma,bcl2 like 1
12776,metaraminol,liver cancer,membrane spanning 4-domains a1
12777,befunolol,chancroid,checkpoint kinase 2
12778,oxybutynin,epilepsy,ornithine transcarbamylase
12779,alclometasone dipropionate,severe major depression with psychotic features,thyroid peroxidase
12780,afamelanotide,fibromyalgia,cholinergic receptor nicotinic beta 4 subunit
12781,aripiprazole,invasive ductal breast carcinoma,holocarboxylase synthetase
12782,clobazam,keratitis,cytochrome p450 family 51 subfamily a member 1
12783,iloperidone,onchocerciasis,amine oxidase copper containing 1
12784,levosalbutamol,endometrium neoplasm,5-hydroxytryptamine receptor 2a
12785,empagliflozin,poems syndrome,tumor protein p53
12786,fluoxetine,"chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 7
12787,brompheniramine,postencephalitic parkinson disease,neurotrophic receptor tyrosine kinase 2
12788,isotretinoin,back pain,sodium voltage-gated channel alpha subunit 10
12789,fluocinonide,gastrointestinal stromal tumor,tyrosine kinase non receptor 2
12790,buclizine,gastroesophageal reflux disease,unc-51 like kinase 3
12791,dronedarone,rosacea,leukotriene b4 receptor
12792,carbamazepine,wilms tumor,platelet activating factor receptor
12793,triprolidine,gastric cancer,g protein-coupled receptor kinase 4
12794,lenalidomide,punctate epithelial keratoconjunctivitis,"ros proto-oncogene 1, receptor tyrosine kinase"
12795,diclofenac,acromegaly,cyp3a7-cyp3a51p readthrough
12796,cabozantinib,autism spectrum disorder,mechanistic target of rapamycin kinase
12797,saxagliptin,hypercholesterolemia,hypoxanthine phosphoribosyltransferase 1
12798,lisinopril,vitiligo,gamma-glutamyl carboxylase
12799,indapamide,angle-closure glaucoma,phosphodiesterase 1c
12800,piretanide,islet cell adenomatosis,atpase copper transporting alpha
12801,nitric oxide,nasal congestion,metabolism of cobalamin associated c
12802,pentostatin,leiomyosarcoma,"troponin c1, slow skeletal and cardiac type"
12803,fluoxetine,eosinophilic pneumonia,potassium calcium-activated channel subfamily m alpha 1
12804,gilteritinib,erdheim-chester disease,discoidin domain receptor tyrosine kinase 2
12805,tofacitinib,primary myelofibrosis,potassium inwardly rectifying channel subfamily j member 2
12806,imipramine,escherichia coli infection,histone deacetylase 8
12807,fluphenazine,anxiety,ret proto-oncogene
12808,cytarabine,drooling,unc-51 like kinase 3
12809,diazoxide,tinea corporis,potassium voltage-gated channel modifier subfamily s member 2
12810,diphenidol,autosomal dominant polycystic kidney disease,prostaglandin d2 receptor
12811,penicillamine,granuloma annulare,serine/threonine kinase 11
12812,prochlorperazine,colonic neoplasm,ornithine transcarbamylase
12813,felodipine,choroiditis,arginine vasopressin receptor 2
12814,lercanidipine,meniere disease,solute carrier family 22 member 8
12815,gefitinib,early myoclonic encephalopathy,melatonin receptor 1b
12816,dehydroepiandrosterone,stroke disorder,cytochrome p450 family 1 subfamily a member 1
12817,alteplase,allergic bronchopulmonary aspergillosis,microtubule associated protein 1a
12818,aspirin,raynaud disease,potassium voltage-gated channel subfamily a member 7
12819,floxuridine,peyronie disease,glutamate ionotropic receptor kainate type subunit 2
12820,sulpiride,pernicious anemia,cubilin
12821,aliskiren,hyperlipidemia,5-hydroxytryptamine receptor 1f
12822,biperiden,cycloplegia,ribonucleotide reductase regulatory subunit m2
12823,empagliflozin,renal osteodystrophy,prostaglandin e receptor 4
12824,ixazomib,b-cell chronic lymphocytic leukemia,microtubule affinity regulating kinase 3
12825,azacitidine,"hydatidiform mole, recurrent, 1",opioid receptor delta 1
12826,phendimetrazine,delirium,macrophage stimulating 1 receptor
12827,irbesartan,intermittent vascular claudication,testis specific serine kinase 1b
12828,solifenacin,endometritis,caspase 1
12829,sitagliptin,castleman disease,5-hydroxytryptamine receptor 3e
12830,cephalotaxine,congenital adrenal hyperplasia,"fes proto-oncogene, tyrosine kinase"
12831,lorazepam,pemphigus,sodium voltage-gated channel alpha subunit 1
12832,carmustine,acute gonococcal endometritis,aryl hydrocarbon receptor
12833,oxymetazoline,diffuse large b-cell lymphoma,ebp like
12834,hydromorphone,epilepsy with generalized tonic-clonic seizures,glutathione s-transferase theta 1
12835,clopidogrel,amyloidosis,ribosomal protein s6 kinase a6
12836,ticagrelor,thyroid gland carcinoma,prostaglandin-endoperoxide synthase 2
12837,clopidogrel,arteriosclerosis disorder,mapk interacting serine/threonine kinase 2
12838,simvastatin,testicular cancer,potassium voltage-gated channel subfamily a member 3
12839,nintedanib,cervical cancer,pre-mrna splicing tri-snrnp complex factor prpf4
12840,fluorometholone,lung neoplasm,protein tyrosine kinase 2
12841,hydroxychloroquine,acne,aldehyde dehydrogenase 5 family member a1
12842,amiloride,osteomalacia,solute carrier family 47 member 1
12843,promethazine,hyperinsulinism,cyp3a7-cyp3a51p readthrough
12844,fesoterodine,focal epilepsy,death associated protein kinase 3
12845,bazedoxifene,postmenopausal osteoporosis,5-hydroxytryptamine receptor 3c
12846,agomelatine,myalgia,5-hydroxytryptamine receptor 3a
12847,salmeterol,attrv122i amyloidosis,cobalamin binding intrinsic factor
12848,cobicistat,endemic goiter,atpase na+/k+ transporting subunit alpha 1
12849,phenytoin,anxiety disorder,cdc like kinase 4
12850,ruxolitinib,mature t-cell and nk-cell non-hodgkin lymphoma,gamma-aminobutyric acid type a receptor subunit theta
12851,naltrexone,tourette syndrome,cytochrome p450 family 1 subfamily a member 1
12852,flurbiprofen,cluster headache syndrome,"lck proto-oncogene, src family tyrosine kinase"
12853,crotamiton,chronic beryllium disease,cytochrome p450 family 19 subfamily a member 1
12854,ethynodiol diacetate,enterocolitis,gamma-aminobutyric acid type a receptor subunit gamma2
12855,acenocoumarol,malignant hyperthermia of anesthesia,inhibitor of nuclear factor kappa b kinase subunit beta
12856,acarbose,glioma,homeodomain interacting protein kinase 4
12857,imiquimod,autoimmune hemolytic anemia,cytochrome p450 family 2 subfamily d member 6
12858,olaparib,intermittent vascular claudication,tachykinin precursor 1
12859,norfloxacin,onchocerciasis,potassium voltage-gated channel modifier subfamily g member 1
12860,alprazolam,graves disease,angiotensin ii receptor type 1
12861,gemcitabine,social phobia,fkbp prolyl isomerase 5
12862,zileuton,thyroiditis,atpase na+/k+ transporting subunit beta 3
12863,repaglinide,vitiligo,tubulin beta 3 class iii
12864,cefalotin,burkitt lymphoma,dna methyltransferase 3 alpha
12865,minoxidil,patent ductus arteriosus,gamma-aminobutyric acid type a receptor subunit gamma3
12866,oxymetholone,cryopyrin-associated periodic syndrome,solute carrier family 46 member 1
12867,epa,malignant pleural mesothelioma,cholinergic receptor muscarinic 3
12868,zafirlukast,scleroderma,tubulin beta 4a class iva
12869,apremilast,acute pain,glucose-6-phosphate dehydrogenase
12870,modafinil,pulmonary artery stenosis,phosphodiesterase 6b
12871,lenvatinib,acute interstitial pneumonia,phosphodiesterase 6d
12872,cyclizine,congenital adrenal hyperplasia,5-hydroxytryptamine receptor 6
12873,dromostanolone propionate,premature obstetric labor,death associated protein kinase 1
12874,pregabalin,blepharoconjunctivitis,dihydropyrimidine dehydrogenase
12875,anagrelide,ornithine carbamoyltransferase deficiency,calcium voltage-gated channel subunit alpha1 g
12876,lansoprazole,frozen shoulder,fibroblast growth factor receptor 2
12877,canagliflozin,gastric ulcer,histone deacetylase 1
12878,niraparib,homozygous familial hypercholesterolemia,adenosine a2b receptor
12879,triamcinolone,psychologic dyspareunia,serine/threonine kinase 10
12880,piribedil,metastatic melanoma,"yes proto-oncogene 1, src family tyrosine kinase"
12881,bunolol,malignant pleural mesothelioma,eph receptor a1
12882,nitisinone,angle-closure glaucoma,solute carrier organic anion transporter family member 1b3
12883,lifitegrast,polyuria,somatostatin receptor 3
12884,nizatidine,juvenile idiopathic arthritis,synaptic vesicle glycoprotein 2a
12885,pranlukast,hemorrhoid,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
12886,loteprednol etabonate,hyperglycemia,aldo-keto reductase family 1 member c3
12887,ripasudil,head and neck neoplasm,protein kinase n2
12888,moclobemide,ovarian epithelial tumor,vascular cell adhesion molecule 1
12889,lifitegrast,escherichia coli infection,gamma-aminobutyric acid type a receptor subunit epsilon
12890,hydroquinone,acquired thrombocytopenia,potassium voltage-gated channel modifier subfamily s member 3
12891,apalutamide,sickle cell anemia,unc-51 like autophagy activating kinase 2
12892,aripiprazole,ascites,colony stimulating factor 1 receptor
12893,nicardipine,gastric ulcer,calcium/calmodulin dependent protein kinase ii alpha
12894,brinzolamide,enterocolitis,atpase copper transporting alpha
12895,miconazole,gastric ulcer,opioid receptor kappa 1
12896,goserelin,respiratory syncytial virus infectious disease,serine/threonine kinase 10
12897,drospirenone,fever,cd33 molecule
12898,dapagliflozin,epicondylitis,kelch like ech associated protein 1
12899,mitoxantrone,liposarcoma,discoidin domain receptor tyrosine kinase 1
12900,dihydroergotamine,pulmonary artery stenosis,phosphodiesterase 2a
12901,vindesine,frozen shoulder,potassium voltage-gated channel subfamily a member 3
12902,diamicron,schizophrenia,tyrosine hydroxylase
12903,auranofin,persistent fetal circulation syndrome,glycine receptor alpha 3
12904,fingolimod,rheumatoid arthritis,cdc like kinase 4
12905,hydromorphone,streptococcal pneumonia,"jun proto-oncogene, ap-1 transcription factor subunit"
12906,molindone,primary ovarian failure,sex hormone binding globulin
12907,probenecid,scleroderma,carbonic anhydrase 4
12908,acetylmethadol,ovarian epithelial tumor,solute carrier family 22 member 3
12909,guanabenz,brain edema,tubulin beta 8 class viii
12910,primidone,tinea corporis,fkbp prolyl isomerase 4
12911,candesartan,eosinophilic pneumonia,ornithine transcarbamylase
12912,desogestrel,renal cell carcinoma,histone deacetylase 4
12913,doxepin,invasive ductal breast carcinoma,"met proto-oncogene, receptor tyrosine kinase"
12914,fexofenadine,schizophrenia,peptidylprolyl isomerase b
12915,asenapine,cycloplegia,glucagon like peptide 2 receptor
12916,phenindamine,female infertility,mitogen-activated protein kinase kinase kinase 11
12917,capsaicin,acne,"coagulation factor ii, thrombin"
12918,acebutolol,spasticity,tyrosinase
12919,pimecrolimus,ornithine carbamoyltransferase deficiency,serine/threonine kinase 10
12920,l-glutamine,post-operative pain,inositol monophosphatase 1
12921,troglitazone,oral mucosa leukoplakia,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
12922,nintedanib,bacterial endocarditis,phosphodiesterase 6g
12923,galantamine,congenital adrenal hyperplasia,adenosine a3 receptor
12924,flufenamic acid,dyspepsia,peroxisome proliferator activated receptor gamma
12925,cilastatin,propionic acidemia,solute carrier family 22 member 4
12926,venlafaxine,nausea,"dna polymerase epsilon, catalytic subunit"
12927,levobetaxolol,severe major depression with psychotic features,ribonucleotide reductase regulatory subunit m2
12928,nicorandil,onchocerciasis,"protein phosphatase 3 regulatory subunit b, alpha"
12929,penbutolol,panic disorder,amine oxidase copper containing 3
12930,trichlormethiazide,hypercholesterolemia,kelch like ech associated protein 1
12931,danazol,amyloidosis,"mpl proto-oncogene, thrombopoietin receptor"
12932,treprostinil,non-small cell lung carcinoma,synaptic vesicle glycoprotein 2a
12933,nelfinavir,allergic contact dermatitis,rho associated coiled-coil containing protein kinase 2
12934,penicillamine,dermatophytosis of groin and perianal area,propionyl-coa carboxylase subunit beta
12935,dexamethasone,pulmonary hypertension,platelet derived growth factor receptor alpha
12936,ubidecarenone,dermatomyositis,proteasome 20s subunit beta 8
12937,desipramine,dysmenorrhea,dipeptidyl peptidase 9
12938,acarbose,bronchitis,bradykinin receptor b2
12939,nitisinone,pancreatic insulinoma,ribosomal protein s6 kinase a1
12940,fluticasone,bone osteosarcoma,rho associated coiled-coil containing protein kinase 2
12941,levosalbutamol,postpartum depression,coagulation factor ii thrombin receptor
12942,carfilzomib,premature ejaculation,toll like receptor 4
12943,dehydroepiandrosterone,lichen planus,prune exopolyphosphatase 1
12944,metoclopramide,poisoning of animals with phosphate salts,g protein-coupled receptor 35
12945,pravastatin,breast neoplasm,xanthine dehydrogenase
12946,bethanechol,waldenstrom macroglobulinemia,potassium voltage-gated channel subfamily a member 4
12947,quetiapine,myotonic syndrome,sphingosine-1-phosphate receptor 3
12948,rufinamide,hypophosphatemia,calmodulin 1
12949,pralidoxime,persistent fetal circulation syndrome,cytochrome p450 family 1 subfamily b member 1
12950,pentamidine,acquired thrombocytopenia,g protein-coupled receptor 35
12951,zolpidem,sickle cell anemia,cdgsh iron sulfur domain 1
12952,pseudoephedrine,post-traumatic stress disorder,receptor interacting serine/threonine kinase 3
12953,liraglutide,juvenile idiopathic arthritis,interleukin 6 receptor
12954,pindolol,endometritis,leukotriene a4 hydrolase
12955,celiprolol,essential hypertension,histamine receptor h4
12956,perazine,fever,calcium voltage-gated channel subunit alpha1 c
12957,ketanserin,status epilepticus,cholinergic receptor nicotinic alpha 5 subunit
12958,valdecoxib,pulmonary edema,bcl2 like 2
12959,mesoridazine,glioma,synuclein alpha
12960,chloroquine,atrial fibrillation,cyclin g associated kinase
12961,pramipexole,fabry disease,cholinergic receptor nicotinic alpha 6 subunit
12962,desoximetasone,plasmodium vivax malaria,uridine monophosphate synthetase
12963,hydromorphone,chronic hepatitis c virus infection,potassium voltage-gated channel modifier subfamily g member 4
12964,tapentadol,embolism,potassium voltage-gated channel subfamily a member 4
12965,auranofin,breast cancer,fer tyrosine kinase
12966,fingolimod,influenza,c-x-c motif chemokine receptor 4
12967,antazoline,allergic urticaria,glutamate ionotropic receptor kainate type subunit 1
12968,metipranolol,scabies,dead-box helicase 1
12969,ixazomib,central nervous system origin vertigo,prostaglandin f receptor
12970,abiraterone acetate,hypoglycemia,amylase alpha 1b
12971,prasugrel,anogenital human papillomavirus infection,5-hydroxytryptamine receptor 1b
12972,benoxaprofen,tension-type headache,cytochrome p450 family 11 subfamily b member 2
12973,repaglinide,orthostatic hypotension,5-hydroxytryptamine receptor 1b
12974,trilostane,rhinoscleroma,n-acylsphingosine amidohydrolase 1
12975,pregabalin,premature ventricular contraction,glucosidase ii alpha subunit
12976,eplerenone,myocardial infarction,high mobility group box 1
12977,dyphylline,human african trypanosomiasis,tank binding kinase 1
12978,tropicamide,peyronie disease,gonadotropin releasing hormone receptor
12979,vorinostat,metrorrhagia,glutathione s-transferase mu 1
12980,rivastigmine,acidosis disorder,atpase na+/k+ transporting subunit beta 1
12981,imatinib,pheochromocytoma,unc-51 like kinase 3
12982,physostigmine,delayed puberty,transient receptor potential cation channel subfamily a member 1
12983,adinazolam,common cold,plasminogen
12984,tapentadol,interstitial lung disease,ndufa4 mitochondrial complex associated
12985,valrubicin,hyperglycemia,retinoic acid receptor alpha
12986,felodipine,rosacea,membrane spanning 4-domains a1
12987,levomilnacipran,eunuchism,interleukin 1 receptor type 1
12988,acetophenazine,nocturnal enuresis,potassium voltage-gated channel subfamily a member 10
12989,tenofovir alafenamide,meniere disease,adrenoceptor alpha 2c
12990,oxymetholone,hiv infectious disease,matrix metallopeptidase 2
12991,mizolastine,pharyngitis,n-acetyltransferase 2
12992,piribedil,bone paget disease,potassium calcium-activated channel subfamily m alpha 1
12993,estramustine,sarcoidosis,"lck proto-oncogene, src family tyrosine kinase"
12994,zolpidem,castleman disease,potassium voltage-gated channel subfamily q member 3
12995,pioglitazone,klinefelter syndrome,histone deacetylase 9
12996,mizolastine,dermatitis,cubilin
12997,raltegravir,streptococcal meningitis,tubulin epsilon 1
12998,alclometasone dipropionate,small intestine cancer,calcium voltage-gated channel auxiliary subunit alpha2delta 1
12999,rilmenidine,lewy body dementia,atp binding cassette subfamily c member 9
13000,sertraline,type 1 diabetes mellitus,prostaglandin i2 receptor
13001,zolpidem,respiratory syncytial virus infectious disease,vitamin d receptor
13002,carmustine,chronic schizophrenia,mechanistic target of rapamycin kinase
13003,ivacaftor,torsades de pointes,pre-mrna splicing tri-snrnp complex factor prpf4
13004,dabigatran etexilate,glaucoma,dihydropyrimidine dehydrogenase
13005,carvedilol,breast neoplasm,solute carrier family 12 member 3
13006,betahistine,allergic rhinitis,lipoprotein lipase
13007,carbetocin,pancreatic adenocarcinoma,gamma-aminobutyric acid type a receptor subunit theta
13008,promazine,hairy cell leukemia,eph receptor b2
13009,phenprocoumon,sarcoidosis,dna topoisomerase i
13010,valsartan,common wart,prostaglandin e receptor 4
13011,orciprenaline,thyroid gland papillary carcinoma,calcium voltage-gated channel subunit alpha1 f
13012,nevirapine,sickle cell anemia,serine/threonine kinase 10
13013,baricitinib,miliary tuberculosis,sphingomyelin phosphodiesterase 1
13014,telmisartan,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 21 subfamily a member 2
13015,promazine,autoimmune disease,"pim-2 proto-oncogene, serine/threonine kinase"
13016,nitisinone,osteomalacia,glutamate ionotropic receptor kainate type subunit 2
13017,topotecan,ovarian epithelial tumor,ryanodine receptor 1
13018,octreotide,vasomotor rhinitis,potassium voltage-gated channel subfamily c member 1
13019,vincristine,prostate cancer,tubulin delta 1
13020,rofecoxib,headache,cytochrome p450 family 51 subfamily a member 1
13021,desoximetasone,keloid,bone morphogenetic protein receptor type 1b
13022,azilsartan medoxomil,breast neoplasm,"blk proto-oncogene, src family tyrosine kinase"
13023,ergometrine,eunuchism,sodium channel epithelial 1 subunit gamma
13024,polythiazide,waldenstrom macroglobulinemia,bone morphogenetic protein receptor type 1b
13025,felbinac,malignant colon neoplasm,calcium voltage-gated channel auxiliary subunit alpha2delta 1
13026,vardenafil,xerophthalmia,histone deacetylase 4
13027,piretanide,malaria,24-dehydrocholesterol reductase
13028,anastrozole,thyroid tumor,phosphodiesterase 7a
13029,chlorpropamide,patent ductus arteriosus,tubulin beta 1 class vi
13030,zaleplon,mantle cell lymphoma,kallikrein b1
13031,propylthiouracil,congestive heart failure,guanylate cyclase 1 soluble subunit alpha 2
13032,lidocaine,head and neck neoplasm,progesterone receptor
13033,betamethasone,acute coronary syndrome,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
13034,losartan,pyoderma gangrenosum,tubulin beta 4b class ivb
13035,ebastine,laryngeal edema,calreticulin
13036,sirolimus,social phobia,cytochrome p450 family 2 subfamily c member 9
13037,oxyphencyclimine,dermatomyositis,metabolism of cobalamin associated b
13038,mirodenafil,dermatofibrosarcoma protuberans,epoxide hydrolase 2
13039,ponatinib,amyloidosis,propionyl-coa carboxylase subunit beta
13040,minocycline,lymphangioma,gamma-aminobutyric acid type a receptor subunit beta3
13041,lenalidomide,common wart,"protein phosphatase 3 regulatory subunit b, alpha"
13042,diazoxide,west syndrome,tubulin beta 2a class iia
13043,isotretinoin,gonorrhea,potassium voltage-gated channel modifier subfamily v member 2
13044,lafutidine,osteoarthritis,fatty acid amide hydrolase
13045,anagliptin,motion sickness,sulfotransferase family 1a member 1
13046,candesartan,gingivitis,thyroid stimulating hormone receptor
13047,spiperone,heart failure,serpin family c member 1
13048,pentostatin,ascites,sigma non-opioid intracellular receptor 1
13049,triamcinolone,erdheim-chester disease,tyrosine kinase non receptor 2
13050,dofetilide,duodenal ulcer,tachykinin precursor 1
13051,aclidinium,peptic esophagitis,opioid receptor delta 1
13052,eprosartan,rhinoscleroma,"jun proto-oncogene, ap-1 transcription factor subunit"
13053,estramustine,pemphigus,solute carrier family 2 member 9
13054,fluoxetine,thrombocytopenia,apolipoprotein b
13055,pilocarpine,intrinsic asthma,epidermal growth factor receptor
13056,penbutolol,type 1 diabetes mellitus,cubilin
13057,eletriptan,aspiration pneumonitis,solute carrier family 12 member 2
13058,spironolactone,liver cancer,ribonucleotide reductase regulatory subunit m2
13059,imipramine,dyspnea,potassium voltage-gated channel subfamily h member 7
13060,methoxamine,psoriasis,calcium voltage-gated channel subunit alpha1 g
13061,pemirolast,keratitis,myosin light chain kinase family member 4
13062,tipranavir,gestational trophoblastic neoplasm,calreticulin
13063,clotrimazole,female infertility,steroid 5 alpha-reductase 1
13064,pirbuterol,acute coronary syndrome,potassium voltage-gated channel subfamily h member 3
13065,everolimus,x-linked dominant hypophosphatemic rickets,serine/threonine kinase 11
13066,benzquinamide,dermatophytosis of groin and perianal area,proteasome 20s subunit beta 10
13067,finasteride,endometrial carcinoma,"kras proto-oncogene, gtpase"
13068,trichlormethiazide,bursitis,alpha glucosidase
13069,ethotoin,erdheim-chester disease,mitogen-activated protein kinase kinase kinase 9
13070,udenafil,"cicatrix, hypertrophic",aldehyde dehydrogenase 5 family member a1
13071,midazolam,diabetes mellitus,"lipase f, gastric type"
13072,nateglinide,pityriasis versicolor,salt inducible kinase 1
13073,dapagliflozin,classic hodgkin lymphoma,acyl-coa oxidase 1
13074,dabigatran etexilate,severe major depression with psychotic features,hyperpolarization activated cyclic nucleotide gated potassium channel 3
13075,dorzolamide,enterobiasis,protein phosphatase 3 catalytic subunit alpha
13076,obinutuzumab,orthostatic hypotension,sodium voltage-gated channel alpha subunit 3
13077,pyrimethamine,breast neoplasm,prune exopolyphosphatase 1
13078,quinapril,pain,microtubule associated protein 2
13079,dibucaine,psychosexual disorder,potassium voltage-gated channel subfamily a member 1
13080,felbinac,classic phenylketonuria,5-hydroxytryptamine receptor 2a
13081,ketorolac,superficial multifocal basal cell carcinoma,potassium voltage-gated channel subfamily b member 2
13082,conivaptan,waldenstrom macroglobulinemia,5-methyltetrahydrofolate-homocysteine methyltransferase
13083,zonisamide,schizoaffective disorder,phosphodiesterase 11a
13084,diazoxide,bulimia nervosa,"raf-1 proto-oncogene, serine/threonine kinase"
13085,ribavirin,erythema multiforme,phosphodiesterase 8b
13086,fludroxycortide,prinzmetal angina,myristoylated alanine rich protein kinase c substrate
13087,docetaxel,congenital hypothyroidism,phosphodiesterase 10a
13088,benzbromarone,autism spectrum disorder,gamma-aminobutyric acid type a receptor subunit pi
13089,phendimetrazine,tinea corporis,tyrosinase
13090,chlorhexidine,adrenal gland hyperfunction,insulin receptor
13091,raloxifene,thrombophilia due to thrombin defect,superoxide dismutase 1
13092,ketorolac,tendinopathy,androgen receptor
13093,sirolimus,tinea pedis,phosphodiesterase 6a
13094,phendimetrazine,congenital adrenal hyperplasia,tec protein tyrosine kinase
13095,prazosin,gaucher disease,solute carrier family 12 member 3
13096,vinblastine,"cicatrix, hypertrophic",potassium voltage-gated channel subfamily q member 3
13097,chlophedianol,erectile dysfunction,tyrosinase
13098,riociguat,common cold,gamma-aminobutyric acid type a receptor subunit alpha3
13099,almitrine,wilms tumor,calcium voltage-gated channel auxiliary subunit alpha2delta 2
13100,clobetasol propionate,dysmenorrhea,potassium voltage-gated channel subfamily h member 5
13101,azilsartan medoxomil,hypersensitivity pneumonitis,peptidylprolyl isomerase b
13102,stanozolol,amyloidosis,solute carrier family 12 member 3
13103,azelaic acid,stroke disorder,c-x-c motif chemokine receptor 4
13104,docetaxel,trichuriasis,guanylate cyclase 1 soluble subunit alpha 1
13105,cefalotin,abdominal abscess,kallikrein b1
13106,darunavir,aplastic anemia,fkbp prolyl isomerase 4
13107,olmesartan,psychosexual disorder,neuropeptide y receptor y1
13108,butenafine,short bowel syndrome,phosphodiesterase 2a
13109,pemetrexed,testicular cancer,gamma-aminobutyric acid type a receptor subunit alpha2
13110,topotecan,tinea pedis,glutamate ionotropic receptor nmda type subunit 3a
13111,levocabastine,cardiogenic shock,cytochrome p450 family 1 subfamily b member 1
13112,omarigliptin,anxiety disorder,tek receptor tyrosine kinase
13113,cyclosporin a,eunuchism,adenosine a2a receptor
13114,cabergoline,gonorrhea,fkbp prolyl isomerase 1b
13115,venlafaxine,urethritis,calcium voltage-gated channel subunit alpha1 c
13116,clopidogrel,nicotine dependence,phosphodiesterase 7b
13117,dicumarol,postoperative nausea and vomiting,calcium voltage-gated channel auxiliary subunit alpha2delta 2
13118,atazanavir,hyperprolactinemia,opioid receptor mu 1
13119,desvenlafaxine,dyspnea,histone deacetylase 5
13120,fluvoxamine,brain edema,metabolism of cobalamin associated c
13121,udenafil,prader-willi syndrome,"dna polymerase delta 1, catalytic subunit"
13122,troglitazone,dermatitis,"ran, member ras oncogene family"
13123,lorcaserin,bacterial endocarditis,cysteinyl leukotriene receptor 2
13124,nedocromil,hypophosphatemia,serpin family c member 1
13125,nevirapine,"familial amyloid neuropathy, portuguese type",receptor interacting serine/threonine kinase 3
13126,phenelzine,vernal conjunctivitis,histamine receptor h2
13127,olaparib,sympathetic ophthalmia,potassium voltage-gated channel subfamily d member 3
13128,mitomycin c,postherpetic neuralgia,cathepsin g
13129,salsalate,malignant hyperthermia of anesthesia,carbonic anhydrase 2
13130,ranitidine,otitis externa,"lipase f, gastric type"
13131,adinazolam,hypereosinophilic syndrome,platelet activating factor receptor
13132,atorvastatin,congenital adrenal hyperplasia,dual specificity tyrosine phosphorylation regulated kinase 1b
13133,loperamide,type 1 diabetes mellitus,bcl2 like 2
13134,furosemide,methylmalonic acidemia,angiotensin i converting enzyme
13135,nimodipine,noonan syndrome,atp binding cassette subfamily g member 5
13136,topiroxostat,idiopathic hypereosinophilic syndrome,glucagon like peptide 2 receptor
13137,calcipotriol,hemangioma,unc-51 like autophagy activating kinase 1
13138,diazoxide,cardiac arrest,5-hydroxytryptamine receptor 1f
13139,fingolimod,osteoporosis,cytochrome p450 family 2 subfamily j member 2
13140,valsartan,common wart,aurora kinase c
13141,metoprolol,shock,thromboxane a2 receptor
13142,benazepril,necrobiosis lipoidica,natriuretic peptide b
13143,pentostatin,intracranial embolism,phosphodiesterase 10a
13144,masoprocol,cardiogenic shock,dual specificity tyrosine phosphorylation regulated kinase 2
13145,tipranavir,endometritis,adrenoceptor beta 3
13146,echothiophate,pediculus humanus capitis infestation,solute carrier family 12 member 1
13147,chlophedianol,thyroid crisis,glutamate ionotropic receptor kainate type subunit 4
13148,masoprocol,pituitary dwarfism,phospholipase a2 group ib
13149,isosorbide mononitrate,constipation disorder,phosphodiesterase 8a
13150,desoximetasone,systemic lupus erythematosus,5-hydroxytryptamine receptor 1e
13151,phendimetrazine,congestive heart failure,carbonic anhydrase 4
13152,cabozantinib,vitamin deficiency disorder,histone deacetylase 2
13153,pirenzepine,aspiration pneumonia,dopamine receptor d5
13154,tranylcypromine,opiate dependence,serine/threonine kinase 10
13155,perphenazine,hyperinsulinism,solute carrier family 5 member 6
13156,perospirone,escherichia coli infection,metallothionein 1a
13157,hydrocodone,restless legs syndrome,glutamic-oxaloacetic transaminase 1
13158,lenalidomide,inflammatory bowel disease,estrogen receptor 2
13159,vandetanib,tenosynovitis,"lck proto-oncogene, src family tyrosine kinase"
13160,trospium chloride,hemorrhoid,ryanodine receptor 2
13161,doxazosin,breast ductal adenocarcinoma,potassium voltage-gated channel subfamily a member 3
13162,valbenazine,plasmodium malariae malaria,follicle stimulating hormone receptor
13163,propylthiouracil,bronchial disorder,gamma-aminobutyric acid type a receptor subunit alpha2
13164,nicardipine,bipolar depression,atp binding cassette subfamily a member 1
13165,pimecrolimus,bruxism,delta like non-canonical notch ligand 1
13166,carfilzomib,atopic conjunctivitis,phosphodiesterase 1c
13167,azelaic acid,iritis,sodium voltage-gated channel alpha subunit 11
13168,vilazodone,subarachnoid hemorrhage,kelch like ech associated protein 1
13169,trilostane,cycloplegia,serine/threonine kinase 4
13170,panobinostat,thyroid gland carcinoma,proteasome 20s subunit beta 1
13171,penicillamine,plasmodium falciparum malaria,c-x-c motif chemokine receptor 4
13172,aceclofenac,exfoliative dermatitis,potassium inwardly rectifying channel subfamily j member 12
13173,topotecan,acromegaly,toll like receptor 9
13174,phenelzine,thyroid gland papillary carcinoma,kinase insert domain receptor
13175,pramipexole,hyperbilirubinemia,glutamate ionotropic receptor kainate type subunit 4
13176,piribedil,thrombocytopenia,pre-mrna processing factor kinase prp4k
13177,mizolastine,endometrial carcinoma,melanocortin 3 receptor
13178,oxprenolol,tetanus,solute carrier family 22 member 5
13179,tolcapone,eosinophilic pneumonia,cytochrome p450 family 24 subfamily a member 1
13180,atazanavir,cryopyrin-associated periodic syndrome,guanylate cyclase 2c
13181,levomethadyl acetate,ascariasis,glutamate ionotropic receptor nmda type subunit 3b
13182,carvedilol,chronic obstructive pulmonary disease,histamine receptor h3
13183,eptifibatide,hyperinsulinism,proteasome 20s subunit beta 2
13184,sertindole,"cicatrix, hypertrophic",nischarin
13185,diphenhydramine,seasonal affective disorder,fkbp prolyl isomerase 1b
13186,diphenylpyraline,glossopharyngeal neuralgia,dopamine receptor d3
13187,flurazepam,localized scleroderma,cytochrome p450 family 2 subfamily c member 19
13188,trifluridine,tachycardia,potassium voltage-gated channel subfamily c member 2
13189,secobarbital,renal cell carcinoma,adenosine a1 receptor
13190,tiaprofenic acid,serum sickness,potassium inwardly rectifying channel subfamily j member 2
13191,amphetamine,acquired thrombocytopenia,glutathione s-transferase mu 1
13192,mupirocin,metastatic melanoma,methylmalonyl-coa mutase
13193,docetaxel,chronic bronchitis,glutamic-oxaloacetic transaminase 1
13194,fondaparinux,acute coronary syndrome,glutathione s-transferase alpha 2
13195,benzphetamine,sickle cell anemia,leukotriene a4 hydrolase
13196,cinnarizine,thromboembolism,atp binding cassette subfamily c member 3
13197,levomethadyl acetate,poems syndrome,carbonic anhydrase 2
13198,captodiame,hyperlipidemia,solute carrier family 27 member 2
13199,conjugated estrogens,periodontitis,mitogen-activated protein kinase kinase kinase 19
13200,fesoterodine,obesity disorder,fkbp prolyl isomerase 1b
13201,guanadrel,thyroiditis,cholinergic receptor nicotinic alpha 5 subunit
13202,rotigotine,chronic hepatitis c virus infection,doublecortin like kinase 3
13203,zuclopenthixol,pruritus,"major histocompatibility complex, class i, a"
13204,carbidopa,neuralgia,calcium voltage-gated channel subunit alpha1 s
13205,pralatrexate,acquired polycythemia vera,"lipase f, gastric type"
13206,etizolam,fibromyalgia,unc-51 like kinase 3
13207,bezafibrate,iridocyclitis,"coagulation factor ii, thrombin"
13208,almotriptan,periodontitis,calcium voltage-gated channel subunit alpha1 b
13209,glucagon,migraine disorder,sodium voltage-gated channel alpha subunit 11
13210,tolazamide,dyschromatosis universalis hereditaria,activin a receptor type 1
13211,orlistat,scalp dermatosis,cyclin dependent kinase 6
13212,vernakalant,hypoglycemia,propionyl-coa carboxylase subunit beta
13213,bortezomib,severe major depression with psychotic features,janus kinase 3
13214,eliglustat,pharyngitis,solute carrier family 12 member 1
13215,leflunomide,pediculus humanus capitis infestation,serine/threonine kinase 11
13216,budesonide,chronic eosinophilic leukemia,bcl2 like 2
13217,reproterol,congestive heart failure,5-hydroxytryptamine receptor 6
13218,captodiame,spasticity,glutamate ionotropic receptor kainate type subunit 3
13219,acebutolol,homocystinuria,solute carrier family 25 member 5
13220,amiodarone,myeloproliferative neoplasm,proteasome 20s subunit beta 10
13221,guanethidine,actinic keratosis,phosphoribosyl pyrophosphate amidotransferase
13222,histamine,kaposi's sarcoma,myosin heavy chain 10
13223,difenoxin,brain cancer,n-acylsphingosine amidohydrolase 1
13224,probucol,hypereosinophilic syndrome,leucine rich repeat kinase 2
13225,chlorothiazide,interstitial lung disease 2,discoidin domain receptor tyrosine kinase 2
13226,promethazine,hypoactive sexual desire disorder,bone gamma-carboxyglutamate protein
13227,pentostatin,premature ventricular contraction,dipeptidyl peptidase 9
13228,ciprofloxacin,cervical cancer,mitogen-activated protein kinase kinase kinase 9
13229,pentostatin,status epilepticus,serine/threonine kinase 33
13230,mometasone,exanthem,cholinergic receptor nicotinic alpha 4 subunit
13231,sulindac,diabetes mellitus,phosphodiesterase 7b
13232,crisaborole,crohn disease,butyrylcholinesterase
13233,fomepizole,impetigo,adenosine a3 receptor
13234,choline,precocious puberty,cannabinoid receptor 1
13235,acetylcholine,focal epilepsy,potassium inwardly rectifying channel subfamily j member 12
13236,bazedoxifene,ascariasis,tyrosine kinase non receptor 1
13237,floctafenine,tetany,integrin subunit alpha 2b
13238,doxepin,hepatocellular carcinoma,retinoic acid receptor alpha
13239,colchicine,precocious puberty,"glucosidase alpha, neutral c"
13240,isoxsuprine,supraventricular tachycardia,amylase alpha 1b
13241,guanabenz,ascariasis,potassium voltage-gated channel subfamily c member 3
13242,doxapram,hypophosphatemia,bcl2 like 2
13243,famotidine,neonatal diabetes mellitus,eph receptor b2
13244,phenacemide,hypercholesterolemia,isoleucyl-trna synthetase 1
13245,efavirenz,erythropoietic protoporphyria,adrenoceptor beta 2
13246,almotriptan,ascites,15-hydroxyprostaglandin dehydrogenase
13247,olodaterol,mast cell leukemia,sodium voltage-gated channel alpha subunit 2
13248,clomiphene,rhinitis,estrogen receptor 1
13249,diethylcarbamazine,central nervous system origin vertigo,polo like kinase 4
13250,halcinonide,hyperlipoproteinemia type 3,cholinergic receptor nicotinic beta 2 subunit
13251,epinastine,chronic myelomonocytic leukemia,fms related receptor tyrosine kinase 4
13252,benoxaprofen,acute interstitial pneumonia,prostaglandin e receptor 2
13253,paliperidone,cough,ornithine decarboxylase 1
13254,enzalutamide,non-small cell lung carcinoma,gonadotropin releasing hormone receptor
13255,podophyllotoxin,thromboembolism,solute carrier family 6 member 1
13256,mitomycin c,homozygous familial hypercholesterolemia,histamine receptor h1
13257,norfloxacin,gingivitis,endothelin receptor type a
13258,methyltestosterone,breast ductal adenocarcinoma,histone deacetylase 8
13259,thioguanine,cough,axl receptor tyrosine kinase
13260,nedocromil,cluster headache syndrome,sodium voltage-gated channel alpha subunit 10
13261,alogliptin,eye disorder,phosphodiesterase 6c
13262,choline magnesium trisalicylate,psychotic disorder,retinoid x receptor gamma
13263,triazolam,benign prostatic hyperplasia,atpase na+/k+ transporting subunit alpha 4
13264,trospium chloride,myocardial infarction,nuclear receptor subfamily 3 group c member 2
13265,dopamine,rickets,serine/threonine kinase 10
13266,zuclopenthixol,frozen shoulder,solute carrier family 22 member 2
13267,loratadine,diffuse large b-cell lymphoma,s100 calcium binding protein p
13268,alprazolam,fabry disease,calcium voltage-gated channel auxiliary subunit alpha2delta 1
13269,glipizide,hyperlipoproteinemia type 3,opioid receptor mu 1
13270,tiagabine,vascular disorder,"yes proto-oncogene 1, src family tyrosine kinase"
13271,vorinostat,obsessive-compulsive disorder,glutamate ionotropic receptor nmda type subunit 1
13272,ibuprofen,"cicatrix, hypertrophic",potassium voltage-gated channel modifier subfamily s member 3
13273,topotecan,b-cell chronic lymphocytic leukemia,low density lipoprotein receptor
13274,ivermectin,tetanus,janus kinase 1
13275,cariprazine,impetigo,phosphorylase kinase catalytic subunit gamma 1
13276,penbutolol,kaposi's sarcoma,calcium voltage-gated channel auxiliary subunit beta 1
13277,amantadine,atrophic vulva,peroxisome proliferator activated receptor gamma
13278,ribavirin,exfoliative dermatitis,"raf-1 proto-oncogene, serine/threonine kinase"
13279,pitavastatin,persistent fetal circulation syndrome,tachykinin precursor 1
13280,lafutidine,thyroid gland carcinoma,protein kinase cgmp-dependent 1
13281,carfilzomib,superficial multifocal basal cell carcinoma,macrophage stimulating 1 receptor
13282,fludroxycortide,pellagra,peptidylprolyl isomerase b
13283,fomepizole,idiopathic acute eosinophilic pneumonia,polo like kinase 4
13284,clobetasol propionate,acidosis disorder,cholinergic receptor nicotinic alpha 7 subunit
13285,carbenoxolone,graves disease,phosphodiesterase 10a
13286,miconazole,acute coronary syndrome,receptor interacting serine/threonine kinase 3
13287,teriflunomide,systemic lupus erythematosus,somatostatin receptor 2
13288,desoximetasone,hairy cell leukemia,fms related receptor tyrosine kinase 3
13289,disulfiram,hypoparathyroidism,ribonucleotide reductase catalytic subunit m1
13290,mebendazole,endometrium neoplasm,bruton tyrosine kinase
13291,colestipol,thyroid gland follicular carcinoma,adrenoceptor alpha 2c
13292,cycrimine,angle-closure glaucoma,fatty acid amide hydrolase
13293,nilotinib,insomnia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
13294,trifluoperazine,hypotensive disorder,calcium voltage-gated channel subunit alpha1 b
13295,tenofovir alafenamide,ascariasis,somatostatin receptor 2
13296,niraparib,gingivitis,discoidin domain receptor tyrosine kinase 1
13297,lorazepam,abdominal infection,bone morphogenetic protein receptor type 1b
13298,norethisterone,onchocerciasis,glutamate ionotropic receptor nmda type subunit 1
13299,eliglustat,type 2 diabetes mellitus,atp binding cassette subfamily c member 2
13300,dexfenfluramine,cryopyrin-associated periodic syndrome,salt inducible kinase 1
13301,eliglustat,acute gonococcal cervicitis,amine oxidase copper containing 1
13302,saquinavir,gynecomastia disorder,glutathione s-transferase mu 1
13303,pimozide,epicondylitis,eph receptor a5
13304,desmopressin,tinea corporis,5-hydroxytryptamine receptor 3c
13305,olaparib,chronic beryllium disease,udp-glucose ceramide glucosyltransferase
13306,phenylbutazone,pain,sodium voltage-gated channel alpha subunit 3
13307,ulobetasol propionate,hypertensive disorder,potassium voltage-gated channel subfamily h member 6
13308,tazarotene,ulcerative colitis,potassium voltage-gated channel modifier subfamily g member 4
13309,clobetasol propionate,psoriasis,tank binding kinase 1
13310,cobicistat,hypophosphatemia,gamma-aminobutyric acid type a receptor subunit gamma3
13311,clemastine,periodontitis,phosphodiesterase 4c
13312,captodiame,hereditary angioedema,mechanistic target of rapamycin kinase
13313,pimecrolimus,prinzmetal angina,serine/threonine kinase 11
13314,felodipine,scalp dermatosis,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
13315,imrecoxib,epicondylitis,cholinergic receptor nicotinic beta 2 subunit
13316,tulobuterol,erectile dysfunction,serine/threonine kinase 25
13317,nizatidine,adrenocortical insufficiency,eph receptor b6
13318,dronedarone,epilepsy,catechol-o-methyltransferase
13319,salbutamol,eunuchism,hydroxysteroid 11-beta dehydrogenase 1
13320,aripiprazole,bacterial meningitis,calmodulin 1
13321,goserelin,pulmonary fibrosis,dipeptidyl peptidase 4
13322,topiramate,pituitary dwarfism,potassium voltage-gated channel subfamily c member 4
13323,benzocaine,thromboangiitis obliterans,septin 9
13324,bupropion,acute intermittent porphyria,serine/threonine kinase 16
13325,fludroxycortide,chronic kidney disease,5-hydroxytryptamine receptor 6
13326,selegiline,anxiety,5-hydroxytryptamine receptor 2c
13327,bumetanide,brain edema,discoidin domain receptor tyrosine kinase 1
13328,dextromethorphan,acute interstitial pneumonia,calmodulin 1
13329,reproterol,chronic beryllium disease,5-hydroxytryptamine receptor 1e
13330,loxoprofen,myasthenia gravis,sigma non-opioid intracellular receptor 1
13331,cladribine,schizoaffective disorder,calcium voltage-gated channel subunit alpha1 i
13332,primidone,psychologic dyspareunia,peptidylprolyl isomerase d
13333,ruxolitinib,lung lymphangioleiomyomatosis,cathepsin g
13334,enzalutamide,discoid lupus erythematosus,myeloperoxidase
13335,dantrolene,trichinellosis,alpha glucosidase
13336,paroxetine,trichinellosis,dopamine receptor d5
13337,brigatinib,anxiety disorder,5-hydroxytryptamine receptor 6
13338,bepotastine,laryngeal edema,nuclear receptor subfamily 1 group i member 2
13339,cabergoline,headache disorder,24-dehydrocholesterol reductase
13340,acth,premature ejaculation,cytochrome p450 family 27 subfamily b member 1
13341,flufenamic acid,nephrotic syndrome,cannabinoid receptor 2
13342,ofloxacin,hemangioma,estrogen receptor 2
13343,treprostinil,pancreatic insulinoma,protein kinase c theta
13344,papaverine,chronic obstructive pulmonary disease,rio kinase 1
13345,l-glutamine,chronic kidney disease,cereblon
13346,colestipol,intracranial embolism,atpase na+/k+ transporting subunit beta 3
13347,ethynodiol diacetate,motion sickness,arginine vasopressin receptor 2
13348,bortezomib,brain glioblastoma,gonadotropin releasing hormone receptor
13349,tipiracil,diamond-blackfan anemia,adrenoceptor alpha 2a
13350,ceritinib,thrombotic disease,"lck proto-oncogene, src family tyrosine kinase"
13351,epinastine,erythema multiforme,phosphorylase kinase catalytic subunit gamma 2
13352,oxymorphone,diabetic kidney disease,kinase insert domain receptor
13353,ticagrelor,lewy body dementia,prostaglandin d2 receptor 2
13354,naltrexone,irritable bowel syndrome,tankyrase 2
13355,estramustine,chancroid,vitamin k epoxide reductase complex subunit 1
13356,trimetaphan,bipolar depression,dopamine receptor d3
13357,rasagiline,diabetes mellitus,3-hydroxy-3-methylglutaryl-coa reductase
13358,quinapril,dermatomyositis,potassium voltage-gated channel subfamily h member 8
13359,efavirenz,pellagra,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
13360,ibandronic acid,scabies,s100 calcium binding protein p
13361,rupatadine,chronic obstructive pulmonary disease,angiotensin ii receptor type 1
13362,methoxamine,intermittent vascular claudication,"kras proto-oncogene, gtpase"
13363,calcifediol,mature t-cell and nk-cell non-hodgkin lymphoma,atp binding cassette subfamily g member 8
13364,bromocriptine,panic disorder,cholinergic receptor nicotinic alpha 5 subunit
13365,ethacrynic acid,skin basal cell carcinoma,gamma-aminobutyric acid type a receptor subunit beta2
13366,glymidine,polymyalgia rheumatica,myosin light chain kinase
13367,mirtazapine,motion sickness,somatostatin receptor 5
13368,buspirone,hypercalcemia disease,srsf protein kinase 3
13369,fludrocortisone,type 2 diabetes mellitus,isoleucyl-trna synthetase 1
13370,landiolol,thyroid gland follicular carcinoma,neutrophil cytosolic factor 1
13371,salsalate,pancreatic insulinoma,cytochrome p450 family 3 subfamily a member 5
13372,azatadine,postmenopausal osteoporosis,phosphodiesterase 4b
13373,lisuride,gynecomastia disorder,phosphodiesterase 3a
13374,perampanel,hodgkins lymphoma,atp binding cassette subfamily c member 9
13375,everolimus,gastric neoplasm,3-hydroxy-3-methylglutaryl-coa reductase
13376,stanozolol,noonan syndrome,5-hydroxytryptamine receptor 3d
13377,megestrol,cryopyrin-associated periodic syndrome,mitogen-activated protein kinase kinase kinase 9
13378,treprostinil,atrioventricular block,bcl2 like 2
13379,torsemide,non-hodgkin lymphoma,glutamate ionotropic receptor nmda type subunit 2b
13380,spirapril,delayed puberty,tubulin beta 2b class iib
13381,dipivefrine,dermatitis herpetiformis,methylmalonyl-coa mutase
13382,silodosin,ulcerative colitis,tubulin beta 6 class v
13383,voglibose,"hydatidiform mole, recurrent, 1",janus kinase 3
13384,clofazimine,headache disorder,thyroid stimulating hormone receptor
13385,amoxapine,decreased cardiac output,sodium voltage-gated channel alpha subunit 4
13386,blonanserin,dermatitis,receptor interacting serine/threonine kinase 2
13387,fingolimod,allergic asthma,serpin family c member 1
13388,pemirolast,oppositional defiant disorder,kelch like ech associated protein 1
13389,amlodipine,chronic beryllium disease,retinoic acid receptor gamma
13390,omarigliptin,basal ganglia disorder,phosphodiesterase 4c
13391,isosorbide mononitrate,drooling,transient receptor potential cation channel subfamily v member 1
13392,alcaftadine,obsessive-compulsive disorder,cannabinoid receptor 2
13393,butorphanol,hyperbilirubinemia,atm serine/threonine kinase
13394,atomoxetine,vitiligo,5-hydroxytryptamine receptor 2b
13395,sertindole,post-partum hemorrhage,synuclein alpha
13396,calcium gluconate,erythropoietic protoporphyria,solute carrier family 22 member 6
13397,ipragliflozin,delirium,sodium voltage-gated channel alpha subunit 11
13398,ipragliflozin,myalgia,interleukin 1 receptor associated kinase 1
13399,hydroxychloroquine,acute interstitial pneumonia,solute carrier family 6 member 4
13400,dihydrotachysterol,disruptive behavior disorder,bcr activator of rhogef and gtpase
13401,anagrelide,altitude sickness,potassium voltage-gated channel subfamily c member 1
13402,mitiglinide,enterocolitis,solute carrier family 12 member 1
13403,lenvatinib,acute gonococcal endometritis,casein kinase 1 delta
13404,fluspirilene,postpartum depression,trace amine associated receptor 1
13405,oxyphencyclimine,pulmonary fibrosis,vitamin k epoxide reductase complex subunit 1
13406,meclofenamic acid,hyperthyroidism,ribosomal protein s6 kinase a1
13407,travoprost,stargardt disease,phosphodiesterase 10a
13408,doxepin,hemophilia a,ribonucleotide reductase regulatory subunit m2
13409,glycopyrrolate,idiopathic acute eosinophilic pneumonia,carbonic anhydrase 7
13410,vonoprazan,tension-type headache,atpase copper transporting beta
13411,fingolimod,glaucoma,calcitonin receptor
13412,fomepizole,asthma-chronic obstructive pulmonary disease overlap syndrome,potassium inwardly rectifying channel subfamily j member 8
13413,clozapine,esophageal cancer,hydroxycarboxylic acid receptor 2
13414,sapropterin,uveitis,sodium voltage-gated channel alpha subunit 3
13415,mitomycin c,bipolar disorder,transthyretin
13416,safinamide,restless legs syndrome,purinergic receptor p2y12
13417,isosorbide mononitrate,plasma cell myeloma,gamma-aminobutyric acid type a receptor subunit alpha2
13418,selexipag,early myoclonic encephalopathy,histone deacetylase 4
13419,amlodipine,oppositional defiant disorder,ste20 like kinase
13420,nitroglycerin,familial mediterranean fever,kelch like ech associated protein 1
13421,dextrothyroxine,chancroid,bcl2 like 1
13422,atorvastatin,multiple sclerosis,growth hormone releasing hormone receptor
13423,agomelatine,intracranial embolism,delta like non-canonical notch ligand 1
13424,carbimazole,chronic bronchitis,nuak family kinase 2
13425,apalutamide,acute gonococcal endometritis,cytochrome p450 family 11 subfamily b member 2
13426,prednisone,eunuchism,g protein-coupled receptor kinase 2
13427,masoprocol,alzheimer disease,cyp3a7-cyp3a51p readthrough
13428,dabigatran etexilate,breast cancer,doublecortin like kinase 3
13429,alteplase,seasonal allergic rhinitis,peroxisome proliferator activated receptor alpha
13430,amantadine,malignant glioma,adrenoceptor beta 3
13431,befunolol,actinic keratosis,g protein-coupled receptor kinase 2
13432,ziconotide,intrinsic asthma,glutathione s-transferase pi 1
13433,verapamil,spasticity,hyperpolarization activated cyclic nucleotide gated potassium channel 4
13434,cilazapril,pemphigus,gamma-aminobutyric acid type a receptor subunit alpha4
13435,phytomenadione,corneal ulcer,glutathione s-transferase mu 1
13436,perampanel,canker sore,prostaglandin-endoperoxide synthase 1
13437,enzalutamide,stevens-johnson syndrome,integrin subunit alpha 2b
13438,acth,pain,phosphodiesterase 6d
13439,isosorbide mononitrate,angina pectoris,phosphodiesterase 6c
13440,diphenhydramine,diarrheal disease,caspase 1
13441,paclitaxel,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",microtubule associated protein 2
13442,thalidomide,bruxism,potassium voltage-gated channel modifier subfamily g member 3
13443,vandetanib,hereditary angioedema,ryanodine receptor 2
13444,tetracycline,dementia,cytochrome p450 family 2 subfamily b member 6
13445,propantheline,dyschromatosis universalis hereditaria,ryanodine receptor 2
13446,trihexyphenidyl,myeloid neoplasm associated with pdgfra rearrangement,solute carrier family 27 member 2
13447,ergocalciferol,nocturnal enuresis,farnesyl diphosphate synthase
13448,naloxone,primary cutaneous t-cell non-hodgkin lymphoma,tubulin delta 1
13449,almitrine,parkinsonian disorder,ribosomal protein s6 kinase a2
13450,cyproheptadine,benign prostatic hyperplasia,cytochrome p450 family 1 subfamily a member 2
13451,verapamil,vitamin d deficiency,carbonic anhydrase 14
13452,rivaroxaban,dermatitis,5-hydroxytryptamine receptor 3b
13453,promazine,lymphangioma,unc-51 like kinase 3
13454,macitentan,breast ductal adenocarcinoma,udp-glucose ceramide glucosyltransferase
13455,lansoprazole,pulmonary fibrosis,atpase h+/k+ transporting subunit alpha
13456,dutasteride,langerhans cell histiocytosis,cereblon
13457,carbidopa,interstitial lung disease,angiotensin ii receptor type 2
13458,methotrexate,nephrotic syndrome,guanylate cyclase 1 soluble subunit alpha 1
13459,balsalazide,erdheim-chester disease,apolipoprotein a1
13460,pge1,pyoderma gangrenosum,solute carrier family 47 member 1
13461,desonide,hypersensitivity pneumonitis,mitogen-activated protein kinase kinase kinase 7
13462,procyclidine,psoriasis,xanthine dehydrogenase
13463,norfloxacin,common wart,calcium voltage-gated channel subunit alpha1 s
13464,almitrine,irritable bowel syndrome,guanylate cyclase 1 soluble subunit alpha 1
13465,fomepizole,corneal ulcer,integrin subunit alpha l
13466,hydromorphone,synovitis,guanylate cyclase 2c
13467,sorafenib,malignant essential hypertension,potassium voltage-gated channel modifier subfamily g member 2
13468,fentanyl,polymyalgia rheumatica,atp binding cassette subfamily c member 2
13469,letrozole,hypoactive sexual desire disorder,melatonin receptor 1a
13470,terfenadine,anterior uveitis,vitamin k epoxide reductase complex subunit 1
13471,nafarelin,atopic conjunctivitis,potassium voltage-gated channel subfamily c member 3
13472,pitavastatin,hyperbilirubinemia,somatostatin receptor 2
13473,pentobarbitone,vascular headaches,testis specific serine kinase 1b
13474,abacavir,choroiditis,carbonic anhydrase 3
13475,diphenhydramine,dry eye syndrome,histone deacetylase 1
13476,metaraminol,bacterial pneumonia,hypoxanthine phosphoribosyltransferase 1
13477,colecalciferol,relapsing-remitting multiple sclerosis,homeodomain interacting protein kinase 2
13478,ospemifene,necrobiosis lipoidica,atpase h+ transporting v1 subunit a
13479,insulin detemir,thyroid gland papillary carcinoma,mitogen-activated protein kinase kinase 5
13480,tofacitinib,respiratory failure,tankyrase 2
13481,pinacidil,pernicious anemia,bcl2 apoptosis regulator
13482,propafenone,focal epilepsy,leukotriene c4 synthase
13483,fondaparinux,autoimmune disease,gamma-glutamyl carboxylase
13484,ecallantide,seborrheic dermatitis,glutamate ionotropic receptor kainate type subunit 1
13485,clomiphene,sarcoidosis,retinoid x receptor alpha
13486,biperiden,pulmonary fibrosis,eph receptor a3
13487,allopurinol,disruptive behavior disorder,nuclear receptor subfamily 3 group c member 1
13488,valdecoxib,dermatofibrosarcoma protuberans,mitogen-activated protein kinase kinase kinase 19
13489,nimodipine,mantle cell lymphoma,cytochrome p450 family 19 subfamily a member 1
13490,mestranol,ovarian cancer,activin a receptor type 1
13491,anastrozole,non-small cell lung carcinoma,succinate dehydrogenase complex flavoprotein subunit a
13492,reboxetine,rhinoscleroma,leukocyte receptor tyrosine kinase
13493,clomipramine,glaucoma,aldo-keto reductase family 1 member c3
13494,tandospirone,postpartum depression,5-methyltetrahydrofolate-homocysteine methyltransferase
13495,dextrothyroxine,epicondylitis,"dna polymerase alpha 1, catalytic subunit"
13496,azatadine,back pain,calcyon neuron specific vesicular protein
13497,diazoxide,bone paget disease,inositol monophosphatase 1
13498,docetaxel,pulmonary embolism,vascular endothelial growth factor a
13499,telmisartan,tetany,janus kinase 1
13500,clonazepam,hypertrichosis of eyelid,prostaglandin e receptor 2
13501,chlordiazepoxide,aspiration pneumonitis,toll like receptor 7
13502,beclometasone,myeloproliferative neoplasm,"lck proto-oncogene, src family tyrosine kinase"
13503,vildagliptin,leiomyosarcoma,solute carrier family 12 member 3
13504,carboplatin,necrobiosis lipoidica,cyclin dependent kinase 6
13505,trospium chloride,scleroderma,janus kinase 1
13506,isopropamide,dyschromatosis universalis hereditaria,neurotrophic receptor tyrosine kinase 1
13507,vinblastine,prostate cancer,receptor interacting serine/threonine kinase 3
13508,fluocinonide,acute gonococcal cervicitis,thymidine phosphorylase
13509,menatetrenone,fibromyalgia,solute carrier family 7 member 11
13510,atorvastatin,"dermatitis, atopic",selectin e
13511,eletriptan,"malignant hyperthermia, susceptibility to, 1",propionyl-coa carboxylase subunit alpha
13512,aceclofenac,punctate epithelial keratoconjunctivitis,carbonic anhydrase 12
13513,trimetazidine,social phobia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
13514,tamibarotene,chronic pain,gamma-aminobutyric acid type a receptor subunit alpha6
13515,reproterol,plasmodium malariae malaria,prostaglandin-endoperoxide synthase 1
13516,zonisamide,congenital hypothyroidism,melatonin receptor 1b
13517,nicardipine,canker sore,melatonin receptor 1a
13518,alimemazine,eunuchism,cytochrome p450 family 2 subfamily c member 8
13519,glisoxepide,trigeminal neuralgia,receptor interacting serine/threonine kinase 3
13520,pseudoephedrine,osteomalacia,cdc like kinase 2
13521,clopidogrel,gestational trophoblastic neoplasm,glutamate ionotropic receptor nmda type subunit 2a
13522,vandetanib,xerophthalmia,coagulation factor x
13523,vemurafenib,opiate dependence,5-hydroxytryptamine receptor 3a
13524,rufinamide,acute monocytic leukemia,guanylate cyclase 1 soluble subunit alpha 1
13525,dorzolamide,status epilepticus,"fyn proto-oncogene, src family tyrosine kinase"
13526,salicylamide,congenital adrenal hyperplasia,udp-glucose ceramide glucosyltransferase
13527,gemtuzumab ozogamicin,neoplasm of esophagus,interleukin 1 beta
13528,etelcalcetide,toxic shock syndrome,toll like receptor 2
13529,biotin,punctate epithelial keratoconjunctivitis,cholinergic receptor muscarinic 4
13530,guanadrel,epilepsy,histamine receptor h3
13531,meclizine,dyspepsia,phospholipase a2 group iie
13532,loxoprofen,ovarian epithelial tumor,low density lipoprotein receptor
13533,digoxin,prostate cancer,tubulin alpha 1a
13534,nicardipine,cardiogenic shock,epoxide hydrolase 2
13535,azilsartan medoxomil,chancroid,structural maintenance of chromosomes 1a
13536,balsalazide,acute monocytic leukemia,potassium voltage-gated channel subfamily h member 2
13537,n-methyl scopolamine,chancroid,interleukin 1 receptor associated kinase 1
13538,lamotrigine,trichuriasis,sodium voltage-gated channel alpha subunit 8
13539,benzocaine,psychologic dyspareunia,potassium voltage-gated channel subfamily a member 10
13540,lenvatinib,alzheimer disease,phosphodiesterase 4c
13541,orphenadrine,postmenopausal atrophic vaginitis,eukaryotic translation initiation factor 4e
13542,clofibrate,pulmonary fibrosis,cytochrome p450 family 2 subfamily r member 1
13543,masoprocol,chronic primary adrenal insufficiency,histone deacetylase 5
13544,cilostazol,rhabdomyosarcoma,tubulin delta 1
13545,valrubicin,neonatal diabetes mellitus,c-x-c motif chemokine receptor 4
13546,vindesine,renal osteodystrophy,somatostatin receptor 5
13547,gemigliptin,peripheral vascular disease,testis specific serine kinase 1b
13548,5-fluorouracil,headache disorder,histamine receptor h4
13549,leuprolide,hypoparathyroidism,epoxide hydrolase 2
13550,teriflunomide,hypoalphalipoproteinemia,potassium voltage-gated channel subfamily q member 3
13551,doxorubicin,polyuria,transient receptor potential cation channel subfamily v member 3
13552,oxcarbazepine,acne,dihydrofolate reductase
13553,tofacitinib,alzheimer disease,interleukin 11 receptor subunit alpha
13554,acenocoumarol,diffuse large b-cell lymphoma,"abl proto-oncogene 1, non-receptor tyrosine kinase"
13555,regorafenib,tendinopathy,histamine receptor h4
13556,salicylic acid,malignant pleural mesothelioma,sodium voltage-gated channel alpha subunit 1
13557,epirubicin,vulvovaginal candidiasis,cf transmembrane conductance regulator
13558,guanfacine,urinary retention,dihydrofolate reductase
13559,vonoprazan,"familial amyloid neuropathy, portuguese type","hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
13560,n-methyl scopolamine,peptic ulcer disease,potassium voltage-gated channel subfamily c member 3
13561,selumetinib,zollinger-ellison syndrome,aldehyde dehydrogenase 2 family member
13562,guanethidine,pellagra,calcium voltage-gated channel auxiliary subunit alpha2delta 2
13563,warfarin,enterocolitis,serine/threonine kinase 17a
13564,formoterol,temporal arteritis,gamma-aminobutyric acid type a receptor subunit beta1
13565,carbamazepine,hepatocellular carcinoma,macrophage migration inhibitory factor
13566,benzbromarone,congestive heart failure,ribosomal protein l3
13567,lercanidipine,xerophthalmia,bruton tyrosine kinase
13568,raltegravir,hypertriglyceridemia,hydroxycarboxylic acid receptor 2
13569,sirolimus,dry eye syndrome,ornithine transcarbamylase
13570,valdecoxib,gastric neoplasm,gamma-aminobutyric acid type a receptor subunit gamma1
13571,befunolol,allergic asthma,atpase h+ transporting v1 subunit a
13572,hydralazine,diffuse alopecia areata,5-hydroxytryptamine receptor 2a
13573,agomelatine,trichinellosis,potassium inwardly rectifying channel subfamily j member 2
13574,trazodone,vulvovaginal candidiasis,atm serine/threonine kinase
13575,fludarabine,cough,7-dehydrocholesterol reductase
13576,ziprasidone,neurogenic bladder,"met proto-oncogene, receptor tyrosine kinase"
13577,chlorothiazide,head and neck neoplasm,delta like non-canonical notch ligand 1
13578,dobutamine,thyroid tumor,complement c5
13579,sofalcone,osteoporosis,dipeptidyl peptidase 4
13580,propranolol,ascariasis,dna topoisomerase ii beta
13581,nateglinide,cervical cancer,5-methyltetrahydrofolate-homocysteine methyltransferase
13582,bezafibrate,common cold,methylenetetrahydrofolate reductase
13583,betamethasone,intrinsic asthma,calcyon neuron specific vesicular protein
13584,dexamfetamine,bruxism,cholinergic receptor nicotinic alpha 3 subunit
13585,trabectedin,gaucher disease,transient receptor potential cation channel subfamily v member 3
13586,fluoxetine,short bowel syndrome,atpase na+/k+ transporting subunit beta 2
13587,riboflavin,polymyalgia rheumatica,5-hydroxytryptamine receptor 7
13588,clofazimine,postherpetic neuralgia,protein kinase n2
13589,fexofenadine,pulmonary edema,gamma-aminobutyric acid type a receptor subunit alpha3
13590,rofecoxib,erectile dysfunction,casein kinase 1 delta
13591,docetaxel,epilepsy with generalized tonic-clonic seizures,5-hydroxytryptamine receptor 1f
13592,olmutinib,altitude sickness,phenylalanine hydroxylase
13593,blonanserin,nasal congestion,glutamate ionotropic receptor kainate type subunit 2
13594,ixabepilone,trigeminal neuralgia,potassium calcium-activated channel subfamily n member 4
13595,plerixafor,colonic neoplasm,"dna polymerase delta 1, catalytic subunit"
13596,choline magnesium trisalicylate,allergic urticaria,platelet derived growth factor receptor beta
13597,lorcaserin,tendinitis,5-methyltetrahydrofolate-homocysteine methyltransferase
13598,levofloxacin,diffuse alopecia areata,solute carrier family 22 member 2
13599,clopidogrel,obesity disorder,udp glucuronosyltransferase family 1 member a1
13600,biperiden,allergic urticaria,cytochrome p450 family 2 subfamily c member 19
13601,emtricitabine,hairy cell leukemia,calcium voltage-gated channel subunit alpha1 h
13602,azatadine,congestive heart failure,serine/threonine kinase 17a
13603,dextromethorphan,scleroderma,"elastase, neutrophil expressed"
13604,cisapride,nausea,atpase copper transporting beta
13605,pethidine,labor pain,opioid related nociceptin receptor 1
13606,insulin glargine,skin disorder,sodium voltage-gated channel alpha subunit 3
13607,tretinoin,hyperlipidemia,colony stimulating factor 1 receptor
13608,cefonicid,interstitial lung disease 2,cyclin dependent kinase 19
13609,vilanterol,cervical cancer,hydroxycarboxylic acid receptor 3
13610,methylprednisolone,male infertility,somatostatin receptor 5
13611,carfilzomib,gastroesophageal reflux disease,sonic hedgehog signaling molecule
13612,vardenafil,serum sickness,salt inducible kinase 1
13613,heparin,postpartum depression,mechanistic target of rapamycin kinase
13614,migalastat,idiopathic acute eosinophilic pneumonia,sodium voltage-gated channel alpha subunit 5
13615,ruxolitinib,chronic eosinophilic leukemia,gamma-aminobutyric acid type a receptor subunit beta2
13616,mizolastine,premature ventricular contraction,histone deacetylase 7
13617,cisapride,nephrotic syndrome,phenylalanine hydroxylase
13618,fentanyl,autism spectrum disorder,potassium voltage-gated channel subfamily a member 1
13619,icatibant,amenorrhea,cdc like kinase 4
13620,metoclopramide,klinefelter syndrome,integrin subunit beta 3
13621,mitiglinide,thrombotic disease,thyroid peroxidase
13622,etelcalcetide,allergic urticaria,hyperpolarization activated cyclic nucleotide gated potassium channel 4
13623,biperiden,mature t-cell and nk-cell non-hodgkin lymphoma,cholinergic receptor nicotinic alpha 3 subunit
13624,guanethidine,essential hypertension,somatostatin receptor 2
13625,etidronic acid,bacterial pneumonia,dipeptidyl peptidase 4
13626,clonidine,oppositional defiant disorder,potassium voltage-gated channel subfamily q member 1
13627,fenoldopam,malignant essential hypertension,calreticulin
13628,brexpiprazole,manic bipolar affective disorder,5-hydroxytryptamine receptor 1e
13629,paracetamol,metastatic melanoma,5-hydroxytryptamine receptor 2a
13630,clomipramine,vitamin deficiency disorder,mitogen-activated protein kinase 14
13631,riboflavin,hereditary von willebrand disease,gamma-aminobutyric acid type a receptor subunit epsilon
13632,diflunisal,glioma,plasminogen
13633,lisuride,cervical cancer,cytochrome p450 family 2 subfamily c member 19
13634,menatetrenone,benign prostatic hyperplasia,eph receptor a1
13635,methdilazine,postmenopausal osteoporosis,potassium voltage-gated channel subfamily d member 1
13636,paclitaxel,proctitis,solute carrier family 19 member 1
13637,echothiophate,mantle cell lymphoma,synaptic vesicle glycoprotein 2a
13638,cinnarizine,arthritic joint disease,cyclin dependent kinase 16
13639,ambenonium,postmenopausal osteoporosis,electron transfer flavoprotein dehydrogenase
13640,bosentan,pulmonary emphysema,c-x-c motif chemokine receptor 4
13641,cefalotin,meningococcal meningitis,"pim-2 proto-oncogene, serine/threonine kinase"
13642,mianserin,homocystinuria,histone deacetylase 7
13643,methotrexate,iridocyclitis,5-hydroxytryptamine receptor 6
13644,acetylcholine,x-linked dominant hypophosphatemic rickets,potassium voltage-gated channel subfamily c member 3
13645,zonisamide,raynaud disease,4-hydroxyphenylpyruvate dioxygenase
13646,digoxin,pituitary dwarfism,calcium voltage-gated channel auxiliary subunit gamma 1
13647,alimemazine,thrombocytopenia,neuropeptide y receptor y1
13648,almitrine,acute monocytic leukemia,glucosidase ii alpha subunit
13649,aripiprazole,burkitt lymphoma,mitogen-activated protein kinase kinase kinase 19
13650,sermorelin,post-operative pain,srsf protein kinase 3
13651,phenylephrine,inappropriate adh syndrome,fkbp prolyl isomerase 5
13652,ecallantide,narcolepsy,solute carrier family 12 member 3
13653,fluvoxamine,urinary retention,atp binding cassette subfamily a member 1
13654,pyridostigmine,sjogren syndrome,gamma-aminobutyric acid type a receptor subunit alpha2
13655,morphine,peptic ulcer disease,adrenoceptor beta 2
13656,docetaxel,pulmonary fibrosis,receptor interacting serine/threonine kinase 3
13657,labetalol,colonic neoplasm,tubulin beta 2b class iib
13658,somatropin,cervical cancer,histamine receptor h3
13659,albiglutide,arteriosclerosis disorder,cytochrome p450 family 21 subfamily a member 2
13660,secobarbital,delayed puberty,5-hydroxytryptamine receptor 1f
13661,beraprost,propionic acidemia,gamma-aminobutyric acid type a receptor subunit gamma1
13662,conjugated estrogens,breast fibrocystic disease,cf transmembrane conductance regulator
13663,chlorthalidone,onchocerciasis,septin 9
13664,ruxolitinib,acquired polycythemia vera,neurotrophic receptor tyrosine kinase 3
13665,trimetazidine,ascites,protein phosphatase 3 catalytic subunit alpha
13666,desoximetasone,anxiety,solute carrier organic anion transporter family member 1a2
13667,bezafibrate,liver cancer,adrenoceptor beta 3
13668,atazanavir,methylmalonic acidemia,dopamine receptor d2
13669,paracetamol,otitis externa,potassium calcium-activated channel subfamily m alpha 1
13670,dextrothyroxine,endometritis,ret proto-oncogene
13671,triazolam,pyoderma gangrenosum,calcium voltage-gated channel subunit alpha1 h
13672,bosentan,manic bipolar affective disorder,calcium sensing receptor
13673,tafamidis,polymyalgia rheumatica,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
13674,nicotinic acid,common cold,melanocortin 1 receptor
13675,methoxamine,shock,"mpl proto-oncogene, thrombopoietin receptor"
13676,vortioxetine,mast cell leukemia,eph receptor b2
13677,prucalopride,seasonal affective disorder,serine/threonine kinase 4
13678,conjugated estrogens,hypoalphalipoproteinemia,atpase copper transporting beta
13679,promazine,brain cancer,fibroblast growth factor receptor 2
13680,ethacrynic acid,"hydatidiform mole, recurrent, 1",paraoxonase 1
13681,olmutinib,gastroesophageal reflux disease,potassium voltage-gated channel subfamily d member 2
13682,pemetrexed,benign prostatic hyperplasia,aryl hydrocarbon receptor
13683,clomiphene,gout,5-hydroxytryptamine receptor 2c
13684,insulin glulisine,panic disorder,tec protein tyrosine kinase
13685,ergometrine,thrombocytopenia,cytochrome p450 family 1 subfamily a member 2
13686,levomethadyl acetate,malignant colon neoplasm,tumor necrosis factor
13687,probenecid,pulmonary eosinophilia,gamma-aminobutyric acid type a receptor subunit alpha1
13688,ofloxacin,streptococcal meningitis,carbonic anhydrase 2
13689,betahistine,gynecomastia disorder,calcium voltage-gated channel auxiliary subunit beta 2
13690,tranexamic acid,panic disorder,guanylate cyclase 1 soluble subunit alpha 1
13691,vorinostat,systemic lupus erythematosus,"mer proto-oncogene, tyrosine kinase"
13692,cladribine,pharyngitis,solute carrier family 6 member 2
13693,chlorpheniramine,insomnia,annexin a1
13694,glycopyrrolate,lung lymphangioleiomyomatosis,cd33 molecule
13695,valsartan,zollinger-ellison syndrome,unc-51 like autophagy activating kinase 2
13696,nizatidine,dermatomyositis,atpase na+/k+ transporting subunit beta 3
13697,indacaterol,chronic bronchitis,xanthine dehydrogenase
13698,polythiazide,humoral hypercalcemia of malignancy,bcl2 like 2
13699,acetazolamide,essential thrombocythemia,methylmalonyl-coa mutase
13700,dexmethylphenidate,sarcoidosis,acetyl-coa acyltransferase 2
13701,omacetaxine mepesuccinate,pulmonary emphysema,ndufa4 mitochondrial complex associated
13702,etelcalcetide,classic hodgkin lymphoma,dopamine receptor d3
13703,trifluoperazine,brain glioblastoma,opioid receptor mu 1
13704,ethinylestradiol,glioma,leukotriene a4 hydrolase
13705,camphor,status epilepticus,hyperpolarization activated cyclic nucleotide gated potassium channel 3
13706,fenfluramine,arthritic joint disease,atpase na+/k+ transporting subunit alpha 3
13707,norethisterone,postoperative nausea and vomiting,histone deacetylase 6
13708,cilastatin,exanthem,"fes proto-oncogene, tyrosine kinase"
13709,formoterol,inflammatory bowel disease,cholinergic receptor muscarinic 4
13710,levosimendan,chronic hepatitis c virus infection,leukotriene c4 synthase
13711,verapamil,gynecomastia disorder,bcr activator of rhogef and gtpase
13712,biperiden,amyotrophic lateral sclerosis,aldo-keto reductase family 1 member c1
13713,methixene,hot flashes,dopamine receptor d4
13714,apomorphine,central nervous system origin vertigo,ndufa4 mitochondrial complex associated like 2
13715,diclofenac,plasma cell myeloma,cytochrome p450 family 27 subfamily a member 1
13716,fluoxymesterone,central nervous system origin vertigo,hydroxycarboxylic acid receptor 3
13717,cobicistat,hypoparathyroidism,serpin family e member 1
13718,lamivudine,endometrium neoplasm,cytidine/uridine monophosphate kinase 1
13719,ramatroban,nasal congestion,cysteinyl leukotriene receptor 2
13720,nicotinic acid,islet cell adenomatosis,estrogen related receptor alpha
13721,pioglitazone,bulimia nervosa,4-aminobutyrate aminotransferase
13722,piribedil,hot flashes,follicle stimulating hormone receptor
13723,carvedilol,bacterial conjunctivitis,gamma-aminobutyric acid type a receptor subunit alpha4
13724,cariprazine,miliary tuberculosis,cholinergic receptor nicotinic beta 4 subunit
13725,tofacitinib,depressive disorder,metabolism of cobalamin associated b
13726,vilazodone,rickets,5-hydroxytryptamine receptor 2c
13727,guanadrel,adrenocortical insufficiency,glucagon receptor
13728,cephalotaxine,bipolar depression,dopamine receptor d2
13729,carvedilol,acute coronary syndrome,proteasome 20s subunit beta 2
13730,midodrine,rickets,glutamate ionotropic receptor nmda type subunit 3a
13731,methylprednisolone,severe major depression with psychotic features,24-dehydrocholesterol reductase
13732,tenofovir alafenamide,rhinitis,dipeptidyl peptidase 9
13733,bexarotene,acute myeloid leukemia,adrenoceptor alpha 2c
13734,mesoridazine,keloid,proteasome 20s subunit beta 5
13735,silodosin,tetany,cytochrome p450 family 3 subfamily a member 4
13736,lenvatinib,dermatomyositis,cdc like kinase 4
13737,pyridostigmine,castleman disease,atpase h+/k+ transporting subunit alpha
13738,doxapram,multiple sclerosis,steroid 5 alpha-reductase 1
13739,zuclopenthixol,hypertensive disorder,nuclear receptor subfamily 3 group c member 1
13740,fampridine,acute interstitial pneumonia,metallothionein 2a
13741,selexipag,lewy body dementia,glutamate ionotropic receptor nmda type subunit 3b
13742,pge1,tendinitis,glucagon like peptide 2 receptor
13743,pyridostigmine,seasonal allergic rhinitis,progesterone receptor
13744,bimatoprost,tendinopathy,dual specificity tyrosine phosphorylation regulated kinase 1b
13745,pilsicainide,adrenocortical insufficiency,potassium voltage-gated channel subfamily b member 1
13746,calcium acetate,hairy cell leukemia,interleukin 1 beta
13747,olmutinib,neurofibromatosis 1,calcyon neuron specific vesicular protein
13748,landiolol,hyperbilirubinemia,acid sensing ion channel subunit 1
13749,methoxamine,primary cutaneous t-cell non-hodgkin lymphoma,sodium channel epithelial 1 subunit gamma
13750,etodolac,breast neoplasm,cytochrome c1
13751,cilastatin,chronic eosinophilic leukemia,histone deacetylase 11
13752,vinblastine,trichuriasis,"elastase, neutrophil expressed"
13753,tocilizumab,thromboangiitis obliterans,melatonin receptor 1a
13754,celecoxib,necrobiosis lipoidica,dopamine receptor d3
13755,thiopental,pemphigus,geranylgeranyl diphosphate synthase 1
13756,metyrapone,inflammatory bowel disease,iodothyronine deiodinase 1
13757,dromostanolone propionate,anogenital human papillomavirus infection,coagulation factor x
13758,sildenafil,common cold,potassium calcium-activated channel subfamily m alpha 1
13759,heparin,pulmonary fibrosis,sphingomyelin phosphodiesterase 1
13760,mesoridazine,nasal congestion,somatostatin receptor 4
13761,dimenhydrinate,actinic keratosis,bcl2 like 2
13762,lansoprazole,dermatomyositis,protein kinase cgmp-dependent 1
13763,insulin detemir,diabetic kidney disease,proteasome 20s subunit beta 8
13764,linaclotide,uterine corpus leiomyoma,eukaryotic translation initiation factor 4e
13765,oprelvekin,liposarcoma,catechol-o-methyltransferase
13766,ketanserin,autoimmune disease,estrogen related receptor beta
13767,rimonabant,acute lymphoblastic leukemia,"fes proto-oncogene, tyrosine kinase"
13768,ifosfamide,granuloma annulare,adrenoceptor alpha 1a
13769,diflorasone diacetate,common wart,thyroid hormone receptor beta
13770,olodaterol,abdominal abscess,transforming growth factor beta receptor 2
13771,aminoglutethimide,decreased cardiac output,dna methyltransferase 3 alpha
13772,estrone sulphate,status epilepticus,epoxide hydrolase 2
13773,orciprenaline,vascular headaches,solute carrier family 27 member 2
13774,capsaicin,hypothyroidism,atp binding cassette subfamily c member 8
13775,cabozantinib,female stress incontinence,serpin family c member 1
13776,haloperidol,bone osteosarcoma,phosphodiesterase 6b
13777,diphenhydramine,altitude sickness,cytochrome p450 family 2 subfamily c member 9
13778,isocarboxazid,hyperglycemia,glutathione s-transferase alpha 2
13779,rotigotine,parkinson disease,proteasome 20s subunit beta 10
13780,glutethimide,cardiac arrest,hypoxanthine phosphoribosyltransferase 1
13781,ticagrelor,lichen planus,dopa decarboxylase
13782,miglitol,enterocolitis,galactosidase alpha
13783,mepyramine,mature t-cell and nk-cell non-hodgkin lymphoma,low density lipoprotein receptor
13784,ritonavir,delayed puberty,phosphodiesterase 3b
13785,paliperidone,focal epilepsy,solute carrier family 25 member 6
13786,daunorubicin,post-partum hemorrhage,calcium voltage-gated channel subunit alpha1 d
13787,meclofenamic acid,lewy body dementia,cyclin dependent kinase 8
13788,mesoridazine,raynaud disease,potassium voltage-gated channel modifier subfamily s member 2
13789,luseogliflozin,orthostatic hypotension,cholinergic receptor nicotinic alpha 6 subunit
13790,radotinib,prostate cancer,vitamin k epoxide reductase complex subunit 1
13791,bendroflumethiazide,thromboangiitis obliterans,calcium voltage-gated channel subunit alpha1 h
13792,hydroquinone,malignant colon neoplasm,"raf-1 proto-oncogene, serine/threonine kinase"
13793,lenvatinib,neurogenic bladder,protein kinase cgmp-dependent 1
13794,insulin glulisine,premature ejaculation,glutamic-oxaloacetic transaminase 1
13795,insulin detemir,poems syndrome,janus kinase 2
13796,indacaterol,uveitis,acetyl-coa acetyltransferase 1
13797,afamelanotide,postmenopausal osteoporosis,solute carrier family 25 member 5
13798,baclofen,delirium,solute carrier family 18 member a2
13799,moxonidine,"hydatidiform mole, recurrent, 1",fms related receptor tyrosine kinase 1
13800,bromocriptine,trichinellosis,potassium two pore domain channel subfamily k member 3
13801,tofacitinib,klinefelter syndrome,peroxisome proliferator activated receptor gamma
13802,amitriptyline,peptic ulcer disease,solute carrier family 18 member a2
13803,brinzolamide,acquired thrombocytopenia,inosine monophosphate dehydrogenase 1
13804,indapamide,tendinitis,structural maintenance of chromosomes 2
13805,incadronic acid,aspiration pneumonitis,transient receptor potential cation channel subfamily v member 4
13806,azelaic acid,hypotensive disorder,alk receptor tyrosine kinase
13807,sermorelin,chronic bronchitis,potassium voltage-gated channel subfamily h member 2
13808,ephedrine,canker sore,phospholipase a2 group ib
13809,salsalate,vitamin b12 deficiency,farnesyl diphosphate synthase
13810,ivacaftor,migraine disorder,protein tyrosine kinase 2 beta
13811,tamibarotene,colonic neoplasm,amylase alpha 1b
13812,pitavastatin,sympathetic ophthalmia,phosphodiesterase 6a
13813,piroxicam,aspiration pneumonia,ryanodine receptor 1
13814,pentoxifylline,tardive dyskinesia,cytidine deaminase
13815,caffeine,skin disorder,peptidylprolyl isomerase b
13816,buprenorphine,discoid lupus erythematosus,cytochrome p450 family 2 subfamily r member 1
13817,dopamine,malaria,potassium voltage-gated channel modifier subfamily s member 2
13818,phenprocoumon,sebaceous adenoma,5-hydroxytryptamine receptor 1a
13819,naloxone,follicular lymphoma,protein phosphatase 3 catalytic subunit alpha
13820,biperiden,abdominal abscess,angiotensin ii receptor type 1
13821,candesartan,cluster headache syndrome,platelet activating factor receptor
13822,lidocaine,hypereosinophilic syndrome,atpase na+/k+ transporting subunit alpha 2
13823,clidinium,rickets,aurora kinase b
13824,adapalene,streptococcal pneumonia,trace amine associated receptor 1
13825,hydroxychloroquine,asthma,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
13826,trichlormethiazide,"leukemia, myeloid, chronic-phase",c-c motif chemokine receptor 1
13827,frovatriptan,esophageal cancer,myristoylated alanine rich protein kinase c substrate
13828,salicylic acid,trigeminal neuralgia,dead-box helicase 1
13829,desvenlafaxine,pruritus,thromboxane a2 receptor
13830,suramin,common wart,potassium voltage-gated channel subfamily q member 2
13831,haloperidol,adrenogenital syndrome,cannabinoid receptor 1
13832,chlorhexidine,humoral hypercalcemia of malignancy,calcyon neuron specific vesicular protein
13833,cisplatin,schizoaffective disorder,monoamine oxidase a
13834,dimethyl fumarate,castleman disease,eukaryotic translation initiation factor 4e
13835,vernakalant,sitosterolemia,phosphodiesterase 6g
13836,felbinac,inappropriate adh syndrome,prostaglandin d2 receptor 2
13837,fluoxetine,chronic bronchitis,holocarboxylase synthetase
13838,insulin aspart,prader-willi syndrome,interleukin 6 receptor
13839,calcium acetate,invasive ductal breast carcinoma,acetyl-coa acetyltransferase 1
13840,imipramine,vernal conjunctivitis,butyrylcholinesterase
13841,fluocinonide,liposarcoma,5-hydroxytryptamine receptor 2a
13842,alendronate,psychosexual disorder,potassium voltage-gated channel subfamily c member 4
13843,alpha-methyltyrosine,delayed puberty,glutathione s-transferase alpha 2
13844,insulin glulisine,punctate epithelial keratoconjunctivitis,selectin e
13845,diclofenamide,dry eye syndrome,5-hydroxytryptamine receptor 1e
13846,clofazimine,tetany,glutamate ionotropic receptor nmda type subunit 2b
13847,ceftriaxone,diarrheal disease,potassium voltage-gated channel subfamily h member 8
13848,etelcalcetide,ventricular fibrillation,potassium voltage-gated channel subfamily h member 8
13849,ergocalciferol,delirium,methylenetetrahydrofolate reductase
13850,dicyclomine,liposarcoma,solute carrier organic anion transporter family member 1a2
13851,triamcinolone,b-cell chronic lymphocytic leukemia,hydroxysteroid 11-beta dehydrogenase 1
13852,tranexamic acid,seasonal allergic rhinitis,transient receptor potential cation channel subfamily v member 4
13853,finasteride,erectile dysfunction,mitogen-activated protein kinase kinase kinase 20
13854,methixene,strongyloidiasis,ribonucleotide reductase catalytic subunit m1
13855,pyrimethamine,tetralogy of fallot,potassium voltage-gated channel subfamily q member 3
13856,desoximetasone,medullary thyroid gland carcinoma,calcium voltage-gated channel auxiliary subunit beta 1
13857,metoprolol,nausea,phosphodiesterase 4b
13858,methyltestosterone,pityriasis versicolor,potassium inwardly rectifying channel subfamily j member 2
13859,apremilast,allergic urticaria,adrenoceptor alpha 2c
13860,sufentanil,dry eye syndrome,serpin family c member 1
13861,crotamiton,chronic beryllium disease,atpase na+/k+ transporting subunit alpha 1
13862,lasofoxifene,sarcoidosis,proteasome 20s subunit beta 2
13863,eletriptan,hereditary angioedema,solute carrier family 22 member 12
13864,ziconotide,homocystinuria,solute carrier family 47 member 1
13865,beraprost,pancreatic insulinoma,cholinergic receptor muscarinic 2
13866,prednisolone,autism spectrum disorder,janus kinase 2
13867,biperiden,bacterial pneumonia,adenosine a2b receptor
13868,hydroquinone,ornithine carbamoyltransferase deficiency,solute carrier family 22 member 4
13869,mizolastine,allergic urticaria,potassium voltage-gated channel modifier subfamily v member 2
13870,triamcinolone,marginal zone lymphoma,cholinergic receptor muscarinic 2
13871,betaxolol,pulmonary cystic fibrosis,ret proto-oncogene
13872,fingolimod,west syndrome,calcium voltage-gated channel subunit alpha1 b
13873,medrysone,female infertility,cyclin dependent kinase 8
13874,oxymorphone,heart failure,estrogen receptor 1
13875,citalopram,dysmenorrhea,sodium voltage-gated channel alpha subunit 1
13876,histamine,thromboembolism,synuclein alpha
13877,romidepsin,fabry disease,somatostatin receptor 1
13878,azelnidipine,alcohol abuse,phosphodiesterase 4d
13879,nedocromil,bursitis,prostaglandin e receptor 1
13880,clemastine,delirium,acyl-coa oxidase 1
13881,ticagrelor,nocturnal enuresis,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
13882,pseudoephedrine,vitamin deficiency disorder,integrin subunit alpha 2b
13883,lusutrombopag,bacterial meningitis,tyrosine kinase non receptor 1
13884,ergometrine,thrombocytopenia,cholinergic receptor nicotinic beta 2 subunit
13885,lamotrigine,gaucher disease,"coagulation factor ii, thrombin"
13886,metformin,rickets,thyroid stimulating hormone receptor
13887,nabumetone,decreased cardiac output,parathyroid hormone 1 receptor
13888,ripasudil,pruritus,angiotensin ii receptor type 1
13889,guanabenz,osteoarthritis,potassium voltage-gated channel modifier subfamily g member 3
13890,tenofovir alafenamide,vitiligo,apolipoprotein a1
13891,atropine,temporal arteritis,calcium voltage-gated channel auxiliary subunit alpha2delta 1
13892,docetaxel,"cicatrix, hypertrophic",atpase na+/k+ transporting subunit beta 2
13893,lansoprazole,ascariasis,cytochrome p450 family 3 subfamily a member 7
13894,mirodenafil,metrorrhagia,npc1 like intracellular cholesterol transporter 1
13895,acrivastine,kaposi's sarcoma,cytochrome p450 family 21 subfamily a member 2
13896,tretinoin,"hyperlipidemia, familial combined, lpl related",toll like receptor 2
13897,fluorometholone,neurogenic bladder,retinoid x receptor beta
13898,apremilast,drooling,vascular cell adhesion molecule 1
13899,vinorelbine,benign prostatic hyperplasia,estrogen related receptor alpha
13900,lorazepam,huntington disease,phosphodiesterase 1c
13901,droxidopa,atopic conjunctivitis,hypoxanthine phosphoribosyltransferase 1
13902,lusutrombopag,"chronic myelogenous leukemia, bcr-abl1 positive",renin
13903,methylphenobarbital,hypoactive sexual desire disorder,mitogen-activated protein kinase kinase kinase 2
13904,eptifibatide,hypertrophic cardiomyopathy,janus kinase 3
13905,cisplatin,atrial fibrillation,glucagon receptor
13906,butalbital,turner syndrome,cytidine deaminase
13907,safinamide,methylmalonic acidemia,serpin family e member 1
13908,triamterene,"attention deficit hyperactivity disorder, inattentive type",solute carrier family 2 member 9
13909,rivaroxaban,amyotrophic lateral sclerosis,peroxisome proliferator activated receptor alpha
13910,esomeprazole,post-partum hemorrhage,apolipoprotein a1
13911,milnacipran,bone osteosarcoma,sodium channel epithelial 1 subunit beta
13912,thioguanine,scalp dermatosis,opioid related nociceptin receptor 1
13913,umeclidinium,hypothyroidism,calcium voltage-gated channel auxiliary subunit beta 1
13914,phenylephrine,chancroid,adrenoceptor alpha 1b
13915,conivaptan,neonatal abstinence syndrome,potassium voltage-gated channel subfamily h member 2
13916,halcinonide,liposarcoma,"mpl proto-oncogene, thrombopoietin receptor"
13917,rabeprazole,hemorrhagic disease of newborn,tubulin beta 3 class iii
13918,acitretin,allergic asthma,alk receptor tyrosine kinase
13919,pseudoephedrine,female infertility,solute carrier family 6 member 4
13920,paclitaxel,acute pain,protein kinase c theta
13921,mebendazole,ascites,myosin light chain kinase 3
13922,flunisolide,osteomalacia,solute carrier family 22 member 8
13923,pemirolast,premenstrual dysphoric disorder,calcitonin receptor
13924,pentoxifylline,type 2 diabetes mellitus,"kras proto-oncogene, gtpase"
13925,buspirone,prostate neoplasm,bone morphogenetic protein receptor type 1b
13926,blonanserin,oligospermia,potassium inwardly rectifying channel subfamily j member 11
13927,etelcalcetide,myocardial infarction,complement c5
13928,hydralazine,homozygous familial hypercholesterolemia,amine oxidase copper containing 3
13929,crotamiton,acute gonococcal cervicitis,atpase copper transporting beta
13930,cortisol,thyroiditis,interleukin 1 receptor associated kinase 3
13931,mestranol,acute lymphoblastic leukemia,adrenoceptor alpha 2c
13932,tenofovir alafenamide,hyperinsulinism,s100 calcium binding protein b
13933,roxatidine acetate,bipolar depression,amine oxidase copper containing 1
13934,amphetamine,pruritus,calcium sensing receptor
13935,cetuximab,anxiety,epidermal growth factor receptor
13936,dutasteride,hyperbilirubinemia,glutamate ionotropic receptor nmda type subunit 2c
13937,diphenoxylate,persistent fetal circulation syndrome,calcium voltage-gated channel auxiliary subunit beta 1
13938,isoxsuprine,common cold,potassium voltage-gated channel subfamily q member 2
13939,olanzapine,bipolar depression,arginine vasopressin receptor 2
13940,daunorubicin,gastroesophageal reflux disease,nuclear receptor subfamily 0 group b member 1
13941,lafutidine,neurofibromatosis 1,rho associated coiled-coil containing protein kinase 1
13942,tirofiban,hairy cell leukemia,tumor necrosis factor
13943,hydroxychloroquine,lichen planus,ribosomal protein s6 kinase a5
13944,trospium chloride,ulcerative colitis,guanylate cyclase 2c
13945,diphenoxylate,hyperbilirubinemia,unc-51 like autophagy activating kinase 1
13946,lisuride,manic bipolar affective disorder,dopamine receptor d5
13947,penicillamine,stevens-johnson syndrome,nuak family kinase 2
13948,bepridil,narcolepsy,aldo-keto reductase family 1 member c3
13949,tolazamide,seborrheic dermatitis,interleukin 1 beta
13950,diethylcarbamazine,gastric neoplasm,atm serine/threonine kinase
13951,torsemide,tenosynovitis,calcium voltage-gated channel subunit alpha1 g
13952,cromoglicic acid,urge incontinence,follicle stimulating hormone receptor
13953,clofazimine,oral candidiasis,c-x-c motif chemokine ligand 8
13954,physostigmine,depressive disorder,tachykinin receptor 1
13955,alfuzosin,pruritus ani,dead-box helicase 1
13956,norfloxacin,pulmonary eosinophilia,solute carrier family 22 member 5
13957,vandetanib,adrenocortical insufficiency,bmx non-receptor tyrosine kinase
13958,lansoprazole,amenorrhea,transient receptor potential cation channel subfamily m member 8
13959,dextrothyroxine,pancreatic insulinoma,eph receptor a1
13960,donepezil,brain glioblastoma,thyroid stimulating hormone receptor
13961,anagrelide,pancreatic insulinoma,eph receptor a3
13962,lamivudine,pain,5-hydroxytryptamine receptor 4
13963,fludroxycortide,anxiety disorder,matrix metallopeptidase 2
13964,colestipol,otitis externa,cytidine/uridine monophosphate kinase 1
13965,chlordiazepoxide,primary cutaneous t-cell non-hodgkin lymphoma,potassium voltage-gated channel subfamily q member 4
13966,lopinavir,localized scleroderma,aldehyde dehydrogenase 5 family member a1
13967,alclometasone dipropionate,nausea,nuak family kinase 2
13968,trimipramine,musculoskeletal system disorder,"abl proto-oncogene 1, non-receptor tyrosine kinase"
13969,tretinoin,hyperuricemia,toll like receptor 2
13970,ropinirole,gout,solute carrier family 12 member 3
13971,pregabalin,myeloid neoplasm associated with pdgfra rearrangement,acetyl-coa acetyltransferase 1
13972,phytomenadione,prinzmetal angina,toll like receptor 4
13973,tamoxifen,atopic conjunctivitis,"kras proto-oncogene, gtpase"
13974,rizatriptan,urge incontinence,bcl2 like 1
13975,fluocinolone acetonide,islet cell adenomatosis,s100 calcium binding protein p
13976,suramin,renal cell carcinoma,neurotensin receptor 2
13977,glymidine,vitamin deficiency disorder,phosphodiesterase 11a
13978,carbimazole,respiratory syncytial virus infectious disease,histone deacetylase 5
13979,pomalidomide,crohn disease,death associated protein kinase 2
13980,tolvaptan,interstitial lung disease 2,5-hydroxytryptamine receptor 3b
13981,rimonabant,impetigo,proteasome 20s subunit beta 9
13982,azelastine,toxic shock syndrome,discoidin domain receptor tyrosine kinase 2
13983,flurbiprofen,impetigo,adenosine a3 receptor
13984,everolimus,hyperlipidemia,doublecortin like kinase 3
13985,radotinib,acute intermittent porphyria,potassium voltage-gated channel subfamily h member 5
13986,olodaterol,hypoalphalipoproteinemia,gamma-aminobutyric acid type a receptor subunit delta
13987,indapamide,pruritus ani,5-hydroxytryptamine receptor 3d
13988,abiraterone acetate,anaphylaxis,mitogen-activated protein kinase kinase 1
13989,vincristine,schizoaffective disorder,glutathione-disulfide reductase
13990,nifedipine,urinary retention,"tu translation elongation factor, mitochondrial"
13991,clotrimazole,atopic eczema,integrin subunit alpha l
13992,methyl salicylate,influenza,atp binding cassette subfamily a member 1
13993,dutasteride,pseudotumor cerebri,androgen receptor
13994,cetuximab,inflammatory bowel disease,dna topoisomerase i mitochondrial
13995,desoximetasone,skin basal cell carcinoma,unc-51 like autophagy activating kinase 1
13996,bromocriptine,eosinophilic esophagitis,cytochrome p450 family 27 subfamily b member 1
13997,cyclizine,angioedema,bone gamma-carboxyglutamate protein
13998,chlordiazepoxide,stroke disorder,protein kinase c theta
13999,tadalafil,"malignant hyperthermia, susceptibility to, 1",maltase-glucoamylase
14000,alogliptin,hemorrhagic disease of newborn,ornithine transcarbamylase
14001,anakinra,hypertrichosis of eyelid,ribosomal protein s6 kinase a6
14002,vorinostat,acute monocytic leukemia,dna topoisomerase i
14003,oxymetholone,nephrotic syndrome,tubulin alpha 1a
14004,lovastatin,anxiety disorder,ryanodine receptor 2
14005,minoxidil,neonatal abstinence syndrome,dead-box helicase 1
14006,bethanechol,strongyloidiasis,aryl hydrocarbon receptor
14007,hydroxychloroquine,sympathetic ophthalmia,bmp2 inducible kinase
14008,atorvastatin,gastric neoplasm,death associated protein kinase 1
14009,emedastine,oppositional defiant disorder,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
14010,sermorelin,post-operative pain,thymidine phosphorylase
14011,asenapine,precocious puberty,potassium voltage-gated channel subfamily c member 1
14012,terazosin,dermatitis,epidermal growth factor receptor
14013,adapalene,nocturnal enuresis,gamma-aminobutyric acid type a receptor subunit theta
14014,epirubicin,ornithine carbamoyltransferase deficiency,integrin subunit alpha 2b
14015,ipragliflozin,alopecia,"fes proto-oncogene, tyrosine kinase"
14016,carbetocin,anxiety disorder,"hck proto-oncogene, src family tyrosine kinase"
14017,diphenhydramine,allergic asthma,carbonic anhydrase 11
14018,rofecoxib,sympathetic ophthalmia,gamma-aminobutyric acid type a receptor subunit alpha2
14019,phenindamine,subarachnoid hemorrhage,solute carrier family 6 member 3
14020,raloxifene,myotonic syndrome,phosphodiesterase 4c
14021,troglitazone,osteoporosis,cytochrome p450 family 2 subfamily b member 6
14022,sertaconazole,alzheimer disease,phosphodiesterase 4d
14023,olanzapine,diabetic kidney disease,serine/threonine kinase 11
14024,floxuridine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",solute carrier family 22 member 3
14025,vemurafenib,headache disorder,aryl hydrocarbon receptor
14026,nefazodone,postencephalitic parkinson disease,opioid receptor delta 1
14027,losartan,colonic neoplasm,serpin family c member 1
14028,mizolastine,tetany,mitogen-activated protein kinase kinase kinase 20
14029,dextropropoxyphene,x-linked dominant hypophosphatemic rickets,cubilin
14030,diphenylpyraline,metastatic melanoma,dihydropyrimidine dehydrogenase
14031,danazol,non-small cell lung carcinoma,sphingosine-1-phosphate receptor 5
14032,cromoglicic acid,malignant glioma,metabolism of cobalamin associated b
14033,pralidoxime,humoral hypercalcemia of malignancy,bone morphogenetic protein receptor type 1b
14034,hydroxyurea,pneumonia,serpin family c member 1
14035,everolimus,neoplasm of esophagus,atp binding cassette subfamily a member 1
14036,tramazoline,seasonal allergic rhinitis,growth hormone receptor
14037,mitomycin c,pulmonary artery stenosis,cytochrome p450 family 3 subfamily a member 5
14038,ramipril,hepatic veno-occlusive disease,isoleucyl-trna synthetase 1
14039,metaraminol,congenital hypothyroidism,thyroid stimulating hormone receptor
14040,triazolam,hyperbilirubinemia,neurotrophic receptor tyrosine kinase 3
14041,quetiapine,decreased cardiac output,integrin subunit alpha 2b
14042,mitoxantrone,irritable bowel syndrome,dna topoisomerase ii beta
14043,ergotamine,"cicatrix, hypertrophic",gamma-aminobutyric acid type a receptor subunit alpha3
14044,axitinib,postmenopausal osteoporosis,integrin subunit alpha l
14045,lesinurad,x-linked dominant hypophosphatemic rickets,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
14046,lafutidine,fever,potassium voltage-gated channel subfamily a member 1
14047,tofacitinib,pulmonary eosinophilia,cholinergic receptor nicotinic alpha 3 subunit
14048,acenocoumarol,cluster headache syndrome,cdc like kinase 2
14049,glipizide,urinary bladder cancer,dopamine receptor d1
14050,phenacemide,central nervous system origin vertigo,mitogen-activated protein kinase kinase kinase 19
14051,bromfenac,amenorrhea,unc-51 like autophagy activating kinase 2
14052,sibutramine,alcohol abuse,leukotriene a4 hydrolase
14053,parathyroid hormone,bacterial pneumonia,cdc like kinase 2
14054,tranylcypromine,postoperative nausea and vomiting,homeodomain interacting protein kinase 2
14055,ethinylestradiol,pheochromocytoma,calcium voltage-gated channel auxiliary subunit alpha2delta 1
14056,penbutolol,huntington disease,pancreatic lipase
14057,phenazone,classic hodgkin lymphoma,fer tyrosine kinase
14058,eplerenone,musculoskeletal system disorder,thyroid hormone receptor alpha
14059,phenylbutazone,basal ganglia disorder,adrenoceptor alpha 2c
14060,piribedil,pulmonary artery stenosis,glutathione s-transferase alpha 2
14061,topotecan,pulmonary cystic fibrosis,integrin subunit alpha l
14062,pitavastatin,propionic acidemia,transforming growth factor beta receptor 2
14063,dimethyl fumarate,sarcoma,solute carrier family 2 member 9
14064,pentobarbitone,escherichia coli infection,calcium voltage-gated channel subunit alpha1 c
14065,phenytoin,superficial multifocal basal cell carcinoma,solute carrier family 22 member 8
14066,azatadine,acromegaly,carbonic anhydrase 13
14067,midazolam,open-angle glaucoma,phosphodiesterase 8b
14068,oxprenolol,pulmonary eosinophilia,potassium voltage-gated channel subfamily h member 1
14069,flibanserin,pruritus,gamma-aminobutyric acid type a receptor subunit delta
14070,udenafil,canker sore,solute carrier family 47 member 2
14071,crotamiton,sjogren syndrome,fibroblast growth factor receptor 3
14072,ergotamine,vernal conjunctivitis,adrenoceptor beta 3
14073,sonidegib,iritis,"kit proto-oncogene, receptor tyrosine kinase"
14074,eldecalcitol,manic bipolar affective disorder,histone deacetylase 8
14075,pregabalin,dermatitis,cholinergic receptor nicotinic alpha 10 subunit
14076,alogliptin,gingivitis,synuclein alpha
14077,methimazole,malignant essential hypertension,potassium inwardly rectifying channel subfamily j member 11
14078,benzbromarone,iridocyclitis,glutamate ionotropic receptor nmda type subunit 1
14079,carfilzomib,islet cell adenomatosis,bruton tyrosine kinase
14080,colestipol,juvenile idiopathic arthritis,cereblon
14081,triprolidine,chronic beryllium disease,dna topoisomerase ii alpha
14082,triamterene,intermittent vascular claudication,cytochrome p450 family 46 subfamily a member 1
14083,butorphanol,gastrointestinal stromal tumor,atpase na+/k+ transporting subunit alpha 1
14084,mebendazole,subarachnoid hemorrhage,transient receptor potential cation channel subfamily v member 3
14085,prednicarbate,allergic contact dermatitis,cdgsh iron sulfur domain 1
14086,milnacipran,toothache,adenosine deaminase
14087,lornoxicam,familial mediterranean fever,sphingosine-1-phosphate receptor 5
14088,fenfluramine,intracranial embolism,cysteinyl leukotriene receptor 2
14089,trospium chloride,precocious puberty,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
14090,pinacidil,tenosynovitis,matrix metallopeptidase 9
14091,bromfenac,pulmonary eosinophilia,toll like receptor 7
14092,dipyridamole,classic phenylketonuria,bcl2 like 2
14093,hydroxyurea,sjogren syndrome,leukotriene b4 receptor
14094,dexbrompheniramine,dacryocystitis,atp binding cassette subfamily c member 8
14095,dicyclomine,chronic urticaria,serpin family a member 6
14096,vinorelbine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",glutamic-oxaloacetic transaminase 1
14097,polythiazide,head and neck neoplasm,somatostatin receptor 5
14098,pilocarpine,meningococcal meningitis,arginine vasopressin receptor 1a
14099,diclofenac,systemic lupus erythematosus,"met proto-oncogene, receptor tyrosine kinase"
14100,oxazepam,basal ganglia disorder,solute carrier family 5 member 4
14101,perospirone,malignant glioma,protein phosphatase 3 catalytic subunit alpha
14102,tiaprofenic acid,primary ovarian failure,adenosine a3 receptor
14103,benzocaine,tenosynovitis,rho associated coiled-coil containing protein kinase 1
14104,echothiophate,uterine corpus leiomyoma,"coagulation factor ii, thrombin"
14105,olodaterol,amyotrophic lateral sclerosis,transient receptor potential cation channel subfamily v member 1
14106,valdecoxib,actinic keratosis,potassium voltage-gated channel subfamily a member 2
14107,dapoxetine,osteoarthritis,calcium voltage-gated channel subunit alpha1 g
14108,teniposide,female infertility,cytochrome p450 family 2 subfamily d member 6
14109,dexibuprofen,diarrheal disease,mitogen-activated protein kinase kinase kinase 19
14110,ixazomib,essential thrombocythemia,synuclein alpha
14111,budesonide,breast fibrocystic disease,cyclin dependent kinase 6
14112,l-citrulline,generalized anxiety disorder,paraoxonase 1
14113,pge1,angioedema,cholinergic receptor nicotinic alpha 10 subunit
14114,glipizide,hypoactive sexual desire disorder,protein phosphatase 3 catalytic subunit alpha
14115,mosapramine,hodgkins lymphoma,histone deacetylase 4
14116,nifedipine,seasonal allergic rhinitis,glutamate ionotropic receptor nmda type subunit 2b
14117,lofepramine,erectile dysfunction,potassium voltage-gated channel subfamily q member 1
14118,terfenadine,hereditary angioedema,fkbp prolyl isomerase 4
14119,terazosin,sebaceous adenoma,fatty acid binding protein 2
14120,ketotifen,peptic esophagitis,sphingosine-1-phosphate receptor 1
14121,milnacipran,trichinellosis,glutathione s-transferase pi 1
14122,istradefylline,bursitis,fibroblast growth factor receptor 1
14123,clozapine,islet cell adenomatosis,bmp2 inducible kinase
14124,gliquidone,meniere disease,melanocortin 1 receptor
14125,darifenacin,prader-willi syndrome,pre-mrna splicing tri-snrnp complex factor prpf4
14126,bisoprolol,renal osteodystrophy,cholinergic receptor muscarinic 4
14127,venetoclax,chronic pain,gamma-aminobutyric acid type a receptor subunit beta2
14128,estradiol valerate,persistent fetal circulation syndrome,receptor interacting serine/threonine kinase 3
14129,pergolide,seasonal allergic rhinitis,calcium voltage-gated channel auxiliary subunit alpha2delta 2
14130,sofalcone,severe major depression with psychotic features,steroid 5 alpha-reductase 2
14131,mirodenafil,hodgkins lymphoma,interleukin 1 receptor associated kinase 1
14132,albiglutide,hypoparathyroidism,farnesyl diphosphate synthase
14133,leuprolide,plasmodium vivax malaria,cytochrome p450 family 2 subfamily b member 6
14134,anakinra,mature t-cell and nk-cell non-hodgkin lymphoma,peptidylprolyl isomerase b
14135,dexamethasone,malignant pleural mesothelioma,prostaglandin-endoperoxide synthase 2
14136,gemfibrozil,psoriasis,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
14137,gonadorelin,hypertriglyceridemia,hypoxanthine phosphoribosyltransferase 1
14138,trabectedin,hypoparathyroidism,aldo-keto reductase family 1 member c3
14139,ketamine,gynecomastia disorder,serine/threonine kinase 17a
14140,ergocalciferol,aorta coarctation,potassium voltage-gated channel subfamily a member 4
14141,doxylamine,pneumonia,melanocortin 2 receptor
14142,codeine,embolism,phosphodiesterase 11a
14143,lorcaserin,chronic kidney disease,cytochrome c1
14144,valbenazine,methylmalonic acidemia,potassium calcium-activated channel subfamily n member 4
14145,brompheniramine,toothache,platelet derived growth factor receptor alpha
14146,acetylmethadol,adrenocortical insufficiency,salt inducible kinase 1
14147,risedronate,bronchial disorder,histone deacetylase 3
14148,quizartinib,motion sickness,retinoid x receptor gamma
14149,trabectedin,urge incontinence,glutamate ionotropic receptor nmda type subunit 3b
14150,anisotropine methylbromide,arthritic joint disease,potassium voltage-gated channel subfamily h member 7
14151,levosimendan,non-small cell lung carcinoma,cytochrome p450 family 11 subfamily b member 1
14152,lorcaserin,disseminated intravascular coagulation,cyclin dependent kinase 6
14153,sitagliptin,peripheral vascular disease,neurotrophic receptor tyrosine kinase 1
14154,tacrolimus,hemorrhoid,ryanodine receptor 2
14155,diphenhydramine,dysmenorrhea,"src proto-oncogene, non-receptor tyrosine kinase"
14156,topotecan,migraine disorder,histamine receptor h3
14157,gemtuzumab ozogamicin,urge incontinence,cytochrome p450 family 2 subfamily b member 6
14158,pindolol,acute interstitial pneumonia,discoidin domain receptor tyrosine kinase 1
14159,alfuzosin,adrenal gland hyperfunction,tubulin alpha 1a
14160,leflunomide,sebaceous adenoma,hyperpolarization activated cyclic nucleotide gated potassium channel 4
14161,alpha-methyltyrosine,intrinsic asthma,carbonic anhydrase 7
14162,dopamine,hepatic veno-occlusive disease,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
14163,nelfinavir,hypereosinophilic syndrome,solute carrier family 47 member 1
14164,alendronate,common wart,ebp cholestenol delta-isomerase
14165,roxatidine acetate,osteomalacia,solute carrier family 9 member a1
14166,salbutamol,hypotensive disorder,sodium channel epithelial 1 subunit gamma
14167,tafamidis,bipolar depression,atp binding cassette subfamily c member 3
14168,acetylmethadol,tourette syndrome,5-hydroxytryptamine receptor 3b
14169,mitomycin c,burkitt lymphoma,carbonic anhydrase 13
14170,pirenzepine,pemphigus,phosphodiesterase 6g
14171,cilastatin,male infertility,toll like receptor 9
14172,raltegravir,prader-willi syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
14173,levofloxacin,aggressive systemic mastocytosis,sodium voltage-gated channel alpha subunit 11
14174,dorzolamide,punctate epithelial keratoconjunctivitis,"elastase, neutrophil expressed"
14175,cladribine,hypoalphalipoproteinemia,atpase na+/k+ transporting subunit beta 1
14176,vinpocetine,xerophthalmia,potassium voltage-gated channel subfamily h member 8
14177,irbesartan,keratitis,histone deacetylase 10
14178,guanethidine,head and neck neoplasm,atpase h+ transporting v1 subunit a
14179,vindesine,vascular headaches,insulin receptor related receptor
14180,dicyclomine,iridocyclitis,myosin light chain kinase family member 4
14181,tolvaptan,thyroid gland follicular carcinoma,retinoid x receptor alpha
14182,letrozole,pain,dipeptidase 1
14183,valsartan,trigeminal neuralgia,histamine receptor h2
14184,phenelzine,pulmonary emphysema,bcl2 apoptosis regulator
14185,colestipol,alcohol dependence,phosphodiesterase 3a
14186,flutamide,hereditary angioedema,solute carrier family 46 member 1
14187,mephentermine,malaria,bcl2 like 1
14188,epa,brain edema,calmodulin 2
14189,benazepril,endometriosis,peptidylprolyl isomerase a
14190,clobetasone,shock,tyrosine kinase non receptor 1
14191,midazolam,brain edema,discoidin domain receptor tyrosine kinase 2
14192,butorphanol,rhinoscleroma,inosine monophosphate dehydrogenase 1
14193,linaclotide,vitamin d deficiency,selectin e
14194,probenecid,atrial fibrillation,cytochrome p450 family 51 subfamily a member 1
14195,gemfibrozil,myalgia,galactosidase alpha
14196,sildenafil,anaphylaxis,carbonic anhydrase 12
14197,efonidipine,visual epilepsy,"protein phosphatase 3 regulatory subunit b, alpha"
14198,minocycline,acquired polycythemia vera,insulin receptor related receptor
14199,dextromethorphan,gestational trophoblastic neoplasm,protein tyrosine kinase 2
14200,prednisolone,severe major depression with psychotic features,peptidylprolyl isomerase b
14201,vernakalant,holocarboxylase synthetase deficiency,potassium voltage-gated channel subfamily h member 4
14202,efonidipine,seasonal affective disorder,microtubule affinity regulating kinase 3
14203,treprostinil,prader-willi syndrome,aurora kinase c
14204,pentobarbitone,orthostatic hypotension,aryl hydrocarbon receptor
14205,bromocriptine,acute interstitial pneumonia,solute carrier family 2 member 9
14206,cariprazine,prostate neoplasm,cyclin dependent kinase 19
14207,tazarotene,angioedema,bmx non-receptor tyrosine kinase
14208,thalidomide,skin disorder,kelch like ech associated protein 1
14209,carvedilol,tetany,potassium voltage-gated channel modifier subfamily g member 4
14210,ketanserin,turner syndrome,calcium voltage-gated channel subunit alpha1 s
14211,glipizide,acute coronary syndrome,hypoxanthine phosphoribosyltransferase 1
14212,disulfiram,proctitis,bromodomain containing 4
14213,dipivefrine,hypothyroidism,s100 calcium binding protein b
14214,linaclotide,oppositional defiant disorder,gamma-aminobutyric acid type a receptor subunit gamma1
14215,mepyramine,edema,potassium voltage-gated channel subfamily h member 2
14216,butorphanol,testicular cancer,farnesyl diphosphate synthase
14217,panobinostat,oppositional defiant disorder,cytidine deaminase
14218,levosimendan,"hyperlipidemia, familial combined, lpl related",platelet derived growth factor receptor alpha
14219,irinotecan,gingivitis,microtubule associated protein 1a
14220,trimethobenzamide,cutaneous candidiasis,gc vitamin d binding protein
14221,acalabrutinib,post-partum hemorrhage,gamma-aminobutyric acid type a receptor subunit beta1
14222,cetirizine,rheumatic heart disease,carbonic anhydrase 11
14223,apraclonidine,male infertility,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
14224,pentoxifylline,focal epilepsy,chymotrypsinogen b1
14225,pazopanib,tinea corporis,atpase h+/k+ transporting subunit alpha
14226,imiquimod,bulimia nervosa,gc vitamin d binding protein
14227,anakinra,restless legs syndrome,potassium voltage-gated channel modifier subfamily g member 2
14228,midodrine,autosomal dominant polycystic kidney disease,carbonic anhydrase 7
14229,estrone sulphate,uveitis,potassium voltage-gated channel subfamily a member 4
14230,tetracosactide,myxedema,cytochrome p450 family 27 subfamily a member 1
14231,nebivolol,"familial amyloid neuropathy, portuguese type",5-hydroxytryptamine receptor 3a
14232,dibucaine,precocious puberty,erb-b2 receptor tyrosine kinase 2
14233,methyltestosterone,lung disorder,serine/threonine kinase 25
14234,felbinac,pituitary dwarfism,potassium voltage-gated channel modifier subfamily g member 2
14235,trimetazidine,vascular headaches,"dna polymerase delta 1, catalytic subunit"
14236,loxapine,gastric cancer,potassium voltage-gated channel subfamily b member 2
14237,atorvastatin,diffuse alopecia areata,phosphodiesterase 8a
14238,bepotastine,gout,serine/threonine kinase 4
14239,diethylcarbamazine,hypoactive sexual desire disorder,cholinergic receptor nicotinic alpha 10 subunit
14240,mepyramine,congestive heart failure,atpase na+/k+ transporting subunit beta 3
14241,entacapone,influenza,phosphodiesterase 1c
14242,vincristine,rhinoscleroma,structural maintenance of chromosomes 2
14243,clofarabine,absence epilepsy,cdgsh iron sulfur domain 1
14244,raloxifene,gout,cytochrome p450 family 46 subfamily a member 1
14245,bazedoxifene,dermatomyositis,ste20 like kinase
14246,cabozantinib,rosacea,cd33 molecule
14247,tenoxicam,medullary thyroid gland carcinoma,15-hydroxyprostaglandin dehydrogenase
14248,atorvastatin,dacryocystitis,aldehyde dehydrogenase 5 family member a1
14249,levodopa,pruritus ani,structural maintenance of chromosomes 2
14250,gonadorelin,rhinitis,propionyl-coa carboxylase subunit alpha
14251,empagliflozin,spasticity,fms related receptor tyrosine kinase 1
14252,probenecid,humoral hypercalcemia of malignancy,bromodomain containing 4
14253,meloxicam,osteomalacia,hydroxycarboxylic acid receptor 3
14254,pseudoephedrine,rickets,histone deacetylase 9
14255,ethosuximide,tension-type headache,gamma-aminobutyric acid type a receptor subunit alpha1
14256,ecallantide,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",ndufa4 mitochondrial complex associated
14257,tetracosactide,goiter,platelet derived growth factor receptor alpha
14258,vemurafenib,insomnia,cdc like kinase 2
14259,phenacemide,prostate cancer,calmodulin 1
14260,meloxicam,shock,mapk interacting serine/threonine kinase 2
14261,pemetrexed,hyperlipidemia,solute carrier organic anion transporter family member 4a1
14262,panobinostat,uterine corpus leiomyoma,butyrylcholinesterase
14263,tofacitinib,nausea,lipoprotein lipase
14264,ceritinib,obsessive-compulsive disorder,7-dehydrocholesterol reductase
14265,sulindac,narcolepsy,mitogen-activated protein kinase kinase 1
14266,pilsicainide,glossopharyngeal neuralgia,kelch like ech associated protein 1
14267,n-methyl scopolamine,eye disorder,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
14268,fludarabine,erdheim-chester disease,histamine receptor h4
14269,trimetaphan,acute gonococcal cervicitis,sodium voltage-gated channel alpha subunit 5
14270,cilostazol,non-hodgkin lymphoma,mapk interacting serine/threonine kinase 2
14271,lisinopril,acquired polycythemia vera,cubilin
14272,metoclopramide,metastatic melanoma,g protein-coupled receptor kinase 4
14273,belotecan,hyperparathyroidism,"hck proto-oncogene, src family tyrosine kinase"
14274,lenalidomide,idiopathic hypereosinophilic syndrome,5-hydroxytryptamine receptor 2c
14275,alendronate,inappropriate adh syndrome,potassium voltage-gated channel subfamily d member 2
14276,niraparib,persistent fetal circulation syndrome,myeloperoxidase
14277,alprazolam,hyperparathyroidism,receptor interacting serine/threonine kinase 2
14278,diazoxide,atopic conjunctivitis,potassium voltage-gated channel modifier subfamily g member 3
14279,voclosporin,alopecia,phosphodiesterase 10a
14280,tafluprost,rheumatoid arthritis,ryanodine receptor 2
14281,moclobemide,pulmonary fibrosis,potassium voltage-gated channel subfamily a member 1
14282,l-citrulline,rhinoscleroma,cholinergic receptor muscarinic 1
14283,pramipexole,tricuspid atresia,vitamin d receptor
14284,rizatriptan,angioedema,aurora kinase b
14285,fenfluramine,diffuse alopecia areata,acetyl-coa acyltransferase 2
14286,perindopril,epilepsy,sigma non-opioid intracellular receptor 1
14287,azacitidine,classic phenylketonuria,janus kinase 1
14288,amoxapine,"attention deficit hyperactivity disorder, inattentive type",matrix metallopeptidase 2
14289,dutasteride,trichuriasis,atpase na+/k+ transporting subunit alpha 2
14290,dicumarol,familial dermatographia,tubulin beta 6 class v
14291,ofatumumab,acute myeloid leukemia,potassium calcium-activated channel subfamily n member 4
14292,epa,"malignant hyperthermia, susceptibility to, 1",transient receptor potential cation channel subfamily v member 1
14293,tirofiban,endometriosis,ribonucleotide reductase regulatory subunit m2
14294,toloxatone,ocular hypertension,phosphodiesterase 6c
14295,levonorgestrel,pituitary dwarfism,5-hydroxytryptamine receptor 3a
14296,glibenclamide,atrophic vulva,transient receptor potential cation channel subfamily v member 1
14297,apalutamide,stargardt disease,colony stimulating factor 1 receptor
14298,calcium acetate,hyponatremia,serine/threonine kinase 25
14299,azatadine,psychologic dyspareunia,cholesteryl ester transfer protein
14300,alteplase,fibromyalgia,endothelin receptor type a
14301,cefonicid,acidosis disorder,potassium voltage-gated channel subfamily a member 3
14302,drospirenone,vascular headaches,"elastase, neutrophil expressed"
14303,eszopiclone,myeloid neoplasm associated with pdgfra rearrangement,bromodomain containing 4
14304,mesalazine,breast fibrocystic disease,microtubule associated protein 2
14305,bitolterol,erythropoietic protoporphyria,atp binding cassette subfamily g member 8
14306,pimecrolimus,essential hypertension,atp binding cassette subfamily c member 8
14307,echothiophate,adrenal gland hyperfunction,phosphodiesterase 7b
14308,promethazine,acute gonococcal cervicitis,cereblon
14309,clorazepate,ornithine carbamoyltransferase deficiency,potassium voltage-gated channel subfamily a member 6
14310,incadronic acid,hypercholesterolemia,atp binding cassette subfamily b member 11
14311,doxylamine,eye disorder,transient receptor potential cation channel subfamily v member 1
14312,pralatrexate,crohn disease,solute carrier family 18 member a2
14313,dronedarone,otitis externa,aldo-keto reductase family 1 member c1
14314,perindopril,epilepsy with generalized tonic-clonic seizures,estrogen receptor 2
14315,dicyclomine,visual epilepsy,calcium voltage-gated channel subunit alpha1 s
14316,ebastine,hemangioma,interleukin 1 receptor type 1
14317,silodosin,idiopathic hypereosinophilic syndrome,chymotrypsinogen b1
14318,tetracosactide,epilepsy,cyclin dependent kinase 8
14319,zalcitabine,hypertrichosis of eyelid,fibroblast growth factor receptor 1
14320,penicillamine,hypoalphalipoproteinemia,maltase-glucoamylase
14321,methyclothiazide,necrobiosis lipoidica,guanylate cyclase 1 soluble subunit alpha 1
14322,protriptyline,testicular cancer,potassium voltage-gated channel subfamily c member 1
14323,icatibant,endometritis,toll like receptor 4
14324,alimemazine,panic disorder,transforming growth factor beta receptor 2
14325,captodiame,vitiligo,neurotrophic receptor tyrosine kinase 3
14326,clofazimine,prinzmetal angina,retinoid x receptor alpha
14327,estradiol valerate,juvenile idiopathic arthritis,potassium voltage-gated channel subfamily d member 1
14328,clobetasone,stevens-johnson syndrome,glutamate ionotropic receptor kainate type subunit 1
14329,masoprocol,hypophosphatemia,toll like receptor 4
14330,desonide,respiratory syncytial virus infectious disease,cytochrome p450 family 2 subfamily c member 8
14331,dexamethasone,chronic schizophrenia,activin a receptor type 1
14332,levorphanol,essential hypertension,potassium voltage-gated channel subfamily q member 3
14333,isopropamide,respiratory syncytial virus infectious disease,calcium voltage-gated channel subunit alpha1 s
14334,metoclopramide,oral candidiasis,gamma-aminobutyric acid type a receptor subunit gamma1
14335,mepyramine,amenorrhea,histone deacetylase 11
14336,eldecalcitol,choroiditis,retinoic acid receptor gamma
14337,nedocromil,actinic keratosis,glutathione-disulfide reductase
14338,carbamazepine,rosacea,janus kinase 3
14339,epinastine,castleman disease,"glucosidase alpha, neutral c"
14340,chlorothiazide,lung disorder,glutathione s-transferase theta 1
14341,carbimazole,trigeminal neuralgia,mitogen-activated protein kinase kinase 2
14342,chloroquine,adrenogenital syndrome,solute carrier family 12 member 2
14343,hydrocodone,pulmonary tuberculosis,sucrase-isomaltase
14344,midazolam,proctitis,phosphodiesterase 1c
14345,pimozide,rhinoscleroma,hypoxanthine phosphoribosyltransferase 1
14346,sildenafil,hyperlipoproteinemia type 3,dihydropyrimidine dehydrogenase
14347,phenylephrine,myalgia,histamine receptor h3
14348,ivermectin,phenylketonuria,proteasome 20s subunit beta 10
14349,donepezil,hiv infectious disease,adrenoceptor alpha 1a
14350,glucagon,hypophosphatemia,"kit proto-oncogene, receptor tyrosine kinase"
14351,vardenafil,phenylketonuria,phosphodiesterase 3a
14352,midazolam,dyspnea,acetyl-coa acyltransferase 2
14353,levofloxacin,"leukemia, myeloid, chronic-phase",cdc like kinase 2
14354,theophylline,tetanus,phosphoribosyl pyrophosphate amidotransferase
14355,buclizine,motion sickness,progesterone receptor
14356,rasagiline,bronchial disorder,aldo-keto reductase family 1 member c3
14357,dromostanolone propionate,dementia,somatostatin receptor 4
14358,ripasudil,punctate epithelial keratoconjunctivitis,glutamate ionotropic receptor kainate type subunit 5
14359,fluspirilene,pyoderma gangrenosum,cdc like kinase 1
14360,cisplatin,lewy body dementia,cholesteryl ester transfer protein
14361,doxorubicin,esotropia,atp binding cassette subfamily b member 1
14362,cyclophosphamide,gastric neoplasm,tubulin gamma 1
14363,hydralazine,hyperbilirubinemia,atp binding cassette subfamily g member 8
14364,capecitabine,urinary bladder neoplasm,protein kinase cgmp-dependent 1
14365,sorafenib,ornithine carbamoyltransferase deficiency,solute carrier family 5 member 2
14366,escitalopram,rheumatoid arthritis,atpase na+/k+ transporting subunit beta 1
14367,maprotiline,perennial allergic rhinitis,protein kinase n2
14368,pentamidine,rhinitis,cytochrome p450 family 17 subfamily a member 1
14369,oseltamivir,renal cell carcinoma,histone deacetylase 10
14370,flunisolide,malignant pleural mesothelioma,calcium voltage-gated channel auxiliary subunit alpha2delta 2
14371,procyclidine,pharyngitis,calcium voltage-gated channel subunit alpha1 b
14372,prucalopride,intrinsic asthma,gamma-aminobutyric acid type a receptor subunit theta
14373,salicylic acid,potassium deficiency disease,prostaglandin-endoperoxide synthase 1
14374,miglitol,thyroid gland follicular carcinoma,hydroxysteroid 11-beta dehydrogenase 1
14375,asenapine,severe major depression with psychotic features,glutamate ionotropic receptor nmda type subunit 1
14376,ospemifene,allergic bronchopulmonary aspergillosis,sodium channel epithelial 1 subunit gamma
14377,propafenone,onchocerciasis,dead-box helicase 1
14378,everolimus,stargardt disease,glutamate ionotropic receptor ampa type subunit 3
14379,sapropterin,persistent fetal circulation syndrome,24-dehydrocholesterol reductase
14380,tramazoline,hepatic veno-occlusive disease,aryl hydrocarbon receptor
14381,alteplase,lichen planus,cytochrome p450 family 11 subfamily b member 2
14382,histrelin,mycosis fungoides,atpase h+ transporting v1 subunit a
14383,fludroxycortide,erectile dysfunction,potassium voltage-gated channel subfamily h member 6
14384,gonadorelin,iridocyclitis,carbonic anhydrase 12
14385,drospirenone,schizophrenia,homeodomain interacting protein kinase 1
14386,alfacalcidol,postmenopausal osteoporosis,dopa decarboxylase
14387,cetirizine,persistent fetal circulation syndrome,cathepsin g
14388,insulin degludec,brain cancer,structural maintenance of chromosomes 1a
14389,esomeprazole,central nervous system origin vertigo,protein kinase n1
14390,ofloxacin,plasma cell myeloma,tyrosine hydroxylase
14391,risperidone,acute intermittent porphyria,structural maintenance of chromosomes 2
14392,carbetocin,contact dermatitis,gamma-aminobutyric acid type a receptor subunit beta2
14393,pantoprazole,acute gonococcal endometritis,metabolism of cobalamin associated a
14394,ketamine,pheochromocytoma,potassium voltage-gated channel subfamily h member 6
14395,glutethimide,aspiration pneumonitis,solute carrier family 46 member 1
14396,dosulepin,hyperthyroidism,kinase insert domain receptor
14397,plerixafor,chronic schizophrenia,potassium voltage-gated channel subfamily a member 2
14398,mitiglinide,pulmonary edema,structural maintenance of chromosomes 2
14399,lenalidomide,rhinoscleroma,histamine receptor h2
14400,phenazone,thyroid gland papillary carcinoma,glucose-6-phosphate dehydrogenase
14401,voglibose,chronic myelomonocytic leukemia,guanylate cyclase 1 soluble subunit alpha 2
14402,ramatroban,potassium deficiency disease,cholinergic receptor nicotinic alpha 2 subunit
14403,loperamide,pancreatic adenocarcinoma,solute carrier family 22 member 11
14404,teduglutide,blepharoconjunctivitis,prostaglandin-endoperoxide synthase 1
14405,calcium gluconate,myalgia,5-hydroxytryptamine receptor 1b
14406,valbenazine,hyperthyroidism,riboflavin kinase
14407,histrelin,renal osteodystrophy,adrenoceptor beta 3
14408,difenoxin,colonic neoplasm,adenosine deaminase
14409,dehydroepiandrosterone,myalgia,kinase insert domain receptor
14410,oxybutynin,alcohol abuse,fibroblast growth factor receptor 2
14411,loxoprofen,erdheim-chester disease,dopamine receptor d5
14412,diphenylpyraline,post-traumatic stress disorder,glutathione s-transferase pi 1
14413,acetophenazine,melanoma,melanocortin 1 receptor
14414,dobutamine,amyotrophic lateral sclerosis,potassium voltage-gated channel subfamily a member 4
14415,migalastat,neurofibromatosis 1,"blk proto-oncogene, src family tyrosine kinase"
14416,pinacidil,thyroid crisis,adenosine a2a receptor
14417,piribedil,hyperglycemia,hyperpolarization activated cyclic nucleotide gated potassium channel 1
14418,celecoxib,thyroid gland papillary carcinoma,atp binding cassette subfamily c member 3
14419,belotecan,"dermatitis, atopic",calcium sensing receptor
14420,ticagrelor,myxedema,electron transfer flavoprotein dehydrogenase
14421,voglibose,hyperaldosteronism,metallothionein 2a
14422,tranylcypromine,tetanus,thyroid hormone receptor beta
14423,mesuximide,ankylosing spondylitis,metallothionein 2a
14424,atomoxetine,oral candidiasis,gamma-aminobutyric acid type a receptor subunit theta
14425,allopurinol,central nervous system origin vertigo,cannabinoid receptor 2
14426,eprosartan,lichen planus,potassium voltage-gated channel subfamily a member 5
14427,glutethimide,adrenogenital syndrome,il2 inducible t cell kinase
14428,chlordiazepoxide,hypertensive disorder,sodium voltage-gated channel alpha subunit 4
14429,phentolamine,blepharoconjunctivitis,potassium voltage-gated channel subfamily h member 5
14430,simvastatin,chronic urticaria,leukotriene c4 synthase
14431,dexamethasone,systemic mastocytosis,fms related receptor tyrosine kinase 3
14432,loteprednol etabonate,hyperaldosteronism,tubulin beta 8 class viii
14433,pazopanib,arthritic joint disease,sphingosine-1-phosphate receptor 5
14434,fesoterodine,rhinoscleroma,phosphodiesterase 1a
14435,clonidine,prostate cancer,solute carrier family 22 member 12
14436,dibucaine,essential hypertension,sodium voltage-gated channel alpha subunit 4
14437,mitomycin c,erythema multiforme,hypoxanthine phosphoribosyltransferase 1
14438,oxymetholone,idiopathic hypereosinophilic syndrome,erb-b2 receptor tyrosine kinase 2
14439,acetyldigitoxin,polyuria,solute carrier family 6 member 4
14440,olanzapine,inappropriate adh syndrome,calcium voltage-gated channel auxiliary subunit beta 1
14441,dexmethylphenidate,malignant pleural mesothelioma,microtubule associated protein 1a
14442,benoxaprofen,heart failure,cytochrome p450 family 2 subfamily e member 1
14443,acetylcholine,melanoma,ribonucleotide reductase regulatory subunit m2
14444,codeine,islet cell adenomatosis,androgen receptor
14445,pilsicainide,pyoderma gangrenosum,ribosomal protein s6 kinase a2
14446,metoprolol,metastatic melanoma,janus kinase 2
14447,loxapine,sarcoidosis,homeodomain interacting protein kinase 4
14448,trihexyphenidyl,acute intermittent porphyria,paraoxonase 1
14449,erlotinib,mantle cell lymphoma,glutamate ionotropic receptor ampa type subunit 3
14450,esomeprazole,psychosexual disorder,thymidine phosphorylase
14451,canagliflozin,sneeze,microtubule associated protein 1a
14452,clofazimine,endometritis,neuropeptide y
14453,oxcarbazepine,hyperprolactinemia,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
14454,formoterol,vulvovaginal candidiasis,acyl-coa dehydrogenase short/branched chain
14455,vindesine,secondary hyperparathyroidism,atm serine/threonine kinase
14456,menatetrenone,brain edema,glutamate ionotropic receptor kainate type subunit 4
14457,clobetasone,thrombophilia due to thrombin defect,sodium voltage-gated channel alpha subunit 5
14458,fenfluramine,keratitis,fms related receptor tyrosine kinase 4
14459,pranlukast,pulmonary embolism,gamma-aminobutyric acid type a receptor subunit alpha4
14460,oxprenolol,allergic urticaria,mitogen-activated protein kinase kinase 2
14461,captodiame,embolism,potassium voltage-gated channel modifier subfamily g member 2
14462,naltrexone,visual epilepsy,glutamate ionotropic receptor nmda type subunit 3a
14463,halcinonide,aggressive systemic mastocytosis,interleukin 2
14464,prasugrel,urinary retention,epoxide hydrolase 2
14465,flecainide,common wart,polo like kinase 4
14466,benoxaprofen,graves disease,hyperpolarization activated cyclic nucleotide gated potassium channel 1
14467,dimethyl fumarate,dry eye syndrome,cholinergic receptor nicotinic alpha 10 subunit
14468,promethazine,phenylketonuria,solute carrier family 5 member 6
14469,maprotiline,neoplasm of esophagus,integrin subunit alpha l
14470,prasugrel,postencephalitic parkinson disease,cytochrome p450 family 2 subfamily c member 19
14471,tolazamide,intermittent vascular claudication,phosphorylase kinase catalytic subunit gamma 1
14472,nefazodone,malignant pleural mesothelioma,axl receptor tyrosine kinase
14473,lenalidomide,thyroid gland carcinoma,neurotrophic receptor tyrosine kinase 1
14474,fluoxymesterone,pityriasis versicolor,cytochrome p450 family 24 subfamily a member 1
14475,lafutidine,renal osteodystrophy,solute carrier family 19 member 1
14476,dihydrotachysterol,pulmonary cystic fibrosis,thyroid hormone receptor beta
14477,captopril,epilepsy,vascular endothelial growth factor a
14478,fluvoxamine,acidosis disorder,estrogen related receptor beta
14479,lopinavir,multiple endocrine neoplasia,toll like receptor 4
14480,procyclidine,enterobiasis,misshapen like kinase 1
14481,paliperidone,pancreatic adenocarcinoma,atpase na+/k+ transporting subunit alpha 3
14482,methylergonovine,postencephalitic parkinson disease,potassium voltage-gated channel subfamily h member 5
14483,vorapaxar,poems syndrome,isoleucyl-trna synthetase 1
14484,chlorpromazine,allergic rhinitis,potassium voltage-gated channel subfamily a member 4
14485,nabumetone,decreased cardiac output,cytochrome p450 family 21 subfamily a member 2
14486,molindone,stevens-johnson syndrome,potassium two pore domain channel subfamily k member 2
14487,pinacidil,aggressive systemic mastocytosis,integrin subunit alpha l
14488,pamidronic acid,opiate dependence,atpase copper transporting alpha
14489,acrivastine,pediculus humanus capitis infestation,sodium voltage-gated channel alpha subunit 10
14490,spironolactone,pulmonary valve atresia,caspase 1
14491,felodipine,human african trypanosomiasis,selectin e
14492,celecoxib,focal epilepsy,mitogen-activated protein kinase kinase kinase 20
14493,eldecalcitol,klinefelter syndrome,calcium voltage-gated channel subunit alpha1 a
14494,apalutamide,gastrointestinal stromal tumor,acid sensing ion channel subunit 1
14495,methoxamine,pyelonephritis,microtubule affinity regulating kinase 3
14496,dapagliflozin,psychologic dyspareunia,protein kinase c theta
14497,zuclopenthixol,epilepsy,dihydrofolate reductase
14498,vonoprazan,spasticity,microtubule affinity regulating kinase 3
14499,nintedanib,migraine disorder,bcr activator of rhogef and gtpase
14500,teniposide,hyperbilirubinemia,cart prepropeptide
14501,indapamide,bacterial conjunctivitis,salt inducible kinase 1
14502,5-fluorouracil,alzheimer disease,sodium voltage-gated channel alpha subunit 7
14503,paclitaxel,plasmodium malariae malaria,proteasome 20s subunit beta 1
14504,tafamidis,bacterial endocarditis,histone deacetylase 9
14505,radotinib,hypertriglyceridemia,iodothyronine deiodinase 1
14506,tetracosactide,tinea corporis,"ros proto-oncogene 1, receptor tyrosine kinase"
14507,bosutinib,thyroid gland follicular carcinoma,rio kinase 1
14508,phenelzine,pruritus,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
14509,istradefylline,atrioventricular block,thyroid stimulating hormone receptor
14510,diphenoxylate,persistent fetal circulation syndrome,superoxide dismutase 1
14511,selumetinib,angle-closure glaucoma,thymidine phosphorylase
14512,famotidine,sympathetic ophthalmia,hypoxia inducible factor 1 subunit alpha
14513,nedocromil,pruritus ani,potassium voltage-gated channel subfamily h member 2
14514,guanadrel,congenital adrenal hyperplasia,solute carrier organic anion transporter family member 2b1
14515,bepridil,hyperuricemia,cannabinoid receptor 1
14516,prilocaine,chronic myelomonocytic leukemia,thyroid hormone receptor beta
14517,phenylbutazone,ocular hypertension,cereblon
14518,gemigliptin,mycosis fungoides,potassium voltage-gated channel subfamily q member 1
14519,clofazimine,canker sore,dopamine receptor d2
14520,enalaprilat,basal ganglia disorder,potassium voltage-gated channel subfamily c member 1
14521,imiquimod,sickle cell anemia,ribonucleotide reductase regulatory subunit m2
14522,pravastatin,hypertriglyceridemia,dipeptidase 1
14523,eribulin,psychosexual disorder,fibroblast growth factor receptor 1
14524,entacapone,pulmonary edema,solute carrier organic anion transporter family member 2b1
14525,pentobarbitone,vitamin deficiency disorder,dna topoisomerase i mitochondrial
14526,dibucaine,amyotrophic lateral sclerosis,phospholipase a2 group ib
14527,probucol,dermatophytosis of groin and perianal area,calcium voltage-gated channel subunit alpha1 s
14528,limaprost,allergic asthma,estrogen related receptor beta
14529,codeine,vernal conjunctivitis,high mobility group box 1
14530,ezetimibe,keratitis,ribosomal protein s6 kinase a5
14531,doxorubicin,dry eye syndrome,"ros proto-oncogene 1, receptor tyrosine kinase"
14532,mestranol,localized scleroderma,potassium voltage-gated channel subfamily a member 2
14533,isopropamide,pruritus ani,ribosomal protein s6 kinase a5
14534,oxcarbazepine,discoid lupus erythematosus,"fes proto-oncogene, tyrosine kinase"
14535,polmacoxib,contact dermatitis,steroid 5 alpha-reductase 2
14536,suramin,hypertensive disorder,histone deacetylase 8
14537,nicotinic acid,allergic contact dermatitis,cytochrome p450 family 3 subfamily a member 4
14538,stanozolol,liposarcoma,cytochrome p450 family 11 subfamily b member 2
14539,calcium acetate,acute intermittent porphyria,phosphodiesterase 6a
14540,desoximetasone,subarachnoid hemorrhage,guanylate cyclase 1 soluble subunit alpha 1
14541,pomalidomide,temporal arteritis,unc-51 like kinase 3
14542,fsh,endometritis,monoamine oxidase b
14543,voglibose,disruptive behavior disorder,glutamate ionotropic receptor kainate type subunit 3
14544,metolazone,stargardt disease,tubulin beta 6 class v
14545,flecainide,sebaceous adenoma,tyrosine kinase non receptor 2
14546,nizatidine,tetany,cereblon
14547,ivacaftor,seasonal allergic rhinitis,cholinergic receptor muscarinic 3
14548,tipranavir,acute lung injury,histone deacetylase 3
14549,oseltamivir,myeloproliferative neoplasm,angiotensin converting enzyme 2
14550,conivaptan,gastrointestinal stromal tumor,g protein-coupled receptor kinase 2
14551,colestipol,insomnia,carbonic anhydrase 11
14552,modafinil,classic phenylketonuria,solute carrier family 5 member 6
14553,norfloxacin,neurofibromatosis 1,cyclin dependent kinase 16
14554,lansoprazole,vomiting,methylenetetrahydrofolate reductase
14555,trabectedin,acute intermittent porphyria,potassium voltage-gated channel subfamily a member 6
14556,sofalcone,tetanus,sodium voltage-gated channel alpha subunit 4
14557,tirofiban,gastric cancer,cytochrome p450 family 3 subfamily a member 4
14558,famotidine,alzheimer disease,propionyl-coa carboxylase subunit alpha
14559,fluvastatin,cardiogenic shock,potassium voltage-gated channel modifier subfamily g member 4
14560,valsartan,strongyloidiasis,gap junction protein alpha 1
14561,apraclonidine,urge incontinence,dual specificity tyrosine phosphorylation regulated kinase 2
14562,vilanterol,tinea corporis,neurotensin receptor 2
14563,teniposide,asthma-chronic obstructive pulmonary disease overlap syndrome,atp binding cassette subfamily a member 1
14564,ibandronic acid,testicular cancer,phenylalanine hydroxylase
14565,darifenacin,hypersensitivity pneumonitis,dipeptidase 1
14566,riluzole,escherichia coli infection,sodium channel epithelial 1 subunit beta
14567,parathyroid hormone,hyperbilirubinemia,potassium voltage-gated channel subfamily h member 3
14568,cortisone,pulmonary tuberculosis,protein tyrosine kinase 2
14569,cephalotaxine,hypoglycemia,adrenoceptor alpha 1a
14570,mebendazole,bronchiectasis,eph receptor a1
14571,podophyllotoxin,autism spectrum disorder,"coagulation factor ii, thrombin"
14572,toloxatone,testicular cancer,calcium voltage-gated channel subunit alpha1 a
14573,dosulepin,gaucher disease,amylase alpha 1b
14574,cortisone,sarcoma,dihydropyrimidine dehydrogenase
14575,insulin aspart,thyroiditis,atpase na+/k+ transporting subunit alpha 3
14576,testosterone propionate,ascariasis,solute carrier family 6 member 4
14577,edoxaban,bacterial pneumonia,somatostatin receptor 1
14578,cimetidine,chronic urticaria,"mpl proto-oncogene, thrombopoietin receptor"
14579,hydroquinone,sarcoidosis,atp binding cassette subfamily c member 2
14580,cinnarizine,toxic shock syndrome,atpase na+/k+ transporting subunit beta 1
14581,metyrapone,secondary hyperparathyroidism,cytochrome p450 family 2 subfamily b member 6
14582,methylphenidate,chronic myelomonocytic leukemia,leukocyte receptor tyrosine kinase
14583,phentermine,familial mediterranean fever,maternal embryonic leucine zipper kinase
14584,metyrapone,pulmonary tuberculosis,structural maintenance of chromosomes 1a
14585,mirodenafil,sitosterolemia,dual specificity tyrosine phosphorylation regulated kinase 2
14586,nelfinavir,metastatic melanoma,cholinergic receptor muscarinic 4
14587,leuprolide,systemic mastocytosis,myosin light chain kinase family member 4
14588,diflunisal,leprosy,potassium voltage-gated channel subfamily c member 4
14589,dexfenfluramine,thyroid crisis,udp-glucose ceramide glucosyltransferase
14590,darunavir,inappropriate adh syndrome,glutamate ionotropic receptor ampa type subunit 4
14591,oxymetholone,stevens-johnson syndrome,peptidylprolyl isomerase a
14592,dromostanolone propionate,pruritus ani,potassium voltage-gated channel modifier subfamily g member 3
14593,bilastine,erythropoietic protoporphyria,solute carrier family 19 member 1
14594,ketoprofen,manic bipolar affective disorder,5-hydroxytryptamine receptor 1a
14595,lamivudine,erdheim-chester disease,cathepsin g
14596,apomorphine,primary myelofibrosis,solute carrier family 22 member 12
14597,oxcarbazepine,bulimia nervosa,fms related receptor tyrosine kinase 4
14598,triazolam,psoriatic arthritis,tyrosinase
14599,eribulin,tinea pedis,potassium voltage-gated channel subfamily a member 6
14600,sapropterin,familial dermatographia,cholinergic receptor nicotinic alpha 6 subunit
14601,quinestrol,hereditary angioedema,bcl2 like 1
14602,clomipramine,stargardt disease,"fyn proto-oncogene, src family tyrosine kinase"
14603,doxazosin,thrombotic disease,gamma-aminobutyric acid type a receptor subunit beta3
14604,irinotecan,"leukemia, myeloid, chronic-phase",aurora kinase a
14605,metformin,discoid lupus erythematosus,prostaglandin f receptor
14606,eletriptan,fabry disease,carbonic anhydrase 7
14607,promazine,endometrium neoplasm,hyperpolarization activated cyclic nucleotide gated potassium channel 1
14608,sufentanil,disseminated intravascular coagulation,carbonic anhydrase 9
14609,octreotide,post-partum hemorrhage,phospholipase a2 group iie
14610,quinine,hypophosphatemia,serine/threonine kinase 11
14611,crisaborole,rhinitis,dopamine receptor d1
14612,trimetazidine,liposarcoma,tubulin delta 1
14613,fenofibrate,lung disorder,calreticulin
14614,ephedrine,neuralgia,serine/threonine kinase 16
14615,sermorelin,malignant glioma,sodium voltage-gated channel alpha subunit 3
14616,icatibant,prader-willi syndrome,g protein-coupled receptor 35
14617,mephentermine,post-traumatic stress disorder,hydroxycarboxylic acid receptor 3
14618,amobarbital,neuralgia,integrin subunit alpha l
14619,nitric oxide,delirium,steroid 5 alpha-reductase 2
14620,vorinostat,impetigo,metabolism of cobalamin associated c
14621,acetyldigitoxin,gastric cancer,tec protein tyrosine kinase
14622,clocortolone pivalate,hypersensitivity pneumonitis,pre-mrna processing factor kinase prp4k
14623,dipivefrine,oral mucosa leukoplakia,trace amine associated receptor 1
14624,acth,premature ejaculation,gamma-aminobutyric acid type a receptor subunit epsilon
14625,regorafenib,meniere disease,histone deacetylase 6
14626,megestrol,focal epilepsy,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
14627,riluzole,stevens-johnson syndrome,cytochrome p450 family 2 subfamily b member 6
14628,hydroflumethiazide,impetigo,tubulin delta 1
14629,betamethasone,"hydatidiform mole, recurrent, 1",arginine vasopressin receptor 1a
14630,carbetocin,schizoaffective disorder,gamma-aminobutyric acid type a receptor subunit pi
14631,trospium chloride,rheumatic heart disease,s100 calcium binding protein p
14632,valsartan,pellagra,adrenoceptor beta 1
14633,paracetamol,secondary hyperparathyroidism,rho associated coiled-coil containing protein kinase 2
14634,dasatinib,orthostatic hypotension,eph receptor a5
14635,anagliptin,asthma-chronic obstructive pulmonary disease overlap syndrome,atpase na+/k+ transporting subunit beta 2
14636,nilotinib,inflammatory bowel disease,glutamate ionotropic receptor kainate type subunit 1
14637,triamcinolone,"chronic myelogenous leukemia, bcr-abl1 positive",erb-b2 receptor tyrosine kinase 2
14638,irinotecan,basal ganglia disorder,calcium voltage-gated channel subunit alpha1 c
14639,eliglustat,polymyalgia rheumatica,solute carrier family 5 member 11
14640,saxagliptin,diamond-blackfan anemia,carbonic anhydrase 13
14641,metyrapone,west syndrome,fkbp prolyl isomerase 1b
14642,cisapride,breast fibrocystic disease,peptidylprolyl isomerase b
14643,hydrochlorothiazide,menorrhagia,dipeptidyl peptidase 4
14644,methapyrilene,hypertriglyceridemia,nuclear receptor subfamily 3 group c member 2
14645,mefenamic acid,keratitis,ndufa4 mitochondrial complex associated
14646,parathyroid hormone,delirium,5-hydroxytryptamine receptor 7
14647,teduglutide,malignant essential hypertension,solute carrier organic anion transporter family member 1b1
14648,venlafaxine,non-hodgkin lymphoma,tubulin beta 6 class v
14649,tolmetin,psychotic disorder,solute carrier family 47 member 2
14650,pralatrexate,esophageal cancer,cytochrome p450 family 2 subfamily a member 6
14651,eflornithine,hemorrhagic disease of newborn,mitogen-activated protein kinase kinase 5
14652,incadronic acid,motion sickness,growth hormone receptor
14653,ciprofloxacin,hypertrichosis of eyelid,proteasome 20s subunit beta 1
14654,desloratadine,aggressive systemic mastocytosis,platelet activating factor receptor
14655,butenafine,poems syndrome,bub1 mitotic checkpoint serine/threonine kinase
14656,guanabenz,secondary hyperparathyroidism,hyperpolarization activated cyclic nucleotide gated potassium channel 1
14657,rimexolone,thromboembolism,adrenoceptor beta 3
14658,acetazolamide,prostate cancer,peroxisome proliferator activated receptor gamma
14659,regorafenib,sickle cell anemia,neutrophil cytosolic factor 1
14660,diflorasone diacetate,motion sickness,phosphodiesterase 1b
14661,nicardipine,biotinidase deficiency,angiotensin ii receptor type 1
14662,mercaptopurine,uterine corpus leiomyoma,atpase copper transporting beta
14663,quizartinib,thyroid crisis,bmp2 inducible kinase
14664,carbamazepine,systemic lupus erythematosus,sphingosine-1-phosphate receptor 4
14665,sotalol,breast ductal adenocarcinoma,tubulin beta 4a class iva
14666,methdilazine,eye disorder,mitogen-activated protein kinase kinase 5
14667,salbutamol,respiratory failure,endothelin receptor type b
14668,icotinib,diarrheal disease,sodium channel epithelial 1 subunit alpha
14669,norgestimate,bacterial pneumonia,gc vitamin d binding protein
14670,chlorambucil,x-linked dominant hypophosphatemic rickets,potassium voltage-gated channel subfamily d member 3
14671,ergocalciferol,thrombocytopenia,"met proto-oncogene, receptor tyrosine kinase"
14672,quizartinib,primary myelofibrosis,purinergic receptor p2y12
14673,thiothixene,pheochromocytoma,5-hydroxytryptamine receptor 6
14674,methimazole,acquired thrombocytopenia,fer tyrosine kinase
14675,naloxone,pellagra,toll like receptor 2
14676,acetyldigitoxin,heart failure,5-hydroxytryptamine receptor 1d
14677,eldecalcitol,diamond-blackfan anemia,"kras proto-oncogene, gtpase"
14678,desoximetasone,headache,tubulin delta 1
14679,methyltestosterone,meningococcal meningitis,prostaglandin-endoperoxide synthase 1
14680,lopinavir,follicular lymphoma,metallothionein 1a
14681,propranolol,wilms tumor,thromboxane a2 receptor
14682,triazolam,xerophthalmia,glutathione s-transferase alpha 2
14683,candesartan,dermatophytosis of groin and perianal area,coagulation factor ii thrombin receptor
14684,clobetasol propionate,erythema multiforme,g protein-coupled receptor 35
14685,benzphetamine,thyroid gland follicular carcinoma,"abl proto-oncogene 1, non-receptor tyrosine kinase"
14686,mirtazapine,angle-closure glaucoma,"tu translation elongation factor, mitochondrial"
14687,quinine,torsades de pointes,calcium voltage-gated channel auxiliary subunit alpha2delta 1
14688,estramustine,menorrhagia,annexin a1
14689,teduglutide,hepatic veno-occlusive disease,gamma-aminobutyric acid type a receptor subunit alpha4
14690,olaparib,frozen shoulder,cytochrome p450 family 1 subfamily a member 2
14691,dosulepin,potassium deficiency disease,cathepsin g
14692,dezocine,granuloma annulare,cytochrome p450 family 51 subfamily a member 1
14693,protriptyline,allergic bronchopulmonary aspergillosis,glutathione s-transferase alpha 2
14694,bupropion,pruritus ani,"yes proto-oncogene 1, src family tyrosine kinase"
14695,brigatinib,orthostatic hypotension,transforming growth factor beta receptor 2
14696,adinazolam,generalized anxiety disorder,matrix metallopeptidase 2
14697,floctafenine,pthirus pubis infestation,albumin
14698,hydrocodone,fibromyalgia,hypoxanthine phosphoribosyltransferase 1
14699,clobazam,ovarian cancer,solute carrier family 46 member 1
14700,mexiletine,congenital adrenal hyperplasia,tachykinin precursor 1
14701,befunolol,stroke disorder,cholinergic receptor muscarinic 3
14702,tramadol,tardive dyskinesia,phosphodiesterase 3b
14703,bretylium,gestational trophoblastic neoplasm,catechol-o-methyltransferase
14704,pramipexole,post-operative pain,gamma-aminobutyric acid type a receptor subunit alpha6
14705,chlorthalidone,bronchial disorder,cytochrome p450 family 11 subfamily b member 1
14706,isotretinoin,subarachnoid hemorrhage,"dna polymerase epsilon, catalytic subunit"
14707,bilastine,acute monocytic leukemia,metabolism of cobalamin associated c
14708,5-fluorouracil,postmenopausal atrophic vaginitis,histone deacetylase 4
14709,fluvoxamine,castleman disease,tubulin gamma 1
14710,ethosuximide,major depressive disorder,gonadotropin releasing hormone receptor
14711,simvastatin,prinzmetal angina,angiotensin converting enzyme 2
14712,ulobetasol propionate,"leukemia, myeloid, chronic-phase",tubulin beta 2a class iia
14713,crisaborole,brain glioblastoma,retinoic acid receptor gamma
14714,norgestimate,pellagra,potassium voltage-gated channel subfamily c member 3
14715,terazosin,acute monocytic leukemia,mitogen-activated protein kinase kinase kinase 2
14716,valsartan,medullary thyroid gland carcinoma,electron transfer flavoprotein dehydrogenase
14717,amantadine,hyperglycemia,calcium/calmodulin dependent protein kinase ii alpha
14718,cephalotaxine,acute coronary syndrome,peroxisome proliferator activated receptor delta
14719,butenafine,rheumatic heart disease,"ran, member ras oncogene family"
14720,prochlorperazine,atrophic vulva,adenosine a3 receptor
14721,migalastat,gestational trophoblastic neoplasm,srsf protein kinase 3
14722,tamsulosin,klinefelter syndrome,sodium channel epithelial 1 subunit beta
14723,fenoldopam,polyuria,potassium inwardly rectifying channel subfamily j member 2
14724,saquinavir,postherpetic neuralgia,carbonic anhydrase 9
14725,cefmetazole,tendinopathy,cholinergic receptor muscarinic 2
14726,vinblastine,erythema multiforme,carbonic anhydrase 13
14727,fampridine,dyspepsia,bcl2 like 2
14728,doxepin,oral mucosa leukoplakia,inosine monophosphate dehydrogenase 2
14729,topiramate,hypocalcemia,transthyretin
14730,naftopidil,allergic rhinitis,gamma-aminobutyric acid type a receptor subunit delta
14731,raloxifene,migraine disorder,"abl proto-oncogene 1, non-receptor tyrosine kinase"
14732,albiglutide,amyloidosis,mitogen-activated protein kinase kinase kinase 19
14733,pirbuterol,dermatitis herpetiformis,uridine monophosphate synthetase
14734,tramadol,aplastic anemia,integrin subunit alpha 2b
14735,loteprednol etabonate,tetany,histone deacetylase 11
14736,carteolol,castleman disease,carbonic anhydrase 9
14737,acenocoumarol,headache,glutamate ionotropic receptor nmda type subunit 2b
14738,beclometasone,autoimmune hemolytic anemia,janus kinase 1
14739,bimatoprost,renal osteodystrophy,monoamine oxidase a
14740,zileuton,thyroiditis,interleukin 2
14741,hydroflumethiazide,abdominal abscess,calcium voltage-gated channel subunit alpha1 c
14742,drospirenone,rhabdomyosarcoma,monoamine oxidase a
14743,tofacitinib,contact dermatitis,dna topoisomerase i
14744,eldecalcitol,toothache,potassium voltage-gated channel subfamily q member 1
14745,febuxostat,bursitis,potassium calcium-activated channel subfamily n member 4
14746,cilostazol,gynecomastia disorder,calcitonin receptor
14747,levomilnacipran,dermatitis,calcium voltage-gated channel auxiliary subunit beta 1
14748,conivaptan,brain cancer,potassium voltage-gated channel subfamily q member 4
14749,polmacoxib,pityriasis versicolor,atpase h+/k+ transporting subunit beta
14750,diflorasone diacetate,choroiditis,potassium inwardly rectifying channel subfamily j member 1
14751,dasatinib,hyperlipidemia,cytochrome p450 family 27 subfamily a member 1
14752,chlorhexidine,lewy body dementia,serine/threonine kinase 33
14753,enalapril,relapsing-remitting multiple sclerosis,ribosomal protein l3
14754,oseltamivir,tenosynovial giant cell tumor,phosphodiesterase 7a
14755,levorphanol,hyponatremia,phosphodiesterase 3a
14756,probenecid,menorrhagia,calcium voltage-gated channel auxiliary subunit gamma 1
14757,glutethimide,"dermatitis, atopic",histamine receptor h4
14758,methyl salicylate,amyloidosis,sirtuin 1
14759,pralatrexate,panic disorder,sphingosine-1-phosphate receptor 5
14760,neostigmine,fever,adrenoceptor beta 3
14761,zaleplon,acute lung injury,cholinergic receptor nicotinic alpha 5 subunit
14762,cabozantinib,amenorrhea,potassium voltage-gated channel subfamily a member 2
14763,silodosin,homozygous familial hypercholesterolemia,sonic hedgehog signaling molecule
14764,carbidopa,mature t-cell and nk-cell non-hodgkin lymphoma,hyperpolarization activated cyclic nucleotide gated potassium channel 3
14765,acamprosate,schizophrenia,phosphodiesterase 10a
14766,ixabepilone,myotonic syndrome,tubulin gamma 1
14767,chlorpheniramine,zollinger-ellison syndrome,potassium voltage-gated channel modifier subfamily s member 2
14768,fsh,goiter,membrane spanning 4-domains a1
14769,ifosfamide,hypoactive sexual desire disorder,potassium two pore domain channel subfamily k member 9
14770,luseogliflozin,"cicatrix, hypertrophic",maltase-glucoamylase
14771,polythiazide,systemic mastocytosis,eph receptor a5
14772,triamterene,myalgia,glucosidase ii alpha subunit
14773,tiaprofenic acid,hyperprolactinemia,cholinergic receptor nicotinic beta 3 subunit
14774,ergotamine,serum sickness,structural maintenance of chromosomes 2
14775,protriptyline,pulmonary tuberculosis,opioid receptor kappa 1
14776,opipramol,myeloproliferative neoplasm,atpase na+/k+ transporting subunit alpha 1
14777,anisotropine methylbromide,obsessive-compulsive disorder,solute carrier family 6 member 4
14778,goserelin,allergic asthma,potassium voltage-gated channel subfamily c member 1
14779,viloxazine,congestive heart failure,nuclear receptor subfamily 0 group b member 1
14780,belotecan,pulmonary valve atresia,cytochrome p450 family 27 subfamily b member 1
14781,sermorelin,cluster headache syndrome,bcr activator of rhogef and gtpase
14782,maprotiline,langerhans cell histiocytosis,ribosomal protein s6 kinase a2
14783,bromfenac,nasal congestion,vascular endothelial growth factor a
14784,doxorubicin,propionic acidemia,"mer proto-oncogene, tyrosine kinase"
14785,chlorambucil,sympathetic ophthalmia,hyperpolarization activated cyclic nucleotide gated potassium channel 4
14786,cilazapril,head and neck neoplasm,calcyon neuron specific vesicular protein
14787,pyrimethamine,fibromyalgia,5-hydroxytryptamine receptor 3d
14788,pioglitazone,neuralgia,sodium voltage-gated channel alpha subunit 2
14789,lisinopril,diarrheal disease,"pim-2 proto-oncogene, serine/threonine kinase"
14790,mephentermine,thrombotic disease,tumor protein p53
14791,liraglutide,thyroid gland carcinoma,adrenoceptor beta 2
14792,ezetimibe,hepatic veno-occlusive disease,nischarin
14793,pazopanib,embolism,ndufa4 mitochondrial complex associated
14794,fesoterodine,castleman disease,carnitine palmitoyltransferase 1a
14795,oxyphencyclimine,hemangioma,cdc like kinase 1
14796,somatropin,diarrheal disease,solute carrier family 12 member 1
14797,sunitinib,intermittent vascular claudication,cysteinyl leukotriene receptor 1
14798,aminobenzoic acid,laryngeal edema,il2 inducible t cell kinase
14799,timolol,restless legs syndrome,monoamine oxidase a
14800,efonidipine,"leukemia, myeloid, chronic-phase",calcium voltage-gated channel subunit alpha1 f
14801,clocortolone pivalate,autosomal dominant polycystic kidney disease,serpin family e member 1
14802,anagliptin,poems syndrome,solute carrier family 18 member a2
14803,butenafine,schizophrenia,calmodulin 2
14804,sapropterin,"hydatidiform mole, recurrent, 1",casein kinase 1 delta
14805,fluoxetine,duodenal ulcer,solute carrier organic anion transporter family member 1b3
14806,nitric oxide,pemphigus,janus kinase 1
14807,mianserin,hyperglycemia,complement c5
14808,sildenafil,bacterial endocarditis,glutamate ionotropic receptor nmda type subunit 2c
14809,conjugated estrogens,delirium,endothelin receptor type a
14810,ticagrelor,common wart,inhibitor of nuclear factor kappa b kinase subunit beta
14811,phytomenadione,diarrheal disease,sodium channel epithelial 1 subunit beta
14812,clobazam,depressive disorder,matrix metallopeptidase 2
14813,oxazepam,menorrhagia,endothelin receptor type a
14814,acamprosate,"cicatrix, hypertrophic",potassium voltage-gated channel subfamily a member 5
14815,lifitegrast,tetanus,galactosidase alpha
14816,bepotastine,rheumatoid arthritis,solute carrier family 47 member 1
14817,crotamiton,prostate neoplasm,potassium voltage-gated channel subfamily q member 5
14818,docetaxel,congenital adrenal hyperplasia,thromboxane a2 receptor
14819,loxapine,pulmonary fibrosis,sodium voltage-gated channel alpha subunit 10
14820,capecitabine,myeloid neoplasm associated with pdgfra rearrangement,apolipoprotein a1
14821,terazosin,ankylosing spondylitis,ebp cholestenol delta-isomerase
14822,floxuridine,hyperprolactinemia,transient receptor potential cation channel subfamily v member 3
14823,bimatoprost,respiratory sounds,potassium voltage-gated channel modifier subfamily g member 4
14824,goserelin,endometrial carcinoma,phosphodiesterase 6b
14825,terbutaline,secondary hyperparathyroidism,ribonucleotide reductase regulatory subunit m2
14826,prilocaine,heart failure,fatty acid amide hydrolase
14827,linaclotide,breast fibrocystic disease,aurora kinase a
14828,pinacidil,noonan syndrome,"plasminogen activator, tissue type"
14829,dabrafenib,skin basal cell carcinoma,unc-51 like autophagy activating kinase 2
14830,simvastatin,primary myelofibrosis,retinoic acid receptor gamma
14831,glucagon,choroiditis,amine oxidase copper containing 1
14832,somatrem,inflammatory bowel disease,septin 9
14833,tolmetin,subarachnoid hemorrhage,dna methyltransferase 3 alpha
14834,enalapril,"hyperlipidemia, familial combined, lpl related",janus kinase 1
14835,zileuton,brain edema,glutathione s-transferase pi 1
14836,acebutolol,seborrheic dermatitis,atpase na+/k+ transporting subunit beta 2
14837,danazol,skin basal cell carcinoma,phosphodiesterase 6b
14838,codeine,prinzmetal angina,phosphodiesterase 7b
14839,orciprenaline,chancroid,dopamine receptor d4
14840,quizartinib,serum sickness,thyroid peroxidase
14841,menatetrenone,vitamin b12 deficiency,polo like kinase 4
14842,fexofenadine,tendinopathy,polo like kinase 4
14843,teduglutide,pain,prostaglandin d2 receptor 2
14844,alpha-methyltyrosine,chronic eosinophilic leukemia,plasminogen
14845,mexiletine,cardiac arrest,transient receptor potential cation channel subfamily v member 3
14846,methixene,"cicatrix, hypertrophic",atpase h+/k+ transporting subunit beta
14847,vincristine,hot flashes,solute carrier family 22 member 5
14848,etoposide,postmenopausal osteoporosis,phosphodiesterase 4b
14849,rupatadine,angle-closure glaucoma,hydroxysteroid 11-beta dehydrogenase 1
14850,estradiol valerate,pruritus ani,potassium voltage-gated channel subfamily d member 2
14851,sufentanil,west syndrome,methylmalonyl-coa mutase
14852,troglitazone,primary myelofibrosis,hypoxanthine phosphoribosyltransferase 1
14853,ospemifene,gout,"abl proto-oncogene 1, non-receptor tyrosine kinase"
14854,mesoridazine,alcohol abuse,cholinergic receptor nicotinic alpha 4 subunit
14855,nefazodone,cardiogenic shock,gamma-glutamyl carboxylase
14856,diphenoxylate,allergic rhinitis,interleukin 1 receptor associated kinase 3
14857,pimavanserin,hyperparathyroidism,metabolism of cobalamin associated c
14858,etizolam,myotonic syndrome,tec protein tyrosine kinase
14859,etelcalcetide,influenza,discoidin domain receptor tyrosine kinase 1
14860,hydroxyzine,arteriosclerosis disorder,solute carrier family 9 member a1
14861,eliglustat,hypoactive sexual desire disorder,metallothionein 2a
14862,propantheline,dyschromatosis universalis hereditaria,somatostatin receptor 5
14863,clofarabine,turner syndrome,paraoxonase 1
14864,nizatidine,phenylketonuria,gamma-aminobutyric acid type a receptor subunit epsilon
14865,prazosin,enterobiasis,glutamate ionotropic receptor nmda type subunit 2a
14866,ephedrine,tinea pedis,glutamate ionotropic receptor nmda type subunit 3a
14867,piroxicam,hemorrhagic disease of newborn,steroid 5 alpha-reductase 2
14868,ecallantide,lung disorder,toll like receptor 2
14869,benzphetamine,bronchial disorder,salt inducible kinase 1
14870,nilotinib,malignant colon neoplasm,insulin receptor
14871,prednisone,gastric cancer,histone deacetylase 6
14872,dexibuprofen,seborrheic dermatitis,tubulin delta 1
14873,eszopiclone,prostate neoplasm,glucosidase ii alpha subunit
14874,tipiracil,duodenal ulcer,growth hormone receptor
14875,vernakalant,mature t-cell and nk-cell non-hodgkin lymphoma,cdgsh iron sulfur domain 1
14876,acetazolamide,exfoliative dermatitis,"blk proto-oncogene, src family tyrosine kinase"
14877,methylphenidate,stroke disorder,g protein-coupled receptor kinase 4
14878,pentostatin,vascular disorder,potassium voltage-gated channel subfamily c member 1
14879,disulfiram,vascular disorder,solute carrier family 19 member 1
14880,losartan,persistent fetal circulation syndrome,cholinergic receptor nicotinic alpha 10 subunit
14881,nabumetone,biotinidase deficiency,receptor interacting serine/threonine kinase 2
14882,ciprofloxacin,bronchial disorder,atpase h+ transporting v1 subunit a
14883,phenacemide,plasma cell myeloma,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
14884,sufentanil,dermatofibrosarcoma protuberans,dopamine receptor d1
14885,pheniramine,thyroid gland carcinoma,glutamate ionotropic receptor ampa type subunit 3
14886,ethinylestradiol,cryopyrin-associated periodic syndrome,hyperpolarization activated cyclic nucleotide gated potassium channel 3
14887,treprostinil,chancroid,histone deacetylase 9
14888,sorafenib,klinefelter syndrome,sigma non-opioid intracellular receptor 1
14889,eletriptan,psoriatic arthritis,cytochrome p450 family 24 subfamily a member 1
14890,secobarbital,hypercalcemia disease,adrenoceptor alpha 1a
14891,magnesium salicylate,impetigo,carbonic anhydrase 3
14892,sibutramine,gynecomastia disorder,"ran, member ras oncogene family"
14893,dapoxetine,hemangioma,vitamin k epoxide reductase complex subunit 1
14894,hydroflumethiazide,gout,potassium voltage-gated channel subfamily d member 3
14895,calcifediol,laryngeal edema,5-hydroxytryptamine receptor 2b
14896,dantrolene,seasonal affective disorder,5-hydroxytryptamine receptor 6
14897,sitagliptin,polyuria,"major histocompatibility complex, class i, a"
14898,medrysone,vitamin deficiency disorder,opioid related nociceptin receptor 1
14899,choline,essential hypertension,interleukin 1 receptor associated kinase 3
14900,nateglinide,parkinsonian disorder,phosphodiesterase 1c
14901,ponatinib,nutritional biotin deficiency,dopa decarboxylase
14902,risperidone,hypoactive sexual desire disorder,"src proto-oncogene, non-receptor tyrosine kinase"
14903,halcinonide,obesity disorder,high mobility group box 1
14904,tofacitinib,mantle cell lymphoma,dead-box helicase 1
14905,lovastatin,bipolar depression,glutathione s-transferase pi 1
14906,verapamil,cryptorchidism,purinergic receptor p2y12
14907,efonidipine,hypercholesterolemia,tumor protein p53
14908,riboflavin,contact dermatitis,neutrophil cytosolic factor 1
14909,bendroflumethiazide,strongyloidiasis,solute carrier organic anion transporter family member 1a2
14910,pethidine,thyroid tumor,monoamine oxidase a
14911,dutasteride,hemorrhagic disease of newborn,aurora kinase c
14912,phentermine,urinary bladder cancer,glutamate ionotropic receptor nmda type subunit 2a
14913,salmeterol,respiratory failure,cytochrome p450 family 21 subfamily a member 2
14914,dextropropoxyphene,aspiration pneumonia,phosphodiesterase 1b
14915,incadronic acid,prostate neoplasm,potassium inwardly rectifying channel subfamily j member 8
14916,landiolol,propionic acidemia,phosphodiesterase 7b
14917,apalutamide,adrenogenital syndrome,checkpoint kinase 2
14918,meloxicam,uveitis,melanocortin 3 receptor
14919,norfloxacin,nasal congestion,amine oxidase copper containing 1
14920,isosorbide mononitrate,dermatophytosis of groin and perianal area,udp-glucose ceramide glucosyltransferase
14921,antazoline,neuralgia,proteasome 20s subunit beta 9
14922,apalutamide,inflammatory bowel disease,ryanodine receptor 3
14923,metaraminol,allergic contact dermatitis,"dna polymerase alpha 1, catalytic subunit"
14924,phendimetrazine,short bowel syndrome,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
14925,halcinonide,cryopyrin-associated periodic syndrome,retinoid x receptor gamma
14926,zolmitriptan,gonorrhea,hyperpolarization activated cyclic nucleotide gated potassium channel 1
14927,omacetaxine mepesuccinate,major depressive disorder,membrane spanning 4-domains a1
14928,losartan,liver cancer,receptor interacting serine/threonine kinase 3
14929,entacapone,vomiting,cytochrome p450 family 51 subfamily a member 1
14930,rimexolone,subarachnoid hemorrhage,vitamin k epoxide reductase complex subunit 1
14931,ulobetasol propionate,dermatitis herpetiformis,insulin receptor related receptor
14932,promazine,malignant glioma,nischarin
14933,tafluprost,aspiration pneumonia,5-hydroxytryptamine receptor 1a
14934,phenazone,neurogenic bladder,solute carrier family 18 member a1
14935,metolazone,bacterial endocarditis,bub1 mitotic checkpoint serine/threonine kinase
14936,mosapramine,thrombophilia due to thrombin defect,androgen receptor
14937,gemtuzumab ozogamicin,dysmenorrhea,serine/threonine kinase 33
14938,pindolol,hyperglycemia,cubilin
14939,zaleplon,erdheim-chester disease,"pim-2 proto-oncogene, serine/threonine kinase"
14940,silodosin,allergic urticaria,cholinergic receptor nicotinic alpha 4 subunit
14941,enzalutamide,bulimia nervosa,atp binding cassette subfamily g member 5
14942,ulobetasol propionate,west syndrome,inosine monophosphate dehydrogenase 2
14943,pentostatin,parkinsonian disorder,protein kinase cgmp-dependent 1
14944,rivaroxaban,ovarian epithelial tumor,integrin subunit alpha 2b
14945,penbutolol,decreased cardiac output,mitogen-activated protein kinase kinase kinase 9
14946,bendroflumethiazide,neuroblastoma,galactosidase alpha
14947,cephalotaxine,premenstrual dysphoric disorder,riboflavin kinase
14948,teriflunomide,social phobia,"dna polymerase alpha 1, catalytic subunit"
14949,baricitinib,hypertriglyceridemia,cholinergic receptor nicotinic alpha 7 subunit
14950,fondaparinux,hemophilia a,cyclin g associated kinase
14951,eszopiclone,bone paget disease,potassium voltage-gated channel subfamily d member 2
14952,ergocalciferol,bulimia nervosa,membrane spanning 4-domains a1
14953,linagliptin,adrenal gland hyperfunction,dna topoisomerase i
14954,teriflunomide,atrophic vulva,platelet derived growth factor receptor beta
14955,zidovudine,atrial fibrillation,pancreatic lipase
14956,paliperidone,burkitt lymphoma,histamine receptor h3
14957,carmustine,thromboembolism,24-dehydrocholesterol reductase
14958,acarbose,meningococcal meningitis,4-hydroxyphenylpyruvate dioxygenase
14959,fludroxycortide,allergic contact dermatitis,fxyd domain containing ion transport regulator 2
14960,fesoterodine,bacterial conjunctivitis,tumor necrosis factor
14961,vemurafenib,exanthem,cholesteryl ester transfer protein
14962,nicotine,sneeze,potassium two pore domain channel subfamily k member 3
14963,chlorambucil,graves disease,neurotrophic receptor tyrosine kinase 1
14964,vortioxetine,canker sore,glutamate ionotropic receptor kainate type subunit 4
14965,teniposide,discoid lupus erythematosus,protein kinase c alpha
14966,minoxidil,west syndrome,histamine receptor h4
14967,leuprolide,psychosexual disorder,carbonic anhydrase 1
14968,alclofenac,angioedema,potassium voltage-gated channel modifier subfamily f member 1
14969,trimethadione,cluster headache syndrome,neurotrophic receptor tyrosine kinase 3
14970,rizatriptan,keratitis,gamma-aminobutyric acid type a receptor subunit alpha1
14971,betaxolol,erectile dysfunction,glutamate ionotropic receptor nmda type subunit 2b
14972,tofacitinib,small intestine cancer,atpase na+/k+ transporting subunit beta 1
14973,choline magnesium trisalicylate,discoid lupus erythematosus,"plasminogen activator, tissue type"
14974,morphine,pulmonary fibrosis,glucosidase ii alpha subunit
14975,triflupromazine,type 1 diabetes mellitus,potassium voltage-gated channel subfamily q member 3
14976,sertindole,pulmonary arterial hypertension,homeodomain interacting protein kinase 4
14977,ubidecarenone,urinary bladder cancer,bradykinin receptor b2
14978,apomorphine,hypercholesterolemia,glutamate ionotropic receptor ampa type subunit 1
14979,febuxostat,human african trypanosomiasis,calcium/calmodulin dependent protein kinase ii alpha
14980,vigabatrin,short bowel syndrome,tankyrase 2
14981,chlorpheniramine,pityriasis versicolor,sonic hedgehog signaling molecule
14982,alogliptin,atrial fibrillation,glutathione s-transferase theta 1
14983,tranexamic acid,cardiogenic shock,myosin heavy chain 10
14984,opipramol,marginal zone lymphoma,potassium voltage-gated channel subfamily h member 7
14985,methimazole,thyroid crisis,retinoid x receptor alpha
14986,limaprost,trigeminal neuralgia,hydroxysteroid 11-beta dehydrogenase 1
14987,nisoldipine,intrinsic asthma,cyclin g associated kinase
14988,eflornithine,pulmonary arterial hypertension,calcium voltage-gated channel subunit alpha1 d
14989,procyclidine,kidney angiomyolipoma,cyclin dependent kinase 19
14990,ubidecarenone,precocious puberty,potassium voltage-gated channel modifier subfamily g member 4
14991,fosamprenavir,osteomalacia,lipoprotein lipase
14992,l-glutamine,mast cell leukemia,aurora kinase b
14993,menatetrenone,pediculus humanus capitis infestation,myristoylated alanine rich protein kinase c substrate
14994,propylthiouracil,asthma,protein kinase c theta
14995,lithium ion,anogenital human papillomavirus infection,toll like receptor 9
14996,chlorpheniramine,lung lymphangioleiomyomatosis,atp binding cassette subfamily g member 5
14997,loxoprofen,malignant essential hypertension,cholinergic receptor muscarinic 1
14998,piribedil,thyroid gland papillary carcinoma,adrenoceptor beta 3
14999,agomelatine,liposarcoma,adrenoceptor beta 2
15000,flufenamic acid,neoplasm of esophagus,chymotrypsinogen b1
15001,viloxazine,ascites,neurotrophic receptor tyrosine kinase 3
15002,saquinavir,prinzmetal angina,thyroid hormone receptor beta
15003,spirapril,subarachnoid hemorrhage,cholinergic receptor nicotinic alpha 10 subunit
15004,fenofibrate,anxiety disorder,proteasome 20s subunit beta 8
15005,topotecan,cardiogenic shock,cytochrome p450 family 2 subfamily a member 6
15006,imipramine,head and neck cancer,cholinergic receptor nicotinic beta 3 subunit
15007,phenazone,bacterial pneumonia,gamma-aminobutyric acid type a receptor subunit beta3
15008,phenelzine,skin disorder,cysteinyl leukotriene receptor 2
15009,clobetasol propionate,acute lymphoblastic leukemia,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
15010,amantadine,gastroesophageal reflux disease,histone deacetylase 5
15011,tofacitinib,chronic urticaria,"protein phosphatase 3 regulatory subunit b, alpha"
15012,triamterene,acne,farnesyl diphosphate synthase
15013,tolmetin,metrorrhagia,diacylglycerol o-acyltransferase 1
15014,zoledronic acid,pellagra,cholinergic receptor muscarinic 5
15015,selegiline,oppositional defiant disorder,cytochrome p450 family 3 subfamily a member 4
15016,tranilast,pheochromocytoma,transient receptor potential cation channel subfamily v member 1
15017,alteplase,depressive disorder,carbonic anhydrase 4
15018,minocycline,hyperthyroidism,dipeptidyl peptidase 8
15019,pge1,major depressive disorder,tyrosine kinase 2
15020,clidinium,idiopathic hypereosinophilic syndrome,potassium voltage-gated channel subfamily h member 6
15021,gefitinib,acute gonococcal cervicitis,protein tyrosine kinase 2
15022,gilteritinib,polymyalgia rheumatica,thymidylate synthetase
15023,fingolimod,exfoliative dermatitis,eph receptor a1
15024,safinamide,serum sickness,solute carrier family 6 member 1
15025,delavirdine,acute gonococcal cervicitis,phosphorylase kinase catalytic subunit gamma 2
15026,naratriptan,periodontitis,purinergic receptor p2y12
15027,alogliptin,pulmonary artery stenosis,receptor interacting serine/threonine kinase 2
15028,bromodiphenhydramine,headache,pre-mrna splicing tri-snrnp complex factor prpf4
15029,armodafinil,chronic primary adrenal insufficiency,potassium voltage-gated channel subfamily a member 5
15030,bisoprolol,severe major depression with psychotic features,carnitine palmitoyltransferase 1a
15031,apraclonidine,thyroiditis,cholinergic receptor nicotinic alpha 6 subunit
15032,emtricitabine,hypersensitivity pneumonitis,cdc like kinase 4
15033,vemurafenib,persistent fetal circulation syndrome,proteasome 20s subunit beta 8
15034,digoxin,irritable bowel syndrome,neurotrophic receptor tyrosine kinase 2
15035,digoxin,vomiting,tubulin delta 1
15036,dexamethasone,classic phenylketonuria,bcl2 like 1
15037,flurbiprofen,frozen shoulder,thymidine phosphorylase
15038,valrubicin,urinary bladder neoplasm,atp binding cassette subfamily c member 8
15039,insulin lispro,chronic hepatitis c virus infection,myeloperoxidase
15040,bilastine,angina pectoris,cytochrome p450 family 3 subfamily a member 43
15041,sibutramine,esophageal cancer,homeodomain interacting protein kinase 2
15042,azatadine,b-cell chronic lymphocytic leukemia,solute carrier family 22 member 3
15043,dabrafenib,opiate dependence,low density lipoprotein receptor
15044,hydrochlorothiazide,dermatitis,sodium channel epithelial 1 subunit alpha
15045,hydroquinone,anogenital human papillomavirus infection,phosphoribosyl pyrophosphate amidotransferase
15046,propafenone,malignant pleural mesothelioma,cytochrome p450 family 11 subfamily b member 1
15047,valdecoxib,myeloid neoplasm associated with pdgfra rearrangement,carbonic anhydrase 14
15048,tacrolimus,eosinophilic pneumonia,dna methyltransferase 1
15049,estrone sulphate,follicular lymphoma,microtubule associated protein 1a
15050,tolazoline,asthma-chronic obstructive pulmonary disease overlap syndrome,potassium voltage-gated channel subfamily c member 3
15051,fluoxetine,diffuse alopecia areata,histone deacetylase 4
15052,umeclidinium,streptococcal pneumonia,fatty acid amide hydrolase
15053,antazoline,esophageal cancer,cytochrome p450 family 24 subfamily a member 1
15054,nateglinide,multiple sclerosis,cubilin
15055,olaparib,pruritus,s100 calcium binding protein p
15056,adapalene,pseudotumor cerebri,uridine monophosphate synthetase
15057,aripiprazole,hypercalcemia disease,ttk protein kinase
15058,mirtazapine,islet cell adenomatosis,natriuretic peptide b
15059,mefenamic acid,dermatitis,casein kinase 1 delta
15060,macitentan,atopic conjunctivitis,gamma-aminobutyric acid type a receptor subunit beta1
15061,bilastine,autoimmune disease,protein kinase cgmp-dependent 1
15062,acetophenazine,endometriosis,potassium inwardly rectifying channel subfamily j member 8
15063,phenytoin,opiate dependence,gamma-aminobutyric acid type a receptor subunit epsilon
15064,allopurinol,chancroid,calmodulin 1
15065,pamidronic acid,acquired thrombocytopenia,cytochrome p450 oxidoreductase
15066,floxuridine,ventricular fibrillation,4-aminobutyrate aminotransferase
15067,amprenavir,parkinsonian disorder,synuclein alpha
15068,propantheline,classic phenylketonuria,phenylalanine hydroxylase
15069,sumatriptan,amyotrophic lateral sclerosis,cytochrome p450 family 21 subfamily a member 2
15070,mepyramine,basal ganglia disorder,nuclear receptor subfamily 3 group c member 1
15071,acetylmethadol,sarcoidosis,potassium voltage-gated channel subfamily h member 1
15072,trimipramine,parkinson disease,phosphodiesterase 10a
15073,diflorasone diacetate,parkinsonian disorder,protein kinase n1
15074,icatibant,homozygous familial hypercholesterolemia,sodium voltage-gated channel alpha subunit 7
15075,esmolol,pulmonary fibrosis,potassium voltage-gated channel subfamily a member 4
15076,isoxsuprine,pulmonary fibrosis,carbonic anhydrase 14
15077,lorlatinib,headache disorder,glycine receptor alpha 3
15078,caffeine,eosinophilic esophagitis,estrogen receptor 2
15079,vildagliptin,hypertensive disorder,homeodomain interacting protein kinase 2
15080,tetrabenazine,oligospermia,casein kinase 1 delta
15081,piroxicam,primary myelofibrosis,5-hydroxytryptamine receptor 6
15082,rivaroxaban,dermatitis herpetiformis,fkbp prolyl isomerase 4
15083,alpha-methyltyrosine,poems syndrome,methylenetetrahydrofolate reductase
15084,pge1,hemophilia a,nuak family kinase 2
15085,zonisamide,congenital hypothyroidism,inhibitor of nuclear factor kappa b kinase subunit beta
15086,sofalcone,nephrotic syndrome,potassium voltage-gated channel modifier subfamily g member 4
15087,clocortolone pivalate,postmenopausal osteoporosis,insulin receptor
15088,tetracosactide,pyoderma gangrenosum,iodothyronine deiodinase 1
15089,pioglitazone,psychologic dyspareunia,"mer proto-oncogene, tyrosine kinase"
15090,vandetanib,renal cell carcinoma,homeodomain interacting protein kinase 2
15091,famotidine,meniere disease,glucosidase ii alpha subunit
15092,orciprenaline,cryopyrin-associated periodic syndrome,hypoxanthine phosphoribosyltransferase 1
15093,phenylephrine,gastroesophageal reflux disease,natriuretic peptide receptor 1
15094,dapoxetine,eye disorder,cytochrome p450 family 2 subfamily c member 19
15095,mesuximide,nutritional biotin deficiency,cubilin
15096,tofacitinib,type 1 diabetes mellitus,microtubule associated protein 2
15097,tafluprost,plasmodium vivax malaria,solute carrier family 22 member 5
15098,fesoterodine,lung lymphangioleiomyomatosis,potassium voltage-gated channel subfamily c member 3
15099,clomipramine,dementia,hydroxycarboxylic acid receptor 3
15100,ipragliflozin,toxic shock syndrome,bcl2 like 1
15101,nortriptyline,"leukemia, myeloid, chronic-phase","mer proto-oncogene, tyrosine kinase"
15102,tolmetin,polycystic ovary syndrome,trace amine associated receptor 1
15103,aminosalicylic acid,granuloma annulare,cyclin dependent kinase 8
15104,eprosartan,disseminated intravascular coagulation,opioid related nociceptin receptor 1
15105,olmutinib,temporal arteritis,histone deacetylase 8
15106,haloperidol,psoriatic arthritis,cholinergic receptor nicotinic alpha 3 subunit
15107,acth,gastrointestinal stromal tumor,"raf-1 proto-oncogene, serine/threonine kinase"
15108,diazepam,ventricular fibrillation,sodium voltage-gated channel alpha subunit 3
15109,propantheline,pheochromocytoma,carbonic anhydrase 4
15110,methimazole,fever,solute carrier family 6 member 4
15111,camphor,"malignant hyperthermia, susceptibility to, 1",interleukin 1 receptor associated kinase 1
15112,insulin glulisine,cough,dipeptidyl peptidase 4
15113,mometasone,thrombotic disease,solute carrier family 22 member 4
15114,pirbuterol,amyotrophic lateral sclerosis,potassium voltage-gated channel modifier subfamily s member 2
15115,oxycodone,autoimmune disease,atpase na+/k+ transporting subunit alpha 2
15116,azelastine,actinic keratosis,5-hydroxytryptamine receptor 6
15117,trazodone,aspiration pneumonia,tyrosinase
15118,enzalutamide,bronchial disorder,tubulin beta 6 class v
15119,duloxetine,gastric cancer,glutathione s-transferase pi 1
15120,polmacoxib,glossopharyngeal neuralgia,carbonic anhydrase 12
15121,doxorubicin,autoimmune hemolytic anemia,transmembrane protein 97
15122,ezetimibe,malignant hyperthermia of anesthesia,potassium voltage-gated channel modifier subfamily g member 1
15123,methylprednisolone,pthirus pubis infestation,toll like receptor 2
15124,isopropamide,eosinophilic pneumonia,glutamate ionotropic receptor ampa type subunit 1
15125,dimethyl fumarate,central nervous system origin vertigo,fms related receptor tyrosine kinase 3
15126,risedronate,duodenal ulcer,peptidylprolyl isomerase b
15127,tolazamide,dyspnea,carbonic anhydrase 13
15128,gilteritinib,thyroid gland carcinoma,bruton tyrosine kinase
15129,topotecan,pneumonia,potassium inwardly rectifying channel subfamily j member 8
15130,carbamazepine,urethritis,peptidylprolyl isomerase b
15131,nebivolol,interstitial lung disease 2,mitogen-activated protein kinase kinase kinase 11
15132,parathyroid hormone,hyperinsulinism,tubulin beta 2a class iia
15133,vortioxetine,dermatomyositis,bmx non-receptor tyrosine kinase
15134,topiroxostat,canker sore,matrix metallopeptidase 9
15135,prednisolone,cutaneous candidiasis,adenosine deaminase
15136,teriparatide,rhinoscleroma,histone deacetylase 5
15137,flibanserin,endometritis,monoamine oxidase b
15138,promethazine,noonan syndrome,5-hydroxytryptamine receptor 5a
15139,chlorambucil,adrenal gland hyperfunction,melanocortin 2 receptor
15140,escitalopram,breast cancer,glutamate ionotropic receptor ampa type subunit 2
15141,cephalotaxine,"leukemia, myeloid, chronic-phase",calcium voltage-gated channel subunit alpha1 d
15142,oxymetazoline,diabetic kidney disease,hydroxysteroid 11-beta dehydrogenase 1
15143,bezafibrate,female stress incontinence,somatostatin receptor 2
15144,vilanterol,marginal zone lymphoma,potassium voltage-gated channel subfamily a member 2
15145,diphenoxylate,brain edema,ribosomal protein s6 kinase a1
15146,ethosuximide,skin basal cell carcinoma,"plasminogen activator, tissue type"
15147,acetazolamide,post-traumatic stress disorder,potassium two pore domain channel subfamily k member 9
15148,carteolol,hyperlipoproteinemia type 3,guanylate cyclase 1 soluble subunit alpha 2
15149,ketotifen,embolism,gamma-aminobutyric acid type a receptor subunit beta2
15150,amiodarone,hot flashes,potassium voltage-gated channel subfamily h member 1
15151,pentostatin,hypoactive sexual desire disorder,fxyd domain containing ion transport regulator 2
15152,ibuprofen,myalgia,leukotriene c4 synthase
15153,almotriptan,punctate epithelial keratoconjunctivitis,ebp like
15154,olmutinib,miliary tuberculosis,atp binding cassette subfamily b member 1
15155,masoprocol,cough,activin a receptor type 1
15156,telmisartan,acute gonococcal cervicitis,potassium voltage-gated channel modifier subfamily g member 2
15157,pirbuterol,acute promyelocytic leukemia,phosphodiesterase 1a
15158,dorzolamide,focal epilepsy,histone deacetylase 4
15159,tolmetin,ovarian cancer,mitogen-activated protein kinase kinase kinase 19
15160,fluocinolone acetonide,hypotensive disorder,adenosine a1 receptor
15161,penbutolol,multiple sclerosis,histone deacetylase 1
15162,felbamate,synovitis,ste20 like kinase
15163,sulfasalazine,potassium deficiency disease,solute carrier family 9 member a1
15164,furosemide,myeloproliferative neoplasm,riboflavin kinase
15165,bumetanide,hypertrophic cardiomyopathy,glutamate ionotropic receptor kainate type subunit 5
15166,mebendazole,severe major depression with psychotic features,colony stimulating factor 1 receptor
15167,difenoxin,brain edema,dopamine receptor d5
15168,tramadol,brain glioblastoma,melatonin receptor 1a
15169,rivaroxaban,manic bipolar affective disorder,prostaglandin d2 receptor
15170,acrivastine,contact dermatitis,sulfotransferase family 2a member 1
15171,rivastigmine,chronic bronchitis,solute carrier family 22 member 3
15172,danazol,epilepsy,arginine vasopressin receptor 1a
15173,fentanyl,diffuse large b-cell lymphoma,angiotensin converting enzyme 2
15174,methamphetamine,homocystinuria,"src proto-oncogene, non-receptor tyrosine kinase"
15175,quinestrol,biotinidase deficiency,atp binding cassette subfamily c member 9
15176,abiraterone acetate,acute interstitial pneumonia,selectin e
15177,piretanide,myeloid neoplasm associated with pdgfra rearrangement,structural maintenance of chromosomes 2
15178,teduglutide,bacterial endocarditis,potassium inwardly rectifying channel subfamily j member 2
15179,captodiame,pyoderma gangrenosum,phosphodiesterase 4d
15180,nelfinavir,metrorrhagia,vascular endothelial growth factor a
15181,ramatroban,chronic beryllium disease,propionyl-coa carboxylase subunit alpha
15182,morphine,asthma-chronic obstructive pulmonary disease overlap syndrome,c-c motif chemokine receptor 1
15183,pergolide,focal epilepsy,calcium voltage-gated channel subunit alpha1 i
15184,tranylcypromine,bone paget disease,sodium voltage-gated channel alpha subunit 3
15185,chloroquine,bronchiectasis,atpase copper transporting alpha
15186,flunisolide,thrombophilia due to thrombin defect,gamma-aminobutyric acid type a receptor subunit delta
15187,choline magnesium trisalicylate,fever,monoamine oxidase a
15188,insulin lispro,atrophic vulva,estrogen related receptor alpha
15189,hydroxocobalamin,strongyloidiasis,cholinergic receptor nicotinic beta 2 subunit
15190,"1,25-dihydroxyvitamin d3",epicondylitis,atp binding cassette subfamily a member 1
15191,vorapaxar,hypoactive sexual desire disorder,cyclin dependent kinase 19
15192,caffeine,x-linked dominant hypophosphatemic rickets,nuclear factor kappa b subunit 1
15193,vonoprazan,common wart,coagulation factor ii thrombin receptor
15194,perampanel,biotinidase deficiency,solute carrier family 22 member 2
15195,chlorpheniramine,mast cell leukemia,cholinergic receptor nicotinic beta 4 subunit
15196,prednisone,dyspepsia,cytochrome p450 family 3 subfamily a member 4
15197,flurbiprofen,laryngeal edema,potassium voltage-gated channel subfamily a member 3
15198,mirodenafil,stroke disorder,interleukin 1 receptor associated kinase 3
15199,nimodipine,graves disease,estrogen receptor 1
15200,goserelin,myxedema,dna methyltransferase 1
15201,pirenzepine,thrombotic disease,diacylglycerol o-acyltransferase 1
15202,5-fluorouracil,"hyperlipidemia, familial combined, lpl related",potassium voltage-gated channel subfamily h member 7
15203,difenoxin,dysmenorrhea,solute carrier family 18 member a1
15204,apalutamide,attrv122i amyloidosis,amylase alpha 1c
15205,labetalol,atrioventricular block,glutamate ionotropic receptor kainate type subunit 3
15206,nadolol,premenstrual dysphoric disorder,solute carrier family 18 member a2
15207,auranofin,psychotic disorder,prostaglandin-endoperoxide synthase 1
15208,acarbose,breast fibrocystic disease,sodium voltage-gated channel alpha subunit 2
15209,edoxaban,non-small cell lung carcinoma,phosphodiesterase 6g
15210,penicillamine,autoimmune hemolytic anemia,proteasome 20s subunit beta 8
15211,mesuximide,manic bipolar affective disorder,dopamine beta-hydroxylase
15212,icosapent,schizoaffective disorder,glutathione s-transferase theta 1
15213,lusutrombopag,exfoliative dermatitis,sodium voltage-gated channel alpha subunit 2
15214,cortisone,endometritis,phosphodiesterase 6d
15215,alpha-methyltyrosine,nephrotic syndrome,protein tyrosine kinase 2 beta
15216,gefitinib,raynaud disease,mitogen-activated protein kinase 14
15217,eliglustat,pituitary dwarfism,sphingosine-1-phosphate receptor 1
15218,indomethacin,renal osteodystrophy,unc-51 like autophagy activating kinase 1
15219,idelalisib,depressive disorder,carbonic anhydrase 14
15220,pirfenidone,panic disorder,sodium voltage-gated channel alpha subunit 9
15221,gliquidone,delayed puberty,7-dehydrocholesterol reductase
15222,rasagiline,ovarian epithelial tumor,gamma-aminobutyric acid type a receptor subunit alpha6
15223,zuclopenthixol,diabetes mellitus,unc-51 like kinase 3
15224,fluvoxamine,acute lung injury,guanylate cyclase 1 soluble subunit beta 1
15225,histamine,enterobiasis,somatostatin receptor 3
15226,camphor,esophageal cancer,phosphodiesterase 8b
15227,clorazepate,acute monocytic leukemia,atpase h+/k+ transporting subunit beta
15228,fluoxetine,diabetic kidney disease,mitogen-activated protein kinase kinase kinase 20
15229,dezocine,fever,glucosidase ii alpha subunit
15230,carbamazepine,type 2 diabetes mellitus,fms related receptor tyrosine kinase 3
15231,dicumarol,exfoliative dermatitis,cytochrome p450 family 3 subfamily a member 4
15232,ketanserin,social phobia,polo like kinase 4
15233,heparin,duodenal ulcer,lipoprotein lipase
15234,ketoprofen,atrioventricular block,propionyl-coa carboxylase subunit beta
15235,ethacrynic acid,autosomal dominant polycystic kidney disease,axl receptor tyrosine kinase
15236,vandetanib,sarcoma,gamma-aminobutyric acid type a receptor subunit gamma2
15237,moclobemide,dementia,eukaryotic translation initiation factor 4e
15238,risperidone,post-partum hemorrhage,cytochrome p450 family 2 subfamily c member 18
15239,l-citrulline,lung neoplasm,5-hydroxytryptamine receptor 2c
15240,nelfinavir,myasthenia gravis,carnitine palmitoyltransferase 1a
15241,nefazodone,premature ventricular contraction,galactosidase alpha
15242,montelukast,corneal ulcer,c-c motif chemokine receptor 1
15243,lobeglitazone,myeloid neoplasm associated with pdgfra rearrangement,eph receptor b6
15244,physostigmine,contact dermatitis,histamine receptor h3
15245,fenfluramine,rhinoscleroma,peroxisome proliferator activated receptor delta
15246,anisotropine methylbromide,pthirus pubis infestation,5-hydroxytryptamine receptor 3e
15247,fenfluramine,hypercholesterolemia,iodothyronine deiodinase 1
15248,clofarabine,hiv infectious disease,gamma-aminobutyric acid type a receptor subunit theta
15249,topiroxostat,malignant colon neoplasm,uridine monophosphate synthetase
15250,nicardipine,interstitial lung disease 2,monoamine oxidase a
15251,medroxyprogesterone,zollinger-ellison syndrome,glutamate ionotropic receptor ampa type subunit 3
15252,reserpine,familial mediterranean fever,geranylgeranyl diphosphate synthase 1
15253,tolazoline,mast cell leukemia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
15254,rabeprazole,waldenstrom macroglobulinemia,potassium voltage-gated channel subfamily a member 1
15255,voclosporin,homocystinuria,cytochrome p450 family 3 subfamily a member 43
15256,roxatidine acetate,hyperinsulinism,tek receptor tyrosine kinase
15257,ketorolac,rheumatic heart disease,peptidylprolyl isomerase d
15258,thyrotropin alfa,malignant colon neoplasm,5-hydroxytryptamine receptor 4
15259,levodopa,pancreatic insulinoma,atpase h+/k+ transporting subunit beta
15260,pranlukast,mast cell leukemia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
15261,axitinib,short bowel syndrome,natriuretic peptide b
15262,indapamide,hypoglycemia,"plasminogen activator, tissue type"
15263,apraclonidine,pediculus humanus capitis infestation,melatonin receptor 1a
15264,quinapril,inflammatory bowel disease,colony stimulating factor 1 receptor
15265,phenacemide,nutritional biotin deficiency,calmodulin 1
15266,spiperone,atrial fibrillation,solute carrier family 5 member 6
15267,isoprenaline,headache,dipeptidyl peptidase 8
15268,nevirapine,menorrhagia,4-aminobutyrate aminotransferase
15269,ethotoin,seasonal affective disorder,thyroid hormone receptor alpha
15270,venetoclax,sebaceous adenoma,gamma-aminobutyric acid type a receptor subunit beta3
15271,zoledronic acid,thyroiditis,gamma-aminobutyric acid type a receptor subunit alpha3
15272,cisapride,eunuchism,thymidylate synthetase
15273,venlafaxine,cluster headache syndrome,phosphoribosyl pyrophosphate amidotransferase
15274,dipyridamole,atrophic vulva,serpin family e member 1
15275,pirenzepine,tetanus,cubilin
15276,darunavir,osteoarthritis,somatostatin receptor 2
15277,glycopyrrolate,acute gonococcal endometritis,retinoic acid receptor beta
15278,docetaxel,gastric ulcer,dopa decarboxylase
15279,caffeine,alcohol dependence,fibroblast growth factor receptor 2
15280,albiglutide,postmenopausal osteoporosis,potassium voltage-gated channel subfamily h member 4
15281,atropine,respiratory failure,"hck proto-oncogene, src family tyrosine kinase"
15282,pyrimethamine,pthirus pubis infestation,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
15283,naproxen,urinary bladder neoplasm,histone deacetylase 6
15284,captopril,psychologic dyspareunia,phospholipase a2 group ib
15285,prilocaine,chronic eosinophilic leukemia,gamma-aminobutyric acid type a receptor subunit alpha3
15286,trimipramine,pulmonary hypertension,"elastase, neutrophil expressed"
15287,diclofenac,pulmonary eosinophilia,cyclin dependent kinase 19
15288,digoxin,contact dermatitis,catechol-o-methyltransferase
15289,eldecalcitol,common wart,5-hydroxytryptamine receptor 3d
15290,amiodarone,meningococcal meningitis,udp-glucose ceramide glucosyltransferase
15291,mebendazole,onchocerciasis,monoamine oxidase b
15292,cabergoline,orthostatic hypotension,gamma-aminobutyric acid type a receptor subunit alpha4
15293,maprotiline,prinzmetal angina,"abl proto-oncogene 1, non-receptor tyrosine kinase"
15294,nitric oxide,peripheral vascular disease,gamma-aminobutyric acid type a receptor subunit gamma2
15295,ceritinib,amyloidosis,gamma-aminobutyric acid type a receptor subunit theta
15296,nitisinone,medullary thyroid gland carcinoma,epidermal growth factor receptor
15297,mesalazine,vitiligo,solute carrier family 19 member 1
15298,phenylephrine,crohn disease,ryanodine receptor 1
15299,lamotrigine,b-cell chronic lymphocytic leukemia,androgen receptor
15300,butenafine,cerebrovascular disorder,carbonic anhydrase 13
15301,linaclotide,hodgkins lymphoma,cathepsin g
15302,beclometasone,nocturnal enuresis,solute carrier family 18 member a1
15303,voglibose,myasthenia gravis,glutathione s-transferase pi 1
15304,axitinib,myocardial infarction,interleukin 1 receptor associated kinase 3
15305,pranlukast,sitosterolemia,ap2 associated kinase 1
15306,fomepizole,"attention deficit hyperactivity disorder, inattentive type",nuclear receptor subfamily 3 group c member 1
15307,liraglutide,peripheral vascular disease,interleukin 6 receptor
15308,pemetrexed,type 1 diabetes mellitus,carbonic anhydrase 3
15309,sapropterin,gaucher disease,atp binding cassette subfamily g member 5
15310,ibuprofen,chronic schizophrenia,carnitine palmitoyltransferase 1a
15311,procyclidine,hypertrophic cardiomyopathy,unc-51 like autophagy activating kinase 1
15312,cortisol,asthma-chronic obstructive pulmonary disease overlap syndrome,delta like non-canonical notch ligand 1
15313,nitrazepam,uterine corpus leiomyoma,protein kinase c alpha
15314,acth,heart failure,aldehyde dehydrogenase 5 family member a1
15315,isoxsuprine,anterior uveitis,adrenoceptor alpha 1d
15316,clozapine,hereditary von willebrand disease,solute carrier family 22 member 1
15317,valproic acid,dacryocystitis,carbonic anhydrase 14
15318,flunisolide,peripheral vascular disease,solute carrier family 19 member 1
15319,maprotiline,ankylosing spondylitis,angiotensin ii receptor type 2
15320,cisapride,amyotrophic lateral sclerosis,phosphodiesterase 6h
15321,clocortolone pivalate,sickle cell anemia,cytochrome p450 family 3 subfamily a member 5
15322,5-fluorouracil,bone osteosarcoma,glutamate ionotropic receptor nmda type subunit 2b
15323,methylphenidate,superficial multifocal basal cell carcinoma,h1.0 linker histone
15324,tocilizumab,early myoclonic encephalopathy,toll like receptor 2
15325,flutamide,diarrheal disease,cytochrome p450 family 17 subfamily a member 1
15326,lorlatinib,intracranial embolism,5-hydroxytryptamine receptor 1b
15327,levodopa,duodenal ulcer,homeodomain interacting protein kinase 2
15328,sildenafil,hypersensitivity pneumonitis,cyp3a7-cyp3a51p readthrough
15329,epinastine,meningococcal meningitis,cyclin dependent kinase 14
15330,tirofiban,peptic ulcer disease,dna topoisomerase ii beta
15331,bosentan,iritis,potassium voltage-gated channel subfamily h member 3
15332,icotinib,psychotic disorder,acetyl-coa acyltransferase 2
15333,propranolol,gastric ulcer,insulin receptor
15334,chlorhexidine,anogenital human papillomavirus infection,bmp2 inducible kinase
15335,flunisolide,chronic bronchitis,steroid 5 alpha-reductase 1
15336,podophyllotoxin,gastroesophageal reflux disease,vitamin d receptor
15337,cisapride,vomiting,solute carrier family 22 member 11
15338,pirenzepine,lennox-gastaut syndrome,sodium voltage-gated channel alpha subunit 5
15339,sertraline,goiter,protein tyrosine kinase 2
15340,theophylline,liposarcoma,phosphodiesterase 8b
15341,etoposide,aspiration pneumonitis,microtubule associated protein 2
15342,nizatidine,hepatic veno-occlusive disease,potassium voltage-gated channel modifier subfamily g member 4
15343,mesoridazine,hyperlipoproteinemia type 3,ttk protein kinase
15344,dronedarone,gout,5-hydroxytryptamine receptor 2b
15345,sermorelin,motion sickness,cholinergic receptor nicotinic alpha 4 subunit
15346,phentermine,pulmonary valve atresia,gamma-aminobutyric acid type b receptor subunit 2
15347,ziprasidone,edema,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
15348,menatetrenone,iritis,phosphoribosyl pyrophosphate amidotransferase
15349,riboflavin,hyperglycemia,prostaglandin d2 receptor 2
15350,atorvastatin,chronic bronchitis,potassium inwardly rectifying channel subfamily j member 12
15351,tetracycline,alopecia,15-hydroxyprostaglandin dehydrogenase
15352,umeclidinium,abdominal abscess,"elastase, neutrophil expressed"
15353,dosulepin,ovarian epithelial tumor,matrix metallopeptidase 9
15354,benoxaprofen,oligospermia,aldo-keto reductase family 1 member c1
15355,clonidine,eye disorder,potassium voltage-gated channel subfamily d member 1
15356,voclosporin,oral candidiasis,kallikrein b1
15357,atenolol,post-traumatic stress disorder,eph receptor a5
15358,octreotide,leiomyosarcoma,5-hydroxytryptamine receptor 7
15359,propranolol,classic phenylketonuria,acyl-coa synthetase long chain family member 5
15360,dorzolamide,hypoactive sexual desire disorder,calcyon neuron specific vesicular protein
15361,imatinib,gastric ulcer,squalene epoxidase
15362,bosutinib,alopecia,potassium voltage-gated channel subfamily a member 4
15363,teriparatide,eosinophilic esophagitis,monoamine oxidase a
15364,aceclofenac,breast carcinoma,bmp2 inducible kinase
15365,physostigmine,pulmonary hypertension,dead-box helicase 1
15366,tazarotene,urticaria,phosphodiesterase 4a
15367,diazepam,aggressive systemic mastocytosis,dual specificity tyrosine phosphorylation regulated kinase 1b
15368,perampanel,schizoaffective disorder,peptidylprolyl isomerase d
15369,anisotropine methylbromide,diffuse alopecia areata,serine/threonine kinase 4
15370,clonidine,persistent fetal circulation syndrome,angiotensin converting enzyme 2
15371,oxymetholone,allergic urticaria,histone deacetylase 11
15372,sertaconazole,polycystic ovary syndrome,mitogen-activated protein kinase 14
15373,celecoxib,xerophthalmia,5-hydroxytryptamine receptor 2c
15374,tipranavir,attrv122i amyloidosis,adrenoceptor alpha 2b
15375,pexidartinib,scalp dermatosis,eph receptor b6
15376,cladribine,hyponatremia,srsf protein kinase 3
15377,acth,idiopathic acute eosinophilic pneumonia,prostaglandin e synthase 3
15378,vildagliptin,eunuchism,uridine monophosphate synthetase
15379,cyclopentolate,pulmonary arterial hypertension,protein tyrosine kinase 2
15380,ropinirole,anxiety disorder,24-dehydrocholesterol reductase
15381,tenofovir alafenamide,proctitis,peptidylprolyl isomerase d
15382,melatonin,severe major depression with psychotic features,retinoid x receptor alpha
15383,repaglinide,arteriosclerosis disorder,cytochrome p450 family 46 subfamily a member 1
15384,dihydrotachysterol,breast fibrocystic disease,guanylate cyclase 1 soluble subunit alpha 1
15385,milnacipran,pulmonary tuberculosis,h1.0 linker histone
15386,salmeterol,trichuriasis,mitogen-activated protein kinase kinase kinase 20
15387,carbinoxamine,oppositional defiant disorder,histamine receptor h3
15388,phytomenadione,torsades de pointes,opioid related nociceptin receptor 1
15389,calcipotriol,nasal congestion,gamma-aminobutyric acid type a receptor subunit delta
15390,furosemide,pheochromocytoma,cholinergic receptor muscarinic 2
15391,fenoprofen,nasal congestion,mitogen-activated protein kinase kinase 2
15392,promethazine,dermatophytosis of groin and perianal area,fatty acid binding protein 2
15393,rufinamide,skin basal cell carcinoma,prostaglandin f receptor
15394,oxybutynin,plasmodium ovale malaria,nuclear factor kappa b subunit 1
15395,etodolac,breast carcinoma,leukotriene b4 receptor
15396,mirtazapine,dacryocystitis,dna polymerase beta
15397,epa,respiratory sounds,glutathione-disulfide reductase
15398,icosapent,toothache,solute carrier family 12 member 3
15399,tafamidis,early myoclonic encephalopathy,proteasome 20s subunit beta 5
15400,thyrotropin alfa,myocardial infarction,adrenoceptor alpha 1d
15401,letrozole,"dermatitis, atopic",tumor protein p53
15402,minocycline,torsades de pointes,glutamate ionotropic receptor ampa type subunit 4
15403,neostigmine,duodenal ulcer,toll like receptor 9
15404,stanozolol,west syndrome,sphingosine-1-phosphate receptor 4
15405,butalbital,gastroesophageal reflux disease,tachykinin receptor 1
15406,saxagliptin,peripheral vascular disease,purinergic receptor p2y12
15407,axitinib,postherpetic neuralgia,thymidylate synthetase
15408,teriparatide,stargardt disease,"blk proto-oncogene, src family tyrosine kinase"
15409,lurasidone,tenosynovial giant cell tumor,adrenoceptor alpha 1b
15410,bepridil,acne,phosphodiesterase 1c
15411,desipramine,early myoclonic encephalopathy,opioid receptor mu 1
15412,piroxicam,multiple endocrine neoplasia,cytochrome p450 family 27 subfamily b member 1
15413,ketorolac,meniere disease,bradykinin receptor b2
15414,pinacidil,oral mucosa leukoplakia,transient receptor potential cation channel subfamily m member 8
15415,magnesium salicylate,testicular cancer,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
15416,olanzapine,peptic ulcer disease,tek receptor tyrosine kinase
15417,clozapine,neonatal diabetes mellitus,phosphodiesterase 2a
15418,pramipexole,chronic beryllium disease,integrin subunit alpha 2b
15419,conjugated estrogens,pulmonary eosinophilia,potassium voltage-gated channel subfamily b member 1
15420,captodiame,eunuchism,transforming growth factor beta receptor 2
15421,pheniramine,streptococcal meningitis,15-hydroxyprostaglandin dehydrogenase
15422,riociguat,skin disorder,bcl2 apoptosis regulator
15423,caffeine,lung disorder,apolipoprotein b
15424,dabrafenib,plasmodium falciparum malaria,solute carrier family 18 member a2
15425,dosulepin,gestational trophoblastic neoplasm,thyroid hormone receptor beta
15426,loxapine,bursitis,potassium voltage-gated channel subfamily a member 6
15427,valsartan,eye disorder,tachykinin precursor 1
15428,acth,alopecia,5-hydroxytryptamine receptor 3c
15429,dipyridamole,gaucher disease,butyrylcholinesterase
15430,chloroquine,bacterial meningitis,thyroid stimulating hormone receptor
15431,apraclonidine,pulmonary emphysema,dna polymerase beta
15432,valrubicin,postoperative nausea and vomiting,bruton tyrosine kinase
15433,udenafil,pituitary dwarfism,glutathione s-transferase theta 1
15434,acalabrutinib,"leukemia, myeloid, chronic-phase",renin
15435,erlotinib,ornithine carbamoyltransferase deficiency,homeodomain interacting protein kinase 2
15436,clocortolone pivalate,premature obstetric labor,fms related receptor tyrosine kinase 4
15437,nadolol,scabies,phosphodiesterase 6h
15438,nicorandil,anogenital human papillomavirus infection,potassium inwardly rectifying channel subfamily j member 1
15439,lasofoxifene,neonatal diabetes mellitus,gamma-aminobutyric acid type a receptor subunit beta3
15440,alclofenac,rhinoscleroma,"dna polymerase epsilon, catalytic subunit"
15441,tadalafil,pancreatic adenocarcinoma,sphingosine-1-phosphate receptor 3
15442,pravastatin,cardiac arrest,neutrophil cytosolic factor 1
15443,glutethimide,neonatal diabetes mellitus,"protein phosphatase 3 regulatory subunit b, alpha"
15444,valdecoxib,short bowel syndrome,protein kinase cgmp-dependent 1
15445,afamelanotide,angioedema,histone deacetylase 4
15446,isopropamide,trichinellosis,"dna polymerase alpha 1, catalytic subunit"
15447,phenytoin,bulimia nervosa,toll like receptor 7
15448,iloperidone,myalgia,histone deacetylase 3
15449,dabrafenib,rhabdomyosarcoma,platelet activating factor receptor
15450,alfacalcidol,major depressive disorder,gamma-aminobutyric acid type a receptor subunit gamma1
15451,mebendazole,pulmonary embolism,solute carrier family 5 member 4
15452,clopidogrel,poems syndrome,potassium calcium-activated channel subfamily n member 4
15453,benazepril,contact dermatitis,5-hydroxytryptamine receptor 1f
15454,midazolam,allergic contact dermatitis,tyrosine hydroxylase
15455,indomethacin,visual epilepsy,electron transfer flavoprotein dehydrogenase
15456,fluocinolone acetonide,thyroid tumor,"src proto-oncogene, non-receptor tyrosine kinase"
15457,octreotide,arthralgia,septin 9
15458,delavirdine,"cicatrix, hypertrophic",phosphodiesterase 6b
15459,ceftriaxone,klinefelter syndrome,membrane spanning 4-domains a1
15460,sulfasalazine,angle-closure glaucoma,catechol-o-methyltransferase
15461,diphenhydramine,migraine disorder,"pim-2 proto-oncogene, serine/threonine kinase"
15462,goserelin,discoid lupus erythematosus,bcl2 like 2
15463,vinorelbine,bipolar depression,transient receptor potential cation channel subfamily v member 1
15464,ciprofloxacin,seborrheic dermatitis,myosin light chain kinase 3
15465,dasatinib,parkinsonian disorder,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
15466,pyrimethamine,epicondylitis,sodium voltage-gated channel alpha subunit 2
15467,prucalopride,anxiety,histone deacetylase 10
15468,dorzolamide,headache,cholinergic receptor nicotinic alpha 6 subunit
15469,ergometrine,sjogren syndrome,tyrosine kinase non receptor 2
15470,crisaborole,psychosexual disorder,ribosomal protein s6 kinase a5
15471,rofecoxib,chronic schizophrenia,retinoic acid receptor beta
15472,benzphetamine,delayed puberty,cd33 molecule
15473,bumetanide,ventricular fibrillation,sodium channel epithelial 1 subunit gamma
15474,acth,small cell lung carcinoma,macrophage stimulating 1 receptor
15475,felbamate,premenstrual dysphoric disorder,sonic hedgehog signaling molecule
15476,acitretin,tetany,ribonucleotide reductase catalytic subunit m1
15477,tirofiban,onchocerciasis,"raf-1 proto-oncogene, serine/threonine kinase"
15478,nicorandil,chronic beryllium disease,nuclear receptor subfamily 0 group b member 1
15479,glipizide,amenorrhea,mitogen-activated protein kinase kinase kinase 9
15480,dicyclomine,urticaria,low density lipoprotein receptor
15481,pentoxifylline,autosomal dominant polycystic kidney disease,"jun proto-oncogene, ap-1 transcription factor subunit"
15482,apalutamide,hypoactive sexual desire disorder,atp binding cassette subfamily c member 9
15483,terfenadine,neurogenic bladder,propionyl-coa carboxylase subunit alpha
15484,isopropamide,strongyloidiasis,il2 inducible t cell kinase
15485,travoprost,dacryocystitis,dihydropyrimidine dehydrogenase
15486,bosutinib,dysmenorrhea,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
15487,azelnidipine,essential thrombocythemia,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
15488,oprelvekin,psychotic disorder,cyclin dependent kinase 16
15489,olmutinib,oral mucosa leukoplakia,nuclear receptor subfamily 3 group c member 2
15490,mefenamic acid,scabies,dopamine receptor d1
15491,apraclonidine,esotropia,somatostatin receptor 1
15492,methylphenobarbital,chronic schizophrenia,interleukin 1 receptor type 1
15493,meloxicam,hereditary angioedema,adenosine deaminase
15494,cladribine,"leukemia, myeloid, chronic-phase",cannabinoid receptor 2
15495,bunazosin,pemphigus,sodium voltage-gated channel alpha subunit 4
15496,acamprosate,atrioventricular block,histamine receptor h1
15497,levocabastine,acute intermittent porphyria,solute carrier organic anion transporter family member 4a1
15498,metipranolol,acute coronary syndrome,ndufa4 mitochondrial complex associated
15499,dosulepin,dacryocystitis,sulfotransferase family 2a member 1
15500,efavirenz,schizoaffective disorder,dihydropyrimidine dehydrogenase
15501,ripasudil,exanthem,cytochrome p450 family 19 subfamily a member 1
15502,opipramol,scabies,mitogen-activated protein kinase kinase kinase kinase 1
15503,isoxsuprine,cardiogenic shock,cytochrome p450 family 2 subfamily a member 6
15504,cefmetazole,urge incontinence,homeodomain interacting protein kinase 2
15505,nevirapine,tourette syndrome,potassium voltage-gated channel modifier subfamily s member 1
15506,suramin,bacterial endocarditis,steroid 5 alpha-reductase 1
15507,calcipotriol,constipation disorder,prostaglandin d2 receptor 2
15508,tadalafil,b-cell chronic lymphocytic leukemia,solute carrier family 22 member 12
15509,mesalazine,hypercholesterolemia,cd33 molecule
15510,naratriptan,polymyalgia rheumatica,solute carrier family 12 member 3
15511,sivelestat,non-small cell lung carcinoma,potassium voltage-gated channel modifier subfamily g member 3
15512,tripelennamine,hyperuricemia,cytochrome p450 family 24 subfamily a member 1
15513,furosemide,primary myelofibrosis,amylase alpha 1a
15514,alpha-methyltyrosine,marginal zone lymphoma,unc-51 like kinase 3
15515,quizartinib,allergic contact dermatitis,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
15516,choline magnesium trisalicylate,oral mucosa leukoplakia,prostaglandin e synthase 3
15517,fluoxetine,heart failure,melatonin receptor 1a
15518,pralidoxime,scalp dermatosis,calcium voltage-gated channel auxiliary subunit alpha2delta 1
15519,moxonidine,superficial multifocal basal cell carcinoma,somatostatin receptor 2
15520,thiothixene,drooling,insulin receptor related receptor
15521,dabrafenib,tenosynovitis,phosphorylase kinase catalytic subunit gamma 1
15522,heparin,alopecia,phosphorylase kinase catalytic subunit gamma 2
15523,glimepiride,vasomotor rhinitis,angiotensin i converting enzyme
15524,azelaic acid,dermatofibrosarcoma protuberans,retinoid x receptor gamma
15525,prucalopride,angle-closure glaucoma,potassium voltage-gated channel subfamily b member 2
15526,fenfluramine,peptic ulcer disease,eph receptor a1
15527,diethylpropion,myeloid neoplasm associated with pdgfra rearrangement,misshapen like kinase 1
15528,dosulepin,thyroid tumor,transient receptor potential cation channel subfamily m member 8
15529,mitomycin c,lung neoplasm,gamma-aminobutyric acid type a receptor subunit theta
15530,sulindac,sympathetic ophthalmia,mitogen-activated protein kinase kinase kinase 19
15531,ketoprofen,vascular disorder,holocarboxylase synthetase
15532,triamcinolone,west syndrome,proteasome 20s subunit beta 9
15533,bupropion,myalgia,mitogen-activated protein kinase kinase kinase 11
15534,bazedoxifene,shock,prune exopolyphosphatase 1
15535,vorinostat,thyroid gland carcinoma,glutamate ionotropic receptor kainate type subunit 1
15536,levorphanol,attrv122i amyloidosis,potassium inwardly rectifying channel subfamily j member 12
15537,defibrotide,hypoparathyroidism,potassium voltage-gated channel modifier subfamily s member 3
15538,trimetazidine,juvenile idiopathic arthritis,dual specificity tyrosine phosphorylation regulated kinase 2
15539,duloxetine,human african trypanosomiasis,gamma-aminobutyric acid type a receptor subunit gamma2
15540,mesalazine,nausea,coagulation factor x
15541,voglibose,fabry disease,fxyd domain containing ion transport regulator 2
15542,secobarbital,tendinitis,glucose-6-phosphate dehydrogenase
15543,oxycodone,intermittent vascular claudication,interleukin 1 receptor associated kinase 1
15544,dexfenfluramine,potassium deficiency disease,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
15545,ospemifene,eunuchism,potassium voltage-gated channel subfamily q member 3
15546,propafenone,delayed puberty,potassium calcium-activated channel subfamily m alpha 1
15547,chlorpropamide,non-small cell lung carcinoma,protein kinase n2
15548,phenazone,urge incontinence,nuclear factor kappa b subunit 1
15549,eflornithine,relapsing-remitting multiple sclerosis,cytidine deaminase
15550,blonanserin,keratitis,septin 9
15551,nifedipine,gastroesophageal reflux disease,dipeptidyl peptidase 8
15552,milnacipran,myalgia,somatostatin receptor 1
15553,chlorcyclizine,small cell lung carcinoma,potassium voltage-gated channel subfamily d member 3
15554,fesoterodine,peptic esophagitis,dipeptidyl peptidase 4
15555,ixabepilone,hypothyroidism,ryanodine receptor 1
15556,lornoxicam,dermatofibrosarcoma protuberans,glutamate ionotropic receptor ampa type subunit 4
15557,desipramine,bacterial meningitis,platelet derived growth factor receptor beta
15558,dehydroepiandrosterone,osteoarthritis,c-x-c motif chemokine receptor 4
15559,roxatidine acetate,peptic ulcer disease,opioid receptor mu 1
15560,rotigotine,skin basal cell carcinoma,"dna polymerase delta 1, catalytic subunit"
15561,iloperidone,influenza,opioid receptor mu 1
15562,ciprofloxacin,ascariasis,dopamine receptor d4
15563,zidovudine,shock,"kras proto-oncogene, gtpase"
15564,midostaurin,sarcoidosis,bcl2 apoptosis regulator
15565,hydralazine,malignant colon neoplasm,homeodomain interacting protein kinase 1
15566,bosentan,erythema multiforme,calcium voltage-gated channel subunit alpha1 s
15567,brexpiprazole,aspiration pneumonitis,growth hormone receptor
15568,alogliptin,bacterial conjunctivitis,tubulin beta 1 class vi
15569,dicumarol,type 1 diabetes mellitus,bcl2 apoptosis regulator
15570,lorcaserin,constipation disorder,doublecortin like kinase 1
15571,raloxifene,postpartum depression,atpase na+/k+ transporting subunit alpha 1
15572,clidinium,vitamin d deficiency,adenosine deaminase
15573,anagrelide,chronic myelomonocytic leukemia,5-hydroxytryptamine receptor 1f
15574,eprosartan,influenza,potassium voltage-gated channel modifier subfamily g member 2
15575,digoxin,humoral hypercalcemia of malignancy,leukocyte receptor tyrosine kinase
15576,prasugrel,urethritis,dopamine receptor d5
15577,ethinylestradiol,homocystinuria,transmembrane protein 97
15578,canagliflozin,urge incontinence,5-methyltetrahydrofolate-homocysteine methyltransferase
15579,methyltestosterone,hairy cell leukemia,gamma-aminobutyric acid type a receptor subunit alpha6
15580,cefalotin,pancreatic adenocarcinoma,structural maintenance of chromosomes 1a
15581,clemastine,acute myeloid leukemia,nuak family kinase 2
15582,vasopressin,bronchiectasis,casein kinase 1 delta
15583,metformin,hypotensive disorder,sodium channel epithelial 1 subunit gamma
15584,romidepsin,congenital adrenal hyperplasia,n-acylsphingosine amidohydrolase 1
15585,benazepril,plasmodium malariae malaria,dipeptidyl peptidase 8
15586,codeine,pyelonephritis,dihydrofolate reductase
15587,molindone,enterocolitis,cdc like kinase 1
15588,tranilast,interstitial lung disease,cytochrome p450 family 2 subfamily d member 6
15589,betamethasone,hot flashes,4-aminobutyrate aminotransferase
15590,oxaprozin,proctitis,g protein-coupled receptor 35
15591,methyl salicylate,parkinson disease,txk tyrosine kinase
15592,hydroxyzine,hereditary angioedema,cytochrome p450 family 19 subfamily a member 1
15593,benzocaine,bone paget disease,tubulin beta 1 class vi
15594,galantamine,psychologic dyspareunia,ribosomal protein s6 kinase a2
15595,hydroxocobalamin,pancreatic insulinoma,carbonic anhydrase 11
15596,stanozolol,ovarian cancer,potassium inwardly rectifying channel subfamily j member 1
15597,acrivastine,idiopathic acute eosinophilic pneumonia,nuak family kinase 2
15598,clobazam,sickle cell anemia,prostaglandin i2 receptor
15599,hydralazine,tetanus,somatostatin receptor 1
15600,eribulin,adrenocortical insufficiency,gamma-aminobutyric acid type a receptor subunit epsilon
15601,sitagliptin,gastroesophageal reflux disease,mapk interacting serine/threonine kinase 2
15602,fenoprofen,bipolar disorder,calmodulin 2
15603,mirodenafil,osteomalacia,transient receptor potential cation channel subfamily v member 1
15604,carmustine,pityriasis versicolor,solute carrier organic anion transporter family member 2b1
15605,clobetasone,malignant essential hypertension,cytochrome p450 family 2 subfamily c member 8
15606,ethacrynic acid,impetigo,inositol monophosphatase 1
15607,darunavir,keloid,rio kinase 1
15608,tocilizumab,otitis externa,cytochrome p450 family 3 subfamily a member 7
15609,minoxidil,rhabdomyosarcoma,"yes proto-oncogene 1, src family tyrosine kinase"
15610,vigabatrin,ventricular fibrillation,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
15611,dantrolene,autoimmune disease,potassium voltage-gated channel subfamily c member 4
15612,idelalisib,adrenogenital syndrome,ribosomal protein s6 kinase a5
15613,fluocinonide,myxedema,phosphodiesterase 10a
15614,etodolac,adrenal gland hyperfunction,histone deacetylase 5
15615,l-citrulline,psychotic disorder,low density lipoprotein receptor
15616,topiroxostat,breast neoplasm,kelch like ech associated protein 1
15617,hydralazine,nausea,"dna polymerase epsilon, catalytic subunit"
15618,crisaborole,ocular hypertension,doublecortin like kinase 3
15619,torsemide,scalp dermatosis,dna topoisomerase ii beta
15620,carbachol,gynecomastia disorder,cdgsh iron sulfur domain 1
15621,sulfasalazine,temporal arteritis,phosphodiesterase 6b
15622,minocycline,female infertility,ndufa4 mitochondrial complex associated
15623,sotalol,ovarian epithelial tumor,adenosine a2a receptor
15624,fampridine,hemorrhoid,adrenoceptor beta 3
15625,baricitinib,dry eye syndrome,riboflavin kinase
15626,beclometasone,urge incontinence,potassium inwardly rectifying channel subfamily j member 11
15627,aminoglutethimide,blepharoconjunctivitis,dna methyltransferase 1
15628,liraglutide,pulmonary emphysema,"dna polymerase epsilon, catalytic subunit"
15629,calcium citrate,depressive disorder,fer tyrosine kinase
15630,suramin,intermittent vascular claudication,low density lipoprotein receptor
15631,teduglutide,hemorrhoid,cholinergic receptor nicotinic beta 3 subunit
15632,gefitinib,embolism,gamma-aminobutyric acid type a receptor subunit alpha1
15633,lifitegrast,hereditary angioedema,angiotensin ii receptor type 1
15634,telmisartan,ascites,atpase copper transporting beta
15635,methapyrilene,epicondylitis,potassium voltage-gated channel subfamily h member 7
15636,dimenhydrinate,rheumatic heart disease,opioid receptor delta 1
15637,trospium chloride,endemic goiter,kallikrein b1
15638,cyclophosphamide,female infertility,5-hydroxytryptamine receptor 3d
15639,apraclonidine,central nervous system origin vertigo,solute carrier family 47 member 2
15640,dextropropoxyphene,erdheim-chester disease,tank binding kinase 1
15641,loratadine,relapsing-remitting multiple sclerosis,c-x-c motif chemokine receptor 4
15642,meclizine,onchocerciasis,solute carrier family 22 member 2
15643,phenylephrine,diffuse alopecia areata,cholinergic receptor nicotinic alpha 2 subunit
15644,loratadine,hypercalcemia disease,cholinergic receptor nicotinic beta 4 subunit
15645,ramipril,meniere disease,5-hydroxytryptamine receptor 1d
15646,sulindac,idiopathic acute eosinophilic pneumonia,checkpoint kinase 2
15647,levoketoconazole,adrenocortical insufficiency,synaptic vesicle glycoprotein 2a
15648,flurazepam,endemic goiter,calcium voltage-gated channel subunit alpha1 d
15649,amiloride,disruptive behavior disorder,mitogen-activated protein kinase kinase kinase 11
15650,sotalol,huntington disease,calcium voltage-gated channel subunit alpha1 a
15651,methdilazine,intermittent vascular claudication,solute carrier family 7 member 11
15652,indapamide,pulmonary fibrosis,dipeptidyl peptidase 4
15653,celecoxib,chronic kidney disease,ribosomal protein l3
15654,phendimetrazine,dysmenorrhea,discoidin domain receptor tyrosine kinase 1
15655,nimodipine,anterior uveitis,platelet derived growth factor receptor beta
15656,apraclonidine,cycloplegia,histone deacetylase 11
15657,lixisenatide,shock,sphingosine-1-phosphate receptor 5
15658,oxymetazoline,periodontitis,solute carrier family 18 member a1
15659,maprotiline,pityriasis versicolor,nuak family kinase 2
15660,vilazodone,tenosynovial giant cell tumor,potassium voltage-gated channel subfamily d member 2
15661,ethinylestradiol,zollinger-ellison syndrome,solute carrier organic anion transporter family member 1b3
15662,phenobarbital,plasma cell myeloma,transient receptor potential cation channel subfamily v member 1
15663,prasugrel,tetanus,dna methyltransferase 3 alpha
15664,trimipramine,embolism,integrin subunit alpha 2b
15665,lenvatinib,social phobia,tubulin gamma 1
15666,bromfenac,anaphylaxis,steroid 5 alpha-reductase 2
15667,clobetasol propionate,oligospermia,arachidonate 5-lipoxygenase
15668,somatrem,chronic schizophrenia,fkbp prolyl isomerase 1a
15669,mitiglinide,pain,interleukin 1 receptor associated kinase 3
15670,fexofenadine,oral mucosa leukoplakia,fkbp prolyl isomerase 1b
15671,acth,secondary hyperparathyroidism,gamma-aminobutyric acid type a receptor subunit alpha4
15672,ciprofloxacin,acute monocytic leukemia,sodium voltage-gated channel alpha subunit 9
15673,clonidine,dermatomyositis,lipoprotein lipase
15674,icatibant,delirium,tyrosine kinase non receptor 1
15675,norethisterone,lichen planus,somatostatin receptor 5
15676,fluspirilene,depressive disorder,dipeptidase 1
15677,acetazolamide,pruritus,cytochrome p450 family 27 subfamily b member 1
15678,insulin detemir,respiratory failure,ribosomal protein s6 kinase a2
15679,fenoldopam,renal cell carcinoma,cytidine deaminase
15680,buclizine,ascariasis,interleukin 2
15681,dapoxetine,central nervous system origin vertigo,cannabinoid receptor 1
15682,dipyridamole,aspiration pneumonia,histamine receptor h4
15683,estrone sulphate,parkinson disease,mitogen-activated protein kinase 14
15684,thioguanine,primary ovarian failure,potassium voltage-gated channel subfamily h member 6
15685,atorvastatin,labor pain,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
15686,ethosuximide,synovitis,testis specific serine kinase 1b
15687,masoprocol,ankylosing spondylitis,monoamine oxidase b
15688,trimetazidine,scalp dermatosis,unc-51 like autophagy activating kinase 1
15689,apremilast,migraine disorder,glutamate ionotropic receptor nmda type subunit 3a
15690,cilastatin,stroke disorder,g protein-coupled receptor kinase 4
15691,carfilzomib,central nervous system origin vertigo,5-hydroxytryptamine receptor 2a
15692,calcipotriol,vasomotor rhinitis,sodium voltage-gated channel alpha subunit 2
15693,dextrothyroxine,alcohol dependence,amylase alpha 1a
15694,levobetaxolol,tenosynovitis,cytochrome p450 family 2 subfamily c member 8
15695,fenoldopam,pulmonary artery stenosis,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
15696,fosamprenavir,pyoderma gangrenosum,glucagon receptor
15697,estradiol valerate,meningococcal meningitis,potassium two pore domain channel subfamily k member 9
15698,digoxin,ascariasis,h1.0 linker histone
15699,tetracosactide,serum sickness,macrophage stimulating 1 receptor
15700,heparin,systemic mastocytosis,solute carrier family 22 member 4
15701,alimemazine,type 1 diabetes mellitus,prostaglandin d2 receptor
15702,pimavanserin,vitamin b12 deficiency,sodium voltage-gated channel alpha subunit 7
15703,letrozole,diffuse large b-cell lymphoma,angiotensin ii receptor type 1
15704,trimetaphan,osteomalacia,thyroid hormone receptor alpha
15705,entacapone,pruritus ani,potassium voltage-gated channel subfamily q member 5
15706,pinacidil,hyponatremia,salt inducible kinase 1
15707,caffeine,female stress incontinence,calcyon neuron specific vesicular protein
15708,befunolol,pancreatic insulinoma,potassium inwardly rectifying channel subfamily j member 12
15709,diclofenac,hairy cell leukemia,hydroxysteroid 11-beta dehydrogenase 1
15710,alogliptin,liposarcoma,adrenoceptor alpha 2b
15711,acarbose,familial mediterranean fever,calcium voltage-gated channel subunit alpha1 b
15712,glimepiride,diarrheal disease,sphingosine-1-phosphate receptor 5
15713,guanabenz,vitamin deficiency disorder,nuclear receptor subfamily 5 group a member 1
15714,desloratadine,abdominal abscess,cytochrome p450 family 11 subfamily b member 1
15715,apomorphine,angina pectoris,cathepsin g
15716,dexibuprofen,seasonal affective disorder,serine/threonine kinase 16
15717,ramipril,gynecomastia disorder,angiotensin i converting enzyme
15718,insulin glulisine,sjogren syndrome,cdc like kinase 1
15719,biotin,pyelonephritis,atp binding cassette subfamily a member 1
15720,rotigotine,oral candidiasis,glutamate ionotropic receptor kainate type subunit 1
15721,stanozolol,hyperthyroidism,mitogen-activated protein kinase kinase kinase 11
15722,methotrexate,type 1 diabetes mellitus,paraoxonase 1
15723,thiothixene,metrorrhagia,synuclein alpha
15724,nelfinavir,meningococcal meningitis,propionyl-coa carboxylase subunit alpha
15725,lisuride,tenosynovial giant cell tumor,carbonic anhydrase 4
15726,paclitaxel,hypercalcemia disease,eph receptor a3
15727,conjugated estrogens,adrenogenital syndrome,tachykinin precursor 1
15728,histamine,idiopathic acute eosinophilic pneumonia,myosin light chain kinase family member 4
15729,lansoprazole,plasma cell myeloma,septin 9
15730,aminosalicylic acid,"leukemia, myeloid, chronic-phase",phosphodiesterase 7b
15731,ripasudil,hypertensive disorder,tyrosine hydroxylase
15732,betamethasone,dermatophytosis of groin and perianal area,thymidylate synthetase
15733,medroxyprogesterone,gynecomastia disorder,cytochrome p450 family 2 subfamily r member 1
15734,teriparatide,renal osteodystrophy,discoidin domain receptor tyrosine kinase 1
15735,tolmetin,cardiac arrest,carbonic anhydrase 14
15736,penicillamine,streptococcal pneumonia,nuclear factor kappa b subunit 1
15737,ezetimibe,pharyngitis,interleukin 1 receptor associated kinase 3
15738,gliquidone,migraine disorder,phenylalanine hydroxylase
15739,dofetilide,"hydatidiform mole, recurrent, 1",atp binding cassette subfamily b member 11
15740,carbimazole,schizophrenia,potassium voltage-gated channel modifier subfamily g member 1
15741,valdecoxib,autoimmune hemolytic anemia,pre-mrna splicing tri-snrnp complex factor prpf4
15742,pyridostigmine,atopic conjunctivitis,gamma-aminobutyric acid type a receptor subunit alpha3
15743,homatropine methylbromide,primary myelofibrosis,insulin receptor
15744,capecitabine,rhinoscleroma,interleukin 11 receptor subunit alpha
15745,zafirlukast,motion sickness,acid sensing ion channel subunit 1
15746,tripelennamine,classic hodgkin lymphoma,high mobility group box 1
15747,doxylamine,secondary hyperparathyroidism,dead-box helicase 3 x-linked
15748,metoprolol,plasmodium falciparum malaria,cytochrome p450 family 2 subfamily a member 6
15749,guanfacine,hodgkins lymphoma,tubulin beta 2b class iib
15750,dihydrotachysterol,early myoclonic encephalopathy,dihydropyrimidine dehydrogenase
15751,eplerenone,meningococcal meningitis,cart prepropeptide
15752,midazolam,brain cancer,histone deacetylase 10
15753,rilmenidine,actinic keratosis,"smoothened, frizzled class receptor"
15754,calcium gluconate,premature obstetric labor,npc1 like intracellular cholesterol transporter 1
15755,aminosalicylic acid,rheumatoid arthritis,3-hydroxy-3-methylglutaryl-coa reductase
15756,cephalotaxine,cryopyrin-associated periodic syndrome,acyl-coa dehydrogenase short/branched chain
15757,diphenidol,ocular hypertension,ttk protein kinase
15758,oxymorphone,neurofibromatosis 1,protein kinase n1
15759,orlistat,breast ductal adenocarcinoma,phosphodiesterase 10a
15760,almotriptan,major depressive disorder,cdc like kinase 1
15761,entacapone,angioedema,atpase na+/k+ transporting subunit beta 1
15762,moxonidine,fabry disease,15-hydroxyprostaglandin dehydrogenase
15763,reboxetine,pemphigus,cf transmembrane conductance regulator
15764,dexmethylphenidate,keratitis,phosphodiesterase 8b
15765,mupirocin,tetralogy of fallot,transient receptor potential cation channel subfamily m member 8
15766,asenapine,iridocyclitis,toll like receptor 9
15767,buspirone,relapsing-remitting multiple sclerosis,angiotensin converting enzyme 2
15768,mitoxantrone,hypertriglyceridemia,tubulin beta 4b class ivb
15769,carbachol,tachycardia,potassium voltage-gated channel subfamily c member 2
15770,paramethadione,altitude sickness,epoxide hydrolase 2
15771,fluphenazine,myasthenia gravis,tubulin beta 4b class ivb
15772,oprelvekin,rhinoscleroma,catechol-o-methyltransferase
15773,ropinirole,nicotine dependence,"mer proto-oncogene, tyrosine kinase"
15774,diphenylpyraline,phenylketonuria,potassium voltage-gated channel subfamily h member 6
15775,glipizide,hodgkins lymphoma,structural maintenance of chromosomes 2
15776,ribavirin,lymphangioma,tubulin beta 1 class vi
15777,orlistat,gingivitis,gamma-aminobutyric acid type a receptor subunit theta
15778,dabigatran etexilate,diabetes mellitus,microtubule affinity regulating kinase 3
15779,perazine,anaphylaxis,carbonic anhydrase 3
15780,auranofin,"cicatrix, hypertrophic",amnion associated transmembrane protein
15781,calcium acetate,pulmonary artery stenosis,bcl2 apoptosis regulator
15782,bromfenac,basal ganglia disorder,carbonic anhydrase 1
15783,paracetamol,hot flashes,gamma-aminobutyric acid type a receptor subunit beta3
15784,phenobarbital,proctitis,myosin light chain kinase 3
15785,gefitinib,urethritis,c-x-c motif chemokine ligand 8
15786,pimavanserin,lichen planus,phosphodiesterase 6d
15787,trimipramine,gestational trophoblastic neoplasm,ribonucleotide reductase regulatory subunit m2
15788,tipiracil,amenorrhea,mitogen-activated protein kinase kinase kinase 7
15789,famotidine,pemphigus,carbonic anhydrase 7
15790,choline,autoimmune hemolytic anemia,glutamate ionotropic receptor kainate type subunit 4
15791,aminobenzoic acid,hyperlipoproteinemia type 3,activin a receptor type 1
15792,fluocinonide,small intestine cancer,cholinergic receptor nicotinic beta 4 subunit
15793,indomethacin,persistent fetal circulation syndrome,potassium voltage-gated channel subfamily q member 3
15794,raloxifene,medullary thyroid gland carcinoma,ribonucleotide reductase regulatory subunit m2
15795,icatibant,meningococcal meningitis,calcium voltage-gated channel subunit alpha1 b
15796,pomalidomide,postoperative nausea and vomiting,riboflavin kinase
15797,olmesartan,vitamin d deficiency,gamma-aminobutyric acid type a receptor subunit alpha4
15798,tandospirone,esophageal cancer,retinoic acid receptor alpha
15799,5-fluorouracil,early myoclonic encephalopathy,unc-51 like autophagy activating kinase 2
15800,vasopressin,post-operative pain,dna methyltransferase 1
15801,calcium acetate,delirium,adrenoceptor alpha 1d
15802,venlafaxine,gastric cancer,eph receptor a1
15803,phentolamine,post-traumatic stress disorder,cholinergic receptor nicotinic alpha 3 subunit
15804,allopurinol,acute coronary syndrome,solute carrier family 46 member 1
15805,nelfinavir,myocardial infarction,gonadotropin releasing hormone receptor
15806,riociguat,oral candidiasis,potassium inwardly rectifying channel subfamily j member 1
15807,eprosartan,choroiditis,3-hydroxy-3-methylglutaryl-coa reductase
15808,ivermectin,stargardt disease,solute carrier family 47 member 1
15809,citalopram,dermatophytosis of groin and perianal area,cytochrome p450 family 11 subfamily b member 2
15810,epa,streptococcal pneumonia,proteasome 20s subunit beta 5
15811,diazoxide,pemphigus,ndufa4 mitochondrial complex associated
15812,thiothixene,female stress incontinence,natriuretic peptide b
15813,iloperidone,turner syndrome,ryanodine receptor 3
15814,diphenhydramine,pulmonary tuberculosis,neutrophil cytosolic factor 1
15815,alteplase,miliary tuberculosis,erb-b2 receptor tyrosine kinase 2
15816,acetylcholine,attrv122i amyloidosis,integrin subunit alpha 2b
15817,isoprenaline,post-traumatic stress disorder,toll like receptor 4
15818,trifluridine,vulvovaginal candidiasis,microtubule associated protein 2
15819,cromoglicic acid,headache,gamma-aminobutyric acid type a receptor subunit alpha4
15820,icatibant,"leukemia, myeloid, chronic-phase",dopamine receptor d3
15821,tiagabine,angioedema,potassium voltage-gated channel subfamily h member 4
15822,safinamide,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,cytochrome p450 family 3 subfamily a member 43
15823,flurbiprofen,acne,dopamine receptor d3
15824,lofepramine,ankylosing spondylitis,cytochrome p450 family 3 subfamily a member 43
15825,colchicine,pulmonary cystic fibrosis,thromboxane a2 receptor
15826,cyproheptadine,absence epilepsy,hyperpolarization activated cyclic nucleotide gated potassium channel 3
15827,guanfacine,biotinidase deficiency,adrenoceptor beta 2
15828,risedronate,impetigo,ste20 like kinase
15829,lorcaserin,trigeminal neuralgia,synuclein alpha
15830,troglitazone,acute monocytic leukemia,interleukin 6 receptor
15831,leflunomide,lung disorder,unc-51 like autophagy activating kinase 1
15832,propantheline,ascariasis,phosphorylase kinase catalytic subunit gamma 2
15833,lamotrigine,glossopharyngeal neuralgia,phosphodiesterase 4b
15834,loratadine,urethritis,pre-mrna processing factor kinase prp4k
15835,diltiazem,chronic schizophrenia,solute carrier family 6 member 2
15836,sulindac,pediculus humanus capitis infestation,dead-box helicase 1
15837,menatetrenone,metastatic melanoma,serine/threonine kinase 11
15838,cephalotaxine,follicular lymphoma,nuclear receptor subfamily 3 group c member 1
15839,aceclofenac,premature ventricular contraction,protein kinase cgmp-dependent 1
15840,auranofin,hypercalcemia disease,gamma-glutamyl carboxylase
15841,umeclidinium,adrenocortical insufficiency,myosin heavy chain 10
15842,benzbromarone,hyperthyroidism,calcium voltage-gated channel auxiliary subunit beta 1
15843,carteolol,kidney angiomyolipoma,potassium voltage-gated channel subfamily q member 2
15844,oxaprozin,post-operative pain,dna topoisomerase i
15845,carbidopa,gastric neoplasm,"kit proto-oncogene, receptor tyrosine kinase"
15846,pimavanserin,non-small cell lung carcinoma,cathepsin g
15847,benoxaprofen,juvenile idiopathic arthritis,solute carrier family 22 member 6
15848,dromostanolone propionate,type 1 diabetes mellitus,nuclear factor kappa b subunit 1
15849,nilotinib,bipolar depression,annexin a1
15850,zileuton,colonic neoplasm,carbonic anhydrase 4
15851,apomorphine,hypotensive disorder,solute carrier family 6 member 1
15852,vinblastine,chronic pain,cholinergic receptor nicotinic alpha 2 subunit
15853,proguanil,myalgia,membrane spanning 4-domains a1
15854,istradefylline,insomnia,prostaglandin e receptor 1
15855,ramatroban,neurodermatitis,atp binding cassette subfamily c member 2
15856,rasagiline,nephrotic syndrome,atpase copper transporting beta
15857,celiprolol,exanthem,homeodomain interacting protein kinase 2
15858,luseogliflozin,acute pain,dna methyltransferase 1
15859,topotecan,breast carcinoma,potassium two pore domain channel subfamily k member 3
15860,anisotropine methylbromide,dermatofibrosarcoma protuberans,catechol-o-methyltransferase
15861,eribulin,tension-type headache,casein kinase 1 delta
15862,rupatadine,thyroid gland papillary carcinoma,protein tyrosine kinase 2
15863,cilastatin,neonatal diabetes mellitus,myeloperoxidase
15864,alcaftadine,pediculus humanus capitis infestation,glutamate ionotropic receptor ampa type subunit 3
15865,reproterol,primary myelofibrosis,solute carrier family 19 member 1
15866,bepridil,synovitis,structural maintenance of chromosomes 2
15867,pyrimethamine,pituitary dwarfism,superoxide dismutase 1
15868,clomiphene,exfoliative dermatitis,cdc like kinase 4
15869,nafarelin,seasonal allergic rhinitis,potassium voltage-gated channel subfamily a member 5
15870,pseudoephedrine,autosomal dominant polycystic kidney disease,phosphodiesterase 6c
15871,vortioxetine,hemophilia a,sodium voltage-gated channel alpha subunit 2
15872,sildenafil,skin basal cell carcinoma,potassium voltage-gated channel subfamily q member 1
15873,mefenamic acid,pulmonary valve atresia,solute carrier family 46 member 1
15874,flunisolide,onchocerciasis,gamma-aminobutyric acid type a receptor subunit epsilon
15875,ciprofloxacin,anaphylaxis,adrenoceptor alpha 1b
15876,idelalisib,acidosis disorder,chymotrypsinogen b1
15877,metformin,acute myeloid leukemia,glutathione s-transferase alpha 2
15878,zonisamide,oral candidiasis,propionyl-coa carboxylase subunit alpha
15879,norethisterone,post-operative pain,glutamate ionotropic receptor ampa type subunit 1
15880,pramipexole,acromegaly,transient receptor potential cation channel subfamily v member 1
15881,vinpocetine,renal cell carcinoma,gamma-aminobutyric acid type a receptor subunit alpha4
15882,azelastine,bursitis,calcium voltage-gated channel subunit alpha1 c
15883,promazine,cycloplegia,bradykinin receptor b2
15884,masoprocol,mydriasis,serine/threonine kinase 11
15885,bosentan,alzheimer disease,potassium voltage-gated channel modifier subfamily g member 2
15886,ramipril,"malignant hyperthermia, susceptibility to, 1",transient receptor potential cation channel subfamily a member 1
15887,dapoxetine,thyroiditis,gamma-aminobutyric acid type a receptor subunit alpha1
15888,salsalate,klinefelter syndrome,kinase insert domain receptor
15889,allopurinol,chronic bronchitis,tumor necrosis factor
15890,amobarbital,dacryocystitis,fkbp prolyl isomerase 4
15891,pemirolast,otitis externa,dna topoisomerase i mitochondrial
15892,candesartan,mydriasis,eph receptor b2
15893,spironolactone,benign prostatic hyperplasia,interleukin 1 receptor associated kinase 1
15894,vorinostat,nutritional biotin deficiency,ndufa4 mitochondrial complex associated
15895,piribedil,plasmodium malariae malaria,fkbp prolyl isomerase 4
15896,acrivastine,iridocyclitis,"abl proto-oncogene 1, non-receptor tyrosine kinase"
15897,emtricitabine,bruxism,cholinergic receptor nicotinic beta 2 subunit
15898,tazarotene,tetany,calcium voltage-gated channel subunit alpha1 g
15899,ezetimibe,burkitt lymphoma,bmx non-receptor tyrosine kinase
15900,vorinostat,motion sickness,dopamine receptor d2
15901,echothiophate,escherichia coli infection,c-x-c motif chemokine receptor 1
15902,methotrexate,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",cytochrome p450 family 17 subfamily a member 1
15903,crotamiton,influenza,albumin
15904,drospirenone,tyrosinemia,transthyretin
15905,prednicarbate,blepharoconjunctivitis,nuak family kinase 2
15906,rotigotine,type 2 diabetes mellitus,ribosomal protein s6 kinase a2
15907,trimethadione,trigeminal neuralgia,phosphodiesterase 3a
15908,dobutamine,leiomyosarcoma,ornithine decarboxylase 1
15909,benzocaine,ankylosing spondylitis,inosine monophosphate dehydrogenase 2
15910,droxidopa,bruxism,janus kinase 2
15911,olaparib,hypophosphatemia,glucagon like peptide 2 receptor
15912,pitavastatin,dacryocystitis,aldehyde dehydrogenase 5 family member a1
15913,aranidipine,acne,atpase h+/k+ transporting subunit alpha
15914,betamethasone,anterior uveitis,monoamine oxidase b
15915,insulin lispro,non-hodgkin lymphoma,sucrase-isomaltase
15916,fsh,chronic bronchitis,nuak family kinase 2
15917,dexfenfluramine,vascular headaches,carnitine palmitoyltransferase 1a
15918,tioconazole,hypereosinophilic syndrome,sonic hedgehog signaling molecule
15919,axitinib,endometrial carcinoma,glucagon receptor
15920,chlorhexidine,vitiligo,potassium voltage-gated channel subfamily h member 1
15921,pentostatin,chancroid,udp glucuronosyltransferase family 1 member a1
15922,nefazodone,acute myeloid leukemia,superoxide dismutase 1
15923,ipragliflozin,congestive heart failure,cytochrome p450 family 2 subfamily c member 8
15924,carteolol,superficial multifocal basal cell carcinoma,"smoothened, frizzled class receptor"
15925,cyproheptadine,acquired polycythemia vera,integrin subunit alpha 2b
15926,methotrexate,eunuchism,sonic hedgehog signaling molecule
15927,anagliptin,glaucoma,leukocyte receptor tyrosine kinase
15928,morphine,patent ductus arteriosus,prostaglandin d2 receptor
15929,choline magnesium trisalicylate,thrombocytopenia,thyroid hormone receptor alpha
15930,diphenoxylate,cycloplegia,glutamate ionotropic receptor kainate type subunit 3
15931,frovatriptan,poisoning of animals with phosphate salts,phosphodiesterase 7a
15932,topotecan,islet cell adenomatosis,phosphodiesterase 3b
15933,dextropropoxyphene,congenital adrenal hyperplasia,discoidin domain receptor tyrosine kinase 2
15934,perospirone,hyperprolactinemia,janus kinase 2
15935,nizatidine,small intestine cancer,platelet derived growth factor receptor alpha
15936,mexiletine,hyperparathyroidism,coagulation factor x
15937,pargyline,xerophthalmia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
15938,chlordiazepoxide,classic phenylketonuria,synuclein alpha
15939,vindesine,hyperglycemia,prostaglandin e synthase 3
15940,bumetanide,ankylosing spondylitis,ribosomal protein s6 kinase a1
15941,cromoglicic acid,aplastic anemia,discoidin domain receptor tyrosine kinase 2
15942,pimozide,periodontitis,apolipoprotein b
15943,bunazosin,influenza,cytochrome p450 family 2 subfamily c member 8
15944,vernakalant,wilms tumor,bmp2 inducible kinase
15945,phenmetrazine,acute lung injury,bcr activator of rhogef and gtpase
15946,gemtuzumab ozogamicin,myeloid neoplasm associated with pdgfra rearrangement,"b-raf proto-oncogene, serine/threonine kinase"
15947,clobetasol propionate,dermatitis herpetiformis,melanocortin 1 receptor
15948,tapentadol,melanoma,"hck proto-oncogene, src family tyrosine kinase"
15949,warfarin,osteoporosis,interleukin 1 beta
15950,hydroxychloroquine,frozen shoulder,progesterone receptor
15951,sunitinib,dermatofibrosarcoma protuberans,potassium voltage-gated channel subfamily a member 3
15952,clobetasol propionate,nephrotic syndrome,homeodomain interacting protein kinase 4
15953,chlorpheniramine,"hydatidiform mole, recurrent, 1",unc-51 like autophagy activating kinase 2
15954,hydralazine,hyperlipoproteinemia type 3,albumin
15955,carbamazepine,atrioventricular block,amylase alpha 1b
15956,pralidoxime,tetanus,metallothionein 2a
15957,dimethyl fumarate,polymyalgia rheumatica,cysteinyl leukotriene receptor 2
15958,bezafibrate,dementia,estrogen related receptor alpha
15959,diflunisal,epilepsy,eph receptor a5
15960,goserelin,acute lung injury,solute carrier family 27 member 2
15961,isocarboxazid,thrombophilia due to thrombin defect,solute carrier organic anion transporter family member 1b1
15962,apalutamide,pulmonary fibrosis,phosphodiesterase 6c
15963,estramustine,headache disorder,fms related receptor tyrosine kinase 3
15964,icatibant,inflammatory bowel disease,cyclin g associated kinase
15965,sivelestat,pellagra,monoamine oxidase b
15966,dextrothyroxine,schizoaffective disorder,casein kinase 1 delta
15967,cobicistat,cryopyrin-associated periodic syndrome,macrophage stimulating 1 receptor
15968,acetophenazine,hodgkins lymphoma,solute carrier family 6 member 3
15969,nitrazepam,pancreatic insulinoma,n-acylsphingosine amidohydrolase 1
15970,clozapine,superficial multifocal basal cell carcinoma,opioid related nociceptin receptor 1
15971,niraparib,chronic kidney disease,calreticulin
15972,dextromethorphan,opiate dependence,s100 calcium binding protein p
15973,limaprost,cardiogenic shock,"dna polymerase delta 1, catalytic subunit"
15974,diamicron,tardive dyskinesia,tyrosinase
15975,rimonabant,pityriasis versicolor,g protein-coupled receptor kinase 4
15976,acetylmethadol,vitamin d deficiency,amylase alpha 2a
15977,venlafaxine,huntington disease,"b-raf proto-oncogene, serine/threonine kinase"
15978,tocilizumab,hyperlipoproteinemia type 3,epidermal growth factor receptor
15979,ropinirole,urinary retention,dipeptidase 1
15980,sulpiride,wilms tumor,potassium calcium-activated channel subfamily n member 4
15981,rimonabant,escherichia coli infection,natriuretic peptide receptor 1
15982,emtricitabine,urinary bladder cancer,solute carrier family 25 member 6
15983,chlorothiazide,lung disorder,bcl2 like 1
15984,phentolamine,prader-willi syndrome,solute carrier family 22 member 5
15985,defibrotide,idiopathic acute eosinophilic pneumonia,receptor interacting serine/threonine kinase 2
15986,metoclopramide,pheochromocytoma,cyclin dependent kinase 8
15987,ospemifene,visual epilepsy,"troponin c1, slow skeletal and cardiac type"
15988,mepyramine,bursitis,glutathione s-transferase pi 1
15989,floctafenine,female infertility,mitogen-activated protein kinase kinase kinase 20
15990,thyrotropin alfa,melanoma,dipeptidase 1
15991,amantadine,musculoskeletal system disorder,tubulin gamma 1
15992,ethynodiol diacetate,humoral hypercalcemia of malignancy,mitogen-activated protein kinase kinase kinase 2
15993,lopinavir,sitosterolemia,glucagon like peptide 2 receptor
15994,cortisone,vasomotor rhinitis,leukotriene a4 hydrolase
15995,acetazolamide,bipolar depression,protein tyrosine kinase 2
15996,bepotastine,dacryocystitis,peroxisome proliferator activated receptor delta
15997,cromoglicic acid,anxiety,interleukin 1 beta
15998,clidinium,polycystic ovary syndrome,mitogen-activated protein kinase kinase 2
15999,lorazepam,bacterial pneumonia,sodium channel epithelial 1 subunit alpha
16000,bepotastine,type 1 diabetes mellitus,proteasome 20s subunit beta 8
16001,hydromorphone,cutaneous candidiasis,ryanodine receptor 2
16002,codeine,goiter,"smoothened, frizzled class receptor"
16003,clotrimazole,canker sore,high mobility group box 1
16004,alimemazine,acute gonococcal endometritis,dna primase subunit 2
16005,tranylcypromine,plasmodium vivax malaria,phosphodiesterase 6d
16006,bosutinib,pulmonary cystic fibrosis,eph receptor b2
16007,ticagrelor,bruxism,cytochrome p450 family 1 subfamily b member 1
16008,ergometrine,classic hodgkin lymphoma,death associated protein kinase 1
16009,befunolol,hyperlipidemia,steroid 5 alpha-reductase 2
16010,repaglinide,thyroiditis,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"
16011,ponatinib,humoral hypercalcemia of malignancy,potassium voltage-gated channel modifier subfamily s member 3
16012,alteplase,influenza,monoamine oxidase a
16013,loxapine,acquired thrombocytopenia,cdc like kinase 4
16014,trichlormethiazide,shock,"troponin c1, slow skeletal and cardiac type"
16015,safinamide,poisoning of animals with phosphate salts,cytochrome p450 family 2 subfamily c member 18
16016,thioguanine,castleman disease,gc vitamin d binding protein
16017,triazolam,insomnia,phosphodiesterase 1c
16018,trimethadione,pulmonary emphysema,glutathione s-transferase pi 1
16019,medrysone,early myoclonic encephalopathy,receptor interacting serine/threonine kinase 2
16020,afamelanotide,canker sore,sodium channel epithelial 1 subunit alpha
16021,ziconotide,vulvovaginal candidiasis,potassium voltage-gated channel modifier subfamily s member 1
16022,acitretin,inappropriate adh syndrome,prostaglandin d2 receptor 2
16023,choline magnesium trisalicylate,disseminated intravascular coagulation,cholesteryl ester transfer protein
16024,cyclobenzaprine,aorta coarctation,"smoothened, frizzled class receptor"
16025,pindolol,female infertility,cholinergic receptor nicotinic alpha 2 subunit
16026,selexipag,fever,cytochrome p450 family 1 subfamily b member 1
16027,bumetanide,pyoderma gangrenosum,fibroblast growth factor receptor 1
16028,anakinra,pulmonary cystic fibrosis,pre-mrna processing factor kinase prp4k
16029,conjugated estrogens,cryptorchidism,potassium inwardly rectifying channel subfamily j member 8
16030,alclometasone dipropionate,gastric ulcer,bromodomain containing 4
16031,felbamate,leprosy,potassium voltage-gated channel modifier subfamily s member 1
16032,sildenafil,primary myelofibrosis,protein kinase n2
16033,capecitabine,attrv122i amyloidosis,protein phosphatase 3 catalytic subunit alpha
16034,sibutramine,rickets,carnitine palmitoyltransferase 1a
16035,flecainide,endometrium neoplasm,5-hydroxytryptamine receptor 1b
16036,fesoterodine,thyroid gland carcinoma,acyl-coa synthetase long chain family member 5
16037,celecoxib,postmenopausal atrophic vaginitis,protein kinase c theta
16038,bethanechol,drooling,atp binding cassette subfamily c member 3
16039,gilteritinib,proctitis,bcl2 like 1
16040,crisaborole,embolism,retinoic acid receptor alpha
16041,dexlansoprazole,tenosynovial giant cell tumor,ribosomal protein s6 kinase a5
16042,valproic acid,methylmalonic acidemia,phosphodiesterase 7b
16043,theophylline,drooling,"mer proto-oncogene, tyrosine kinase"
16044,selumetinib,thyroid gland carcinoma,phospholipase a2 group ib
16045,olodaterol,gonorrhea,phenylalanine hydroxylase
16046,vardenafil,prader-willi syndrome,melanocortin 3 receptor
16047,dicyclomine,hypertriglyceridemia,gamma-aminobutyric acid type a receptor subunit alpha5
16048,mitoxantrone,adrenal gland hyperfunction,cytochrome p450 family 2 subfamily a member 6
16049,cilostazol,langerhans cell histiocytosis,insulin receptor
16050,fexofenadine,thyroid tumor,solute carrier family 47 member 2
16051,insulin degludec,chronic schizophrenia,atpase copper transporting alpha
16052,rilmenidine,congestive heart failure,"ran, member ras oncogene family"
16053,tolazamide,hepatic veno-occlusive disease,aldo-keto reductase family 1 member c3
16054,piretanide,thyroid gland follicular carcinoma,retinoic acid receptor beta
16055,valproic acid,chronic obstructive pulmonary disease,tubulin epsilon 1
16056,meloxicam,periodontitis,myeloperoxidase
16057,topiroxostat,cutaneous candidiasis,potassium voltage-gated channel subfamily h member 2
16058,losartan,hereditary angioedema,vitamin k epoxide reductase complex subunit 1
16059,rimonabant,humoral hypercalcemia of malignancy,calcium sensing receptor
16060,sunitinib,trichinellosis,polo like kinase 4
16061,tetracycline,huntington disease,arachidonate 5-lipoxygenase
16062,losartan,brain edema,ornithine decarboxylase 1
16063,befunolol,hypertrophic cardiomyopathy,dna topoisomerase ii alpha
16064,epa,cycloplegia,opioid receptor kappa 1
16065,selexipag,anxiety disorder,cholinergic receptor nicotinic alpha 10 subunit
16066,butenafine,hairy cell leukemia,ste20 like kinase
16067,pentamidine,breast neoplasm,potassium voltage-gated channel subfamily a member 4
16068,levosalbutamol,psoriasis,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
16069,asenapine,trigeminal neuralgia,"jun proto-oncogene, ap-1 transcription factor subunit"
16070,avanafil,mast cell leukemia,"smoothened, frizzled class receptor"
16071,incadronic acid,inflammatory bowel disease,cd33 molecule
16072,alectinib,acute gonococcal endometritis,solute carrier family 22 member 6
16073,quinine,alcohol abuse,"abl proto-oncogene 2, non-receptor tyrosine kinase"
16074,tafluprost,alopecia,sulfotransferase family 1a member 1
16075,azatadine,early myoclonic encephalopathy,gamma-aminobutyric acid type a receptor subunit gamma1
16076,pregabalin,bone paget disease,sodium voltage-gated channel alpha subunit 10
16077,azacitidine,exfoliative dermatitis,protein phosphatase 3 catalytic subunit alpha
16078,istradefylline,cardiac arrest,steroid 5 alpha-reductase 2
16079,hydrocodone,tinea pedis,solute carrier family 9 member a1
16080,nizatidine,atopic conjunctivitis,histamine receptor h1
16081,ranitidine,allergic asthma,potassium voltage-gated channel modifier subfamily v member 1
16082,phenprocoumon,nephrotic syndrome,carbonic anhydrase 11
16083,duloxetine,chronic primary adrenal insufficiency,histone deacetylase 3
16084,pravastatin,hypertrophic cardiomyopathy,fatty acid binding protein 2
16085,roxatidine acetate,xerophthalmia,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
16086,loteprednol etabonate,islet cell adenomatosis,monoamine oxidase b
16087,camphor,juvenile idiopathic arthritis,cholinergic receptor muscarinic 3
16088,leflunomide,anterior uveitis,potassium two pore domain channel subfamily k member 9
16089,dutasteride,rhabdomyosarcoma,histone deacetylase 3
16090,insulin glargine,anxiety disorder,"abl proto-oncogene 1, non-receptor tyrosine kinase"
16091,minocycline,absence epilepsy,albumin
16092,omacetaxine mepesuccinate,hypercalcemia disease,dopa decarboxylase
16093,fingolimod,myeloid neoplasm associated with pdgfra rearrangement,glutamate ionotropic receptor kainate type subunit 4
16094,baclofen,tardive dyskinesia,growth hormone receptor
16095,dibucaine,diabetic kidney disease,natriuretic peptide receptor 1
16096,frovatriptan,ventricular fibrillation,histone deacetylase 11
16097,brexpiprazole,polycystic ovary syndrome,dead-box helicase 3 x-linked
16098,calcium citrate,hypophosphatemia,sphingosine-1-phosphate receptor 3
16099,levodopa,mast cell leukemia,cytochrome p450 family 3 subfamily a member 4
16100,fenfluramine,arthritic joint disease,pre-mrna processing factor kinase prp4k
16101,febuxostat,endometritis,g protein-coupled receptor kinase 4
16102,raltegravir,orthostatic hypotension,phosphodiesterase 2a
16103,pimecrolimus,urethritis,adrenoceptor alpha 1b
16104,phenelzine,rheumatic heart disease,adenosine deaminase
16105,amitriptyline,gaucher disease,insulin receptor related receptor
16106,dabigatran etexilate,uterine corpus leiomyoma,interleukin 1 beta
16107,incadronic acid,neuroblastoma,potassium inwardly rectifying channel subfamily j member 2
16108,ramipril,tetralogy of fallot,5-hydroxytryptamine receptor 3d
16109,chlorhexidine,autoimmune disease,calcitonin receptor
16110,anakinra,arteriosclerosis disorder,doublecortin like kinase 1
16111,triflupromazine,peptic esophagitis,c-x-c motif chemokine ligand 8
16112,dehydroepiandrosterone,thromboembolism,transforming growth factor beta receptor 2
16113,piribedil,hypertrophic cardiomyopathy,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
16114,naproxen,hyperthyroidism,serpin family c member 1
16115,vilazodone,epilepsy,tubulin epsilon 1
16116,macitentan,sneeze,mitogen-activated protein kinase kinase kinase 9
16117,teriparatide,tardive dyskinesia,discoidin domain receptor tyrosine kinase 1
16118,cilastatin,eunuchism,histone deacetylase 2
16119,lixisenatide,autism spectrum disorder,potassium voltage-gated channel subfamily d member 3
16120,fluvoxamine,"hydatidiform mole, recurrent, 1",doublecortin like kinase 1
16121,capsaicin,autoimmune hemolytic anemia,prostaglandin i2 receptor
16122,butorphanol,pharyngitis,receptor interacting serine/threonine kinase 3
16123,nabumetone,langerhans cell histiocytosis,proteasome 20s subunit beta 10
16124,phytomenadione,tension-type headache,cf transmembrane conductance regulator
16125,methamphetamine,lung lymphangioleiomyomatosis,potassium voltage-gated channel subfamily c member 4
16126,gabapentin,dry eye syndrome,fibroblast growth factor receptor 3
16127,prednisone,cough,ryanodine receptor 1
16128,felodipine,thromboembolism,salt inducible kinase 1
16129,halcinonide,chancroid,cytochrome p450 family 2 subfamily a member 6
16130,dronedarone,"hyperlipidemia, familial combined, lpl related",solute carrier family 5 member 6
16131,azacitidine,ankylosing spondylitis,microtubule associated protein 1a
16132,salsalate,keratitis,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
16133,ulobetasol propionate,pellagra,potassium voltage-gated channel modifier subfamily v member 2
16134,captopril,oral mucosa leukoplakia,glutathione s-transferase alpha 2
16135,pregabalin,anterior uveitis,farnesyl diphosphate synthase
16136,chlorothiazide,hemorrhoid,inosine monophosphate dehydrogenase 1
16137,phentolamine,onchocerciasis,prostaglandin-endoperoxide synthase 2
16138,ergometrine,essential thrombocythemia,nuclear receptor subfamily 0 group b member 1
16139,diphenylpyraline,aggressive systemic mastocytosis,cobalamin binding intrinsic factor
16140,oseltamivir,rheumatic heart disease,atp binding cassette subfamily c member 3
16141,fingolimod,poisoning of animals with phosphate salts,g protein-coupled receptor 35
16142,reproterol,keloid,eph receptor a5
16143,levoketoconazole,thrombotic disease,phosphodiesterase 1c
16144,lesinurad,hemangioma,5-methyltetrahydrofolate-homocysteine methyltransferase
16145,pimozide,onchocerciasis,bcl2 like 1
16146,levosimendan,inflammatory bowel disease,cholinergic receptor nicotinic alpha 10 subunit
16147,enzalutamide,cryptorchidism,serine/threonine kinase 10
16148,oxcarbazepine,mydriasis,protein phosphatase 3 catalytic subunit alpha
16149,aliskiren,atopic conjunctivitis,eukaryotic translation initiation factor 4e
16150,clidinium,generalized anxiety disorder,cytochrome p450 family 2 subfamily c member 18
16151,vismodegib,neuroblastoma,solute carrier family 22 member 6
16152,cilastatin,tetralogy of fallot,toll like receptor 2
16153,desogestrel,malignant glioma,phosphodiesterase 6d
16154,tetracosactide,common cold,ribonucleotide reductase catalytic subunit m1
16155,flurbiprofen,head and neck neoplasm,serine/threonine kinase 17a
16156,rizatriptan,cerebrovascular disorder,calcium/calmodulin dependent protein kinase ii alpha
16157,baricitinib,pulmonary fibrosis,atpase h+/k+ transporting subunit alpha
16158,lisinopril,common wart,mitogen-activated protein kinase kinase 1
16159,lurasidone,fibromyalgia,adrenoceptor beta 3
16160,dabigatran etexilate,bronchiectasis,phosphodiesterase 8b
16161,nelfinavir,fever,proteasome 20s subunit beta 2
16162,frovatriptan,mature t-cell and nk-cell non-hodgkin lymphoma,potassium voltage-gated channel subfamily c member 3
16163,conjugated estrogens,plasmodium malariae malaria,adenosine deaminase
16164,sulindac,bipolar depression,acyl-coa synthetase long chain family member 5
16165,venetoclax,streptococcal pneumonia,atp binding cassette subfamily c member 2
16166,lamotrigine,menorrhagia,solute carrier family 22 member 1
16167,fluocinonide,raynaud disease,atpase h+/k+ transporting subunit beta
16168,quinestrol,tetany,ornithine decarboxylase 1
16169,tiaprofenic acid,acute gonococcal cervicitis,5-hydroxytryptamine receptor 1d
16170,torsemide,generalized anxiety disorder,cholinergic receptor nicotinic beta 2 subunit
16171,salmeterol,allergic urticaria,"abl proto-oncogene 2, non-receptor tyrosine kinase"
16172,metoclopramide,multiple endocrine neoplasia,"b-raf proto-oncogene, serine/threonine kinase"
16173,quinestrol,chronic myelomonocytic leukemia,interleukin 11 receptor subunit alpha
16174,magnesium sulfate,tetanus,calcium voltage-gated channel auxiliary subunit alpha2delta 1
16175,triamterene,hyperbilirubinemia,5-hydroxytryptamine receptor 2c
16176,paracetamol,motion sickness,histone deacetylase 11
16177,irinotecan,small intestine cancer,potassium voltage-gated channel subfamily a member 5
16178,dexfenfluramine,invasive ductal breast carcinoma,serine/threonine kinase 25
16179,sapropterin,classic phenylketonuria,phospholipase a2 group iva
16180,vigabatrin,post-operative pain,serine/threonine kinase 10
16181,tranexamic acid,glossopharyngeal neuralgia,4-aminobutyrate aminotransferase
16182,fluoxymesterone,narcolepsy,h1.0 linker histone
16183,bunolol,bipolar depression,amine oxidase copper containing 3
16184,drospirenone,bacterial endocarditis,platelet activating factor receptor
16185,rofecoxib,tetralogy of fallot,c-x-c motif chemokine receptor 1
16186,nilotinib,wilms tumor,solute carrier family 47 member 1
16187,dihydrotachysterol,toothache,bcl2 like 1
16188,diphenoxylate,hepatocellular carcinoma,cytochrome p450 family 27 subfamily a member 1
16189,flutamide,sarcoma,natriuretic peptide receptor 1
16190,erlotinib,allergic bronchopulmonary aspergillosis,transient receptor potential cation channel subfamily v member 3
16191,metoclopramide,plasmodium ovale malaria,calcium voltage-gated channel subunit alpha1 i
16192,cilazapril,drooling,cf transmembrane conductance regulator
16193,trospium chloride,streptococcal pneumonia,cytochrome p450 family 2 subfamily b member 6
16194,calcium acetate,human african trypanosomiasis,arachidonate 5-lipoxygenase
16195,icotinib,multiple sclerosis,electron transfer flavoprotein dehydrogenase
16196,eprosartan,bipolar depression,isoleucyl-trna synthetase 1
16197,beclometasone,anaphylaxis,"dna polymerase epsilon, catalytic subunit"
16198,pemirolast,labor pain,sodium voltage-gated channel alpha subunit 3
16199,gabapentin,anterior uveitis,sodium voltage-gated channel alpha subunit 5
16200,sermorelin,adrenocortical insufficiency,guanylate cyclase 2c
16201,quinapril,myalgia,somatostatin receptor 4
16202,guanadrel,aplastic anemia,lipoprotein lipase
16203,levosimendan,bursitis,"raf-1 proto-oncogene, serine/threonine kinase"
16204,bitolterol,contact dermatitis,sodium voltage-gated channel alpha subunit 4
16205,goserelin,acute pain,solute carrier family 6 member 3
16206,triprolidine,"familial amyloid neuropathy, portuguese type",adrenoceptor alpha 1d
16207,tenoxicam,tenosynovial giant cell tumor,alk receptor tyrosine kinase
16208,thalidomide,non-hodgkin lymphoma,cysteinyl leukotriene receptor 2
16209,fluorometholone,breast fibrocystic disease,hyperpolarization activated cyclic nucleotide gated potassium channel 4
16210,salbutamol,allergic bronchopulmonary aspergillosis,uridine monophosphate synthetase
16211,flumethasone pivalate,pulmonary hypertension,carbonic anhydrase 2
16212,aspirin,glioma,gamma-aminobutyric acid type a receptor subunit delta
16213,benzocaine,graves disease,cholinergic receptor muscarinic 3
16214,desipramine,neurodermatitis,glutamate ionotropic receptor ampa type subunit 3
16215,amiodarone,premenstrual dysphoric disorder,tankyrase 2
16216,levobetaxolol,escherichia coli infection,opioid receptor mu 1
16217,homatropine methylbromide,chronic hepatitis c virus infection,phosphodiesterase 10a
16218,ketamine,sebaceous adenoma,potassium voltage-gated channel modifier subfamily g member 4
16219,glymidine,vascular headaches,solute carrier family 22 member 4
16220,nitisinone,gingivitis,calmodulin 1
16221,diphenhydramine,ankylosing spondylitis,sodium voltage-gated channel alpha subunit 8
16222,bisoprolol,liver cancer,dihydrofolate reductase
16223,tipiracil,acquired polycythemia vera,oxytocin receptor
16224,quinine,myeloproliferative neoplasm,complement c5
16225,docetaxel,sarcoma,death associated protein kinase 2
16226,tafluprost,tyrosinemia,prostaglandin d2 receptor 2
16227,piretanide,cycloplegia,natriuretic peptide b
16228,gabapentin,glioma,adrenoceptor beta 1
16229,cyclobenzaprine,ornithine carbamoyltransferase deficiency,potassium voltage-gated channel subfamily c member 4
16230,moxonidine,congenital adrenal hyperplasia,septin 9
16231,amitriptyline,opiate dependence,atpase na+/k+ transporting subunit beta 3
16232,icotinib,acute pain,protein tyrosine kinase 2 beta
16233,mitoxantrone,arteriosclerosis disorder,thromboxane a2 receptor
16234,leuprolide,visual epilepsy,"hck proto-oncogene, src family tyrosine kinase"
16235,methylergonovine,autoimmune disease,riboflavin kinase
16236,risperidone,iritis,eukaryotic translation initiation factor 4e
16237,methdilazine,acute monocytic leukemia,cholinergic receptor nicotinic alpha 5 subunit
16238,phenelzine,hyperprolactinemia,"mer proto-oncogene, tyrosine kinase"
16239,methylphenobarbital,edema,structural maintenance of chromosomes 2
16240,formoterol,waldenstrom macroglobulinemia,solute carrier family 19 member 1
16241,naloxone,postmenopausal atrophic vaginitis,potassium voltage-gated channel modifier subfamily g member 3
16242,promethazine,waldenstrom macroglobulinemia,potassium voltage-gated channel modifier subfamily g member 2
16243,rofecoxib,laryngeal edema,histone deacetylase 1
16244,sertaconazole,pulmonary tuberculosis,ornithine decarboxylase 1
16245,calcifediol,obsessive-compulsive disorder,neurotrophic receptor tyrosine kinase 1
16246,methyl salicylate,vitiligo,histone deacetylase 8
16247,darunavir,metrorrhagia,cannabinoid receptor 2
16248,mercaptopurine,labor pain,aurora kinase a
16249,acitretin,spasticity,solute carrier family 47 member 1
16250,thioguanine,vomiting,g protein-coupled receptor kinase 4
16251,nabumetone,familial mediterranean fever,somatostatin receptor 4
16252,vardenafil,exfoliative dermatitis,cholinergic receptor muscarinic 3
16253,betaxolol,headache,cholinergic receptor nicotinic beta 2 subunit
16254,dipivefrine,dementia,solute carrier family 6 member 3
16255,pyrimethamine,pityriasis versicolor,leukocyte receptor tyrosine kinase
16256,mepyramine,asthma,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
16257,gabapentin,aggressive systemic mastocytosis,potassium voltage-gated channel modifier subfamily f member 1
16258,zuclopenthixol,rhinoscleroma,paraoxonase 1
16259,capsaicin,"cicatrix, hypertrophic",hyperpolarization activated cyclic nucleotide gated potassium channel 4
16260,imipramine,post-traumatic stress disorder,solute carrier family 22 member 5
16261,voglibose,psoriasis,acid sensing ion channel subunit 1
16262,ceftriaxone,gout,sodium voltage-gated channel alpha subunit 8
16263,dromostanolone propionate,hemorrhagic disease of newborn,peptidylprolyl isomerase b
16264,lidocaine,hairy cell leukemia,polo like kinase 4
16265,emedastine,non-small cell lung carcinoma,prostaglandin e receptor 4
16266,norfloxacin,tenosynovial giant cell tumor,dihydropyrimidine dehydrogenase
16267,buspirone,vascular headaches,potassium voltage-gated channel subfamily q member 2
16268,pregabalin,iridocyclitis,5-hydroxytryptamine receptor 3d
16269,selexipag,myotonic syndrome,4-aminobutyrate aminotransferase
16270,vigabatrin,"cicatrix, hypertrophic",integrin subunit alpha 2b
16271,zidovudine,vitamin b12 deficiency,calcyon neuron specific vesicular protein
16272,molindone,myeloid neoplasm associated with pdgfra rearrangement,"lipase f, gastric type"
16273,alcaftadine,dermatomyositis,opioid receptor kappa 1
16274,fsh,nicotine dependence,phosphodiesterase 7a
16275,lurasidone,dermatomyositis,proteasome 20s subunit alpha 1
16276,histamine,hypoglycemia,potassium voltage-gated channel subfamily q member 5
16277,befunolol,tyrosinemia,solute carrier family 9 member a1
16278,fludarabine,osteoporosis,phosphodiesterase 11a
16279,escitalopram,bacterial pneumonia,insulin receptor related receptor
16280,triamcinolone,gout,toll like receptor 4
16281,acenocoumarol,scleroderma,peptidylprolyl isomerase b
16282,romidepsin,cardiac arrest,"kit proto-oncogene, receptor tyrosine kinase"
16283,oxazepam,dermatofibrosarcoma protuberans,toll like receptor 7
16284,promazine,thromboembolism,"coagulation factor ii, thrombin"
16285,dutasteride,musculoskeletal system disorder,phosphodiesterase 10a
16286,ziconotide,cluster headache syndrome,sodium voltage-gated channel alpha subunit 9
16287,defibrotide,fabry disease,ttk protein kinase
16288,quetiapine,peyronie disease,dopamine receptor d5
16289,loxapine,humoral hypercalcemia of malignancy,carbonic anhydrase 1
16290,metolazone,malaria,sphingosine-1-phosphate receptor 1
16291,naratriptan,allergic urticaria,adrenoceptor alpha 1a
16292,sertraline,scabies,cd33 molecule
16293,pravastatin,abdominal infection,cytochrome p450 family 21 subfamily a member 2
16294,"1,25-dihydroxyvitamin d3",systemic mastocytosis,prostaglandin d2 receptor 2
16295,histamine,pemphigus,phosphorylase kinase catalytic subunit gamma 2
16296,tolvaptan,attrv122i amyloidosis,homeodomain interacting protein kinase 4
16297,amobarbital,parkinsonian disorder,bradykinin receptor b2
16298,lenvatinib,benign prostatic hyperplasia,cyp3a7-cyp3a51p readthrough
16299,axitinib,"familial amyloid neuropathy, portuguese type",prostaglandin e receptor 1
16300,saquinavir,allergic asthma,thymidylate synthetase
16301,amiloride,orthostatic hypotension,angiotensin i converting enzyme
16302,lithium ion,intermittent vascular claudication,alpha glucosidase
16303,avanafil,bacterial pneumonia,fer tyrosine kinase
16304,sunitinib,mast cell leukemia,"smoothened, frizzled class receptor"
16305,amlodipine,plasmodium ovale malaria,"met proto-oncogene, receptor tyrosine kinase"
16306,pseudoephedrine,tension-type headache,cholinergic receptor muscarinic 5
16307,cilostazol,psoriatic arthritis,uridine monophosphate synthetase
16308,niraparib,dermatitis herpetiformis,interleukin 1 receptor associated kinase 1
16309,aminoglutethimide,onchocerciasis,serine/threonine kinase 33
16310,cobicistat,interstitial lung disease,potassium voltage-gated channel subfamily a member 5
16311,dextrothyroxine,skin disorder,5-hydroxytryptamine receptor 3d
16312,hydromorphone,intracranial embolism,maternal embryonic leucine zipper kinase
16313,fluoxetine,atopic eczema,catechol-o-methyltransferase
16314,phenelzine,delirium,melanocortin 3 receptor
16315,phytomenadione,poisoning of animals with phosphate salts,inosine monophosphate dehydrogenase 1
16316,oxaprozin,dacryocystitis,calcium voltage-gated channel auxiliary subunit beta 2
16317,escitalopram,urinary bladder neoplasm,5-hydroxytryptamine receptor 4
16318,rimexolone,sickle cell anemia,atpase copper transporting beta
16319,physostigmine,rickets,potassium voltage-gated channel modifier subfamily g member 3
16320,tretinoin,arteriosclerosis disorder,histone deacetylase 8
16321,zidovudine,visual epilepsy,casein kinase 1 delta
16322,pentobarbitone,autosomal dominant polycystic kidney disease,plasminogen
16323,propantheline,hypoactive sexual desire disorder,solute carrier family 5 member 6
16324,acrivastine,tetanus,hyperpolarization activated cyclic nucleotide gated potassium channel 3
16325,oxprenolol,hypoactive sexual desire disorder,neuropeptide y receptor y1
16326,apraclonidine,fibromyalgia,cubilin
16327,cladribine,hereditary angioedema,"met proto-oncogene, receptor tyrosine kinase"
16328,balsalazide,malignant essential hypertension,calcium voltage-gated channel subunit alpha1 a
16329,etidronic acid,endometrium neoplasm,rio kinase 1
16330,cladribine,phenylketonuria,glutamate ionotropic receptor kainate type subunit 4
16331,bethanechol,trichuriasis,mitogen-activated protein kinase kinase 2
16332,trifluoperazine,renal osteodystrophy,atp binding cassette subfamily a member 1
16333,acalabrutinib,early myoclonic encephalopathy,cytidine deaminase
16334,oxymetholone,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",atpase na+/k+ transporting subunit beta 3
16335,flibanserin,gynecomastia disorder,bmp2 inducible kinase
16336,pranlukast,homozygous familial hypercholesterolemia,"jun proto-oncogene, ap-1 transcription factor subunit"
16337,bumetanide,skin disorder,mitogen-activated protein kinase kinase 2
16338,lusutrombopag,myxedema,phosphodiesterase 1a
16339,finasteride,exfoliative dermatitis,c-c motif chemokine receptor 1
16340,clotrimazole,benign prostatic hyperplasia,melanocortin 2 receptor
16341,tiagabine,tricuspid atresia,prostaglandin d2 receptor 2
16342,disulfiram,hypoalphalipoproteinemia,"fyn proto-oncogene, src family tyrosine kinase"
16343,miconazole,endometrial carcinoma,albumin
16344,tamibarotene,mature t-cell and nk-cell non-hodgkin lymphoma,phosphodiesterase 3b
16345,amcinonide,peripheral vascular disease,calcium/calmodulin dependent protein kinase ii alpha
16346,vonoprazan,bulimia nervosa,tankyrase 2
16347,halcinonide,iridocyclitis,endothelin receptor type a
16348,amitriptyline,pulmonary embolism,death associated protein kinase 1
16349,clidinium,hyperlipidemia,proteasome 20s subunit beta 9
16350,sertindole,persistent fetal circulation syndrome,atpase na+/k+ transporting subunit beta 3
16351,ipragliflozin,chronic eosinophilic leukemia,neurotensin receptor 2
16352,trifluoperazine,renal cell carcinoma,calcyon neuron specific vesicular protein
16353,pitavastatin,social phobia,somatostatin receptor 2
16354,trandolapril,benign prostatic hyperplasia,cholinergic receptor nicotinic beta 4 subunit
16355,aceclofenac,dysmenorrhea,traf2 and nck interacting kinase
16356,nilotinib,sickle cell anemia,atpase copper transporting beta
16357,timolol,thyroiditis,testis specific serine kinase 1b
16358,selexipag,cerebrovascular disorder,cholinergic receptor nicotinic alpha 5 subunit
16359,nebivolol,hypertrophic cardiomyopathy,complement c5
16360,levosimendan,endometrium neoplasm,janus kinase 1
16361,methapyrilene,mydriasis,nuclear receptor subfamily 3 group c member 2
16362,pirbuterol,sickle cell anemia,toll like receptor 4
16363,raltegravir,prostate neoplasm,serine/threonine kinase 4
16364,cyclobenzaprine,precocious puberty,solute carrier family 22 member 1
16365,tamsulosin,hereditary angioedema,thyroid peroxidase
16366,tenoxicam,toothache,thymidine phosphorylase
16367,danazol,chronic primary adrenal insufficiency,xanthine dehydrogenase
16368,lumiracoxib,manic bipolar affective disorder,proteasome 20s subunit beta 8
16369,galantamine,myasthenia gravis,acetyl-coa acyltransferase 2
16370,crisaborole,pulmonary cystic fibrosis,phosphodiesterase 11a
16371,vernakalant,aggressive systemic mastocytosis,sodium channel epithelial 1 subunit alpha
16372,phenprocoumon,premature obstetric labor,potassium voltage-gated channel subfamily a member 4
16373,formoterol,classic hodgkin lymphoma,proteasome 20s subunit beta 8
16374,ifosfamide,atrophic vulva,"mpl proto-oncogene, thrombopoietin receptor"
16375,formoterol,small cell lung carcinoma,txk tyrosine kinase
16376,cyclophosphamide,tendinitis,inositol monophosphatase 1
16377,quinine,dermatomyositis,structural maintenance of chromosomes 2
16378,tacrolimus,acute lymphoblastic leukemia,somatostatin receptor 4
16379,fampridine,absence epilepsy,solute carrier family 22 member 5
16380,finasteride,dermatitis herpetiformis,npc1 like intracellular cholesterol transporter 1
16381,azelaic acid,endometrium neoplasm,potassium voltage-gated channel subfamily q member 3
16382,cetuximab,necrobiosis lipoidica,cytochrome p450 family 21 subfamily a member 2
16383,emtricitabine,duodenal ulcer,prostaglandin-endoperoxide synthase 1
16384,azelnidipine,obsessive-compulsive disorder,hydroxycarboxylic acid receptor 3
16385,acenocoumarol,multiple sclerosis,solute carrier family 5 member 4
16386,loteprednol etabonate,choroiditis,melanocortin 2 receptor
16387,papaverine,plasma cell myeloma,dopamine receptor d3
16388,metaraminol,bacterial pneumonia,carbonic anhydrase 11
16389,linaclotide,eosinophilic esophagitis,potassium voltage-gated channel subfamily h member 3
16390,aspirin,delayed puberty,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
16391,vinpocetine,angle-closure glaucoma,metabolism of cobalamin associated c
16392,mefenamic acid,thyroid gland papillary carcinoma,phosphodiesterase 7a
16393,prucalopride,hypoparathyroidism,proteasome 20s subunit beta 9
16394,cyclopentolate,tourette syndrome,leukocyte receptor tyrosine kinase
16395,dimenhydrinate,trigeminal neuralgia,solute carrier family 9 member a1
16396,tandospirone,dry eye syndrome,5-hydroxytryptamine receptor 3c
16397,bromfenac,metrorrhagia,adenosine a2b receptor
16398,rimexolone,hepatic veno-occlusive disease,acyl-coa oxidase 1
16399,omarigliptin,toxic shock syndrome,transthyretin
16400,heparin,hyperlipidemia,ryanodine receptor 3
16401,leuprolide,cough,fatty acid amide hydrolase
16402,docetaxel,myalgia,platelet derived growth factor receptor beta
16403,sotalol,synovitis,sigma non-opioid intracellular receptor 1
16404,meclizine,autoimmune hemolytic anemia,potassium voltage-gated channel modifier subfamily s member 3
16405,nitroglycerin,invasive ductal breast carcinoma,atp binding cassette subfamily c member 3
16406,estradiol valerate,tricuspid atresia,membrane spanning 4-domains a1
16407,leuprolide,amyotrophic lateral sclerosis,metallothionein 1a
16408,pemetrexed,pseudotumor cerebri,potassium voltage-gated channel subfamily h member 7
16409,bazedoxifene,erdheim-chester disease,glutathione s-transferase pi 1
16410,cyclopentolate,pheochromocytoma,nuclear receptor subfamily 1 group i member 2
16411,ibrutinib,scabies,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
16412,cilostazol,essential thrombocythemia,nischarin
16413,adinazolam,pulmonary embolism,potassium inwardly rectifying channel subfamily j member 11
16414,dibucaine,bipolar disorder,histone deacetylase 4
16415,vildagliptin,autism spectrum disorder,potassium calcium-activated channel subfamily n member 4
16416,phenprocoumon,raynaud disease,potassium voltage-gated channel modifier subfamily s member 1
16417,calcium gluconate,wilms tumor,tubulin epsilon 1
16418,trandolapril,streptococcal pneumonia,low density lipoprotein receptor
16419,landiolol,diffuse large b-cell lymphoma,ryanodine receptor 2
16420,sirolimus,corneal ulcer,transforming growth factor beta receptor 2
16421,regorafenib,thyroid crisis,potassium voltage-gated channel subfamily c member 2
16422,echothiophate,tetanus,proteasome 20s subunit beta 8
16423,paclitaxel,homozygous familial hypercholesterolemia,potassium voltage-gated channel modifier subfamily g member 3
16424,felodipine,hypophosphatemia,aldehyde dehydrogenase 5 family member a1
16425,prednisolone,ovarian epithelial tumor,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
16426,pilsicainide,migraine disorder,potassium two pore domain channel subfamily k member 2
16427,pantoprazole,vitiligo,metabolism of cobalamin associated c
16428,allopurinol,congenital adrenal hyperplasia,acid sensing ion channel subunit 1
16429,carmofur,tourette syndrome,eph receptor a5
16430,celiprolol,myeloproliferative neoplasm,solute carrier family 6 member 1
16431,sufentanil,hypoparathyroidism,histamine receptor h4
16432,defibrotide,tetanus,cholinergic receptor nicotinic alpha 5 subunit
16433,fluphenazine,perennial allergic rhinitis,methylmalonyl-coa mutase
16434,cilostazol,nephrotic syndrome,calcium voltage-gated channel subunit alpha1 s
16435,selegiline,labor pain,tachykinin precursor 1
16436,chloroquine,hypercholesterolemia,potassium voltage-gated channel subfamily a member 6
16437,nicardipine,thyroid gland carcinoma,calcium voltage-gated channel subunit alpha1 b
16438,piroxicam,hypophosphatemia,phosphodiesterase 1c
16439,reboxetine,head and neck neoplasm,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
16440,tamsulosin,trigeminal neuralgia,cubilin
16441,vigabatrin,cervical cancer,phosphodiesterase 11a
16442,ergometrine,early myoclonic encephalopathy,inositol monophosphatase 1
16443,desvenlafaxine,menorrhagia,atp binding cassette subfamily a member 1
16444,chlorothiazide,myalgia,neuropeptide y
16445,phenylbutazone,epilepsy with generalized tonic-clonic seizures,myosin light chain kinase family member 4
16446,tramadol,pediculus humanus capitis infestation,glutamate ionotropic receptor kainate type subunit 2
16447,carmofur,endometrium neoplasm,phosphodiesterase 1c
16448,fosamprenavir,head and neck cancer,phosphodiesterase 6h
16449,tapentadol,head and neck neoplasm,"ran, member ras oncogene family"
16450,erlotinib,open-angle glaucoma,natriuretic peptide receptor 1
16451,benzquinamide,streptococcal meningitis,cytochrome p450 family 2 subfamily r member 1
16452,betahistine,pemphigus,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
16453,fenfluramine,allergic asthma,guanylate cyclase 1 soluble subunit beta 1
16454,valsartan,shock,potassium voltage-gated channel subfamily d member 1
16455,levosimendan,parkinson disease,dopamine receptor d1
16456,valproic acid,uveitis,tubulin beta 3 class iii
16457,eliglustat,marginal zone lymphoma,5-hydroxytryptamine receptor 3c
16458,saxagliptin,headache disorder,dopa decarboxylase
16459,5-fluorouracil,lung disorder,complement c5
16460,nebivolol,classic phenylketonuria,potassium voltage-gated channel modifier subfamily g member 1
16461,terfenadine,synovitis,prostaglandin-endoperoxide synthase 2
16462,saxagliptin,benign prostatic hyperplasia,phosphodiesterase 2a
16463,trichlormethiazide,chronic obstructive pulmonary disease,trace amine associated receptor 1
16464,tramadol,seasonal allergic rhinitis,myosin light chain kinase
16465,carboplatin,fibromyalgia,adrenoceptor beta 2
16466,limaprost,motion sickness,traf2 and nck interacting kinase
16467,methylphenidate,hypophosphatemia,dead-box helicase 3 x-linked
16468,reserpine,breast carcinoma,adenosine a2b receptor
16469,sitagliptin,gingivitis,guanylate cyclase 1 soluble subunit alpha 1
16470,flurazepam,breast fibrocystic disease,"fyn proto-oncogene, src family tyrosine kinase"
16471,emedastine,pulmonary eosinophilia,fer tyrosine kinase
16472,betaxolol,menorrhagia,gamma-aminobutyric acid type a receptor subunit theta
16473,cladribine,gout,"b-raf proto-oncogene, serine/threonine kinase"
16474,pimavanserin,obsessive-compulsive disorder,cholinergic receptor muscarinic 1
16475,nadolol,postherpetic neuralgia,cytochrome p450 family 2 subfamily a member 6
16476,isosorbide dinitrate,tetany,serine/threonine kinase 17a
16477,benoxaprofen,precocious puberty,death associated protein kinase 2
16478,ibrutinib,"malignant hyperthermia, susceptibility to, 1",tubulin beta 4a class iva
16479,amantadine,hypoglycemia,5-hydroxytryptamine receptor 3c
16480,vandetanib,diabetic kidney disease,tubulin alpha 4a
16481,penbutolol,chronic hepatitis c virus infection,tyrosine kinase non receptor 1
16482,alfuzosin,neuralgia,solute carrier family 5 member 2
16483,cephalotaxine,pancreatic adenocarcinoma,metabolism of cobalamin associated c
16484,mupirocin,colonic neoplasm,natriuretic peptide b
16485,pemirolast,tetanus,phosphodiesterase 7b
16486,isocarboxazid,atrioventricular block,peptidylprolyl isomerase a
16487,pregabalin,acquired thrombocytopenia,"mpl proto-oncogene, thrombopoietin receptor"
16488,diamicron,corneal ulcer,gonadotropin releasing hormone receptor
16489,cyclopentolate,systemic mastocytosis,"tu translation elongation factor, mitochondrial"
16490,lisuride,nausea,paraoxonase 1
16491,fondaparinux,dacryocystitis,catechol-o-methyltransferase
16492,trimethadione,urticaria,gc vitamin d binding protein
16493,romidepsin,premature obstetric labor,sucrase-isomaltase
16494,glibenclamide,melanoma,amine oxidase copper containing 3
16495,talinolol,stroke disorder,solute carrier family 47 member 2
16496,gilteritinib,pulmonary cystic fibrosis,somatostatin receptor 4
16497,losartan,interstitial lung disease,mapk interacting serine/threonine kinase 2
16498,docetaxel,endemic goiter,tyrosine hydroxylase
16499,levocabastine,interstitial lung disease,glucosidase ii alpha subunit
16500,loxapine,mycosis fungoides,potassium voltage-gated channel subfamily a member 1
16501,pindolol,postoperative nausea and vomiting,phosphodiesterase 6g
16502,viloxazine,"malignant hyperthermia, susceptibility to, 1",guanylate cyclase 1 soluble subunit alpha 1
16503,ranitidine,islet cell adenomatosis,ribosomal protein s6 kinase a2
16504,doxapram,classic hodgkin lymphoma,potassium inwardly rectifying channel subfamily j member 1
16505,zolmitriptan,allergic asthma,glucagon like peptide 1 receptor
16506,buprenorphine,acquired thrombocytopenia,tubulin beta 4a class iva
16507,tetrabenazine,anterior uveitis,adenosine deaminase
16508,captodiame,lung lymphangioleiomyomatosis,"src proto-oncogene, non-receptor tyrosine kinase"
16509,fenoprofen,hepatic veno-occlusive disease,potassium voltage-gated channel subfamily a member 7
16510,metoclopramide,hereditary angioedema,potassium voltage-gated channel subfamily d member 2
16511,nisoldipine,chronic schizophrenia,"yes proto-oncogene 1, src family tyrosine kinase"
16512,rimonabant,"malignant hyperthermia, susceptibility to, 1",gamma-aminobutyric acid type a receptor subunit pi
16513,aranidipine,acquired polycythemia vera,cytochrome p450 family 1 subfamily a member 2
16514,eletriptan,schizophrenia,glutamate ionotropic receptor ampa type subunit 3
16515,nevirapine,prader-willi syndrome,potassium voltage-gated channel subfamily a member 10
16516,medroxyprogesterone,erythropoietic protoporphyria,"smoothened, frizzled class receptor"
16517,paclitaxel,invasive ductal breast carcinoma,atpase na+/k+ transporting subunit beta 1
16518,dosulepin,tenosynovial giant cell tumor,erb-b2 receptor tyrosine kinase 2
16519,liraglutide,pancreatic adenocarcinoma,potassium inwardly rectifying channel subfamily j member 12
16520,flumethasone pivalate,short bowel syndrome,phosphodiesterase 6c
16521,glycopyrrolate,pseudotumor cerebri,melanocortin 3 receptor
16522,phenprocoumon,polymyalgia rheumatica,fatty acid binding protein 2
16523,calcium gluconate,acquired thrombocytopenia,sodium voltage-gated channel alpha subunit 4
16524,brompheniramine,tachycardia,guanylate cyclase 2c
16525,zoledronic acid,endemic goiter,sodium channel epithelial 1 subunit alpha
16526,travoprost,islet cell adenomatosis,"hck proto-oncogene, src family tyrosine kinase"
16527,clofarabine,tetralogy of fallot,ap2 associated kinase 1
16528,clotrimazole,enterocolitis,steroid 5 alpha-reductase 2
16529,perphenazine,chronic beryllium disease,nuclear receptor subfamily 0 group b member 1
16530,piretanide,exfoliative dermatitis,calcium voltage-gated channel subunit alpha1 b
16531,simvastatin,congestive heart failure,amylase alpha 2a
16532,cisapride,dermatitis,polo like kinase 4
16533,terguride,acromegaly,transthyretin
16534,naratriptan,bronchitis,follicle stimulating hormone receptor
16535,anagliptin,actinic keratosis,histone deacetylase 11
16536,thalidomide,tenosynovial giant cell tumor,atp binding cassette subfamily g member 8
16537,dapagliflozin,hyperuricemia,interleukin 2
16538,ketotifen,gastric neoplasm,cart prepropeptide
16539,phenmetrazine,renal cell carcinoma,ornithine transcarbamylase
16540,esmolol,thyroid gland carcinoma,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
16541,carfilzomib,rheumatoid arthritis,solute carrier family 25 member 5
16542,orciprenaline,epilepsy,metabolism of cobalamin associated b
16543,ramipril,neonatal abstinence syndrome,cholinergic receptor nicotinic alpha 4 subunit
16544,isradipine,marginal zone lymphoma,misshapen like kinase 1
16545,desvenlafaxine,noonan syndrome,sodium voltage-gated channel alpha subunit 4
16546,ixabepilone,otitis externa,calcium voltage-gated channel subunit alpha1 d
16547,trospium chloride,meniere disease,acyl-coa dehydrogenase short/branched chain
16548,cabergoline,bronchial disorder,potassium inwardly rectifying channel subfamily j member 8
16549,levodopa,pulmonary eosinophilia,tank binding kinase 1
16550,fludarabine,urinary bladder cancer,potassium voltage-gated channel subfamily q member 2
16551,dabigatran etexilate,cerebrovascular disorder,serine/threonine kinase 33
16552,fluoxymesterone,type 2 diabetes mellitus,aldo-keto reductase family 1 member c1
16553,tapentadol,pruritus ani,cholinergic receptor nicotinic alpha 5 subunit
16554,vigabatrin,rhabdomyosarcoma,butyrylcholinesterase
16555,celecoxib,pulmonary valve atresia,amylase alpha 2a
16556,papaverine,fibromyalgia,cytochrome p450 family 2 subfamily b member 6
16557,hydroxocobalamin,granuloma annulare,solute carrier organic anion transporter family member 2b1
16558,trichlormethiazide,essential hypertension,peroxisome proliferator activated receptor delta
16559,venetoclax,allergic rhinitis,transient receptor potential cation channel subfamily v member 1
16560,emedastine,enterobiasis,cholinergic receptor nicotinic alpha 5 subunit
16561,capsaicin,vitamin d deficiency,phosphodiesterase 2a
16562,topiroxostat,goiter,potassium inwardly rectifying channel subfamily j member 1
16563,pitavastatin,endometrium neoplasm,interleukin 1 receptor associated kinase 1
16564,vemurafenib,premature ejaculation,atpase na+/k+ transporting subunit beta 2
16565,rimonabant,biotinidase deficiency,gamma-aminobutyric acid type a receptor subunit theta
16566,nimodipine,holocarboxylase synthetase deficiency,fms related receptor tyrosine kinase 3
16567,meclizine,dermatitis herpetiformis,opioid receptor mu 1
16568,cyclosporin a,melanoma,cdc like kinase 2
16569,obinutuzumab,hyperbilirubinemia,guanylate cyclase 1 soluble subunit alpha 1
16570,reboxetine,torsades de pointes,phosphodiesterase 3a
16571,clemastine,urinary retention,gamma-aminobutyric acid type a receptor subunit beta3
16572,troglitazone,hyponatremia,g protein-coupled receptor 35
16573,glimepiride,severe major depression with psychotic features,c-x-c motif chemokine ligand 8
16574,physostigmine,renal cell carcinoma,potassium voltage-gated channel subfamily c member 4
16575,piretanide,sitosterolemia,sodium voltage-gated channel alpha subunit 11
16576,clozapine,peptic ulcer disease,caspase 1
16577,dimethyl fumarate,adrenal gland hyperfunction,dipeptidyl peptidase 9
16578,metformin,hypertrophic cardiomyopathy,glucagon like peptide 1 receptor
16579,tamoxifen,zollinger-ellison syndrome,dna polymerase beta
16580,rosuvastatin,sneeze,solute carrier family 5 member 11
16581,mometasone,chronic urticaria,rio kinase 1
16582,cetuximab,pruritus,melanocortin 1 receptor
16583,ceftriaxone,bacterial conjunctivitis,maltase-glucoamylase
16584,carbidopa,migraine disorder,alk receptor tyrosine kinase
16585,dapsone,restless legs syndrome,prostaglandin d2 receptor
16586,phenprocoumon,goiter,bmp2 inducible kinase
16587,l-citrulline,meningococcal meningitis,riboflavin kinase
16588,buspirone,uterine corpus leiomyoma,phosphodiesterase 4a
16589,buclizine,allergic contact dermatitis,carbonic anhydrase 1
16590,rotigotine,cardiac arrest,prostaglandin-endoperoxide synthase 2
16591,bunolol,obesity disorder,somatostatin receptor 5
16592,flutamide,aspiration pneumonitis,serine/threonine kinase 25
16593,magnesium salicylate,enterocolitis,chymotrypsinogen b1
16594,aliskiren,hypocalcemia,adrenoceptor alpha 2b
16595,probucol,severe major depression with psychotic features,oxytocin receptor
16596,mizolastine,respiratory failure,sulfotransferase family 2a member 1
16597,estrone,gingivitis,protein kinase c theta
16598,pasireotide,oral candidiasis,sodium channel epithelial 1 subunit beta
16599,chlorhexidine,thyroid gland papillary carcinoma,death associated protein kinase 1
16600,flurazepam,ankylosing spondylitis,amylase alpha 1b
16601,citalopram,insomnia,5-hydroxytryptamine receptor 3d
16602,zafirlukast,holocarboxylase synthetase deficiency,fms related receptor tyrosine kinase 1
16603,tretinoin,bone paget disease,homeodomain interacting protein kinase 2
16604,rupatadine,west syndrome,phosphodiesterase 11a
16605,eflornithine,pyoderma gangrenosum,bcl2 like 2
16606,apraclonidine,dyspepsia,glutamate ionotropic receptor nmda type subunit 1
16607,tocilizumab,bruxism,udp-glucose ceramide glucosyltransferase
16608,acrivastine,diabetes mellitus,solute carrier family 6 member 1
16609,nisoldipine,endemic goiter,phosphodiesterase 3a
16610,quinestrol,nausea,serine/threonine kinase 33
16611,opipramol,bronchitis,5-methyltetrahydrofolate-homocysteine methyltransferase reductase
16612,dosulepin,scabies,cyclin dependent kinase 6
16613,diclofenamide,sympathetic ophthalmia,potassium voltage-gated channel subfamily h member 6
16614,choline magnesium trisalicylate,female stress incontinence,amine oxidase copper containing 1
16615,torsemide,xerophthalmia,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
16616,gilteritinib,brain cancer,mitogen-activated protein kinase kinase kinase 19
16617,clofazimine,social phobia,protein kinase n2
16618,calcifediol,arthralgia,hyperpolarization activated cyclic nucleotide gated potassium channel 4
16619,nevirapine,diarrheal disease,carbonic anhydrase 12
16620,bisoprolol,drooling,cytochrome p450 family 1 subfamily a member 1
16621,blonanserin,pyoderma gangrenosum,udp glucuronosyltransferase family 1 member a1
16622,gefitinib,delayed puberty,mitogen-activated protein kinase kinase 1
16623,amitriptyline,breast neoplasm,bone gamma-carboxyglutamate protein
16624,bisoprolol,pain,bmp2 inducible kinase
16625,formoterol,corneal ulcer,aurora kinase c
16626,tramadol,anogenital human papillomavirus infection,cholinergic receptor nicotinic alpha 4 subunit
16627,bosutinib,altitude sickness,potassium inwardly rectifying channel subfamily j member 2
16628,ibandronic acid,myocardial infarction,calcium voltage-gated channel subunit alpha1 f
16629,omacetaxine mepesuccinate,thromboembolism,sodium voltage-gated channel alpha subunit 10
16630,probenecid,hyperglycemia,macrophage stimulating 1 receptor
16631,cinnarizine,goiter,potassium voltage-gated channel modifier subfamily f member 1
16632,alimemazine,vulvovaginal candidiasis,fer tyrosine kinase
16633,choline magnesium trisalicylate,ovarian cancer,leukotriene a4 hydrolase
16634,eprosartan,thyroiditis,cytochrome p450 family 1 subfamily a member 2
16635,acebutolol,erdheim-chester disease,potassium voltage-gated channel subfamily q member 5
16636,iloprost,lewy body dementia,potassium voltage-gated channel subfamily h member 3
16637,calcium gluconate,intracranial embolism,solute carrier family 22 member 5
16638,celiprolol,bronchial disorder,atpase na+/k+ transporting subunit beta 1
16639,digoxin,uterine corpus leiomyoma,5-methyltetrahydrofolate-homocysteine methyltransferase
16640,paliperidone,tetany,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
16641,butenafine,actinic keratosis,glucosidase ii alpha subunit
16642,methotrexate,meningococcal meningitis,propionyl-coa carboxylase subunit alpha
16643,zidovudine,diabetic kidney disease,calcium voltage-gated channel subunit alpha1 c
16644,migalastat,orthostatic hypotension,estrogen receptor 2
16645,bromodiphenhydramine,familial dermatographia,5-hydroxytryptamine receptor 3d
16646,pentostatin,ocular hypertension,tubulin beta 1 class vi
16647,vindesine,ovarian cancer,glutamate ionotropic receptor nmda type subunit 2c
16648,sivelestat,autoimmune hemolytic anemia,somatostatin receptor 2
16649,ropinirole,abdominal infection,sodium voltage-gated channel alpha subunit 1
16650,rivaroxaban,vitiligo,cytochrome p450 family 2 subfamily a member 6
16651,migalastat,contact dermatitis,glutamate ionotropic receptor kainate type subunit 4
16652,quinestrol,small cell lung carcinoma,"ran, member ras oncogene family"
16653,saquinavir,canker sore,5-hydroxytryptamine receptor 3d
16654,crisaborole,classic hodgkin lymphoma,"met proto-oncogene, receptor tyrosine kinase"
16655,cabergoline,eye disorder,endothelin receptor type a
16656,glymidine,type 2 diabetes mellitus,glutathione-disulfide reductase
16657,empagliflozin,ocular hypertension,nischarin
16658,flunisolide,cough,"fyn proto-oncogene, src family tyrosine kinase"
16659,clomiphene,allergic bronchopulmonary aspergillosis,tubulin alpha 4a
16660,desoximetasone,disruptive behavior disorder,arginine vasopressin receptor 1a
16661,adinazolam,scleroderma,calcium/calmodulin dependent protein kinase ii alpha
16662,trihexyphenidyl,postoperative nausea and vomiting,aldo-keto reductase family 1 member c3
16663,brigatinib,dysmenorrhea,growth hormone receptor
16664,isoxsuprine,urticaria,cytochrome p450 family 3 subfamily a member 7
16665,lafutidine,atrioventricular block,eph receptor a1
16666,cariprazine,atrophic vulva,phosphorylase kinase catalytic subunit gamma 1
16667,hydroxocobalamin,breast cancer,ryanodine receptor 3
16668,halcinonide,adrenogenital syndrome,"kit proto-oncogene, receptor tyrosine kinase"
16669,gemigliptin,cough,cytochrome p450 family 3 subfamily a member 4
16670,bromfenac,intracranial embolism,tumor protein p53
16671,lofepramine,chronic bronchitis,potassium voltage-gated channel subfamily h member 2
16672,eribulin,hypertrophic cardiomyopathy,gamma-aminobutyric acid type a receptor subunit beta3
16673,vandetanib,dry eye syndrome,tyrosine kinase 2
16674,selexipag,acromegaly,protein kinase c theta
16675,colchicine,iritis,retinoic acid receptor gamma
16676,alectinib,atrial fibrillation,discoidin domain receptor tyrosine kinase 2
16677,tolvaptan,small cell lung carcinoma,insulin receptor
16678,mepyramine,pulmonary embolism,solute carrier family 25 member 6
16679,felodipine,lung neoplasm,kallikrein b1
16680,nalbuphine,opiate dependence,angiotensin converting enzyme 2
16681,hydroxocobalamin,nausea,phosphodiesterase 7a
16682,fenoldopam,prader-willi syndrome,erb-b2 receptor tyrosine kinase 2
16683,somatropin,hypercholesterolemia,cholesteryl ester transfer protein
16684,defibrotide,chronic beryllium disease,myosin heavy chain 10
16685,bupropion,"hyperlipidemia, familial combined, lpl related",transient receptor potential cation channel subfamily m member 8
16686,indacaterol,absence epilepsy,"lipase f, gastric type"
16687,bezafibrate,urinary bladder neoplasm,adrenoceptor alpha 2b
16688,anagliptin,classic hodgkin lymphoma,solute carrier family 27 member 2
16689,riluzole,systemic mastocytosis,solute carrier family 9 member a1
16690,brexpiprazole,gaucher disease,adenosine a3 receptor
16691,afamelanotide,polycystic ovary syndrome,structural maintenance of chromosomes 1a
16692,meclofenamic acid,castleman disease,cytochrome p450 family 3 subfamily a member 5
16693,icatibant,inflammatory bowel disease,hypoxanthine phosphoribosyltransferase 1
16694,procyclidine,severe major depression with psychotic features,atp binding cassette subfamily g member 8
16695,carbidopa,tardive dyskinesia,kallikrein b1
16696,alpha-methyltyrosine,acute interstitial pneumonia,nuclear receptor subfamily 1 group i member 2
16697,levorphanol,ocular hypertension,atpase na+/k+ transporting subunit alpha 2
16698,ibrutinib,dermatophytosis of groin and perianal area,"b-raf proto-oncogene, serine/threonine kinase"
16699,miconazole,chronic eosinophilic leukemia,acid sensing ion channel subunit 1
16700,vorapaxar,atrophic vulva,glutamate ionotropic receptor kainate type subunit 1
16701,indomethacin,female infertility,atp binding cassette subfamily c member 3
16702,levetiracetam,plasmodium vivax malaria,adrenoceptor alpha 1d
16703,idelalisib,hypercholesterolemia,atpase na+/k+ transporting subunit beta 3
16704,amlodipine,hemorrhoid,microtubule associated protein 1a
16705,epa,arteriosclerosis disorder,atp binding cassette subfamily a member 1
16706,roxatidine acetate,islet cell adenomatosis,unc-51 like kinase 3
16707,etoposide,inflammatory bowel disease,ndufa4 mitochondrial complex associated
16708,l-glutamine,focal epilepsy,fkbp prolyl isomerase 4
16709,ripasudil,eosinophilic pneumonia,il2 inducible t cell kinase
16710,biotin,female stress incontinence,retinoid x receptor beta
16711,adapalene,visual epilepsy,5-hydroxytryptamine receptor 3d
16712,histrelin,necrobiosis lipoidica,cholinergic receptor nicotinic alpha 5 subunit
16713,loperamide,thrombocytopenia,tumor protein p53
16714,oxycodone,pthirus pubis infestation,glutathione s-transferase alpha 2
16715,goserelin,premature ventricular contraction,retinoid x receptor beta
16716,migalastat,small cell lung carcinoma,dna polymerase beta
16717,alcaftadine,cluster headache syndrome,cytidine deaminase
16718,menatetrenone,motion sickness,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
16719,ciprofloxacin,follicular lymphoma,prostaglandin e synthase 3
16720,mizolastine,disseminated intravascular coagulation,inosine monophosphate dehydrogenase 1
16721,sapropterin,pruritus ani,sulfotransferase family 1a member 1
16722,tretinoin,prostate cancer,"dna polymerase delta 1, catalytic subunit"
16723,thiothixene,prostate cancer,hydroxysteroid 11-beta dehydrogenase 1
16724,sapropterin,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",carbonic anhydrase 1
16725,ethacrynic acid,autism spectrum disorder,phosphodiesterase 6b
16726,liraglutide,decreased cardiac output,diacylglycerol o-acyltransferase 1
16727,pentobarbitone,rosacea,tubulin beta 8 class viii
16728,acetyldigitoxin,atopic conjunctivitis,activin a receptor type 1
16729,zaleplon,pituitary dwarfism,dopamine receptor d4
16730,gepirone,castleman disease,kinase insert domain receptor
16731,drospirenone,alcohol dependence,gc vitamin d binding protein
16732,prednisolone,chronic urticaria,angiotensin ii receptor type 2
16733,aminoglutethimide,seborrheic dermatitis,melanocortin 1 receptor
16734,orlistat,congenital adrenal hyperplasia,mitogen-activated protein kinase kinase 2
16735,tramadol,angina pectoris,"dna polymerase alpha 1, catalytic subunit"
16736,acetylmethadol,hyperuricemia,sodium voltage-gated channel alpha subunit 7
16737,metipranolol,trichinellosis,dead-box helicase 3 x-linked
16738,propafenone,b-cell chronic lymphocytic leukemia,ornithine decarboxylase 1
16739,salmeterol,ventricular fibrillation,rio kinase 1
16740,pregabalin,hypotensive disorder,retinoic acid receptor alpha
16741,methdilazine,malignant glioma,4-aminobutyrate aminotransferase
16742,dasatinib,autoimmune hemolytic anemia,prostaglandin d2 receptor 2
16743,ecallantide,enterobiasis,solute carrier organic anion transporter family member 1a2
16744,alpha-methyltyrosine,stargardt disease,"dna polymerase epsilon, catalytic subunit"
16745,aliskiren,leiomyosarcoma,succinate dehydrogenase complex flavoprotein subunit a
16746,nitroglycerin,small cell lung carcinoma,toll like receptor 7
16747,trifluridine,thromboembolism,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
16748,nizatidine,fibromyalgia,angiotensin converting enzyme 2
16749,indomethacin,pruritus,phosphodiesterase 7a
16750,panobinostat,polyuria,butyrylcholinesterase
16751,fludarabine,urinary retention,"plasminogen activator, tissue type"
16752,pramipexole,cerebrovascular disorder,fatty acid binding protein 2
16753,gemcitabine,cardiogenic shock,histone deacetylase 6
16754,calcium citrate,sebaceous adenoma,cytochrome p450 family 2 subfamily c member 18
16755,dihydrotachysterol,sebaceous adenoma,albumin
16756,isradipine,hypoglycemia,phosphatidylinositol-5-phosphate 4-kinase type 2 beta
16757,darunavir,eosinophilic esophagitis,cytochrome p450 family 51 subfamily a member 1
16758,prochlorperazine,prostate cancer,gamma-aminobutyric acid type a receptor subunit gamma1
16759,chlorcyclizine,tachycardia,cytochrome p450 family 11 subfamily b member 1
16760,ospemifene,kaposi's sarcoma,phosphodiesterase 7b
16761,mometasone,acute lymphoblastic leukemia,mechanistic target of rapamycin kinase
16762,apraclonidine,hypoalphalipoproteinemia,ribosomal protein s6 kinase a1
16763,carfilzomib,delayed puberty,leukotriene a4 hydrolase
16764,adinazolam,respiratory syncytial virus infectious disease,cytochrome p450 family 2 subfamily a member 6
16765,salicylic acid,endometrium neoplasm,npc1 like intracellular cholesterol transporter 1
16766,betahistine,poems syndrome,atp binding cassette subfamily g member 5
16767,amobarbital,dry eye syndrome,transthyretin
16768,olodaterol,allergic contact dermatitis,propionyl-coa carboxylase subunit beta
16769,nefazodone,hypertrichosis of eyelid,ste20 like kinase
16770,benazepril,tricuspid atresia,tubulin beta 3 class iii
16771,ubidecarenone,brain edema,sphingosine-1-phosphate receptor 5
16772,levoketoconazole,streptococcal meningitis,phospholipase a2 group iie
16773,thalidomide,pulmonary artery stenosis,solute carrier family 6 member 2
16774,tolazamide,chronic myelomonocytic leukemia,cannabinoid receptor 2
16775,azatadine,adrenogenital syndrome,matrix metallopeptidase 9
16776,pimozide,tinea corporis,transient receptor potential cation channel subfamily m member 8
16777,lenvatinib,kaposi's sarcoma,potassium voltage-gated channel modifier subfamily g member 3
16778,triflupromazine,subarachnoid hemorrhage,pre-mrna processing factor kinase prp4k
16779,alclofenac,bacterial endocarditis,tachykinin precursor 1
16780,vismodegib,peyronie disease,nuclear receptor subfamily 3 group c member 2
16781,timolol,liver cancer,dna topoisomerase ii beta
16782,lorazepam,dyschromatosis universalis hereditaria,calcium voltage-gated channel subunit alpha1 h
16783,prilocaine,pulmonary embolism,butyrylcholinesterase
16784,umeclidinium,tension-type headache,glutathione s-transferase mu 1
16785,levoketoconazole,hereditary von willebrand disease,"smoothened, frizzled class receptor"
16786,metformin,strongyloidiasis,maltase-glucoamylase
16787,fentanyl,acute gonococcal endometritis,macrophage stimulating 1 receptor
16788,loteprednol etabonate,"attention deficit hyperactivity disorder, inattentive type",cholesteryl ester transfer protein
16789,rotigotine,hypertrichosis of eyelid,"abl proto-oncogene 1, non-receptor tyrosine kinase"
16790,lovastatin,postencephalitic parkinson disease,adrenoceptor beta 1
16791,isoprenaline,rhinoscleroma,gamma-aminobutyric acid type a receptor subunit beta3
16792,orlistat,erectile dysfunction,atpase h+ transporting v1 subunit a
16793,somatrem,ovarian cancer,coagulation factor ii thrombin receptor
16794,midostaurin,bronchiectasis,inosine monophosphate dehydrogenase 1
16795,progesterone,brain glioblastoma,potassium voltage-gated channel subfamily d member 3
16796,trimetazidine,sympathetic ophthalmia,carbonic anhydrase 9
16797,repaglinide,postpartum depression,cdc like kinase 1
16798,indomethacin,peptic esophagitis,serine/threonine kinase 11
16799,methyclothiazide,sarcoma,prostaglandin e receptor 4
16800,oprelvekin,arthropathy,potassium voltage-gated channel subfamily a member 3
16801,dexmethylphenidate,neuroblastoma,adrenoceptor alpha 2a
16802,crisaborole,"cicatrix, hypertrophic",ribosomal protein s6 kinase a5
16803,desonide,breast fibrocystic disease,somatostatin receptor 2
16804,regorafenib,postpartum depression,phosphodiesterase 4b
16805,bimatoprost,premature ejaculation,glutathione s-transferase alpha 2
16806,niraparib,epilepsy,discoidin domain receptor tyrosine kinase 1
16807,ketoprofen,urge incontinence,epoxide hydrolase 2
16808,megestrol,motion sickness,cytochrome p450 family 21 subfamily a member 2
16809,phenylephrine,neuralgia,histone deacetylase 11
16810,betamethasone,pyoderma gangrenosum,solute carrier family 6 member 1
16811,methylergonovine,persistent fetal circulation syndrome,sphingosine-1-phosphate receptor 4
16812,chlorambucil,aorta coarctation,fatty acid binding protein 2
16813,thalidomide,postmenopausal osteoporosis,platelet derived growth factor receptor alpha
16814,pentoxifylline,intrinsic asthma,potassium voltage-gated channel subfamily b member 1
16815,fludrocortisone,hyperglycemia,nuclear receptor subfamily 3 group c member 2
16816,phentermine,premature ventricular contraction,dopamine receptor d3
16817,adinazolam,pulmonary emphysema,dopamine receptor d4
16818,levodopa,diarrheal disease,gamma-aminobutyric acid type a receptor subunit alpha1
16819,apalutamide,acute gonococcal endometritis,matrix metallopeptidase 2
16820,candesartan,myasthenia gravis,peptidylprolyl isomerase a
16821,benzquinamide,depressive disorder,holocarboxylase synthetase
16822,carbenoxolone,"hydatidiform mole, recurrent, 1",glutathione s-transferase mu 1
16823,secobarbital,plasmodium malariae malaria,potassium voltage-gated channel modifier subfamily v member 1
16824,dibucaine,trigeminal neuralgia,nuclear factor kappa b subunit 1
16825,brinzolamide,status epilepticus,15-hydroxyprostaglandin dehydrogenase
16826,vindesine,head and neck neoplasm,phosphodiesterase 1a
16827,dexlansoprazole,pharyngitis,neurotensin receptor 2
16828,lopinavir,stargardt disease,receptor interacting serine/threonine kinase 3
16829,cortisone,anogenital human papillomavirus infection,potassium calcium-activated channel subfamily n member 4
16830,teriparatide,dacryocystitis,low density lipoprotein receptor
16831,zoledronic acid,periodontitis,dna topoisomerase i mitochondrial
16832,isradipine,thromboangiitis obliterans,carbonic anhydrase 12
16833,hydroxyurea,x-linked dominant hypophosphatemic rickets,plasminogen
16834,apremilast,adrenogenital syndrome,kinase insert domain receptor
16835,naloxone,attrv122i amyloidosis,traf2 and nck interacting kinase
16836,balsalazide,basal ganglia disorder,fkbp prolyl isomerase 4
16837,clonazepam,chronic obstructive pulmonary disease,toll like receptor 4
16838,metoclopramide,hyperglycemia,solute carrier family 19 member 1
16839,etidronic acid,dyspnea,pre-mrna processing factor kinase prp4k
16840,salmeterol,gastric ulcer,vascular endothelial growth factor a
16841,phenelzine,chronic eosinophilic leukemia,integrin subunit alpha 2b
16842,cyclizine,rosacea,cytochrome p450 family 19 subfamily a member 1
16843,phenprocoumon,abdominal abscess,integrin subunit alpha 2b
16844,ergotamine,hyperglycemia,cholinergic receptor nicotinic beta 4 subunit
16845,alprazolam,marginal zone lymphoma,"dna polymerase delta 1, catalytic subunit"
16846,fomepizole,adrenogenital syndrome,glucagon like peptide 1 receptor
16847,topiroxostat,nocturnal enuresis,cdc like kinase 1
16848,tolterodine,lichen planus,eph receptor a3
16849,lamivudine,hyperuricemia,calreticulin
16850,guanethidine,altitude sickness,gamma-aminobutyric acid type a receptor subunit beta1
16851,teniposide,kaposi's sarcoma,colony stimulating factor 1 receptor
16852,diazoxide,vitamin d deficiency,acetyl-coa acetyltransferase 1
16853,glibenclamide,attrv122i amyloidosis,inhibitor of nuclear factor kappa b kinase subunit beta
16854,ipragliflozin,seasonal allergic rhinitis,solute carrier family 18 member a2
16855,tipranavir,autoimmune disease,sodium voltage-gated channel alpha subunit 5
16856,pentobarbitone,tinea pedis,dna topoisomerase i mitochondrial
16857,methapyrilene,trigeminal neuralgia,solute carrier family 12 member 3
16858,nefazodone,trigeminal neuralgia,adrenoceptor alpha 1b
16859,loxapine,absence epilepsy,serine/threonine kinase 25
16860,tamsulosin,raynaud disease,il2 inducible t cell kinase
16861,sibutramine,"dermatitis, atopic",opioid related nociceptin receptor 1
16862,benoxaprofen,blepharoconjunctivitis,ebp cholestenol delta-isomerase
16863,hydroxocobalamin,polymyalgia rheumatica,dual specificity tyrosine phosphorylation regulated kinase 2
16864,levorphanol,choroiditis,tubulin beta 2a class iia
16865,ranitidine,meningococcal meningitis,cytochrome p450 family 27 subfamily a member 1
16866,nalbuphine,perennial allergic rhinitis,cholinergic receptor nicotinic beta 2 subunit
16867,naratriptan,hypocalcemia,histone deacetylase 10
16868,lusutrombopag,tinea pedis,"jun proto-oncogene, ap-1 transcription factor subunit"
16869,pentamidine,peripheral vascular disease,phosphodiesterase 4c
16870,penbutolol,type 2 diabetes mellitus,potassium inwardly rectifying channel subfamily j member 8
16871,hydroflumethiazide,stroke disorder,gamma-aminobutyric acid type a receptor subunit alpha1
16872,floxuridine,male infertility,phenylalanine hydroxylase
16873,paramethadione,bronchial disorder,udp glucuronosyltransferase family 1 member a1
16874,emtricitabine,hypertrophic cardiomyopathy,glutamate ionotropic receptor ampa type subunit 3
16875,zalcitabine,arthritic joint disease,gamma-aminobutyric acid type a receptor subunit alpha3
16876,bezafibrate,cutaneous candidiasis,c-x-c motif chemokine receptor 4
16877,phenylbutazone,erectile dysfunction,phosphorylase kinase catalytic subunit gamma 1
16878,amprenavir,scabies,tubulin alpha 1a
16879,etoposide,ovarian epithelial tumor,dipeptidyl peptidase 8
16880,thiothixene,anxiety disorder,"ran, member ras oncogene family"
16881,eszopiclone,bacterial endocarditis,bmx non-receptor tyrosine kinase
16882,isoprenaline,postoperative nausea and vomiting,atm serine/threonine kinase
16883,paliperidone,"attention deficit hyperactivity disorder, inattentive type",serine/threonine kinase 17a
16884,cortisol,tinea corporis,trace amine associated receptor 1
16885,pravastatin,urinary bladder neoplasm,solute carrier family 46 member 1
16886,rizatriptan,gaucher disease,hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
16887,glucagon,hyperglycemia,gamma-aminobutyric acid type a receptor subunit alpha3
16888,gemcitabine,congenital hypothyroidism,ribonucleotide reductase regulatory subunit m2
16889,emtricitabine,asthma-chronic obstructive pulmonary disease overlap syndrome,histamine receptor h2
16890,flibanserin,acromegaly,n-acylsphingosine amidohydrolase 1
16891,aminobenzoic acid,waldenstrom macroglobulinemia,7-dehydrocholesterol reductase
16892,dopamine,cycloplegia,structural maintenance of chromosomes 2
16893,docetaxel,hyperlipidemia,ndufa4 mitochondrial complex associated
16894,cetirizine,klinefelter syndrome,adrenoceptor beta 2
16895,trazodone,orthostatic hypotension,histone deacetylase 10
16896,paclitaxel,impetigo,tyrosine kinase non receptor 1
16897,ramatroban,urticaria,sodium channel epithelial 1 subunit gamma
16898,mosapramine,primary cutaneous t-cell non-hodgkin lymphoma,lipoprotein lipase
16899,landiolol,arthropathy,interleukin 1 beta
16900,empagliflozin,propionic acidemia,somatostatin receptor 1
16901,dexamfetamine,acute lung injury,caspase 1
16902,salicylic acid,malaria,somatostatin receptor 2
16903,dyphylline,nutritional biotin deficiency,kallikrein b1
16904,ketotifen,psoriatic arthritis,solute carrier family 19 member 1
16905,ergometrine,allergic rhinitis,neurotrophic receptor tyrosine kinase 3
16906,metformin,lung neoplasm,melatonin receptor 1b
16907,propafenone,head and neck cancer,gamma-aminobutyric acid type a receptor subunit beta2
16908,choline,stroke disorder,solute carrier family 6 member 4
16909,gonadorelin,"hydatidiform mole, recurrent, 1",calcium voltage-gated channel auxiliary subunit beta 2
16910,sumatriptan,open-angle glaucoma,solute carrier family 7 member 11
16911,desonide,plasma cell myeloma,sphingosine-1-phosphate receptor 5
16912,terazosin,cough,histone deacetylase 5
16913,sulfasalazine,esophageal cancer,potassium voltage-gated channel subfamily a member 10
16914,propranolol,musculoskeletal system disorder,isoleucyl-trna synthetase 1
16915,pentostatin,aspiration pneumonitis,eukaryotic translation initiation factor 4e
16916,bethanechol,multiple endocrine neoplasia,hyperpolarization activated cyclic nucleotide gated potassium channel 3
16917,crisaborole,acute coronary syndrome,aldo-keto reductase family 1 member c1
16918,pemetrexed,prader-willi syndrome,prostaglandin-endoperoxide synthase 2
16919,carbetocin,essential thrombocythemia,tubulin delta 1
16920,bortezomib,diarrheal disease,cholinergic receptor muscarinic 3
16921,dipivefrine,pulmonary embolism,cholinergic receptor nicotinic alpha 4 subunit
16922,guanadrel,rickets,"mpl proto-oncogene, thrombopoietin receptor"
16923,drospirenone,cryptorchidism,il2 inducible t cell kinase
16924,progesterone,autosomal dominant polycystic kidney disease,gamma-aminobutyric acid type a receptor subunit alpha5
16925,fluorometholone,chancroid,acetyl-coa acetyltransferase 1
16926,atropine,interstitial lung disease 2,cholinergic receptor muscarinic 5
16927,pexidartinib,bronchitis,atpase na+/k+ transporting subunit beta 1
16928,fenoprofen,stevens-johnson syndrome,tubulin beta 4b class ivb
16929,rupatadine,thyroid gland follicular carcinoma,dna methyltransferase 3 alpha
16930,anagrelide,thyroiditis,5-hydroxytryptamine receptor 1a
16931,acenocoumarol,rickets,bcl2 apoptosis regulator
16932,istradefylline,skin basal cell carcinoma,ribosomal protein s6 kinase a1
16933,melatonin,female infertility,calcium voltage-gated channel auxiliary subunit alpha2delta 1
16934,tenoxicam,enterocolitis,atp binding cassette subfamily a member 1
16935,methoxamine,neurogenic bladder,phospholipase a2 group iie
16936,hydroxychloroquine,acute interstitial pneumonia,solute carrier organic anion transporter family member 1b1
16937,triiodothyronine,idiopathic hypereosinophilic syndrome,srsf protein kinase 3
16938,hydroxyzine,plasmodium vivax malaria,calcium voltage-gated channel subunit alpha1 d
16939,reproterol,early myoclonic encephalopathy,dopamine receptor d1
16940,nifedipine,prader-willi syndrome,superoxide dismutase 1
16941,atenolol,"chronic myelogenous leukemia, bcr-abl1 positive",cannabinoid receptor 2
16942,travoprost,aspiration pneumonia,cd33 molecule
16943,clemastine,"hyperlipidemia, familial combined, lpl related",natriuretic peptide b
16944,crisaborole,scalp dermatosis,sigma non-opioid intracellular receptor 1
16945,eribulin,premenstrual dysphoric disorder,cytochrome p450 family 3 subfamily a member 4
16946,esomeprazole,parkinson disease,receptor interacting serine/threonine kinase 3
16947,tamsulosin,thyroid gland carcinoma,solute carrier family 12 member 2
16948,amiloride,urinary bladder cancer,microtubule affinity regulating kinase 3
16949,estrone sulphate,endometrial carcinoma,tec protein tyrosine kinase
16950,felodipine,systemic mastocytosis,dopamine receptor d3
16951,celecoxib,constipation disorder,g protein-coupled receptor kinase 4
16952,brigatinib,urticaria,prostaglandin e synthase 3
16953,pemetrexed,hereditary von willebrand disease,solute carrier family 12 member 1
16954,lenvatinib,hyperparathyroidism,gamma-aminobutyric acid type a receptor subunit gamma3
16955,everolimus,hypoparathyroidism,sphingosine-1-phosphate receptor 3
16956,amcinonide,premature ventricular contraction,activin a receptor type 1
16957,desipramine,oligospermia,follicle stimulating hormone receptor
16958,dihydroergotamine,respiratory syncytial virus infectious disease,potassium voltage-gated channel subfamily h member 4
16959,eptifibatide,dermatofibrosarcoma protuberans,sodium channel epithelial 1 subunit beta
16960,tazarotene,bipolar depression,cyclin dependent kinase 16
16961,bilastine,familial dermatographia,calcium voltage-gated channel subunit alpha1 s
16962,capecitabine,pulmonary arterial hypertension,ribosomal protein s6 kinase a5
16963,moxonidine,sickle cell anemia,solute carrier family 22 member 6
16964,paclitaxel,brain glioblastoma,potassium two pore domain channel subfamily k member 3
16965,icosapent,persistent fetal circulation syndrome,macrophage stimulating 1 receptor
16966,progesterone,"hydatidiform mole, recurrent, 1",cytochrome c1
16967,oprelvekin,embolism,fer tyrosine kinase
16968,ketotifen,alopecia,cereblon
16969,choline,urinary bladder neoplasm,udp-glucose ceramide glucosyltransferase
16970,losartan,endometriosis,histone deacetylase 3
16971,ethinylestradiol,acute intermittent porphyria,ribosomal protein s6 kinase a6
16972,ofatumumab,atrophic vulva,nuclear factor kappa b subunit 1
16973,ripasudil,autosomal dominant polycystic kidney disease,tubulin beta 1 class vi
16974,mizolastine,parkinsonian disorder,solute carrier family 9 member a1
16975,vilazodone,anogenital human papillomavirus infection,dipeptidyl peptidase 8
16976,desloratadine,familial mediterranean fever,gamma-glutamyl carboxylase
16977,alectinib,hepatic veno-occlusive disease,holocarboxylase synthetase
16978,eliglustat,tricuspid atresia,ryanodine receptor 3
16979,lenvatinib,"dermatitis, atopic",toll like receptor 4
16980,dexmethylphenidate,hemorrhoid,potassium voltage-gated channel modifier subfamily g member 2
16981,entacapone,hepatic veno-occlusive disease,tubulin beta 2a class iia
16982,testosterone propionate,acute intermittent porphyria,follicle stimulating hormone receptor
16983,alfuzosin,chancroid,tubulin gamma 1
16984,levomilnacipran,peripheral vascular disease,annexin a1
16985,hydromorphone,streptococcal pneumonia,mitogen-activated protein kinase kinase kinase 9
16986,somatrem,myxedema,kinase insert domain receptor
16987,zopiclone,intermittent vascular claudication,cholesteryl ester transfer protein
16988,desipramine,nocturnal enuresis,"dna polymerase delta 1, catalytic subunit"
16989,dexamethasone,premature ejaculation,dopamine beta-hydroxylase
16990,amitriptyline,thyroid crisis,thyroid hormone receptor beta
16991,clofazimine,thyroid gland papillary carcinoma,tek receptor tyrosine kinase
16992,teriflunomide,autoimmune hemolytic anemia,growth hormone receptor
16993,isopropamide,granuloma annulare,"plasminogen activator, tissue type"
16994,icosapent,urethritis,retinoid x receptor gamma
16995,betamethasone,marginal zone lymphoma,5-hydroxytryptamine receptor 3b
16996,dabigatran etexilate,common wart,potassium voltage-gated channel subfamily c member 3
16997,olodaterol,tinea pedis,"dna polymerase epsilon, catalytic subunit"
16998,pirbuterol,vitamin deficiency disorder,holocarboxylase synthetase
16999,methyl salicylate,thrombocytopenia,kinase insert domain receptor
17000,levomethadyl acetate,discoid lupus erythematosus,solute carrier family 5 member 4
17001,thalidomide,atrophic vulva,solute carrier family 22 member 5
17002,doxepin,schizophrenia,gamma-aminobutyric acid type a receptor subunit alpha4
17003,methyclothiazide,cryopyrin-associated periodic syndrome,retinoid x receptor alpha
17004,sirolimus,choroiditis,myeloperoxidase
17005,diazoxide,pulmonary cystic fibrosis,transient receptor potential cation channel subfamily v member 4
17006,oxytocin,hyperparathyroidism,calcium voltage-gated channel subunit alpha1 g
17007,finasteride,anaphylaxis,cytochrome p450 family 51 subfamily a member 1
17008,ropinirole,torsades de pointes,atp binding cassette subfamily g member 5
17009,pralatrexate,hyperlipoproteinemia type 3,histone deacetylase 5
17010,celecoxib,crohn disease,doublecortin like kinase 1
17011,tolmetin,urticaria,cysteinyl leukotriene receptor 2
17012,norethisterone,pulmonary cystic fibrosis,cytochrome p450 family 27 subfamily a member 1
17013,camphor,type 2 diabetes mellitus,bmp2 inducible kinase
17014,trazodone,disseminated intravascular coagulation,tank binding kinase 1
17015,ubidecarenone,gingivitis,phenylalanine hydroxylase
17016,ziprasidone,temporal arteritis,cholesteryl ester transfer protein
17017,phenacemide,urticaria,phosphodiesterase 3a
17018,triamterene,endemic goiter,cytochrome p450 family 17 subfamily a member 1
17019,calcipotriol,anxiety disorder,c-c motif chemokine receptor 1
17020,ruxolitinib,acute lymphoblastic leukemia,bradykinin receptor b2
17021,chlorhexidine,eosinophilic pneumonia,cytochrome p450 family 3 subfamily a member 5
17022,thiothixene,acute monocytic leukemia,3-hydroxy-3-methylglutaryl-coa reductase
17023,anisotropine methylbromide,tension-type headache,prune exopolyphosphatase 1
17024,flumethasone pivalate,prinzmetal angina,microtubule affinity regulating kinase 3
17025,flibanserin,aorta coarctation,bone gamma-carboxyglutamate protein
17026,solifenacin,uterine corpus leiomyoma,potassium voltage-gated channel modifier subfamily v member 2
17027,travoprost,schizophrenia,srsf protein kinase 3
17028,phenindamine,colonic neoplasm,holocarboxylase synthetase
17029,acamprosate,brain edema,nuclear receptor subfamily 5 group a member 1
17030,salbutamol,exanthem,fibroblast growth factor receptor 1
17031,fenoprofen,bruxism,histone deacetylase 7
17032,dimenhydrinate,hodgkins lymphoma,amylase alpha 1c
17033,tirofiban,kaposi's sarcoma,ornithine transcarbamylase
17034,triflupromazine,hyperaldosteronism,gamma-aminobutyric acid type a receptor subunit beta2
17035,prednisolone,seasonal affective disorder,adrenoceptor beta 2
17036,diclofenac,tyrosinemia,janus kinase 3
17037,nintedanib,familial mediterranean fever,calcium voltage-gated channel subunit alpha1 h
17038,dyphylline,plasmodium vivax malaria,g protein-coupled receptor kinase 2
17039,tamsulosin,malignant hyperthermia of anesthesia,phosphodiesterase 6g
17040,sertraline,cardiac arrest,proteasome 20s subunit alpha 1
17041,alfacalcidol,fibromyalgia,4-aminobutyrate aminotransferase
17042,pindolol,acute myeloid leukemia,solute carrier family 47 member 2
17043,imipramine,pityriasis versicolor,transient receptor potential cation channel subfamily a member 1
17044,trandolapril,acidosis disorder,cholinergic receptor nicotinic alpha 5 subunit
17045,fenfluramine,intermittent vascular claudication,tank binding kinase 1
17046,ubidecarenone,otitis externa,gap junction protein alpha 1
17047,hydrochlorothiazide,benign prostatic hyperplasia,transforming growth factor beta receptor 2
17048,enzalutamide,aplastic anemia,5-hydroxytryptamine receptor 5a
17049,homatropine methylbromide,pellagra,leukotriene c4 synthase
17050,glutethimide,bronchitis,doublecortin like kinase 3
17051,astemizole,peptic ulcer disease,5-hydroxytryptamine receptor 2c
17052,tranexamic acid,leprosy,high mobility group box 1
17053,tandospirone,bronchial disorder,atp binding cassette subfamily c member 8
17054,perazine,heart failure,transmembrane protein 97
17055,zolpidem,abdominal infection,eph receptor b6
17056,rofecoxib,tourette syndrome,melanocortin 1 receptor
17057,eletriptan,peyronie disease,atpase na+/k+ transporting subunit beta 1
17058,mosapramine,hypophosphatemia,tankyrase 2
17059,protriptyline,rhabdomyosarcoma,potassium inwardly rectifying channel subfamily j member 8
17060,felbinac,vasomotor rhinitis,solute carrier family 47 member 2
17061,probenecid,premenstrual dysphoric disorder,cubilin
17062,gliquidone,gastric cancer,opioid receptor delta 1
17063,dipivefrine,dementia,oxytocin receptor
17064,fingolimod,vitamin deficiency disorder,neurotensin receptor 2
17065,mercaptopurine,plasma cell myeloma,potassium two pore domain channel subfamily k member 9
17066,carbenoxolone,pyelonephritis,homeodomain interacting protein kinase 2
17067,raltegravir,thrombocytopenia,5-hydroxytryptamine receptor 3b
17068,cyclobenzaprine,primary ovarian failure,nischarin
17069,tirofiban,vitamin b12 deficiency,potassium voltage-gated channel subfamily a member 3
17070,bortezomib,thromboembolism,mitogen-activated protein kinase kinase kinase 20
17071,paclitaxel,sebaceous adenoma,potassium voltage-gated channel subfamily q member 5
17072,rabeprazole,bacterial pneumonia,potassium inwardly rectifying channel subfamily j member 1
17073,famotidine,opiate dependence,acid sensing ion channel subunit 1
17074,risperidone,premature ventricular contraction,phosphodiesterase 7b
17075,cetuximab,pulmonary eosinophilia,growth hormone releasing hormone receptor
17076,sonidegib,vomiting,aryl hydrocarbon receptor
17077,iloperidone,aggressive systemic mastocytosis,histone deacetylase 11
17078,pasireotide,homocystinuria,phospholipase a2 group ib
17079,bromfenac,breast ductal adenocarcinoma,5-hydroxytryptamine receptor 7
17080,bumetanide,nicotine dependence,leukotriene a4 hydrolase
17081,iloperidone,tension-type headache,tubulin beta 2b class iib
17082,methoxamine,essential thrombocythemia,parathyroid hormone 1 receptor
17083,floctafenine,lichen planus,5-hydroxytryptamine receptor 3b
17084,zafirlukast,urge incontinence,atm serine/threonine kinase
17085,sulindac,vulvovaginal candidiasis,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/imp cyclohydrolase
17086,felodipine,bacterial pneumonia,calcium voltage-gated channel subunit alpha1 i
17087,raloxifene,non-hodgkin lymphoma,microtubule affinity regulating kinase 3
17088,voclosporin,pyoderma gangrenosum,bromodomain containing 4
17089,ketanserin,keloid,metabolism of cobalamin associated c
17090,perospirone,decreased cardiac output,atp binding cassette subfamily g member 8
17091,ketoprofen,panic disorder,fibroblast growth factor receptor 2
17092,mirtazapine,benign prostatic hyperplasia,cholinergic receptor nicotinic beta 2 subunit
17093,bendroflumethiazide,ulcerative colitis,nuak family kinase 2
17094,calcifediol,bronchitis,eph receptor b2
17095,modafinil,pituitary dwarfism,ribosomal protein s6 kinase a2
17096,troglitazone,propionic acidemia,calcium voltage-gated channel subunit alpha1 h
17097,dexlansoprazole,dyspepsia,cholinergic receptor muscarinic 5
17098,butorphanol,sarcoma,"plasminogen activator, tissue type"
17099,icatibant,hypoalphalipoproteinemia,aldo-keto reductase family 1 member c1
17100,phentolamine,ocular hypertension,serine/threonine kinase 4
17101,dexlansoprazole,choroiditis,calcium voltage-gated channel subunit alpha1 a
17102,saquinavir,narcolepsy,ornithine transcarbamylase
17103,oxytocin,oral candidiasis,fer tyrosine kinase
17104,ketamine,aorta coarctation,traf2 and nck interacting kinase
17105,edoxaban,streptococcal pneumonia,lipoprotein lipase
17106,bromfenac,zollinger-ellison syndrome,3-hydroxy-3-methylglutaryl-coa reductase
17107,butorphanol,ocular hypertension,calcium sensing receptor
17108,lamotrigine,abdominal abscess,toll like receptor 7
17109,pge1,acute pain,phosphodiesterase 1b
17110,tripelennamine,arthritic joint disease,serpin family e member 1
17111,anisotropine methylbromide,peyronie disease,potassium voltage-gated channel subfamily a member 1
17112,clozapine,myeloproliferative neoplasm,retinoid x receptor gamma
17113,gefitinib,aspiration pneumonia,electron transfer flavoprotein dehydrogenase
17114,imrecoxib,glaucoma,checkpoint kinase 2
17115,selexipag,intermittent vascular claudication,calcium voltage-gated channel subunit alpha1 f
17116,travoprost,menorrhagia,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
17117,thioguanine,interstitial lung disease,s100 calcium binding protein p
17118,chlorcyclizine,hyperuricemia,casein kinase 1 delta
17119,phenmetrazine,humoral hypercalcemia of malignancy,"mer proto-oncogene, tyrosine kinase"
17120,baricitinib,postherpetic neuralgia,calcium voltage-gated channel subunit alpha1 f
17121,aspirin,toxic shock syndrome,homeodomain interacting protein kinase 4
17122,triamterene,oral mucosa leukoplakia,sonic hedgehog signaling molecule
17123,"1,25-dihydroxyvitamin d3",autoimmune hemolytic anemia,myosin light chain kinase 3
17124,anagliptin,neonatal diabetes mellitus,solute carrier organic anion transporter family member 1b3
17125,tulobuterol,atrial fibrillation,peptidylprolyl isomerase b
17126,bazedoxifene,wilms tumor,bone morphogenetic protein receptor type 1b
17127,fenoldopam,epilepsy with generalized tonic-clonic seizures,24-dehydrocholesterol reductase
17128,sonidegib,chronic hepatitis c virus infection,microtubule associated protein 2
17129,ziconotide,breast carcinoma,tachykinin receptor 1
17130,dyphylline,premature ejaculation,cholinergic receptor nicotinic beta 3 subunit
17131,avanafil,anxiety,sodium voltage-gated channel alpha subunit 5
17132,polmacoxib,hemophilia a,growth hormone releasing hormone receptor
17133,umeclidinium,pseudotumor cerebri,tank binding kinase 1
17134,amitriptyline,vomiting,testis specific serine kinase 1b
17135,buprenorphine,anxiety,cyclin dependent kinase 8
17136,alectinib,bacterial endocarditis,microtubule associated protein 1a
17137,ropinirole,malignant essential hypertension,leukocyte receptor tyrosine kinase
17138,oxyphencyclimine,acne,5-hydroxytryptamine receptor 3b
17139,venetoclax,hypersensitivity pneumonitis,myristoylated alanine rich protein kinase c substrate
17140,toloxatone,breast carcinoma,retinoic acid receptor beta
17141,ramatroban,vasomotor rhinitis,gamma-aminobutyric acid type a receptor subunit alpha1
17142,phenacemide,klinefelter syndrome,gamma-aminobutyric acid type b receptor subunit 2
17143,cortisol,dementia,sulfotransferase family 2a member 1
17144,insulin glulisine,urinary bladder neoplasm,interleukin 1 receptor type 1
17145,methapyrilene,polycystic ovary syndrome,cytochrome p450 family 19 subfamily a member 1
17146,escitalopram,hypertensive disorder,calcium voltage-gated channel auxiliary subunit gamma 1
17147,dicyclomine,chronic schizophrenia,mitogen-activated protein kinase kinase kinase 20
17148,gemtuzumab ozogamicin,breast fibrocystic disease,transient receptor potential cation channel subfamily m member 8
17149,vernakalant,tachycardia,potassium voltage-gated channel modifier subfamily g member 2
17150,triazolam,rickets,calcium/calmodulin dependent protein kinase ii alpha
17151,cladribine,malaria,steroid 5 alpha-reductase 2
17152,rosuvastatin,brain cancer,neutrophil cytosolic factor 1
17153,clomipramine,bacterial endocarditis,solute carrier family 46 member 1
17154,alfuzosin,miliary tuberculosis,dna topoisomerase i mitochondrial
17155,amantadine,neoplasm of esophagus,carbonic anhydrase 2
17156,pyridostigmine,pituitary dwarfism,peptidylprolyl isomerase a
17157,colchicine,escherichia coli infection,protein kinase cgmp-dependent 1
17158,aranidipine,laryngeal edema,mitogen-activated protein kinase kinase 5
17159,clomipramine,nocturnal enuresis,solute carrier family 9 member a1
17160,hydrochlorothiazide,tetanus,dna primase subunit 2
17161,progesterone,huntington disease,thymidylate synthetase
17162,eprosartan,diarrheal disease,uridine monophosphate synthetase
17163,glisoxepide,atrioventricular block,natriuretic peptide receptor 1
17164,fsh,idiopathic hypereosinophilic syndrome,tyrosinase
17165,zalcitabine,proctitis,nuclear receptor subfamily 3 group c member 1
17166,allopurinol,premature ventricular contraction,sodium voltage-gated channel alpha subunit 3
17167,ibrutinib,type 1 diabetes mellitus,complement c5
17168,clozapine,"hyperlipidemia, familial combined, lpl related",ryanodine receptor 1
17169,tiagabine,tourette syndrome,fkbp prolyl isomerase 1b
17170,lenvatinib,turner syndrome,cubilin
17171,dosulepin,malignant pleural mesothelioma,cholinergic receptor muscarinic 5
17172,riociguat,pain,cytochrome p450 family 3 subfamily a member 4
17173,treprostinil,lennox-gastaut syndrome,sphingosine-1-phosphate receptor 3
17174,fsh,torsades de pointes,calcium voltage-gated channel subunit alpha1 h
17175,amcinonide,multiple endocrine neoplasia,gc vitamin d binding protein
17176,amitriptyline,psychologic dyspareunia,mechanistic target of rapamycin kinase
17177,trifluoperazine,arthropathy,endothelin receptor type b
17178,fluphenazine,pulmonary artery stenosis,glycine receptor alpha 3
17179,nadolol,neoplasm of esophagus,glucose-6-phosphate dehydrogenase
17180,auranofin,pernicious anemia,guanylate cyclase 1 soluble subunit alpha 1
17181,carbenoxolone,visual epilepsy,cytidine/uridine monophosphate kinase 1
17182,chlorcyclizine,acute coronary syndrome,serine/threonine kinase 25
17183,midodrine,torsades de pointes,acyl-coa oxidase 1
17184,trimipramine,melanoma,glucagon like peptide 2 receptor
17185,betamethasone,sjogren syndrome,adrenoceptor alpha 1d
17186,nedocromil,lymphangioma,retinoic acid receptor alpha
17187,pimozide,cerebrovascular disorder,acetyl-coa acetyltransferase 1
17188,thiothixene,castleman disease,cytochrome p450 oxidoreductase
17189,valrubicin,castleman disease,atp binding cassette subfamily c member 2
17190,indapamide,strongyloidiasis,solute carrier family 6 member 1
17191,tropicamide,burkitt lymphoma,homeodomain interacting protein kinase 2
17192,mirodenafil,acute promyelocytic leukemia,protein kinase n2
17193,cabergoline,langerhans cell histiocytosis,gamma-glutamyl carboxylase
17194,pergolide,pediculus humanus capitis infestation,matrix metallopeptidase 9
17195,amlodipine,epilepsy,protein kinase n2
17196,carmustine,alcohol abuse,potassium voltage-gated channel subfamily a member 2
17197,fsh,opiate dependence,ryanodine receptor 1
17198,travoprost,malignant glioma,cytochrome p450 oxidoreductase
17199,salbutamol,brain edema,doublecortin like kinase 1
17200,paclitaxel,abdominal abscess,cholinergic receptor muscarinic 5
17201,chlorambucil,malignant essential hypertension,macrophage stimulating 1 receptor
17202,raltegravir,vitamin b12 deficiency,somatostatin receptor 5
17203,ethynodiol diacetate,atrial fibrillation,uridine monophosphate synthetase
17204,acalabrutinib,post-traumatic stress disorder,carbonic anhydrase 9
17205,primidone,arthropathy,superoxide dismutase 1
17206,atropine,"chronic myelogenous leukemia, bcr-abl1 positive",gamma-aminobutyric acid type a receptor subunit beta3
17207,eprosartan,escherichia coli infection,cytochrome p450 family 2 subfamily a member 6
17208,tolterodine,hypertrichosis of eyelid,glutamate ionotropic receptor nmda type subunit 1
17209,hydroflumethiazide,mycosis fungoides,potassium voltage-gated channel subfamily a member 10
17210,alclometasone dipropionate,intrinsic asthma,macrophage stimulating 1 receptor
17211,alprazolam,sitosterolemia,transforming growth factor beta receptor 2
17212,benzocaine,psoriatic arthritis,solute carrier family 22 member 6
17213,pergolide,corneal ulcer,coagulation factor x
17214,indomethacin,tyrosinemia,phospholipase a2 group iie
17215,aminobenzoic acid,obsessive-compulsive disorder,glutamic-oxaloacetic transaminase 1
17216,nitisinone,hepatocellular carcinoma,acetyl-coa acetyltransferase 1
17217,orlistat,autoimmune hemolytic anemia,solute carrier family 12 member 1
17218,amiloride,peptic ulcer disease,5-hydroxytryptamine receptor 1e
17219,diltiazem,gout,proteasome 20s subunit beta 1
17220,vismodegib,acute intermittent porphyria,fms related receptor tyrosine kinase 4
17221,clemastine,classic hodgkin lymphoma,protein tyrosine kinase 2
17222,bromfenac,goiter,activin a receptor type 1
17223,guanadrel,stroke disorder,adrenoceptor alpha 2c
17224,montelukast,iridocyclitis,ret proto-oncogene
17225,antazoline,toxic shock syndrome,apolipoprotein b
17226,donepezil,bulimia nervosa,potassium voltage-gated channel modifier subfamily g member 4
17227,vemurafenib,musculoskeletal system disorder,cytochrome p450 family 2 subfamily e member 1
17228,teriparatide,eosinophilic esophagitis,potassium inwardly rectifying channel subfamily j member 11
17229,vernakalant,nicotine dependence,nuclear receptor subfamily 3 group c member 1
17230,esomeprazole,hyperaldosteronism,solute carrier family 22 member 12
17231,topiroxostat,vitamin d deficiency,histamine receptor h3
17232,ergometrine,aorta coarctation,cannabinoid receptor 2
17233,everolimus,bacterial endocarditis,homeodomain interacting protein kinase 2
17234,alendronate,plasmodium ovale malaria,amnion associated transmembrane protein
17235,tropicamide,acute interstitial pneumonia,phosphodiesterase 3a
17236,nitisinone,persistent fetal circulation syndrome,5-hydroxytryptamine receptor 4
17237,metformin,turner syndrome,"lck proto-oncogene, src family tyrosine kinase"
17238,anagliptin,trigeminal neuralgia,arachidonate 5-lipoxygenase
17239,flunisolide,pruritus,ryanodine receptor 1
17240,isosorbide mononitrate,anxiety disorder,dopamine receptor d1
17241,quinapril,huntington disease,receptor interacting serine/threonine kinase 2
17242,pemetrexed,congenital hypothyroidism,proteasome 20s subunit beta 5
17243,pheniramine,familial dermatographia,cytochrome p450 family 2 subfamily c member 8
17244,metaraminol,juvenile idiopathic arthritis,tubulin beta 2a class iia
17245,doxorubicin,ornithine carbamoyltransferase deficiency,phosphodiesterase 4b
17246,tafamidis,adrenocortical insufficiency,cytochrome p450 family 24 subfamily a member 1
17247,imiquimod,disseminated intravascular coagulation,histone deacetylase 11
17248,epinastine,actinic keratosis,gamma-aminobutyric acid type b receptor subunit 2
17249,clotrimazole,nausea,casein kinase 1 delta
17250,selumetinib,bacterial pneumonia,5-hydroxytryptamine receptor 2a
17251,labetalol,otitis externa,cytochrome p450 family 17 subfamily a member 1
17252,duloxetine,cough,"dna polymerase epsilon, catalytic subunit"
17253,tocilizumab,esophageal cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
17254,dihydroergotamine,pyelonephritis,axl receptor tyrosine kinase
17255,lornoxicam,esophageal cancer,"dna polymerase delta 1, catalytic subunit"
17256,methylphenobarbital,essential thrombocythemia,amylase alpha 1b
17257,omacetaxine mepesuccinate,diabetic kidney disease,phosphodiesterase 11a
17258,clozapine,head and neck cancer,somatostatin receptor 1
17259,doxylamine,burkitt lymphoma,gc vitamin d binding protein
17260,aripiprazole,altitude sickness,5-hydroxytryptamine receptor 3b
17261,methamphetamine,postmenopausal osteoporosis,adenosine deaminase
17262,sivelestat,aplastic anemia,proteasome 20s subunit beta 1
17263,ethotoin,acquired polycythemia vera,dipeptidase 1
17264,nicotinic acid,torsades de pointes,solute carrier family 22 member 5
17265,medrysone,supraventricular tachycardia,interleukin 1 receptor type 1
17266,canagliflozin,breast fibrocystic disease,bradykinin receptor b2
17267,fludroxycortide,psychologic dyspareunia,hydroxycarboxylic acid receptor 3
17268,cobicistat,cycloplegia,sonic hedgehog signaling molecule
17269,n-methyl scopolamine,intracranial embolism,5-hydroxytryptamine receptor 1a
17270,tipiracil,multiple endocrine neoplasia,proteasome 20s subunit beta 10
17271,venlafaxine,multiple endocrine neoplasia,metabolism of cobalamin associated c
17272,prednicarbate,ventricular fibrillation,xanthine dehydrogenase
17273,medrysone,trichinellosis,somatostatin receptor 1
17274,icosapent,vitamin b12 deficiency,gamma-aminobutyric acid type a receptor subunit gamma2
17275,tadalafil,breast ductal adenocarcinoma,cholinergic receptor nicotinic beta 3 subunit
17276,cefalotin,postpartum depression,phosphodiesterase 8b
17277,droxidopa,periodontitis,cdc like kinase 4
17278,ambenonium,humoral hypercalcemia of malignancy,cytochrome p450 family 3 subfamily a member 7
17279,gliquidone,erdheim-chester disease,prostaglandin e synthase 3
17280,riluzole,dementia,5-hydroxytryptamine receptor 1d
17281,lifitegrast,bipolar disorder,cholinergic receptor nicotinic beta 4 subunit
17282,desloratadine,renal cell carcinoma,microtubule associated protein 1a
17283,thyrotropin alfa,congestive heart failure,7-dehydrocholesterol reductase
17284,bazedoxifene,myotonic syndrome,"src proto-oncogene, non-receptor tyrosine kinase"
17285,somatrem,hemangioma,caspase 1
17286,phendimetrazine,tyrosinemia,solute carrier family 12 member 1
17287,"1,25-dihydroxyvitamin d3",exanthem,cholinergic receptor nicotinic alpha 4 subunit
17288,halcinonide,endometrial carcinoma,retinoic acid receptor beta
17289,benzbromarone,endometrium neoplasm,potassium voltage-gated channel subfamily d member 2
17290,apremilast,tetany,glutamate ionotropic receptor nmda type subunit 3b
17291,ramatroban,tension-type headache,c-x-c motif chemokine receptor 4
17292,pantoprazole,vitamin b12 deficiency,guanylate cyclase 1 soluble subunit beta 1
17293,belotecan,chronic beryllium disease,"lipase f, gastric type"
17294,prucalopride,stevens-johnson syndrome,"blk proto-oncogene, src family tyrosine kinase"
17295,hydralazine,thyroid tumor,cytochrome p450 family 11 subfamily b member 2
17296,fenoldopam,tyrosinemia,glucagon like peptide 1 receptor
17297,maprotiline,malignant colon neoplasm,atp binding cassette subfamily b member 11
17298,mesuximide,renal cell carcinoma,sodium voltage-gated channel alpha subunit 8
17299,parathyroid hormone,endemic goiter,mitogen-activated protein kinase kinase kinase 19
17300,perazine,bulimia nervosa,protein tyrosine kinase 2 beta
17301,alteplase,arthropathy,ribonucleotide reductase catalytic subunit m1
17302,pranlukast,mycosis fungoides,solute carrier family 47 member 2
17303,tranilast,scalp dermatosis,death associated protein kinase 1
17304,lorazepam,gout,solute carrier family 22 member 6
17305,apraclonidine,orthostatic hypotension,nuclear receptor subfamily 5 group a member 1
17306,modafinil,subarachnoid hemorrhage,carbonic anhydrase 3
17307,topiramate,schizoaffective disorder,phosphodiesterase 4c
17308,tocilizumab,superficial multifocal basal cell carcinoma,cholesteryl ester transfer protein
17309,diclofenac,malaria,geranylgeranyl diphosphate synthase 1
17310,tamsulosin,bursitis,aldo-keto reductase family 1 member c1
17311,levomethadyl acetate,endometrial carcinoma,calcium voltage-gated channel subunit alpha1 h
17312,phenylbutazone,sarcoma,solute carrier family 18 member a1
17313,carbimazole,aspiration pneumonitis,24-dehydrocholesterol reductase
17314,cephalotaxine,glossopharyngeal neuralgia,opioid related nociceptin receptor 1
17315,moxonidine,thyroiditis,"fes proto-oncogene, tyrosine kinase"
17316,bromocriptine,hemorrhoid,potassium voltage-gated channel modifier subfamily g member 3
17317,bupivacaine,disruptive behavior disorder,pre-mrna splicing tri-snrnp complex factor prpf4
17318,anagliptin,breast fibrocystic disease,"dna polymerase alpha 1, catalytic subunit"
17319,dicumarol,secondary hyperparathyroidism,eph receptor a3
17320,zonisamide,glaucoma,eph receptor a3
17321,pimozide,tetany,calcium voltage-gated channel auxiliary subunit gamma 1
17322,pralatrexate,autoimmune hemolytic anemia,bcl2 like 2
17323,glucagon,zollinger-ellison syndrome,glycine receptor alpha 3
17324,mirtazapine,female infertility,ribosomal protein l3
17325,pentostatin,congestive heart failure,5-hydroxytryptamine receptor 1f
17326,pirenzepine,acute interstitial pneumonia,potassium voltage-gated channel modifier subfamily s member 1
17327,bromocriptine,gaucher disease,adenosine a1 receptor
17328,trimipramine,diabetes mellitus,ribosomal protein s6 kinase a6
17329,buclizine,pruritus,ryanodine receptor 1
17330,landiolol,constipation disorder,glutathione-disulfide reductase
17331,pemirolast,cervical cancer,vitamin k epoxide reductase complex subunit 1
17332,dantrolene,familial dermatographia,histamine receptor h2
17333,alogliptin,cough,solute carrier family 5 member 4
17334,lenvatinib,post-traumatic stress disorder,atpase h+ transporting v1 subunit a
17335,epirubicin,plasmodium malariae malaria,adrenoceptor beta 2
17336,delavirdine,female stress incontinence,hyperpolarization activated cyclic nucleotide gated potassium channel 1
17337,escitalopram,hepatocellular carcinoma,rio kinase 1
17338,trimethadione,pruritus ani,toll like receptor 2
17339,imatinib,neurodermatitis,methylenetetrahydrofolate reductase
17340,fluticasone,bursitis,phosphodiesterase 6a
17341,mometasone,headache disorder,neurotrophic receptor tyrosine kinase 3
17342,bumetanide,bacterial endocarditis,solute carrier family 25 member 6
17343,pamidronic acid,dysmenorrhea,5-methyltetrahydrofolate-homocysteine methyltransferase
17344,milnacipran,post-operative pain,atp binding cassette subfamily g member 5
17345,paliperidone,basal ganglia disorder,synaptic vesicle glycoprotein 2a
17346,insulin lispro,osteoporosis,fkbp prolyl isomerase 1a
17347,tadalafil,thrombotic disease,carnitine palmitoyltransferase 1a
17348,clotrimazole,allergic rhinitis,bub1 mitotic checkpoint serine/threonine kinase
17349,dexbrompheniramine,tourette syndrome,dipeptidyl peptidase 9
17350,salmeterol,autosomal dominant polycystic kidney disease,endothelin receptor type a
17351,nadolol,peptic esophagitis,homeodomain interacting protein kinase 1
17352,carbimazole,vitamin deficiency disorder,carbonic anhydrase 12
17353,axitinib,gastric cancer,"src proto-oncogene, non-receptor tyrosine kinase"
17354,triprolidine,postherpetic neuralgia,bruton tyrosine kinase
17355,ketanserin,stargardt disease,5-hydroxytryptamine receptor 3a
17356,amoxapine,plasmodium falciparum malaria,guanylate cyclase 2c
17357,mefenamic acid,post-traumatic stress disorder,"hck proto-oncogene, src family tyrosine kinase"
17358,solifenacin,pyoderma gangrenosum,hydroxycarboxylic acid receptor 3
17359,vardenafil,ankylosing spondylitis,solute carrier family 12 member 3
17360,fludrocortisone,perennial allergic rhinitis,cytochrome p450 oxidoreductase
17361,trihexyphenidyl,brain glioblastoma,carbonic anhydrase 14
17362,everolimus,atrioventricular block,growth hormone receptor
17363,dosulepin,irritable bowel syndrome,phosphodiesterase 4c
17364,quinestrol,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,solute carrier family 22 member 4
17365,donepezil,anaphylaxis,potassium voltage-gated channel subfamily h member 8
17366,hydromorphone,pemphigus,leukotriene a4 hydrolase
17367,zaleplon,lung disorder,cyclin dependent kinase 16
17368,phenmetrazine,vitamin deficiency disorder,cytochrome p450 family 24 subfamily a member 1
17369,glibenclamide,actinic keratosis,glutamate ionotropic receptor kainate type subunit 3
17370,dorzolamide,osteoarthritis,potassium voltage-gated channel subfamily d member 2
17371,carmofur,exfoliative dermatitis,"met proto-oncogene, receptor tyrosine kinase"
17372,brompheniramine,endometrial carcinoma,tubulin alpha 4a
17373,flufenamic acid,prinzmetal angina,calcium voltage-gated channel subunit alpha1 c
17374,tetrabenazine,"cicatrix, hypertrophic",transforming growth factor beta receptor 2
17375,baclofen,dermatomyositis,fibroblast growth factor receptor 1
17376,desloratadine,poems syndrome,cytochrome p450 family 2 subfamily c member 18
17377,orciprenaline,myocardial infarction,calcium voltage-gated channel subunit alpha1 g
17378,tropicamide,urinary bladder neoplasm,potassium voltage-gated channel subfamily h member 7
17379,pemirolast,hypoglycemia,gamma-aminobutyric acid type a receptor subunit delta
17380,oxcarbazepine,central nervous system origin vertigo,carbonic anhydrase 12
17381,nicotine,thyroid gland follicular carcinoma,adenosine deaminase
17382,piroxicam,plasmodium ovale malaria,potassium voltage-gated channel modifier subfamily f member 1
17383,calcium acetate,human african trypanosomiasis,potassium voltage-gated channel subfamily a member 7
17384,phenytoin,brain glioblastoma,galactosidase alpha
17385,paliperidone,hypoactive sexual desire disorder,histone deacetylase 4
17386,cobicistat,vascular disorder,cyclin g associated kinase
17387,eptifibatide,human african trypanosomiasis,steroid 5 alpha-reductase 2
17388,thioguanine,intracranial embolism,calcium voltage-gated channel subunit alpha1 c
17389,umeclidinium,essential thrombocythemia,methylmalonyl-coa mutase
17390,thiothixene,atopic conjunctivitis,guanylate cyclase 1 soluble subunit beta 1
17391,fampridine,holocarboxylase synthetase deficiency,ndufa4 mitochondrial complex associated like 2
17392,conivaptan,hypertriglyceridemia,dipeptidyl peptidase 4
17393,valproic acid,amyloidosis,cysteinyl leukotriene receptor 1
17394,romidepsin,humoral hypercalcemia of malignancy,protein tyrosine kinase 2
17395,atorvastatin,obsessive-compulsive disorder,atm serine/threonine kinase
17396,spiperone,thromboembolism,prostaglandin e receptor 1
17397,lasofoxifene,allergic contact dermatitis,insulin receptor
17398,fentanyl,hyponatremia,ryanodine receptor 3
17399,fenfluramine,respiratory syncytial virus infectious disease,tyrosine kinase 2
17400,quinestrol,pellagra,serine/threonine kinase 17a
17401,tranexamic acid,vernal conjunctivitis,protein tyrosine kinase 2
17402,oxybutynin,social phobia,doublecortin like kinase 3
17403,entacapone,pulmonary eosinophilia,sphingosine-1-phosphate receptor 1
17404,fondaparinux,hypoparathyroidism,phosphodiesterase 6c
17405,phenylbutazone,multiple sclerosis,solute carrier family 47 member 1
17406,umeclidinium,non-hodgkin lymphoma,cyclin dependent kinase 8
17407,vindesine,prostate cancer,delta like non-canonical notch ligand 1
17408,fenofibrate,rhinitis,peroxisome proliferator activated receptor alpha
17409,sumatriptan,peptic ulcer disease,dual specificity tyrosine phosphorylation regulated kinase 2
17410,flumethasone pivalate,status epilepticus,serine/threonine kinase 17a
17411,fludarabine,autism spectrum disorder,structural maintenance of chromosomes 2
17412,halcinonide,interstitial lung disease 2,cytochrome p450 family 1 subfamily a member 2
17413,bromfenac,epilepsy,atm serine/threonine kinase
17414,erlotinib,open-angle glaucoma,estrogen receptor 1
17415,aclidinium,actinic keratosis,neurotrophic receptor tyrosine kinase 1
17416,methapyrilene,lung disorder,glucagon like peptide 1 receptor
17417,levetiracetam,myeloid neoplasm associated with pdgfra rearrangement,atp binding cassette subfamily c member 9
17418,chlorhexidine,peyronie disease,solute carrier family 22 member 12
17419,migalastat,mature t-cell and nk-cell non-hodgkin lymphoma,calmodulin 1
17420,ramipril,x-linked dominant hypophosphatemic rickets,histamine receptor h1
17421,floxuridine,lichen planus,hyperpolarization activated cyclic nucleotide gated potassium channel 3
17422,sonidegib,erythropoietic protoporphyria,melanocortin 1 receptor
17423,bimatoprost,human african trypanosomiasis,tubulin beta 6 class v
17424,acebutolol,inflammatory bowel disease,"met proto-oncogene, receptor tyrosine kinase"
17425,buprenorphine,oligospermia,delta like non-canonical notch ligand 1
17426,quetiapine,classic hodgkin lymphoma,ryanodine receptor 1
17427,dexlansoprazole,panic disorder,cholinergic receptor nicotinic alpha 4 subunit
17428,brexpiprazole,iritis,synuclein alpha
17429,amiodarone,hypocalcemia,prostaglandin d2 receptor 2
17430,norgestimate,female infertility,nuclear receptor subfamily 1 group i member 2
17431,darifenacin,drooling,somatostatin receptor 4
17432,tropicamide,chronic urticaria,interleukin 2
17433,dopamine,"malignant hyperthermia, susceptibility to, 1",solute carrier family 5 member 4
17434,theophylline,glossopharyngeal neuralgia,g protein-coupled receptor kinase 2
17435,phenobarbital,asthma-chronic obstructive pulmonary disease overlap syndrome,sulfotransferase family 1a member 1
17436,idelalisib,polycystic ovary syndrome,phenylalanine hydroxylase
17437,cobicistat,pulmonary valve atresia,potassium voltage-gated channel subfamily q member 2
17438,conjugated estrogens,acute pain,aurora kinase b
17439,alcaftadine,colonic neoplasm,neuropeptide y receptor y1
17440,lamivudine,neurodermatitis,ndufa4 mitochondrial complex associated
17441,travoprost,depressive disorder,cdc like kinase 4
17442,trilostane,blepharoconjunctivitis,butyrylcholinesterase
17443,felodipine,type 2 diabetes mellitus,serine/threonine kinase 33
17444,ibandronic acid,urticaria,atpase copper transporting beta
17445,diethylpropion,disseminated intravascular coagulation,gamma-aminobutyric acid type a receptor subunit beta1
17446,clofarabine,interstitial lung disease,growth hormone releasing hormone receptor
17447,piribedil,primary ovarian failure,cholinergic receptor muscarinic 4
17448,desoximetasone,sneeze,dopamine receptor d5
17449,amiloride,small intestine cancer,bmp2 inducible kinase
17450,cilastatin,dyspnea,potassium voltage-gated channel subfamily c member 2
17451,tazarotene,alcohol dependence,potassium voltage-gated channel subfamily d member 3
17452,paroxetine,poems syndrome,natriuretic peptide b
17453,rilmenidine,dermatophytosis of groin and perianal area,glutamate ionotropic receptor ampa type subunit 4
17454,colchicine,relapsing-remitting multiple sclerosis,matrix metallopeptidase 9
17455,idelalisib,zollinger-ellison syndrome,calcium voltage-gated channel subunit alpha1 a
17456,guanfacine,medullary thyroid gland carcinoma,hypoxia inducible factor 1 subunit alpha
17457,furosemide,familial mediterranean fever,chymotrypsinogen b1
17458,insulin glulisine,chronic myelomonocytic leukemia,4-aminobutyrate aminotransferase
17459,dicyclomine,aplastic anemia,amylase alpha 1c
17460,triazolam,neurofibromatosis 1,solute carrier family 22 member 4
17461,rupatadine,pruritus,carbonic anhydrase 14
17462,trilostane,attrv122i amyloidosis,neurotrophic receptor tyrosine kinase 2
17463,adapalene,meniere disease,h1.0 linker histone
17464,alimemazine,diarrheal disease,7-dehydrocholesterol reductase
17465,ixabepilone,epilepsy with generalized tonic-clonic seizures,tubulin delta 1
17466,pimavanserin,autoimmune hemolytic anemia,calcium voltage-gated channel auxiliary subunit alpha2delta 2
17467,dromostanolone propionate,mantle cell lymphoma,cholinergic receptor nicotinic beta 3 subunit
17468,indomethacin,familial mediterranean fever,pre-mrna splicing tri-snrnp complex factor prpf4
17469,bosentan,allergic bronchopulmonary aspergillosis,kinase insert domain receptor
17470,mitiglinide,hemophilia a,fkbp prolyl isomerase 5
17471,vindesine,common wart,phosphodiesterase 1a
17472,propantheline,persistent fetal circulation syndrome,cytochrome p450 family 2 subfamily c member 19
17473,lixisenatide,breast carcinoma,structural maintenance of chromosomes 1a
17474,lafutidine,amyloidosis,cd33 molecule
17475,ciprofloxacin,fever,c-c motif chemokine receptor 1
17476,flecainide,narcolepsy,potassium voltage-gated channel modifier subfamily f member 1
17477,eszopiclone,diffuse large b-cell lymphoma,ribonucleotide reductase regulatory subunit m2
17478,levosalbutamol,pemphigus,solute carrier family 5 member 2
17479,celiprolol,allergic bronchopulmonary aspergillosis,s100 calcium binding protein p
17480,mirodenafil,essential hypertension,potassium voltage-gated channel subfamily c member 4
17481,methixene,sebaceous adenoma,serine/threonine kinase 11
17482,raloxifene,myotonic syndrome,dipeptidyl peptidase 8
17483,bromocriptine,oral mucosa leukoplakia,ryanodine receptor 3
17484,vincristine,neoplasm of esophagus,potassium inwardly rectifying channel subfamily j member 11
17485,selexipag,glossopharyngeal neuralgia,tumor protein p53
17486,topiroxostat,dermatophytosis of groin and perianal area,dead-box helicase 1
17487,carteolol,psoriatic arthritis,carbonic anhydrase 12
17488,cortisol,exfoliative dermatitis,retinoic acid receptor alpha
17489,rabeprazole,heart failure,glutamic-oxaloacetic transaminase 1
17490,brompheniramine,postpartum depression,cytochrome p450 family 27 subfamily b member 1
17491,guanabenz,strongyloidiasis,atp binding cassette subfamily c member 9
17492,estrone sulphate,rhabdomyosarcoma,acyl-coa synthetase long chain family member 5
17493,flutamide,arthritic joint disease,atpase copper transporting alpha
17494,masoprocol,aorta coarctation,methylenetetrahydrofolate reductase
17495,levodopa,pediculus humanus capitis infestation,cholinergic receptor nicotinic beta 4 subunit
17496,sermorelin,focal epilepsy,tubulin beta 8 class viii
17497,floxuridine,cardiogenic shock,adenosine a3 receptor
17498,captodiame,castleman disease,hyperpolarization activated cyclic nucleotide gated potassium channel 1
17499,ethinylestradiol,urge incontinence,potassium voltage-gated channel subfamily c member 4
17500,colchicine,vascular disorder,paraoxonase 1
17501,neostigmine,breast neoplasm,cholinergic receptor nicotinic alpha 6 subunit
17502,vildagliptin,sitosterolemia,tumor necrosis factor
17503,orlistat,proctitis,somatostatin receptor 5
17504,triamcinolone,hyperuricemia,riboflavin kinase
17505,loratadine,hyperthyroidism,tumor protein p53
17506,quinine,scabies,inosine monophosphate dehydrogenase 1
17507,cisplatin,psoriatic arthritis,gamma-aminobutyric acid type a receptor subunit gamma3
17508,calcifediol,gout,cytochrome p450 family 1 subfamily b member 1
17509,zidovudine,diffuse alopecia areata,protein tyrosine kinase 2 beta
17510,cabergoline,subarachnoid hemorrhage,caspase 1
17511,acetophenazine,chronic beryllium disease,potassium voltage-gated channel subfamily a member 2
17512,delavirdine,narcolepsy,carbonic anhydrase 2
17513,meloxicam,vitamin b12 deficiency,prostaglandin e receptor 4
17514,capecitabine,esophageal cancer,ryanodine receptor 1
17515,ceritinib,neuralgia,serpin family e member 1
17516,frovatriptan,osteomalacia,amine oxidase copper containing 1
17517,chlorcyclizine,myalgia,testis specific serine kinase 1b
17518,clofibrate,arthritic joint disease,histamine receptor h1
17519,tofacitinib,"hydatidiform mole, recurrent, 1",homeodomain interacting protein kinase 4
17520,sibutramine,scalp dermatosis,potassium voltage-gated channel subfamily a member 3
17521,tamibarotene,hyperbilirubinemia,sphingosine-1-phosphate receptor 4
17522,apraclonidine,chronic primary adrenal insufficiency,tubulin beta class i
17523,loperamide,idiopathic acute eosinophilic pneumonia,alk receptor tyrosine kinase
17524,flutamide,sickle cell anemia,protein kinase c theta
17525,diclofenac,holocarboxylase synthetase deficiency,aurora kinase c
17526,"1,25-dihydroxyvitamin d3",malignant glioma,n-acylsphingosine amidohydrolase 1
17527,crisaborole,uveitis,tubulin epsilon 1
17528,valproic acid,colonic neoplasm,follicle stimulating hormone receptor
17529,obinutuzumab,medullary thyroid gland carcinoma,peptidylprolyl isomerase b
17530,calcium citrate,bacterial meningitis,5-hydroxytryptamine receptor 2c
17531,cobicistat,panic disorder,solute carrier family 5 member 11
17532,ceftriaxone,atopic conjunctivitis,il2 inducible t cell kinase
17533,levetiracetam,irritable bowel syndrome,solute carrier organic anion transporter family member 1a2
17534,opipramol,hemorrhoid,hypoxanthine phosphoribosyltransferase 1
17535,metformin,rhinoscleroma,toll like receptor 2
17536,olanzapine,parkinson disease,guanylate cyclase 1 soluble subunit beta 1
17537,anisotropine methylbromide,influenza,gamma-aminobutyric acid type a receptor subunit alpha3
17538,regorafenib,aorta coarctation,monoamine oxidase a
17539,everolimus,"hyperlipidemia, familial combined, lpl related",gamma-aminobutyric acid type a receptor subunit beta2
17540,trimipramine,autosomal dominant polycystic kidney disease,potassium voltage-gated channel modifier subfamily g member 4
17541,felodipine,premature obstetric labor,atp binding cassette subfamily c member 8
17542,warfarin,hypoparathyroidism,s100 calcium binding protein b
17543,asenapine,vitamin b12 deficiency,aryl hydrocarbon receptor
17544,promazine,myeloproliferative neoplasm,prostaglandin i2 receptor
17545,enalaprilat,idiopathic acute eosinophilic pneumonia,"lck proto-oncogene, src family tyrosine kinase"
17546,methotrexate,orthostatic hypotension,s100 calcium binding protein p
17547,miconazole,marginal zone lymphoma,cytochrome p450 family 11 subfamily b member 2
17548,icosapent,small cell lung carcinoma,nuclear receptor subfamily 5 group a member 1
17549,etidronic acid,esotropia,steroid 5 alpha-reductase 2
17550,anagrelide,abdominal abscess,monoamine oxidase b
17551,rosuvastatin,acute pain,calcium voltage-gated channel subunit alpha1 g
17552,delavirdine,proctitis,cdgsh iron sulfur domain 1
17553,vortioxetine,acute lymphoblastic leukemia,carnitine palmitoyltransferase 1a
17554,armodafinil,small cell lung carcinoma,potassium voltage-gated channel modifier subfamily f member 1
17555,bendroflumethiazide,breast neoplasm,calcium voltage-gated channel subunit alpha1 f
17556,calcium gluconate,basal ganglia disorder,"fyn proto-oncogene, src family tyrosine kinase"
17557,tropicamide,vulvovaginal candidiasis,cyp3a7-cyp3a51p readthrough
17558,dantrolene,premenstrual dysphoric disorder,solute carrier family 12 member 1
17559,toloxatone,pityriasis versicolor,potassium two pore domain channel subfamily k member 3
17560,indapamide,vitamin d deficiency,ndufa4 mitochondrial complex associated like 2
17561,nitroglycerin,plasmodium falciparum malaria,"met proto-oncogene, receptor tyrosine kinase"
17562,alimemazine,testicular cancer,peroxisome proliferator activated receptor gamma
17563,isoprenaline,basal ganglia disorder,cytochrome p450 family 2 subfamily b member 6
17564,carboplatin,short bowel syndrome,"kit proto-oncogene, receptor tyrosine kinase"
17565,ticagrelor,hepatocellular carcinoma,myristoylated alanine rich protein kinase c substrate
17566,auranofin,esotropia,sphingosine-1-phosphate receptor 4
17567,bumetanide,pediculus humanus capitis infestation,macrophage stimulating 1 receptor
17568,oxybutynin,allergic contact dermatitis,solute carrier family 22 member 5
17569,incadronic acid,xerophthalmia,glutamate ionotropic receptor ampa type subunit 2
17570,vildagliptin,thyroid gland papillary carcinoma,ndufa4 mitochondrial complex associated
17571,naftopidil,trichuriasis,mitogen-activated protein kinase kinase kinase kinase 1
17572,glisoxepide,homocystinuria,glutamate ionotropic receptor nmda type subunit 3a
17573,sofalcone,gaucher disease,potassium voltage-gated channel subfamily a member 5
17574,tropicamide,vulvovaginal candidiasis,potassium voltage-gated channel modifier subfamily v member 2
17575,tofacitinib,lymphangioma,ret proto-oncogene
17576,cladribine,bronchiectasis,bone morphogenetic protein receptor type 1b
17577,enalapril,eunuchism,g protein-coupled receptor kinase 2
17578,chlorambucil,congenital adrenal hyperplasia,cytochrome p450 family 51 subfamily a member 1
17579,calcifediol,dry eye syndrome,adrenoceptor alpha 2c
17580,bosutinib,back pain,phosphodiesterase 6c
17581,etelcalcetide,alcohol abuse,"troponin c1, slow skeletal and cardiac type"
17582,pyridostigmine,seborrheic dermatitis,glutamate ionotropic receptor nmda type subunit 2b
17583,rizatriptan,idiopathic acute eosinophilic pneumonia,histone deacetylase 2
17584,diflorasone diacetate,pulmonary tuberculosis,peptidylprolyl isomerase d
17585,rimonabant,schizoaffective disorder,epoxide hydrolase 2
17586,5-fluorouracil,arthropathy,ribosomal protein s6 kinase a1
17587,vinorelbine,renal osteodystrophy,peptidylprolyl isomerase a
17588,fluspirilene,lymphangioma,fxyd domain containing ion transport regulator 2
17589,lurasidone,proctitis,propionyl-coa carboxylase subunit beta
17590,lamotrigine,leiomyosarcoma,il2 inducible t cell kinase
17591,methapyrilene,pulmonary cystic fibrosis,melanocortin 2 receptor
17592,triamcinolone,breast neoplasm,g protein-coupled receptor kinase 2
17593,gliquidone,frozen shoulder,tachykinin receptor 1
17594,flufenamic acid,precocious puberty,glutamate ionotropic receptor nmda type subunit 1
17595,pargyline,hypertensive disorder,acyl-coa oxidase 1
17596,sunitinib,alzheimer disease,gc vitamin d binding protein
17597,acrivastine,hyperbilirubinemia,insulin receptor related receptor
17598,ethacrynic acid,hairy cell leukemia,gamma-aminobutyric acid type a receptor subunit alpha4
17599,ipragliflozin,angina pectoris,cyclin dependent kinase 6
17600,metoprolol,parkinson disease,sodium channel epithelial 1 subunit alpha
17601,vorinostat,visual epilepsy,ebp cholestenol delta-isomerase
17602,goserelin,essential hypertension,potassium inwardly rectifying channel subfamily j member 12
17603,vilazodone,pseudotumor cerebri,misshapen like kinase 1
17604,atropine,vitamin b12 deficiency,bcl2 like 2
17605,norfloxacin,dacryocystitis,glutathione s-transferase theta 1
17606,mesuximide,ovarian cancer,receptor interacting serine/threonine kinase 2
17607,colecalciferol,gastroesophageal reflux disease,gamma-aminobutyric acid type a receptor subunit delta
17608,aminobenzoic acid,opiate dependence,"ran, member ras oncogene family"
17609,midazolam,actinic keratosis,mitogen-activated protein kinase kinase 1
17610,cetirizine,neonatal abstinence syndrome,h1.0 linker histone
17611,bexarotene,thromboembolism,caspase 1
17612,carbetocin,polymyalgia rheumatica,microtubule associated protein 1a
17613,oxprenolol,precocious puberty,cytochrome c1
17614,dofetilide,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",dead-box helicase 1
17615,montelukast,necrobiosis lipoidica,hydroxycarboxylic acid receptor 3
17616,tretinoin,polymyalgia rheumatica,eph receptor b6
17617,olaparib,hypereosinophilic syndrome,lipoprotein lipase
17618,docetaxel,hyperuricemia,gc vitamin d binding protein
17619,tenoxicam,head and neck cancer,fatty acid binding protein 2
17620,doxorubicin,hypertensive disorder,ribonucleotide reductase regulatory subunit m2
17621,montelukast,peripheral vascular disease,c-c motif chemokine receptor 1
17622,metaraminol,hyperbilirubinemia,"plasminogen activator, tissue type"
17623,sibutramine,hyperthyroidism,rho associated coiled-coil containing protein kinase 1
17624,diclofenac,pulmonary edema,phosphodiesterase 3b
17625,digoxin,wilms tumor,cytochrome p450 family 27 subfamily a member 1
17626,testosterone propionate,pneumonia,dual specificity tyrosine phosphorylation regulated kinase 1b
17627,dexfenfluramine,tetralogy of fallot,5-hydroxytryptamine receptor 3d
17628,primidone,vascular headaches,proteasome 20s subunit alpha 1
17629,cefalotin,headache disorder,cannabinoid receptor 1
17630,amcinonide,metastatic melanoma,phosphodiesterase 8b
17631,mitomycin c,sarcoma,selectin e
17632,phenylephrine,x-linked dominant hypophosphatemic rickets,cytochrome p450 family 2 subfamily c member 8
17633,ospemifene,thyroid gland carcinoma,tankyrase 2
17634,niraparib,tension-type headache,solute carrier family 46 member 1
17635,methylphenobarbital,hypotensive disorder,tubulin gamma 1
17636,benzocaine,drooling,discoidin domain receptor tyrosine kinase 2
17637,hydroxyzine,atrophic vulva,calcium voltage-gated channel auxiliary subunit beta 1
17638,pargyline,chronic primary adrenal insufficiency,cholinergic receptor muscarinic 1
17639,tadalafil,anxiety,myeloperoxidase
17640,isoxsuprine,lewy body dementia,gamma-aminobutyric acid type a receptor subunit theta
17641,tocilizumab,tendinopathy,tubulin beta 4b class ivb
17642,estramustine,irritable bowel syndrome,colony stimulating factor 1 receptor
17643,nefazodone,polycystic ovary syndrome,ribonucleotide reductase regulatory subunit m2
17644,fenofibrate,rhinitis,"glucosidase alpha, neutral c"
17645,riociguat,crohn disease,phosphodiesterase 6b
17646,suramin,congenital hypothyroidism,solute carrier family 5 member 6
17647,aliskiren,acute gonococcal cervicitis,dipeptidase 1
17648,alpha-methyltyrosine,insomnia,fms related receptor tyrosine kinase 1
17649,mesoridazine,liver cancer,leukotriene c4 synthase
17650,floxuridine,dermatophytosis of groin and perianal area,androgen receptor
17651,mesoridazine,allergic contact dermatitis,aldo-keto reductase family 1 member c3
17652,butorphanol,neurodermatitis,sirtuin 1
17653,betamethasone,chronic primary adrenal insufficiency,calcium voltage-gated channel subunit alpha1 f
17654,clemastine,raynaud disease,serpin family e member 1
17655,ephedrine,peptic ulcer disease,tumor necrosis factor
17656,tamibarotene,thromboembolism,glutathione s-transferase mu 1
17657,perospirone,peptic esophagitis,phospholipase a2 group iie
17658,chlorpropamide,myalgia,gc vitamin d binding protein
17659,nebivolol,rheumatoid arthritis,proteasome 20s subunit beta 1
17660,vildagliptin,urinary bladder neoplasm,3-hydroxy-3-methylglutaryl-coa reductase
17661,troglitazone,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",leukocyte receptor tyrosine kinase
17662,tretinoin,graves disease,phosphodiesterase 1a
17663,udenafil,hypertrophic cardiomyopathy,annexin a1
17664,perindopril,urethritis,gonadotropin releasing hormone receptor
17665,docetaxel,hypertrichosis of eyelid,coagulation factor ii thrombin receptor
17666,pemirolast,pernicious anemia,gamma-aminobutyric acid type b receptor subunit 2
17667,fluocinolone acetonide,brain glioblastoma,cytochrome p450 family 2 subfamily e member 1
17668,aspirin,toxic shock syndrome,cytochrome p450 family 2 subfamily r member 1
17669,maprotiline,arthralgia,high mobility group box 1
17670,thalidomide,laryngeal edema,cytidine deaminase
17671,thyrotropin alfa,eye disorder,cholinergic receptor nicotinic alpha 6 subunit
17672,selumetinib,drooling,integrin subunit alpha 2b
17673,trimetaphan,cutaneous candidiasis,prostaglandin e receptor 4
17674,alendronate,hyperglycemia,tubulin gamma 1
17675,cilazapril,pulmonary valve atresia,g protein-coupled receptor kinase 4
17676,diphenoxylate,hypocalcemia,cholinergic receptor nicotinic alpha 6 subunit
17677,furosemide,chronic eosinophilic leukemia,cytochrome p450 family 1 subfamily a member 1
17678,acetyldigitoxin,hereditary angioedema,fkbp prolyl isomerase 5
17679,opipramol,post-operative pain,melatonin receptor 1b
17680,lercanidipine,peripheral vascular disease,sodium voltage-gated channel alpha subunit 1
17681,rabeprazole,torsades de pointes,thromboxane a2 receptor
17682,sertindole,alzheimer disease,acetyl-coa acetyltransferase 1
17683,mebendazole,malignant essential hypertension,somatostatin receptor 3
17684,pge1,dementia,riboflavin kinase
17685,mesuximide,interstitial lung disease 2,txk tyrosine kinase
17686,floxuridine,arthropathy,solute carrier family 12 member 3
17687,candesartan,breast neoplasm,steroid 5 alpha-reductase 2
17688,nitroglycerin,secondary hyperparathyroidism,pre-mrna splicing tri-snrnp complex factor prpf4
17689,hydrochlorothiazide,autism spectrum disorder,estrogen receptor 1
17690,insulin degludec,eunuchism,dopamine receptor d1
17691,aliskiren,gaucher disease,fms related receptor tyrosine kinase 1
17692,solifenacin,atopic eczema,gamma-aminobutyric acid type a receptor subunit beta2
17693,capsaicin,thyroiditis,cytochrome p450 family 3 subfamily a member 4
17694,reserpine,ocular hypertension,somatostatin receptor 3
17695,umeclidinium,dyspnea,adrenoceptor beta 2
17696,carbidopa,uveitis,tachykinin precursor 1
17697,molindone,postoperative nausea and vomiting,eph receptor b2
17698,fluoxetine,erythema multiforme,glutamate ionotropic receptor ampa type subunit 1
17699,ibuprofen,musculoskeletal system disorder,solute carrier family 12 member 1
17700,pimecrolimus,duodenal ulcer,vascular cell adhesion molecule 1
17701,ciprofloxacin,cryopyrin-associated periodic syndrome,cyclin g associated kinase
17702,lidocaine,hiv infectious disease,carbonic anhydrase 14
17703,abiraterone acetate,acute monocytic leukemia,calcium voltage-gated channel subunit alpha1 f
17704,bunolol,phenylketonuria,gc vitamin d binding protein
17705,methdilazine,gonorrhea,bcl2 apoptosis regulator
17706,clidinium,acute gonococcal cervicitis,"yes proto-oncogene 1, src family tyrosine kinase"
17707,crizotinib,gynecomastia disorder,5-hydroxytryptamine receptor 7
17708,cinnarizine,plasmodium vivax malaria,dna polymerase beta
17709,pioglitazone,common cold,prune exopolyphosphatase 1
17710,oxaliplatin,pulmonary tuberculosis,"lck proto-oncogene, src family tyrosine kinase"
17711,fampridine,acute gonococcal cervicitis,tachykinin receptor 1
17712,hydrochlorothiazide,premature ejaculation,tubulin delta 1
17713,cabergoline,scabies,solute carrier family 5 member 2
17714,pranlukast,malignant glioma,synuclein alpha
17715,dasatinib,atopic conjunctivitis,sodium voltage-gated channel alpha subunit 7
17716,cefonicid,opiate dependence,eph receptor a1
17717,clofazimine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",alpha glucosidase
17718,trospium chloride,hepatocellular carcinoma,cholinergic receptor muscarinic 1
17719,pirbuterol,urinary retention,phosphodiesterase 4c
17720,propranolol,serum sickness,dna topoisomerase i mitochondrial
17721,carvedilol,allergic rhinitis,dead-box helicase 1
17722,ambenonium,torsades de pointes,calcium voltage-gated channel auxiliary subunit alpha2delta 1
17723,disulfiram,b-cell chronic lymphocytic leukemia,metallothionein 2a
17724,umeclidinium,acute monocytic leukemia,sphingosine-1-phosphate receptor 5
17725,bazedoxifene,dyspepsia,metabolism of cobalamin associated a
17726,venlafaxine,crohn disease,cathepsin g
17727,diphenoxylate,oral mucosa leukoplakia,aldehyde dehydrogenase 5 family member a1
17728,amprenavir,polymyalgia rheumatica,"major histocompatibility complex, class i, a"
17729,tranexamic acid,hypertrichosis of eyelid,toll like receptor 9
17730,olodaterol,relapsing-remitting multiple sclerosis,nuclear receptor subfamily 3 group c member 2
17731,pimecrolimus,cerebrovascular disorder,solute carrier family 5 member 2
17732,sertindole,skin disorder,monoamine oxidase a
17733,eflornithine,hypertriglyceridemia,thyroid hormone receptor alpha
17734,gemtuzumab ozogamicin,escherichia coli infection,axl receptor tyrosine kinase
17735,triazolam,arthropathy,dopamine receptor d2
17736,flumethasone pivalate,tourette syndrome,glycine receptor alpha 3
17737,cortisol,pseudotumor cerebri,neurotrophic receptor tyrosine kinase 2
17738,capecitabine,rhabdomyosarcoma,solute carrier organic anion transporter family member 4a1
17739,nedocromil,mycosis fungoides,"carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"
17740,lesinurad,autism spectrum disorder,vascular cell adhesion molecule 1
17741,cetuximab,"malignant hyperthermia, susceptibility to, 1",carbonic anhydrase 4
17742,minocycline,myocardial infarction,adrenoceptor alpha 1a
17743,flufenamic acid,thyroid gland follicular carcinoma,hydroxysteroid 11-beta dehydrogenase 1
17744,difenoxin,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,ribosomal protein s6 kinase a2
17745,umeclidinium,seborrheic dermatitis,dipeptidyl peptidase 9
17746,dasatinib,eunuchism,potassium voltage-gated channel modifier subfamily s member 1
17747,icotinib,bipolar depression,phosphodiesterase 1a
17748,ribavirin,castleman disease,cholinergic receptor nicotinic beta 3 subunit
17749,buclizine,breast carcinoma,atp binding cassette subfamily c member 3
17750,zalcitabine,classic phenylketonuria,adrenoceptor beta 2
17751,lofepramine,systemic lupus erythematosus,metallothionein 1a
17752,alogliptin,narcolepsy,dead-box helicase 3 x-linked
17753,zileuton,urge incontinence,protein phosphatase 3 catalytic subunit alpha
17754,gilteritinib,arthropathy,structural maintenance of chromosomes 2
17755,ospemifene,pulmonary fibrosis,arachidonate 5-lipoxygenase
17756,sulindac,sebaceous adenoma,albumin
17757,diphenidol,amyotrophic lateral sclerosis,"raf-1 proto-oncogene, serine/threonine kinase"
17758,rimexolone,heart failure,potassium voltage-gated channel modifier subfamily s member 3
17759,milnacipran,neoplasm of esophagus,carbonic anhydrase 12
17760,bepridil,"hyperlipidemia, familial combined, lpl related",phosphodiesterase 6d
17761,pemetrexed,epilepsy with generalized tonic-clonic seizures,glutathione s-transferase alpha 2
17762,milnacipran,chronic kidney disease,gamma-aminobutyric acid type a receptor subunit beta1
17763,labetalol,enterobiasis,atpase na+/k+ transporting subunit beta 3
17764,celecoxib,sitosterolemia,calcyon neuron specific vesicular protein
17765,ulobetasol propionate,hyperphenylalaninemia due to tetrahydrobiopterin deficiency,homeodomain interacting protein kinase 2
17766,dasatinib,urticaria,cytochrome p450 family 2 subfamily d member 6
17767,iloperidone,dyspnea,cholinergic receptor nicotinic alpha 5 subunit
17768,acitretin,kaposi's sarcoma,gonadotropin releasing hormone receptor
17769,calcium gluconate,chronic obstructive pulmonary disease,calmodulin 2
17770,fexofenadine,osteoarthritis,cholinergic receptor muscarinic 4
17771,oxymorphone,hypertriglyceridemia,gamma-aminobutyric acid type a receptor subunit delta
17772,mianserin,pain,potassium voltage-gated channel subfamily d member 1
17773,spironolactone,familial mediterranean fever,cobalamin binding intrinsic factor
17774,piroxicam,abdominal infection,sigma non-opioid intracellular receptor 1
17775,paroxetine,female infertility,nischarin
17776,cladribine,labor pain,eukaryotic translation initiation factor 4e
17777,dorzolamide,acute pain,maternal embryonic leucine zipper kinase
17778,acarbose,renal osteodystrophy,dual specificity tyrosine phosphorylation regulated kinase 2
17779,acitretin,embolism,steroid 5 alpha-reductase 1
17780,acalabrutinib,ornithine carbamoyltransferase deficiency,tumor protein p53
17781,mosapramine,osteomalacia,protein kinase c alpha
17782,chlorpropamide,pulmonary arterial hypertension,solute carrier organic anion transporter family member 2b1
17783,lamotrigine,erythropoietic protoporphyria,dna topoisomerase i
17784,flutamide,gestational trophoblastic neoplasm,"kras proto-oncogene, gtpase"
17785,carbenoxolone,"malignant hyperthermia, susceptibility to, 1","yes proto-oncogene 1, src family tyrosine kinase"
17786,gepirone,hypoparathyroidism,cytochrome p450 family 51 subfamily a member 1
17787,chlorhexidine,small intestine cancer,"mer proto-oncogene, tyrosine kinase"
17788,isoprenaline,endometritis,gamma-aminobutyric acid type a receptor subunit beta2
17789,carbenoxolone,vitamin d deficiency,glutathione-disulfide reductase
17790,capecitabine,postencephalitic parkinson disease,5-hydroxytryptamine receptor 3d
17791,avanafil,necrobiosis lipoidica,hypoxanthine phosphoribosyltransferase 1
17792,loxoprofen,depressive disorder,atp binding cassette subfamily c member 2
17793,romidepsin,cryptorchidism,platelet derived growth factor receptor alpha
17794,agomelatine,onchocerciasis,potassium voltage-gated channel subfamily h member 6
17795,methapyrilene,drooling,serine/threonine kinase 10
17796,camphor,iritis,phosphodiesterase 8a
17797,bitolterol,mature t-cell and nk-cell non-hodgkin lymphoma,apolipoprotein b
17798,triamterene,poems syndrome,tyrosine kinase non receptor 1
17799,clotrimazole,diarrheal disease,adrenoceptor alpha 1d
17800,mianserin,malignant hyperthermia of anesthesia,gamma-aminobutyric acid type a receptor subunit beta1
17801,pregabalin,pheochromocytoma,propionyl-coa carboxylase subunit alpha
17802,cyclizine,hyperbilirubinemia,low density lipoprotein receptor
17803,indomethacin,diffuse large b-cell lymphoma,prostaglandin e receptor 1
17804,nitric oxide,enterobiasis,integrin subunit alpha l
17805,selegiline,laryngeal edema,potassium voltage-gated channel modifier subfamily f member 1
17806,oprelvekin,erectile dysfunction,solute carrier family 22 member 5
17807,alpha-methyltyrosine,osteomalacia,leukotriene a4 hydrolase
17808,atenolol,hypertrichosis of eyelid,glucose-6-phosphate dehydrogenase
17809,nitric oxide,ulcerative colitis,prostaglandin e receptor 1
17810,ergocalciferol,familial mediterranean fever,atpase na+/k+ transporting subunit alpha 2
17811,clidinium,chronic bronchitis,septin 9
17812,colecalciferol,tinea pedis,potassium voltage-gated channel subfamily h member 7
17813,probenecid,ankylosing spondylitis,tubulin beta 4a class iva
17814,alprazolam,west syndrome,ebp like
17815,lorazepam,headache disorder,tubulin beta 4b class ivb
17816,pergolide,disseminated intravascular coagulation,tubulin delta 1
17817,antazoline,brain edema,tec protein tyrosine kinase
17818,cephalotaxine,diarrheal disease,tubulin beta 3 class iii
17819,belotecan,enterocolitis,toll like receptor 2
17820,rabeprazole,oral candidiasis,arginine vasopressin receptor 2
17821,pramipexole,sympathetic ophthalmia,fibroblast growth factor receptor 2
17822,omarigliptin,oral candidiasis,bmp2 inducible kinase
17823,losartan,proctitis,carbonic anhydrase 2
17824,lumiracoxib,thyroid tumor,iodothyronine deiodinase 1
17825,lasofoxifene,lennox-gastaut syndrome,inhibitor of nuclear factor kappa b kinase subunit beta
17826,timolol,chancroid,5-hydroxytryptamine receptor 1d
17827,procyclidine,chronic kidney disease,phosphodiesterase 4d
17828,lofepramine,hyperuricemia,gamma-aminobutyric acid type a receptor subunit theta
17829,medrysone,atopic eczema,neurotrophic receptor tyrosine kinase 3
17830,fluocinonide,localized scleroderma,g protein-coupled receptor kinase 2
17831,pranlukast,abdominal abscess,calcium voltage-gated channel subunit alpha1 b
17832,alpha-methyltyrosine,patent ductus arteriosus,sonic hedgehog signaling molecule
17833,dapagliflozin,malignant essential hypertension,toll like receptor 9
17834,lifitegrast,patent ductus arteriosus,gamma-aminobutyric acid type b receptor subunit 2
17835,nifedipine,intracranial embolism,inhibitor of nuclear factor kappa b kinase subunit beta
17836,ulobetasol propionate,peyronie disease,unc-51 like kinase 3
17837,pralidoxime,classic hodgkin lymphoma,galactosidase alpha
17838,migalastat,corneal ulcer,lipoprotein lipase
17839,clorazepate,erectile dysfunction,fibroblast growth factor receptor 2
17840,phenindamine,"dermatitis, atopic",low density lipoprotein receptor
17841,cetirizine,"familial amyloid neuropathy, portuguese type",arginine vasopressin receptor 1a
17842,chlorcyclizine,localized scleroderma,5-hydroxytryptamine receptor 3d
17843,parathyroid hormone,aorta coarctation,androgen receptor
17844,digoxin,hyperparathyroidism,cathepsin g
17845,loperamide,chronic obstructive pulmonary disease,cytochrome p450 family 2 subfamily c member 19
17846,difenoxin,seborrheic dermatitis,serpin family c member 1
17847,prucalopride,chronic myelomonocytic leukemia,tyrosinase
17848,baricitinib,pthirus pubis infestation,mitogen-activated protein kinase kinase kinase 2
17849,capecitabine,plasmodium malariae malaria,thyroid hormone receptor beta
17850,methixene,thromboangiitis obliterans,protein tyrosine kinase 2 beta
17851,bendroflumethiazide,dyschromatosis universalis hereditaria,potassium voltage-gated channel subfamily h member 4
17852,levomethadyl acetate,fibromyalgia,ret proto-oncogene
17853,bezafibrate,type 2 diabetes mellitus,sigma non-opioid intracellular receptor 1
17854,acetylmethadol,gynecomastia disorder,amine oxidase copper containing 1
17855,terazosin,postoperative nausea and vomiting,leukotriene b4 receptor
17856,gefitinib,endometrial carcinoma,5-hydroxytryptamine receptor 6
17857,perospirone,"attention deficit hyperactivity disorder, inattentive type",3-hydroxy-3-methylglutaryl-coa reductase
17858,pralatrexate,toothache,caspase 1
17859,eplerenone,trichuriasis,complement c5
17860,fluspirilene,bursitis,coagulation factor ii thrombin receptor
17861,empagliflozin,erdheim-chester disease,sulfotransferase family 1a member 1
17862,dextrothyroxine,thrombophilia due to thrombin defect,dipeptidase 1
17863,tocilizumab,tyrosinemia,dead-box helicase 1
17864,pexidartinib,neuroblastoma,24-dehydrocholesterol reductase
17865,meclizine,dysmenorrhea,"protein phosphatase 3 regulatory subunit b, alpha"
17866,triazolam,endometrium neoplasm,iodothyronine deiodinase 1
17867,olmutinib,visual epilepsy,solute carrier family 6 member 1
17868,anagrelide,persistent fetal circulation syndrome,melatonin receptor 1b
17869,loratadine,primary myelofibrosis,renin
17870,carbinoxamine,pulmonary valve atresia,thymidine phosphorylase
17871,prednisone,hyperaldosteronism,low density lipoprotein receptor
17872,sunitinib,epilepsy,cytochrome p450 family 27 subfamily b member 1
17873,tetrabenazine,stargardt disease,vascular cell adhesion molecule 1
17874,molindone,gastric neoplasm,histone deacetylase 9
17875,clonazepam,seasonal allergic rhinitis,tachykinin precursor 1
17876,gabapentin,brain edema,sodium voltage-gated channel alpha subunit 4
17877,lesinurad,chronic pain,"glucosidase alpha, neutral c"
17878,tetracosactide,toxic shock syndrome,potassium voltage-gated channel modifier subfamily v member 2
17879,trabectedin,pituitary dwarfism,sulfotransferase family 2a member 1
17880,cephalotaxine,pulmonary fibrosis,hyperpolarization activated cyclic nucleotide gated potassium channel 4
17881,beraprost,prinzmetal angina,dipeptidyl peptidase 9
17882,mebendazole,chronic hepatitis c virus infection,follicle stimulating hormone receptor
17883,capsaicin,streptococcal pneumonia,progesterone receptor
17884,repaglinide,follicular lymphoma,carbonic anhydrase 7
17885,tofacitinib,diffuse alopecia areata,cytochrome p450 family 27 subfamily a member 1
17886,benzbromarone,torsades de pointes,prostaglandin i2 receptor
17887,estrone,raynaud disease,cholinergic receptor nicotinic beta 4 subunit
17888,piretanide,attrv122i amyloidosis,phosphorylase kinase catalytic subunit gamma 2
17889,lixisenatide,meniere disease,monoamine oxidase b
17890,pethidine,adrenal gland hyperfunction,solute carrier family 22 member 5
17891,fsh,sitosterolemia,myosin light chain kinase 3
17892,flufenamic acid,anxiety,atpase h+/k+ transporting subunit beta
17893,glutethimide,opiate dependence,solute carrier family 18 member a2
17894,secobarbital,endemic goiter,phosphodiesterase 4c
17895,"1,25-dihydroxyvitamin d3",tinea pedis,potassium voltage-gated channel subfamily a member 3
17896,linaclotide,hypoglycemia,atpase na+/k+ transporting subunit beta 1
17897,naftopidil,respiratory syncytial virus infectious disease,calcium voltage-gated channel auxiliary subunit alpha2delta 1
17898,mizolastine,pneumonia,matrix metallopeptidase 9
17899,bitolterol,stevens-johnson syndrome,methylmalonyl-coa mutase
17900,pemetrexed,neoplasm of esophagus,bcr activator of rhogef and gtpase
17901,vismodegib,postherpetic neuralgia,phosphodiesterase 8b
17902,methyl salicylate,thyroid gland follicular carcinoma,tubulin beta 6 class v
17903,nisoldipine,tourette syndrome,dipeptidyl peptidase 8
17904,pasireotide,neonatal abstinence syndrome,fkbp prolyl isomerase 1b
17905,pirbuterol,acute myeloid leukemia,prostaglandin-endoperoxide synthase 2
17906,pheniramine,diamond-blackfan anemia,thromboxane a2 receptor
17907,pentoxifylline,osteoarthritis,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
17908,felodipine,peyronie disease,receptor interacting serine/threonine kinase 2
17909,loratadine,endometritis,histone deacetylase 8
17910,montelukast,neuralgia,unc-51 like autophagy activating kinase 2
17911,methimazole,bulimia nervosa,toll like receptor 4
17912,buspirone,pulmonary arterial hypertension,gamma-aminobutyric acid type a receptor subunit gamma2
17913,clidinium,strongyloidiasis,g protein-coupled receptor 35
17914,midazolam,dyspepsia,peroxisome proliferator activated receptor gamma
17915,erlotinib,headache,gamma-aminobutyric acid type a receptor subunit pi
17916,mirtazapine,proctitis,ebp like
17917,nebivolol,acute coronary syndrome,potassium voltage-gated channel subfamily a member 4
17918,progesterone,lennox-gastaut syndrome,matrix metallopeptidase 9
17919,theophylline,aggressive systemic mastocytosis,calcium voltage-gated channel subunit alpha1 f
17920,hydroxyurea,rosacea,doublecortin like kinase 1
17921,cabozantinib,poisoning of animals with phosphate salts,solute carrier family 22 member 6
17922,glycopyrrolate,liver cancer,phosphodiesterase 7a
17923,anisotropine methylbromide,prostate neoplasm,solute carrier family 22 member 5
17924,methdilazine,peripheral vascular disease,potassium inwardly rectifying channel subfamily j member 8
17925,ixazomib,vasomotor rhinitis,5-hydroxytryptamine receptor 7
17926,doxorubicin,small intestine cancer,protein kinase n1
17927,desloratadine,neoplasm of esophagus,parathyroid hormone 1 receptor
17928,digoxin,inflammatory bowel disease,insulin receptor
17929,gemcitabine,"hydatidiform mole, recurrent, 1",microtubule associated protein 1a
17930,dimenhydrinate,punctate epithelial keratoconjunctivitis,transient receptor potential cation channel subfamily v member 4
17931,levosimendan,myocardial infarction,potassium voltage-gated channel modifier subfamily v member 1
17932,clobetasol propionate,thyroiditis,hypoxanthine phosphoribosyltransferase 1
17933,rofecoxib,chronic bronchitis,neuropeptide y receptor y1
17934,floctafenine,thyroid gland follicular carcinoma,fatty acid binding protein 2
17935,agomelatine,kaposi's sarcoma,dopamine receptor d3
17936,ebastine,embolism,5-hydroxytryptamine receptor 1f
17937,omarigliptin,tachycardia,potassium voltage-gated channel subfamily b member 1
17938,rivastigmine,acute gonococcal cervicitis,hydroxysteroid 11-beta dehydrogenase 1
17939,empagliflozin,classic hodgkin lymphoma,checkpoint kinase 2
17940,silodosin,dyspnea,activin a receptor type 1
17941,fluvastatin,punctate epithelial keratoconjunctivitis,calcium voltage-gated channel subunit alpha1 i
17942,almitrine,pharyngitis,hyperpolarization activated cyclic nucleotide gated potassium channel 3
17943,dimethyl fumarate,atrophic vulva,ornithine transcarbamylase
17944,acetylcholine,trichuriasis,transmembrane protein 97
17945,cetirizine,thyroid gland papillary carcinoma,dual specificity tyrosine phosphorylation regulated kinase 2
17946,sibutramine,nicotine dependence,"dna polymerase alpha 1, catalytic subunit"
17947,lidocaine,head and neck cancer,aurora kinase b
17948,tenoxicam,anogenital human papillomavirus infection,propionyl-coa carboxylase subunit beta
17949,enalaprilat,localized scleroderma,myosin light chain kinase family member 4
17950,orlistat,torsades de pointes,tachykinin precursor 1
17951,masoprocol,rickets,death associated protein kinase 1
17952,dexamfetamine,chronic beryllium disease,traf2 and nck interacting kinase
17953,meclizine,post-operative pain,glutamate ionotropic receptor nmda type subunit 1
17954,ziprasidone,homocystinuria,tyrosine kinase non receptor 2
17955,aceclofenac,pthirus pubis infestation,carbonic anhydrase 1
17956,rasagiline,acute interstitial pneumonia,high mobility group box 1
17957,amcinonide,glioma,15-hydroxyprostaglandin dehydrogenase
17958,ambenonium,myxedema,proteasome 20s subunit beta 2
17959,phentermine,pituitary dwarfism,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"
17960,benzquinamide,neurodermatitis,phosphodiesterase 8a
17961,nitrazepam,acute myeloid leukemia,cysteinyl leukotriene receptor 2
17962,torsemide,parkinsonian disorder,glutathione s-transferase theta 1
17963,diphenoxylate,uterine corpus leiomyoma,atpase na+/k+ transporting subunit alpha 2
17964,dexamethasone,visual epilepsy,solute carrier family 25 member 5
17965,choline,prostate neoplasm,thyroid hormone receptor beta
17966,zalcitabine,labor pain,nuak family kinase 2
17967,haloperidol,vomiting,melanocortin 3 receptor
17968,tramadol,acute promyelocytic leukemia,s100 calcium binding protein p
17969,octreotide,thrombotic disease,bruton tyrosine kinase
17970,irinotecan,polyuria,caspase 1
17971,terguride,amyloidosis,potassium voltage-gated channel subfamily c member 2
17972,alclofenac,gastric neoplasm,bmp2 inducible kinase
17973,guanabenz,common cold,histamine receptor h2
17974,amcinonide,hypothyroidism,cytochrome p450 family 3 subfamily a member 7
17975,tranylcypromine,liposarcoma,fibroblast growth factor receptor 1
17976,mirodenafil,anxiety,phospholipase a2 group iie
17977,fluphenazine,impetigo,myristoylated alanine rich protein kinase c substrate
17978,orciprenaline,postoperative nausea and vomiting,glutamate ionotropic receptor kainate type subunit 2
17979,melatonin,ornithine carbamoyltransferase deficiency,il2 inducible t cell kinase
17980,carboplatin,angioedema,fkbp prolyl isomerase 5
17981,fingolimod,congestive heart failure,calcyon neuron specific vesicular protein
17982,bitolterol,myotonic syndrome,gamma-aminobutyric acid type a receptor subunit gamma2
17983,mometasone,propionic acidemia,phosphoribosyl pyrophosphate amidotransferase
17984,teniposide,dacryocystitis,"mpl proto-oncogene, thrombopoietin receptor"
17985,dyphylline,epilepsy with generalized tonic-clonic seizures,kinase insert domain receptor
17986,chlordiazepoxide,erythema multiforme,tubulin beta class i
17987,enzalutamide,gonorrhea,dead-box helicase 3 x-linked
17988,trilostane,labor pain,potassium voltage-gated channel subfamily a member 3
17989,hydroflumethiazide,allergic urticaria,somatostatin receptor 5
17990,isradipine,liposarcoma,homeodomain interacting protein kinase 4
17991,loxapine,meniere disease,estrogen related receptor beta
17992,fenoprofen,headache,phosphoribosyl pyrophosphate amidotransferase
17993,mirodenafil,meningococcal meningitis,macrophage migration inhibitory factor
17994,carvedilol,hereditary angioedema,atpase na+/k+ transporting subunit alpha 1
17995,lorazepam,malignant colon neoplasm,cytochrome p450 family 24 subfamily a member 1
17996,vinpocetine,islet cell adenomatosis,calcium voltage-gated channel subunit alpha1 g
17997,ephedrine,nausea,serine/threonine kinase 25
17998,clotrimazole,embolism,atpase na+/k+ transporting subunit beta 3
17999,pentoxifylline,asthma-chronic obstructive pulmonary disease overlap syndrome,toll like receptor 2
18000,flurazepam,esotropia,calcium voltage-gated channel auxiliary subunit alpha2delta 1
18001,umeclidinium,b-cell chronic lymphocytic leukemia,atpase copper transporting alpha
18002,trifluridine,rhinitis,ryanodine receptor 1
18003,cyclosporin a,dermatitis,solute carrier family 6 member 1
18004,nevirapine,skin basal cell carcinoma,microtubule associated protein 2
18005,captopril,hypothyroidism,kinase insert domain receptor
18006,lorcaserin,tricuspid atresia,potassium voltage-gated channel subfamily c member 1
18007,pinacidil,narcolepsy,dipeptidyl peptidase 8
18008,medrysone,marginal zone lymphoma,gamma-aminobutyric acid type a receptor subunit delta
18009,meclofenamic acid,endometrium neoplasm,gamma-aminobutyric acid type a receptor subunit gamma3
18010,chlophedianol,localized scleroderma,phosphodiesterase 6a
18011,carvedilol,narcolepsy,proteasome 20s subunit beta 8
18012,butenafine,malignant colon neoplasm,ribosomal protein s6 kinase a2
18013,benzphetamine,chronic schizophrenia,insulin receptor
18014,ketorolac,brain glioblastoma,"hck proto-oncogene, src family tyrosine kinase"
18015,ibuprofen,asthma,angiotensin ii receptor type 1
18016,eplerenone,thromboembolism,aldehyde dehydrogenase 5 family member a1
18017,sufentanil,arteriosclerosis disorder,potassium voltage-gated channel subfamily a member 5
18018,ezetimibe,bronchitis,g protein-coupled receptor 35
18019,desonide,pulmonary fibrosis,melanocortin 2 receptor
18020,doxorubicin,rheumatoid arthritis,doublecortin like kinase 3
18021,crizotinib,obsessive-compulsive disorder,solute carrier family 22 member 6
18022,nifedipine,neurofibromatosis 1,cytochrome p450 family 2 subfamily a member 6
18023,protriptyline,leiomyosarcoma,calcium/calmodulin dependent protein kinase ii alpha
18024,hydrochlorothiazide,thromboembolism,vascular endothelial growth factor a
18025,pinacidil,langerhans cell histiocytosis,sodium voltage-gated channel alpha subunit 11
18026,bilastine,raynaud disease,traf2 and nck interacting kinase
18027,bortezomib,"leukemia, myeloid, chronic-phase",glutathione s-transferase mu 1
18028,imrecoxib,hypertriglyceridemia,cyclin dependent kinase 8
18029,dimethyl fumarate,gastric neoplasm,tubulin beta 1 class vi
18030,alimemazine,hepatocellular carcinoma,glucagon like peptide 2 receptor
18031,alclofenac,familial mediterranean fever,cytochrome p450 family 2 subfamily j member 2
18032,glucagon,back pain,atp binding cassette subfamily c member 2
18033,paracetamol,human african trypanosomiasis,cyclin g associated kinase
18034,secobarbital,tenosynovitis,potassium voltage-gated channel subfamily c member 3
18035,tranylcypromine,erythropoietic protoporphyria,"pim-2 proto-oncogene, serine/threonine kinase"
18036,guanabenz,systemic lupus erythematosus,adenosine a2b receptor
18037,thiothixene,urticaria,cholinergic receptor muscarinic 3
18038,apremilast,eosinophilic esophagitis,glutamate ionotropic receptor nmda type subunit 3b
18039,isradipine,rosacea,nuclear receptor subfamily 0 group b member 1
18040,cimetidine,iritis,5-hydroxytryptamine receptor 1e
18041,chlordiazepoxide,attrv122i amyloidosis,gamma-aminobutyric acid type a receptor subunit alpha5
18042,duloxetine,common cold,cholinergic receptor nicotinic alpha 4 subunit
18043,hydroxyurea,lung disorder,prune exopolyphosphatase 1
18044,galantamine,glioma,gamma-aminobutyric acid type a receptor subunit theta
18045,trichlormethiazide,hemangioma,gamma-aminobutyric acid type b receptor subunit 2
18046,ivermectin,synovitis,superoxide dismutase 1
18047,aminoglutethimide,synovitis,atpase na+/k+ transporting subunit beta 2
18048,mercaptopurine,chronic bronchitis,tyrosine kinase 2
18049,ethotoin,scabies,kinase insert domain receptor
18050,chlorpheniramine,intermittent vascular claudication,fatty acid binding protein 2
18051,tazarotene,small cell lung carcinoma,histone deacetylase 5
18052,azilsartan medoxomil,scalp dermatosis,sex hormone binding globulin
18053,hydroxocobalamin,osteoporosis,sodium voltage-gated channel alpha subunit 10
18054,trimetaphan,persistent fetal circulation syndrome,catechol-o-methyltransferase
18055,metoprolol,major depressive disorder,angiotensin converting enzyme 2
18056,colestipol,peripheral vascular disease,cytochrome p450 family 1 subfamily b member 1
18057,buprenorphine,x-linked dominant hypophosphatemic rickets,phosphodiesterase 6d
18058,desogestrel,premenstrual dysphoric disorder,histone deacetylase 10
18059,dexamfetamine,ascites,glutamate ionotropic receptor ampa type subunit 4
18060,molindone,wilms tumor,phosphodiesterase 6d
18061,metipranolol,allergic rhinitis,somatostatin receptor 2
18062,parathyroid hormone,chronic myelomonocytic leukemia,adenosine a2a receptor
18063,amiloride,urinary bladder cancer,neuropeptide y
18064,ergometrine,hemorrhagic disease of newborn,myosin heavy chain 10
18065,methoxamine,thyroid crisis,5-hydroxytryptamine receptor 3d
18066,toloxatone,mydriasis,cytochrome p450 oxidoreductase
18067,carbinoxamine,breast cancer,atpase h+/k+ transporting subunit beta
18068,lovastatin,pneumonia,phospholipase a2 group ib
18069,tolmetin,endometritis,estrogen related receptor alpha
18070,norgestimate,pellagra,"fes proto-oncogene, tyrosine kinase"
18071,diclofenamide,systemic mastocytosis,sigma non-opioid intracellular receptor 1
18072,nadolol,pulmonary valve atresia,solute carrier family 12 member 1
18073,methylphenobarbital,prostate neoplasm,high mobility group box 1
18074,carvedilol,opiate dependence,peptidylprolyl isomerase a
18075,saquinavir,short bowel syndrome,solute carrier family 5 member 11
18076,estramustine,tenosynovial giant cell tumor,solute carrier family 18 member a1
18077,somatrem,ascariasis,phosphodiesterase 8a
18078,cetirizine,bacterial meningitis,calmodulin 1
18079,hydromorphone,relapsing-remitting multiple sclerosis,sodium voltage-gated channel alpha subunit 3
18080,pimozide,basal ganglia disorder,neutrophil cytosolic factor 1
18081,salicylic acid,leprosy,calcium voltage-gated channel subunit alpha1 g
18082,lixisenatide,eunuchism,npc1 like intracellular cholesterol transporter 1
18083,tocilizumab,relapsing-remitting multiple sclerosis,atp binding cassette subfamily b member 11
18084,aceclofenac,thromboembolism,gamma-glutamyl carboxylase
18085,dofetilide,metastatic melanoma,dopamine beta-hydroxylase
18086,rosuvastatin,hypoglycemia,atpase na+/k+ transporting subunit alpha 4
18087,ribavirin,prader-willi syndrome,cytochrome c1
18088,lamotrigine,duodenal ulcer,solute carrier family 22 member 12
18089,linaclotide,testicular cancer,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"
18090,phytomenadione,allergic urticaria,cytochrome p450 family 2 subfamily c member 19
18091,ergotamine,prinzmetal angina,solute carrier family 12 member 2
18092,spirapril,chronic pain,neurotrophic receptor tyrosine kinase 2
18093,pyridostigmine,zollinger-ellison syndrome,atp binding cassette subfamily b member 11
18094,sildenafil,blepharoconjunctivitis,neutrophil cytosolic factor 1
18095,dibucaine,xerophthalmia,"glucosidase alpha, neutral c"
18096,acamprosate,aggressive systemic mastocytosis,testis specific serine kinase 1b
18097,pirfenidone,waldenstrom macroglobulinemia,sphingomyelin phosphodiesterase 1
18098,nefazodone,embolism,tubulin alpha 4a
18099,sibutramine,psychosexual disorder,aurora kinase c
18100,insulin glulisine,arteriosclerosis disorder,phosphodiesterase 2a
18101,fenofibrate,dermatophytosis of groin and perianal area,gamma-aminobutyric acid type a receptor subunit alpha5
18102,meloxicam,prader-willi syndrome,tyrosinase
18103,triamterene,gaucher disease,kallikrein b1
18104,codeine,oral mucosa leukoplakia,thymidine phosphorylase
18105,balsalazide,malignant colon neoplasm,potassium voltage-gated channel modifier subfamily s member 2
18106,pranlukast,renal osteodystrophy,5-hydroxytryptamine receptor 6
18107,vilanterol,acute intermittent porphyria,sodium voltage-gated channel alpha subunit 7
18108,propantheline,manic bipolar affective disorder,transient receptor potential cation channel subfamily m member 8
18109,cilazapril,periodontitis,calcium sensing receptor
18110,acetylmethadol,colonic neoplasm,sodium voltage-gated channel alpha subunit 4
18111,bretylium,humoral hypercalcemia of malignancy,phosphodiesterase 1c
18112,ranitidine,blepharoconjunctivitis,phosphodiesterase 6a
18113,acalabrutinib,thyroid gland carcinoma,discoidin domain receptor tyrosine kinase 1
18114,brinzolamide,west syndrome,tubulin beta 6 class v
18115,zoledronic acid,lung lymphangioleiomyomatosis,mitogen-activated protein kinase kinase kinase 9
18116,bunolol,malignant glioma,potassium voltage-gated channel subfamily d member 1
18117,estrone,hyperaldosteronism,c-c motif chemokine receptor 1
18118,phenylephrine,anterior uveitis,"kit proto-oncogene, receptor tyrosine kinase"
18119,methdilazine,thrombotic disease,amnion associated transmembrane protein
18120,emtricitabine,thyroid gland papillary carcinoma,thyroid peroxidase
18121,riluzole,status epilepticus,atpase na+/k+ transporting subunit beta 2
18122,phenmetrazine,anterior uveitis,c-x-c motif chemokine ligand 8
18123,diflunisal,atrophic vulva,gamma-aminobutyric acid type b receptor subunit 2
18124,teriflunomide,leprosy,calcium voltage-gated channel subunit alpha1 d
18125,clomiphene,raynaud disease,ribosomal protein s6 kinase a6
18126,clobetasol propionate,bacterial conjunctivitis,il2 inducible t cell kinase
18127,toloxatone,thrombotic disease,glutamate ionotropic receptor kainate type subunit 2
18128,lamotrigine,otitis externa,cytidine/uridine monophosphate kinase 1
18129,pregabalin,delirium,inhibitor of nuclear factor kappa b kinase subunit beta
18130,tramazoline,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",maltase-glucoamylase
18131,clorazepate,necrobiosis lipoidica,protein tyrosine kinase 2
18132,levobetaxolol,phenylketonuria,s100 calcium binding protein b
18133,mestranol,gestational trophoblastic neoplasm,dipeptidyl peptidase 4
18134,ethacrynic acid,atrioventricular block,dihydrofolate reductase
18135,pergolide,motion sickness,5-hydroxytryptamine receptor 1b
18136,lurasidone,premenstrual dysphoric disorder,gamma-aminobutyric acid type a receptor subunit epsilon
18137,baricitinib,keratitis,guanylate cyclase 2c
18138,icosapent,hypercholesterolemia,propionyl-coa carboxylase subunit beta
18139,azelnidipine,multiple endocrine neoplasia,potassium voltage-gated channel subfamily h member 3
18140,tadalafil,orthostatic hypotension,holocarboxylase synthetase
18141,cytarabine,serum sickness,phosphodiesterase 6a
18142,mestranol,neurofibromatosis 1,cholinergic receptor nicotinic beta 3 subunit
18143,estradiol valerate,chronic schizophrenia,somatostatin receptor 1
18144,benzphetamine,keloid,histone deacetylase 3
18145,dapsone,anterior uveitis,hydroxycarboxylic acid receptor 3
18146,olmutinib,subarachnoid hemorrhage,calcium voltage-gated channel subunit alpha1 c
18147,topotecan,rheumatoid arthritis,delta like non-canonical notch ligand 1
18148,ketamine,pulmonary tuberculosis,cholinergic receptor nicotinic alpha 5 subunit
18149,agomelatine,dry eye syndrome,tubulin beta class i
18150,lurasidone,postmenopausal osteoporosis,phospholipase a2 group ib
18151,promazine,osteoporosis,potassium voltage-gated channel subfamily h member 2
18152,gefitinib,myocardial infarction,4-hydroxyphenylpyruvate dioxygenase
18153,tramazoline,langerhans cell histiocytosis,discoidin domain receptor tyrosine kinase 2
18154,fingolimod,hyperprolactinemia,structural maintenance of chromosomes 2
18155,desmopressin,polycystic ovary syndrome,annexin a1
18156,atomoxetine,choroiditis,acyl-coa synthetase long chain family member 5
18157,naloxone,raynaud disease,receptor interacting serine/threonine kinase 3
18158,verapamil,gastric ulcer,gamma-aminobutyric acid type a receptor subunit gamma2
18159,epinastine,leprosy,neurotrophic receptor tyrosine kinase 1
18160,gefitinib,hypocalcemia,toll like receptor 2
18161,alpha-methyltyrosine,congenital adrenal hyperplasia,histamine receptor h3
18162,aliskiren,vascular disorder,coagulation factor ii thrombin receptor
18163,lusutrombopag,cutaneous candidiasis,24-dehydrocholesterol reductase
18164,l-citrulline,actinic keratosis,cytochrome p450 family 2 subfamily a member 6
18165,dexfenfluramine,secondary hyperparathyroidism,calmodulin 1
18166,gliquidone,postoperative nausea and vomiting,cytochrome p450 family 1 subfamily a member 2
18167,bunolol,superficial multifocal basal cell carcinoma,tubulin epsilon 1
18168,teniposide,hypoactive sexual desire disorder,atpase na+/k+ transporting subunit beta 3
18169,nevirapine,hypothyroidism,dna topoisomerase ii alpha
18170,ifosfamide,thromboembolism,bone morphogenetic protein receptor type 1b
18171,prednisolone,hepatic veno-occlusive disease,phosphodiesterase 3b
18172,miconazole,glaucoma,gamma-aminobutyric acid type a receptor subunit alpha6
18173,trichlormethiazide,x-linked dominant hypophosphatemic rickets,5-hydroxytryptamine receptor 7
18174,gemfibrozil,anxiety disorder,phosphodiesterase 1b
18175,desvenlafaxine,acidosis disorder,"ran, member ras oncogene family"
18176,metaraminol,enterocolitis,cholinergic receptor muscarinic 1
18177,lesinurad,insomnia,neurotrophic receptor tyrosine kinase 2
18178,triprolidine,superficial multifocal basal cell carcinoma,potassium calcium-activated channel subfamily n member 4
18179,iloperidone,hypotensive disorder,solute carrier family 22 member 6
18180,telmisartan,neonatal diabetes mellitus,gamma-aminobutyric acid type a receptor subunit beta3
18181,bilastine,homocystinuria,tubulin delta 1
18182,sertindole,metastatic melanoma,toll like receptor 9
18183,lornoxicam,pulmonary eosinophilia,sodium voltage-gated channel alpha subunit 7
18184,buprenorphine,short bowel syndrome,tubulin alpha 4a
18185,brigatinib,hypoglycemia,"met proto-oncogene, receptor tyrosine kinase"
18186,thiopental,adrenocortical insufficiency,cyclin dependent kinase 16
18187,niraparib,urge incontinence,kinase insert domain receptor
18188,vernakalant,classic phenylketonuria,"peptidylprolyl cis/trans isomerase, nima-interacting 1"
18189,rasagiline,pancreatic adenocarcinoma,axl receptor tyrosine kinase
18190,sivelestat,hypothyroidism,trace amine associated receptor 1
18191,pyrimethamine,amyloidosis,s100 calcium binding protein p
18192,cladribine,generalized anxiety disorder,follicle stimulating hormone receptor
18193,tolazamide,strongyloidiasis,angiotensin converting enzyme 2
18194,labetalol,type 1 diabetes mellitus,cytidine/uridine monophosphate kinase 1
18195,ipragliflozin,nicotine dependence,maternal embryonic leucine zipper kinase
18196,pinacidil,goiter,cytochrome p450 oxidoreductase
18197,frovatriptan,rosacea,epoxide hydrolase 2
18198,icatibant,"hyperlipidemia, familial combined, lpl related",5-hydroxytryptamine receptor 3a
18199,belotecan,actinic keratosis,cytochrome p450 family 51 subfamily a member 1
18200,mitomycin c,chronic obstructive pulmonary disease,5-hydroxytryptamine receptor 2b
18201,trospium chloride,"familial amyloid neuropathy, portuguese type",glutamate ionotropic receptor nmda type subunit 2b
18202,levofloxacin,postherpetic neuralgia,thyroid hormone receptor beta
18203,vinpocetine,essential hypertension,5-methyltetrahydrofolate-homocysteine methyltransferase
18204,luseogliflozin,peripheral vascular disease,calcium voltage-gated channel auxiliary subunit alpha2delta 1
18205,bunazosin,hypoalphalipoproteinemia,glutamate ionotropic receptor nmda type subunit 2b
18206,ranitidine,angle-closure glaucoma,cdc like kinase 2
18207,triamterene,b-cell chronic lymphocytic leukemia,dopamine beta-hydroxylase
18208,ofatumumab,endometritis,tubulin beta 1 class vi
18209,tafluprost,hereditary von willebrand disease,unc-51 like autophagy activating kinase 2
18210,phenytoin,neurodermatitis,potassium voltage-gated channel subfamily h member 5
18211,icosapent,cryptorchidism,microtubule affinity regulating kinase 3
18212,5-fluorouracil,interstitial lung disease,doublecortin like kinase 1
18213,apomorphine,asthma-chronic obstructive pulmonary disease overlap syndrome,5-hydroxytryptamine receptor 5a
18214,perphenazine,skin basal cell carcinoma,protein tyrosine kinase 2
18215,parathyroid hormone,idiopathic acute eosinophilic pneumonia,phosphodiesterase 7b
18216,benzocaine,gonorrhea,peroxisome proliferator activated receptor delta
18217,carbenoxolone,oppositional defiant disorder,dual specificity tyrosine phosphorylation regulated kinase 2
18218,quizartinib,ulcerative colitis,delta like non-canonical notch ligand 1
18219,nisoldipine,atrial fibrillation,arginine vasopressin receptor 1b
18220,naftopidil,lymphangioma,myosin light chain kinase family member 4
18221,benzbromarone,dermatitis herpetiformis,potassium voltage-gated channel subfamily a member 2
18222,caffeine,influenza,sodium voltage-gated channel alpha subunit 9
18223,lurasidone,allergic contact dermatitis,mitogen-activated protein kinase 14
18224,metolazone,uterine corpus leiomyoma,serine/threonine kinase 33
18225,isopropamide,pellagra,carbonic anhydrase 12
18226,zileuton,wilms tumor,"dna polymerase epsilon, catalytic subunit"
18227,furosemide,escherichia coli infection,cytidine deaminase
18228,cephalotaxine,"blast phase chronic myelogenous leukemia, bcr-abl1 positive",histamine receptor h3
18229,lamivudine,lennox-gastaut syndrome,"troponin c1, slow skeletal and cardiac type"
18230,reserpine,esotropia,calmodulin 2
18231,dimethyl fumarate,hypocalcemia,5-hydroxytryptamine receptor 3a
18232,sertraline,goiter,"raf-1 proto-oncogene, serine/threonine kinase"
18233,cefmetazole,castleman disease,janus kinase 1
18234,betaxolol,ascariasis,neuropeptide y receptor y1
18235,alfuzosin,localized scleroderma,colony stimulating factor 1 receptor
18236,benzbromarone,ovarian epithelial tumor,protein phosphatase 3 catalytic subunit alpha
18237,acarbose,trigeminal neuralgia,carbonic anhydrase 1
18238,fluvastatin,endometriosis,melanocortin 3 receptor
18239,amoxapine,amyloidosis,carbonic anhydrase 13
18240,alclometasone dipropionate,multiple sclerosis,phospholipase a2 group ib
18241,quinine,homocystinuria,somatostatin receptor 4
18242,fluoxetine,polyuria,srsf protein kinase 3
18243,phentolamine,bacterial conjunctivitis,calcium voltage-gated channel subunit alpha1 d
18244,metformin,female stress incontinence,gonadotropin releasing hormone receptor
18245,gefitinib,alopecia,nuclear receptor subfamily 0 group b member 1
18246,acalabrutinib,respiratory failure,glutamate ionotropic receptor ampa type subunit 2
18247,isosorbide dinitrate,malignant colon neoplasm,platelet derived growth factor receptor alpha
18248,alcaftadine,bursitis,amylase alpha 1a
18249,lafutidine,cycloplegia,dihydropyrimidine dehydrogenase
18250,ephedrine,ventricular fibrillation,sphingosine-1-phosphate receptor 4
18251,vinblastine,allergic asthma,5-hydroxytryptamine receptor 2b
18252,rimexolone,gout,microtubule affinity regulating kinase 3
18253,mupirocin,breast neoplasm,microtubule affinity regulating kinase 3
18254,chlorpropamide,amyloidosis,solute carrier family 12 member 2
18255,ofatumumab,endometrium neoplasm,membrane spanning 4-domains a1
18256,carbetocin,chronic hepatitis c virus infection,atpase h+ transporting v1 subunit a
18257,clidinium,ovarian cancer,npc1 like intracellular cholesterol transporter 1
18258,mesalazine,superficial multifocal basal cell carcinoma,adrenoceptor alpha 1b
18259,irinotecan,pellagra,arginine vasopressin receptor 1b
18260,lamivudine,essential hypertension,calcyon neuron specific vesicular protein
18261,bosentan,hyperparathyroidism,7-dehydrocholesterol reductase
18262,ebastine,interstitial lung disease,unc-51 like kinase 3
18263,polmacoxib,chronic myelomonocytic leukemia,integrin subunit alpha 2b
18264,lamivudine,vomiting,bcr activator of rhogef and gtpase
18265,carmofur,back pain,nuclear receptor subfamily 5 group a member 1
18266,isoprenaline,acquired thrombocytopenia,transforming growth factor beta receptor 2
18267,iloperidone,lung disorder,dna primase subunit 2
18268,dapagliflozin,aspiration pneumonitis,insulin receptor related receptor
18269,zileuton,heart failure,calreticulin
18270,primidone,klinefelter syndrome,fkbp prolyl isomerase 5
18271,chlordiazepoxide,dermatitis herpetiformis,gonadotropin releasing hormone receptor
18272,befunolol,pernicious anemia,potassium voltage-gated channel subfamily d member 3
18273,acenocoumarol,myeloproliferative neoplasm,calmodulin 2
18274,chlophedianol,hypotensive disorder,cytochrome p450 family 2 subfamily a member 6
18275,vasopressin,acute myeloid leukemia,serpin family c member 1
18276,methylprednisolone,localized scleroderma,ebp cholestenol delta-isomerase
18277,plerixafor,psychotic disorder,thymidylate synthetase
18278,riluzole,rickets,"troponin c1, slow skeletal and cardiac type"
18279,tetracosactide,orthostatic hypotension,cholinergic receptor nicotinic alpha 3 subunit
18280,n-methyl scopolamine,generalized anxiety disorder,5-methyltetrahydrofolate-homocysteine methyltransferase
18281,oxprenolol,postmenopausal atrophic vaginitis,cholinergic receptor nicotinic alpha 6 subunit
18282,nintedanib,nephrotic syndrome,potassium voltage-gated channel modifier subfamily g member 3
18283,ebastine,heart failure,atpase h+/k+ transporting subunit alpha
18284,triamcinolone,rheumatic heart disease,calcium voltage-gated channel auxiliary subunit beta 2
18285,galantamine,respiratory failure,atm serine/threonine kinase
18286,phentermine,alcohol abuse,pancreatic lipase
18287,vismodegib,cryptorchidism,proteasome 20s subunit beta 1
18288,dextrothyroxine,nicotine dependence,glutamate ionotropic receptor kainate type subunit 4
18289,methyltestosterone,neonatal diabetes mellitus,npc1 like intracellular cholesterol transporter 1
18290,bilastine,anaphylaxis,histone deacetylase 6
18291,budesonide,chronic beryllium disease,axl receptor tyrosine kinase
18292,methimazole,"chronic myelogenous leukemia, bcr-abl1 positive",prostaglandin d2 receptor 2
18293,efavirenz,bronchiectasis,neurotrophic receptor tyrosine kinase 2
18294,carvedilol,premenstrual dysphoric disorder,steroid 5 alpha-reductase 2
18295,lovastatin,iritis,inositol monophosphatase 1
18296,pindolol,thyroid tumor,polo like kinase 4
18297,thalidomide,hyperprolactinemia,interleukin 1 receptor type 1
18298,bromfenac,renal cell carcinoma,cytochrome p450 family 2 subfamily a member 6
18299,flibanserin,acute coronary syndrome,amnion associated transmembrane protein
18300,droxidopa,hypertrichosis of eyelid,metabolism of cobalamin associated c
